<SEC-DOCUMENT>0001628280-17-004975.txt : 20170505
<SEC-HEADER>0001628280-17-004975.hdr.sgml : 20170505
<ACCEPTANCE-DATETIME>20170504173656
ACCESSION NUMBER:		0001628280-17-004975
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		68
CONFORMED PERIOD OF REPORT:	20170331
FILED AS OF DATE:		20170505
DATE AS OF CHANGE:		20170504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CROSS COUNTRY HEALTHCARE INC
		CENTRAL INDEX KEY:			0001141103
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HELP SUPPLY SERVICES [7363]
		IRS NUMBER:				134066229
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-33169
		FILM NUMBER:		17815414

	BUSINESS ADDRESS:	
		STREET 1:		5201 CONGRESS AVENUE
		STREET 2:		SUITE 100B
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487
		BUSINESS PHONE:		8003472264

	MAIL ADDRESS:	
		STREET 1:		5201 CONGRESS AVENUE
		STREET 2:		SUITE 100B
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROSS COUNTRY INC
		DATE OF NAME CHANGE:	20010521
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ccrn20170331-10q.htm
<DESCRIPTION>10-Q
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sFB9481B4A8C2D79CDAA7FC5D3CA0DCBD"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, DC 20549</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">FORM 10-Q</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;font-weight:bold;">&#254;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;Quarterly Report Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Quarterly Period Ended </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Or</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;font-weight:bold;">o</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;Transition Report Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Transition Period From</font><font style="font-family:inherit;font-size:10pt;">&#32;_________ </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">to</font><font style="font-family:inherit;font-size:10pt;">&#32;_________</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><img src="cchlogoq314a06.jpg" alt="cchlogoq314a06.jpg" style="height:88px;width:249px;"></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">0-33169</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13-4066229</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(State or other jurisdiction of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Incorporation or organization)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Commission</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">file number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(I.R.S. Employer</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Identification Number)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5201 Congress Avenue, Suite 100B</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Boca Raton, Florida 33487</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Address of principal executive offices)(Zip Code)</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(561) 998-2232</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Registrant&#8217;s telephone number, including area code)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Not Applicable</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Former name, former address and former fiscal year, if changed since last report)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;Yes&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font><font style="font-family:inherit;font-size:10pt;">&#32;No&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit and post such files).&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font><font style="font-family:inherit;font-size:10pt;">&#160;Yes </font><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;No</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of &#8220;accelerated filer and large accelerated filer&#8221; in Rule&#160;12b-2 of the Exchange Act:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Large&#160;accelerated filer&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#32;Accelerated&#160;filer&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-accelerated&#160;filer&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;(Do not check if a smaller reporting company) Smaller Reporting Company&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by checkmark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#32;No&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant had outstanding </font><font style="font-family:inherit;font-size:10pt;">36,433,655</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock, par value $0.0001 per share, as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><hr style="page-break-after:always"><div><a name="s92D5419E87AB51D0E25DFC5D4D7CF814"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to historical information, this Form&#160;10-Q contains statements relating to our future results (including certain projections and business trends) that are &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and are subject to the &#8220;safe harbor&#8221; created by those sections. Forward-looking statements consist of statements that are predictive in nature, depend upon or refer to future events. Words such as &#8220;expects&#8221;, &#8220;anticipates&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;believes&#8221;, &#8220;estimates&#8221;, &#8220;suggests&#8221;, "appears", &#8220;seeks&#8221;, &#8220;will&#8221;, and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include, but are not limited to, the following: our ability to attract and retain qualified nurses, physicians and other healthcare personnel, costs and availability of short-term housing for our travel healthcare professionals, demand for the healthcare services we provide, both nationally and in the regions in which we operate, the functioning of our information systems, the effect of cyber security risks and cyber incidents on our business, the effect of existing or future government regulation and federal and state legislative and enforcement initiatives on our business, our clients&#8217; ability to pay us for our services, our ability to successfully implement our acquisition and development strategies, including our ability to successfully integrate acquired businesses and realize synergies from such acquisitions, the effect of liabilities and other claims asserted against us, the effect of competition in the markets we serve, our ability to successfully defend the Company, its subsidiaries, and its officers and directors on the merits of any lawsuit or determine its potential liability, if any, and other factors set forth in Item 1.A. &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2016, as filed and updated in our Quarterly Reports on Form&#160;10-Q and other filings with the Securities and Exchange Commission.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management&#8217;s opinions only as of the date of this filing. There can be no assurance that (i)&#160;we have correctly measured or identified all of the factors affecting our business or the extent of these factors&#8217; likely impact, (ii)&#160;the available information with respect to these factors on which such analysis is based is complete or accurate, (iii)&#160;such analysis is correct or (iv)&#160;our strategy, which is based in part on this analysis, will be successful. The Company undertakes no obligation to update or revise forward-looking statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All references to "the Company", &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, or &#8220;Cross Country&#8221; in this Quarterly Report on Form&#160;10-Q mean Cross Country Healthcare, Inc., and its consolidated subsidiaries.</font></div><div><br></div><hr style="page-break-after:always"><div><a name="s11B062F39FFCF92CC242FC5D4D9C90F0"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INDEX</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FORM 10-Q</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MARCH 31, 2017</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:85%;"></td><td style="width:7%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PAGE</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sCFF1539A2971745E36EFFC5D4DCEC056"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">PART I. &#8211; FINANCIAL INFORMATION</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sCFF1539A2971745E36EFFC5D4DCEC056">1</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s18565A426C402333CF55FC5D4DF1D691"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Item 1.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s18565A426C402333CF55FC5D4DF1D691"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Condensed Consolidated Financial Statements</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s18565A426C402333CF55FC5D4DF1D691">1</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s2FE9C613C1147FE8970AFC5D3CA85D1B"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Condensed Consolidated Balance Sheets (Unaudited)</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s2FE9C613C1147FE8970AFC5D3CA85D1B">1</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sC04B40858FAFCE88B0E5FC5D3CFB968D"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Condensed Consolidated Statements of Operations (Unaudited)</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sC04B40858FAFCE88B0E5FC5D3CFB968D">2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sA87594B40449F22CD681FC5D3D54D7D7"><font style="font-family:inherit;font-size:10pt;">Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited)</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sA87594B40449F22CD681FC5D3D54D7D7">3</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s400EC367E07D4BE72980FC5D3D71E477"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Condensed Consolidated Statements of Cash Flows (Unaudited)</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s400EC367E07D4BE72980FC5D3D71E477">4</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s69F5BD820DAC7B1C5C2BFC5D4F237705"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Notes to Condensed Consolidated Financial Statements (Unaudited)</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s69F5BD820DAC7B1C5C2BFC5D4F237705">5</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s17C2F2F61785B359A500FC5D52B03781"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Item 2.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s17C2F2F61785B359A500FC5D52B03781"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s17C2F2F61785B359A500FC5D52B03781">18</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sBA5326807E226A961B2AFC5D4433B9A5"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Item 3.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sBA5326807E226A961B2AFC5D4433B9A5"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Quantitative and Qualitative Disclosures About Market Risk</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sBA5326807E226A961B2AFC5D4433B9A5">27</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sF170042775F2432D1836FC5D554CEB9B"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Item 4.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sF170042775F2432D1836FC5D554CEB9B"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Controls and Procedures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sF170042775F2432D1836FC5D554CEB9B">28</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sC2845EB5388875130AC4FC5D556D8F5E"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">PART II. &#8211; OTHER INFORMATION</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sC2845EB5388875130AC4FC5D556D8F5E">29</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s364BE15B49C1F8A0B36EFC5D559FA7FB"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Item 1.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s364BE15B49C1F8A0B36EFC5D559FA7FB"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Legal Proceedings</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s364BE15B49C1F8A0B36EFC5D559FA7FB">29</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sD0DE19F51779EAC478F6FC5D55C1F2A2"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Item 1A.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sD0DE19F51779EAC478F6FC5D55C1F2A2"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Risk Factors</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sD0DE19F51779EAC478F6FC5D55C1F2A2">29</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s27ABCB2663F5D3D39F3FFC5D55F3C4A6"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Item 6.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s27ABCB2663F5D3D39F3FFC5D55F3C4A6"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibits</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#s27ABCB2663F5D3D39F3FFC5D55F3C4A6">29</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sF3A56B6C4936C48F1A15FC5D56151195"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Signatures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;text-decoration:underline;" href="#sF3A56B6C4936C48F1A15FC5D56151195">30</a></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">i</font></div></div><hr style="page-break-after:always"><div><a name="sCFF1539A2971745E36EFFC5D4DCEC056"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PART I.&#160;FINANCIAL INFORMATION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s18565A426C402333CF55FC5D4DF1D691"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 1.&#160;CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s2FE9C613C1147FE8970AFC5D3CA85D1B"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited, amounts in thousands)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March&#160;31, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,401</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,630</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable, net of allowances of $3,473 in 2017 and $3,245 in 2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">161,765</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">173,620</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Prepaid expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,727</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Insurance recovery receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,386</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,037</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,857</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,198</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">186,136</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">205,611</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Property and equipment, net of accumulated depreciation of $44,178 in 2017 and $43,141 in 2016</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,779</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,818</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79,648</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79,648</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Trade names, indefinite-lived</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35,402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35,402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35,762</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36,835</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Other non-current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,668</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,064</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">368,395</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">388,378</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities and Stockholders' Equity</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Current liabilities:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable and accrued expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,606</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,837</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Accrued compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,745</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33,243</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,546</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,012</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79,897</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">97,092</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt and capital lease obligations, less current portion</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36,169</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84,760</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Non-current deferred tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,751</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,154</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term accrued claims</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29,512</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,870</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,571</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,301</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,601</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,399</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">172,501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">236,576</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Commitments and contingencies</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Stockholders' equity:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Common stock</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Additional paid-in capital</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">303,115</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">256,570</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,207</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,241</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Accumulated deficit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(106,634</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(104,089</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Cross Country Healthcare, Inc. stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">195,278</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">151,243</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">616</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">559</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">195,894</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">151,802</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Total liabilities and stockholders' equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">368,395</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">388,378</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes to the condensed consolidated financial statements</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></div><hr style="page-break-after:always"><div><a name="sC04B40858FAFCE88B0E5FC5D3CFB968D"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited, amounts in thousands, except per share data)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207,573</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,583</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of services</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154,298</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145,537</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,275</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,046</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,236</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,933</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bad debt expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">323</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">249</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,412</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Total operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,881</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,255</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,165</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other expenses (income):</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,219</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,635</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,436</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on early extinguishment of debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,969</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,352</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,983</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Income tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">797</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,718</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,186</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Less: Net income attributable to noncontrolling interest in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,010</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,022</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.09</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,872</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,956</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes to the condensed consolidated financial statements</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><div><a name="sA87594B40449F22CD681FC5D3D54D7D7"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited, amounts in thousands)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net (loss) income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,718</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,186</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss), before income tax:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized foreign currency translation gain (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss), net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,684</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,179</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net income attributable to noncontrolling interest in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive (loss) income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,976</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes to the condensed consolidated financial statements</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><div><a name="s400EC367E07D4BE72980FC5D3D71E477"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited, amounts in thousands)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from operating activities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net (loss) income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,718</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,186</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,191</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,412</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of debt discount and debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">470</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for allowances</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,038</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">798</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,436</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on early extinguishment of debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,969</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">737</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">648</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non-cash costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in operating assets and liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,817</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(264</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,087</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,068</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,599</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash provided by operating activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,410</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,564</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related settlements - Mediscan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases of property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,090</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(982</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,090</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repayments of debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,005</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59,227</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings on debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Extinguishment fees</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(578</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(403</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,583</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,430</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of exchange rate changes on cash</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,229</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(577</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents at beginning of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,630</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,453</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,401</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,876</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes to the condensed consolidated financial statements</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></div><hr style="page-break-after:always"><div><a name="s69F5BD820DAC7B1C5C2BFC5D4F237705"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sEA03363BD4FDE706BF9CFC5D3DBA8F54"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ORGANIZATION AND BASIS OF PRESENTATION</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). The condensed consolidated financial statements include all assets, liabilities, revenue, and expenses of InteliStaf of Oklahoma, LLC, which is controlled by the Company but not wholly-owned. The Company records the ownership interest of the noncontrolling shareholder as noncontrolling interest in subsidiary. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (U.S. GAAP) for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2016 included in the Company&#8217;s Annual Report on Form&#160;10-K as filed with the Securities and Exchange Commission. The </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">&#32;condensed consolidated balance sheet included herein was derived from the </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">&#32;audited consolidated balance sheet included in the Company&#8217;s Annual Report on Form&#160;10-K.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sF8AB6B92D61FEA3697C1FC5D3DBC3F64"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions are used for, but not limited to: (1) the valuation of accounts receivable; (2) goodwill, trade names, and other intangible assets; (3) other long-lived assets; (4) share-based compensation; (5) accruals for health, workers&#8217; compensation and professional liability claims; (6) valuation of deferred tax assets; (7) purchase price allocation; (8) derivative liability; (9) legal contingencies; (10) contingent considerations; (11) income taxes; and (12) sales and other non-income tax liabilities. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. Actual results could differ from those estimates.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments</font><font style="font-family:inherit;font-size:10pt;">, which amends the guidance in ASC 230 on the classification of certain cash receipts and payments in the statement of cash flows. This update intended to reduce the diversity that has resulted from the lack of consistent principles on this topic by adding or clarifying guidance on eight cash flow issues, including: debt prepayment or debt extinguishment costs, contingent consideration payments made after a business combination, and separately identifiable cash flows and application of the predominance principle. ASU 2016-15 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. Early adoption was permitted. The Company elected to early adopt this standard in its first quarter of 2017, applying the guidance retrospectively with no material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation-Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. </font><font style="font-family:inherit;font-size:10pt;">The Company adopted this guidance in the first quarter of 2017. ASU 2016-09 eliminates the requirement to delay the recognition of excess tax benefits until they reduce current taxes payable. Required method of adoption is modified retrospective transition method. Upon adoption, previously unrecognized excess tax benefits of </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;had no impact on the Company's accumulated deficit balance as the related deferred tax assets were fully offset by a valuation allowance. ASU 2016-09 also requires excess tax benefits and deficiencies to be recognized prospectively in the provision for income taxes rather than additional paid-in capital. As a result of the adoption, the Company's provision for income taxes was not impacted due to its full valuation allowance. Additionally, as permitted by the ASU, the Company elected to account for forfeitures as they occur rather than estimate expected forfeitures using a modified retrospective transition </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">method. As a result, the Company recorded a cumulative-effect adjustment of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to accumulated deficit and lower share-based compensation expense of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the amount of expense that would have been recorded for its first quarter of 2017. Under ASU 2016-09, the threshold for awards to qualify for equity treatment permits withholding up to the maximum statutory tax rates in the applicable jurisdictions. Prior to the adoption of ASU 2016-09, the Company did not allow an award to be partially settled in cash in excess of the minimum statutory withholding requirements. Subsequent to the adoption of the standard, the Company will allow awards to be partially settled at the maximum applicable statutory rates. Finally, ASU 2016-09 requires excess tax benefits to be presented as a component of operating cash flows rather than financing cash flows. The Company elected to adopt this requirement prospectively and accordingly, prior periods have not been adjusted. Excess tax benefits were not material for all periods presented.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-06, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments</font><font style="font-family:inherit;font-size:10pt;">, to clarify the steps required to assess whether a call or put option meets the criteria for bifurcation as an embedded derivative. ASU 2016-06 is effective for interim and annual periods beginning after December 15, 2016, and requires a modified retrospective approach to adoption. The Company adopted this guidance in the first quarter of 2017. The adoption of this guidance had no impact on the Company's results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s789FD9BF149B542F06F6FC5D3DD3991F"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3.&#160;&#160;&#160;&#160;ACQUISITIONS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">US Resources Healthcare</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 1, 2016, the Company completed the acquisition of a recruitment process outsourcing business, US Resources Healthcare, LLC (USR). This acquisition expands the Company's workforce solutions offerings to deliver financial and operating efficiencies through labor optimization services while enhancing the quality of care.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition was deemed immaterial and has been accounted for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">using the acquisition method of accounting. USR's results of operations are included in the consolidated statements of operations from December 1, 2016 and have been included in the Company's Nurse and Allied Staffing business segment. See Note 6 - Goodwill, Trade Names, and Other Intangible Assets and Note 9 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Mediscan</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 30, 2015, the Company completed the acquisition of all of the membership interests of New Mediscan II, LLC, Mediscan Diagnostic Services, LLC, and Mediscan Nursing Staffing, LLC (collectively Mediscan) for a purchase price of  </font><font style="font-family:inherit;font-size:10pt;">$29.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in cash (</font><font style="font-family:inherit;font-size:10pt;">$28.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;plus working capital estimate) and </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in shares (or </font><font style="font-family:inherit;font-size:10pt;">349,871</font><font style="font-family:inherit;font-size:10pt;">&#32;shares) of the Company's Common Stock, subject to a net working capital adjustment. The shares of Common Stock issued in connection with the acquisition were subject to a lockup period, which ended April 30, 2016. In the first quarter of 2016, the net working capital adjustment was settled consistent with the receivable balance as of December 31, 2015. An amount of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of the purchase price was held in escrow to cover any post-closing liabilities, which was released to the seller on May 3, 2017. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The agreement also specified that the sellers were eligible to receive additional purchase price consideration of </font><font style="font-family:inherit;font-size:10pt;">$7.0 million</font><font style="font-family:inherit;font-size:10pt;">, with </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;per year based on attainment of specific performance criteria in 2016 and 2017. As of December 31, 2016, the Company determined that the first year earnout was not achieved for 2016 and as a result, only </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;remains as a potential earnout for 2017. As of March 31, 2017, the fair value of the remaining obligation was estimated at </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Mediscan acquisition, the Company also assumed additional contingent purchase price liabilities for a previously acquired business that are payable annually based on specific performance criteria for the 2016 through 2019 years. Payments related to the 2016 through 2018 years are limited to </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;per year and 2019 is uncapped. During the three months ended March 31, 2017, the Company paid </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">. As of March 31, 2017, the fair value of the remaining obligations on an undiscounted basis was estimated at </font><font style="font-family:inherit;font-size:10pt;">$3.6 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of March 31, 2017, a total of </font><font style="font-family:inherit;font-size:10pt;">$4.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was estimated as the fair value of these contingent consideration payments and is included in other current liabilities and contingent consideration on the condensed consolidated balance sheets. See Note 9 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Medical Staffing Network</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 30, 2014, the Company acquired substantially all of the assets and certain liabilities of Medical Staffing Network Healthcare, LLC (MSN). Of the purchase price, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was deferred and due to the seller </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">21 months</font><font style="font-family:inherit;font-size:10pt;">&#32;from the acquisition date, less any COBRA expenses incurred by the Company on behalf of former MSN employees over that period.  The Company incurred </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in COBRA expenses since the MSN acquisition and, on April 1, 2016, released to the seller the remaining liability of </font><font style="font-family:inherit;font-size:10pt;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sA9CBA36DABAC4DAD73E6FC5D3E045D58"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">COMPREHENSIVE INCOME (LOSS)</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total comprehensive income (loss) includes net income or loss and foreign currency translation adjustments, net of any related deferred taxes. Certain of the Company&#8217;s foreign subsidiaries use their respective local currency as their functional currency. In accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Matters </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying condensed consolidated balance sheets and was approximately </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;at both </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There was no income tax impact related to foreign currency translation adjustments for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;month periods ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sC47CF0FEAA86C0816152FC5D3E0E474C"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EARNINGS PER SHARE</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:69%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td rowspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,010</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,022</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Interest on Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,436</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net (loss) income attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,897</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,424</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,872</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,956</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Effective of diluted shares:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based awards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">703</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Convertible Notes </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,934</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,521</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.09</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the periods presented, no tax benefits have been assumed in the weighted average share calculation due to a full valuation allowance on the Company's deferred tax assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes were repaid in full on March 17, 2017. Applying the if-converted method, </font><font style="font-family:inherit;font-size:10pt;">2,934,271</font><font style="font-family:inherit;font-size:10pt;">&#32;shares (the weighted average shares outstanding through March 17, 2017) were included in diluted weighted average shares for the three months ended March 31, 2017 because their effect was dilutive.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></div><hr style="page-break-after:always"><div><a name="sE3C03AB8F913DAC1B594FC5D3E43D876"></a></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6.&#160;&#160;&#160;&#160;GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had the following acquired intangible assets:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"></td></tr><tr><td style="width:20%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets subject to amortization:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Databases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,609</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,655</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,954</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,609</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,147</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,462</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,724</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,793</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,931</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,724</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,316</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,408</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,619</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,537</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,619</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,527</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names, definite-lived</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,216</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">421</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,216</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">343</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,873</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,168</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,406</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,762</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,168</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,835</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets not subject to amortization:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,164</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72,237</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, estimated annual amortization expense is as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:82%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,175</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,111</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,799</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,522</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,762</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The March 31, 2017 and December 31, 2016 carrying amount of goodwill by segment is as follows:&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:58%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,685</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,685</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended March 31, 2017 and 2016, the Company noted no indicators at any of its reporting units that warranted impairment testing.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></div><hr style="page-break-after:always"><div><a name="sF40CFDD0B1F67E876391FC5D3EADC6CC"></a></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">7.&#160;&#160;&#160;&#160;DEBT</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, long-term debt consists of the following:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unamortized Discount and Debt Issuance Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unamortized Discount and Debt Issuance Costs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan, interest 2.78%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes, fixed rate interest of 8.00%</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,669</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Convertible Notes derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,518</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,032</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,010</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,263</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,508</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(339</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,792</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,032</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the aggregate scheduled maturities of debt are as follows: </font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:72%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Term Loan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capital Leases </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Through Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company and certain of its domestic subsidiaries entered into a Convertible Note Purchase Agreement (the Note Purchase Agreement), with certain note holders (collectively, the Noteholders) on June 30, 2014. Pursuant to the Note Purchase Agreement, the Company sold to the Noteholders an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of convertible senior notes (the Convertible Notes). On March 17, 2017, the Company repaid in full the Convertible Notes. In connection with the repayment, the Company issued to the Noteholders an aggregate of </font><font style="font-family:inherit;font-size:10pt;">3,175,584</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock, par value </font><font style="font-family:inherit;font-size:10pt;">$0.0001</font><font style="font-family:inherit;font-size:10pt;">, and cash in the aggregate amount of </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(of which </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;is included in repayment of debt and </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;is presented as extinguishment fees, both within financing activities on the condensed consolidated statements of cash flows).&#160;Upon derecognition of the net carrying amounts of the Convertible Notes (the remaining </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;after the </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;cash payment) and derivative liability (</font><font style="font-family:inherit;font-size:10pt;">$26.0 million</font><font style="font-family:inherit;font-size:10pt;">), the Company recognized a non-cash charge of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as loss on early extinguishment and a non-cash addition to additional paid-in capital of </font><font style="font-family:inherit;font-size:10pt;">$46.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the fair value of the shares, which is not presented on the condensed consolidated statements of cash flows. The loss on early extinguishment of debt includes the write-off of unamortized loan fees and remaining interest due through the Forced Conversion date (defined below) of June 30, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes were convertible at the option of the holders thereof at any time into shares of the Company&#8217;s common stock, par value </font><font style="font-family:inherit;font-size:10pt;">$0.0001</font><font style="font-family:inherit;font-size:10pt;">&#32;per share (Common Stock), at a conversion price of </font><font style="font-family:inherit;font-size:10pt;">$7.10</font><font style="font-family:inherit;font-size:10pt;">&#32;per share, or </font><font style="font-family:inherit;font-size:10pt;">3,521,126</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock.  After </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;">&#32;from the issuance date, the Company had the right to force a conversion of the Convertible Notes if the volume-weighted average price (VWAP) per share of its Common Stock exceeded </font><font style="font-family:inherit;font-size:10pt;">125%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the then conversion price for </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;">&#32;days of a </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;">&#32;day trading period (Forced Conversion date).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes bore interest at a rate of </font><font style="font-family:inherit;font-size:10pt;">8.00%</font><font style="font-family:inherit;font-size:10pt;">&#32;per annum, payable in quarterly cash installments. The Convertible Notes would have matured on June 30, 2020, unless earlier repurchased, redeemed or converted. Subject to certain exceptions, the Company was not permitted to redeem the Convertible Notes until June 30, 2017. If the Company redeemed the Convertible Notes on or after June 30, 2017, the Company was required to pay a premium of </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the amount of principal of the Convertible Notes redeemed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2016 Senior Credit Facilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a senior credit agreement (Credit Agreement), entered into on June 22, 2016, which provides a term loan of </font><font style="font-family:inherit;font-size:10pt;">$40.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(Term Loan) and a revolving credit facility of up to </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(Revolving Credit Facility) (together with the Term Loan, the Senior Credit Facilities) both of which mature on June 22, 2021. The Revolving Credit Facility includes a subfacility for swingline loans up to an amount not to exceed </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;">, and a </font><font style="font-family:inherit;font-size:10pt;">$35.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;sublimit for the issuance of standby letters of credit.&#160; The Credit Agreement also includes a provision permitting the Company, subject to certain conditions, to increase the aggregate amount of the commitments under the Revolving Credit Facility or establish one or more additional term loans in an aggregate amount of up to </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;with optional additional commitments from existing lenders or new commitments from additional lenders. The Term Loan is payable in quarterly installments, with the first payment made September 30, 2016, and each such installment being in the aggregate principal amount (subject to adjustment as a result of prepayments) equal to </font><font style="font-family:inherit;font-size:10pt;">1.25%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the principal amount for the first four installments, </font><font style="font-family:inherit;font-size:10pt;">1.875%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the next eight installments and </font><font style="font-family:inherit;font-size:10pt;">2.50%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the principal amount for the remaining installments. The Revolving Credit Facility can be used to provide ongoing working capital, fund permitted acquisitions and for other general corporate purposes of the Company and its subsidiaries.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to the Credit Agreement, the Company pays interest on (i) each Base Rate Loan at the Base Rate (as defined therein) plus the Applicable Margin in effect from time to time, (ii) each LIBOR Index Rate Loan at the One Month LIBOR Index Rate (as defined therein) plus the Applicable Margin in effect from time to time and (iii) each Eurodollar Loan at the Adjusted LIBOR for the applicable Interest Period (as defined therein) in effect for such Loan plus the Applicable Margin in effect from time to time.  The Applicable Margin, as of any date, is a percentage per annum determined by reference to the applicable Consolidated Net Leverage Ratio (as defined by the agreement) in effect on such date as set forth in the table below.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:8%;"></td><td style="width:35%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:19%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Level</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Consolidated Net Leverage Ratio</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Eurodollar Loans, LIBOR Index Rate Loans and Letter of Credit Fee</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Base Rate Loans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Commitment Fee</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">I</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Less than 1.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.25%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">II</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 1.50:1.00 <br>but less than 2.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">III</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 2.00:1.00<br> but less than 2.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">IV</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 2.50:1.00<br> but less than 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.35%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">V</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.40%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Term Loan and Revolving Credit Facility bore interest at a rate equal to </font><font style="font-family:inherit;font-size:10pt;">One Month LIBOR</font><font style="font-family:inherit;font-size:10pt;">&#32;plus </font><font style="font-family:inherit;font-size:10pt;">200</font><font style="font-family:inherit;font-size:10pt;">&#32;basis points. The interest rate is subject to an increase of </font><font style="font-family:inherit;font-size:10pt;">200</font><font style="font-family:inherit;font-size:10pt;">&#32;basis points if an event of default exists under the Credit Agreement.  The Company is required to pay a commitment fee on the average daily unused portion of the Revolving Credit Facility, based on the Applicable Margin which was </font><font style="font-family:inherit;font-size:10pt;">0.30%</font><font style="font-family:inherit;font-size:10pt;">&#32;as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has the right at any time and from time to time to prepay any borrowing, in whole or in part, without premium or penalty, by giving irrevocable written notice (or telephonic notice promptly confirmed in writing) except that such notice shall be revocable if a prepayment is being made in anticipation of concluding a financing arrangement, and the Company is ultimately unable to secure such financing arrangement.  The Company is required to prepay the Senior Credit Facilities under certain circumstances including from net cash proceeds from asset sales or dispositions in excess of certain thresholds, as well as from net cash proceeds from the issuance of certain debt by the Company.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement contains customary representations, warranties, and affirmative covenants. The Credit Agreement also contains customary negative covenants, subject to some exceptions, on (i)&#160;indebtedness and preferred equity, (ii)&#160;liens, (iii)&#160;fundamental changes, (iv)&#160;investments, (v)&#160;restricted payments, and (vi) sale of assets and certain other restrictive </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">agreements. The Credit Agreement also contains customary events of default, such as payment defaults, cross-defaults to other material indebtedness, bankruptcy and insolvency, the occurrence of a defined change in control and the failure to observe the negative covenants and other covenants related to the operation of the Company&#8217;s business.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement also includes </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;financial covenants: (i) limiting a maximum Consolidated Total Leverage ratio (as defined therein) to be no greater than </font><font style="font-family:inherit;font-size:10pt;">3.50</font><font style="font-family:inherit;font-size:10pt;">:1.00 for the fiscal quarters ending September 30, 2016 through June 30, 2017, </font><font style="font-family:inherit;font-size:10pt;">3.25</font><font style="font-family:inherit;font-size:10pt;">:1.00 for the fiscal quarters ending September 30, 2017 through June 30, 2018, and </font><font style="font-family:inherit;font-size:10pt;">3.00</font><font style="font-family:inherit;font-size:10pt;">:1.00 for each fiscal quarter ending thereafter and as adjusted pursuant to a Qualified Permitted Acquisition (as defined therein); and (ii) requiring a minimum Consolidated Fixed Charge Coverage ratio (as defined therein) as of the end of each fiscal quarter of </font><font style="font-family:inherit;font-size:10pt;">1.50</font><font style="font-family:inherit;font-size:10pt;">:1.00. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company was in compliance with the financial covenants and other covenants contained in the Credit Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The obligations under the Credit Agreement are guaranteed by all of the Company&#8217;s domestic wholly-owned subsidiaries. The obligations under the Credit Agreement are secured by a first-priority security interest in the Collateral (as defined therein).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$22.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;letters of credit outstanding and </font><font style="font-family:inherit;font-size:10pt;">$77.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;available under the Revolving Credit Facility. The letters of credit relate to the Company&#8217;s workers&#8217; compensation and professional liability insurance policies.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sB8B98EB0D43C5718C75FFC5D3F6966C3"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8.&#160;&#160;&#160;&#160;CONVERTIBLE NOTES DERIVATIVE LIABILITY</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, wrote off the derivative liability. See Note 7 - Debt. The Company does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company issued Convertible Notes with features that were either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting for Derivative Financial Instruments and Hedging Activities </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC, in certain instances, these instruments were required to be carried as derivative liabilities, at fair value, in the financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes were subject to anti-dilution adjustments that allowed for the reduction in the Conversion Price, as defined in the agreement, in the event the Company subsequently issued equity securities including Common Stock or any security convertible or exchangeable for shares of Common Stock for a price less than the then current conversion price. In addition, the Convertible Notes allowed the issuer to exercise optional redemption features and the holder to exercise an offer to purchase feature, under certain conditions. The Company accounted for the conversion option in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting for Derivative Financial Instruments and Hedging Activities </font><font style="font-family:inherit;font-size:10pt;">Topic. Since this conversion feature is not considered to be solely indexed to the Company&#8217;s own stock the derivative was recorded as a liability in the line item long-term debt on the Company's condensed consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s Convertible Notes derivative liability was measured at fair value using a trinomial lattice model. The optional redemption features, along with the offer to purchase features were incorporated into the valuation model. Inputs into the model required estimates, including such items as estimated volatility of the Company's stock, estimated credit risk of the Company, estimated probabilities of change of control and issuance of additional financing, risk-free interest rate, and the estimated life of the financial instruments being fair valued. In addition, since the conversion price contained an anti-dilution adjustment, the probability that the Conversion Price of the Notes would decrease as the share price decreased was incorporated into the valuation calculation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the derivative liability was primarily determined by fluctuations in our stock price. In addition, changes in our credit risk profile impacted the fair value determination. These fluctuations resulted in a current period gain or loss that was presented on the condensed consolidated statements of operations as (gain) loss on derivative liability. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s6FBF69990D3E70BEE825FC5D3F7AC585"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FAIR VALUE MEASUREMENTS</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 1</font><font style="font-family:inherit;font-size:10pt;">&#8212;Quoted prices in active markets for identical assets or liabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 2</font><font style="font-family:inherit;font-size:10pt;">&#8212;Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 3</font><font style="font-family:inherit;font-size:10pt;">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Items Measured at Fair Value on a Recurring Basis:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s financial assets/liabilities required to be measured on a recurring basis were its: deferred compensation liability included in other long-term liabilities, Convertible Notes derivative liability included in long-term debt and capital lease obligations, and contingent consideration liabilities included in other current liabilities and contingent consideration on the condensed consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred compensation</font><font style="font-family:inherit;font-size:10pt;">&#8212;The Company utilizes Level 1 inputs to value its deferred compensation liability. The Company&#8217;s deferred compensation liability is measured using publicly available indices that define the liability amounts, as per the plan documents.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes derivative liability</font><font style="font-family:inherit;font-size:10pt;">&#8212;The Company utilized Level 3 inputs to value its Convertible Notes derivative liability.  See Note 7 - Debt and Note 8 - Convertible Notes derivative liability.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent consideration liabilities</font><font style="font-family:inherit;font-size:10pt;">&#8212;Potential earnout payments related to the acquisition of Mediscan and USR are contingent upon meeting certain performance requirements through 2019. See Note 3 - Acquisitions. The long-term portion of these liabilities is included in contingent consideration, and the short-term portion is included in other current liabilities on the condensed consolidated balance sheets. The Company utilized Level 3 inputs to value these contingent consideration liabilities as significant unobservable inputs were used in the calculation of their fair value. The Mediscan contingent consideration is recorded as a liability and measured at fair value using a discounted cash flow model in a Monte Carlo simulation setting, utilizing significant unobservable inputs, including the expected volatility of the acquisitions' gross profits and an estimated discount rate commensurate with the risks of the expected gross profit stream. The USR contingent consideration is recorded as a liability and measured at fair value using a discounted cash flow model utilizing significant unobservable inputs, including the probability of achieving each of the potential milestones and an estimated discount rate commensurate with the risks of the expected cash flows attributable to the milestones.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of contingent consideration and the associated liabilities will be adjusted to fair value at each reporting date until actual settlement occurs, with the changes in fair value and related accretion reflected as acquisition-related contingent consideration on the condensed consolidated statements of operations. Significant increases (decreases) in the volatility or in any of the probabilities of success, or decreases (increases) in the discount rate would result in a significantly higher (lower) fair value, respectively, and commensurate changes to these liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table which follows summarizes the estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:58%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Financial Liabilities:</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Deferred compensation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,213</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Convertible Notes derivative liability</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,773</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,603</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table which follows reconciles the opening balances to the closing balances for fair value measurements categorized within Level 3 of the fair value hierarchy:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingent Consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Convertible Notes</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities (a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative Liability</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,951</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation gain for the period</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,773</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Related to the Mediscan acquisition on October 30, 2015 and the USR acquisition on December 1, 2016. See Note 3 - Acquisitions. Valuation gain and accretion expense is included as acquisition-related contingent consideration on the condensed consolidated statements of operations.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Items Measured at Fair Value on a Non-Recurring Basis:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's non-financial assets, such as goodwill, trade names, other intangible assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. During the three months ended March 31, 2017 and December 31, 2016, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;impairment charges were deemed necessary.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Fair Value Disclosures:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments not measured or recorded at fair value in the accompanying condensed consolidated balance sheets consist of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and short and long-term debt. The estimated fair value of accounts receivable, accounts payable and&#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. The estimated fair value of the Company's debt was calculated using a discounted cash flow analysis and appropriate valuation methodologies using Level 2 inputs from available market information.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:34%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March&#160;31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying<br>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair<br>Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying<br>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair<br>Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Financial Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">(amounts in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 2)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Term Loan, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,161</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,137</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,331</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,250</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Risk:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has invested its excess cash in highly-rated overnight funds and other highly-rated liquid accounts. The Company has been exposed to credit risk associated with these investments. The Company minimizes its credit risk relating to these positions by monitoring the financial condition of the financial institutions involved and by primarily conducting business with large, well established financial institutions and diversifying its counterparties.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts represents the Company&#8217;s estimate of uncollectible receivables based on a review of specific accounts and the Company&#8217;s historical collection experience. The Company writes off specific&#160;accounts </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">based on an ongoing review of collectability as well as past experience with the customer. The Company&#8217;s contract terms typically require payment between </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;">&#32;days from the date services are provided and are considered past due based on the particular negotiated contract terms. Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s3F63BA69BA91E7C9ECF5FC5D3FCA2EAD"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">10.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">STOCKHOLDERS&#8217; EQUITY</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Repurchase Program</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the Company did not repurchase any shares of its Common Stock under its February 2008 Board authorization. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company may purchase up to an additional </font><font style="font-family:inherit;font-size:10pt;">942,443</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock under the February 2008 Board authorization, subject to certain conditions in the Company's Credit Agreement.  The Company may repurchase up to an aggregate amount not to exceed </font><font style="font-family:inherit;font-size:10pt;">$2.5</font><font style="font-family:inherit;font-size:10pt;">&#32;million in any fiscal year, or an unlimited amount if the Company meets certain conditions as described in its Credit Agreement. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">35,596,380</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock outstanding.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Share-Based Payments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended </font><font style="font-family:inherit;font-size:10pt;text-transform:default;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">244,205</font><font style="font-family:inherit;font-size:10pt;">&#32;of restricted stock awards and </font><font style="font-family:inherit;font-size:10pt;">181,067</font><font style="font-family:inherit;font-size:10pt;">&#32;of performance stock awards were granted under the 2014 Omnibus Incentive Plan (2014 Plan) to the Company's management team. Pursuant to the 2014 Plan, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets.&#160;If the minimum level of performance is attained for the 2017 awards, restricted stock will be issued with a vesting date of March 31, 2020, subject to the employee&#8217;s continuing employment.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2017, the Company's Compensation Committee of the Board of Directors approved a </font><font style="font-family:inherit;font-size:10pt;">48%</font><font style="font-family:inherit;font-size:10pt;">&#32;level of attainment for the 2016 performance-based share awards, resulting in the issuance of </font><font style="font-family:inherit;font-size:10pt;">86,784</font><font style="font-family:inherit;font-size:10pt;">&#32;performance shares that will vest on December 31, 2018.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2014 Plan for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:41%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Performance Stock Awards</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br>Average<br>Grant Date<br>Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Target <br>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br>Average<br>Grant Date<br>Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, January&#160;1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">532,294</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332,092</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.73</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244,205</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.21</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181,067</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.36</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(122,061</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,838</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.39</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(112,434</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.65</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628,600</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">400,725</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was included in selling, general and administrative expenses related to share-based payments, and a net of </font><font style="font-family:inherit;font-size:10pt;">74,878</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock were issued upon the vesting of restricted stock.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was included in selling, general and administrative expenses related to share-based payments, and a net of </font><font style="font-family:inherit;font-size:10pt;">51,091</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock were issued upon the vesting of restricted stock.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sBA011405E8E9BD923E28FC5D3FE2D966"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SEGMENT DATA</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC, the Company reports </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;business segments &#8211; Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Company manages and segments its business based on the services it offers to its customers as described below:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></div><hr style="page-break-after:always"><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Nurse and Allied Staffing </font><font style="font-family:inherit;font-size:10pt;">&#8211; Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added workforce solutions including: temporary and permanent placement of travel and local branch-based nurse and allied professionals, MSP services, education healthcare services, and outsourcing services. Its clients include: public and private acute-care and non-acute care hospitals, government facilities, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and many other healthcare providers throughout the U.S. The results of the Mediscan and USR acquisitions have been aggregated with the Company's Nurse and Allied Staffing business segment. See Note 3 - Acquisitions.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Physician Staffing</font><font style="font-family:inherit;font-size:10pt;">&#32;&#8211; Physician Staffing provides physicians in many specialties, certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) as independent contractors on temporary assignments throughout the U.S. at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Human Capital Management Services</font><font style="font-family:inherit;font-size:10pt;">&#32;&#8211; Other Human Capital Management Services includes retained and contingent search services for physicians, healthcare executives and other healthcare professionals within the U.S.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s management evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income or loss from operations before depreciation, amortization, loss on sale of business, acquisition and integration costs, acquisition-related contingent consideration, restructuring costs, impairment charges, and corporate expenses not specifically identified to a reporting segment. Contribution income is a financial measure used by management when assessing segment performance and is provided in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC. The Company&#8217;s management does not evaluate, manage or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&#8217; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information on operating segments and a</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">reconciliation to income (loss) from operations for the periods indicated are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183,108</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168,765</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,464</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,001</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,365</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207,573</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,583</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,622</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,790</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(440</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(111</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,002</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate overhead</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,286</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,191</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,412</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,255</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></div><hr style="page-break-after:always"><div><a name="sCC4A0CE9DEA868CEEAB3FC5D400632C1"></a></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">12.&#160;&#160;&#160;&#160;COMMITMENTS AND CONTINGENCIES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingencies:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Legal Proceedings</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to legal proceedings and claims that arise in the ordinary course of its business. The Company does not believe the outcome of these matters will have a material adverse effect on the Company's business, financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sales and Other State Non-Income Tax Liabilities </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company's business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions.&#160;The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised. The expense is included in selling, general and administrative expenses on its condensed consolidated statements of operations and the liability is reflected in other current liabilities as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, on its condensed consolidated balance sheets. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sC18DD53342103E20D4FCFC5D400BA24C"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCOME TAXES</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the periods ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the Company has calculated its effective tax rate based on year-to-date results as opposed to estimating its annual effective tax rate.&#160;The Company&#8217;s effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">(27.1)%</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">4.0%</font><font style="font-family:inherit;font-size:10pt;">, respectively, including the impact of discrete items. Excluding discrete items, the Company&#8217;s effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">(53.8)%</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">3.9%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The effective tax rates are different than the statutory rates primarily due to the impact from amortization of indefinite-lived intangible assets for tax purposes, the partial non-deductibility of certain per diem expenses, and international and state taxes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company records valuation allowances to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The assessment of whether or not a valuation allowance is required often requires significant judgment, including the long-range forecast of future taxable income and the evaluation of tax planning initiatives. Adjustments to the deferred tax valuation allowances are made to earnings in the period when such assessments are made. The Company believes it is necessary to see further positive evidence, such as sustained achievement of cumulative profits, before these valuation allowances can be released. If such positive evidence develops, the Company may release all or a portion of the remaining valuation allowances, but at this point in time cannot determine in which period they would reverse. The Company will continue to assess the realizability of its deferred tax assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had approximately </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of unrecognized tax benefits included in other current liabilities and other long-term liabilities (</font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;">, net of deferred taxes, which would affect the effective tax rate if recognized). During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had gross increases of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to its current year unrecognized tax benefits related to federal and state tax issues.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax years of </font><font style="font-family:inherit;font-size:10pt;">2004, 2005, 2008, and 2010 through 2016</font><font style="font-family:inherit;font-size:10pt;">&#32;remain open to examination by certain taxing jurisdictions to which the Company is subject to tax, other than certain states in which the statute of limitations has been extended.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s40E26D4205AB0868C581FC5D4010E4AE"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">14.&#160;&#160;&#160;&#160;RELATED PARTY TRANSACTIONS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company provides services to hospitals which are affiliated with certain members of the Company&#8217;s Board of Directors. Management believes services with related parties were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. Accounts receivable due from these hospitals at </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">&#32;were approximately </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the acquisition of MSN, the Company acquired a </font><font style="font-family:inherit;font-size:10pt;">68%</font><font style="font-family:inherit;font-size:10pt;">&#32;ownership interest in InteliStaf of Oklahoma, LLC, a joint venture between the Company and a hospital system.&#160;The Company generated revenue providing staffing services to the </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">hospital system of </font><font style="font-family:inherit;font-size:10pt;">$4.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had a receivable balance of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and a payable balance of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subsequent to the Company's acquisition of Mediscan on October 30, 2015, Mediscan continued to operate at premises owned, in part, by the founding members of Mediscan. The Company paid </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in rent expense for these premises for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s88A45E9384ED4712D9FFFC5D401C8116"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">15.&#160;&#160;&#160;&#160;RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, </font><font style="font-family:inherit;font-size:10pt;">to simplify how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under this guidance, an entity would perform its annual, or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity would consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019 and is to be applied prospectively. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company expects to early adopt this standard in 2017 in the first quarter in which an impairment test is performed, and does not expect this guidance to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations (Topic 805): Clarifying the Definition of a Business</font><font style="font-family:inherit;font-size:10pt;">, which clarifies the definition of a business, with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This update provides a framework to assist entities in evaluating whether both an input and a substantive process are present, and narrows the definition of the term output so that the term is consistent with how outputs are described in the new revenue recognition standard. ASU 2017-01 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. Early adoption is permitted depending upon the date of the transaction. Entities should apply the guidance prospectively on or after the effective date. No disclosures are required at transition. The Company expects to adopt this standard in its first quarter of 2018, and does not expect this guidance to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;">, which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Full retrospective application is prohibited. The Company expects the valuation of right of use assets and lease liabilities, previously described as operating leases, to be the present value of our forecasted future lease commitments. The Company is continuing to assess the overall impacts of the new standard, including the discount rate to be applied in these valuations. See Note 12 - Commitments and Contingencies to the audited consolidated financial statements included in the Company's Annual Report on Form 10-K.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB and the International Accounting Standards Board jointly issued ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Topic 606)</font><font style="font-family:inherit;font-size:10pt;">, that introduces a new five-step revenue recognition model in which an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires disclosures sufficient to enable users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers, including qualitative and quantitative disclosures about contracts with customers, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. In March 2016, the FASB issued ASU 2016-08 which further clarifies the guidance on the principal versus agent considerations within ASU 2014-09. In April 2016, the FASB issued ASU 2016-10 to expand the guidance on identifying performance obligations and licensing within ASU 2014-09. In May 2016, the FASB issued ASU 2016-12 to improve revenue recognition in the areas of collectability, presentation of sales tax and other similar taxes collected from customers, non-cash consideration, contract modifications and completed contracts at transition. This update also amends the disclosure requirements within ASU 2014-09 for entities that retrospectively apply the guidance. The latest amendments are intended to address implementation issues that were raised by stakeholders and discussed </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">by the Revenue Recognition Transition Resource Group, and provide additional practical expedients. These updates are effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period. The Company established a cross-functional implementation team consisting of representatives from across all of its business segments. Management is in the process of reviewing its contract portfolio and its existing accounting policies and practices to identify potential differences that would result from applying the requirements of the new standard to its contracts. Management expects this assessment will continue throughout the first half of 2017. Once this phase has been completed, if applicable,</font><font style="font-family:inherit;font-size:10pt;color:#1f497d;">&#32;</font><font style="font-family:inherit;font-size:10pt;">management intends to implement appropriate changes to its business processes, systems and controls to support the recognition and disclosure under the new standard. The Company is continuing to assess which transition method it will use to adopt this accounting standard and expects a full assessment by the fourth quarter of 2017.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s17C2F2F61785B359A500FC5D52B03781"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purpose of the following Management&#8217;s Discussion and Analysis (MD&amp;A) is to help facilitate the understanding of significant factors influencing the quarterly operating results, financial condition and cash flows of Cross Country Healthcare, Inc. Additionally, the MD&amp;A also conveys our expectations of the potential impact of known trends, events or uncertainties that may impact future results. This discussion supplements the detailed information presented in the condensed consolidated financial statements and notes thereto which should be read in conjunction with the consolidated financial statements and related notes contained in the Company&#8217;s Annual Report on Form&#160;10-K, filed for the year ended December 31, 2016.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s436D35A76793F06C2E93FC5D52D3977A"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Overview</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We provide healthcare staffing, recruiting and workforce solutions to our customers through our vast network of 74 office locations throughout the U.S. Our services include placing clinicians on travel and per diem assignments, local short-term contracts and permanent positions. In addition, we offer flexible workforce management solutions to our customers including: managed service programs (MSP), education healthcare, recruitment process outsourcing (RPO) and other outsourcing and value-added services as described in Item 1. Business in our Annual Report on Form 10-K for the year ended December 31, 2016. In addition, we provide both retained and contingent placement services for healthcare executives, physicians, and other healthcare professionals.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We manage and segment our business based on the nature of our services we offer to our customers. As a result, in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC, we report three business segments &#8211; Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Nurse and Allied Staffing</font><font style="font-family:inherit;font-size:10pt;">&#32;&#8211; Nurse and Allied Staffing represented approximately </font><font style="font-family:inherit;font-size:10pt;">88%</font><font style="font-family:inherit;font-size:10pt;">&#32;of our total revenue in the first quarter of 2017. Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added workforce solutions including: temporary and permanent placement of travel and local branch-based nurse and allied professionals, MSP services, education healthcare services, and outsourcing services. The results of our Mediscan and US Resources Healthcare, LLC (USR) acquisitions have been aggregated with our Nurse and Allied Staffing business segment. See Note 3 - Acquisitions to our condensed consolidated financial statements.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Physician Staffing</font><font style="font-family:inherit;font-size:10pt;">&#32;&#8211; Physician Staffing represented approximately </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">&#32;of our total revenue in the first quarter of 2017. Physician Staffing provides physicians in many specialties, certified registered nurse anesthetists, nurse practitioners and physician assistants under our Medical Doctor Associates (MDA) brand as independent contractors on temporary assignments throughout the U.S.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Human Capital Management Services</font><font style="font-family:inherit;font-size:10pt;">&#32;&#8211; Other Human Capital Management Services (OHCMS) represented approximately </font><font style="font-family:inherit;font-size:10pt;">2%</font><font style="font-family:inherit;font-size:10pt;">&#32;of our total revenue in the first quarter of 2017. OHCMS is comprised of retained and contingent search services for physicians, healthcare executives, and other healthcare professionals within the U.S.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Summary of Operations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the quarter ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, revenue from services grew 6% to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$207.6 million</font><font style="font-family:inherit;font-size:10pt;">, due to growth in volume and improved pricing. Revenue growth of 8% in Nurse and Allied Staffing was partially offset by lower revenue from our Physician Staffing and OHCMS businesses. Net loss attributable to common shareholders was </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.08</font><font style="font-family:inherit;font-size:10pt;">&#32;per diluted share. The consolidated net loss includes a loss on early extinguishment of debt of $5.0 million, partially offset by an unrealized gain on derivative liability of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the three months ended March 31, 2017, we generated cash flow from operations of $1.4 million. On March 17, 2017, the Company repaid in full its Convertible Notes. In connection with the repayment, the Company issued to the Noteholders an aggregate of </font><font style="font-family:inherit;font-size:10pt;">3,175,584</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock and cash in the aggregate amount of </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;">, resulting in a </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;loss on early extinguishment of debt. As of March 31, 2017, we had $13.4 million of cash and cash equivalents and $38.2 million of total debt. There were no borrowings drawn on our $100.0 million revolving credit facility, and $22.1 million of letters of credit outstanding, leaving $77.9 million available for borrowing. See Note 7 - Debt to our condensed consolidated financial statements. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Results from Operations, Segments Results and Liquidity and Capital Resources sections that follow for further information.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Operating Metrics</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We evaluate our financial condition by tracking operating metrics and financial results specific to each of our segments. Key operating metrics include hours worked, days filled, number of FTEs, revenue per FTE, and revenue per day filled. Other operating metrics include number of open orders, candidate applications, contract bookings, length of assignment, bill and pay rates, and renewal and fill rates, number of active searches, and number of placements. These operating metrics are representative of trends that assist management in evaluating business performance.&#160;Due to the timing of our business process and other factors, certain of these operating metrics may not necessarily correlate to the reported GAAP results for the periods presented. Some of the segment financial results analyzed include revenue, gross profit margins, operating expenses, and contribution income. In addition, we monitor cash flow as well as operating and leverage ratios to help us assess our liquidity needs.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:45%;"></td><td style="width:55%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Segment</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Measurement</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nurse and Allied Staffing </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FTEs represent the average number of Nurse and Allied Staffing contract personnel on a full-time equivalent basis.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average revenue per FTE per day is calculated by dividing the Nurse and Allied Staffing revenue by the number of days worked in the respective periods.  Nurse and Allied Staffing revenue also includes revenue from the permanent placement of nurses.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:22px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:22px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Physician Staffing</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Days filled is calculated by dividing the total hours invoiced during the period by 8 hours.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue per day filled is calculated by dividing revenue invoiced by days filled for the period presented. Invoiced revenue excludes revenue from permanent placement and accrued revenue.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></div><hr style="page-break-after:always"><div><a name="s9573909439ED774B0E77FC5D53051FB5"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Results of Operations</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes, for the periods indicated, selected condensed consolidated statements of operations data expressed as a&#160;percentage of revenue.  Our historical results of operations are not necessarily indicative of future operating results.&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:73%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of services</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bad debt expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on early extinguishment of debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax expense</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net (loss) income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net income attributable to noncontrolling interest in subsidiary</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></div><hr style="page-break-after:always"><div><a name="s58887043B492907C3897FC5D42BF89FA"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Comparison of Results for the </font><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Three Months Ended March 31, 2017</font><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">&#32;compared to the </font><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Three Months Ended March 31, 2016</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Increase (Decrease)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Increase (Decrease)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Dollars in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207,573</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,583</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Costs of services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">154,298</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145,537</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,761</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,046</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,236</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,933</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,303</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bad debt expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">323</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">249</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,191</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,412</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(221</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,255</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,165</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,910</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,219</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,635</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(416</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,436</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,855</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on early extinguishment of debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,969</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,969</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,983</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(106.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">797</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(431</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,718</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,186</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20,904</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(109.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net income attributable to noncontrolling interest in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">292</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,010</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,022</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,032</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(110.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue from services</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from services </font><font style="font-family:inherit;font-size:10pt;">increased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">5.6%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$207.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">$196.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. The increase was entirely from Nurse and Allied Staffing, partially offset by lower revenue from Physician Staffing and OHCMS. See further discussion in Segment Results.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Gross profit</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit increased 4.4% to $53.3 million for the three months ended March 31, 2017, as compared to $51.0 million for the three months ended March 31, 2016, with gross margins of 25.7% and 26.0%, respectively. The decrease in consolidated gross margin was primarily due to higher compensation costs for healthcare professionals at certain large accounts.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Selling, general and administrative expenses</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative expenses </font><font style="font-family:inherit;font-size:10pt;">increased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">10.0%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$47.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">$42.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. The increase was primarily due to investments in revenue producing headcount and higher marketing costs for candidate attraction. As a&#160;percentage of total revenue, selling, general and administrative expenses were </font><font style="font-family:inherit;font-size:10pt;">22.8%</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">21.9%</font><font style="font-family:inherit;font-size:10pt;">, for the three months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Depreciation and amortization expense</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization expense</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:10pt;">totaled </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. The decrease is primarily due to lower amortization of other intangible assets related to a second quarter 2016 impairment charge to customer relationships of our Physician Staffing business. As a&#160;percentage of revenue, depreciation and amortization expense was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1.0%</font><font style="font-family:inherit;font-size:10pt;">&#32;and 1.2% for the three months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and 2016, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition-related contingent consideration</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration totaled </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for both of the three month periods ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and March 31, 2016 and was related to our acquisitions of Mediscan and USR. See Note 9 - Fair Value Measurements to our condensed consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Interest expense</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:10pt;">totaled </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. We refinanced our debt structure late in the second quarter of 2016, which resulted in lower overall borrowing costs. In addition, we settled our 8% fixed rate Convertible Notes on March 17, 2017. The effective interest rate on our borrowings was </font><font style="font-family:inherit;font-size:10pt;">7.1%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three month period ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to </font><font style="font-family:inherit;font-size:10pt;">9.3%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Gain on derivative liability</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We incurred a gain on derivative liability of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$16.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to the change in the fair value of embedded features of our Convertible Notes from the end of the prior quarters. The gains in both periods primarily resulted from decreases in our share price for the respective periods. See Note 7 - Debt and Note 8 - Convertible Notes Derivative Liability to our condensed consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Loss on early extinguishment of debt</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on early extinguishment of debt relates to the early settlement of our Convertible Notes and was $5.0 million for the three months ended March 31, 2017. See Note 7 - Debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income tax expense</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax expense from continuing operations totaled </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, compared to </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Income tax for the quarter is primarily related to the impact from amortization of indefinite-lived intangible assets for tax purposes, and partly offset by a discrete tax benefit. </font></div><div style="line-height:120%;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></div><hr style="page-break-after:always"><div><a name="s1C7CFBE5D4FBD3305E4CFC5D44C2063E"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Segment Results</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information on operating segments and a reconciliation to income from operations for the periods indicated are as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183,108</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168,765</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,464</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,001</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,365</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207,573</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,583</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,622</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,790</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(440</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(111</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,002</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate overhead</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,286</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,191</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,412</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,255</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain statistical data for our business segments for the periods indicated are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:44%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Percent</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Change</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Nurse and Allied Staffing statistical data: (a)</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">FTEs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,204</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,817</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">387</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Average Nurse and Allied Staffing revenue per FTE per day </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">272</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Physician Staffing statistical data: (a)</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Days filled </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,036</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,842</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,806</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue per day filled </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,592</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,521</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;%</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See definition of Business Measurement under the Operating Metrics section of our Management's Discussion and Analysis.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 11 - Segment Data.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Segment Comparison - </font><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Three Months Ended March 31, 2017</font><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">&#32;compared to the </font><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">Three Months Ended March 31, 2016</font></div><div style="line-height:120%;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;"><br></font></div><div style="line-height:120%;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-style:italic;font-weight:bold;">Nurse and Allied Staffing</font></div><div style="line-height:120%;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from Nurse and Allied Staffing </font><font style="font-family:inherit;font-size:10pt;">increased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$14.3 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">8.5%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$183.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">$168.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. The year-over-year </font><font style="font-family:inherit;font-size:10pt;">increase</font><font style="font-family:inherit;font-size:10pt;">&#32;was due to growth in volume and improved pricing.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income from Nurse and Allied Staffing </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;or </font><font style="font-family:inherit;font-size:10pt;">7.0%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$15.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">$16.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. As a&#160;percentage of segment revenue, contribution income was </font><font style="font-family:inherit;font-size:10pt;">8.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, compared to </font><font style="font-family:inherit;font-size:10pt;">9.9%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. The decrease is primarily attributable to higher compensation packages provided to our field staff and increased investments in revenue producing headcount and marketing spend to support recent contract wins.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Metrics</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The average number of Nurse and Allied Staffing FTEs on contract during the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">increased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">5.7%</font><font style="font-family:inherit;font-size:10pt;">&#32;from the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. The average Nurse and Allied Staffing revenue per FTE per day </font><font style="font-family:inherit;font-size:10pt;">increased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">3.7%</font><font style="font-family:inherit;font-size:10pt;">, reflecting higher average bill rates.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Physician Staffing</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from Physician Staffing </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">12.2%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$21.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">$24.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. The </font><font style="font-family:inherit;font-size:10pt;">decrease</font><font style="font-family:inherit;font-size:10pt;">&#32;in revenue was entirely due to lower volume of days filled.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income from Physician Staffing </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;$0.7 million or </font><font style="font-family:inherit;font-size:10pt;">47.2%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. As a&#160;percentage of segment revenue, contribution income was </font><font style="font-family:inherit;font-size:10pt;">3.8%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">6.4%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Metrics</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing days filled </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">10.7%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">15,036</font><font style="font-family:inherit;font-size:10pt;">&#32;days in the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">16,842</font><font style="font-family:inherit;font-size:10pt;">&#32;days in the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Revenue per day filled for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$1,592</font><font style="font-family:inherit;font-size:10pt;">, up </font><font style="font-family:inherit;font-size:10pt;">4.7%</font><font style="font-family:inherit;font-size:10pt;">&#32;over the prior year. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Human Capital Management Services</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from OHCMS </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">10.8%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">$3.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. The decrease in revenue was primarily due to a lower level of executive placements made in the first quarter of 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution loss from OHCMS was </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. The </font><font style="font-family:inherit;font-size:10pt;">decrease</font><font style="font-family:inherit;font-size:10pt;">&#32;was primarily due to the lower revenue.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Unallocated Corporate Overhead</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included in unallocated corporate overhead is corporate compensation and benefits, and general and administrative expenses including rent and utilities, computer supplies and expenses, insurance, professional expenses, corporate-wide projects (initiatives), and public company expenses. Unallocated corporate overhead was </font><font style="font-family:inherit;font-size:10pt;">$10.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended March 31, 2017 compared to </font><font style="font-family:inherit;font-size:10pt;">$10.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended March 31, 2016. As a percentage of consolidated revenue, unallocated corporate overhead was </font><font style="font-family:inherit;font-size:10pt;">5.0%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended March 31, 2017 and </font><font style="font-family:inherit;font-size:10pt;">5.3%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended March 31, 2016.</font></div><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sAE9612167BEE6C03F897FC5D5414055F"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Transactions with Related Parties</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 14 - Related Party Transactions to our condensed consolidated financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s18D6732DB0752588185AFC5D436E3629"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Liquidity and Capital Resources</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">$13.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in cash and cash equivalents and </font><font style="font-family:inherit;font-size:10pt;">$38.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of total debt. Working capital decreased to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$106.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$108.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Our net days' sales outstanding (DSO), which excludes amounts owed to subcontractors, increased 3 days to </font><font style="font-family:inherit;font-size:10pt;">58</font><font style="font-family:inherit;font-size:10pt;">&#32;days as of March 31, 2017, compared to 55 days as of December 31, 2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our operating cash flow constitutes our primary source of liquidity, and historically, has been sufficient to fund our working capital, capital expenditures, internal business expansion and debt service, including our commitments as described in the Commitments table which follows.&#160;We expect to meet our future needs for working capital, capital expenditures, internal </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">business expansion and debt service from a combination of cash on hand, operating cash flows and funds available through the revolving loan portion of our Credit Agreement. Operating cash flows and cash on hand, along with amounts available under our revolving credit facility, should be sufficient to meet these needs during the next twelve months.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash provided by operating activities was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, primarily due to a decrease in net working capital in the three months ended March 31, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in investing activities was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, compared to </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the three months ended March 31, 2016, primarily for capital expenditures in both periods. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in financing activities during the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$7.6 million</font><font style="font-family:inherit;font-size:10pt;">, compared to </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, primarily due to the repayments of debt in both periods. During the three months ended March 31, 2017, we settled our Convertible Notes with a partial cash payment of $5.0 million and paid $0.6 million in related extinguishment fees.&#160;We also reduced the principal amount of our term debt by $1.0 million. During the three months ended March 31, 2016, we repaid total debt, net of borrowings, of $2.0 million.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="sEF638969FFD56792606DFC5D5451A89E"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Debt</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2016 Senior Credit Facilities </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As more fully described in Note 7 - Debt to our condensed consolidated financial statements, as of March 31, 2017, our debt includes a senior credit agreement (Credit Agreement), which provides a term loan of $40.0 million (Term Loan) and a revolving credit facility of up to $100.0 million (Revolving Credit Facility) (together with the Term Loan, the Senior Credit Facilities) both of which mature in five years. The Revolving Credit Facility includes a subfacility for swingline loans up to an amount not to exceed $15.0 million, and a $35.0 million sublimit for the issuance of standby letters of credit.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of March&#160;31, 2017, the Term Loan and Revolving Credit Facility bore interest at a rate equal to One Month LIBOR plus 200 basis points and $77.9 million was available under the Revolving Credit Facility. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 17, 2017, we repaid in full our fixed rate 8% Convertible Notes. The Convertible Notes, had an aggregate principal amount of $25.0 million, and were convertible into shares of our Common Stock, at a conversion price of $7.10 per share. As a result of the early repayment, we recognized $5.0 million as loss on early extinguishment of debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At inception of the notes, and at the time of the payoff, the conversion price of $7.10 was below the market price. The initial agreement allowed us to force conversion of the Notes only after three years, beginning July 1, 2017, and if the VWAP exceeded 125% of the Conversion Price for 20 days of a 30 day trading period (the threshold was $8.88, which we were well above). As such, we and the Noteholders agreed to an early settlement at fair value based on the stock price. In connection with the repayment, we issued to the Noteholders an aggregate of 3,175,584 shares of Common Stock and cash in the aggregate amount of </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;">.&#160;See Note 7 - Debt.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sE8713986FBD61CA743BDFC5D401DEA06"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Stockholders&#8217; Equity</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 10 - Stockholders' Equity to our condensed consolidated financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></div><hr style="page-break-after:always"><div><a name="s6E307A9084C48F1D5BDCFC5D4439688F"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Commitments and Off-Balance Sheet Arrangements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We do not have any off-balance sheet arrangements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reflects our contractual obligations and other commitments as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="29"></td></tr><tr><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:0px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Thereafter</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="27" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited, amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan (a)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest on debt (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,301</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,148</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,085</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,715</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,602</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">751</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration (c)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,862</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,867</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,070</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,746</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital lease obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease obligations (d)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,968</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,415</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,933</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,209</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,867</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,193</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,649</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,061</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,220</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,557</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,618</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,193</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under our senior credit agreement which provides our Term Loan, we are required to comply with certain financial covenants. Our inability to comply with the required covenants or other provisions could result in default. In the event of any such default and our inability to obtain a waiver of the default, all amounts outstanding under the Term Loan could be declared immediately due and payable.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest on debt represents payments due through maturity for our Term Loan, calculated using the March 31, 2017 applicable LIBOR and margin rate totaling 2.8%.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contingent consideration represents the estimated payments due to the sellers related to the Mediscan and USR acquisitions, including accretion. While it is not certain if, or when, these contingent payments will be made, we have included the payments in the table based on our best estimates of the amounts and dates when the contingencies may be resolved.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents future minimum lease payments associated with operating lease agreements with original terms of more than one year.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 12 - Commitments and Contingencies to our condensed consolidated financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sC0CDCBBA35E0EBF56D7BFC5D43691D8E"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Critical Accounting Policies and Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our critical accounting policies and estimates remain consistent with those reported in our Annual Report on Form 10-K for the year ended December 31, 2016, filed with the SEC.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sCCDD80CCC45697540658FC5D54F9C135"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 15 - Recent Accounting Pronouncements to our condensed consolidated financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></div><hr style="page-break-after:always"><div><a name="sBA5326807E226A961B2AFC5D4433B9A5"></a></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest Rate Risk</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are exposed to the risk of fluctuation in interest rates relating to our variable rate debt related to our Senior Credit Facilities.  During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;or 2016, we did not use interest rate swaps or other types of derivative financial instruments to hedge our interest rate risk. Our current credit agreement charges us interest at a rate of LIBOR plus a leverage-based margin. See Note 7 - Debt to our condensed consolidated financial statements for further information. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Risks</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aside from settlement of our Convertible Notes as described in Note 7 - Debt to our condensed consolidated financial statements, there have been no material changes to our other exposures as disclosed in our Annual Report on Form&#160;10-K filed for the year ended December 31, 2016.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></div><hr style="page-break-after:always"><div><a name="sF170042775F2432D1836FC5D554CEB9B"></a></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONTROLS AND PROCEDURES </font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our &#8220;disclosure controls and procedures&#8221; (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act), as of the end of the period covered by this report. Based upon the evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective. Disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, communicated to management, including the Chief Executive Officer and the Chief Financial Officer, and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms. The disclosure controls and procedures are designed to ensure that information required to be disclosed by us in reports required under the Exchange Act of 1934, as amended, is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, in order to allow timely decisions regarding any required disclosure.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The evaluation has not identified any changes in our internal controls over financial reporting or in other factors that occurred during the last fiscal quarter that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28</font></div></div><hr style="page-break-after:always"><div><a name="sC2845EB5388875130AC4FC5D556D8F5E"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PART II. &#8211; OTHER INFORMATION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s364BE15B49C1F8A0B36EFC5D559FA7FB"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LEGAL PROCEEDINGS</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are subject to legal proceedings and claims that arise in the ordinary course of our business. We do not believe the outcome of these matters will have a material adverse effect on our business, financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sD0DE19F51779EAC478F6FC5D55C1F2A2"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 1A.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RISK FACTORS</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There are no material changes to our Risk Factors as previously disclosed in our Form 10-K for the year ended December 31,</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s27ABCB2663F5D3D39F3FFC5D55F3C4A6"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 6.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBITS</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Exhibit&#160;Index immediately following signature page.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></div><hr style="page-break-after:always"><div><a name="sF3A56B6C4936C48F1A15FC5D56151195"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:50%;"></td><td style="width:5%;"></td><td style="width:45%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS&#160;COUNTRY&#160;HEALTHCARE,&#160;INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: May 5, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ William J. Burns</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">William J. Burns</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EVP &amp; Chief&#160;Financial&#160;Officer                         (Principal Accounting and Financial Officer)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></div><hr style="page-break-after:always"><div><a name="sCF020B223C8AA77AD0F9FC5D564613B5"></a></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT INDEX</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:3%;"></td><td style="width:86%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*31.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certification pursuant to Rule&#160;13a-14(a) and Rule&#160;15d-14 (a) by William J. Grubbs,&#160;President, Chief Executive Officer, Director (Principal Executive Officer)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*31.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certification pursuant to Rule&#160;13a-14(a) and Rule&#160;15d-14 (a) by William J. Burns, EVP &amp; Chief Financial Officer (Principal Accounting and Financial Officer)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*32.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certification pursuant to 18 U.S.C. Section&#160;1350 by William J. Grubbs,&#160;President, Chief Executive Officer, Director (Principal Executive Officer)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*32.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certification pursuant to 18 U.S.C. Section&#160;1350 by William J. Burns, EVP &amp; Chief Financial Officer (Principal Accounting and Financial Officer)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.INS</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Instance Document</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.SCH</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Schema Document</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.DEF</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Definition Linkbase Document</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.LAB</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Label Linkbase Document</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.CAL</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Calculation Linkbase Document</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.PRE</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Presentation Linkbase Document</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Filed herewith</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furnished herewith</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ccrn2017-03x31x10qex31x11.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s7513823F0A89027F9878FC5D61ACBD99"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT 31.1</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Certification</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, William J. Grubbs, certify that:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I have reviewed this quarterly report on Form&#160;10-Q of Cross Country Healthcare, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and&#160;&#160;&#160;&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:6%;"></td><td style="width:21%;"></td><td style="width:73%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 5, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ William J. Grubbs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">William J. Grubbs</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President, Chief&#160;Executive Officer, Director</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal&#160;Executive&#160;Officer)</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ccrn2017-03x31x10qex31x21.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s2877FC4D5FD50C25F4AEFC5D6251D802"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT 31.2</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Certification</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, William J. Burns, certify that:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I have reviewed this quarterly report on Form&#160;10-Q of Cross Country Healthcare, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and&#160;&#160;&#160;&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:6%;"></td><td style="width:21%;"></td><td style="width:73%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 5, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ William J. Burns</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">William J. Burns</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EVP &amp; Chief&#160;Financial&#160;Officer                                                                                    (Principal Accounting and Financial Officer)</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ccrn2017-03x31x10qex32x11.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s70F096EB0B8C8F0D8A24FC5D62F91075"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT 32.1</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the accompanying Quarterly Report on Form&#160;10-Q of Cross Country Healthcare, Inc. (the Company) for the quarterly period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, (the "Periodic Report"), I, William J. Grubbs, President and Chief Executive Officer of the Company, hereby certify pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge the Periodic Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:6%;"></td><td style="width:21%;"></td><td style="width:73%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 5, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ William J. Grubbs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">William J. Grubbs</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President, Chief&#160;Executive Officer, Director</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal&#160;Executive&#160;Officer)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to Cross Country Healthcare, Inc. and will be retained by Cross Country Healthcare, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foregoing certification is provided solely for purposes of complying with the provisions of Section&#160;906 of the Sarbanes-Oxley Act of 2002.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ccrn2017-03x31x10qex32x21.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sB35043F261C06CCD04CCFC5D63A1019E"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT 32.2</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the accompanying Quarterly Report on Form&#160;10-Q of Cross Country Healthcare, Inc. (the "Company") for the quarterly period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, (the "Periodic Report"), I, William J. Burns, EVP &amp; Chief Financial Officer of the Company, hereby certify pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge the Periodic Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:6%;"></td><td style="width:21%;"></td><td style="width:73%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 5, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ William J. Burns</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">William J. Burns</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EVP &amp; Chief&#160;Financial&#160;Officer                                                                                    (Principal Accounting and Financial Officer)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to Cross Country Healthcare, Inc. and will be retained by Cross Country Healthcare, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foregoing certification is provided solely for purposes of complying with the provisions of Section&#160;906 of the Sarbanes-Oxley Act of 2002.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>ccrn-20170331.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:be977d59f71541c59f8e9487d8d9dd18,x:cfd6caecae784a6bb0562200652274bc-->
<xbrli:xbrl xmlns:ccrn="http://www.crosscountryhealthcare.com/20170331" xmlns:country="http://xbrl.sec.gov/country/2016-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2016-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
	<link:schemaRef xlink:href="ccrn-20170331.xsd" xlink:type="simple" />
	<xbrli:context id="FD2017Q1YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q2April30">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-04-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q1YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ccrn:AccountingStandardsUpdate201609ForfeitureRateComponentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ccrn_AccountingStandardsUpdate201609Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ccrn:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ccrn_AccountingStandardsUpdate201609Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ccrn:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-01-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2015Q4Oct30-30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-10-30</xbrli:startDate>
			<xbrli:endDate>2015-10-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-10-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:AssumedAdditionalContingentPurchasePriceLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2April1_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MedicalStaffingNetworkMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-04-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-10-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1May3_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-05-03</xbrli:startDate>
			<xbrli:endDate>2017-05-03</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:AssumedAdditionalContingentPurchasePriceLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q2_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MedicalStaffingNetworkMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:PotentialEarnoutMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2014Q2Jun30_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MedicalStaffingNetworkMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-06-30</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q1Mar31_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MedicalStaffingNetworkMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-07-01</xbrli:startDate>
			<xbrli:endDate>2016-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-10-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_DebtInstrumentAxis_ccrn_ConvertibleNoteDerivativeLiabilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:ConvertibleNoteDerivativeLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_ConvertibleNoteDerivativeLiabilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:ConvertibleNoteDerivativeLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_DebtInstrumentAxis_ccrn_A8ConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A8ConvertibleNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_A8ConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A8ConvertibleNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:FiscalQuartersEndingSeptember302016throughJune302017Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-17</xbrli:startDate>
			<xbrli:endDate>2017-03-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2June22_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-22</xbrli:startDate>
			<xbrli:endDate>2016-06-22</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q1March17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Marc17_us-gaap_DebtInstrumentAxis_ccrn_ConvertibleNoteDerivativeLiabilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:ConvertibleNoteDerivativeLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-17</xbrli:startDate>
			<xbrli:endDate>2017-03-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:FiscalQuartersEndingSeptember302017throughJune302018Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2June22_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-06-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_EachFiscalQuarterEndingThereafterMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:EachFiscalQuarterEndingThereafterMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q2_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2June22_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-06-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Marc17_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-17</xbrli:startDate>
			<xbrli:endDate>2017-03-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Marc17_us-gaap_DebtInstrumentAxis_ccrn_A8ConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A8ConvertibleNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-17</xbrli:startDate>
			<xbrli:endDate>2017-03-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:LetterofCreditFeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:LetterofCreditFeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:LetterofCreditFeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:LetterofCreditFeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:LetterofCreditFeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:ConvertibleNotesNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:ConvertibleNotesNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:ConvertibleNotesNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:ConvertibleNotesNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByLiabilityClassAxis_ccrn_DeferredCompensationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByLiabilityClassAxis_ccrn_DeferredCompensationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesDerivativeLiabilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:ConvertibleNotesDerivativeLiabilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesDerivativeLiabilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:ConvertibleNotesDerivativeLiabilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-10-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_AffiliatedEntityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:AffiliatedEntityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q1YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q1YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_AffiliatedEntityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:AffiliatedEntityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="segment">
		<xbrli:measure>ccrn:segment</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="instrument">
		<xbrli:measure>ccrn:instrument</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="d">
		<xbrli:measure>utreg:D</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit>
	<xbrli:unit id="financial_covenant">
		<xbrli:measure>ccrn:financial_covenant</xbrli:measure>
	</xbrli:unit>
	<ccrn:BusinessCombinationConsiderationDeferredPeriod contextRef="D2014Q2Jun30_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember" id="Fact-5FCE6E9DF120BF9336BFFC5D3DF261F8">P21M</ccrn:BusinessCombinationConsiderationDeferredPeriod>
	<ccrn:BusinessCombinationConsiderationTransferredCashConsiderationNegotiated contextRef="D2015Q4Oct30-30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="-5" id="Fact-B1620CA07BF7F26C2352FC5D3DF284B8" unitRef="usd">28000000</ccrn:BusinessCombinationConsiderationTransferredCashConsiderationNegotiated>
	<ccrn:BusinessCombinationContingentConsiderationArrangementsExpense contextRef="FD2016Q1YTD" decimals="-3" id="Fact-4BA21EBBF635038E9F84FC5D3D537B0C" unitRef="usd">287000</ccrn:BusinessCombinationContingentConsiderationArrangementsExpense>
	<ccrn:BusinessCombinationContingentConsiderationArrangementsExpense contextRef="FD2017Q1YTD" decimals="-3" id="Fact-BC2631B48E27829A9048FC5D3D4BE3A1" unitRef="usd">270000</ccrn:BusinessCombinationContingentConsiderationArrangementsExpense>
	<ccrn:BusinessCombinationEscrowDepositRelease contextRef="D2017Q1May3_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-5" id="Fact-2EC5FA40564E3F58B7BFAB12931DFACE" unitRef="usd">5000000</ccrn:BusinessCombinationEscrowDepositRelease>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="INF" id="Fact-331F3EF668BB7877EE63FC5D3F51D4CA" unitRef="number">1.50</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="INF" id="Fact-133840509D0F6744BDF9FC5D3F516CFE" unitRef="number">2.00</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MinimumMember" decimals="INF" id="Fact-2673196F9EB5647D97A9FC5D3F524A51" unitRef="number">1.50</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="INF" id="Fact-723F13E0100CAE65EEA2FC5D3F51BA1F" unitRef="number">2.50</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MinimumMember" decimals="INF" id="Fact-04851F81D511C5C6DDB5FC5D3F523B12" unitRef="number">2.00</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="INF" id="Fact-EC7FD3A60617024E665DFC5D3F5237E4" unitRef="number">3.00</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MinimumMember" decimals="INF" id="Fact-C172596004C322D43F18FC5D3F5275D3" unitRef="number">2.50</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MinimumMember" decimals="INF" id="Fact-229505A1858005195FE6FC5D3F523A78" unitRef="number">3.00</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal contextRef="FD2017Q1YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-74362B6AAFA3F4C0952CA89E0CC7D949" unitRef="number">0.15</ccrn:ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal>
	<ccrn:DebtCovenantConsolidatedFixedChargeCoverageRatio contextRef="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MinimumMember" decimals="INF" id="Fact-EF4396ED516279D83AE8FC5D3EEAF44C" unitRef="number">1.50</ccrn:DebtCovenantConsolidatedFixedChargeCoverageRatio>
	<ccrn:DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate contextRef="FD2017Q1YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" id="Fact-519F4BB6FEEB1B0059EAA8A034A45ABE">P3Y</ccrn:DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate>
	<ccrn:DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault contextRef="FD2017Q1YTD_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-8B9E5F9C0F1135B2013AFC5D3F5C3435" unitRef="number">0.02</ccrn:DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault>
	<ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems contextRef="FD2016Q1YTD" decimals="3" id="Fact-A73C12F45771C962ACECFC5D400F4712" unitRef="number">0.039</ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems>
	<ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems contextRef="FD2017Q1YTD" decimals="3" id="Fact-26AB82C073671DBFF6E9FC5D400F153C" unitRef="number">0.538</ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems>
	<ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense contextRef="FD2017Q1YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-86B6AA482B70D935816CFC5D3F99DA60" unitRef="usd">270000</ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense>
	<ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense contextRef="FD2017Q1YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-1BA4367FE522CD9ABCFDFC5D3F98E260" unitRef="usd">0</ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense>
	<ccrn:JointVenturePercentOwnership contextRef="FI2017Q1_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="2" id="Fact-3E7872002B720CB0A73CFC5D401840BB" unitRef="number">0.68</ccrn:JointVenturePercentOwnership>
	<ccrn:LineOfCreditFacilitySubFacilityForSwinglineLoans contextRef="I2016Q2June22_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-D1FE935BC80AFC897BA1FC5D3EEAA62A" unitRef="usd">15000000.0</ccrn:LineOfCreditFacilitySubFacilityForSwinglineLoans>
	<ccrn:LineOfCreditFacilitySubLimitForLettersOfCredit contextRef="I2016Q2June22_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-58AFBDE78578FFCA9D7BFC5D3EE8C6C4" unitRef="usd">35000000.0</ccrn:LineOfCreditFacilitySubLimitForLettersOfCredit>
	<ccrn:LineofCreditFacilityAdditionalCapacity contextRef="I2016Q2June22_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-53CC515DF03ADDBC6038FC5D3EE2245C" unitRef="usd">50000000.0</ccrn:LineofCreditFacilityAdditionalCapacity>
	<ccrn:LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments contextRef="D2016Q2June22_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="INF" id="Fact-158218FA3BCD098039A1FC5D3EEAD707" unitRef="number">0.0125</ccrn:LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments>
	<ccrn:LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments contextRef="D2016Q2June22_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="INF" id="Fact-3D5F29855560223901EDFC5D3EEAF50F" unitRef="number">0.01875</ccrn:LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments>
	<ccrn:LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments contextRef="D2016Q2June22_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="INF" id="Fact-D629FFEE4AD5751B5637FC5D3EE22C5C" unitRef="number">0.025</ccrn:LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments>
	<ccrn:LongtermDebtandCapitalLeaseObligationsGross contextRef="FI2016Q4" decimals="-3" id="Fact-0ED828F891A6F47E1BF6FC5D3F0DB163" unitRef="usd">89792000</ccrn:LongtermDebtandCapitalLeaseObligationsGross>
	<ccrn:LongtermDebtandCapitalLeaseObligationsGross contextRef="FI2017Q1" decimals="-3" id="Fact-16E418FFA403F73A8696FC5D3F079A95" unitRef="usd">36508000</ccrn:LongtermDebtandCapitalLeaseObligationsGross>
	<ccrn:NumberofFinancialCovenants contextRef="FD2017Q1YTD_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-59CA7C5B4D2F30D1D2DDFC5D3EE9AFD2" unitRef="financial_covenant">2</ccrn:NumberofFinancialCovenants>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses contextRef="FD2016Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-3FEBD9064B1C963B3710FC5D40044668" unitRef="usd">16790000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses contextRef="FD2016Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-2DB3099B26F520611946FC5D4006C7B4" unitRef="usd">-111000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses contextRef="FD2016Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-3BFA5794C4566FCD9251FC5D3FFFCEB6" unitRef="usd">1553000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses contextRef="FD2016Q1YTD" decimals="-3" id="Fact-C97EC0E6B8DE71D6818AFC5D3FFF4C94" unitRef="usd">18232000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-0812DF61219351715FBEFC5D4005FC7E" unitRef="usd">15622000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-B197B332F097037DA3CCFC5D3FFF2352" unitRef="usd">-440000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-598DF36F5B84ECF79116FC5D40024F1A" unitRef="usd">820000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses contextRef="FD2017Q1YTD" decimals="-3" id="Fact-4D86229AF50CE0DA54D1FC5D40006013" unitRef="usd">16002000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses>
	<ccrn:PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-D33E882EDEA382C42969A8A515F35913" unitRef="usd">5600000</ccrn:PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt>
	<ccrn:ProvisionforDoubtfulAccountsandOtherAllowances contextRef="FD2016Q1YTD" decimals="-3" id="Fact-721EE14AB6BA602A5FDCFC5D3DA8C82F" unitRef="usd">798000</ccrn:ProvisionforDoubtfulAccountsandOtherAllowances>
	<ccrn:ProvisionforDoubtfulAccountsandOtherAllowances contextRef="FD2017Q1YTD" decimals="-3" id="Fact-6EE9360CC7A40AA9E255FC5D3DB2B02B" unitRef="usd">1038000</ccrn:ProvisionforDoubtfulAccountsandOtherAllowances>
	<ccrn:SegmentReportingUnallocatedCorporateExpenses contextRef="FD2016Q1YTD" decimals="-3" id="Fact-4613F6CED28BADB37438FC5D40064EDD" unitRef="usd">10368000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
	<ccrn:SegmentReportingUnallocatedCorporateExpenses contextRef="FD2017Q1YTD" decimals="-3" id="Fact-876F50FCA52356EC3DA3FC5D4001238C" unitRef="usd">10286000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
	<ccrn:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet contextRef="FD2016Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-F41055D69554744870C1FC5D3FD46A98" unitRef="shares">51091</ccrn:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet>
	<ccrn:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-907483CB43E80D2B01C4FC5D3FD5FD51" unitRef="shares">74878</ccrn:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet>
	<ccrn:SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" decimals="2" id="Fact-AA1DDBCC6C8699E05E5BFC5D3FD55A3F" unitRef="number">0.48</ccrn:SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage>
	<ccrn:ThresholdPeriodPastDueforPaymentofServicesProvided contextRef="FD2017Q1YTD_us-gaap_RangeAxis_us-gaap_MaximumMember" id="Fact-485553E265342FF33261FC5D3FCA11AC">P60D</ccrn:ThresholdPeriodPastDueforPaymentofServicesProvided>
	<ccrn:ThresholdPeriodPastDueforPaymentofServicesProvided contextRef="FD2017Q1YTD_us-gaap_RangeAxis_us-gaap_MinimumMember" id="Fact-50E52C341DA60F825E9BFC5D3FC9C76B">P15D</ccrn:ThresholdPeriodPastDueforPaymentofServicesProvided>
	<ccrn:WorkingCapitalAdjustmentInvestingActivities contextRef="FD2016Q1YTD" decimals="-3" id="Fact-85D94059965B202D5BAAFC5D3DAF0F4B" unitRef="usd">277000</ccrn:WorkingCapitalAdjustmentInvestingActivities>
	<ccrn:WorkingCapitalAdjustmentInvestingActivities contextRef="FD2017Q1YTD" decimals="-3" id="Fact-246765D6096D436D0AB0FC5D3DB14965" unitRef="usd">0</ccrn:WorkingCapitalAdjustmentInvestingActivities>
	<dei:AmendmentFlag contextRef="FD2017Q1YTD" id="Fact-65E5C8D881304E2F7959FC5D3CA892C8">false</dei:AmendmentFlag>
	<dei:CurrentFiscalYearEndDate contextRef="FD2017Q1YTD" id="Fact-E652630D3F811AA27E7BFC5D3CA86BF3">--12-31</dei:CurrentFiscalYearEndDate>
	<dei:DocumentFiscalPeriodFocus contextRef="FD2017Q1YTD" id="Fact-4F3295BA22FF48E68F7DFC5D3CA72495">Q1</dei:DocumentFiscalPeriodFocus>
	<dei:DocumentFiscalYearFocus contextRef="FD2017Q1YTD" id="Fact-F9AC282289153A5FD952FC5D3CA7B128">2017</dei:DocumentFiscalYearFocus>
	<dei:DocumentPeriodEndDate contextRef="FD2017Q1YTD" id="Fact-925C8286837744826A5DFC5D3CA746B5">2017-03-31</dei:DocumentPeriodEndDate>
	<dei:DocumentType contextRef="FD2017Q1YTD" id="Fact-627FB02C99312A18E0DEFC5D3CA82E96">10-Q</dei:DocumentType>
	<dei:EntityCentralIndexKey contextRef="FD2017Q1YTD" id="Fact-4A02313BBD55213A5678FC5D3CA733D0">0001141103</dei:EntityCentralIndexKey>
	<dei:EntityCommonStockSharesOutstanding contextRef="I2017Q2April30" decimals="INF" id="Fact-15068C93B92231EF3781FC5D3CA7779D" unitRef="shares">36433655</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityFilerCategory contextRef="FD2017Q1YTD" id="Fact-69038C6F6C5E92E73F14FC5D3CA84F5A">Accelerated Filer</dei:EntityFilerCategory>
	<dei:EntityRegistrantName contextRef="FD2017Q1YTD" id="Fact-1080E41726CC695BFE7FFC5D3CA8623A">CROSS COUNTRY HEALTHCARE INC</dei:EntityRegistrantName>
	<dei:TradingSymbol contextRef="FD2017Q1YTD" id="Fact-2F25EB03703AF0BFB7AFFC5D3CA705E3">CCRN</dei:TradingSymbol>
	<us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="FI2016Q4" decimals="-3" id="Fact-0235E7B36812BBDF8DDAFC5D3CE91606" unitRef="usd">58837000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
	<us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="FI2017Q1" decimals="-3" id="Fact-89ACA9754EECC2465175FC5D3CDFA8F2" unitRef="usd">46606000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
	<us-gaap:AccountsReceivableNetCurrent contextRef="FI2016Q4" decimals="-3" id="Fact-836DE00B79D893BF2990FC5D3CE799F0" unitRef="usd">173620000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccountsReceivableNetCurrent contextRef="FI2017Q1" decimals="-3" id="Fact-CEFA027422175410CF9EFC5D3CF1ABE4" unitRef="usd">161765000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccountsReceivableRelatedParties contextRef="FI2016Q4" decimals="-5" id="Fact-D7CC8344736E72F164A1FC5D401846B9" unitRef="usd">1000000</us-gaap:AccountsReceivableRelatedParties>
	<us-gaap:AccountsReceivableRelatedParties contextRef="FI2017Q1" decimals="-5" id="Fact-5F310237D0775DDA3B18A07C23ADF91C" unitRef="usd">800000</us-gaap:AccountsReceivableRelatedParties>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="FI2016Q4" decimals="-3" id="Fact-E7707CDD143FB51745FBFC5D3CFB5C3D" unitRef="usd">43141000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="FI2017Q1" decimals="-3" id="Fact-C37BC2AA74C3FE68E884FC5D3CFA7326" unitRef="usd">44178000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="FI2016Q4" decimals="-5" id="Fact-CD73D113C14D9C19EA03FC5D3E088D89" unitRef="usd">-1200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="FI2017Q1" decimals="-5" id="Fact-5D4BA0235E755952D6A8FC5D3E0574A0" unitRef="usd">-1200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2016Q4" decimals="-3" id="Fact-DFE156F93C1DF1282005FC5D3CE1955B" unitRef="usd">-1241000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2017Q1" decimals="-3" id="Fact-FADE9EE6CF1A005E4436FC5D3CEF7D68" unitRef="usd">-1207000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="FI2016Q4" decimals="-3" id="Fact-353BC20ECBF259D462E8FC5D3CE00A31" unitRef="usd">256570000</us-gaap:AdditionalPaidInCapitalCommonStock>
	<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="FI2017Q1" decimals="-3" id="Fact-DC4BB7F5EF07CEA555ABFC5D3CE7BB29" unitRef="usd">303115000</us-gaap:AdditionalPaidInCapitalCommonStock>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2016Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" decimals="-5" id="Fact-05B9615B56A7997B3802FC5D3FD4CF49" unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q1YTD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ccrn_AccountingStandardsUpdate201609Member" decimals="-5" id="Fact-3A1B4566CC05013C94D9A061F443730B" unitRef="usd">-100000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember" decimals="-5" id="Fact-05FCE94E109FD4B2CC2AFC5D3FD4500C" unitRef="usd">700000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="FI2016Q4" decimals="-3" id="Fact-73CDEFCFDB26E171C294FC5D3CFAFC56" unitRef="usd">3245000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="FI2017Q1" decimals="-3" id="Fact-521A8AEAEB11BE6E5957FC5D3CFB3F59" unitRef="usd">3473000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<us-gaap:AmortizationOfFinancingCosts contextRef="FD2016Q1YTD" decimals="-3" id="Fact-2D24BB407504A5B6F48CFC5D3DAFD321" unitRef="usd">470000</us-gaap:AmortizationOfFinancingCosts>
	<us-gaap:AmortizationOfFinancingCosts contextRef="FD2017Q1YTD" decimals="-3" id="Fact-648DB7D00A64F3E423BCFC5D3DA7E707" unitRef="usd">354000</us-gaap:AmortizationOfFinancingCosts>
	<us-gaap:AssetImpairmentCharges contextRef="FD2016Q4QTD" decimals="INF" id="Fact-7969234FC6D31289906AAAF98D555AF4" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
	<us-gaap:AssetImpairmentCharges contextRef="FD2017Q1YTD" decimals="INF" id="Fact-09FAFD9C69BD3EDA4376AAF8A00B3495" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
	<us-gaap:Assets contextRef="FI2016Q4" decimals="-3" id="Fact-80D053228F55FCC81894FC5D3CE660DC" unitRef="usd">388378000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2017Q1" decimals="-3" id="Fact-CE29EEADD863FAF0D4A4FC5D3CE1BD2A" unitRef="usd">368395000</us-gaap:Assets>
	<us-gaap:AssetsCurrent contextRef="FI2016Q4" decimals="-3" id="Fact-3CF5DA88F8F21719E65FFC5D3CF183BF" unitRef="usd">205611000</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent contextRef="FI2017Q1" decimals="-3" id="Fact-6324DC51E218DFF7AC45FC5D3CE7EBEA" unitRef="usd">186136000</us-gaap:AssetsCurrent>
	<us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="D2015Q4Oct30-30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="INF" id="Fact-688FD214C7736B9540E2FC5D3DF225CA" unitRef="shares">349871</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
	<us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="D2015Q4Oct30-30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="-5" id="Fact-9D83A51FA9E97A931C5FFC5D3DF27EFC" unitRef="usd">4700000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="D2016Q1Mar31_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember" decimals="-5" id="Fact-69628DC82E831F2EF77AFC5D3DF32616" unitRef="usd">-400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="FD2016Q1YTD" decimals="-3" id="Fact-00622BEBE667516648E8FC5D3DA8413F" unitRef="usd">287000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="FD2017Q1YTD" decimals="-3" id="Fact-67988E3CAF77EE7E95F1FC5D3DA7B938" unitRef="usd">270000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="FI2017Q1_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" decimals="-5" id="Fact-E28BDA3E3C690F444E4987D055DD0C69" unitRef="usd">300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="-5" id="Fact-66BD4E92ED8EE3A5AFB5FC5D3DF3596C" unitRef="usd">7000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" decimals="-5" id="Fact-2E5BCD543C9F7FB4A95687CF7D039D34" unitRef="usd">3500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" decimals="-5" id="Fact-C8612D8669642586C96287CFB238CE81" unitRef="usd">3500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2014Q2_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember" decimals="-5" id="Fact-A3F5A6EB7380C20A832BFC5D3DF2484E" unitRef="usd">2500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="-3" id="Fact-EB8CB4252F8A153F53C3FC5D3FC58E2A" unitRef="usd">5603000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q1_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="-5" id="Fact-D813FCA550D8C0421770FC5D3DF23352" unitRef="usd">4400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q1_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" decimals="-5" id="Fact-A0DC64E78321B95A1F8787D09B251DDA" unitRef="usd">3600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q1_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutMember" decimals="-5" id="Fact-2AF94E0621AD72B252BC87CFF2637D95" unitRef="usd">800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="-3" id="Fact-6B607931EF2CE5BAF9E5FC5D3FC64279" unitRef="usd">5773000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="I2016Q2April1_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember" decimals="-5" id="Fact-37EAA677544FFBE443C3FC5D3DF263BD" unitRef="usd">2100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="FI2016Q4" decimals="-3" id="Fact-3A7F0885364E62807DB1FC5D3CE71FC8" unitRef="usd">5301000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="FI2017Q1" decimals="-3" id="Fact-D522964C20AE9DCE26A0FC5D3CE6C47A" unitRef="usd">5571000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
	<us-gaap:CapitalLeaseObligations contextRef="FI2016Q4" decimals="-3" id="Fact-26C7EF1ADD61605407F1FC5D3F0FD52C" unitRef="usd">23000</us-gaap:CapitalLeaseObligations>
	<us-gaap:CapitalLeaseObligations contextRef="FI2017Q1" decimals="-3" id="Fact-85490402CE6479769F31FC5D3F0ECD64" unitRef="usd">18000</us-gaap:CapitalLeaseObligations>
	<us-gaap:CapitalLeasesFutureMinimumPaymentsDue contextRef="FI2017Q1" decimals="-3" id="Fact-04747DE2946441369B67FC5D3F2EB81F" unitRef="usd">18000</us-gaap:CapitalLeasesFutureMinimumPaymentsDue>
	<us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears contextRef="FI2017Q1" decimals="-3" id="Fact-A9BBB823312D7EFFBE89FC5D3F2DF827" unitRef="usd">0</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears>
	<us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears contextRef="FI2017Q1" decimals="-3" id="Fact-F7918673503D0A0396F7FC5D3F2DD562" unitRef="usd">0</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears>
	<us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears contextRef="FI2017Q1" decimals="-3" id="Fact-1FA2766BFFA0069A519AFC5D3F2C6C04" unitRef="usd">2000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears>
	<us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears contextRef="FI2017Q1" decimals="-3" id="Fact-ECDAE6198C33B8F33DC9FC5D3F2CCD18" unitRef="usd">8000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears>
	<us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear contextRef="FI2017Q1" decimals="-3" id="Fact-2EA4F9AFDD4EF86E955CFC5D3F2D4B00" unitRef="usd">8000</us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2015Q4" decimals="-3" id="Fact-E308414D002C5A47A8CEFC5D3DAF4E58" unitRef="usd">2453000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2016Q1" decimals="-3" id="Fact-C39CBFE0731D3F4D19AFFC5D3DAEF9B1" unitRef="usd">1876000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2016Q4" decimals="-3" id="Fact-39C7207B044995E6DF8EFC5D3CE90DC1" unitRef="usd">20630000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2017Q1" decimals="-3" id="Fact-8EF862D9581C02110C96FC5D3CEF1521" unitRef="usd">13401000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2016Q1YTD" decimals="-3" id="Fact-1C52C27D41BCB6B2BC37FC5D3DA50945" unitRef="usd">-577000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2017Q1YTD" decimals="-3" id="Fact-B30299FA7D734C47DE12FC5D3DB0465A" unitRef="usd">-7229000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CommitmentsAndContingencies contextRef="FI2016Q4" id="Fact-74D3DBD270C6E2621232FC5D3CE9E84E" unitRef="usd" xsi:nil="true" />
	<us-gaap:CommitmentsAndContingencies contextRef="FI2017Q1" id="Fact-A4A52F6BC74A875A70AFFC5D3CE8307B" unitRef="usd" xsi:nil="true" />
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2017Q1_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-7C207745242F4F1C93CDA89F2098EB7F" unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="I2017Q1March17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-B48DA2F2CA098D305B2DA8A0FAF6D0E0" unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesOutstanding contextRef="FI2017Q1" decimals="INF" id="Fact-B93A3208698FB19D767CFC5D3FD57488" unitRef="shares">35596380</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockValue contextRef="FI2016Q4" decimals="-3" id="Fact-423A91D47F176003FD09FC5D3CF1CE21" unitRef="usd">3000</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue contextRef="FI2017Q1" decimals="-3" id="Fact-46EDC62FB5281AED3A4FFC5D3CE93A24" unitRef="usd">4000</us-gaap:CommonStockValue>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2016Q1YTD" decimals="-3" id="Fact-B4EA76B06481D0D825FAFC5D3D69DA37" unitRef="usd">19015000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2017Q1YTD" decimals="-3" id="Fact-6A639EF229F18C6323ECFC5D3D697DA3" unitRef="usd">-1976000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="FD2016Q1YTD" decimals="-3" id="Fact-FDE0E2585CE8255FEB69FC5D3D6A4C14" unitRef="usd">19179000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="FD2017Q1YTD" decimals="-3" id="Fact-AC596329D8F7D76EB144FC5D3D6F6B12" unitRef="usd">-1684000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:CostOfServices contextRef="FD2016Q1YTD" decimals="-3" id="Fact-9936409CF4ED1F5AB096FC5D3D483AC4" unitRef="usd">145537000</us-gaap:CostOfServices>
	<us-gaap:CostOfServices contextRef="FD2017Q1YTD" decimals="-3" id="Fact-8AEE924020E802308355FC5D3D40A5F5" unitRef="usd">154298000</us-gaap:CostOfServices>
	<us-gaap:CostsAndExpenses contextRef="FD2016Q1YTD" decimals="-3" id="Fact-F1C143005615899758B9FC5D3D49F9D0" unitRef="usd">45881000</us-gaap:CostsAndExpenses>
	<us-gaap:CostsAndExpenses contextRef="FD2017Q1YTD" decimals="-3" id="Fact-FA1AD3D02DF7B7E5F7FFFC5D3D3DE7CE" unitRef="usd">50020000</us-gaap:CostsAndExpenses>
	<us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption contextRef="FI2017Q1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-5" id="Fact-A89F1AC9D7CE0A7B97DEA061F44543B4" unitRef="usd">500000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
	<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-1753467DCEB412CF5DF3AB1DCC7262E1" unitRef="usd">46000000</us-gaap:DebtConversionConvertedInstrumentAmount1>
	<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="D2017Q1Marc17_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-B91018232E30BF5C4C06A8A4FFC8E009" unitRef="shares">3175584</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
	<us-gaap:DebtConversionOriginalDebtAmount1 contextRef="D2017Q1Marc17_us-gaap_DebtInstrumentAxis_ccrn_A8ConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-775FE309A6EC6A8518A3B2B4AEE5850A" unitRef="usd">20000000</us-gaap:DebtConversionOriginalDebtAmount1>
	<us-gaap:DebtConversionOriginalDebtAmount1 contextRef="D2017Q1Marc17_us-gaap_DebtInstrumentAxis_ccrn_ConvertibleNoteDerivativeLiabilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-8D601A9A035F9F269C99B2B4127FF981" unitRef="usd">26000000</us-gaap:DebtConversionOriginalDebtAmount1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember" decimals="INF" id="Fact-F1428F956E530C978C78FC5D3F51CC72" unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-64013E6E9B5467086D2FFC5D3F1B5046" unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="INF" id="Fact-11BBB0F48AD6F8775F93FC5D3F1B46F0" unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="INF" id="Fact-B97D1B9322CBECAF7482FC5D3F51B183" unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember" decimals="INF" id="Fact-F4A47C2FF98ACC2931E9FC5D3F52465E" unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-F8FA960B2B593D8BEF5DFC5D3F206030" unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="INF" id="Fact-3948D7895D13F45EA9A4FC5D3F1B436B" unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="INF" id="Fact-A1C6711D39B89588CB30FC5D3F50AB8A" unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember" decimals="INF" id="Fact-EE03D17AAAE321647C5AFC5D3F51FD2E" unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-A0E203AED9B7210FE3C6FC5D3F1BAFE7" unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="INF" id="Fact-4609C51395488C894569FC5D3F1A2FA6" unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="INF" id="Fact-5621E1DC0EC1262CAA75FC5D3F52C290" unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember" decimals="INF" id="Fact-B60B9EB9BF32B9FFFCFAFC5D3F529935" unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-EF46216AAA5FD10FE64FFC5D3F2173AC" unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="INF" id="Fact-7B2BBE782A20550F59BAFC5D3F1B4545" unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="INF" id="Fact-AD27E688F2C3D797D405FC5D3F522BA6" unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember" decimals="INF" id="Fact-83BE3A3F9038611D3878FC5D3F516BCE" unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-D6A8237F8EB75C814771FC5D3F1BBA69" unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="INF" id="Fact-F951AC217BAD92FFA8E5FC5D3F21B1AC" unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="INF" id="Fact-5F6E1219FF70DEF21F35FC5D3F51ABA2" unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="INF" id="Fact-E54D91803AB4A2F7FF8BFC5D3F5CF25D" unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2017Q1YTD_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="INF" id="Fact-B69AED2A44A3F6016A15FC5D3F5C4411" unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2016Q4_us-gaap_DebtInstrumentAxis_ccrn_A8ConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-3" id="Fact-2BCB4C55F0B8F94E9E8AFC5D3F078D77" unitRef="usd">25000000</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2016Q4_us-gaap_DebtInstrumentAxis_ccrn_ConvertibleNoteDerivativeLiabilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-3" id="Fact-DD82A749704D5A564B83FC5D3F07E83B" unitRef="usd">27532000</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2016Q4_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-C92F187DAF5B86C78319FC5D3F08D898" unitRef="usd">39500000</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_A8ConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-3" id="Fact-F5B2CD859017DE25984FFC5D3F0E35AC" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_ConvertibleNoteDerivativeLiabilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-3" id="Fact-14DC554098A1EDBF24BBFC5D3F0E7867" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-4EBAA415660F19DDFCDFFC5D3F0E30A1" unitRef="usd">38500000</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="FI2017Q1_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-0421447A3E682F50C4AAA89F495650E3" unitRef="usdPerShare">7.10</us-gaap:DebtInstrumentConvertibleConversionPrice1>
	<us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments contextRef="FD2017Q1YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-C1D26AE6BABAE12C35C0A89F795AEBAC" unitRef="instrument">3521126</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
	<us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays contextRef="FD2017Q1YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" id="Fact-4DFB8178B7C6135E96E8A89E8763ABBE">P30D</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays>
	<us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="FD2017Q1YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-7C63CE97C6DB3A789CECA89EC95022B4" unitRef="number">1.25</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
	<us-gaap:DebtInstrumentConvertibleThresholdTradingDays contextRef="FD2017Q1YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-320474F8F35353E1D35EA89EAAEB35AB" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
	<us-gaap:DebtInstrumentFaceAmount contextRef="FI2014Q2_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-623D46D890C563D16CBCA8A06789EF32" unitRef="usd">25000000.0</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesNetMember" decimals="-3" id="Fact-DA9908289243E649775DFC5D3FBEA2AB" unitRef="usd">27250000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="-3" id="Fact-E832EA1FB9C08D5C417FFC5D3FBD1313" unitRef="usd">41500000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesDerivativeLiabilityMember" decimals="-3" id="Fact-421D2ED6B4A9AEE1AF52FC5D3FC5AF25" unitRef="usd">27532000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesNetMember" decimals="-3" id="Fact-5AE4C701704E82DABD28FC5D3FBCCCA3" unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="-3" id="Fact-5523FFA67B22739B0692FC5D3FBC9A4A" unitRef="usd">39300000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesDerivativeLiabilityMember" decimals="-3" id="Fact-6A7A10B6AC6E3412F905FC5D3FC65956" unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_A8ConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-309CAECEB39018DDB131FC5D3F699514" unitRef="number">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="INF" id="Fact-7B29CDBD0BADFECEB865FC5D3F698793" unitRef="number">0.0278</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2017Q1_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-86728A9E219D25FCCF89A89E417684AD" unitRef="number">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="FI2016Q4" decimals="-3" id="Fact-E511810E83B0DC599B53FC5D3F0DE349" unitRef="usd">5032000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
	<us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="FI2016Q4_us-gaap_DebtInstrumentAxis_ccrn_A8ConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-3" id="Fact-1425A74FB2ECD0DD2624FC5D3F086845" unitRef="usd">4669000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
	<us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="FI2016Q4_us-gaap_DebtInstrumentAxis_ccrn_ConvertibleNoteDerivativeLiabilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-3" id="Fact-D6277FF5E409DDEAB1A1FC5D3F08CD34" unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
	<us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="FI2016Q4_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-10E20D8EAEE4405DAB3FFC5D3F073F8B" unitRef="usd">363000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
	<us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="FI2017Q1" decimals="-3" id="Fact-74F4AE54C355ADD929E9FC5D3F0882EE" unitRef="usd">339000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
	<us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_A8ConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-3" id="Fact-B925A11EA57B6550BA38FC5D3F0ED8A9" unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
	<us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_ConvertibleNoteDerivativeLiabilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-3" id="Fact-2AEC3973C52823D4E16AFC5D3F0F826B" unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
	<us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="FI2017Q1_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-2FF86E7A64F3C9A9E6FDFC5D3F0E3CC5" unitRef="usd">339000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2016Q1YTD" decimals="-3" id="Fact-B67F755837E493F417E1FC5D3DB27725" unitRef="usd">471000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2017Q1YTD" decimals="-3" id="Fact-90CAB1E0E866A3952CBAFC5D3DA71843" unitRef="usd">597000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredTaxAssetsGross contextRef="I2017Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ccrn_AccountingStandardsUpdate201609Member" decimals="-5" id="Fact-BD4E9128A87ED7D9D55DA05FEBA8EDE0" unitRef="usd">1300000</us-gaap:DeferredTaxAssetsGross>
	<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="I2017Q1Jan1_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ccrn_AccountingStandardsUpdate201609Member" decimals="-5" id="Fact-CC2B4D447D81E23E42A3CF3339363FE8" unitRef="usd">1300000</us-gaap:DeferredTaxAssetsValuationAllowance>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="FI2016Q4" decimals="-3" id="Fact-318479A880DE620CC54FFC5D3CE04821" unitRef="usd">13154000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="FI2017Q1" decimals="-3" id="Fact-901D3802D0AA60F4B42AFC5D3CE9AEEB" unitRef="usd">13751000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:DepreciationDepletionAndAmortization contextRef="FD2016Q1YTD" decimals="-3" id="Fact-0CAB2D792A904C73B70AA8940C5913D2" unitRef="usd">2412000</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:DepreciationDepletionAndAmortization contextRef="FD2017Q1YTD" decimals="-3" id="Fact-9E53476C6644601AEBC7A8940C75B3DD" unitRef="usd">2191000</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="FD2016Q1YTD" decimals="-3" id="Fact-9013A0F5450CD18DA212FC5D3D3E7B04" unitRef="usd">16436000</us-gaap:DerivativeGainLossOnDerivativeNet>
	<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="FD2017Q1YTD" decimals="-3" id="Fact-A00F614857E6DFA6E6F5FC5D3D42C20D" unitRef="usd">1581000</us-gaap:DerivativeGainLossOnDerivativeNet>
	<us-gaap:DueFromJointVenturesCurrent contextRef="FI2016Q4_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-923341A12AF6BBD1EFAAFC5D4017B6C1" unitRef="usd">1500000</us-gaap:DueFromJointVenturesCurrent>
	<us-gaap:DueFromJointVenturesCurrent contextRef="FI2017Q1_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-0901BCFFE73C187A819FFC5D401881D6" unitRef="usd">1000000</us-gaap:DueFromJointVenturesCurrent>
	<us-gaap:DueToRelatedPartiesCurrent contextRef="FI2016Q4_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-F57CAE858F35E26597D8FC5D4019F2CC" unitRef="usd">200000</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:DueToRelatedPartiesCurrent contextRef="FI2017Q1_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-A46E44EE348EEABC12AAA07B82D9EAF2" unitRef="usd">300000</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:EarningsPerShareBasic contextRef="FD2016Q1YTD" decimals="2" id="Fact-0CCF9F738905AAAF87C6FC5D3D4AF98F" unitRef="usdPerShare">0.60</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q1YTD" decimals="2" id="Fact-113691EF77B754A4E2CDFC5D3D41F340" unitRef="usdPerShare">-0.06</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2016Q1YTD" decimals="2" id="Fact-6ACA3F897054F380BAD8FC5D3D4C04A5" unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q1YTD" decimals="2" id="Fact-A1B12462AADC7F5F5C1AFC5D3D4C6054" unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2016Q1YTD" decimals="-3" id="Fact-829B52A9D92114412C46FC5D3DA8367F" unitRef="usd">-6000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2017Q1YTD" decimals="-3" id="Fact-20C33DE9FB75E9403C90FC5D3DA723FF" unitRef="usd">34000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2016Q1YTD" decimals="3" id="Fact-D84C3EF26AB1559CB3CFFC5D400FA4E6" unitRef="number">0.040</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2017Q1YTD" decimals="3" id="Fact-5CFF73E69CD524193D92FC5D400F5DC3" unitRef="number">0.271</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="FI2016Q4" decimals="-3" id="Fact-C42AC81BCFC5D8E4956BFC5D3CE8A73F" unitRef="usd">33243000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="FI2017Q1" decimals="-3" id="Fact-0B2ED4E3C8F1DB78A365FC5D3CE9899D" unitRef="usd">28745000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByLiabilityClassAxis_ccrn_DeferredCompensationMember" decimals="-3" id="Fact-5A55E7B79B43F4629CBCFC5D3FC518A3" unitRef="usd">1472000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByLiabilityClassAxis_ccrn_DeferredCompensationMember" decimals="-3" id="Fact-52CEEEA2C8DE746F4D41FC5D3FC57EA0" unitRef="usd">1213000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2017Q1YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-D7B6195F6BEC3B14CDC7FC5D3F981DA7" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2017Q1YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-B42172AB481FB90B1FB9FC5D3F9AFE71" unitRef="usd">1581000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2017Q1YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-3737351BBE335EFAD820A0A53C4B33A2" unitRef="usd">100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2017Q1YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-CD7343E55D93C6B988C9A0A53C4EA3BE" unitRef="usd">25951000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2016Q4_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-5D46B575213FC603D756FC5D3F9A4AF3" unitRef="usd">5603000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2016Q4_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-1C30EEE28BA88184B13DFC5D3F9A64E7" unitRef="usd">27532000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2017Q1_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-5BA27D32A261E342CC72FC5D3F994C5F" unitRef="usd">5773000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2017Q1_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-4D4316338D1D7D4E437FFC5D3F9A7B40" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2016Q4" decimals="-3" id="Fact-7CCC0F714495CF3C8ECBFC5D3E9CE721" unitRef="usd">43333000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-B6D5C23B8DE4EA2E2579FC5D3E98988C" unitRef="usd">23316000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-42B91635352B18D14DC6FC5D3E994DFF" unitRef="usd">16147000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-5EDFA1DBD1CE7FF0BDFDFC5D3E9B545F" unitRef="usd">3527000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-8DDD64A1AF32E0787899FC5D3E993359" unitRef="usd">343000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q1" decimals="-3" id="Fact-84677DE152D59751C652FC5D3E9BB75F" unitRef="usd">44406000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-A150ADC4471660AAF1FEFC5D3E990034" unitRef="usd">23793000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-664DEC12C6E70CFF2CE1FC5D3E9B1CC8" unitRef="usd">16655000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-0E4025741DD23A1604BBFC5D3E9A80C0" unitRef="usd">3537000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-7AF8C82B7E0DE03A4351FC5D3E99905D" unitRef="usd">421000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="FI2017Q1" decimals="-3" id="Fact-A71CF129F1E53E406F29FC5D3EA4A58C" unitRef="usd">16522000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="FI2017Q1" decimals="-3" id="Fact-46B06E815477A25D16C5FC5D3EA43C58" unitRef="usd">3175000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="FI2017Q1" decimals="-3" id="Fact-5BFC3117A13ABEAEC243FC5D3EA4C256" unitRef="usd">3799000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="FI2017Q1" decimals="-3" id="Fact-CE7C222CBBE983B500CCFC5D3EA44556" unitRef="usd">4007000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="FI2017Q1" decimals="-3" id="Fact-3CD8EEC78A937B655D9DFC5D3EA4760D" unitRef="usd">4111000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="FI2017Q1" decimals="-3" id="Fact-E870ADFCCD5832BC93D6FC5D3EA4863A" unitRef="usd">4148000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2016Q4" decimals="-3" id="Fact-0DCFAD499DDD005B6E5CFC5D3E9BCCFB" unitRef="usd">80168000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-5B88001C345678261827FC5D3E990C49" unitRef="usd">41724000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-F2E62E01F76587B1B088FC5D3E9A539E" unitRef="usd">31609000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-70C1484DE290BA987B4AFC5D3E9B71EB" unitRef="usd">3619000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-172E2B0581508A496AA3FC5D3E9B8956" unitRef="usd">3216000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q1" decimals="-3" id="Fact-648A3EF039F5654ED92FFC5D3E9A3537" unitRef="usd">80168000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-A8A7B9F4D38DA297CF06FC5D3E9B924E" unitRef="usd">41724000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-E9DDC28DC62D9BE7E138FC5D3E9A2FB0" unitRef="usd">31609000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-BEBD788629B677392216FC5D3E996F63" unitRef="usd">3619000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-D698B8C2227297229E9EFC5D3E989AAE" unitRef="usd">3216000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2016Q4" decimals="-3" id="Fact-6C0376E0065D02B8BBE3FC5D3CF142EB" unitRef="usd">36835000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-4DB01F1AC90ECFEDF36AFC5D3E9A151C" unitRef="usd">18408000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-0391C160DE649CEACEA3FC5D3E98B997" unitRef="usd">15462000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-436F51DDDA0D5D18F881FC5D3E9A9D26" unitRef="usd">92000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-9CA99BE9BC586FFA3B27FC5D3E9CA964" unitRef="usd">2873000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q1" decimals="-3" id="Fact-60BEC0B83054C6F15A0AFC5D3CE9E11F" unitRef="usd">35762000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-E616E38C9AFF80F3798DFC5D3E9A8409" unitRef="usd">17931000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-3C7EB68A3FB098189950FC5D3E9A3A19" unitRef="usd">14954000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-D4BA24919AF1D8C0D3C1FC5D3E9A6324" unitRef="usd">82000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-AF69E9A9B127D31D4F77FC5D3E9C6229" unitRef="usd">2795000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2016Q1YTD" decimals="-3" id="Fact-3E2AD030F19CF8C8ACB1FC5D3D489D4B" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2017Q1YTD" decimals="-3" id="Fact-13B3D24AB1BDB44CDAF1FC5D3D3F6068" unitRef="usd">-4969000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2017Q1YTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-359B7BD33A7CEB32DCBEAB1959493614" unitRef="usd">-5000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:Goodwill contextRef="FI2016Q4" decimals="-3" id="Fact-D16B8E06325C707B7796FC5D3CDFBE00" unitRef="usd">79648000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2016Q4_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-E10D64920A44F1462549A8A8439AB825" unitRef="usd">44545000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2016Q4_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-6ED181C64A308B4D8944A8A84394220F" unitRef="usd">9418000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2016Q4_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-15E14C4D73FE6A70678AA8A84390A642" unitRef="usd">25685000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2017Q1" decimals="-3" id="Fact-E7D7ED5AC444FA349A18FC5D3CE06D58" unitRef="usd">79648000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2017Q1_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-45B544CE457354BDD92DA8A8438D3749" unitRef="usd">44545000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2017Q1_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-05AA9366B90F6BBF015BA8A8438A3411" unitRef="usd">9418000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2017Q1_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-B485B74D0AA7B65221D5A8A843B7CB3C" unitRef="usd">25685000</us-gaap:Goodwill>
	<us-gaap:GrossProfit contextRef="FD2016Q1YTD" decimals="-3" id="Fact-ECB051FFC5B2CEB4D87F8796BE5492F4" unitRef="usd">51046000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2017Q1YTD" decimals="-3" id="Fact-4759947645B84A84A88E8796BE4D805A" unitRef="usd">53275000</us-gaap:GrossProfit>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2016Q1YTD" decimals="-3" id="Fact-14E7B183DB1F9F1AEBFAFC5D3D48D5FD" unitRef="usd">19983000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2017Q1YTD" decimals="-3" id="Fact-E61A7CF40A0310390912FC5D3D3F0011" unitRef="usd">-1352000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2016Q1YTD" decimals="-3" id="Fact-259530BC380B096622E4FC5D3D49A0BE" unitRef="usd">797000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2017Q1YTD" decimals="-3" id="Fact-42347572B2896D2BD885FC5D3D4C7A4C" unitRef="usd">366000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="FD2016Q1YTD" decimals="-3" id="Fact-0F36458309CD02798E36FC5D3DA564E6" unitRef="usd">-6068000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="FD2017Q1YTD" decimals="-3" id="Fact-06E0A6C5A5D002219E6CFC5D3DB2B3BD" unitRef="usd">-16087000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2016Q1YTD" decimals="-3" id="Fact-B0E246A6C4FF9B6452F6FC5D3DA6CDC1" unitRef="usd">-2500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2017Q1YTD" decimals="-3" id="Fact-F4D289C8424F3A43F6C2FC5D3DB336BB" unitRef="usd">-10817000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="FD2016Q1YTD" decimals="-3" id="Fact-CB0FA3CFD99E0AF00565FC5D3DA6D6CE" unitRef="usd">105000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
	<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="FD2017Q1YTD" decimals="-3" id="Fact-4E628D21796C479DF50CFC5D3DA6FF30" unitRef="usd">264000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
	<us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="FD2016Q1YTD" decimals="-3" id="Fact-46C5E9F581E9AE88A808FC5D3DAEA9D9" unitRef="usd">-1599000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
	<us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="FD2017Q1YTD" decimals="-3" id="Fact-78D14083676FF403E91DFC5D3DB1BEA9" unitRef="usd">76000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
	<us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="FD2016Q1YTD" decimals="-3" id="Fact-184032C2F211A0DAA121FC5D3E39E6A6" unitRef="shares">3521000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
	<us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="FD2017Q1YTD" decimals="INF" id="Fact-ADFAE8AE7780FC1E367C87DF42F32313" unitRef="shares">2934271</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
	<us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="FD2017Q1YTD" decimals="-3" id="Fact-0004F1DD2E9E380FA6BCFC5D3E3A4BBF" unitRef="shares">2934000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2016Q1YTD" decimals="-3" id="Fact-09117EBB76B4B6A49949FC5D3E397C12" unitRef="shares">703000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2017Q1YTD" decimals="-3" id="Fact-30D9B308B78251C4DA99FC5D3E39521F" unitRef="shares">674000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IndefiniteLivedTradeNames contextRef="FI2016Q4" decimals="-3" id="Fact-361A6DA7741F1CA771E0FC5D3CAAB706" unitRef="usd">35402000</us-gaap:IndefiniteLivedTradeNames>
	<us-gaap:IndefiniteLivedTradeNames contextRef="FI2017Q1" decimals="-3" id="Fact-A1A9054E5DDB32FDC4A9FC5D3CAB31B8" unitRef="usd">35402000</us-gaap:IndefiniteLivedTradeNames>
	<us-gaap:InsuranceSettlementsReceivableCurrent contextRef="FI2016Q4" decimals="-3" id="Fact-727789A21076D65A7479FC5D3CEF9803" unitRef="usd">3037000</us-gaap:InsuranceSettlementsReceivableCurrent>
	<us-gaap:InsuranceSettlementsReceivableCurrent contextRef="FI2017Q1" decimals="-3" id="Fact-67AAD8CFD60C485D1444FC5D3CE6CE40" unitRef="usd">3386000</us-gaap:InsuranceSettlementsReceivableCurrent>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2016Q4" decimals="-3" id="Fact-C01E388ACE5A1D23D7A7FC5D3E9A22BC" unitRef="usd">72237000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2017Q1" decimals="-3" id="Fact-CF74C3D3D11C5B95FE18FC5D3E9B2B80" unitRef="usd">71164000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:InterestExpense contextRef="FD2016Q1YTD" decimals="-3" id="Fact-71FDC529223D6BFCCC0AFC5D3D4AD95F" unitRef="usd">1635000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="FD2017Q1YTD" decimals="-3" id="Fact-D29267F6BBEA977DEE1BFC5D3D41EE3D" unitRef="usd">1219000</us-gaap:InterestExpense>
	<us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="FD2016Q1YTD" decimals="-3" id="Fact-49A208BDB08FD3A6F42F87DD6EA2CDFF" unitRef="usd">838000</us-gaap:InterestOnConvertibleDebtNetOfTax>
	<us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="FD2017Q1YTD" decimals="-3" id="Fact-66743198EB5ABDCCAB49FC5D3E39A87B" unitRef="usd">694000</us-gaap:InterestOnConvertibleDebtNetOfTax>
	<us-gaap:LettersOfCreditOutstandingAmount contextRef="FI2017Q1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="-5" id="Fact-A174DF0DF874225277C3FC5D3EEBDFCA" unitRef="usd">22100000</us-gaap:LettersOfCreditOutstandingAmount>
	<us-gaap:Liabilities contextRef="FI2016Q4" decimals="-3" id="Fact-C30077F058DF6E72BF6CFC5D3CE7B915" unitRef="usd">236576000</us-gaap:Liabilities>
	<us-gaap:Liabilities contextRef="FI2017Q1" decimals="-3" id="Fact-7B8BF3B76B9C205D5DF3FC5D3CE83765" unitRef="usd">172501000</us-gaap:Liabilities>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2016Q4" decimals="-3" id="Fact-36CF64CDBE6EDF2D51CFFC5D3CF1B357" unitRef="usd">388378000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2017Q1" decimals="-3" id="Fact-68CA7E911620E9A54F92FC5D3CF0F16B" unitRef="usd">368395000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesCurrent contextRef="FI2016Q4" decimals="-3" id="Fact-7BA9B392118879C63C85FC5D3CE8A02A" unitRef="usd">97092000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent contextRef="FI2017Q1" decimals="-3" id="Fact-18C3C118AE4082FA2CADFC5D3CEA19C9" unitRef="usd">79897000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="FI2016Q4" decimals="-3" id="Fact-671D984E40FD17A88A71FC5D3CE8415B" unitRef="usd">28870000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
	<us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="FI2017Q1" decimals="-3" id="Fact-2CCE346FA3E2207C5899FC5D3CE7DCAB" unitRef="usd">29512000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
	<us-gaap:LineOfCredit contextRef="FI2017Q1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="-5" id="Fact-1C6C09160F41A2A2BC9CFC5D3EE80EDC" unitRef="usd">77900000</us-gaap:LineOfCredit>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-8F5E41A3C861A0614E28FC5D3F1B62A7" unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-7234F2D594B44ECF7F0DFC5D3F225F31" unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-8BE7CD14967FFF0EB1B6FC5D3F21F312" unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-D5C58BE48FEB65A78BC8FC5D3F1BEDBE" unitRef="number">0.0035</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="FD2017Q1YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-518C07406D7447C90F58FC5D3F215459" unitRef="number">0.0040</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2016Q2June22_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-7427E4F12B0DA619654FFC5D3EE2520B" unitRef="usd">100000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2016Q2June22_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="INF" id="Fact-13C46ED5135E4EDB4A31FC5D3EE87710" unitRef="usd">40000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="FD2017Q1YTD_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-C5CFC07DAD4B74F92137FC5D3EEA6103" unitRef="number">0.003</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
	<us-gaap:LongTermDebt contextRef="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesNetMember" decimals="-3" id="Fact-8B7B6C7C9F165EC46ECFFC5D3FBCBEE9" unitRef="usd">20331000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebt contextRef="FI2016Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="-3" id="Fact-EAE9E55CA6893F8D2823FC5D3FBE05C7" unitRef="usd">39137000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebt contextRef="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_ConvertibleNotesNetMember" decimals="-3" id="Fact-1C729A4883CC37D1A656FC5D3FBD9549" unitRef="usd">0</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebt contextRef="FI2017Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="-3" id="Fact-1F6836E7D6DE3190753EFC5D3FBC776F" unitRef="usd">38161000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebt contextRef="FI2017Q1_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-F2B047815FCD6196BE69FC5D3F2E1669" unitRef="usd">38500000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="FI2016Q4" decimals="-3" id="Fact-C9F0164F8F2D6005CB76FC5D3CE6539A" unitRef="usd">84760000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
	<us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="FI2017Q1" decimals="-3" id="Fact-9527AB3E89D286D2C1FDFC5D3CE017DF" unitRef="usd">36169000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
	<us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="FI2016Q4" decimals="-3" id="Fact-19D92B66E7C880A81431FC5D3F0F7A9B" unitRef="usd">2263000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
	<us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="FI2017Q1" decimals="-3" id="Fact-AA7A888D8AB86FE30EC5FC5D3F0EA0BB" unitRef="usd">2010000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
	<us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities contextRef="FI2016Q4" decimals="-3" id="Fact-D185AC18E1626D8BA39FFC5D3F0E4D0D" unitRef="usd">92055000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
	<us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities contextRef="FI2017Q1" decimals="-3" id="Fact-66E037DFE054AEF3F96FFC5D3F0EE23A" unitRef="usd">38518000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="FI2017Q1_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-AC4F8352238D0672ABEEFC5D3F2D6363" unitRef="usd">26000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="FI2017Q1_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-712B7A0D9F9EF87B1918FC5D3F2CE3A2" unitRef="usd">4000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="FI2017Q1_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-C8FE89CEDC3BB0480D66FC5D3F2DE966" unitRef="usd">3500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="FI2017Q1_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-FA4571F03A12D29C19FCFC5D3F2D000F" unitRef="usd">3750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear contextRef="FI2017Q1_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-8F2D4E44666CEFC78A00FC5D3F2CCC3A" unitRef="usd">1250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
	<us-gaap:MinorityInterest contextRef="FI2016Q4" decimals="-3" id="Fact-652258C002F9F240B84FFC5D3CF0261F" unitRef="usd">559000</us-gaap:MinorityInterest>
	<us-gaap:MinorityInterest contextRef="FI2017Q1" decimals="-3" id="Fact-48E3835427336607943CFC5D3CF0E1CB" unitRef="usd">616000</us-gaap:MinorityInterest>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2016Q1YTD" decimals="-3" id="Fact-09B01C529F0570DD0630FC5D3DA80EFC" unitRef="usd">-2430000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2017Q1YTD" decimals="-3" id="Fact-9FC18C553DCD529BB5F5FC5D3DA8E716" unitRef="usd">-7583000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2016Q1YTD" decimals="-3" id="Fact-349201E8C9E92024CE9DFC5D3DA8549B" unitRef="usd">-705000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2017Q1YTD" decimals="-3" id="Fact-A991DB1CC1D46AB96397FC5D3DA7C805" unitRef="usd">-1090000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2016Q1YTD" decimals="-3" id="Fact-0D171BD3D3C647ACA0FEFC5D3DA83604" unitRef="usd">2564000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2017Q1YTD" decimals="-3" id="Fact-D3E951056CC9580CA132FC5D3DA7283A" unitRef="usd">1410000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetIncomeLoss contextRef="FD2016Q1YTD" decimals="-3" id="Fact-ADB148259B5E8B133DE1FC5D3D5363FD" unitRef="usd">19022000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q1YTD" decimals="-3" id="Fact-5FD9C2C83D75152A06D2FC5D3D48EA7A" unitRef="usd">-2010000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="FD2016Q1YTD" decimals="-3" id="Fact-6487DA422A6122CEFCBFFC5D3D534681" unitRef="usd">164000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
	<us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="FD2017Q1YTD" decimals="-3" id="Fact-93BB94DE847FDBC13A81FC5D3D3F21FB" unitRef="usd">292000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="FD2016Q1YTD" decimals="-3" id="Fact-56C61E21C6CF19FECB78FC5D3E39DB4E" unitRef="usd">19022000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="FD2017Q1YTD" decimals="-3" id="Fact-0E650658EE7616388427FC5D3E403FF1" unitRef="usd">-2010000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="FD2016Q1YTD" decimals="-3" id="Fact-1DAB254773CDC2724313FC5D3E382141" unitRef="usd">3424000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="FD2017Q1YTD" decimals="-3" id="Fact-946EFA5A49E25E2ADB42FC5D3E383DA5" unitRef="usd">-2897000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
	<us-gaap:NumberOfOperatingSegments contextRef="FD2017Q1YTD" decimals="INF" id="Fact-7BA22496D2B591FE007EFC5D3FE5C6A0" unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
	<us-gaap:OperatingIncomeLoss contextRef="FD2016Q1YTD" decimals="-3" id="Fact-7337F8731A2216597E62FC5D3D3F4484" unitRef="usd">5165000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1YTD" decimals="-3" id="Fact-B91CFBF784277E7A8213FC5D3D4B2F0B" unitRef="usd">3255000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OtherAssetsCurrent contextRef="FI2016Q4" decimals="-3" id="Fact-06619AF9F97904457294FC5D3CEA9D07" unitRef="usd">2198000</us-gaap:OtherAssetsCurrent>
	<us-gaap:OtherAssetsCurrent contextRef="FI2017Q1" decimals="-3" id="Fact-14B00E0F563CF04BBEE0FC5D3CE02B5A" unitRef="usd">1857000</us-gaap:OtherAssetsCurrent>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2016Q4" decimals="-3" id="Fact-BCAF65A13B8FC07DD1AEFC5D3CF03318" unitRef="usd">18064000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2017Q1" decimals="-3" id="Fact-3832EEE7F1474D37DF04FC5D3CF0780F" unitRef="usd">18668000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent contextRef="FD2016Q1YTD" decimals="-3" id="Fact-06F6EB64E649FD075678FC5D3D69CBFE" unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent contextRef="FD2017Q1YTD" decimals="-3" id="Fact-059A3C9768F3EC0DD758FC5D3D70AEAD" unitRef="usd">34000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="FD2016Q1YTD" decimals="INF" id="Fact-5D0FD48A01B6A9EFA31FFC5D3E08566A" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="FD2017Q1YTD" decimals="INF" id="Fact-1D5C36B5546DD63D35D8FC5D3E070A34" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2016Q1YTD" decimals="-3" id="Fact-14B28CB4B69C2FAE267CFC5D3D690DBE" unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2017Q1YTD" decimals="-3" id="Fact-A89771910A7340498A23FC5D3D6FC5C4" unitRef="usd">34000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherLiabilitiesCurrent contextRef="FI2016Q4" decimals="-3" id="Fact-CA90CB4ACF3DEACF01BEFC5D3CEF41FC" unitRef="usd">5012000</us-gaap:OtherLiabilitiesCurrent>
	<us-gaap:OtherLiabilitiesCurrent contextRef="FI2017Q1" decimals="-3" id="Fact-5A81EE1E7D5F2BC9C04FFC5D3CE8C80B" unitRef="usd">4546000</us-gaap:OtherLiabilitiesCurrent>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2016Q4" decimals="-3" id="Fact-8FDDC6170AF9373E95CDFC5D3CEF9F70" unitRef="usd">7399000</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2017Q1" decimals="-3" id="Fact-854E87B15A93ABAA5931FC5D3CE1D54A" unitRef="usd">7601000</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherNoncashExpense contextRef="FD2016Q1YTD" decimals="-3" id="Fact-C636081470056F76E0EDFC5D3DA65721" unitRef="usd">0</us-gaap:OtherNoncashExpense>
	<us-gaap:OtherNoncashExpense contextRef="FD2017Q1YTD" decimals="-3" id="Fact-1D64408B13DFD21B5B7CFC5D3DA72E0C" unitRef="usd">11000</us-gaap:OtherNoncashExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2016Q1YTD" decimals="-3" id="Fact-C104235879840DB9EEC3FC5D3D493017" unitRef="usd">17000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2017Q1YTD" decimals="-3" id="Fact-D5C47F58BF23B3E25D3DFC5D3D4AB88D" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:PaymentsForPreviousAcquisition contextRef="FD2017Q1YTD_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" decimals="-5" id="Fact-B2239108293E772E38A4A06D017E4FAA" unitRef="usd">100000</us-gaap:PaymentsForPreviousAcquisition>
	<us-gaap:PaymentsForRent contextRef="FD2016Q1YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_AffiliatedEntityMember" decimals="-5" id="Fact-465BDDD9865EC4C3E255FC5D401C68F6" unitRef="usd">100000</us-gaap:PaymentsForRent>
	<us-gaap:PaymentsForRent contextRef="FD2017Q1YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_AffiliatedEntityMember" decimals="-5" id="Fact-A8A6292973739C352173FC5D401766C3" unitRef="usd">100000</us-gaap:PaymentsForRent>
	<us-gaap:PaymentsOfDebtExtinguishmentCosts contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-8CCE1DF2F58EFAFD8F73B2B12ECF258E" unitRef="usd">600000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
	<us-gaap:PaymentsOfDebtExtinguishmentCosts contextRef="FD2016Q1YTD" decimals="-3" id="Fact-3F354EF0B453E18ECDF1FC5D3DAFAE75" unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
	<us-gaap:PaymentsOfDebtExtinguishmentCosts contextRef="FD2017Q1YTD" decimals="-3" id="Fact-AF45EC3442B0CF55917FFC5D3DB28303" unitRef="usd">578000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="D2015Q4Oct30-30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="-5" id="Fact-7E3E0E17E05C885492DEFC5D3DF24E39" unitRef="usd">29900000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2016Q1YTD" decimals="-3" id="Fact-CABC6649B58836CCC9CAFC5D3DB34107" unitRef="usd">982000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2017Q1YTD" decimals="-3" id="Fact-C70DEFEB3B261BCAFCE6FC5D3DB9E94F" unitRef="usd">1090000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PrepaidExpenseCurrent contextRef="FI2016Q4" decimals="-3" id="Fact-F291F71A6C1A09DF2711FC5D3CF11C64" unitRef="usd">6126000</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:PrepaidExpenseCurrent contextRef="FI2017Q1" decimals="-3" id="Fact-E52417A3345E72943A3FFC5D3CF15EDD" unitRef="usd">5727000</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="FD2016Q1YTD" decimals="-3" id="Fact-7F524EB37DED3CEC3919A8988A6E3E4D" unitRef="usd">57200000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="FD2017Q1YTD" decimals="-3" id="Fact-F1D98A1537DEAD2074DFA8988A70055E" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="FD2016Q1YTD" decimals="-3" id="Fact-C0904F013D6C15B4C45BA8991A241C24" unitRef="usd">-403000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
	<us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="FD2017Q1YTD" decimals="-3" id="Fact-FD5EF1867E1C5BDC2E6EA8991A311DBC" unitRef="usd">-1000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
	<us-gaap:ProfitLoss contextRef="FD2016Q1YTD" decimals="-3" id="Fact-B780DB512756A7C5CF3FFC5D3D48E7A7" unitRef="usd">19186000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2017Q1YTD" decimals="-3" id="Fact-AEF3D0ADF112663013A1FC5D3D42CB89" unitRef="usd">-1718000</us-gaap:ProfitLoss>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2016Q4" decimals="-3" id="Fact-288F187B4F3E77231CF4FC5D3CDFA938" unitRef="usd">12818000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2017Q1" decimals="-3" id="Fact-BFE80FA5536127D6607AFC5D3CEFF295" unitRef="usd">12779000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:ProvisionForDoubtfulAccounts contextRef="FD2016Q1YTD" decimals="-3" id="Fact-95DEB3F8854E1A8BA388FC5D3D52F186" unitRef="usd">249000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:ProvisionForDoubtfulAccounts contextRef="FD2017Q1YTD" decimals="-3" id="Fact-387A368EB80D36B12FD0FC5D3D52A6B0" unitRef="usd">323000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:RatioOfIndebtednessToNetCapital1 contextRef="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_EachFiscalQuarterEndingThereafterMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="INF" id="Fact-7C7F391B00E5A1036DBCFC5D3EE9D7AD" unitRef="number">3.00</us-gaap:RatioOfIndebtednessToNetCapital1>
	<us-gaap:RatioOfIndebtednessToNetCapital1 contextRef="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="INF" id="Fact-78C9A69ECC1A92DFD1E1FC5D3EE9220E" unitRef="number">3.50</us-gaap:RatioOfIndebtednessToNetCapital1>
	<us-gaap:RatioOfIndebtednessToNetCapital1 contextRef="FI2017Q1_ccrn_DebtCovenantTermsAxis_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="INF" id="Fact-763AFF6EA8BCF2AE4384FC5D3EE8BA58" unitRef="number">3.25</us-gaap:RatioOfIndebtednessToNetCapital1>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-A4DACB5B5C65088EE028B2B1F742CD3A" unitRef="usd">5000000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2016Q1YTD" decimals="-3" id="Fact-EB2BAED3F94EEE69BD03A89765A906C0" unitRef="usd">59227000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2017Q1YTD" decimals="-3" id="Fact-525D2968B9145082C144A89765A213FD" unitRef="usd">6005000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2016Q4" decimals="-3" id="Fact-0ABC083EB35B9DF07EC5FC5D3CE62EE8" unitRef="usd">-104089000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2017Q1" decimals="-3" id="Fact-3F1E103BB73317CC970FFC5D3CE0BEE5" unitRef="usd">-106634000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RevenueFromRelatedParties contextRef="FD2016Q1YTD" decimals="-5" id="Fact-26D87DE15CC6237CC825FC5D4018364E" unitRef="usd">1300000</us-gaap:RevenueFromRelatedParties>
	<us-gaap:RevenueFromRelatedParties contextRef="FD2016Q1YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-2360A02D48B073614FFDFC5D40174CA6" unitRef="usd">3100000</us-gaap:RevenueFromRelatedParties>
	<us-gaap:RevenueFromRelatedParties contextRef="FD2017Q1YTD" decimals="-5" id="Fact-212FC5D4E970DEE913F5FC5D40192A98" unitRef="usd">1700000</us-gaap:RevenueFromRelatedParties>
	<us-gaap:RevenueFromRelatedParties contextRef="FD2017Q1YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-7D66623DBB9C419EFFC1FC5D401752BE" unitRef="usd">4200000</us-gaap:RevenueFromRelatedParties>
	<us-gaap:SalesRevenueServicesNet contextRef="FD2016Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-721342C2C14A8D270AF9FC5D3FFE8FCD" unitRef="usd">168765000</us-gaap:SalesRevenueServicesNet>
	<us-gaap:SalesRevenueServicesNet contextRef="FD2016Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-243DC3D7D26A753B4460FC5D3FFF43FF" unitRef="usd">3365000</us-gaap:SalesRevenueServicesNet>
	<us-gaap:SalesRevenueServicesNet contextRef="FD2016Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-BA25B591A3F08009C541FC5D4002A960" unitRef="usd">24453000</us-gaap:SalesRevenueServicesNet>
	<us-gaap:SalesRevenueServicesNet contextRef="FD2016Q1YTD" decimals="-3" id="Fact-3F2F8BE70D7FF4B4625BFC5D3D533DEF" unitRef="usd">196583000</us-gaap:SalesRevenueServicesNet>
	<us-gaap:SalesRevenueServicesNet contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-379F2DDFEDFCEB5FBE0FFC5D4004CC1C" unitRef="usd">183108000</us-gaap:SalesRevenueServicesNet>
	<us-gaap:SalesRevenueServicesNet contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-8ED82DE3CDCC0AB87649FC5D40046306" unitRef="usd">3001000</us-gaap:SalesRevenueServicesNet>
	<us-gaap:SalesRevenueServicesNet contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-0F77CC6348C577841427FC5D40056C52" unitRef="usd">21464000</us-gaap:SalesRevenueServicesNet>
	<us-gaap:SalesRevenueServicesNet contextRef="FD2017Q1YTD" decimals="-3" id="Fact-81D468704A14125937B8FC5D3D3F7DFE" unitRef="usd">207573000</us-gaap:SalesRevenueServicesNet>
	<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="FD2016Q1YTD" decimals="-3" id="Fact-C492663BEF7B9D1CF17FFC5D3D4943E4" unitRef="usd">42933000</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="FD2017Q1YTD" decimals="-3" id="Fact-FCB2A412C3F78C3C0FA5FC5D3D3E21F0" unitRef="usd">47236000</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:ShareBasedCompensation contextRef="FD2016Q1YTD" decimals="-3" id="Fact-349613C14149DEA66E90FC5D3DA79B0A" unitRef="usd">648000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2017Q1YTD" decimals="-3" id="Fact-5B28D2F07AA230D09C59FC5D3DB0F7CE" unitRef="usd">737000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-90545B095D155543234AFC5D3FE1CD84" unitRef="shares">112434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-AC256C8006E44EAE9658FC5D3FE0CBB9" unitRef="shares">25838</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-E17323D09BA7AC7F3382FC5D3FE05500" unitRef="usdPerShare">11.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-EED7D7121C2B185EE19EFC5D3FE17BA9" unitRef="usdPerShare">9.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-7DA35F1CB34133951A15FC5D3FE10B46" unitRef="shares">181067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" decimals="INF" id="Fact-CE557614CDB5A5E6E676FC5D3FD53A5E" unitRef="shares">181067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-36996887201334A352E2FC5D3FE09728" unitRef="shares">244205</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" decimals="INF" id="Fact-707361079185012534D4FC5D3FD36ED6" unitRef="shares">244205</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-8C31EBE9169C0F9AD63DFC5D3FE06E0E" unitRef="usdPerShare">14.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-0318AE7974095DE2F575FC5D3FE1FD35" unitRef="usdPerShare">14.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-D337F52B5AB39FAA4898FC5D3FE169E6" unitRef="shares">332092</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-B90FF7E4575C235EC3B0FC5D3FE0297C" unitRef="shares">532294</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2017Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-7A75E31E560DE0323C22FC5D3FE0F86D" unitRef="shares">400725</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2017Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-6F8A84AF3CE9F4E6032FFC5D3FE0F71E" unitRef="shares">628600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-E3096CA7497A75B088FDFC5D3FE158EA" unitRef="usdPerShare">11.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2016Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-30FFEBF7E601EB241EDBFC5D3FE0DF8F" unitRef="usdPerShare">9.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2017Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-2D6F6035D9CD81ECD3F8FC5D3FE14C83" unitRef="usdPerShare">12.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2017Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-5A42DF750B3430CEEAF6FC5D3FE02491" unitRef="usdPerShare">11.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-261EA3306AF30E0BDB88FC5D3FE0AC86" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-C5FD50E419DD758BD222FC5D3FE047E4" unitRef="shares">122061</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-13A8A19C6038FFD2875FFC5D3FDF7E0C" unitRef="usdPerShare">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-B2958C20549D87FB876CFC5D3FE04A32" unitRef="usdPerShare">10.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" decimals="INF" id="Fact-57E3403984F38C5AC9AAFC5D3FD4D79F" unitRef="shares">86784</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
	<us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="FI2017Q1" decimals="INF" id="Fact-4D566EED8CF813EF47EEFC5D3FD484FF" unitRef="usd">2500000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
	<us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased contextRef="FI2017Q1" decimals="INF" id="Fact-648D830B40E66C608D02FC5D3FD4D133" unitRef="shares">942443</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
	<us-gaap:StockholdersEquity contextRef="FI2016Q4" decimals="-3" id="Fact-7F9111444B6124734F82FC5D3CE61BF2" unitRef="usd">151243000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q1" decimals="-3" id="Fact-36796D980527D7506955FC5D3CE639CA" unitRef="usd">195278000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2016Q4" decimals="-3" id="Fact-A41C3E605775AE2488FDFC5D3CE9C9CB" unitRef="usd">151802000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2017Q1" decimals="-3" id="Fact-C11A44A7FA4A2DCC6AF6FC5D3CE7BA04" unitRef="usd">195894000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2017Q1" decimals="-5" id="Fact-1BD4B93195400C0D7494FC5D400F7543" unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="FD2017Q1YTD" decimals="-5" id="Fact-C732326878E6DF5A84D4FC5D400F4688" unitRef="usd">300000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="FI2017Q1" decimals="-5" id="Fact-DFA44A63F4F2DE598465FC5D400F8CEA" unitRef="usd">5200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2016Q1YTD" decimals="-3" id="Fact-C7CD165142FA43F91DE2FC5D3D4CA0CF" unitRef="shares">36180000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2017Q1YTD" decimals="-3" id="Fact-E9DA936A9E828C8E49ECFC5D3D40038D" unitRef="shares">36480000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2016Q1YTD" decimals="-3" id="Fact-555F6E611E6D11454515FC5D3D4AD784" unitRef="shares">31956000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2017Q1YTD" decimals="-3" id="Fact-BC3356C6943BBA2EA78CFC5D3D4B50D2" unitRef="shares">32872000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<ccrn:FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock contextRef="FD2017Q1YTD" id="Fact-3320AEEBDF9D5D022E6AFC5D3FC986BD">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table which follows reconciles the opening balances to the closing balances for fair value measurements categorized within Level 3 of the fair value hierarchy:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.828125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Contingent Consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Liabilities (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Derivative Liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,603&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,532&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Settlements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(100&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(25,951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Accretion expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;270&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Valuation gain for the period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,581&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,773&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;_______________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:0px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Related to the Mediscan acquisition on October 30, 2015 and the USR acquisition on December 1, 2016. See Note 3 - Acquisitions. Valuation gain and accretion expense is included as acquisition-related contingent consideration on the condensed consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ccrn:FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock>
	<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="FD2017Q1YTD" id="Fact-55B598C9230199FF6225FC5D3DBC301B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form&amp;#160;10-Q and Article 10 of Regulation&amp;#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (U.S. GAAP) for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2016 included in the Company&amp;#8217;s Annual Report on Form&amp;#160;10-K as filed with the Securities and Exchange Commission. The &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; condensed consolidated balance sheet included herein was derived from the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; audited consolidated balance sheet included in the Company&amp;#8217;s Annual Report on Form&amp;#160;10-K.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
	<us-gaap:BusinessCombinationDisclosureTextBlock contextRef="FD2017Q1YTD" id="Fact-A69D065C4F278BC823EAFC5D3DF39B65">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;ACQUISITIONS&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;US Resources Healthcare&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 1, 2016, the Company completed the acquisition of a recruitment process outsourcing business, US Resources Healthcare, LLC (USR). This acquisition expands the Company's workforce solutions offerings to deliver financial and operating efficiencies through labor optimization services while enhancing the quality of care.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The acquisition was deemed immaterial and has been accounted for in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Business Combinations &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Topic of the FASB ASC&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;using the acquisition method of accounting. USR's results of operations are included in the consolidated statements of operations from December 1, 2016 and have been included in the Company's Nurse and Allied Staffing business segment. See Note 6 - Goodwill, Trade Names, and Other Intangible Assets and Note 9 - Fair Value Measurements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Mediscan&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On October 30, 2015, the Company completed the acquisition of all of the membership interests of New Mediscan II, LLC, Mediscan Diagnostic Services, LLC, and Mediscan Nursing Staffing, LLC (collectively Mediscan) for a purchase price of  &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$29.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in cash (&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$28.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; plus working capital estimate) and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in shares (or &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;349,871&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares) of the Company's Common Stock, subject to a net working capital adjustment. The shares of Common Stock issued in connection with the acquisition were subject to a lockup period, which ended April 30, 2016. In the first quarter of 2016, the net working capital adjustment was settled consistent with the receivable balance as of December 31, 2015. An amount of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the purchase price was held in escrow to cover any post-closing liabilities, which was released to the seller on May 3, 2017. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The agreement also specified that the sellers were eligible to receive additional purchase price consideration of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, with &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per year based on attainment of specific performance criteria in 2016 and 2017. As of December 31, 2016, the Company determined that the first year earnout was not achieved for 2016 and as a result, only &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; remains as a potential earnout for 2017. As of March 31, 2017, the fair value of the remaining obligation was estimated at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In connection with the Mediscan acquisition, the Company also assumed additional contingent purchase price liabilities for a previously acquired business that are payable annually based on specific performance criteria for the 2016 through 2019 years. Payments related to the 2016 through 2018 years are limited to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per year and 2019 is uncapped. During the three months ended March 31, 2017, the Company paid &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. As of March 31, 2017, the fair value of the remaining obligations on an undiscounted basis was estimated at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of March 31, 2017, a total of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was estimated as the fair value of these contingent consideration payments and is included in other current liabilities and contingent consideration on the condensed consolidated balance sheets. See Note 9 - Fair Value Measurements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Medical Staffing Network&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On June 30, 2014, the Company acquired substantially all of the assets and certain liabilities of Medical Staffing Network Healthcare, LLC (MSN). Of the purchase price, &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;"&gt;$2.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was deferred and due to the seller &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;"&gt;21 months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; from the acquisition date, less any COBRA expenses incurred by the Company on behalf of former MSN employees over that period.  The Company incurred &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in COBRA expenses since the MSN acquisition and, on April 1, 2016, released to the seller the remaining liability of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="FD2017Q1YTD" id="Fact-605FC7A8F476929C9DE7FC5D4008F34D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;COMMITMENTS AND CONTINGENCIES&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Contingencies:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Legal Proceedings&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is subject to legal proceedings and claims that arise in the ordinary course of its business. The Company does not believe the outcome of these matters will have a material adverse effect on the Company's business, financial condition, results of operations or cash flows.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Sales and Other State Non-Income Tax Liabilities &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company's business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions.&amp;#160;The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised. The expense is included in selling, general and administrative expenses on its condensed consolidated statements of operations and the liability is reflected in other current liabilities as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, on its condensed consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="FD2017Q1YTD" id="Fact-470171B8D3E0D704B833FC5D3E05F60E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;COMPREHENSIVE INCOME (LOSS)&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total comprehensive income (loss) includes net income or loss and foreign currency translation adjustments, net of any related deferred taxes. Certain of the Company&amp;#8217;s foreign subsidiaries use their respective local currency as their functional currency. In accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Foreign Currency Matters &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Topic of the FASB ASC,&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying condensed consolidated balance sheets and was approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at both &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;There was no income tax impact related to foreign currency translation adjustments for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; month periods ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
	<us-gaap:DebtDisclosureTextBlock contextRef="FD2017Q1YTD" id="Fact-1DA4484D962028A0FEF9FC5D3EE23B8C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;DEBT&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;At &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, long-term debt consists of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Principal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Unamortized Discount and Debt Issuance Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Principal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Unamortized Discount and Debt Issuance Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Term Loan, interest 2.78%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(339&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(363&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Convertible Notes, fixed rate interest of 8.00%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,669&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Convertible Notes derivative liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,532&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Capital lease obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,518&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(339&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;92,055&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,032&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less current portion&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,263&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Long-term debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,508&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(339&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,792&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,032&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the aggregate scheduled maturities of debt are as follows: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:72%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Term Loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Capital Leases &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Through Years Ending December&amp;#160;31:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,750&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company and certain of its domestic subsidiaries entered into a Convertible Note Purchase Agreement (the Note Purchase Agreement), with certain note holders (collectively, the Noteholders) on June 30, 2014. Pursuant to the Note Purchase Agreement, the Company sold to the Noteholders an aggregate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$25.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of convertible senior notes (the Convertible Notes). On March 17, 2017, the Company repaid in full the Convertible Notes. In connection with the repayment, the Company issued to the Noteholders an aggregate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,175,584&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of Common Stock, par value &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.0001&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and cash in the aggregate amount of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (of which &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; is included in repayment of debt and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; is presented as extinguishment fees, both within financing activities on the condensed consolidated statements of cash flows).&amp;#160;Upon derecognition of the net carrying amounts of the Convertible Notes (the remaining &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$20.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; after the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; cash payment) and derivative liability (&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$26.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;), the Company recognized a non-cash charge of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; as loss on early extinguishment and a non-cash addition to additional paid-in capital of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$46.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the fair value of the shares, which is not presented on the condensed consolidated statements of cash flows. The loss on early extinguishment of debt includes the write-off of unamortized loan fees and remaining interest due through the Forced Conversion date (defined below) of June 30, 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Convertible Notes were convertible at the option of the holders thereof at any time into shares of the Company&amp;#8217;s common stock, par value &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.0001&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share (Common Stock), at a conversion price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.10&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share, or &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,521,126&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of Common Stock.  After &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; from the issuance date, the Company had the right to force a conversion of the Convertible Notes if the volume-weighted average price (VWAP) per share of its Common Stock exceeded &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;125%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the then conversion price for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; days of a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;30&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; day trading period (Forced Conversion date).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Convertible Notes bore interest at a rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.00%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per annum, payable in quarterly cash installments. The Convertible Notes would have matured on June 30, 2020, unless earlier repurchased, redeemed or converted. Subject to certain exceptions, the Company was not permitted to redeem the Convertible Notes until June 30, 2017. If the Company redeemed the Convertible Notes on or after June 30, 2017, the Company was required to pay a premium of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the amount of principal of the Convertible Notes redeemed.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;2016 Senior Credit Facilities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has a senior credit agreement (Credit Agreement), entered into on June 22, 2016, which provides a term loan of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$40.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (Term Loan) and a revolving credit facility of up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$100.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (Revolving Credit Facility) (together with the Term Loan, the Senior Credit Facilities) both of which mature on June 22, 2021. The Revolving Credit Facility includes a subfacility for swingline loans up to an amount not to exceed &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$15.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$35.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; sublimit for the issuance of standby letters of credit.&amp;#160; The Credit Agreement also includes a provision permitting the Company, subject to certain conditions, to increase the aggregate amount of the commitments under the Revolving Credit Facility or establish one or more additional term loans in an aggregate amount of up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$50.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; with optional additional commitments from existing lenders or new commitments from additional lenders. The Term Loan is payable in quarterly installments, with the first payment made September 30, 2016, and each such installment being in the aggregate principal amount (subject to adjustment as a result of prepayments) equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.25%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the principal amount for the first four installments, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.875%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the next eight installments and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the principal amount for the remaining installments. The Revolving Credit Facility can be used to provide ongoing working capital, fund permitted acquisitions and for other general corporate purposes of the Company and its subsidiaries.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Subject to the Credit Agreement, the Company pays interest on (i) each Base Rate Loan at the Base Rate (as defined therein) plus the Applicable Margin in effect from time to time, (ii) each LIBOR Index Rate Loan at the One Month LIBOR Index Rate (as defined therein) plus the Applicable Margin in effect from time to time and (iii) each Eurodollar Loan at the Adjusted LIBOR for the applicable Interest Period (as defined therein) in effect for such Loan plus the Applicable Margin in effect from time to time.  The Applicable Margin, as of any date, is a percentage per annum determined by reference to the applicable Consolidated Net Leverage Ratio (as defined by the agreement) in effect on such date as set forth in the table below.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:35%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;"&gt;Level&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;"&gt;Consolidated Net Leverage Ratio&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;"&gt;Eurodollar Loans, LIBOR Index Rate Loans and Letter of Credit Fee&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;"&gt;Base Rate Loans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;"&gt;Commitment Fee&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;I&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;Less than 1.50:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;1.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;II&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;Greater than or equal to 1.50:1.00 &lt;br clear="none"/&gt;but less than 2.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;2.00%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;1.00%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.30%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;III&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;Greater than or equal to 2.00:1.00&lt;br clear="none"/&gt; but less than 2.50:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;2.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;1.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.30%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;IV&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;Greater than or equal to 2.50:1.00&lt;br clear="none"/&gt; but less than 3.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;2.50%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;1.50%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.35%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;V&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;Greater than or equal to 3.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;2.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;1.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.40%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Term Loan and Revolving Credit Facility bore interest at a rate equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;One Month LIBOR&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; plus &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; basis points. The interest rate is subject to an increase of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; basis points if an event of default exists under the Credit Agreement.  The Company is required to pay a commitment fee on the average daily unused portion of the Revolving Credit Facility, based on the Applicable Margin which was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.30%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has the right at any time and from time to time to prepay any borrowing, in whole or in part, without premium or penalty, by giving irrevocable written notice (or telephonic notice promptly confirmed in writing) except that such notice shall be revocable if a prepayment is being made in anticipation of concluding a financing arrangement, and the Company is ultimately unable to secure such financing arrangement.  The Company is required to prepay the Senior Credit Facilities under certain circumstances including from net cash proceeds from asset sales or dispositions in excess of certain thresholds, as well as from net cash proceeds from the issuance of certain debt by the Company.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Credit Agreement contains customary representations, warranties, and affirmative covenants. The Credit Agreement also contains customary negative covenants, subject to some exceptions, on (i)&amp;#160;indebtedness and preferred equity, (ii)&amp;#160;liens, (iii)&amp;#160;fundamental changes, (iv)&amp;#160;investments, (v)&amp;#160;restricted payments, and (vi) sale of assets and certain other restrictive agreements. The Credit Agreement also contains customary events of default, such as payment defaults, cross-defaults to other material indebtedness, bankruptcy and insolvency, the occurrence of a defined change in control and the failure to observe the negative covenants and other covenants related to the operation of the Company&amp;#8217;s business.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Credit Agreement also includes &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; financial covenants: (i) limiting a maximum Consolidated Total Leverage ratio (as defined therein) to be no greater than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1.00 for the fiscal quarters ending September 30, 2016 through June 30, 2017, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.25&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1.00 for the fiscal quarters ending September 30, 2017 through June 30, 2018, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1.00 for each fiscal quarter ending thereafter and as adjusted pursuant to a Qualified Permitted Acquisition (as defined therein); and (ii) requiring a minimum Consolidated Fixed Charge Coverage ratio (as defined therein) as of the end of each fiscal quarter of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1.00. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company was in compliance with the financial covenants and other covenants contained in the Credit Agreement.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The obligations under the Credit Agreement are guaranteed by all of the Company&amp;#8217;s domestic wholly-owned subsidiaries. The obligations under the Credit Agreement are secured by a first-priority security interest in the Collateral (as defined therein).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$22.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; letters of credit outstanding and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$77.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; available under the Revolving Credit Facility. The letters of credit relate to the Company&amp;#8217;s workers&amp;#8217; compensation and professional liability insurance policies.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
	<us-gaap:DerivativesAndFairValueTextBlock contextRef="FD2017Q1YTD" id="Fact-C12F8C8D00B84F788CD6FC5D3F7A0610">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;CONVERTIBLE NOTES DERIVATIVE LIABILITY&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, wrote off the derivative liability. See Note 7 - Debt. The Company does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company issued Convertible Notes with features that were either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Accounting for Derivative Financial Instruments and Hedging Activities &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Topic of the FASB ASC, in certain instances, these instruments were required to be carried as derivative liabilities, at fair value, in the financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Convertible Notes were subject to anti-dilution adjustments that allowed for the reduction in the Conversion Price, as defined in the agreement, in the event the Company subsequently issued equity securities including Common Stock or any security convertible or exchangeable for shares of Common Stock for a price less than the then current conversion price. In addition, the Convertible Notes allowed the issuer to exercise optional redemption features and the holder to exercise an offer to purchase feature, under certain conditions. The Company accounted for the conversion option in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Accounting for Derivative Financial Instruments and Hedging Activities &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Topic. Since this conversion feature is not considered to be solely indexed to the Company&amp;#8217;s own stock the derivative was recorded as a liability in the line item long-term debt on the Company's condensed consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s Convertible Notes derivative liability was measured at fair value using a trinomial lattice model. The optional redemption features, along with the offer to purchase features were incorporated into the valuation model. Inputs into the model required estimates, including such items as estimated volatility of the Company's stock, estimated credit risk of the Company, estimated probabilities of change of control and issuance of additional financing, risk-free interest rate, and the estimated life of the financial instruments being fair valued. In addition, since the conversion price contained an anti-dilution adjustment, the probability that the Conversion Price of the Notes would decrease as the share price decreased was incorporated into the valuation calculation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The fair value of the derivative liability was primarily determined by fluctuations in our stock price. In addition, changes in our credit risk profile impacted the fair value determination. These fluctuations resulted in a current period gain or loss that was presented on the condensed consolidated statements of operations as (gain) loss on derivative liability.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DerivativesAndFairValueTextBlock>
	<us-gaap:EarningsPerShareTextBlock contextRef="FD2017Q1YTD" id="Fact-EB0507B6A390C4A7698FFC5D3E108AAC">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;EARNINGS PER SHARE&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:69%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(amounts in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Numerator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income attributable to common shareholders - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Interest on Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;694&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;838&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gain on derivative liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,581&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(16,436&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Net (loss) income attributable to common shareholders - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,897&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,424&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Denominator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average common shares - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;32,872&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,956&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Effective of diluted shares:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;padding-left:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Share-based awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;674&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;703&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;padding-left:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Convertible Notes &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,934&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,521&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average common shares - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,480&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,180&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income per share attributable to common shareholders - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.06&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.60&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income per share attributable to common shareholders - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.08&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.09&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For the periods presented, no tax benefits have been assumed in the weighted average share calculation due to a full valuation allowance on the Company's deferred tax assets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Convertible Notes were repaid in full on March 17, 2017. Applying the if-converted method, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,934,271&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares (the weighted average shares outstanding through March 17, 2017) were included in diluted weighted average shares for the three months ended March 31, 2017 because their effect was dilutive.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
	<us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="FD2017Q1YTD" id="Fact-6586CFE57A47D470E80FFC5D3FC9E3CD">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table represents the carrying amounts and estimated fair value of the Company&amp;#8217;s significant financial instruments that were not measured at fair value:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:34%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair&lt;br clear="none"/&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair&lt;br clear="none"/&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Financial Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;background-color:#cceeff;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;(Level 2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Term Loan, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,161&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,300&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,137&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Convertible Notes, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20,331&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
	<us-gaap:FairValueDisclosuresTextBlock contextRef="FD2017Q1YTD" id="Fact-CFA8FEA825CAA3B3932FFC5D3FC9D9D4">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;FAIR VALUE MEASUREMENTS&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurements and Disclosures &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Topic of the FASB ASC defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurements and Disclosures&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Level 1&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;Quoted prices in active markets for identical assets or liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Level 2&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Level 3&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Items Measured at Fair Value on a Recurring Basis:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s financial assets/liabilities required to be measured on a recurring basis were its: deferred compensation liability included in other long-term liabilities, Convertible Notes derivative liability included in long-term debt and capital lease obligations, and contingent consideration liabilities included in other current liabilities and contingent consideration on the condensed consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Deferred compensation&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;The Company utilizes Level 1 inputs to value its deferred compensation liability. The Company&amp;#8217;s deferred compensation liability is measured using publicly available indices that define the liability amounts, as per the plan documents.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Convertible Notes derivative liability&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;The Company utilized Level 3 inputs to value its Convertible Notes derivative liability.  See Note 7 - Debt and Note 8 - Convertible Notes derivative liability.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Contingent consideration liabilities&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;Potential earnout payments related to the acquisition of Mediscan and USR are contingent upon meeting certain performance requirements through 2019. See Note 3 - Acquisitions. The long-term portion of these liabilities is included in contingent consideration, and the short-term portion is included in other current liabilities on the condensed consolidated balance sheets. The Company utilized Level 3 inputs to value these contingent consideration liabilities as significant unobservable inputs were used in the calculation of their fair value. The Mediscan contingent consideration is recorded as a liability and measured at fair value using a discounted cash flow model in a Monte Carlo simulation setting, utilizing significant unobservable inputs, including the expected volatility of the acquisitions' gross profits and an estimated discount rate commensurate with the risks of the expected gross profit stream. The USR contingent consideration is recorded as a liability and measured at fair value using a discounted cash flow model utilizing significant unobservable inputs, including the probability of achieving each of the potential milestones and an estimated discount rate commensurate with the risks of the expected cash flows attributable to the milestones.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The fair value of contingent consideration and the associated liabilities will be adjusted to fair value at each reporting date until actual settlement occurs, with the changes in fair value and related accretion reflected as acquisition-related contingent consideration on the condensed consolidated statements of operations. Significant increases (decreases) in the volatility or in any of the probabilities of success, or decreases (increases) in the discount rate would result in a significantly higher (lower) fair value, respectively, and commensurate changes to these liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table which follows summarizes the estimated fair value of the Company&amp;#8217;s financial assets and liabilities measured on a recurring basis as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Fair Value Measurements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Financial Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;background-color:#cceeff;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;(Level 1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Deferred compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,213&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,472&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Convertible Notes derivative liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,532&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,773&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,603&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table which follows reconciles the opening balances to the closing balances for fair value measurements categorized within Level 3 of the fair value hierarchy:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.828125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Contingent Consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Liabilities (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Derivative Liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,603&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,532&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Settlements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(100&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(25,951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Accretion expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;270&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Valuation gain for the period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,581&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,773&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;_______________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:0px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Related to the Mediscan acquisition on October 30, 2015 and the USR acquisition on December 1, 2016. See Note 3 - Acquisitions. Valuation gain and accretion expense is included as acquisition-related contingent consideration on the condensed consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Items Measured at Fair Value on a Non-Recurring Basis:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's non-financial assets, such as goodwill, trade names, other intangible assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. During the three months ended March 31, 2017 and December 31, 2016, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; impairment charges were deemed necessary.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Other Fair Value Disclosures:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Financial instruments not measured or recorded at fair value in the accompanying condensed consolidated balance sheets consist of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and short and long-term debt. The estimated fair value of accounts receivable, accounts payable and&amp;#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. The estimated fair value of the Company's debt was calculated using a discounted cash flow analysis and appropriate valuation methodologies using Level 2 inputs from available market information.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table represents the carrying amounts and estimated fair value of the Company&amp;#8217;s significant financial instruments that were not measured at fair value:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:34%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair&lt;br clear="none"/&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair&lt;br clear="none"/&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Financial Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;background-color:#cceeff;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;(Level 2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Term Loan, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,161&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,300&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,137&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Convertible Notes, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20,331&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Concentration of Risk:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has invested its excess cash in highly-rated overnight funds and other highly-rated liquid accounts. The Company has been exposed to credit risk associated with these investments. The Company minimizes its credit risk relating to these positions by monitoring the financial condition of the financial institutions involved and by primarily conducting business with large, well established financial institutions and diversifying its counterparties.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts represents the Company&amp;#8217;s estimate of uncollectible receivables based on a review of specific accounts and the Company&amp;#8217;s historical collection experience. The Company writes off specific&amp;#160;accounts based on an ongoing review of collectability as well as past experience with the customer. The Company&amp;#8217;s contract terms typically require payment between &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;60&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; days from the date services are provided and are considered past due based on the particular negotiated contract terms. Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
	<us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="FD2017Q1YTD" id="Fact-DC33387EE5D0F4D78C78FC5D3E7B06D4">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had the following acquired intangible assets:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="24" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="23" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Databases&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,609&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,655&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,954&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,609&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,147&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,462&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41,724&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23,793&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17,931&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41,724&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23,316&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,408&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-compete agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,619&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,537&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;82&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,619&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,527&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;92&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade names, definite-lived&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;421&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,795&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;343&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,873&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other intangible assets, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;80,168&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,406&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,762&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;80,168&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,333&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,835&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets not subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade names&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,402&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,402&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;71,164&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;72,237&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, estimated annual amortization expense is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:82%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Years Ending December&amp;#160;31:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,175&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,148&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,111&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,007&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,799&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,522&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,762&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The March 31, 2017 and December 31, 2016 carrying amount of goodwill by segment is as follows:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Nurse and Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,685&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,685&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Other Human Capital Management Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,418&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,418&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;79,648&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;79,648&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the three months ended March 31, 2017 and 2016, the Company noted no indicators at any of its reporting units that warranted impairment testing.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
	<us-gaap:IncomeTaxDisclosureTextBlock contextRef="FD2017Q1YTD" id="Fact-181BE76D1FE2A3A87082FC5D400F5388">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;INCOME TAXES&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For the periods ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company has calculated its effective tax rate based on year-to-date results as opposed to estimating its annual effective tax rate.&amp;#160;The Company&amp;#8217;s effective tax rate for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(27.1)%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.0%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, including the impact of discrete items. Excluding discrete items, the Company&amp;#8217;s effective tax rate for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(53.8)%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.9%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. The effective tax rates are different than the statutory rates primarily due to the impact from amortization of indefinite-lived intangible assets for tax purposes, the partial non-deductibility of certain per diem expenses, and international and state taxes.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company records valuation allowances to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The assessment of whether or not a valuation allowance is required often requires significant judgment, including the long-range forecast of future taxable income and the evaluation of tax planning initiatives. Adjustments to the deferred tax valuation allowances are made to earnings in the period when such assessments are made. The Company believes it is necessary to see further positive evidence, such as sustained achievement of cumulative profits, before these valuation allowances can be released. If such positive evidence develops, the Company may release all or a portion of the remaining valuation allowances, but at this point in time cannot determine in which period they would reverse. The Company will continue to assess the realizability of its deferred tax assets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of unrecognized tax benefits included in other current liabilities and other long-term liabilities (&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, net of deferred taxes, which would affect the effective tax rate if recognized). During the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had gross increases of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to its current year unrecognized tax benefits related to federal and state tax issues.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The tax years of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2004, 2005, 2008, and 2010 through 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; remain open to examination by certain taxing jurisdictions to which the Company is subject to tax, other than certain states in which the statute of limitations has been extended.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
	<us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="FD2017Q1YTD" id="Fact-D6BD7D89AE09FAAC88E6FC5D401DA29C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In January 2017, the FASB issued ASU No. 2017-04, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;to simplify how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under this guidance, an entity would perform its annual, or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&amp;#8217;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity would consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019 and is to be applied prospectively. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company expects to early adopt this standard in 2017 in the first quarter in which an impairment test is performed, and does not expect this guidance to have a material impact on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In January 2017, the FASB issued ASU No. 2017-01, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Business Combinations (Topic 805): Clarifying the Definition of a Business&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which clarifies the definition of a business, with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This update provides a framework to assist entities in evaluating whether both an input and a substantive process are present, and narrows the definition of the term output so that the term is consistent with how outputs are described in the new revenue recognition standard. ASU 2017-01 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. Early adoption is permitted depending upon the date of the transaction. Entities should apply the guidance prospectively on or after the effective date. No disclosures are required at transition. The Company expects to adopt this standard in its first quarter of 2018, and does not expect this guidance to have a material impact on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-top:6px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In February 2016, the FASB issued ASU No. 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Full retrospective application is prohibited. The Company expects the valuation of right of use assets and lease liabilities, previously described as operating leases, to be the present value of our forecasted future lease commitments. The Company is continuing to assess the overall impacts of the new standard, including the discount rate to be applied in these valuations. See Note 12 - Commitments and Contingencies to the audited consolidated financial statements included in the Company's Annual Report on Form 10-K.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In May 2014, the FASB and the International Accounting Standards Board jointly issued ASU No. 2014-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;(Topic 606)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, that introduces a new five-step revenue recognition model in which an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires disclosures sufficient to enable users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers, including qualitative and quantitative disclosures about contracts with customers, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. In March 2016, the FASB issued ASU 2016-08 which further clarifies the guidance on the principal versus agent considerations within ASU 2014-09. In April 2016, the FASB issued ASU 2016-10 to expand the guidance on identifying performance obligations and licensing within ASU 2014-09. In May 2016, the FASB issued ASU 2016-12 to improve revenue recognition in the areas of collectability, presentation of sales tax and other similar taxes collected from customers, non-cash consideration, contract modifications and completed contracts at transition. This update also amends the disclosure requirements within ASU 2014-09 for entities that retrospectively apply the guidance. The latest amendments are intended to address implementation issues that were raised by stakeholders and discussed by the Revenue Recognition Transition Resource Group, and provide additional practical expedients. These updates are effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period. The Company established a cross-functional implementation team consisting of representatives from across all of its business segments. Management is in the process of reviewing its contract portfolio and its existing accounting policies and practices to identify potential differences that would result from applying the requirements of the new standard to its contracts. Management expects this assessment will continue throughout the first half of 2017. Once this phase has been completed, if applicable,&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#1f497d;"&gt; &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;management intends to implement appropriate changes to its business processes, systems and controls to support the recognition and disclosure under the new standard. The Company is continuing to assess which transition method it will use to adopt this accounting standard and expects a full assessment by the fourth quarter of 2017.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="FD2017Q1YTD" id="Fact-BF0AAC30DE6983308885FC5D3DCDB7A3">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;"&gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In August 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-15, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which amends the guidance in ASC 230 on the classification of certain cash receipts and payments in the statement of cash flows. This update intended to reduce the diversity that has resulted from the lack of consistent principles on this topic by adding or clarifying guidance on eight cash flow issues, including: debt prepayment or debt extinguishment costs, contingent consideration payments made after a business combination, and separately identifiable cash flows and application of the predominance principle. ASU 2016-15 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. Early adoption was permitted. The Company elected to early adopt this standard in its first quarter of 2017, applying the guidance retrospectively with no material impact on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In March 2016, the FASB issued ASU No. 2016-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Compensation-Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company adopted this guidance in the first quarter of 2017. ASU 2016-09 eliminates the requirement to delay the recognition of excess tax benefits until they reduce current taxes payable. Required method of adoption is modified retrospective transition method. Upon adoption, previously unrecognized excess tax benefits of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; had no impact on the Company's accumulated deficit balance as the related deferred tax assets were fully offset by a valuation allowance. ASU 2016-09 also requires excess tax benefits and deficiencies to be recognized prospectively in the provision for income taxes rather than additional paid-in capital. As a result of the adoption, the Company's provision for income taxes was not impacted due to its full valuation allowance. Additionally, as permitted by the ASU, the Company elected to account for forfeitures as they occur rather than estimate expected forfeitures using a modified retrospective transition method. As a result, the Company recorded a cumulative-effect adjustment of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to accumulated deficit and lower share-based compensation expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; compared to the amount of expense that would have been recorded for its first quarter of 2017. Under ASU 2016-09, the threshold for awards to qualify for equity treatment permits withholding up to the maximum statutory tax rates in the applicable jurisdictions. Prior to the adoption of ASU 2016-09, the Company did not allow an award to be partially settled in cash in excess of the minimum statutory withholding requirements. Subsequent to the adoption of the standard, the Company will allow awards to be partially settled at the maximum applicable statutory rates. Finally, ASU 2016-09 requires excess tax benefits to be presented as a component of operating cash flows rather than financing cash flows. The Company elected to adopt this requirement prospectively and accordingly, prior periods have not been adjusted. Excess tax benefits were not material for all periods presented.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In March 2016, the FASB issued ASU No. 2016-06, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, to clarify the steps required to assess whether a call or put option meets the criteria for bifurcation as an embedded derivative. ASU 2016-06 is effective for interim and annual periods beginning after December 15, 2016, and requires a modified retrospective approach to adoption. The Company adopted this guidance in the first quarter of 2017. The adoption of this guidance had no impact on the Company's results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In January 2017, the FASB issued ASU No. 2017-04, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;to simplify how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under this guidance, an entity would perform its annual, or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&amp;#8217;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity would consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019 and is to be applied prospectively. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company expects to early adopt this standard in 2017 in the first quarter in which an impairment test is performed, and does not expect this guidance to have a material impact on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In January 2017, the FASB issued ASU No. 2017-01, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Business Combinations (Topic 805): Clarifying the Definition of a Business&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which clarifies the definition of a business, with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This update provides a framework to assist entities in evaluating whether both an input and a substantive process are present, and narrows the definition of the term output so that the term is consistent with how outputs are described in the new revenue recognition standard. ASU 2017-01 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. Early adoption is permitted depending upon the date of the transaction. Entities should apply the guidance prospectively on or after the effective date. No disclosures are required at transition. The Company expects to adopt this standard in its first quarter of 2018, and does not expect this guidance to have a material impact on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;padding-top:6px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In February 2016, the FASB issued ASU No. 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Full retrospective application is prohibited. The Company expects the valuation of right of use assets and lease liabilities, previously described as operating leases, to be the present value of our forecasted future lease commitments. The Company is continuing to assess the overall impacts of the new standard, including the discount rate to be applied in these valuations. See Note 12 - Commitments and Contingencies to the audited consolidated financial statements included in the Company's Annual Report on Form 10-K.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In May 2014, the FASB and the International Accounting Standards Board jointly issued ASU No. 2014-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;(Topic 606)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, that introduces a new five-step revenue recognition model in which an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires disclosures sufficient to enable users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers, including qualitative and quantitative disclosures about contracts with customers, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. In March 2016, the FASB issued ASU 2016-08 which further clarifies the guidance on the principal versus agent considerations within ASU 2014-09. In April 2016, the FASB issued ASU 2016-10 to expand the guidance on identifying performance obligations and licensing within ASU 2014-09. In May 2016, the FASB issued ASU 2016-12 to improve revenue recognition in the areas of collectability, presentation of sales tax and other similar taxes collected from customers, non-cash consideration, contract modifications and completed contracts at transition. This update also amends the disclosure requirements within ASU 2014-09 for entities that retrospectively apply the guidance. The latest amendments are intended to address implementation issues that were raised by stakeholders and discussed by the Revenue Recognition Transition Resource Group, and provide additional practical expedients. These updates are effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period. The Company established a cross-functional implementation team consisting of representatives from across all of its business segments. Management is in the process of reviewing its contract portfolio and its existing accounting policies and practices to identify potential differences that would result from applying the requirements of the new standard to its contracts. Management expects this assessment will continue throughout the first half of 2017. Once this phase has been completed, if applicable,&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#1f497d;"&gt; &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;management intends to implement appropriate changes to its business processes, systems and controls to support the recognition and disclosure under the new standard. The Company is continuing to assess which transition method it will use to adopt this accounting standard and expects a full assessment by the fourth quarter of 2017.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="FD2017Q1YTD" id="Fact-2339BE00B4A8071F2490FC5D3DBC80B7">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;ORGANIZATION AND BASIS OF PRESENTATION&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). The condensed consolidated financial statements include all assets, liabilities, revenue, and expenses of InteliStaf of Oklahoma, LLC, which is controlled by the Company but not wholly-owned. The Company records the ownership interest of the noncontrolling shareholder as noncontrolling interest in subsidiary. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form&amp;#160;10-Q and Article 10 of Regulation&amp;#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (U.S. GAAP) for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2016 included in the Company&amp;#8217;s Annual Report on Form&amp;#160;10-K as filed with the Securities and Exchange Commission. The &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; condensed consolidated balance sheet included herein was derived from the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; audited consolidated balance sheet included in the Company&amp;#8217;s Annual Report on Form&amp;#160;10-K.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
	<us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="FD2017Q1YTD" id="Fact-588820AD0339DE3BF6B8FC5D3FE570D2">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Information on operating segments and a&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;reconciliation to income (loss) from operations for the periods indicated are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenues:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Nurse and Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;183,108&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;168,765&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21,464&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,453&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other Human Capital Management Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,001&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,365&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;207,573&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;196,583&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contribution income:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Nurse and Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,622&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,790&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;820&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,553&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other Human Capital Management Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(440&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(111&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,002&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,232&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unallocated corporate overhead&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,286&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,368&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,191&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,412&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquisition-related contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;270&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;287&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income from operations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,255&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,165&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
	<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="FD2017Q1YTD" id="Fact-E1D82CE14C63A854212FFC5D4018BD08">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;RELATED PARTY TRANSACTIONS&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company provides services to hospitals which are affiliated with certain members of the Company&amp;#8217;s Board of Directors. Management believes services with related parties were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. Accounts receivable due from these hospitals at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; were approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In connection with the acquisition of MSN, the Company acquired a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;68%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; ownership interest in InteliStaf of Oklahoma, LLC, a joint venture between the Company and a hospital system.&amp;#160;The Company generated revenue providing staffing services to the hospital system of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. At &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had a receivable balance of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, and a payable balance of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Subsequent to the Company's acquisition of Mediscan on October 30, 2015, Mediscan continued to operate at premises owned, in part, by the founding members of Mediscan. The Company paid &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in rent expense for these premises for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
	<us-gaap:ScheduleOfDebtTableTextBlock contextRef="FD2017Q1YTD" id="Fact-E5887E06A73584A7E10BFC5D3EE201C7">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;At &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, long-term debt consists of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Principal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Unamortized Discount and Debt Issuance Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Principal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Unamortized Discount and Debt Issuance Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Term Loan, interest 2.78%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(339&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(363&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Convertible Notes, fixed rate interest of 8.00%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,669&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Convertible Notes derivative liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,532&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Capital lease obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,518&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(339&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;92,055&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,032&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less current portion&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,263&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Long-term debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,508&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(339&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,792&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,032&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Applicable Margin, as of any date, is a percentage per annum determined by reference to the applicable Consolidated Net Leverage Ratio (as defined by the agreement) in effect on such date as set forth in the table below.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:35%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;"&gt;Level&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;"&gt;Consolidated Net Leverage Ratio&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;"&gt;Eurodollar Loans, LIBOR Index Rate Loans and Letter of Credit Fee&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;"&gt;Base Rate Loans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;"&gt;Commitment Fee&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;I&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;Less than 1.50:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;1.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;II&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;Greater than or equal to 1.50:1.00 &lt;br clear="none"/&gt;but less than 2.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;2.00%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;1.00%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.30%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;III&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;Greater than or equal to 2.00:1.00&lt;br clear="none"/&gt; but less than 2.50:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;2.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;1.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.30%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;IV&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;Greater than or equal to 2.50:1.00&lt;br clear="none"/&gt; but less than 3.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;2.50%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;1.50%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.35%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;V&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;Greater than or equal to 3.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;2.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;1.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#404040;"&gt;0.40%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
	<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="FD2017Q1YTD" id="Fact-55DE7E7CC3828A519C5EFC5D3E101405">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:69%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(amounts in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Numerator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income attributable to common shareholders - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Interest on Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;694&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;838&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gain on derivative liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,581&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(16,436&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Net (loss) income attributable to common shareholders - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,897&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,424&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Denominator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average common shares - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;32,872&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,956&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Effective of diluted shares:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;padding-left:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Share-based awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;674&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;703&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;padding-left:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Convertible Notes &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,934&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,521&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average common shares - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,480&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,180&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income per share attributable to common shareholders - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.06&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.60&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income per share attributable to common shareholders - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.08&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.09&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
	<us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="FD2017Q1YTD" id="Fact-F3315B4E1091CC51936CFC5D3FC9C4C3">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table which follows summarizes the estimated fair value of the Company&amp;#8217;s financial assets and liabilities measured on a recurring basis as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Fair Value Measurements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Financial Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;background-color:#cceeff;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;(Level 1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Deferred compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,213&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,472&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Convertible Notes derivative liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,532&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,773&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,603&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
	<us-gaap:ScheduleOfGoodwillTextBlock contextRef="FD2017Q1YTD" id="Fact-4AD67C0528E220F1A4A5FC5D3E7ACBB1">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The March 31, 2017 and December 31, 2016 carrying amount of goodwill by segment is as follows:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Nurse and Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,685&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,685&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Other Human Capital Management Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,418&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,418&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;79,648&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;79,648&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
	<us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="FD2017Q1YTD" id="Fact-D10A72931D53DD873B1EFC5D3E7C0EDC">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had the following acquired intangible assets:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="24" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:20%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="23" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Databases&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,609&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,655&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,954&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,609&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,147&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,462&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41,724&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23,793&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17,931&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41,724&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23,316&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,408&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-compete agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,619&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,537&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;82&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,619&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,527&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;92&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade names, definite-lived&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;421&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,795&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;343&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,873&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other intangible assets, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;80,168&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,406&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,762&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;80,168&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,333&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,835&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets not subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade names&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,402&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,402&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;71,164&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;72,237&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
	<us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="FD2017Q1YTD" id="Fact-2B504B84D85E4EC33C83FC5D3EEA803F">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the aggregate scheduled maturities of debt are as follows: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:72%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Term Loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Capital Leases &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Through Years Ending December&amp;#160;31:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,750&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
	<us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="FD2017Q1YTD" id="Fact-72D5AA56DE10FE8E442DFC5D3FD4AC06">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes restricted stock awards and performance stock awards activity issued under the 2014 Plan for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Restricted Stock Awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Performance Stock Awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Number of&lt;br clear="none"/&gt;Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Grant Date&lt;br clear="none"/&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Number of Target &lt;br clear="none"/&gt;Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Grant Date&lt;br clear="none"/&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock awards, January&amp;#160;1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;532,294&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9.98&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;332,092&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.73&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;244,205&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14.21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;181,067&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14.36&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(122,061&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(25,838&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9.39&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(112,434&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock awards, March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;628,600&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.48&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;400,725&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.94&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
	<us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="FD2017Q1YTD" id="Fact-25937D5306D0FF8A8AEEFC5D3E7A0381">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, estimated annual amortization expense is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:82%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Years Ending December&amp;#160;31:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,175&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,148&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,111&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,007&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,799&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,522&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,762&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
	<us-gaap:SegmentReportingDisclosureTextBlock contextRef="FD2017Q1YTD" id="Fact-8F2F0ED20BCA04182965FC5D3FE58F1D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;SEGMENT DATA&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Segment Reporting&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC, the Company reports &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; business segments &amp;#8211; Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Company manages and segments its business based on the services it offers to its customers as described below:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#9679;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Nurse and Allied Staffing &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8211; Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added workforce solutions including: temporary and permanent placement of travel and local branch-based nurse and allied professionals, MSP services, education healthcare services, and outsourcing services. Its clients include: public and private acute-care and non-acute care hospitals, government facilities, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and many other healthcare providers throughout the U.S. The results of the Mediscan and USR acquisitions have been aggregated with the Company's Nurse and Allied Staffing business segment. See Note 3 - Acquisitions.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#9679;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Physician Staffing&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; &amp;#8211; Physician Staffing provides physicians in many specialties, certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) as independent contractors on temporary assignments throughout the U.S. at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#9679;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Other Human Capital Management Services&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; &amp;#8211; Other Human Capital Management Services includes retained and contingent search services for physicians, healthcare executives and other healthcare professionals within the U.S.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s management evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income or loss from operations before depreciation, amortization, loss on sale of business, acquisition and integration costs, acquisition-related contingent consideration, restructuring costs, impairment charges, and corporate expenses not specifically identified to a reporting segment. Contribution income is a financial measure used by management when assessing segment performance and is provided in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Segment Reporting&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC. The Company&amp;#8217;s management does not evaluate, manage or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&amp;#8217; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Information on operating segments and a&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;reconciliation to income (loss) from operations for the periods indicated are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenues:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Nurse and Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;183,108&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;168,765&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21,464&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,453&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other Human Capital Management Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,001&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,365&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;207,573&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;196,583&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contribution income:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Nurse and Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,622&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,790&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;820&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,553&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other Human Capital Management Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(440&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(111&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,002&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,232&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unallocated corporate overhead&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,286&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,368&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,191&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,412&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquisition-related contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;270&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;287&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income from operations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,255&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,165&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
	<us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="FD2017Q1YTD" id="Fact-EBB88241AF5F30850009FC5D3FD4B743">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;STOCKHOLDERS&amp;#8217; EQUITY&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Stock Repurchase Program&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company did not repurchase any shares of its Common Stock under its February 2008 Board authorization. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company may purchase up to an additional &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;942,443&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of Common Stock under the February 2008 Board authorization, subject to certain conditions in the Company's Credit Agreement.  The Company may repurchase up to an aggregate amount not to exceed &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.5&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million in any fiscal year, or an unlimited amount if the Company meets certain conditions as described in its Credit Agreement. At &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,596,380&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of Common Stock outstanding.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Share-Based Payments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the three months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;text-transform:default;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;244,205&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of restricted stock awards and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;181,067&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of performance stock awards were granted under the 2014 Omnibus Incentive Plan (2014 Plan) to the Company's management team. Pursuant to the 2014 Plan, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets.&amp;#160;If the minimum level of performance is attained for the 2017 awards, restricted stock will be issued with a vesting date of March 31, 2020, subject to the employee&amp;#8217;s continuing employment.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the first quarter of 2017, the Company's Compensation Committee of the Board of Directors approved a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;48%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; level of attainment for the 2016 performance-based share awards, resulting in the issuance of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;86,784&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; performance shares that will vest on December 31, 2018.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes restricted stock awards and performance stock awards activity issued under the 2014 Plan for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Restricted Stock Awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Performance Stock Awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Number of&lt;br clear="none"/&gt;Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Grant Date&lt;br clear="none"/&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Number of Target &lt;br clear="none"/&gt;Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Grant Date&lt;br clear="none"/&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock awards, January&amp;#160;1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;532,294&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9.98&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;332,092&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.73&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;244,205&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14.21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;181,067&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14.36&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(122,061&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(25,838&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9.39&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(112,434&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock awards, March 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;628,600&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.48&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;400,725&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.94&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;March&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was included in selling, general and administrative expenses related to share-based payments, and a net of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;74,878&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of Common Stock were issued upon the vesting of restricted stock.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;March&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"&gt;$0.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was included in selling, general and administrative expenses related to share-based payments, and a net of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;51,091&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of Common Stock were issued upon the vesting of restricted stock.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
	<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="FD2017Q1YTD" id="Fact-5ABF461303C8ACB41046FC5D3DC781DA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Use of Estimates&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions are used for, but not limited to: (1) the valuation of accounts receivable; (2) goodwill, trade names, and other intangible assets; (3) other long-lived assets; (4) share-based compensation; (5) accruals for health, workers&amp;#8217; compensation and professional liability claims; (6) valuation of deferred tax assets; (7) purchase price allocation; (8) derivative liability; (9) legal contingencies; (10) contingent considerations; (11) income taxes; and (12) sales and other non-income tax liabilities. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. Actual results could differ from those estimates.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;"&gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In August 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-15, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which amends the guidance in ASC 230 on the classification of certain cash receipts and payments in the statement of cash flows. This update intended to reduce the diversity that has resulted from the lack of consistent principles on this topic by adding or clarifying guidance on eight cash flow issues, including: debt prepayment or debt extinguishment costs, contingent consideration payments made after a business combination, and separately identifiable cash flows and application of the predominance principle. ASU 2016-15 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. Early adoption was permitted. The Company elected to early adopt this standard in its first quarter of 2017, applying the guidance retrospectively with no material impact on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In March 2016, the FASB issued ASU No. 2016-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Compensation-Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company adopted this guidance in the first quarter of 2017. ASU 2016-09 eliminates the requirement to delay the recognition of excess tax benefits until they reduce current taxes payable. Required method of adoption is modified retrospective transition method. Upon adoption, previously unrecognized excess tax benefits of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; had no impact on the Company's accumulated deficit balance as the related deferred tax assets were fully offset by a valuation allowance. ASU 2016-09 also requires excess tax benefits and deficiencies to be recognized prospectively in the provision for income taxes rather than additional paid-in capital. As a result of the adoption, the Company's provision for income taxes was not impacted due to its full valuation allowance. Additionally, as permitted by the ASU, the Company elected to account for forfeitures as they occur rather than estimate expected forfeitures using a modified retrospective transition method. As a result, the Company recorded a cumulative-effect adjustment of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to accumulated deficit and lower share-based compensation expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; compared to the amount of expense that would have been recorded for its first quarter of 2017. Under ASU 2016-09, the threshold for awards to qualify for equity treatment permits withholding up to the maximum statutory tax rates in the applicable jurisdictions. Prior to the adoption of ASU 2016-09, the Company did not allow an award to be partially settled in cash in excess of the minimum statutory withholding requirements. Subsequent to the adoption of the standard, the Company will allow awards to be partially settled at the maximum applicable statutory rates. Finally, ASU 2016-09 requires excess tax benefits to be presented as a component of operating cash flows rather than financing cash flows. The Company elected to adopt this requirement prospectively and accordingly, prior periods have not been adjusted. Excess tax benefits were not material for all periods presented.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In March 2016, the FASB issued ASU No. 2016-06, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, to clarify the steps required to assess whether a call or put option meets the criteria for bifurcation as an embedded derivative. ASU 2016-06 is effective for interim and annual periods beginning after December 15, 2016, and requires a modified retrospective approach to adoption. The Company adopted this guidance in the first quarter of 2017. The adoption of this guidance had no impact on the Company's results of operations.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
	<us-gaap:UseOfEstimates contextRef="FD2017Q1YTD" id="Fact-9F4C20DC74F628122955FC5D3DC814FA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Use of Estimates&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions are used for, but not limited to: (1) the valuation of accounts receivable; (2) goodwill, trade names, and other intangible assets; (3) other long-lived assets; (4) share-based compensation; (5) accruals for health, workers&amp;#8217; compensation and professional liability claims; (6) valuation of deferred tax assets; (7) purchase price allocation; (8) derivative liability; (9) legal contingencies; (10) contingent considerations; (11) income taxes; and (12) sales and other non-income tax liabilities. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. Actual results could differ from those estimates.  &lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
	<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
	</link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>ccrn-20170331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.crosscountryhealthcare.com/20170331" xmlns:ccrn="http://www.crosscountryhealthcare.com/20170331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-roles-2016-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2016-01-31" schemaLocation="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2016-01-31" schemaLocation="http://xbrl.sec.gov/currency/2016/currency-2016-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2016-01-31" schemaLocation="http://xbrl.sec.gov/exch/2016/exch-2016-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20170331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20170331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20170331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20170331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="Acquisitions" roleURI="http://www.crosscountryhealthcare.com/role/Acquisitions">
        <link:definition>2103100 - Disclosure - ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2403401 - Disclosure - ACQUISITIONS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingencies" roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies">
        <link:definition>2114100 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeLoss" roleURI="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLoss">
        <link:definition>2106100 - Disclosure - COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveIncomeLossDetails" roleURI="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLossDetails">
        <link:definition>2406401 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1001000 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>1001501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfCashFlowsUnaudited" roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>1004000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited">
        <link:definition>1003000 - Statement - Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfOperationsUnaudited" roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited">
        <link:definition>1002000 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleNotesDerivativeLiability" roleURI="http://www.crosscountryhealthcare.com/role/ConvertibleNotesDerivativeLiability">
        <link:definition>2110100 - Disclosure - CONVERTIBLE NOTES DERIVATIVE LIABILITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.crosscountryhealthcare.com/role/Debt">
        <link:definition>2109100 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConsolidatedNetLeverageRatioDetails" roleURI="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails">
        <link:definition>2409406 - Disclosure - DEBT - Consolidated Net Leverage Ratio (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDebtMaturitiesDetails" roleURI="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails">
        <link:definition>2409403 - Disclosure - DEBT - Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtLongTermDebtDetails" roleURI="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails">
        <link:definition>2409402 - Disclosure - DEBT - Long- Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/DebtNarrativeDetails">
        <link:definition>2409405 - Disclosure - DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails">
        <link:definition>2409404 - Disclosure - DEBT - Private Placement of Convertible Notes Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.crosscountryhealthcare.com/role/DebtTables">
        <link:definition>2309301 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DocumentAndEntityInformation" roleURI="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShare">
        <link:definition>2107100 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails">
        <link:definition>2407402 - Disclosure - EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables">
        <link:definition>2307301 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurements">
        <link:definition>2111100 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
        <link:definition>2411402 - Disclosure - FAIR VALUE MEASUREMENTS - Estimated Fair values Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails">
        <link:definition>2411405 - Disclosure - FAIR VALUE MEASUREMENTS - Financial Instrument that were not Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2411404 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details">
        <link:definition>2411403 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of reconciliation of opening and closing balances for fair value measurements categorized within Level 3 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables">
        <link:definition>2311301 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTradeNamesAndOtherIntangibleAssets" roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets">
        <link:definition>2108100 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails">
        <link:definition>2408402 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails" roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails">
        <link:definition>2408403 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Annual Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails" roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails">
        <link:definition>2408404 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTradeNamesAndOtherIntangibleAssetsTables" roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables">
        <link:definition>2308301 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxes">
        <link:definition>2115100 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesDetails">
        <link:definition>2415401 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationAndBasisOfPresentation" roleURI="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation">
        <link:definition>2101100 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentAccountingPronouncements" roleURI="http://www.crosscountryhealthcare.com/role/RecentAccountingPronouncements">
        <link:definition>2117100 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions">
        <link:definition>2116100 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails">
        <link:definition>2416401 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentData" roleURI="http://www.crosscountryhealthcare.com/role/SegmentData">
        <link:definition>2113100 - Disclosure - SEGMENT DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails" roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails">
        <link:definition>2413403 - Disclosure - SEGMENT DATA - Information on Operating Segments and Reconciliation to Loss From Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataNarrativeDetails">
        <link:definition>2413402 - Disclosure - SEGMENT DATA - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataTables" roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataTables">
        <link:definition>2313301 - Disclosure - SEGMENT DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity">
        <link:definition>2112100 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>2412402 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails">
        <link:definition>2412403 - Disclosure - STOCKHOLDERS' EQUITY - Summary of Restricted Stock and Performance Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables">
        <link:definition>2312301 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPolicies" roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies">
        <link:definition>2102100 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesDetails" roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesDetails">
        <link:definition>2402402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="ccrn_A8ConvertibleNotesMember" name="A8ConvertibleNotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember" name="AccountingStandardsUpdate201609ForfeitureRateComponentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_AccountingStandardsUpdate201609Member" name="AccountingStandardsUpdate201609Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" name="AssumedAdditionalContingentPurchasePriceLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationConsiderationDeferredPeriod" name="BusinessCombinationConsiderationDeferredPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated" name="BusinessCombinationConsiderationTransferredCashConsiderationNegotiated" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" name="BusinessCombinationContingentConsiderationArrangementsExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationEscrowDepositRelease" name="BusinessCombinationEscrowDepositRelease" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_ConsolidatedNetLeverageRatio" name="ConsolidatedNetLeverageRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_ContingentConsiderationLiabilityMember" name="ContingentConsiderationLiabilityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal" name="ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ConvertibleNoteDerivativeLiabilityMember" name="ConvertibleNoteDerivativeLiabilityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ConvertibleNotesDerivativeLiabilityMember" name="ConvertibleNotesDerivativeLiabilityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ConvertibleNotesNetMember" name="ConvertibleNotesNetMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CovenantTerm1Member" name="CovenantTerm1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CovenantTerm2Member" name="CovenantTerm2Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CovenantTerm3Member" name="CovenantTerm3Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CovenantTerm4Member" name="CovenantTerm4Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CovenantTerm5Member" name="CovenantTerm5Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CreditAgreementMember" name="CreditAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio" name="DebtCovenantConsolidatedFixedChargeCoverageRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_DebtCovenantTermsAxis" name="DebtCovenantTermsAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_DebtCovenantTermsDomain" name="DebtCovenantTermsDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate" name="DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault" name="DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_DeferredCompensationMember" name="DeferredCompensationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_DocumentandEntityInformationAbstract" name="DocumentandEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_EachFiscalQuarterEndingThereafterMember" name="EachFiscalQuarterEndingThereafterMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" name="EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock" name="FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_FairValueMeasurementLineItems" name="FairValueMeasurementLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_FairValueMeasurementTable" name="FairValueMeasurementTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense" name="FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member" name="FiscalQuartersEndingSeptember302016throughJune302017Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member" name="FiscalQuartersEndingSeptember302017throughJune302018Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_JointVenturePercentOwnership" name="JointVenturePercentOwnership" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_LetterofCreditFeeMember" name="LetterofCreditFeeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans" name="LineOfCreditFacilitySubFacilityForSwinglineLoans" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit" name="LineOfCreditFacilitySubLimitForLettersOfCredit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ccrn_LineofCreditFacilityAdditionalCapacity" name="LineofCreditFacilityAdditionalCapacity" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments" name="LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments" name="LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments" name="LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_LongtermDebtandCapitalLeaseObligationsGross" name="LongtermDebtandCapitalLeaseObligationsGross" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_MedicalStaffingNetworkMember" name="MedicalStaffingNetworkMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_MediscanMember" name="MediscanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_NumberofFinancialCovenants" name="NumberofFinancialCovenants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_NurseAndAlliedStaffingMember" name="NurseAndAlliedStaffingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_OmnibusPlanMember" name="OmnibusPlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses" name="OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_OtherHumanCapitalManagementServicesMember" name="OtherHumanCapitalManagementServicesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" name="PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_PhysicianStaffingMember" name="PhysicianStaffingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" name="PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" name="PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_PotentialEarnoutMember" name="PotentialEarnoutMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_ProvisionforDoubtfulAccountsandOtherAllowances" name="ProvisionforDoubtfulAccountsandOtherAllowances" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" name="ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_SegmentReportingUnallocatedCorporateExpenses" name="SegmentReportingUnallocatedCorporateExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage" name="SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_TermLoanMember" name="TermLoanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided" name="ThresholdPeriodPastDueforPaymentofServicesProvided" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_WorkingCapitalAdjustmentInvestingActivities" name="WorkingCapitalAdjustmentInvestingActivities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>ccrn-20170331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:href="ccrn-20170331.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:href="ccrn-20170331.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:href="ccrn-20170331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLoss" xlink:href="ccrn-20170331.xsd#ComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLossDetails" xlink:href="ccrn-20170331.xsd#ComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConvertibleNotesDerivativeLiability" xlink:href="ccrn-20170331.xsd#ConvertibleNotesDerivativeLiability" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Debt" xlink:href="ccrn-20170331.xsd#Debt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:href="ccrn-20170331.xsd#DebtConsolidatedNetLeverageRatioDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:href="ccrn-20170331.xsd#DebtDebtMaturitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:href="ccrn-20170331.xsd#DebtLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtNarrativeDetails" xlink:href="ccrn-20170331.xsd#DebtNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:href="ccrn-20170331.xsd#DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:href="ccrn-20170331.xsd#DebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:href="ccrn-20170331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:href="ccrn-20170331.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:href="ccrn-20170331.xsd#EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:href="ccrn-20170331.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:href="ccrn-20170331.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:href="ccrn-20170331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesDetails" xlink:href="ccrn-20170331.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:href="ccrn-20170331.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RecentAccountingPronouncements" xlink:href="ccrn-20170331.xsd#RecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:href="ccrn-20170331.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:href="ccrn-20170331.xsd#RelatedPartyTransactionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:href="ccrn-20170331.xsd#SegmentData" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails" xlink:href="ccrn-20170331.xsd#SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataNarrativeDetails" xlink:href="ccrn-20170331.xsd#SegmentDataNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:href="ccrn-20170331.xsd#SegmentDataTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:href="ccrn-20170331.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:href="ccrn-20170331.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails" xlink:href="ccrn-20170331.xsd#StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:href="ccrn-20170331.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ccrn-20170331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="ccrn-20170331.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ccrn-20170331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLoss" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLossDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_04e17fb3-9b77-1c98-f460-7f5dd0c01008" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_48ae1e41-8bb7-d139-f404-61b44b37e179" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_04e17fb3-9b77-1c98-f460-7f5dd0c01008" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_48ae1e41-8bb7-d139-f404-61b44b37e179" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_2644da13-7baa-0a2f-63e0-0906a691ba01" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_48ae1e41-8bb7-d139-f404-61b44b37e179" xlink:to="loc_us-gaap_StockholdersEquity_2644da13-7baa-0a2f-63e0-0906a691ba01" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_d53388e7-4c8c-4e6d-6e90-7a6e0a100b74" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2644da13-7baa-0a2f-63e0-0906a691ba01" xlink:to="loc_us-gaap_CommonStockValue_d53388e7-4c8c-4e6d-6e90-7a6e0a100b74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b1a68b05-ec26-b896-ce8e-937cca99264e" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2644da13-7baa-0a2f-63e0-0906a691ba01" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b1a68b05-ec26-b896-ce8e-937cca99264e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aeb1020a-508a-a8c1-f34c-bafff16c26cb" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2644da13-7baa-0a2f-63e0-0906a691ba01" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aeb1020a-508a-a8c1-f34c-bafff16c26cb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f759e73e-9f4f-941e-1138-49bc44f6b118" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2644da13-7baa-0a2f-63e0-0906a691ba01" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f759e73e-9f4f-941e-1138-49bc44f6b118" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_0b2dda0f-483d-415e-b849-61eb9013050d" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_48ae1e41-8bb7-d139-f404-61b44b37e179" xlink:to="loc_us-gaap_MinorityInterest_0b2dda0f-483d-415e-b849-61eb9013050d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_6d3ec995-5062-ef92-dd72-b570c1eafdc8" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_04e17fb3-9b77-1c98-f460-7f5dd0c01008" xlink:to="loc_us-gaap_Liabilities_6d3ec995-5062-ef92-dd72-b570c1eafdc8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_a859bb84-8118-88ec-5136-83fdb14e8f32" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6d3ec995-5062-ef92-dd72-b570c1eafdc8" xlink:to="loc_us-gaap_LiabilitiesCurrent_a859bb84-8118-88ec-5136-83fdb14e8f32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_5384bd08-f0f7-1191-88e4-9357198292bd" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a859bb84-8118-88ec-5136-83fdb14e8f32" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_5384bd08-f0f7-1191-88e4-9357198292bd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e20e4396-1ab7-d9ec-b779-e1a72ae620da" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a859bb84-8118-88ec-5136-83fdb14e8f32" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e20e4396-1ab7-d9ec-b779-e1a72ae620da" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_0ff25fd8-f6de-e7fa-c6c3-85d94f17f57b" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a859bb84-8118-88ec-5136-83fdb14e8f32" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_0ff25fd8-f6de-e7fa-c6c3-85d94f17f57b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8946510c-36b9-b4e9-aad5-5a89036a4dfa" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6d3ec995-5062-ef92-dd72-b570c1eafdc8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8946510c-36b9-b4e9-aad5-5a89036a4dfa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_3b38d8c3-335c-53c8-5510-f59766fb81d5" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6d3ec995-5062-ef92-dd72-b570c1eafdc8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_3b38d8c3-335c-53c8-5510-f59766fb81d5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_75b247f6-acf8-264e-d372-996aedbefe30" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6d3ec995-5062-ef92-dd72-b570c1eafdc8" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_75b247f6-acf8-264e-d372-996aedbefe30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_c0cb10ca-c667-9287-e07d-f3879727072b" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6d3ec995-5062-ef92-dd72-b570c1eafdc8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_c0cb10ca-c667-9287-e07d-f3879727072b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b65887e3-1865-ef3e-c8ae-81780cbff9ee" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6d3ec995-5062-ef92-dd72-b570c1eafdc8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b65887e3-1865-ef3e-c8ae-81780cbff9ee" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_49d65a66-0444-b198-9d28-5c0811b1bdf3" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_04e17fb3-9b77-1c98-f460-7f5dd0c01008" xlink:to="loc_us-gaap_CommitmentsAndContingencies_49d65a66-0444-b198-9d28-5c0811b1bdf3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_08bee809-e27e-48c3-da2d-5d52948eb470" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_dbbeeff9-fd43-6151-195d-0532728ac216" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_08bee809-e27e-48c3-da2d-5d52948eb470" xlink:to="loc_us-gaap_AssetsCurrent_dbbeeff9-fd43-6151-195d-0532728ac216" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ec544f28-9c7b-137c-e428-9ae47c2375fc" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dbbeeff9-fd43-6151-195d-0532728ac216" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ec544f28-9c7b-137c-e428-9ae47c2375fc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d28874fa-4543-5746-c91a-559d7ab47f77" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dbbeeff9-fd43-6151-195d-0532728ac216" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d28874fa-4543-5746-c91a-559d7ab47f77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_4cde1efa-07a8-ded0-f592-2cecba3dedaf" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dbbeeff9-fd43-6151-195d-0532728ac216" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_4cde1efa-07a8-ded0-f592-2cecba3dedaf" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_df866d05-0665-6819-5031-77017d332796" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dbbeeff9-fd43-6151-195d-0532728ac216" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableCurrent_df866d05-0665-6819-5031-77017d332796" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_fdb77e30-ba68-0e41-abc1-70858b11de5b" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dbbeeff9-fd43-6151-195d-0532728ac216" xlink:to="loc_us-gaap_OtherAssetsCurrent_fdb77e30-ba68-0e41-abc1-70858b11de5b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_68e7c3c1-9b8d-84fe-3a5c-d69c15dfe7a2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_08bee809-e27e-48c3-da2d-5d52948eb470" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_68e7c3c1-9b8d-84fe-3a5c-d69c15dfe7a2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_279d6efe-4bc1-4837-575f-f4441da9fdac" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_08bee809-e27e-48c3-da2d-5d52948eb470" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_279d6efe-4bc1-4837-575f-f4441da9fdac" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_d723083e-f7a3-6d89-9926-32afaa010d8a" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_08bee809-e27e-48c3-da2d-5d52948eb470" xlink:to="loc_us-gaap_Goodwill_d723083e-f7a3-6d89-9926-32afaa010d8a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_08bee809-e27e-48c3-da2d-5d52948eb470" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e6ade192-0839-bdd8-d08b-20387a0e8201" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_08bee809-e27e-48c3-da2d-5d52948eb470" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e6ade192-0839-bdd8-d08b-20387a0e8201" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_104af714-3829-5d79-3fb3-059f86c366da" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_104af714-3829-5d79-3fb3-059f86c366da" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_00a475d0-9ed4-5ca4-8e09-183f13a0aa46" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_ProfitLoss_00a475d0-9ed4-5ca4-8e09-183f13a0aa46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b0d6e80b-2a71-4b3d-5167-6e414c6a123b" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b0d6e80b-2a71-4b3d-5167-6e414c6a123b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_9a24f45c-1e95-3649-7f52-85ed3c472b12" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_9a24f45c-1e95-3649-7f52-85ed3c472b12" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ProvisionforDoubtfulAccountsandOtherAllowances" xlink:label="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_d856af4e-c1d5-1f0f-d639-0c655fcc6de2" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_d856af4e-c1d5-1f0f-d639-0c655fcc6de2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bc155cc8-6ee1-5ea7-d824-9c91dc052636" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bc155cc8-6ee1-5ea7-d824-9c91dc052636" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_91674616-989d-90e8-1302-b52ff7a33098" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_91674616-989d-90e8-1302-b52ff7a33098" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d64dc88a-3863-cee6-1410-0ab0492ecd56" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d64dc88a-3863-cee6-1410-0ab0492ecd56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a630cdc5-a27f-054d-4089-cf5e52fc4cdd" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a630cdc5-a27f-054d-4089-cf5e52fc4cdd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_432488d8-28ca-5b8d-679b-29be120957b5" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_ShareBasedCompensation_432488d8-28ca-5b8d-679b-29be120957b5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaap_OtherNoncashExpense_ed1c7de3-044d-73c6-628a-8f76a69dc0b3" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_OtherNoncashExpense_ed1c7de3-044d-73c6-628a-8f76a69dc0b3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ffe19198-61f8-be6a-6111-42f645804604" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ffe19198-61f8-be6a-6111-42f645804604" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d8c0a214-0b0d-1fc8-686b-ed5eca49895f" xlink:type="locator" />
    <link:calculationArc order="12" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d8c0a214-0b0d-1fc8-686b-ed5eca49895f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_880f9863-dd81-7240-4418-c9f1ba4fd53e" xlink:type="locator" />
    <link:calculationArc order="13" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_880f9863-dd81-7240-4418-c9f1ba4fd53e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_7a016eeb-d472-4272-2fad-97e749a6fbc2" xlink:type="locator" />
    <link:calculationArc order="14" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_975a3fab-7f49-5162-2cb5-31bb1479931f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_7a016eeb-d472-4272-2fad-97e749a6fbc2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_95f67350-d3ec-5d41-e3b2-a4fe7a19e15b" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_104af714-3829-5d79-3fb3-059f86c366da" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_95f67350-d3ec-5d41-e3b2-a4fe7a19e15b" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_WorkingCapitalAdjustmentInvestingActivities" xlink:label="loc_ccrn_WorkingCapitalAdjustmentInvestingActivities_F8438B4F532250F8A4D2576276DA8301" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_95f67350-d3ec-5d41-e3b2-a4fe7a19e15b" xlink:to="loc_ccrn_WorkingCapitalAdjustmentInvestingActivities_F8438B4F532250F8A4D2576276DA8301" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_991d89e2-25f7-1061-f5f8-86acc91f176b" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_95f67350-d3ec-5d41-e3b2-a4fe7a19e15b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_991d89e2-25f7-1061-f5f8-86acc91f176b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_08614f0c-c3a2-4c92-7c1d-aed5de18fe70" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_104af714-3829-5d79-3fb3-059f86c366da" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_08614f0c-c3a2-4c92-7c1d-aed5de18fe70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_90cd6d89-f315-788f-d750-05a68667e398" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_08614f0c-c3a2-4c92-7c1d-aed5de18fe70" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_90cd6d89-f315-788f-d750-05a68667e398" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_866e0d33-eabf-2b46-aabe-ae0e1d229b78" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_08614f0c-c3a2-4c92-7c1d-aed5de18fe70" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_866e0d33-eabf-2b46-aabe-ae0e1d229b78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_86ce4ca2-d19c-dca3-7b2c-688c1f06e3eb" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_08614f0c-c3a2-4c92-7c1d-aed5de18fe70" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_86ce4ca2-d19c-dca3-7b2c-688c1f06e3eb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7e341d9c-b561-17b2-6b84-9236041ffef0" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_08614f0c-c3a2-4c92-7c1d-aed5de18fe70" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7e341d9c-b561-17b2-6b84-9236041ffef0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_9f72449f-62f6-71b1-0128-c7088f4f3527" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_104af714-3829-5d79-3fb3-059f86c366da" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_9f72449f-62f6-71b1-0128-c7088f4f3527" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_663a641c-b103-1e10-d3ec-c078ec7a031b" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d23b2d61-1407-f3f5-ba7b-69860a5b50dd" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_663a641c-b103-1e10-d3ec-c078ec7a031b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d23b2d61-1407-f3f5-ba7b-69860a5b50dd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_00a475d0-9ed4-5ca4-8e09-183f13a0aa46" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d23b2d61-1407-f3f5-ba7b-69860a5b50dd" xlink:to="loc_us-gaap_ProfitLoss_00a475d0-9ed4-5ca4-8e09-183f13a0aa46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_369c90d1-6da1-8050-c604-fad527301a92" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d23b2d61-1407-f3f5-ba7b-69860a5b50dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_369c90d1-6da1-8050-c604-fad527301a92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_2ef642d8-d394-0eb9-a222-34ad2ae24f23" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_369c90d1-6da1-8050-c604-fad527301a92" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_2ef642d8-d394-0eb9-a222-34ad2ae24f23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_57932a93-02bc-f4e7-4538-5a7fc65a1b5b" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_663a641c-b103-1e10-d3ec-c078ec7a031b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_57932a93-02bc-f4e7-4538-5a7fc65a1b5b" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_8baf87d5-5f2f-7d0d-cb85-b9f249bae0c5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_00a475d0-9ed4-5ca4-8e09-183f13a0aa46" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8baf87d5-5f2f-7d0d-cb85-b9f249bae0c5" xlink:to="loc_us-gaap_ProfitLoss_00a475d0-9ed4-5ca4-8e09-183f13a0aa46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5ba85eae-c4c2-72cc-f9e5-b0edc41783e5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_00a475d0-9ed4-5ca4-8e09-183f13a0aa46" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5ba85eae-c4c2-72cc-f9e5-b0edc41783e5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_800dbb3e-0416-e0ab-a30e-cfaeb17b8c4c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5ba85eae-c4c2-72cc-f9e5-b0edc41783e5" xlink:to="loc_us-gaap_OperatingIncomeLoss_800dbb3e-0416-e0ab-a30e-cfaeb17b8c4c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_1fd2c3b5-12a4-0f06-9816-c6d97d4ac6df" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_800dbb3e-0416-e0ab-a30e-cfaeb17b8c4c" xlink:to="loc_us-gaap_GrossProfit_1fd2c3b5-12a4-0f06-9816-c6d97d4ac6df" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet_a3cfa2ef-65ce-536b-4778-0ecfaa8afbb9" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1fd2c3b5-12a4-0f06-9816-c6d97d4ac6df" xlink:to="loc_us-gaap_SalesRevenueServicesNet_a3cfa2ef-65ce-536b-4778-0ecfaa8afbb9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfServices" xlink:label="loc_us-gaap_CostOfServices_7571626b-4528-208b-4c26-317fe4b6bd60" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1fd2c3b5-12a4-0f06-9816-c6d97d4ac6df" xlink:to="loc_us-gaap_CostOfServices_7571626b-4528-208b-4c26-317fe4b6bd60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_ba9c144a-a131-2335-7bef-6a9a2f344885" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_800dbb3e-0416-e0ab-a30e-cfaeb17b8c4c" xlink:to="loc_us-gaap_CostsAndExpenses_ba9c144a-a131-2335-7bef-6a9a2f344885" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_44B2B2377D25D046DCCA2BFE96FA96F3" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ba9c144a-a131-2335-7bef-6a9a2f344885" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_44B2B2377D25D046DCCA2BFE96FA96F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_51b81a6f-f6af-160e-e526-5abd0f450976" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ba9c144a-a131-2335-7bef-6a9a2f344885" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_51b81a6f-f6af-160e-e526-5abd0f450976" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_33158828-aa18-5ead-beab-c284c08cb606" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ba9c144a-a131-2335-7bef-6a9a2f344885" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_33158828-aa18-5ead-beab-c284c08cb606" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b0d6e80b-2a71-4b3d-5167-6e414c6a123b" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ba9c144a-a131-2335-7bef-6a9a2f344885" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b0d6e80b-2a71-4b3d-5167-6e414c6a123b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_4b6ddf50-6253-3349-fa29-8fc77f744f58" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5ba85eae-c4c2-72cc-f9e5-b0edc41783e5" xlink:to="loc_us-gaap_InterestExpense_4b6ddf50-6253-3349-fa29-8fc77f744f58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d64dc88a-3863-cee6-1410-0ab0492ecd56" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5ba85eae-c4c2-72cc-f9e5-b0edc41783e5" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d64dc88a-3863-cee6-1410-0ab0492ecd56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b936f21a-1a1f-465e-d82c-5e014c9c5399" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5ba85eae-c4c2-72cc-f9e5-b0edc41783e5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b936f21a-1a1f-465e-d82c-5e014c9c5399" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bc155cc8-6ee1-5ea7-d824-9c91dc052636" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5ba85eae-c4c2-72cc-f9e5-b0edc41783e5" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bc155cc8-6ee1-5ea7-d824-9c91dc052636" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9b166675-b7b2-1067-1806-03b1ee0126f1" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_00a475d0-9ed4-5ca4-8e09-183f13a0aa46" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9b166675-b7b2-1067-1806-03b1ee0126f1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_57932a93-02bc-f4e7-4538-5a7fc65a1b5b" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8baf87d5-5f2f-7d0d-cb85-b9f249bae0c5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_57932a93-02bc-f4e7-4538-5a7fc65a1b5b" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConvertibleNotesDerivativeLiability" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/Debt" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_af22c084-5dfa-db11-1d14-662ebdcdba41" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_978bf54f-94f4-6d95-31d0-cc33097dd6a0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_af22c084-5dfa-db11-1d14-662ebdcdba41" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_978bf54f-94f4-6d95-31d0-cc33097dd6a0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_74608514-6c9e-8537-59a6-0d935b66d87e" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_af22c084-5dfa-db11-1d14-662ebdcdba41" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_74608514-6c9e-8537-59a6-0d935b66d87e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_31e1482a-2c65-1330-9267-1f3e05ceda5f" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_af22c084-5dfa-db11-1d14-662ebdcdba41" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_31e1482a-2c65-1330-9267-1f3e05ceda5f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_c9e6708b-c7a2-02bd-ecf0-5193aecad28d" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_af22c084-5dfa-db11-1d14-662ebdcdba41" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_c9e6708b-c7a2-02bd-ecf0-5193aecad28d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_e5ad3cbd-26fd-1084-dbb7-f0db97dcab88" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_af22c084-5dfa-db11-1d14-662ebdcdba41" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_e5ad3cbd-26fd-1084-dbb7-f0db97dcab88" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_69e5de31-e379-3d10-54e1-db1271f781f0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6baa2d31-3357-b671-25ea-61502c236830" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_69e5de31-e379-3d10-54e1-db1271f781f0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6baa2d31-3357-b671-25ea-61502c236830" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_fff555d3-22e2-1be9-15a7-f79f0064a4bb" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_69e5de31-e379-3d10-54e1-db1271f781f0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_fff555d3-22e2-1be9-15a7-f79f0064a4bb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c5420c55-b70f-9186-5b0e-88de7d1b3712" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_69e5de31-e379-3d10-54e1-db1271f781f0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c5420c55-b70f-9186-5b0e-88de7d1b3712" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7b82936a-3efa-d722-acea-fbe08d94cdb3" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_69e5de31-e379-3d10-54e1-db1271f781f0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7b82936a-3efa-d722-acea-fbe08d94cdb3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_6231296c-2b9b-a710-fe01-a01a31f4eeb8" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_69e5de31-e379-3d10-54e1-db1271f781f0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_6231296c-2b9b-a710-fe01-a01a31f4eeb8" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_42387e29-7353-20a4-9c18-a12231859189" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_73b80d47-a1b6-841c-8c0d-41fc44e0a89f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_42387e29-7353-20a4-9c18-a12231859189" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_73b80d47-a1b6-841c-8c0d-41fc44e0a89f" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LongtermDebtandCapitalLeaseObligationsGross" xlink:label="loc_ccrn_LongtermDebtandCapitalLeaseObligationsGross_07380bf2-2a6c-9c46-e06c-0c655f743623" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_42387e29-7353-20a4-9c18-a12231859189" xlink:to="loc_ccrn_LongtermDebtandCapitalLeaseObligationsGross_07380bf2-2a6c-9c46-e06c-0c655f743623" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" xlink:label="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_B22E7090855069F22BC4CEF65FD4AB9B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_90cd6d89-f315-788f-d750-05a68667e398" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_B22E7090855069F22BC4CEF65FD4AB9B" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_90cd6d89-f315-788f-d750-05a68667e398" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_86ce4ca2-d19c-dca3-7b2c-688c1f06e3eb" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_B22E7090855069F22BC4CEF65FD4AB9B" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_86ce4ca2-d19c-dca3-7b2c-688c1f06e3eb" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ae404dc0-76bc-cd1d-811f-e233c07e0569" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e841a58a-f12e-0adc-36de-0299a43719a9" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ae404dc0-76bc-cd1d-811f-e233c07e0569" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e841a58a-f12e-0adc-36de-0299a43719a9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9dba38ce-5067-b4c4-09f7-0cf74e4693de" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ae404dc0-76bc-cd1d-811f-e233c07e0569" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9dba38ce-5067-b4c4-09f7-0cf74e4693de" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_59533250-59d7-f833-2e91-5412c7a9b90c" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ae404dc0-76bc-cd1d-811f-e233c07e0569" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_59533250-59d7-f833-2e91-5412c7a9b90c" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_27b15389-386a-f983-c189-731d6d3c3fbb" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_27b15389-386a-f983-c189-731d6d3c3fbb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_20da5796-2b47-ef11-689a-589894b52fb4" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_20da5796-2b47-ef11-689a-589894b52fb4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d981c90e-1b35-63c2-c258-b2af7bf5b3e0" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d981c90e-1b35-63c2-c258-b2af7bf5b3e0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_279d6efe-4bc1-4837-575f-f4441da9fdac" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_27b15389-386a-f983-c189-731d6d3c3fbb" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_279d6efe-4bc1-4837-575f-f4441da9fdac" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_441e5869-bd08-8d9f-f5d3-2febc2ab5a6e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_441e5869-bd08-8d9f-f5d3-2febc2ab5a6e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_36b3b152-325b-61f4-d066-1d3685b6c394" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_36b3b152-325b-61f4-d066-1d3685b6c394" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_10c80460-5b5e-7e81-facb-0d1ed91293c2" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_10c80460-5b5e-7e81-facb-0d1ed91293c2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ad66514d-dce4-49aa-3300-d457a5d4216a" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ad66514d-dce4-49aa-3300-d457a5d4216a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_df415662-e392-2016-38c7-6c4ddd8a9714" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_df415662-e392-2016-38c7-6c4ddd8a9714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e7896482-8d23-a8f9-52eb-54c2c885aa06" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_70724be1-cf82-e50d-0cc7-fa6194f78b70" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e7896482-8d23-a8f9-52eb-54c2c885aa06" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/RecentAccountingPronouncements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>ccrn-20170331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:href="ccrn-20170331.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:href="ccrn-20170331.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:href="ccrn-20170331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLoss" xlink:href="ccrn-20170331.xsd#ComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLossDetails" xlink:href="ccrn-20170331.xsd#ComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConvertibleNotesDerivativeLiability" xlink:href="ccrn-20170331.xsd#ConvertibleNotesDerivativeLiability" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Debt" xlink:href="ccrn-20170331.xsd#Debt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:href="ccrn-20170331.xsd#DebtConsolidatedNetLeverageRatioDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:href="ccrn-20170331.xsd#DebtDebtMaturitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:href="ccrn-20170331.xsd#DebtLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtNarrativeDetails" xlink:href="ccrn-20170331.xsd#DebtNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:href="ccrn-20170331.xsd#DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:href="ccrn-20170331.xsd#DebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:href="ccrn-20170331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:href="ccrn-20170331.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:href="ccrn-20170331.xsd#EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:href="ccrn-20170331.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:href="ccrn-20170331.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:href="ccrn-20170331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesDetails" xlink:href="ccrn-20170331.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:href="ccrn-20170331.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RecentAccountingPronouncements" xlink:href="ccrn-20170331.xsd#RecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:href="ccrn-20170331.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:href="ccrn-20170331.xsd#RelatedPartyTransactionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:href="ccrn-20170331.xsd#SegmentData" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails" xlink:href="ccrn-20170331.xsd#SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataNarrativeDetails" xlink:href="ccrn-20170331.xsd#SegmentDataNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:href="ccrn-20170331.xsd#SegmentDataTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:href="ccrn-20170331.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:href="ccrn-20170331.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails" xlink:href="ccrn-20170331.xsd#StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:href="ccrn-20170331.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ccrn-20170331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="ccrn-20170331.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ccrn-20170331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_D5FF7FC024416B6BF585D458FCAC29AB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679" xlink:to="loc_us-gaap_SubsequentEventMember_D5FF7FC024416B6BF585D458FCAC29AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PotentialEarnoutMember" xlink:label="loc_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:to="loc_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" xlink:label="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:to="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_MediscanMember" xlink:label="loc_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:to="loc_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_MedicalStaffingNetworkMember" xlink:label="loc_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:to="loc_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_89174C1D3A746DA04C44D458FCADA814" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_89174C1D3A746DA04C44D458FCADA814" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2022F86894C1ED9C3B89D458FCADC96B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2022F86894C1ED9C3B89D458FCADC96B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8F11022F2439542999FCD458FCADB65E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8F11022F2439542999FCD458FCADB65E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationEscrowDepositRelease" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_DFC03624C3039FA5C8D4D458FCAD229C" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_DFC03624C3039FA5C8D4D458FCAD229C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AEE1DDBF1ECC2AAC928CD458FCAD759C" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AEE1DDBF1ECC2AAC928CD458FCAD759C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForPreviousAcquisition" xlink:label="loc_us-gaap_PaymentsForPreviousAcquisition_D397BADF03803F8285B3D458FCAD17FE" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_PaymentsForPreviousAcquisition_D397BADF03803F8285B3D458FCAD17FE" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationConsiderationDeferredPeriod" xlink:label="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5C8208098DAE517BA7A5D458FCADDB1D" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5C8208098DAE517BA7A5D458FCADDB1D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLoss" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLossDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ConvertibleNotesDerivativeLiability" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/Debt" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsAxis" xlink:label="loc_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:to="loc_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:to="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813_default" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:to="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm1Member" xlink:label="loc_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:to="loc_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm2Member" xlink:label="loc_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:to="loc_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm3Member" xlink:label="loc_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:to="loc_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm4Member" xlink:label="loc_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:to="loc_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm5Member" xlink:label="loc_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:to="loc_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_A59659638354BF22CB10FC5D41043DB5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:to="loc_us-gaap_RangeAxis_A59659638354BF22CB10FC5D41043DB5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_1D65F41E5A1AC409D3E6FC5D4104C383_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_A59659638354BF22CB10FC5D41043DB5" xlink:to="loc_us-gaap_RangeMember_1D65F41E5A1AC409D3E6FC5D4104C383_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_1D65F41E5A1AC409D3E6FC5D4104C383" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_A59659638354BF22CB10FC5D41043DB5" xlink:to="loc_us-gaap_RangeMember_1D65F41E5A1AC409D3E6FC5D4104C383" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_BCA126A52C8114B883FFFC5D4104E0CC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_1D65F41E5A1AC409D3E6FC5D4104C383" xlink:to="loc_us-gaap_MinimumMember_BCA126A52C8114B883FFFC5D4104E0CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_4A81D5A84524F7EE216DFC5D410405D4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_1D65F41E5A1AC409D3E6FC5D4104C383" xlink:to="loc_us-gaap_MaximumMember_4A81D5A84524F7EE216DFC5D410405D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:to="loc_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19" xlink:to="loc_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:to="loc_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:to="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:to="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_2D20D6EFDEBE83A6F1E8FC5D410525A2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:to="loc_us-gaap_EurodollarMember_2D20D6EFDEBE83A6F1E8FC5D410525A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_D6EADD3A3C6886894CCCFC5D41058FFE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_D6EADD3A3C6886894CCCFC5D41058FFE" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LetterofCreditFeeMember" xlink:label="loc_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:to="loc_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_41AFDEC2C542794783CAFC5D410556A2" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:to="loc_us-gaap_BaseRateMember_41AFDEC2C542794783CAFC5D410556A2" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConsolidatedNetLeverageRatio" xlink:label="loc_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:to="loc_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_968FFEA7C2557F227EDCFC5D410577A1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_968FFEA7C2557F227EDCFC5D410577A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7F6FE0A0B15A0C71FC05FC5D410538CD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7F6FE0A0B15A0C71FC05FC5D410538CD" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:to="loc_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_4CFAC201BA3B34CADCF3B2A30081A52A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_4CFAC201BA3B34CADCF3B2A30081A52A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_FA840083F61381641E01B2A300815304" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_FA840083F61381641E01B2A300815304" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4EE6064D8FEE34AB354AB2A30082CB7D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4EE6064D8FEE34AB354AB2A30082CB7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3BAE169B338B5863EE0EB2A30082FA1A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3BAE169B338B5863EE0EB2A30082FA1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_D312214273A952B67FB3B2A300826851" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_D312214273A952B67FB3B2A300826851" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ED89FFDF7005060E527B2A30087D697" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ED89FFDF7005060E527B2A30087D697" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_79B460F199D6A570AF23B2A30089C73F" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebt_79B460F199D6A570AF23B2A30089C73F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:label="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:to="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_F271F9983E06867102F5B2A300899438" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_F271F9983E06867102F5B2A300899438" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_046C9C58201DA06D4744B2A300892D1D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_046C9C58201DA06D4744B2A300892D1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_E9AA7D6FD98EF7623895B2A30089CD13" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_E9AA7D6FD98EF7623895B2A30089CD13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_CED8634B2979C95BDD96B2A300893878" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_CED8634B2979C95BDD96B2A300893878" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_F97C028B1B1E483E7563B2A3008AD84E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_F97C028B1B1E483E7563B2A3008AD84E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_791ACB947DBE94796AD4B2A3008A8CDB" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_791ACB947DBE94796AD4B2A3008A8CDB" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_3452E77A4DDFF4EAB0E4CED5130A344B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_DebtInstrumentTable_3452E77A4DDFF4EAB0E4CED5130A344B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_70FAEF2712E889F462BFCED5130BBDBF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3452E77A4DDFF4EAB0E4CED5130A344B" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_70FAEF2712E889F462BFCED5130BBDBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9CF68C4B441786FB5B97CED5130BBE7E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_70FAEF2712E889F462BFCED5130BBDBF" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9CF68C4B441786FB5B97CED5130BBE7E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9CF68C4B441786FB5B97CED5130BBE7E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_70FAEF2712E889F462BFCED5130BBDBF" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9CF68C4B441786FB5B97CED5130BBE7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_BD4D8841EAC6A2FE9F18CED5130BDF13" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9CF68C4B441786FB5B97CED5130BBE7E" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_BD4D8841EAC6A2FE9F18CED5130BDF13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_97989C3F9C8E04928CDECED5130B4EF0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9CF68C4B441786FB5B97CED5130BBE7E" xlink:to="loc_us-gaap_ConvertibleDebtMember_97989C3F9C8E04928CDECED5130B4EF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_0E52E0AE2AA7E7E59EDECED5130B37CA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3452E77A4DDFF4EAB0E4CED5130A344B" xlink:to="loc_us-gaap_DebtInstrumentAxis_0E52E0AE2AA7E7E59EDECED5130B37CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0E52E0AE2AA7E7E59EDECED5130B37CA" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0E52E0AE2AA7E7E59EDECED5130B37CA" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_04FAA021C3D3F447AB48CED5130C1250" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09" xlink:to="loc_ccrn_TermLoanMember_04FAA021C3D3F447AB48CED5130C1250" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_A8ConvertibleNotesMember" xlink:label="loc_ccrn_A8ConvertibleNotesMember_BE2AFF4BC1A9212A94C9CED5130C5340" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09" xlink:to="loc_ccrn_A8ConvertibleNotesMember_BE2AFF4BC1A9212A94C9CED5130C5340" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleNoteDerivativeLiabilityMember" xlink:label="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_6A7797B3DC452AE337B9CED5130CF93F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09" xlink:to="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_6A7797B3DC452AE337B9CED5130CF93F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_736494C0C1CF34972D54CED5130C6251" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_736494C0C1CF34972D54CED5130C6251" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligations" xlink:label="loc_us-gaap_CapitalLeaseObligations_61AE7D7E3E8274909D91CED5130CA854" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_CapitalLeaseObligations_61AE7D7E3E8274909D91CED5130CA854" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_D3D44507BCA6C32B2120CED5130D1DE7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_D3D44507BCA6C32B2120CED5130D1DE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_D165D5657CA30BDC8E31CED5130D08E3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_D165D5657CA30BDC8E31CED5130D08E3" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LongtermDebtandCapitalLeaseObligationsGross" xlink:label="loc_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_92EBD208B7D779E93A4DCED5130EC2E4" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_92EBD208B7D779E93A4DCED5130EC2E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2FF7A1B4CEB06123E3C8CED5130E246D" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2FF7A1B4CEB06123E3C8CED5130E246D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsAxis" xlink:label="loc_ccrn_DebtCovenantTermsAxis_ADCD20C7C21DC990B8B2D0DE6FD2CAB0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_ccrn_DebtCovenantTermsAxis_ADCD20C7C21DC990B8B2D0DE6FD2CAB0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ccrn_DebtCovenantTermsAxis_ADCD20C7C21DC990B8B2D0DE6FD2CAB0" xlink:to="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F_default" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ccrn_DebtCovenantTermsAxis_ADCD20C7C21DC990B8B2D0DE6FD2CAB0" xlink:to="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member" xlink:label="loc_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F" xlink:to="loc_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member" xlink:label="loc_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F" xlink:to="loc_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_EachFiscalQuarterEndingThereafterMember" xlink:label="loc_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F" xlink:to="loc_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:to="loc_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:to="loc_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_13F4B17B89F25D1CBCEAD0DE6FD3BDDC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_13F4B17B89F25D1CBCEAD0DE6FD3BDDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_2CCF727CDDDB05EAAB5BD0DE6FD36B32" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_us-gaap_DebtInstrumentAxis_2CCF727CDDDB05EAAB5BD0DE6FD36B32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_375BE166EC5894B2BD89D0DE6FD398BF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2CCF727CDDDB05EAAB5BD0DE6FD36B32" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_375BE166EC5894B2BD89D0DE6FD398BF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_375BE166EC5894B2BD89D0DE6FD398BF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2CCF727CDDDB05EAAB5BD0DE6FD36B32" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_375BE166EC5894B2BD89D0DE6FD398BF" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_5C2D800AA476E69ACCBCD0DE6FD31278" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_375BE166EC5894B2BD89D0DE6FD398BF" xlink:to="loc_ccrn_CreditAgreementMember_5C2D800AA476E69ACCBCD0DE6FD31278" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_FBFED42160FCF873E844D0DE6FD39560" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_us-gaap_VariableRateAxis_FBFED42160FCF873E844D0DE6FD39560" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_67CBAEB6890980EE7720D0DE6FD375E8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_FBFED42160FCF873E844D0DE6FD39560" xlink:to="loc_us-gaap_VariableRateDomain_67CBAEB6890980EE7720D0DE6FD375E8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_67CBAEB6890980EE7720D0DE6FD375E8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_FBFED42160FCF873E844D0DE6FD39560" xlink:to="loc_us-gaap_VariableRateDomain_67CBAEB6890980EE7720D0DE6FD375E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2F0FBD916C107221F81ED0DE6FD3FCEE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_67CBAEB6890980EE7720D0DE6FD375E8" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2F0FBD916C107221F81ED0DE6FD3FCEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_DA331887DA79BAB2218BD0DE6FD3D174" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_us-gaap_RangeAxis_DA331887DA79BAB2218BD0DE6FD3D174" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_B8C030E968D47210D0B0D0DE6FD34BE3_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_DA331887DA79BAB2218BD0DE6FD3D174" xlink:to="loc_us-gaap_RangeMember_B8C030E968D47210D0B0D0DE6FD34BE3_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_B8C030E968D47210D0B0D0DE6FD34BE3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_DA331887DA79BAB2218BD0DE6FD3D174" xlink:to="loc_us-gaap_RangeMember_B8C030E968D47210D0B0D0DE6FD34BE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_1499E7E5F6392DD5ADDCD0DE6FD4D0E9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_B8C030E968D47210D0B0D0DE6FD34BE3" xlink:to="loc_us-gaap_MaximumMember_1499E7E5F6392DD5ADDCD0DE6FD4D0E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_2E78C39206D149A95BC4D0DE6FD42AB9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_B8C030E968D47210D0B0D0DE6FD34BE3" xlink:to="loc_us-gaap_MinimumMember_2E78C39206D149A95BC4D0DE6FD42AB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_64C79BB2D61DB3CD411CD0DE6FD47EFD" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_64C79BB2D61DB3CD411CD0DE6FD47EFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_311410E46098F4CFDF2ED0DE6FD4DB0B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_64C79BB2D61DB3CD411CD0DE6FD47EFD" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_311410E46098F4CFDF2ED0DE6FD4DB0B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_311410E46098F4CFDF2ED0DE6FD4DB0B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_64C79BB2D61DB3CD411CD0DE6FD47EFD" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_311410E46098F4CFDF2ED0DE6FD4DB0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_5CD2CADAEB58A20048A1D0DE6FD41F48" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_311410E46098F4CFDF2ED0DE6FD4DB0B" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_5CD2CADAEB58A20048A1D0DE6FD41F48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3067B1125843D3F00D3FD0DE6FD44BF1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3067B1125843D3F00D3FD0DE6FD44BF1" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit" xlink:label="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans" xlink:label="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityAdditionalCapacity" xlink:label="loc_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments" xlink:label="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments" xlink:label="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments" xlink:label="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_BB8024451EF657104B36D0DE6FD5C5A2" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_BB8024451EF657104B36D0DE6FD5C5A2" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault" xlink:label="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ECC44F619BFF57897CC1D0DE6FD5EB9D" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ECC44F619BFF57897CC1D0DE6FD5EB9D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_NumberofFinancialCovenants" xlink:label="loc_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RatioOfIndebtednessToNetCapital1" xlink:label="loc_us-gaap_RatioOfIndebtednessToNetCapital1_12391D3675127EFFFB7ED0DE6FD6CF62" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_RatioOfIndebtednessToNetCapital1_12391D3675127EFFFB7ED0DE6FD6CF62" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio" xlink:label="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_E21CEBF9C753746119B1D0DE6FD68CAB" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_E21CEBF9C753746119B1D0DE6FD68CAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_7B8B797D93B9B1AC5ECBD0DE6FD68F96" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_LineOfCredit_7B8B797D93B9B1AC5ECBD0DE6FD68F96" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_74DC275E530A9386A608D49E321F7689" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentTable_74DC275E530A9386A608D49E321F7689" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_AFDB67CF616FDE4DA8A5D49E321F421B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_74DC275E530A9386A608D49E321F7689" xlink:to="loc_us-gaap_DebtInstrumentAxis_AFDB67CF616FDE4DA8A5D49E321F421B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_776F00A46EDC024E7EE5D49E3220150D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_AFDB67CF616FDE4DA8A5D49E321F421B" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_776F00A46EDC024E7EE5D49E3220150D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_776F00A46EDC024E7EE5D49E3220150D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_AFDB67CF616FDE4DA8A5D49E321F421B" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_776F00A46EDC024E7EE5D49E3220150D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_A8ConvertibleNotesMember" xlink:label="loc_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_776F00A46EDC024E7EE5D49E3220150D" xlink:to="loc_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleNoteDerivativeLiabilityMember" xlink:label="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_776F00A46EDC024E7EE5D49E3220150D" xlink:to="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_74DC275E530A9386A608D49E321F7689" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:to="loc_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:to="loc_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_E30510C22AA54B7AB151D49E32201746" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE" xlink:to="loc_us-gaap_CommonStockMember_E30510C22AA54B7AB151D49E32201746" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_DF4E203583DEBE37F813D49E322044F1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_74DC275E530A9386A608D49E321F7689" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_DF4E203583DEBE37F813D49E322044F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_FB4E0186BAB7CA259CA6D49E3220AAC2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_DF4E203583DEBE37F813D49E322044F1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_FB4E0186BAB7CA259CA6D49E3220AAC2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_FB4E0186BAB7CA259CA6D49E3220AAC2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_DF4E203583DEBE37F813D49E322044F1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_FB4E0186BAB7CA259CA6D49E3220AAC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_294B1F86D3580B9C6144D49E32219427" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_FB4E0186BAB7CA259CA6D49E3220AAC2" xlink:to="loc_us-gaap_ConvertibleDebtMember_294B1F86D3580B9C6144D49E32219427" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7C27BEA75FD9AE0E3FAAD49E3221A332" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7C27BEA75FD9AE0E3FAAD49E3221A332" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_40575C3BAB6A575F895ED49E3221C525" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_40575C3BAB6A575F895ED49E3221C525" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8DF72085A8D35E0C3187D49E3221A7EC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8DF72085A8D35E0C3187D49E3221A7EC" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" xlink:label="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_DBAF1BFEEFA0641E3B90D49E32219778" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_DBAF1BFEEFA0641E3B90D49E32219778" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_84A0E7BA79D4C698BD91D49E32216FDF" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_84A0E7BA79D4C698BD91D49E32216FDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_1FC65283B5781761AA18D49E3221B3C0" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_1FC65283B5781761AA18D49E3221B3C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_E71B9AD1B57BB905BFD2D49E3221909E" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_E71B9AD1B57BB905BFD2D49E3221909E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_FED19F45380D55EEACDAD49E374B5A58" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_FED19F45380D55EEACDAD49E374B5A58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0D586396729043BD9542D49E32212D36" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0D586396729043BD9542D49E32212D36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_92FFC93AC63DED910809D49E3221ED8F" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_92FFC93AC63DED910809D49E3221ED8F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate" xlink:label="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_B26824B9B2EA3127737CD49E3221825E" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_B26824B9B2EA3127737CD49E3221825E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_7890E281BFB2AA924068D49E32217098" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_7890E281BFB2AA924068D49E32217098" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_957E3684D1CCE2D9E5FBD49E32215B83" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_957E3684D1CCE2D9E5FBD49E32215B83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_BABADD899713CDB0F033D49E3222B031" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_BABADD899713CDB0F033D49E3222B031" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal" xlink:label="loc_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07945D5CD164127A2B5AD458E7234DF1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07945D5CD164127A2B5AD458E7234DF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E612F0BF714E9E095EE1D458E7245F12_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07945D5CD164127A2B5AD458E7234DF1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E612F0BF714E9E095EE1D458E7245F12_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E612F0BF714E9E095EE1D458E7245F12" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07945D5CD164127A2B5AD458E7234DF1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E612F0BF714E9E095EE1D458E7245F12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_931EE380534C783EE7D9D458E724EEA8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E612F0BF714E9E095EE1D458E7245F12" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_931EE380534C783EE7D9D458E724EEA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_30907EA472B7AB4494BBD458E7293FFB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E612F0BF714E9E095EE1D458E7245F12" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_30907EA472B7AB4494BBD458E7293FFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DeferredCompensationMember" xlink:label="loc_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2" xlink:to="loc_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_365719655A0FDAE47BDED458E72BA2F1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_365719655A0FDAE47BDED458E72BA2F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_289C760D8A7E9B9C48BAD458E72B4037_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_365719655A0FDAE47BDED458E72BA2F1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_289C760D8A7E9B9C48BAD458E72B4037_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_289C760D8A7E9B9C48BAD458E72B4037" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_365719655A0FDAE47BDED458E72BA2F1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_289C760D8A7E9B9C48BAD458E72B4037" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleNotesDerivativeLiabilityMember" xlink:label="loc_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_289C760D8A7E9B9C48BAD458E72B4037" xlink:to="loc_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_FA1A7037B44A76F4BD76D458E72BF727" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_FA1A7037B44A76F4BD76D458E72BF727" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_E69938A3217207C1D99CD458E72D8641" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:to="loc_us-gaap_DebtInstrumentFairValue_E69938A3217207C1D99CD458E72D8641" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8FD998C7496B095C7F43D458E72DD3CE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8FD998C7496B095C7F43D458E72DD3CE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_95985C6CD81D18D546A2A07E9FE164B9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_95985C6CD81D18D546A2A07E9FE164B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8ED881ED8F307EF6F79EA07E9FE12D81_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_95985C6CD81D18D546A2A07E9FE164B9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8ED881ED8F307EF6F79EA07E9FE12D81_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8ED881ED8F307EF6F79EA07E9FE12D81" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_95985C6CD81D18D546A2A07E9FE164B9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8ED881ED8F307EF6F79EA07E9FE12D81" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8ED881ED8F307EF6F79EA07E9FE12D81" xlink:to="loc_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleNotesNetMember" xlink:label="loc_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8ED881ED8F307EF6F79EA07E9FE12D81" xlink:to="loc_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_B964E3055599C8784FF5A07E9FE13291" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_B964E3055599C8784FF5A07E9FE13291" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_23300642F88B5A7745CEA07E9FE1474E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_23300642F88B5A7745CEA07E9FE1474E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0AAB3E2044796EA02F1DA07E9FE20E4D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0AAB3E2044796EA02F1DA07E9FE20E4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_129B05B7EDB808DB379AA07E9FE23F4E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:to="loc_us-gaap_LongTermDebt_129B05B7EDB808DB379AA07E9FE23F4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_AD74BCEFA84DD21D3708A07E9FE22692" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:to="loc_us-gaap_DebtInstrumentFairValue_AD74BCEFA84DD21D3708A07E9FE22692" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FairValueMeasurementLineItems" xlink:label="loc_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FairValueMeasurementTable" xlink:label="loc_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:to="loc_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:to="loc_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:to="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:to="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_E795992FC99F63BCB9FDAAF20B9022B2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:to="loc_us-gaap_MinimumMember_E795992FC99F63BCB9FDAAF20B9022B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_5391AC4EF8DD5A838FCFAAF20B905AEB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:to="loc_us-gaap_MaximumMember_5391AC4EF8DD5A838FCFAAF20B905AEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_ED1A966D1CC8F8644ED1AAF89FC21067" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:to="loc_us-gaap_AssetImpairmentCharges_ED1A966D1CC8F8644ED1AAF89FC21067" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided" xlink:label="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:to="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_B9C1150A77C2228F9C38D458FBCBBBEE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_B9C1150A77C2228F9C38D458FBCBBBEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7D94C625F64FFE095C2DD458FBCB660F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_B9C1150A77C2228F9C38D458FBCBBBEE" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7D94C625F64FFE095C2DD458FBCB660F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7D94C625F64FFE095C2DD458FBCB660F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_B9C1150A77C2228F9C38D458FBCBBBEE" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7D94C625F64FFE095C2DD458FBCB660F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ContingentConsiderationLiabilityMember" xlink:label="loc_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7D94C625F64FFE095C2DD458FBCB660F" xlink:to="loc_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8D3065A33AB94817C2CAD458FBCB5578" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7D94C625F64FFE095C2DD458FBCB660F" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8D3065A33AB94817C2CAD458FBCB5578" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26B04FC74CA6A10EE730D458FBCC2570" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26B04FC74CA6A10EE730D458FBCC2570" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_CBF5B39B768F68076CB4D458FBCCDA88" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_CBF5B39B768F68076CB4D458FBCCDA88" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense" xlink:label="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:to="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AAAF0A2636629FFEE422D458FBCCB66B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AAAF0A2636629FFEE422D458FBCCB66B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DatabasesMember" xlink:label="loc_us-gaap_DatabasesMember_C3B36FD23163B2891FE087FF4C837FB2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:to="loc_us-gaap_DatabasesMember_C3B36FD23163B2891FE087FF4C837FB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3751A1B391BCC126F6B787FF4C849855" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3751A1B391BCC126F6B787FF4C849855" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_6D929DCC185EA3CE96E387FF4C849C8C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_6D929DCC185EA3CE96E387FF4C849C8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_FA47028D3DFC8773B4E287FF4C84EBC1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:to="loc_us-gaap_TradeNamesMember_FA47028D3DFC8773B4E287FF4C84EBC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_85554974152F27DD5D6487FF4C859757" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_85554974152F27DD5D6487FF4C859757" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_B2AF09F7B41CAF6FF95587FF4C8D6DED" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_B2AF09F7B41CAF6FF95587FF4C8D6DED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_D4B50C48E93D7915934587FF4C8D8611" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_D4B50C48E93D7915934587FF4C8D8611" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_9C20C0053FDD1517C5D887FF4C8D5484" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_9C20C0053FDD1517C5D887FF4C8D5484" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6F1C050937296EF45D5F880119391647" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6F1C050937296EF45D5F880119391647" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7" xlink:to="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7" xlink:to="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_69E40631C5268ADA76CCC1EEF79C4D93" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_69E40631C5268ADA76CCC1EEF79C4D93" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_005EB7299FBBE249873EC1EEF79C96B5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:to="loc_ccrn_PhysicianStaffingMember_005EB7299FBBE249873EC1EEF79C96B5" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_6BF9E612DB8DBFB30C65C1EEF79C1C92" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:to="loc_ccrn_OtherHumanCapitalManagementServicesMember_6BF9E612DB8DBFB30C65C1EEF79C1C92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_84446E63B2129C9C717AC1EEF79C7F07" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438" xlink:to="loc_us-gaap_Goodwill_84446E63B2129C9C717AC1EEF79C7F07" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/RecentAccountingPronouncements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:to="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:to="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="loc_us-gaap_CorporateJointVentureMember_DA1953671DCAC6DEAFA3A0745C1EF636" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:to="loc_us-gaap_CorporateJointVentureMember_DA1953671DCAC6DEAFA3A0745C1EF636" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AffiliatedEntityMember" xlink:label="loc_us-gaap_AffiliatedEntityMember_24B5DB0967572403CF26A0745C1FBCDA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:to="loc_us-gaap_AffiliatedEntityMember_24B5DB0967572403CF26A0745C1FBCDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaap_RevenueFromRelatedParties_42544AB5639198B5F7E1A0745C1F5EAA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_us-gaap_RevenueFromRelatedParties_42544AB5639198B5F7E1A0745C1F5EAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableRelatedParties" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_B03E314E7AC55D54718DA07D9911F5C4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_B03E314E7AC55D54718DA07D9911F5C4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_JointVenturePercentOwnership" xlink:label="loc_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueFromJointVenturesCurrent" xlink:label="loc_us-gaap_DueFromJointVenturesCurrent_FFDA41736A8E3D4354EBA0745C1F0EB4" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_us-gaap_DueFromJointVenturesCurrent_FFDA41736A8E3D4354EBA0745C1F0EB4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_5AC5555DBC7735A17C30A0745C1FC85D" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_5AC5555DBC7735A17C30A0745C1FC85D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaap_PaymentsForRent_E9D6EECFBF0057C7B1A8A0745C1F84BC" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_us-gaap_PaymentsForRent_E9D6EECFBF0057C7B1A8A0745C1F84BC" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:to="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:to="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:to="loc_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:to="loc_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet_941F7A81EB5D2ED3BE49CB46A7B68A1B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_us-gaap_SalesRevenueServicesNet_941F7A81EB5D2ED3BE49CB46A7B68A1B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_30110DDCB7D4AF352C24CB51A706364F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_30110DDCB7D4AF352C24CB51A706364F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_2449E7F9B4839B7562B9CB46A7B8C581" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_us-gaap_OperatingIncomeLoss_2449E7F9B4839B7562B9CB46A7B8C581" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_A2CDAA40AA41C2973CE6FC5D407A9779" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_A2CDAA40AA41C2973CE6FC5D407A9779" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_04570A9B4C75EFECDE50FC5D407BDE60" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_A2CDAA40AA41C2973CE6FC5D407A9779" xlink:to="loc_us-gaap_AwardTypeAxis_04570A9B4C75EFECDE50FC5D407BDE60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22A783E405E158ADFD44FC5D407B9BF9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_04570A9B4C75EFECDE50FC5D407BDE60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22A783E405E158ADFD44FC5D407B9BF9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22A783E405E158ADFD44FC5D407B9BF9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_04570A9B4C75EFECDE50FC5D407BDE60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22A783E405E158ADFD44FC5D407B9BF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_4FF718CB868CB5AC796EFC5D407BFFF2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22A783E405E158ADFD44FC5D407B9BF9" xlink:to="loc_us-gaap_RestrictedStockMember_4FF718CB868CB5AC796EFC5D407BFFF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_99CA8CB3921D96A4D1C3FC5D407B8FBB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22A783E405E158ADFD44FC5D407B9BF9" xlink:to="loc_us-gaap_PerformanceSharesMember_99CA8CB3921D96A4D1C3FC5D407B8FBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_A2CDAA40AA41C2973CE6FC5D407A9779" xlink:to="loc_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:to="loc_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:to="loc_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OmnibusPlanMember" xlink:label="loc_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908" xlink:to="loc_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_A2CDAA40AA41C2973CE6FC5D407A9779" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_12A1189BBE0E14B99D3CFC5D407CD223" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_12A1189BBE0E14B99D3CFC5D407CD223" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2C078F6249D5D469EFC0FC5D407C9E1F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2C078F6249D5D469EFC0FC5D407C9E1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4B8497F01B4E8256EAAFFC5D407C71DA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4B8497F01B4E8256EAAFFC5D407C71DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_929F7B019F5A8737882DFC5D407C376C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_929F7B019F5A8737882DFC5D407C376C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1F383B5104C83C2BB9B5FC5D407CC9A4" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1F383B5104C83C2BB9B5FC5D407CC9A4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage" xlink:label="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_E1BAF5BC11108E978572FC5D407C9F41" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_E1BAF5BC11108E978572FC5D407C9F41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9F1B4020589B21C734EFFC5D407C5A1C" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9F1B4020589B21C734EFFC5D407C5A1C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet" xlink:label="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:to="loc_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_411BF831DFEB9CFA42BDFC5D40F666DE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:to="loc_us-gaap_RestrictedStockMember_411BF831DFEB9CFA42BDFC5D40F666DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_BC9F0AE6C74DDA7C98CEFC5D40F6E416" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:to="loc_us-gaap_PerformanceSharesMember_BC9F0AE6C74DDA7C98CEFC5D40F6E416" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9998D71FD7EA74DDCEDFC5D40F6DEC2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9998D71FD7EA74DDCEDFC5D40F6DEC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3F49FE3146A311DDAE27FC5D40F69FD0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3F49FE3146A311DDAE27FC5D40F69FD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ABEAAC98E6ED3ACDBDC0FC5D40F6D4C5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ABEAAC98E6ED3ACDBDC0FC5D40F6D4C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5E889574A7D8BB27D619FC5D40F675C1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5E889574A7D8BB27D619FC5D40F675C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A05334E9EBF954366FEAFC5D40F60F84" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A05334E9EBF954366FEAFC5D40F60F84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_F6544BC491C8E413234EFC5D40F77B0C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_F6544BC491C8E413234EFC5D40F77B0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_93A91F387BAC0F604EA4FC5D40F7A21A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_93A91F387BAC0F604EA4FC5D40F7A21A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_BAD9F7FCE30CFE5D924AFC5D40F76E33" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_BAD9F7FCE30CFE5D924AFC5D40F76E33" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7A429DD4C9E46B88946CCED513829B17" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7A429DD4C9E46B88946CCED513829B17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_4EF9B5A772301A694414CED5138214CB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7A429DD4C9E46B88946CCED513829B17" xlink:to="loc_us-gaap_EquityComponentDomain_4EF9B5A772301A694414CED5138214CB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_4EF9B5A772301A694414CED5138214CB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7A429DD4C9E46B88946CCED513829B17" xlink:to="loc_us-gaap_EquityComponentDomain_4EF9B5A772301A694414CED5138214CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_2802F2A81D26B088E932CED513822C15" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4EF9B5A772301A694414CED5138214CB" xlink:to="loc_us-gaap_RetainedEarningsMember_2802F2A81D26B088E932CED513822C15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:to="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:to="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember" xlink:label="loc_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:to="loc_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_AccountingStandardsUpdate201609Member" xlink:label="loc_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:to="loc_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_FA56EA7DB336D8F2843BCF32BCCC4C8A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_FA56EA7DB336D8F2843BCF32BCCC4C8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5A712F1EB012A605E101CF3338D76812" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5A712F1EB012A605E101CF3338D76812" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_19844520739F7FB00C1DCED51384C011" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_19844520739F7FB00C1DCED51384C011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_57EAB1B13422FAFAC79ECED513846048" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_57EAB1B13422FAFAC79ECED513846048" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>ccrn-20170331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_0E3ACCF3976A8F436C06AAF20B906931_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_0E3ACCF3976A8F436C06AAF20B906931" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0E3ACCF3976A8F436C06AAF20B906931" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0E3ACCF3976A8F436C06AAF20B906931" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_0E3ACCF3976A8F436C06AAF20B906931" xlink:type="arc" />
    <link:label id="lab_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612_terseLabel_en-US" xlink:label="lab_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Table]</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612_label_en-US" xlink:label="lab_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Table]</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612_documentation_en-US" xlink:label="lab_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Table]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FairValueMeasurementTable" xlink:label="loc_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:to="lab_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:type="arc" />
    <link:label id="lab_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605_terseLabel_en-US" xlink:label="lab_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605_label_en-US" xlink:label="lab_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:to="lab_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:type="arc" />
    <link:label id="lab_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381_terseLabel_en-US" xlink:label="lab_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381_label_en-US" xlink:label="lab_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:to="lab_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinimumMember_E795992FC99F63BCB9FDAAF20B9022B2_terseLabel_en-US" xlink:label="lab_us-gaap_MinimumMember_E795992FC99F63BCB9FDAAF20B9022B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_us-gaap_MinimumMember_E795992FC99F63BCB9FDAAF20B9022B2_label_en-US" xlink:label="lab_us-gaap_MinimumMember_E795992FC99F63BCB9FDAAF20B9022B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_E795992FC99F63BCB9FDAAF20B9022B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinimumMember_E795992FC99F63BCB9FDAAF20B9022B2" xlink:to="lab_us-gaap_MinimumMember_E795992FC99F63BCB9FDAAF20B9022B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_MaximumMember_5391AC4EF8DD5A838FCFAAF20B905AEB_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumMember_5391AC4EF8DD5A838FCFAAF20B905AEB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_us-gaap_MaximumMember_5391AC4EF8DD5A838FCFAAF20B905AEB_label_en-US" xlink:label="lab_us-gaap_MaximumMember_5391AC4EF8DD5A838FCFAAF20B905AEB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_5391AC4EF8DD5A838FCFAAF20B905AEB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumMember_5391AC4EF8DD5A838FCFAAF20B905AEB" xlink:to="lab_us-gaap_MaximumMember_5391AC4EF8DD5A838FCFAAF20B905AEB" xlink:type="arc" />
    <link:label id="lab_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E_terseLabel_en-US" xlink:label="lab_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Line Items]</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E_label_en-US" xlink:label="lab_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Line Items]</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E_documentation_en-US" xlink:label="lab_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Line Items]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FairValueMeasurementLineItems" xlink:label="loc_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:to="lab_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetImpairmentCharges_ED1A966D1CC8F8644ED1AAF89FC21067_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges_ED1A966D1CC8F8644ED1AAF89FC21067" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_ED1A966D1CC8F8644ED1AAF89FC21067_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges_ED1A966D1CC8F8644ED1AAF89FC21067" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_ED1A966D1CC8F8644ED1AAF89FC21067" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges_ED1A966D1CC8F8644ED1AAF89FC21067" xlink:to="lab_us-gaap_AssetImpairmentCharges_ED1A966D1CC8F8644ED1AAF89FC21067" xlink:type="arc" />
    <link:label id="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542_terseLabel_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Threshold period, past due for payment of services provided</link:label>
    <link:label id="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542_label_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Threshold Period, Past Due for Payment of Services Provided</link:label>
    <link:label id="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542_documentation_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Threshold Period, Past Due for Payment of Services Provided</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided" xlink:label="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542" xlink:to="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityAbstract_911FF320051077810CAECED5135A6EAC_label_en-US" xlink:label="lab_us-gaap_EquityAbstract_911FF320051077810CAECED5135A6EAC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_911FF320051077810CAECED5135A6EAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract_911FF320051077810CAECED5135A6EAC" xlink:to="lab_us-gaap_EquityAbstract_911FF320051077810CAECED5135A6EAC" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1BD556B31A50276BB220CED5135B3DF8_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1BD556B31A50276BB220CED5135B3DF8" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on currency fluctuations</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1BD556B31A50276BB220CED5135B3DF8_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1BD556B31A50276BB220CED5135B3DF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1BD556B31A50276BB220CED5135B3DF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1BD556B31A50276BB220CED5135B3DF8" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1BD556B31A50276BB220CED5135B3DF8" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_18915BFBC58BCAF703A3CED5135B1BAC_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_18915BFBC58BCAF703A3CED5135B1BAC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax impact related to foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_18915BFBC58BCAF703A3CED5135B1BAC_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_18915BFBC58BCAF703A3CED5135B1BAC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_18915BFBC58BCAF703A3CED5135B1BAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_18915BFBC58BCAF703A3CED5135B1BAC" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_18915BFBC58BCAF703A3CED5135B1BAC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:to="lab_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockMember_411BF831DFEB9CFA42BDFC5D40F666DE_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember_411BF831DFEB9CFA42BDFC5D40F666DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_411BF831DFEB9CFA42BDFC5D40F666DE_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember_411BF831DFEB9CFA42BDFC5D40F666DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_411BF831DFEB9CFA42BDFC5D40F666DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember_411BF831DFEB9CFA42BDFC5D40F666DE" xlink:to="lab_us-gaap_RestrictedStockMember_411BF831DFEB9CFA42BDFC5D40F666DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_BC9F0AE6C74DDA7C98CEFC5D40F6E416_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_BC9F0AE6C74DDA7C98CEFC5D40F6E416" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Stock [Member]</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_BC9F0AE6C74DDA7C98CEFC5D40F6E416_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_BC9F0AE6C74DDA7C98CEFC5D40F6E416" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_BC9F0AE6C74DDA7C98CEFC5D40F6E416" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_BC9F0AE6C74DDA7C98CEFC5D40F6E416" xlink:to="lab_us-gaap_PerformanceSharesMember_BC9F0AE6C74DDA7C98CEFC5D40F6E416" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9998D71FD7EA74DDCEDFC5D40F6DEC2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9998D71FD7EA74DDCEDFC5D40F6DEC2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock awards, Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9998D71FD7EA74DDCEDFC5D40F6DEC2_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9998D71FD7EA74DDCEDFC5D40F6DEC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9998D71FD7EA74DDCEDFC5D40F6DEC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9998D71FD7EA74DDCEDFC5D40F6DEC2" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9998D71FD7EA74DDCEDFC5D40F6DEC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3F49FE3146A311DDAE27FC5D40F69FD0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3F49FE3146A311DDAE27FC5D40F69FD0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3F49FE3146A311DDAE27FC5D40F69FD0_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3F49FE3146A311DDAE27FC5D40F69FD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3F49FE3146A311DDAE27FC5D40F69FD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3F49FE3146A311DDAE27FC5D40F69FD0" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3F49FE3146A311DDAE27FC5D40F69FD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ABEAAC98E6ED3ACDBDC0FC5D40F6D4C5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ABEAAC98E6ED3ACDBDC0FC5D40F6D4C5" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ABEAAC98E6ED3ACDBDC0FC5D40F6D4C5_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ABEAAC98E6ED3ACDBDC0FC5D40F6D4C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ABEAAC98E6ED3ACDBDC0FC5D40F6D4C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ABEAAC98E6ED3ACDBDC0FC5D40F6D4C5" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ABEAAC98E6ED3ACDBDC0FC5D40F6D4C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5E889574A7D8BB27D619FC5D40F675C1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5E889574A7D8BB27D619FC5D40F675C1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5E889574A7D8BB27D619FC5D40F675C1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5E889574A7D8BB27D619FC5D40F675C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5E889574A7D8BB27D619FC5D40F675C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5E889574A7D8BB27D619FC5D40F675C1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5E889574A7D8BB27D619FC5D40F675C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_955AF67A4608BDA50213FC5D40F69F9B_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_955AF67A4608BDA50213FC5D40F69F9B" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock awards, Ending balance (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_955AF67A4608BDA50213FC5D40F69F9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_955AF67A4608BDA50213FC5D40F69F9B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_955AF67A4608BDA50213FC5D40F69F9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A05334E9EBF954366FEAFC5D40F60F84_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A05334E9EBF954366FEAFC5D40F60F84" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock awards, Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A05334E9EBF954366FEAFC5D40F60F84_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A05334E9EBF954366FEAFC5D40F60F84" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A05334E9EBF954366FEAFC5D40F60F84" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A05334E9EBF954366FEAFC5D40F60F84" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A05334E9EBF954366FEAFC5D40F60F84" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_F6544BC491C8E413234EFC5D40F77B0C_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_F6544BC491C8E413234EFC5D40F77B0C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_F6544BC491C8E413234EFC5D40F77B0C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_F6544BC491C8E413234EFC5D40F77B0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_F6544BC491C8E413234EFC5D40F77B0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_F6544BC491C8E413234EFC5D40F77B0C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_F6544BC491C8E413234EFC5D40F77B0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_93A91F387BAC0F604EA4FC5D40F7A21A_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_93A91F387BAC0F604EA4FC5D40F7A21A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_93A91F387BAC0F604EA4FC5D40F7A21A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_93A91F387BAC0F604EA4FC5D40F7A21A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_93A91F387BAC0F604EA4FC5D40F7A21A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_93A91F387BAC0F604EA4FC5D40F7A21A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_93A91F387BAC0F604EA4FC5D40F7A21A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_BAD9F7FCE30CFE5D924AFC5D40F76E33_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_BAD9F7FCE30CFE5D924AFC5D40F76E33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_BAD9F7FCE30CFE5D924AFC5D40F76E33_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_BAD9F7FCE30CFE5D924AFC5D40F76E33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_BAD9F7FCE30CFE5D924AFC5D40F76E33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_BAD9F7FCE30CFE5D924AFC5D40F76E33" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_BAD9F7FCE30CFE5D924AFC5D40F76E33" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_34EF5C53DD404ECBD5ABFC5D40F732B5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_34EF5C53DD404ECBD5ABFC5D40F732B5" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock awards, Ending balance (in dollars per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_34EF5C53DD404ECBD5ABFC5D40F732B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_34EF5C53DD404ECBD5ABFC5D40F732B5" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_34EF5C53DD404ECBD5ABFC5D40F732B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingAbstract_351D40AD8509FA2498CCFC5D405F3575_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract_351D40AD8509FA2498CCFC5D405F3575" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_351D40AD8509FA2498CCFC5D405F3575" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_351D40AD8509FA2498CCFC5D405F3575" xlink:to="lab_us-gaap_SegmentReportingAbstract_351D40AD8509FA2498CCFC5D405F3575" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_0057119D139DB7858934FC5D405F8AB1_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_0057119D139DB7858934FC5D405F8AB1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Information on Operating Segments and Reconciliation to Loss From Operations</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_0057119D139DB7858934FC5D405F8AB1_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_0057119D139DB7858934FC5D405F8AB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_0057119D139DB7858934FC5D405F8AB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_0057119D139DB7858934FC5D405F8AB1" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_0057119D139DB7858934FC5D405F8AB1" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_79E56AFAE4C067FDEA4AFC5D414173CE_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract_79E56AFAE4C067FDEA4AFC5D414173CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_79E56AFAE4C067FDEA4AFC5D414173CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_79E56AFAE4C067FDEA4AFC5D414173CE" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract_79E56AFAE4C067FDEA4AFC5D414173CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_B2D7D048EAF8CC62CD08FC5D414108C9_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_B2D7D048EAF8CC62CD08FC5D414108C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_B2D7D048EAF8CC62CD08FC5D414108C9_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_B2D7D048EAF8CC62CD08FC5D414108C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_B2D7D048EAF8CC62CD08FC5D414108C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_B2D7D048EAF8CC62CD08FC5D414108C9" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_B2D7D048EAF8CC62CD08FC5D414108C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_80389B56CA6737A8009AFC5D40801BDC_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_80389B56CA6737A8009AFC5D40801BDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_80389B56CA6737A8009AFC5D40801BDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_80389B56CA6737A8009AFC5D40801BDC" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_80389B56CA6737A8009AFC5D40801BDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_83B6FC7EB1E0BE46286FFC5D4080E904_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_83B6FC7EB1E0BE46286FFC5D4080E904" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_83B6FC7EB1E0BE46286FFC5D4080E904_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_83B6FC7EB1E0BE46286FFC5D4080E904" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_83B6FC7EB1E0BE46286FFC5D4080E904" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_83B6FC7EB1E0BE46286FFC5D4080E904" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_83B6FC7EB1E0BE46286FFC5D4080E904" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_2EF8B0F97A0B59F1F4D6FC5D4148C816_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_2EF8B0F97A0B59F1F4D6FC5D4148C816" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2EF8B0F97A0B59F1F4D6FC5D4148C816" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2EF8B0F97A0B59F1F4D6FC5D4148C816" xlink:to="lab_us-gaap_EarningsPerShareAbstract_2EF8B0F97A0B59F1F4D6FC5D4148C816" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_840EDAE0D159A889235DFC5D4148B2EC_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_840EDAE0D159A889235DFC5D4148B2EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_840EDAE0D159A889235DFC5D4148B2EC_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_840EDAE0D159A889235DFC5D4148B2EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_840EDAE0D159A889235DFC5D4148B2EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_840EDAE0D159A889235DFC5D4148B2EC" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_840EDAE0D159A889235DFC5D4148B2EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40F8AB7FCB35E716E521FC5D413F71C2_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40F8AB7FCB35E716E521FC5D413F71C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40F8AB7FCB35E716E521FC5D413F71C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40F8AB7FCB35E716E521FC5D413F71C2" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40F8AB7FCB35E716E521FC5D413F71C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_D70A0CC51BD72370818AFC5D413FA126_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock_D70A0CC51BD72370818AFC5D413FA126" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CONVERTIBLE NOTES DERIVATIVE LIABILITY</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_D70A0CC51BD72370818AFC5D413FA126_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock_D70A0CC51BD72370818AFC5D413FA126" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_D70A0CC51BD72370818AFC5D413FA126" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock_D70A0CC51BD72370818AFC5D413FA126" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock_D70A0CC51BD72370818AFC5D413FA126" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_E5F0E2D6CF78FB5DF8DAA0506191C147_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_E5F0E2D6CF78FB5DF8DAA0506191C147" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_E5F0E2D6CF78FB5DF8DAA0506191C147" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_E5F0E2D6CF78FB5DF8DAA0506191C147" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_E5F0E2D6CF78FB5DF8DAA0506191C147" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ADE49B36780FC226C42CA0506191A56A_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ADE49B36780FC226C42CA0506191A56A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Accounting</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ADE49B36780FC226C42CA0506191A56A_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ADE49B36780FC226C42CA0506191A56A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ADE49B36780FC226C42CA0506191A56A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ADE49B36780FC226C42CA0506191A56A" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ADE49B36780FC226C42CA0506191A56A" xlink:type="arc" />
    <link:label id="lab_us-gaap_UseOfEstimates_AE4E9614F60259F25C09A0506191D124_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates_AE4E9614F60259F25C09A0506191D124" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_AE4E9614F60259F25C09A0506191D124_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates_AE4E9614F60259F25C09A0506191D124" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_AE4E9614F60259F25C09A0506191D124" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_AE4E9614F60259F25C09A0506191D124" xlink:to="lab_us-gaap_UseOfEstimates_AE4E9614F60259F25C09A0506191D124" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_AD584DB1FDC7D71808D5A05061915343_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_AD584DB1FDC7D71808D5A05061915343" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Adopted Accounting Pronouncement</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_AD584DB1FDC7D71808D5A05061915343_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_AD584DB1FDC7D71808D5A05061915343" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_AD584DB1FDC7D71808D5A05061915343" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_AD584DB1FDC7D71808D5A05061915343" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_AD584DB1FDC7D71808D5A05061915343" xlink:type="arc" />
    <link:label id="lab_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3_label_en-US" xlink:label="lab_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3_documentation_en-US" xlink:label="lab_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DocumentandEntityInformationAbstract" xlink:label="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="lab_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_2FB0B1144D46D66B01D9FC5D40EA01C1_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_2FB0B1144D46D66B01D9FC5D40EA01C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_2FB0B1144D46D66B01D9FC5D40EA01C1_label_en-US" xlink:label="lab_dei_TradingSymbol_2FB0B1144D46D66B01D9FC5D40EA01C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_2FB0B1144D46D66B01D9FC5D40EA01C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_2FB0B1144D46D66B01D9FC5D40EA01C1" xlink:to="lab_dei_TradingSymbol_2FB0B1144D46D66B01D9FC5D40EA01C1" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_DB21F9603526157B23DCFC5D40EA9F6C_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_DB21F9603526157B23DCFC5D40EA9F6C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_DB21F9603526157B23DCFC5D40EA9F6C_label_en-US" xlink:label="lab_dei_EntityRegistrantName_DB21F9603526157B23DCFC5D40EA9F6C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_DB21F9603526157B23DCFC5D40EA9F6C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_DB21F9603526157B23DCFC5D40EA9F6C" xlink:to="lab_dei_EntityRegistrantName_DB21F9603526157B23DCFC5D40EA9F6C" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_BE9D36F7E97D6E8FBDAEFC5D40EA67CD_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_BE9D36F7E97D6E8FBDAEFC5D40EA67CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_BE9D36F7E97D6E8FBDAEFC5D40EA67CD_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_BE9D36F7E97D6E8FBDAEFC5D40EA67CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_BE9D36F7E97D6E8FBDAEFC5D40EA67CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_BE9D36F7E97D6E8FBDAEFC5D40EA67CD" xlink:to="lab_dei_EntityCentralIndexKey_BE9D36F7E97D6E8FBDAEFC5D40EA67CD" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_FB30D25A5E3D7C1B4657FC5D40EA6D14_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_FB30D25A5E3D7C1B4657FC5D40EA6D14" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_FB30D25A5E3D7C1B4657FC5D40EA6D14_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_FB30D25A5E3D7C1B4657FC5D40EA6D14" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_FB30D25A5E3D7C1B4657FC5D40EA6D14" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_FB30D25A5E3D7C1B4657FC5D40EA6D14" xlink:to="lab_dei_CurrentFiscalYearEndDate_FB30D25A5E3D7C1B4657FC5D40EA6D14" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_AEE6B708C20E3B54DABAFC5D40EA83D0_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_AEE6B708C20E3B54DABAFC5D40EA83D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_AEE6B708C20E3B54DABAFC5D40EA83D0_label_en-US" xlink:label="lab_dei_EntityFilerCategory_AEE6B708C20E3B54DABAFC5D40EA83D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_AEE6B708C20E3B54DABAFC5D40EA83D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_AEE6B708C20E3B54DABAFC5D40EA83D0" xlink:to="lab_dei_EntityFilerCategory_AEE6B708C20E3B54DABAFC5D40EA83D0" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_E21D336984303B94D130FC5D40EA8F6A_terseLabel_en-US" xlink:label="lab_dei_DocumentType_E21D336984303B94D130FC5D40EA8F6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_E21D336984303B94D130FC5D40EA8F6A_label_en-US" xlink:label="lab_dei_DocumentType_E21D336984303B94D130FC5D40EA8F6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_E21D336984303B94D130FC5D40EA8F6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_E21D336984303B94D130FC5D40EA8F6A" xlink:to="lab_dei_DocumentType_E21D336984303B94D130FC5D40EA8F6A" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_01A2D95C5DDCC2A84509FC5D40EACF25_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_01A2D95C5DDCC2A84509FC5D40EACF25" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_01A2D95C5DDCC2A84509FC5D40EACF25_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_01A2D95C5DDCC2A84509FC5D40EACF25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_01A2D95C5DDCC2A84509FC5D40EACF25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_01A2D95C5DDCC2A84509FC5D40EACF25" xlink:to="lab_dei_DocumentPeriodEndDate_01A2D95C5DDCC2A84509FC5D40EACF25" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_C21DD7316DDF21943387FC5D40EAA72C_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_C21DD7316DDF21943387FC5D40EAA72C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_C21DD7316DDF21943387FC5D40EAA72C_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_C21DD7316DDF21943387FC5D40EAA72C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_C21DD7316DDF21943387FC5D40EAA72C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_C21DD7316DDF21943387FC5D40EAA72C" xlink:to="lab_dei_DocumentFiscalYearFocus_C21DD7316DDF21943387FC5D40EAA72C" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_406785DE8460B3EB7373FC5D40EBA4F1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_406785DE8460B3EB7373FC5D40EBA4F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_406785DE8460B3EB7373FC5D40EBA4F1_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_406785DE8460B3EB7373FC5D40EBA4F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_406785DE8460B3EB7373FC5D40EBA4F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_406785DE8460B3EB7373FC5D40EBA4F1" xlink:to="lab_dei_DocumentFiscalPeriodFocus_406785DE8460B3EB7373FC5D40EBA4F1" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_F6B84A50BC6E0C4ACAE7FC5D40EB0620_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_F6B84A50BC6E0C4ACAE7FC5D40EB0620" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_F6B84A50BC6E0C4ACAE7FC5D40EB0620_label_en-US" xlink:label="lab_dei_AmendmentFlag_F6B84A50BC6E0C4ACAE7FC5D40EB0620" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_F6B84A50BC6E0C4ACAE7FC5D40EB0620" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_F6B84A50BC6E0C4ACAE7FC5D40EB0620" xlink:to="lab_dei_AmendmentFlag_F6B84A50BC6E0C4ACAE7FC5D40EB0620" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2AECEFC7506F34A93536FC5D40EB1C29_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_2AECEFC7506F34A93536FC5D40EB1C29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2AECEFC7506F34A93536FC5D40EB1C29_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_2AECEFC7506F34A93536FC5D40EB1C29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2AECEFC7506F34A93536FC5D40EB1C29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_2AECEFC7506F34A93536FC5D40EB1C29" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_2AECEFC7506F34A93536FC5D40EB1C29" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_D9A9D0E2ACEE90800BA6FC5D410C3C9F_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract_D9A9D0E2ACEE90800BA6FC5D410C3C9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_D9A9D0E2ACEE90800BA6FC5D410C3C9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_D9A9D0E2ACEE90800BA6FC5D410C3C9F" xlink:to="lab_us-gaap_BusinessCombinationsAbstract_D9A9D0E2ACEE90800BA6FC5D410C3C9F" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_C95474DB398C1668C0E5FC5D410C63C4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_C95474DB398C1668C0E5FC5D410C63C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_C95474DB398C1668C0E5FC5D410C63C4_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_C95474DB398C1668C0E5FC5D410C63C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_C95474DB398C1668C0E5FC5D410C63C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock_C95474DB398C1668C0E5FC5D410C63C4" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock_C95474DB398C1668C0E5FC5D410C63C4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_E2534A613FED3E168B7CFC5D40541BB6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_E2534A613FED3E168B7CFC5D40541BB6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_E2534A613FED3E168B7CFC5D40541BB6_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_E2534A613FED3E168B7CFC5D40541BB6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_E2534A613FED3E168B7CFC5D40541BB6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_E2534A613FED3E168B7CFC5D40541BB6" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_E2534A613FED3E168B7CFC5D40541BB6" xlink:type="arc" />
    <link:label id="lab_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock_1B05AD5AC33A6684232EFC5D40544EE5_terseLabel_en-US" xlink:label="lab_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock_1B05AD5AC33A6684232EFC5D40544EE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of reconciliation of opening and closing balances for fair value measurements categorized within Level 3</link:label>
    <link:label id="lab_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock_1B05AD5AC33A6684232EFC5D40544EE5_label_en-US" xlink:label="lab_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock_1B05AD5AC33A6684232EFC5D40544EE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock_1B05AD5AC33A6684232EFC5D40544EE5_documentation_en-US" xlink:label="lab_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock_1B05AD5AC33A6684232EFC5D40544EE5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:label="loc_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock_1B05AD5AC33A6684232EFC5D40544EE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock_1B05AD5AC33A6684232EFC5D40544EE5" xlink:to="lab_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock_1B05AD5AC33A6684232EFC5D40544EE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_CF7AA01AB31F7F9E9130FC5D4054DDC0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_CF7AA01AB31F7F9E9130FC5D4054DDC0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_CF7AA01AB31F7F9E9130FC5D4054DDC0_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_CF7AA01AB31F7F9E9130FC5D4054DDC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_CF7AA01AB31F7F9E9130FC5D4054DDC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_CF7AA01AB31F7F9E9130FC5D4054DDC0" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_CF7AA01AB31F7F9E9130FC5D4054DDC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_DCE4DDFA23A3B9F4E1F2FC5D41C2D4B6_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_DCE4DDFA23A3B9F4E1F2FC5D41C2D4B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_DCE4DDFA23A3B9F4E1F2FC5D41C2D4B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_DCE4DDFA23A3B9F4E1F2FC5D41C2D4B6" xlink:to="lab_us-gaap_DebtDisclosureAbstract_DCE4DDFA23A3B9F4E1F2FC5D41C2D4B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_75535A23560086BBCD0BFC5D41C2E672_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_75535A23560086BBCD0BFC5D41C2E672" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_75535A23560086BBCD0BFC5D41C2E672_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_75535A23560086BBCD0BFC5D41C2E672" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_75535A23560086BBCD0BFC5D41C2E672" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_75535A23560086BBCD0BFC5D41C2E672" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_75535A23560086BBCD0BFC5D41C2E672" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_BC72EBA9C4116FDC21EEFC5D408680EA_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_BC72EBA9C4116FDC21EEFC5D408680EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_BC72EBA9C4116FDC21EEFC5D408680EA_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_BC72EBA9C4116FDC21EEFC5D408680EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_BC72EBA9C4116FDC21EEFC5D408680EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock_BC72EBA9C4116FDC21EEFC5D408680EA" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock_BC72EBA9C4116FDC21EEFC5D408680EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventMember_D5FF7FC024416B6BF585D458FCAC29AB_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_D5FF7FC024416B6BF585D458FCAC29AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_D5FF7FC024416B6BF585D458FCAC29AB_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_D5FF7FC024416B6BF585D458FCAC29AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_D5FF7FC024416B6BF585D458FCAC29AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_D5FF7FC024416B6BF585D458FCAC29AB" xlink:to="lab_us-gaap_SubsequentEventMember_D5FF7FC024416B6BF585D458FCAC29AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:type="arc" />
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF_terseLabel_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2016 [Member]</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF_label_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2016 [Member]</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF_documentation_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2016 [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF" xlink:to="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF" xlink:type="arc" />
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116_terseLabel_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2017 [Member]</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116_label_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2017 [Member]</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116_documentation_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2017 [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116" xlink:to="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116" xlink:type="arc" />
    <link:label id="lab_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE_terseLabel_en-US" xlink:label="lab_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential Earnout [Member]</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE_label_en-US" xlink:label="lab_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Earnout [Member]</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE_documentation_en-US" xlink:label="lab_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Earnout [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PotentialEarnoutMember" xlink:label="loc_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE" xlink:to="lab_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE" xlink:type="arc" />
    <link:label id="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57_terseLabel_en-US" xlink:label="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assumed Additional Contingent Purchase Price Liabilities [Member]</link:label>
    <link:label id="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57_label_en-US" xlink:label="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assumed Additional Contingent Purchase Price Liabilities [Member]</link:label>
    <link:label id="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57_documentation_en-US" xlink:label="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assumed Additional Contingent Purchase Price Liabilities [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" xlink:label="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57" xlink:to="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:type="arc" />
    <link:label id="lab_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499_terseLabel_en-US" xlink:label="lab_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mediscan [Member]</link:label>
    <link:label id="lab_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499_label_en-US" xlink:label="lab_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mediscan [Member]</link:label>
    <link:label id="lab_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499_documentation_en-US" xlink:label="lab_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mediscan [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_MediscanMember" xlink:label="loc_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499" xlink:to="lab_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499" xlink:type="arc" />
    <link:label id="lab_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8_terseLabel_en-US" xlink:label="lab_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical Staffing Network [Member]</link:label>
    <link:label id="lab_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8_label_en-US" xlink:label="lab_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Staffing Network [Member]</link:label>
    <link:label id="lab_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8_documentation_en-US" xlink:label="lab_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical Staffing Network [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_MedicalStaffingNetworkMember" xlink:label="loc_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8" xlink:to="lab_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_89174C1D3A746DA04C44D458FCADA814_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_89174C1D3A746DA04C44D458FCADA814" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash purchase price paid at closing</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_89174C1D3A746DA04C44D458FCADA814_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_89174C1D3A746DA04C44D458FCADA814" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_89174C1D3A746DA04C44D458FCADA814" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_89174C1D3A746DA04C44D458FCADA814" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_89174C1D3A746DA04C44D458FCADA814" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash consideration plus working capital estimate</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97_label_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Consideration Negotiated</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Consideration Negotiated</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97" xlink:to="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2022F86894C1ED9C3B89D458FCADC96B_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2022F86894C1ED9C3B89D458FCADC96B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of shares</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2022F86894C1ED9C3B89D458FCADC96B_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2022F86894C1ED9C3B89D458FCADC96B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2022F86894C1ED9C3B89D458FCADC96B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2022F86894C1ED9C3B89D458FCADC96B" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2022F86894C1ED9C3B89D458FCADC96B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8F11022F2439542999FCD458FCADB65E_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8F11022F2439542999FCD458FCADB65E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8F11022F2439542999FCD458FCADB65E_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8F11022F2439542999FCD458FCADB65E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8F11022F2439542999FCD458FCADB65E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8F11022F2439542999FCD458FCADB65E" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8F11022F2439542999FCD458FCADB65E" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Release of escrow to seller</link:label>
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77_label_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Escrow Deposit Release</link:label>
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Escrow Deposit Release</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationEscrowDepositRelease" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77" xlink:to="lab_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_DFC03624C3039FA5C8D4D458FCAD229C_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_DFC03624C3039FA5C8D4D458FCAD229C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration, range of outcomes, high</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_DFC03624C3039FA5C8D4D458FCAD229C_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_DFC03624C3039FA5C8D4D458FCAD229C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_DFC03624C3039FA5C8D4D458FCAD229C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_DFC03624C3039FA5C8D4D458FCAD229C" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_DFC03624C3039FA5C8D4D458FCAD229C" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_AEE1DDBF1ECC2AAC928CD458FCAD759C_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_AEE1DDBF1ECC2AAC928CD458FCAD759C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_AEE1DDBF1ECC2AAC928CD458FCAD759C_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_AEE1DDBF1ECC2AAC928CD458FCAD759C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AEE1DDBF1ECC2AAC928CD458FCAD759C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AEE1DDBF1ECC2AAC928CD458FCAD759C" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_AEE1DDBF1ECC2AAC928CD458FCAD759C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForPreviousAcquisition_D397BADF03803F8285B3D458FCAD17FE_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForPreviousAcquisition_D397BADF03803F8285B3D458FCAD17FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent liability paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForPreviousAcquisition_D397BADF03803F8285B3D458FCAD17FE_label_en-US" xlink:label="lab_us-gaap_PaymentsForPreviousAcquisition_D397BADF03803F8285B3D458FCAD17FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Previous Acquisition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForPreviousAcquisition" xlink:label="loc_us-gaap_PaymentsForPreviousAcquisition_D397BADF03803F8285B3D458FCAD17FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForPreviousAcquisition_D397BADF03803F8285B3D458FCAD17FE" xlink:to="lab_us-gaap_PaymentsForPreviousAcquisition_D397BADF03803F8285B3D458FCAD17FE" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period of deferred consideration</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D_label_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Deferred, Period</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Deferred, Period</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationConsiderationDeferredPeriod" xlink:label="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D" xlink:to="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5C8208098DAE517BA7A5D458FCADDB1D_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5C8208098DAE517BA7A5D458FCADDB1D" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Release of remaining contingent liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5C8208098DAE517BA7A5D458FCADDB1D_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5C8208098DAE517BA7A5D458FCADDB1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5C8208098DAE517BA7A5D458FCADDB1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5C8208098DAE517BA7A5D458FCADDB1D" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5C8208098DAE517BA7A5D458FCADDB1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_FD6242A33EFD57DA6B92AAF20C4314F2_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_FD6242A33EFD57DA6B92AAF20C4314F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_FD6242A33EFD57DA6B92AAF20C4314F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_FD6242A33EFD57DA6B92AAF20C4314F2" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_FD6242A33EFD57DA6B92AAF20C4314F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_2A992D74D03A67686CF5AAF20C437AB7_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_2A992D74D03A67686CF5AAF20C437AB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_2A992D74D03A67686CF5AAF20C437AB7_label_en-US" xlink:label="lab_us-gaap_ProfitLoss_2A992D74D03A67686CF5AAF20C437AB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_2A992D74D03A67686CF5AAF20C437AB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_2A992D74D03A67686CF5AAF20C437AB7" xlink:to="lab_us-gaap_ProfitLoss_2A992D74D03A67686CF5AAF20C437AB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_7A3E4057275781016BA6AAF20C4321E6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_7A3E4057275781016BA6AAF20C4321E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), before income tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_7A3E4057275781016BA6AAF20C4321E6_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_7A3E4057275781016BA6AAF20C4321E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_7A3E4057275781016BA6AAF20C4321E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_7A3E4057275781016BA6AAF20C4321E6" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_7A3E4057275781016BA6AAF20C4321E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_0F1826D5D55E1EB0C73CAAF20C431802_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_0F1826D5D55E1EB0C73CAAF20C431802" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized foreign currency translation gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_0F1826D5D55E1EB0C73CAAF20C431802_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_0F1826D5D55E1EB0C73CAAF20C431802" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_0F1826D5D55E1EB0C73CAAF20C431802" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_0F1826D5D55E1EB0C73CAAF20C431802" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_0F1826D5D55E1EB0C73CAAF20C431802" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_408AC517776D320394C7AAF20C4419FE_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_408AC517776D320394C7AAF20C4419FE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_408AC517776D320394C7AAF20C4419FE_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_408AC517776D320394C7AAF20C4419FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_408AC517776D320394C7AAF20C4419FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_408AC517776D320394C7AAF20C4419FE" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_408AC517776D320394C7AAF20C4419FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_860410B6000C05C2375BAAF20C44B9D5_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_860410B6000C05C2375BAAF20C44B9D5" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_860410B6000C05C2375BAAF20C44B9D5_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_860410B6000C05C2375BAAF20C44B9D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_860410B6000C05C2375BAAF20C44B9D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_860410B6000C05C2375BAAF20C44B9D5" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_860410B6000C05C2375BAAF20C44B9D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_850C397C16C74CB07064AAF20C44E68D_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_850C397C16C74CB07064AAF20C44E68D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Net income attributable to noncontrolling interest in subsidiary</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_850C397C16C74CB07064AAF20C44E68D_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_850C397C16C74CB07064AAF20C44E68D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_850C397C16C74CB07064AAF20C44E68D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_850C397C16C74CB07064AAF20C44E68D" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_850C397C16C74CB07064AAF20C44E68D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_207285694A609867303CAAF20C44FD6E_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_207285694A609867303CAAF20C44FD6E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive (loss) income attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_207285694A609867303CAAF20C44FD6E_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_207285694A609867303CAAF20C44FD6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_207285694A609867303CAAF20C44FD6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_207285694A609867303CAAF20C44FD6E" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_207285694A609867303CAAF20C44FD6E" xlink:type="arc" />
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_DDD2A8CCF3A0DDA22FCFFC5D40EDE47C_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_DDD2A8CCF3A0DDA22FCFFC5D40EDE47C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_DDD2A8CCF3A0DDA22FCFFC5D40EDE47C_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_DDD2A8CCF3A0DDA22FCFFC5D40EDE47C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_DDD2A8CCF3A0DDA22FCFFC5D40EDE47C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_DDD2A8CCF3A0DDA22FCFFC5D40EDE47C" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_DDD2A8CCF3A0DDA22FCFFC5D40EDE47C" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_F7682E2C10D9803DAAEBFC5D407EBD3F_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_F7682E2C10D9803DAAEBFC5D407EBD3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEGMENT DATA</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_F7682E2C10D9803DAAEBFC5D407EBD3F_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_F7682E2C10D9803DAAEBFC5D407EBD3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_F7682E2C10D9803DAAEBFC5D407EBD3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_F7682E2C10D9803DAAEBFC5D407EBD3F" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_F7682E2C10D9803DAAEBFC5D407EBD3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_ADB10997ACB0732106DBFC5D40EC48D5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_ADB10997ACB0732106DBFC5D40EC48D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_ADB10997ACB0732106DBFC5D40EC48D5_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_ADB10997ACB0732106DBFC5D40EC48D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shareholders' Equity and Share-based Payments [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_ADB10997ACB0732106DBFC5D40EC48D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_ADB10997ACB0732106DBFC5D40EC48D5" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_ADB10997ACB0732106DBFC5D40EC48D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_F9142A26094D8BAA75E0FC5D41C0587B_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_F9142A26094D8BAA75E0FC5D41C0587B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_F9142A26094D8BAA75E0FC5D41C0587B_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_F9142A26094D8BAA75E0FC5D41C0587B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_F9142A26094D8BAA75E0FC5D41C0587B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock_F9142A26094D8BAA75E0FC5D41C0587B" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock_F9142A26094D8BAA75E0FC5D41C0587B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8EC23DBDDE9F7B778792FC5D41C0C005_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8EC23DBDDE9F7B778792FC5D41C0C005" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate scheduled maturities of debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8EC23DBDDE9F7B778792FC5D41C0C005_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8EC23DBDDE9F7B778792FC5D41C0C005" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8EC23DBDDE9F7B778792FC5D41C0C005" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8EC23DBDDE9F7B778792FC5D41C0C005" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8EC23DBDDE9F7B778792FC5D41C0C005" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:to="lab_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911_terseLabel_en-US" xlink:label="lab_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Covenant Terms [Axis]</link:label>
    <link:label id="lab_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911_label_en-US" xlink:label="lab_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant Terms [Axis]</link:label>
    <link:label id="lab_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911_documentation_en-US" xlink:label="lab_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Covenant Terms [Axis]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsAxis" xlink:label="loc_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:to="lab_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813_terseLabel_en-US" xlink:label="lab_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Covenant Terms [Domain]</link:label>
    <link:label id="lab_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813_label_en-US" xlink:label="lab_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant Terms [Domain]</link:label>
    <link:label id="lab_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813_documentation_en-US" xlink:label="lab_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Debt Covenant Terms [Axis]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:to="lab_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:type="arc" />
    <link:label id="lab_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6_terseLabel_en-US" xlink:label="lab_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covenant Term 1 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6_label_en-US" xlink:label="lab_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Covenant Term 1 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6_documentation_en-US" xlink:label="lab_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Covenant Term 1 [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm1Member" xlink:label="loc_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6" xlink:to="lab_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6" xlink:type="arc" />
    <link:label id="lab_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18_terseLabel_en-US" xlink:label="lab_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covenant Term 2 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18_label_en-US" xlink:label="lab_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Covenant Term 2 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18_documentation_en-US" xlink:label="lab_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Covenant Term 2 [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm2Member" xlink:label="loc_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18" xlink:to="lab_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18" xlink:type="arc" />
    <link:label id="lab_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4_terseLabel_en-US" xlink:label="lab_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covenant Term 3 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4_label_en-US" xlink:label="lab_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Covenant Term 3 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4_documentation_en-US" xlink:label="lab_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Covenant Term 3 [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm3Member" xlink:label="loc_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4" xlink:to="lab_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4" xlink:type="arc" />
    <link:label id="lab_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806_terseLabel_en-US" xlink:label="lab_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covenant Term 4 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806_label_en-US" xlink:label="lab_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Covenant Term 4 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806_documentation_en-US" xlink:label="lab_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Covenant Term 4 [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm4Member" xlink:label="loc_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806" xlink:to="lab_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806" xlink:type="arc" />
    <link:label id="lab_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E_terseLabel_en-US" xlink:label="lab_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covenant Term 5 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E_label_en-US" xlink:label="lab_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Covenant Term 5 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E_documentation_en-US" xlink:label="lab_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Covenant Term 5 [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm5Member" xlink:label="loc_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E" xlink:to="lab_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:to="lab_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19" xlink:type="arc" />
    <link:label id="lab_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A_terseLabel_en-US" xlink:label="lab_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A_label_en-US" xlink:label="lab_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A_documentation_en-US" xlink:label="lab_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A" xlink:to="lab_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:to="lab_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:to="lab_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:type="arc" />
    <link:label id="lab_us-gaap_EurodollarMember_2D20D6EFDEBE83A6F1E8FC5D410525A2_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember_2D20D6EFDEBE83A6F1E8FC5D410525A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Eurodollar Loans [Member]</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_2D20D6EFDEBE83A6F1E8FC5D410525A2_label_en-US" xlink:label="lab_us-gaap_EurodollarMember_2D20D6EFDEBE83A6F1E8FC5D410525A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_2D20D6EFDEBE83A6F1E8FC5D410525A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember_2D20D6EFDEBE83A6F1E8FC5D410525A2" xlink:to="lab_us-gaap_EurodollarMember_2D20D6EFDEBE83A6F1E8FC5D410525A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_D6EADD3A3C6886894CCCFC5D41058FFE_verboseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_D6EADD3A3C6886894CCCFC5D41058FFE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LIBOR Index Rate Loans [Member]</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_D6EADD3A3C6886894CCCFC5D41058FFE_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_D6EADD3A3C6886894CCCFC5D41058FFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_D6EADD3A3C6886894CCCFC5D41058FFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_D6EADD3A3C6886894CCCFC5D41058FFE" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_D6EADD3A3C6886894CCCFC5D41058FFE" xlink:type="arc" />
    <link:label id="lab_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA_terseLabel_en-US" xlink:label="lab_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of Credit Fee [Member]</link:label>
    <link:label id="lab_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA_label_en-US" xlink:label="lab_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit Fee [Member]</link:label>
    <link:label id="lab_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA_documentation_en-US" xlink:label="lab_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Letter of Credit Fee [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LetterofCreditFeeMember" xlink:label="loc_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA" xlink:to="lab_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA" xlink:type="arc" />
    <link:label id="lab_us-gaap_BaseRateMember_41AFDEC2C542794783CAFC5D410556A2_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember_41AFDEC2C542794783CAFC5D410556A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Base Rate Loans [Member]</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_41AFDEC2C542794783CAFC5D410556A2_label_en-US" xlink:label="lab_us-gaap_BaseRateMember_41AFDEC2C542794783CAFC5D410556A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_41AFDEC2C542794783CAFC5D410556A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember_41AFDEC2C542794783CAFC5D410556A2" xlink:to="lab_us-gaap_BaseRateMember_41AFDEC2C542794783CAFC5D410556A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:type="arc" />
    <link:label id="lab_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2_terseLabel_en-US" xlink:label="lab_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Net Leverage Ratio</link:label>
    <link:label id="lab_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2_label_en-US" xlink:label="lab_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Net Leverage Ratio</link:label>
    <link:label id="lab_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2_documentation_en-US" xlink:label="lab_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consolidated Net Leverage Ratio</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConsolidatedNetLeverageRatio" xlink:label="loc_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2" xlink:to="lab_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_968FFEA7C2557F227EDCFC5D410577A1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_968FFEA7C2557F227EDCFC5D410577A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_968FFEA7C2557F227EDCFC5D410577A1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_968FFEA7C2557F227EDCFC5D410577A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_968FFEA7C2557F227EDCFC5D410577A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_968FFEA7C2557F227EDCFC5D410577A1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_968FFEA7C2557F227EDCFC5D410577A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7F6FE0A0B15A0C71FC05FC5D410538CD_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7F6FE0A0B15A0C71FC05FC5D410538CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7F6FE0A0B15A0C71FC05FC5D410538CD_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7F6FE0A0B15A0C71FC05FC5D410538CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7F6FE0A0B15A0C71FC05FC5D410538CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7F6FE0A0B15A0C71FC05FC5D410538CD" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7F6FE0A0B15A0C71FC05FC5D410538CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98FB7C8841E2729EAA27FC5D4063F944_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98FB7C8841E2729EAA27FC5D4063F944" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98FB7C8841E2729EAA27FC5D4063F944" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98FB7C8841E2729EAA27FC5D4063F944" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98FB7C8841E2729EAA27FC5D4063F944" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_BBCFB9C3DF08B6052A2EFC5D4063CB02_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_BBCFB9C3DF08B6052A2EFC5D4063CB02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_BBCFB9C3DF08B6052A2EFC5D4063CB02_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_BBCFB9C3DF08B6052A2EFC5D4063CB02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_BBCFB9C3DF08B6052A2EFC5D4063CB02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_BBCFB9C3DF08B6052A2EFC5D4063CB02" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_BBCFB9C3DF08B6052A2EFC5D4063CB02" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:to="lab_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:to="lab_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613" xlink:to="lab_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeniorDebtObligationsMember_4CFAC201BA3B34CADCF3B2A30081A52A_verboseLabel_en-US" xlink:label="lab_us-gaap_SeniorDebtObligationsMember_4CFAC201BA3B34CADCF3B2A30081A52A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorDebtObligationsMember_4CFAC201BA3B34CADCF3B2A30081A52A_label_en-US" xlink:label="lab_us-gaap_SeniorDebtObligationsMember_4CFAC201BA3B34CADCF3B2A30081A52A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Debt Obligations [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_4CFAC201BA3B34CADCF3B2A30081A52A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorDebtObligationsMember_4CFAC201BA3B34CADCF3B2A30081A52A" xlink:to="lab_us-gaap_SeniorDebtObligationsMember_4CFAC201BA3B34CADCF3B2A30081A52A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:to="lab_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_FA840083F61381641E01B2A300815304_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_FA840083F61381641E01B2A300815304" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_FA840083F61381641E01B2A300815304_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_FA840083F61381641E01B2A300815304" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_FA840083F61381641E01B2A300815304" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_FA840083F61381641E01B2A300815304" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_FA840083F61381641E01B2A300815304" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4EE6064D8FEE34AB354AB2A30082CB7D_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4EE6064D8FEE34AB354AB2A30082CB7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4EE6064D8FEE34AB354AB2A30082CB7D_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4EE6064D8FEE34AB354AB2A30082CB7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4EE6064D8FEE34AB354AB2A30082CB7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4EE6064D8FEE34AB354AB2A30082CB7D" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4EE6064D8FEE34AB354AB2A30082CB7D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3BAE169B338B5863EE0EB2A30082FA1A_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3BAE169B338B5863EE0EB2A30082FA1A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3BAE169B338B5863EE0EB2A30082FA1A_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3BAE169B338B5863EE0EB2A30082FA1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3BAE169B338B5863EE0EB2A30082FA1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3BAE169B338B5863EE0EB2A30082FA1A" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3BAE169B338B5863EE0EB2A30082FA1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_D312214273A952B67FB3B2A300826851_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_D312214273A952B67FB3B2A300826851" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_D312214273A952B67FB3B2A300826851_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_D312214273A952B67FB3B2A300826851" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_D312214273A952B67FB3B2A300826851" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_D312214273A952B67FB3B2A300826851" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_D312214273A952B67FB3B2A300826851" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ED89FFDF7005060E527B2A30087D697_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ED89FFDF7005060E527B2A30087D697" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ED89FFDF7005060E527B2A30087D697_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ED89FFDF7005060E527B2A30087D697" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ED89FFDF7005060E527B2A30087D697" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ED89FFDF7005060E527B2A30087D697" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ED89FFDF7005060E527B2A30087D697" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_79B460F199D6A570AF23B2A30089C73F_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_79B460F199D6A570AF23B2A30089C73F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_79B460F199D6A570AF23B2A30089C73F_label_en-US" xlink:label="lab_us-gaap_LongTermDebt_79B460F199D6A570AF23B2A30089C73F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_79B460F199D6A570AF23B2A30089C73F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_79B460F199D6A570AF23B2A30089C73F" xlink:to="lab_us-gaap_LongTermDebt_79B460F199D6A570AF23B2A30089C73F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Lease Obligations [Abstract]</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Lease Obligations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:label="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="lab_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_F271F9983E06867102F5B2A300899438_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_F271F9983E06867102F5B2A300899438" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_F271F9983E06867102F5B2A300899438_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_F271F9983E06867102F5B2A300899438" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Leases, Future Minimum Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_F271F9983E06867102F5B2A300899438" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_F271F9983E06867102F5B2A300899438" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_F271F9983E06867102F5B2A300899438" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_046C9C58201DA06D4744B2A300892D1D_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_046C9C58201DA06D4744B2A300892D1D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_046C9C58201DA06D4744B2A300892D1D_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_046C9C58201DA06D4744B2A300892D1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Two Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_046C9C58201DA06D4744B2A300892D1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_046C9C58201DA06D4744B2A300892D1D" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_046C9C58201DA06D4744B2A300892D1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_E9AA7D6FD98EF7623895B2A30089CD13_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_E9AA7D6FD98EF7623895B2A30089CD13" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_E9AA7D6FD98EF7623895B2A30089CD13_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_E9AA7D6FD98EF7623895B2A30089CD13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Three Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_E9AA7D6FD98EF7623895B2A30089CD13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_E9AA7D6FD98EF7623895B2A30089CD13" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_E9AA7D6FD98EF7623895B2A30089CD13" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_CED8634B2979C95BDD96B2A300893878_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_CED8634B2979C95BDD96B2A300893878" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_CED8634B2979C95BDD96B2A300893878_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_CED8634B2979C95BDD96B2A300893878" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Four Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_CED8634B2979C95BDD96B2A300893878" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_CED8634B2979C95BDD96B2A300893878" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_CED8634B2979C95BDD96B2A300893878" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_F97C028B1B1E483E7563B2A3008AD84E_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_F97C028B1B1E483E7563B2A3008AD84E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_F97C028B1B1E483E7563B2A3008AD84E_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_F97C028B1B1E483E7563B2A3008AD84E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Leases, Future Minimum Payments Due in Five Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_F97C028B1B1E483E7563B2A3008AD84E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_F97C028B1B1E483E7563B2A3008AD84E" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_F97C028B1B1E483E7563B2A3008AD84E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_791ACB947DBE94796AD4B2A3008A8CDB_totalLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_791ACB947DBE94796AD4B2A3008A8CDB" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_791ACB947DBE94796AD4B2A3008A8CDB_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_791ACB947DBE94796AD4B2A3008A8CDB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_791ACB947DBE94796AD4B2A3008A8CDB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_791ACB947DBE94796AD4B2A3008A8CDB" xlink:to="lab_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_791ACB947DBE94796AD4B2A3008A8CDB" xlink:type="arc" />
    <link:label id="lab_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F_terseLabel_en-US" xlink:label="lab_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">8% Convertible Notes [Member]</link:label>
    <link:label id="lab_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F_label_en-US" xlink:label="lab_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">8% Convertible Notes [Member]</link:label>
    <link:label id="lab_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F_documentation_en-US" xlink:label="lab_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">8% Convertible Notes [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_A8ConvertibleNotesMember" xlink:label="loc_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F" xlink:to="lab_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F" xlink:type="arc" />
    <link:label id="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1_terseLabel_en-US" xlink:label="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Note Derivative Liability [Member]</link:label>
    <link:label id="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1_label_en-US" xlink:label="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Note Derivative Liability [Member]</link:label>
    <link:label id="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1_documentation_en-US" xlink:label="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Note Derivative Liability [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleNoteDerivativeLiabilityMember" xlink:label="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1" xlink:to="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE" xlink:to="lab_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_E30510C22AA54B7AB151D49E32201746_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_E30510C22AA54B7AB151D49E32201746" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_E30510C22AA54B7AB151D49E32201746_label_en-US" xlink:label="lab_us-gaap_CommonStockMember_E30510C22AA54B7AB151D49E32201746" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_E30510C22AA54B7AB151D49E32201746" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_E30510C22AA54B7AB151D49E32201746" xlink:to="lab_us-gaap_CommonStockMember_E30510C22AA54B7AB151D49E32201746" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleDebtMember_294B1F86D3580B9C6144D49E32219427_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember_294B1F86D3580B9C6144D49E32219427" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes [Member]</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_294B1F86D3580B9C6144D49E32219427_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember_294B1F86D3580B9C6144D49E32219427" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_294B1F86D3580B9C6144D49E32219427" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember_294B1F86D3580B9C6144D49E32219427" xlink:to="lab_us-gaap_ConvertibleDebtMember_294B1F86D3580B9C6144D49E32219427" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_7C27BEA75FD9AE0E3FAAD49E3221A332_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_7C27BEA75FD9AE0E3FAAD49E3221A332" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_7C27BEA75FD9AE0E3FAAD49E3221A332_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_7C27BEA75FD9AE0E3FAAD49E3221A332" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7C27BEA75FD9AE0E3FAAD49E3221A332" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount_7C27BEA75FD9AE0E3FAAD49E3221A332" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount_7C27BEA75FD9AE0E3FAAD49E3221A332" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_40575C3BAB6A575F895ED49E3221C525_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_40575C3BAB6A575F895ED49E3221C525" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_40575C3BAB6A575F895ED49E3221C525_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_40575C3BAB6A575F895ED49E3221C525" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_40575C3BAB6A575F895ED49E3221C525" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_40575C3BAB6A575F895ED49E3221C525" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_40575C3BAB6A575F895ED49E3221C525" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8DF72085A8D35E0C3187D49E3221A7EC_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_8DF72085A8D35E0C3187D49E3221A7EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8DF72085A8D35E0C3187D49E3221A7EC_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_8DF72085A8D35E0C3187D49E3221A7EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8DF72085A8D35E0C3187D49E3221A7EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_8DF72085A8D35E0C3187D49E3221A7EC" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_8DF72085A8D35E0C3187D49E3221A7EC" xlink:type="arc" />
    <link:label id="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2_totalLabel_en-US" xlink:label="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Payment of debt and extinguishment fees</link:label>
    <link:label id="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2_label_en-US" xlink:label="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Debt Extinguishment Costs And Repayment Of Long Term Debt</link:label>
    <link:label id="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2_documentation_en-US" xlink:label="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For Debt Extinguishment Costs And Repayment Of Long Term Debt</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" xlink:label="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2" xlink:to="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_DBAF1BFEEFA0641E3B90D49E32219778_verboseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_DBAF1BFEEFA0641E3B90D49E32219778" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_DBAF1BFEEFA0641E3B90D49E32219778_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_DBAF1BFEEFA0641E3B90D49E32219778" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_DBAF1BFEEFA0641E3B90D49E32219778" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_DBAF1BFEEFA0641E3B90D49E32219778" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_DBAF1BFEEFA0641E3B90D49E32219778" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_84A0E7BA79D4C698BD91D49E32216FDF_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_84A0E7BA79D4C698BD91D49E32216FDF" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Extinguishment fees</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_84A0E7BA79D4C698BD91D49E32216FDF_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_84A0E7BA79D4C698BD91D49E32216FDF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Debt Extinguishment Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_84A0E7BA79D4C698BD91D49E32216FDF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_84A0E7BA79D4C698BD91D49E32216FDF" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_84A0E7BA79D4C698BD91D49E32216FDF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_1FC65283B5781761AA18D49E3221B3C0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1_1FC65283B5781761AA18D49E3221B3C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Original debt amount in debt conversion</link:label>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_1FC65283B5781761AA18D49E3221B3C0_label_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1_1FC65283B5781761AA18D49E3221B3C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Original Debt, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_1FC65283B5781761AA18D49E3221B3C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionOriginalDebtAmount1_1FC65283B5781761AA18D49E3221B3C0" xlink:to="lab_us-gaap_DebtConversionOriginalDebtAmount1_1FC65283B5781761AA18D49E3221B3C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_E71B9AD1B57BB905BFD2D49E3221909E_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_E71B9AD1B57BB905BFD2D49E3221909E" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_E71B9AD1B57BB905BFD2D49E3221909E_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_E71B9AD1B57BB905BFD2D49E3221909E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_E71B9AD1B57BB905BFD2D49E3221909E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_E71B9AD1B57BB905BFD2D49E3221909E" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_E71B9AD1B57BB905BFD2D49E3221909E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_FED19F45380D55EEACDAD49E374B5A58_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_FED19F45380D55EEACDAD49E374B5A58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash write off related to settlement of convertible notes</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_FED19F45380D55EEACDAD49E374B5A58_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_FED19F45380D55EEACDAD49E374B5A58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_FED19F45380D55EEACDAD49E374B5A58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_FED19F45380D55EEACDAD49E374B5A58" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_FED19F45380D55EEACDAD49E374B5A58" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_0D586396729043BD9542D49E32212D36_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_0D586396729043BD9542D49E32212D36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt conversion price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_0D586396729043BD9542D49E32212D36_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_0D586396729043BD9542D49E32212D36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0D586396729043BD9542D49E32212D36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0D586396729043BD9542D49E32212D36" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_0D586396729043BD9542D49E32212D36" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_92FFC93AC63DED910809D49E3221ED8F_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_92FFC93AC63DED910809D49E3221ED8F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, convertible, number of equity instruments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_92FFC93AC63DED910809D49E3221ED8F_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_92FFC93AC63DED910809D49E3221ED8F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Number of Equity Instruments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_92FFC93AC63DED910809D49E3221ED8F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_92FFC93AC63DED910809D49E3221ED8F" xlink:to="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_92FFC93AC63DED910809D49E3221ED8F" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25_terseLabel_en-US" xlink:label="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, convertible, threshold period following issuance date (in years)</link:label>
    <link:label id="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25_label_en-US" xlink:label="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible,Threshold Period Following Issuance Date</link:label>
    <link:label id="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25_documentation_en-US" xlink:label="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible,Threshold Period Following Issuance Date</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate" xlink:label="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25" xlink:to="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_B26824B9B2EA3127737CD49E3221825E_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_B26824B9B2EA3127737CD49E3221825E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, convertible, threshold percentage of stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_B26824B9B2EA3127737CD49E3221825E_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_B26824B9B2EA3127737CD49E3221825E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_B26824B9B2EA3127737CD49E3221825E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_B26824B9B2EA3127737CD49E3221825E" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_B26824B9B2EA3127737CD49E3221825E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_7890E281BFB2AA924068D49E32217098_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_7890E281BFB2AA924068D49E32217098" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, convertible, threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_7890E281BFB2AA924068D49E32217098_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_7890E281BFB2AA924068D49E32217098" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_7890E281BFB2AA924068D49E32217098" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_7890E281BFB2AA924068D49E32217098" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_7890E281BFB2AA924068D49E32217098" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_957E3684D1CCE2D9E5FBD49E32215B83_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_957E3684D1CCE2D9E5FBD49E32215B83" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, convertible, threshold consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_957E3684D1CCE2D9E5FBD49E32215B83_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_957E3684D1CCE2D9E5FBD49E32215B83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_957E3684D1CCE2D9E5FBD49E32215B83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_957E3684D1CCE2D9E5FBD49E32215B83" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_957E3684D1CCE2D9E5FBD49E32215B83" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_BABADD899713CDB0F033D49E3222B031_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_BABADD899713CDB0F033D49E3222B031" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_BABADD899713CDB0F033D49E3222B031_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_BABADD899713CDB0F033D49E3222B031" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_BABADD899713CDB0F033D49E3222B031" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_BABADD899713CDB0F033D49E3222B031" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_BABADD899713CDB0F033D49E3222B031" xlink:type="arc" />
    <link:label id="lab_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2_terseLabel_en-US" xlink:label="lab_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible debt redeemed after permissible date, redemption premium, percent of principal</link:label>
    <link:label id="lab_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2_label_en-US" xlink:label="lab_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt Redeemed After Permissible Date, Redemption Premium, Percent of Principal</link:label>
    <link:label id="lab_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2_documentation_en-US" xlink:label="lab_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Debt Redeemed after Permissible Date, Redemption Premium, Percent of Principal</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal" xlink:label="loc_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2" xlink:to="lab_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_E89A9441424380027BBBFC5D40525B0F_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_E89A9441424380027BBBFC5D40525B0F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_E89A9441424380027BBBFC5D40525B0F_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_E89A9441424380027BBBFC5D40525B0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_E89A9441424380027BBBFC5D40525B0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_E89A9441424380027BBBFC5D40525B0F" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_E89A9441424380027BBBFC5D40525B0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_7D329102F623038BF18EFC5D40AF4D11_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_7D329102F623038BF18EFC5D40AF4D11" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_7D329102F623038BF18EFC5D40AF4D11_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_7D329102F623038BF18EFC5D40AF4D11" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_7D329102F623038BF18EFC5D40AF4D11" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments_7D329102F623038BF18EFC5D40AF4D11" xlink:to="lab_us-gaap_NumberOfOperatingSegments_7D329102F623038BF18EFC5D40AF4D11" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_457F0BE6C73EC58C1FDCB2A3202589C1_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_457F0BE6C73EC58C1FDCB2A3202589C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_457F0BE6C73EC58C1FDCB2A3202589C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_457F0BE6C73EC58C1FDCB2A3202589C1" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_457F0BE6C73EC58C1FDCB2A3202589C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:to="lab_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:to="lab_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_C485E126708C718918B1B2A32025661F_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_C485E126708C718918B1B2A32025661F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_C485E126708C718918B1B2A32025661F_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_C485E126708C718918B1B2A32025661F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_C485E126708C718918B1B2A32025661F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_C485E126708C718918B1B2A32025661F" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_C485E126708C718918B1B2A32025661F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_7BA59E738EE8B8508874B2A320251C83_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_7BA59E738EE8B8508874B2A320251C83" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net of allowances of $3,473 in 2017 and $3,245 in 2016</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_7BA59E738EE8B8508874B2A320251C83_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_7BA59E738EE8B8508874B2A320251C83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Net, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7BA59E738EE8B8508874B2A320251C83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_7BA59E738EE8B8508874B2A320251C83" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_7BA59E738EE8B8508874B2A320251C83" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_7BA0DD91ABF15E359262B2A320250618_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent_7BA0DD91ABF15E359262B2A320250618" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_7BA0DD91ABF15E359262B2A320250618_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent_7BA0DD91ABF15E359262B2A320250618" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_7BA0DD91ABF15E359262B2A320250618" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_7BA0DD91ABF15E359262B2A320250618" xlink:to="lab_us-gaap_PrepaidExpenseCurrent_7BA0DD91ABF15E359262B2A320250618" xlink:type="arc" />
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableCurrent_9EDD9669B054693CA484B2A32025D012_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableCurrent_9EDD9669B054693CA484B2A32025D012" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance recovery receivable</link:label>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableCurrent_9EDD9669B054693CA484B2A32025D012_label_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableCurrent_9EDD9669B054693CA484B2A32025D012" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Settlements Receivable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_9EDD9669B054693CA484B2A32025D012" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceSettlementsReceivableCurrent_9EDD9669B054693CA484B2A32025D012" xlink:to="lab_us-gaap_InsuranceSettlementsReceivableCurrent_9EDD9669B054693CA484B2A32025D012" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsCurrent_945AFBCEF7CAB1F9CCFEB2A320265922_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_945AFBCEF7CAB1F9CCFEB2A320265922" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_945AFBCEF7CAB1F9CCFEB2A320265922_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_945AFBCEF7CAB1F9CCFEB2A320265922" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_945AFBCEF7CAB1F9CCFEB2A320265922" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent_945AFBCEF7CAB1F9CCFEB2A320265922" xlink:to="lab_us-gaap_OtherAssetsCurrent_945AFBCEF7CAB1F9CCFEB2A320265922" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_F89D9135AB944D3229B0B2A320261570_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_F89D9135AB944D3229B0B2A320261570" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_F89D9135AB944D3229B0B2A320261570_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_F89D9135AB944D3229B0B2A320261570" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_F89D9135AB944D3229B0B2A320261570" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_F89D9135AB944D3229B0B2A320261570" xlink:to="lab_us-gaap_AssetsCurrent_F89D9135AB944D3229B0B2A320261570" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_66A154E4D4FF97F5E1B6B2A320268873_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_66A154E4D4FF97F5E1B6B2A320268873" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net of accumulated depreciation of $44,178 in 2017 and $43,141 in 2016</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_66A154E4D4FF97F5E1B6B2A320268873_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_66A154E4D4FF97F5E1B6B2A320268873" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_66A154E4D4FF97F5E1B6B2A320268873" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_66A154E4D4FF97F5E1B6B2A320268873" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_66A154E4D4FF97F5E1B6B2A320268873" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_F209DEF3D712850F97A8B2A320264001_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_F209DEF3D712850F97A8B2A320264001" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_F209DEF3D712850F97A8B2A320264001_label_en-US" xlink:label="lab_us-gaap_Goodwill_F209DEF3D712850F97A8B2A320264001" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_F209DEF3D712850F97A8B2A320264001" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_F209DEF3D712850F97A8B2A320264001" xlink:to="lab_us-gaap_Goodwill_F209DEF3D712850F97A8B2A320264001" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_6599947765D5FB40C578B2A32026F790_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames_6599947765D5FB40C578B2A32026F790" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trade names, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_6599947765D5FB40C578B2A32026F790_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames_6599947765D5FB40C578B2A32026F790" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Trade Names</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_6599947765D5FB40C578B2A32026F790" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedTradeNames_6599947765D5FB40C578B2A32026F790" xlink:to="lab_us-gaap_IndefiniteLivedTradeNames_6599947765D5FB40C578B2A32026F790" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_10D9B7E613E3477C38E5B2A32026DC0B_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_10D9B7E613E3477C38E5B2A32026DC0B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_10D9B7E613E3477C38E5B2A32026DC0B_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_10D9B7E613E3477C38E5B2A32026DC0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_10D9B7E613E3477C38E5B2A32026DC0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_10D9B7E613E3477C38E5B2A32026DC0B" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_10D9B7E613E3477C38E5B2A32026DC0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_2E392B7D6DCECE9CC323B2A320269409_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_2E392B7D6DCECE9CC323B2A320269409" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_2E392B7D6DCECE9CC323B2A320269409_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_2E392B7D6DCECE9CC323B2A320269409" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2E392B7D6DCECE9CC323B2A320269409" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_2E392B7D6DCECE9CC323B2A320269409" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_2E392B7D6DCECE9CC323B2A320269409" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_F7F7DE0368E921AEFAC1B2A32026B788_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_F7F7DE0368E921AEFAC1B2A32026B788" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_F7F7DE0368E921AEFAC1B2A32026B788_label_en-US" xlink:label="lab_us-gaap_Assets_F7F7DE0368E921AEFAC1B2A32026B788" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_F7F7DE0368E921AEFAC1B2A32026B788" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_F7F7DE0368E921AEFAC1B2A32026B788" xlink:to="lab_us-gaap_Assets_F7F7DE0368E921AEFAC1B2A32026B788" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8DED8C7ADC5232E45854B2A32026E844_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8DED8C7ADC5232E45854B2A32026E844" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8DED8C7ADC5232E45854B2A32026E844_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8DED8C7ADC5232E45854B2A32026E844" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8DED8C7ADC5232E45854B2A32026E844" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8DED8C7ADC5232E45854B2A32026E844" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8DED8C7ADC5232E45854B2A32026E844" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1620FB224D7FFCF9B864B2A32026383F_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1620FB224D7FFCF9B864B2A32026383F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1620FB224D7FFCF9B864B2A32026383F_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1620FB224D7FFCF9B864B2A32026383F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1620FB224D7FFCF9B864B2A32026383F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1620FB224D7FFCF9B864B2A32026383F" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1620FB224D7FFCF9B864B2A32026383F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_578700A71BCCE737C549B2A32026A66B_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_578700A71BCCE737C549B2A32026A66B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_578700A71BCCE737C549B2A32026A66B_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_578700A71BCCE737C549B2A32026A66B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_578700A71BCCE737C549B2A32026A66B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_578700A71BCCE737C549B2A32026A66B" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent_578700A71BCCE737C549B2A32026A66B" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_F6092A8FA4E1F79E842BB2A32026516F_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_F6092A8FA4E1F79E842BB2A32026516F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_F6092A8FA4E1F79E842BB2A32026516F_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_F6092A8FA4E1F79E842BB2A32026516F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_F6092A8FA4E1F79E842BB2A32026516F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_F6092A8FA4E1F79E842BB2A32026516F" xlink:to="lab_us-gaap_LiabilitiesCurrent_F6092A8FA4E1F79E842BB2A32026516F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_62A928E198B51A9C571AB2A320268B3B_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_62A928E198B51A9C571AB2A320268B3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt and capital lease obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_62A928E198B51A9C571AB2A320268B3B_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_62A928E198B51A9C571AB2A320268B3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Capital Lease Obligations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_62A928E198B51A9C571AB2A320268B3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_62A928E198B51A9C571AB2A320268B3B" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_62A928E198B51A9C571AB2A320268B3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_162B0B70BD120B7E923CB2A320276931_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_162B0B70BD120B7E923CB2A320276931" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_162B0B70BD120B7E923CB2A320276931_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_162B0B70BD120B7E923CB2A320276931" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_162B0B70BD120B7E923CB2A320276931" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_162B0B70BD120B7E923CB2A320276931" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_162B0B70BD120B7E923CB2A320276931" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42FA6B61FA5CF2AEC32BB2A3202706A1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42FA6B61FA5CF2AEC32BB2A3202706A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term accrued claims</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42FA6B61FA5CF2AEC32BB2A3202706A1_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42FA6B61FA5CF2AEC32BB2A3202706A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42FA6B61FA5CF2AEC32BB2A3202706A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42FA6B61FA5CF2AEC32BB2A3202706A1" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42FA6B61FA5CF2AEC32BB2A3202706A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2F7FF65A35A3B7222DA2B2A320278282_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2F7FF65A35A3B7222DA2B2A320278282" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2F7FF65A35A3B7222DA2B2A320278282_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2F7FF65A35A3B7222DA2B2A320278282" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2F7FF65A35A3B7222DA2B2A320278282" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2F7FF65A35A3B7222DA2B2A320278282" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2F7FF65A35A3B7222DA2B2A320278282" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_FE335318E718E15CF27EB2A320276175_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_FE335318E718E15CF27EB2A320276175" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_FE335318E718E15CF27EB2A320276175_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_FE335318E718E15CF27EB2A320276175" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_FE335318E718E15CF27EB2A320276175" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_FE335318E718E15CF27EB2A320276175" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_FE335318E718E15CF27EB2A320276175" xlink:type="arc" />
    <link:label id="lab_us-gaap_Liabilities_5BF2D27134461CDD2532B2A3202C72D8_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities_5BF2D27134461CDD2532B2A3202C72D8" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_5BF2D27134461CDD2532B2A3202C72D8_label_en-US" xlink:label="lab_us-gaap_Liabilities_5BF2D27134461CDD2532B2A3202C72D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_5BF2D27134461CDD2532B2A3202C72D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_5BF2D27134461CDD2532B2A3202C72D8" xlink:to="lab_us-gaap_Liabilities_5BF2D27134461CDD2532B2A3202C72D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_7BAB41E3098FD7A9FD95B2A3202CE330_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_7BAB41E3098FD7A9FD95B2A3202CE330" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_7BAB41E3098FD7A9FD95B2A3202CE330_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_7BAB41E3098FD7A9FD95B2A3202CE330" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7BAB41E3098FD7A9FD95B2A3202CE330" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_7BAB41E3098FD7A9FD95B2A3202CE330" xlink:to="lab_us-gaap_CommitmentsAndContingencies_7BAB41E3098FD7A9FD95B2A3202CE330" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:to="lab_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_0C246B49CBCBB6FCF5D2B2A3202C4CC7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_0C246B49CBCBB6FCF5D2B2A3202C4CC7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_0C246B49CBCBB6FCF5D2B2A3202C4CC7_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_0C246B49CBCBB6FCF5D2B2A3202C4CC7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_0C246B49CBCBB6FCF5D2B2A3202C4CC7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_0C246B49CBCBB6FCF5D2B2A3202C4CC7" xlink:to="lab_us-gaap_CommonStockValue_0C246B49CBCBB6FCF5D2B2A3202C4CC7" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_4A990CA5817EEF5DE2F7B2A3202C1CBE_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock_4A990CA5817EEF5DE2F7B2A3202C1CBE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_4A990CA5817EEF5DE2F7B2A3202C1CBE_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock_4A990CA5817EEF5DE2F7B2A3202C1CBE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4A990CA5817EEF5DE2F7B2A3202C1CBE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4A990CA5817EEF5DE2F7B2A3202C1CBE" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock_4A990CA5817EEF5DE2F7B2A3202C1CBE" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_677CC919CE02AF306842B2A3202C7C63_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_677CC919CE02AF306842B2A3202C7C63" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_677CC919CE02AF306842B2A3202C7C63_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_677CC919CE02AF306842B2A3202C7C63" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_677CC919CE02AF306842B2A3202C7C63" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_677CC919CE02AF306842B2A3202C7C63" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_677CC919CE02AF306842B2A3202C7C63" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_E95C9DE4C012476D5C34B2A3202C2BDC_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_E95C9DE4C012476D5C34B2A3202C2BDC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_E95C9DE4C012476D5C34B2A3202C2BDC_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_E95C9DE4C012476D5C34B2A3202C2BDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E95C9DE4C012476D5C34B2A3202C2BDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E95C9DE4C012476D5C34B2A3202C2BDC" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_E95C9DE4C012476D5C34B2A3202C2BDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_9EF114D02E79BB68C5B7B2A3202CC677_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_9EF114D02E79BB68C5B7B2A3202CC677" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Cross Country Healthcare, Inc. stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_9EF114D02E79BB68C5B7B2A3202CC677_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_9EF114D02E79BB68C5B7B2A3202CC677" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_9EF114D02E79BB68C5B7B2A3202CC677" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_9EF114D02E79BB68C5B7B2A3202CC677" xlink:to="lab_us-gaap_StockholdersEquity_9EF114D02E79BB68C5B7B2A3202CC677" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterest_D8FE26005DF75D097B8AB2A3202C33B9_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest_D8FE26005DF75D097B8AB2A3202C33B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_D8FE26005DF75D097B8AB2A3202C33B9_label_en-US" xlink:label="lab_us-gaap_MinorityInterest_D8FE26005DF75D097B8AB2A3202C33B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_D8FE26005DF75D097B8AB2A3202C33B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest_D8FE26005DF75D097B8AB2A3202C33B9" xlink:to="lab_us-gaap_MinorityInterest_D8FE26005DF75D097B8AB2A3202C33B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B7C744E87A5D388E3132B2A3202CDF59_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B7C744E87A5D388E3132B2A3202CDF59" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B7C744E87A5D388E3132B2A3202CDF59_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B7C744E87A5D388E3132B2A3202CDF59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B7C744E87A5D388E3132B2A3202CDF59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B7C744E87A5D388E3132B2A3202CDF59" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B7C744E87A5D388E3132B2A3202CDF59" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_8B2BC4E601AAE61AED24B2A3202DB7BD_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_8B2BC4E601AAE61AED24B2A3202DB7BD" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_8B2BC4E601AAE61AED24B2A3202DB7BD_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_8B2BC4E601AAE61AED24B2A3202DB7BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8B2BC4E601AAE61AED24B2A3202DB7BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8B2BC4E601AAE61AED24B2A3202DB7BD" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_8B2BC4E601AAE61AED24B2A3202DB7BD" xlink:type="arc" />
    <link:label id="lab_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F_terseLabel_en-US" xlink:label="lab_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal Quarters Ending September 30, 2016 through June 30, 2017 [Member]</link:label>
    <link:label id="lab_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F_label_en-US" xlink:label="lab_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fiscal Quarters Ending September 30, 2016 through June 30, 2017 [Member]</link:label>
    <link:label id="lab_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F_documentation_en-US" xlink:label="lab_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fiscal Quarters Ending September 30, 2016 through June 30, 2017 [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member" xlink:label="loc_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F" xlink:to="lab_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F" xlink:type="arc" />
    <link:label id="lab_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0_terseLabel_en-US" xlink:label="lab_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal Quarters Ending September 30, 2017 through June 30, 2018 [Member]</link:label>
    <link:label id="lab_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0_label_en-US" xlink:label="lab_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fiscal Quarters Ending September 30, 2017 through June 30, 2018 [Member]</link:label>
    <link:label id="lab_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0_documentation_en-US" xlink:label="lab_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fiscal Quarters Ending September 30, 2017 through June 30, 2018 [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member" xlink:label="loc_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0" xlink:to="lab_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0" xlink:type="arc" />
    <link:label id="lab_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7_terseLabel_en-US" xlink:label="lab_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Each Fiscal Quarter Ending Thereafter [Member]</link:label>
    <link:label id="lab_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7_label_en-US" xlink:label="lab_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Each Fiscal Quarter Ending Thereafter [Member]</link:label>
    <link:label id="lab_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7_documentation_en-US" xlink:label="lab_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Each Fiscal Quarter Ending Thereafter [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_EachFiscalQuarterEndingThereafterMember" xlink:label="loc_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7" xlink:to="lab_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:to="lab_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627" xlink:to="lab_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_13F4B17B89F25D1CBCEAD0DE6FD3BDDC_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_13F4B17B89F25D1CBCEAD0DE6FD3BDDC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_13F4B17B89F25D1CBCEAD0DE6FD3BDDC_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_13F4B17B89F25D1CBCEAD0DE6FD3BDDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_13F4B17B89F25D1CBCEAD0DE6FD3BDDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_13F4B17B89F25D1CBCEAD0DE6FD3BDDC" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember_13F4B17B89F25D1CBCEAD0DE6FD3BDDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_2F0FBD916C107221F81ED0DE6FD3FCEE_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_2F0FBD916C107221F81ED0DE6FD3FCEE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIBOR [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2F0FBD916C107221F81ED0DE6FD3FCEE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2F0FBD916C107221F81ED0DE6FD3FCEE" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_2F0FBD916C107221F81ED0DE6FD3FCEE" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeniorDebtObligationsMember_5CD2CADAEB58A20048A1D0DE6FD41F48_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorDebtObligationsMember_5CD2CADAEB58A20048A1D0DE6FD41F48" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Debt [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_5CD2CADAEB58A20048A1D0DE6FD41F48" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorDebtObligationsMember_5CD2CADAEB58A20048A1D0DE6FD41F48" xlink:to="lab_us-gaap_SeniorDebtObligationsMember_5CD2CADAEB58A20048A1D0DE6FD41F48" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3067B1125843D3F00D3FD0DE6FD44BF1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3067B1125843D3F00D3FD0DE6FD44BF1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit facility maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3067B1125843D3F00D3FD0DE6FD44BF1_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3067B1125843D3F00D3FD0DE6FD44BF1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3067B1125843D3F00D3FD0DE6FD44BF1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3067B1125843D3F00D3FD0DE6FD44BF1" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3067B1125843D3F00D3FD0DE6FD44BF1" xlink:type="arc" />
    <link:label id="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit, subfacility for standby letters of credit</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344_label_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility Sub Limit For Letters Of Credit</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of credit, subfacility for standby letters of credit.</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit" xlink:label="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344" xlink:to="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344" xlink:type="arc" />
    <link:label id="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sub facility for swingline loans</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D_label_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility, Sub Facility For Swingline Loans</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility, Sub Facility For Swingline Loans</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans" xlink:label="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D" xlink:to="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D" xlink:type="arc" />
    <link:label id="lab_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10_terseLabel_en-US" xlink:label="lab_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional capacity</link:label>
    <link:label id="lab_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10_label_en-US" xlink:label="lab_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Additional Capacity</link:label>
    <link:label id="lab_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10_documentation_en-US" xlink:label="lab_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Additional Capacity</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityAdditionalCapacity" xlink:label="loc_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10" xlink:to="lab_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10" xlink:type="arc" />
    <link:label id="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF_terseLabel_en-US" xlink:label="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of principal payment for first four installments</link:label>
    <link:label id="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF_label_en-US" xlink:label="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Periodic Payment, Percentage of Principal, First Four Installments</link:label>
    <link:label id="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF_documentation_en-US" xlink:label="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Periodic Payment, Percentage of Principal, First Four Installments</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments" xlink:label="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF" xlink:to="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF" xlink:type="arc" />
    <link:label id="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D_terseLabel_en-US" xlink:label="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of principal payment for next eight installments</link:label>
    <link:label id="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D_label_en-US" xlink:label="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Periodic Payment, Percentage of Principal, Next Eight Installments</link:label>
    <link:label id="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D_documentation_en-US" xlink:label="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Periodic Payment, Percentage of Principal, Next Eight Installments</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments" xlink:label="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D" xlink:to="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D" xlink:type="arc" />
    <link:label id="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463_terseLabel_en-US" xlink:label="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of principal payment for remaining installments</link:label>
    <link:label id="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463_label_en-US" xlink:label="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Periodic Payment, Percentage of Principal, Remaining Installments</link:label>
    <link:label id="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463_documentation_en-US" xlink:label="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Periodic Payment, Percentage of Principal, Remaining Installments</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments" xlink:label="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463" xlink:to="lab_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4_terseLabel_en-US" xlink:label="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate increase (decrease) (percent)</link:label>
    <link:label id="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4_label_en-US" xlink:label="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Increase (Decrease) in Event of Default</link:label>
    <link:label id="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4_documentation_en-US" xlink:label="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Increase (Decrease) in Event of Default</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault" xlink:label="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4" xlink:to="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ECC44F619BFF57897CC1D0DE6FD5EB9D_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ECC44F619BFF57897CC1D0DE6FD5EB9D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Quarterly commitment fee on the average daily unused portion (percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ECC44F619BFF57897CC1D0DE6FD5EB9D_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ECC44F619BFF57897CC1D0DE6FD5EB9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ECC44F619BFF57897CC1D0DE6FD5EB9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ECC44F619BFF57897CC1D0DE6FD5EB9D" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ECC44F619BFF57897CC1D0DE6FD5EB9D" xlink:type="arc" />
    <link:label id="lab_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140_terseLabel_en-US" xlink:label="lab_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of financial covenants</link:label>
    <link:label id="lab_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140_label_en-US" xlink:label="lab_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Financial Covenants</link:label>
    <link:label id="lab_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140_documentation_en-US" xlink:label="lab_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Financial Covenants</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_NumberofFinancialCovenants" xlink:label="loc_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140" xlink:to="lab_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140" xlink:type="arc" />
    <link:label id="lab_us-gaap_RatioOfIndebtednessToNetCapital1_12391D3675127EFFFB7ED0DE6FD6CF62_terseLabel_en-US" xlink:label="lab_us-gaap_RatioOfIndebtednessToNetCapital1_12391D3675127EFFFB7ED0DE6FD6CF62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Net Leverage Ratio</link:label>
    <link:label id="lab_us-gaap_RatioOfIndebtednessToNetCapital1_12391D3675127EFFFB7ED0DE6FD6CF62_label_en-US" xlink:label="lab_us-gaap_RatioOfIndebtednessToNetCapital1_12391D3675127EFFFB7ED0DE6FD6CF62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ratio of Indebtedness to Net Capital</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RatioOfIndebtednessToNetCapital1" xlink:label="loc_us-gaap_RatioOfIndebtednessToNetCapital1_12391D3675127EFFFB7ED0DE6FD6CF62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RatioOfIndebtednessToNetCapital1_12391D3675127EFFFB7ED0DE6FD6CF62" xlink:to="lab_us-gaap_RatioOfIndebtednessToNetCapital1_12391D3675127EFFFB7ED0DE6FD6CF62" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED_terseLabel_en-US" xlink:label="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Fixed Charge Coverage Ratio</link:label>
    <link:label id="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED_label_en-US" xlink:label="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant, Consolidated Fixed Charge Coverage Ratio</link:label>
    <link:label id="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED_documentation_en-US" xlink:label="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Covenant, Consolidated Fixed Charge Coverage Ratio</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio" xlink:label="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED" xlink:to="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_E21CEBF9C753746119B1D0DE6FD68CAB_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount_E21CEBF9C753746119B1D0DE6FD68CAB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_E21CEBF9C753746119B1D0DE6FD68CAB_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount_E21CEBF9C753746119B1D0DE6FD68CAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_E21CEBF9C753746119B1D0DE6FD68CAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount_E21CEBF9C753746119B1D0DE6FD68CAB" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount_E21CEBF9C753746119B1D0DE6FD68CAB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCredit_7B8B797D93B9B1AC5ECBD0DE6FD68F96_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit_7B8B797D93B9B1AC5ECBD0DE6FD68F96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_7B8B797D93B9B1AC5ECBD0DE6FD68F96_label_en-US" xlink:label="lab_us-gaap_LineOfCredit_7B8B797D93B9B1AC5ECBD0DE6FD68F96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_7B8B797D93B9B1AC5ECBD0DE6FD68F96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit_7B8B797D93B9B1AC5ECBD0DE6FD68F96" xlink:to="lab_us-gaap_LineOfCredit_7B8B797D93B9B1AC5ECBD0DE6FD68F96" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_AE2A25E1CAF2DDA5C0A887FF4C752FCE_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_AE2A25E1CAF2DDA5C0A887FF4C752FCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_AE2A25E1CAF2DDA5C0A887FF4C752FCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_AE2A25E1CAF2DDA5C0A887FF4C752FCE" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_AE2A25E1CAF2DDA5C0A887FF4C752FCE" xlink:type="arc" />
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD_terseLabel_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD_label_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD_documentation_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:to="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DatabasesMember_C3B36FD23163B2891FE087FF4C837FB2_terseLabel_en-US" xlink:label="lab_us-gaap_DatabasesMember_C3B36FD23163B2891FE087FF4C837FB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Database [Member]</link:label>
    <link:label id="lab_us-gaap_DatabasesMember_C3B36FD23163B2891FE087FF4C837FB2_label_en-US" xlink:label="lab_us-gaap_DatabasesMember_C3B36FD23163B2891FE087FF4C837FB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Database Rights [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DatabasesMember" xlink:label="loc_us-gaap_DatabasesMember_C3B36FD23163B2891FE087FF4C837FB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DatabasesMember_C3B36FD23163B2891FE087FF4C837FB2" xlink:to="lab_us-gaap_DatabasesMember_C3B36FD23163B2891FE087FF4C837FB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_3751A1B391BCC126F6B787FF4C849855_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_3751A1B391BCC126F6B787FF4C849855" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_3751A1B391BCC126F6B787FF4C849855_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_3751A1B391BCC126F6B787FF4C849855" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3751A1B391BCC126F6B787FF4C849855" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_3751A1B391BCC126F6B787FF4C849855" xlink:to="lab_us-gaap_CustomerRelationshipsMember_3751A1B391BCC126F6B787FF4C849855" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_6D929DCC185EA3CE96E387FF4C849C8C_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember_6D929DCC185EA3CE96E387FF4C849C8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_6D929DCC185EA3CE96E387FF4C849C8C_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember_6D929DCC185EA3CE96E387FF4C849C8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_6D929DCC185EA3CE96E387FF4C849C8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember_6D929DCC185EA3CE96E387FF4C849C8C" xlink:to="lab_us-gaap_NoncompeteAgreementsMember_6D929DCC185EA3CE96E387FF4C849C8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_TradeNamesMember_FA47028D3DFC8773B4E287FF4C84EBC1_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember_FA47028D3DFC8773B4E287FF4C84EBC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_FA47028D3DFC8773B4E287FF4C84EBC1_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember_FA47028D3DFC8773B4E287FF4C84EBC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_FA47028D3DFC8773B4E287FF4C84EBC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember_FA47028D3DFC8773B4E287FF4C84EBC1" xlink:to="lab_us-gaap_TradeNamesMember_FA47028D3DFC8773B4E287FF4C84EBC1" xlink:type="arc" />
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883_terseLabel_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883_label_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite Lived And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883_documentation_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_85554974152F27DD5D6487FF4C859757_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_85554974152F27DD5D6487FF4C859757" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_85554974152F27DD5D6487FF4C859757_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_85554974152F27DD5D6487FF4C859757" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_85554974152F27DD5D6487FF4C859757" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross_85554974152F27DD5D6487FF4C859757" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross_85554974152F27DD5D6487FF4C859757" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_B2AF09F7B41CAF6FF95587FF4C8D6DED_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_B2AF09F7B41CAF6FF95587FF4C8D6DED" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_B2AF09F7B41CAF6FF95587FF4C8D6DED_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_B2AF09F7B41CAF6FF95587FF4C8D6DED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_B2AF09F7B41CAF6FF95587FF4C8D6DED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_B2AF09F7B41CAF6FF95587FF4C8D6DED" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_B2AF09F7B41CAF6FF95587FF4C8D6DED" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_D4B50C48E93D7915934587FF4C8D8611_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_D4B50C48E93D7915934587FF4C8D8611" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Intangible assets subject to amortization, net carrying amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_D4B50C48E93D7915934587FF4C8D8611" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_D4B50C48E93D7915934587FF4C8D8611" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_D4B50C48E93D7915934587FF4C8D8611" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_9C20C0053FDD1517C5D887FF4C8D5484_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames_9C20C0053FDD1517C5D887FF4C8D5484" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade names</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_9C20C0053FDD1517C5D887FF4C8D5484" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedTradeNames_9C20C0053FDD1517C5D887FF4C8D5484" xlink:to="lab_us-gaap_IndefiniteLivedTradeNames_9C20C0053FDD1517C5D887FF4C8D5484" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6F1C050937296EF45D5F880119391647_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6F1C050937296EF45D5F880119391647" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6F1C050937296EF45D5F880119391647_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6F1C050937296EF45D5F880119391647" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6F1C050937296EF45D5F880119391647" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6F1C050937296EF45D5F880119391647" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6F1C050937296EF45D5F880119391647" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:to="lab_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CorporateJointVentureMember_DA1953671DCAC6DEAFA3A0745C1EF636_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember_DA1953671DCAC6DEAFA3A0745C1EF636" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">InteliStaf [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_DA1953671DCAC6DEAFA3A0745C1EF636_label_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember_DA1953671DCAC6DEAFA3A0745C1EF636" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Joint Venture [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="loc_us-gaap_CorporateJointVentureMember_DA1953671DCAC6DEAFA3A0745C1EF636" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateJointVentureMember_DA1953671DCAC6DEAFA3A0745C1EF636" xlink:to="lab_us-gaap_CorporateJointVentureMember_DA1953671DCAC6DEAFA3A0745C1EF636" xlink:type="arc" />
    <link:label id="lab_us-gaap_AffiliatedEntityMember_24B5DB0967572403CF26A0745C1FBCDA_terseLabel_en-US" xlink:label="lab_us-gaap_AffiliatedEntityMember_24B5DB0967572403CF26A0745C1FBCDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:label id="lab_us-gaap_AffiliatedEntityMember_24B5DB0967572403CF26A0745C1FBCDA_label_en-US" xlink:label="lab_us-gaap_AffiliatedEntityMember_24B5DB0967572403CF26A0745C1FBCDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AffiliatedEntityMember" xlink:label="loc_us-gaap_AffiliatedEntityMember_24B5DB0967572403CF26A0745C1FBCDA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AffiliatedEntityMember_24B5DB0967572403CF26A0745C1FBCDA" xlink:to="lab_us-gaap_AffiliatedEntityMember_24B5DB0967572403CF26A0745C1FBCDA" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_42544AB5639198B5F7E1A0745C1F5EAA_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties_42544AB5639198B5F7E1A0745C1F5EAA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from related parties</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_42544AB5639198B5F7E1A0745C1F5EAA_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties_42544AB5639198B5F7E1A0745C1F5EAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaap_RevenueFromRelatedParties_42544AB5639198B5F7E1A0745C1F5EAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties_42544AB5639198B5F7E1A0745C1F5EAA" xlink:to="lab_us-gaap_RevenueFromRelatedParties_42544AB5639198B5F7E1A0745C1F5EAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_B03E314E7AC55D54718DA07D9911F5C4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties_B03E314E7AC55D54718DA07D9911F5C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_B03E314E7AC55D54718DA07D9911F5C4_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties_B03E314E7AC55D54718DA07D9911F5C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Related Parties</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableRelatedParties" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_B03E314E7AC55D54718DA07D9911F5C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableRelatedParties_B03E314E7AC55D54718DA07D9911F5C4" xlink:to="lab_us-gaap_AccountsReceivableRelatedParties_B03E314E7AC55D54718DA07D9911F5C4" xlink:type="arc" />
    <link:label id="lab_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB_terseLabel_en-US" xlink:label="lab_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Joint venture, percent ownership</link:label>
    <link:label id="lab_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB_label_en-US" xlink:label="lab_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Joint Venture, Percent Ownership</link:label>
    <link:label id="lab_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB_documentation_en-US" xlink:label="lab_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Joint Venture, Percent Ownership</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_JointVenturePercentOwnership" xlink:label="loc_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB" xlink:to="lab_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DueFromJointVenturesCurrent_FFDA41736A8E3D4354EBA0745C1F0EB4_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromJointVenturesCurrent_FFDA41736A8E3D4354EBA0745C1F0EB4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable balance with joint venture</link:label>
    <link:label id="lab_us-gaap_DueFromJointVenturesCurrent_FFDA41736A8E3D4354EBA0745C1F0EB4_label_en-US" xlink:label="lab_us-gaap_DueFromJointVenturesCurrent_FFDA41736A8E3D4354EBA0745C1F0EB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Due from Joint Ventures, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueFromJointVenturesCurrent" xlink:label="loc_us-gaap_DueFromJointVenturesCurrent_FFDA41736A8E3D4354EBA0745C1F0EB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromJointVenturesCurrent_FFDA41736A8E3D4354EBA0745C1F0EB4" xlink:to="lab_us-gaap_DueFromJointVenturesCurrent_FFDA41736A8E3D4354EBA0745C1F0EB4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_5AC5555DBC7735A17C30A0745C1FC85D_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent_5AC5555DBC7735A17C30A0745C1FC85D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payable balance with joint venture</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_5AC5555DBC7735A17C30A0745C1FC85D_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent_5AC5555DBC7735A17C30A0745C1FC85D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Due to Related Parties, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_5AC5555DBC7735A17C30A0745C1FC85D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrent_5AC5555DBC7735A17C30A0745C1FC85D" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrent_5AC5555DBC7735A17C30A0745C1FC85D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRent_E9D6EECFBF0057C7B1A8A0745C1F84BC_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRent_E9D6EECFBF0057C7B1A8A0745C1F84BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_PaymentsForRent_E9D6EECFBF0057C7B1A8A0745C1F84BC_label_en-US" xlink:label="lab_us-gaap_PaymentsForRent_E9D6EECFBF0057C7B1A8A0745C1F84BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Rent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaap_PaymentsForRent_E9D6EECFBF0057C7B1A8A0745C1F84BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRent_E9D6EECFBF0057C7B1A8A0745C1F84BC" xlink:to="lab_us-gaap_PaymentsForRent_E9D6EECFBF0057C7B1A8A0745C1F84BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5BBE2DF84FFA5E8ABFDAD15D471F3186_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5BBE2DF84FFA5E8ABFDAD15D471F3186" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income attributable to common shareholders - Basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5BBE2DF84FFA5E8ABFDAD15D471F3186_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5BBE2DF84FFA5E8ABFDAD15D471F3186" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5BBE2DF84FFA5E8ABFDAD15D471F3186" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5BBE2DF84FFA5E8ABFDAD15D471F3186" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5BBE2DF84FFA5E8ABFDAD15D471F3186" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_7926FA089577221CD871D15D471F2E85_terseLabel_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_7926FA089577221CD871D15D471F2E85" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on Convertible Notes</link:label>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_7926FA089577221CD871D15D471F2E85_label_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_7926FA089577221CD871D15D471F2E85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_7926FA089577221CD871D15D471F2E85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_7926FA089577221CD871D15D471F2E85" xlink:to="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_7926FA089577221CD871D15D471F2E85" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_A861DC3CD566AA060197D15D471FB949_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet_A861DC3CD566AA060197D15D471FB949" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gain on derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_A861DC3CD566AA060197D15D471FB949_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet_A861DC3CD566AA060197D15D471FB949" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_A861DC3CD566AA060197D15D471FB949" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet_A861DC3CD566AA060197D15D471FB949" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet_A861DC3CD566AA060197D15D471FB949" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_422F8F1861A6F3A0F589D15D471FC8D5_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_422F8F1861A6F3A0F589D15D471FC8D5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income attributable to common shareholders - Diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_422F8F1861A6F3A0F589D15D471FC8D5_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_422F8F1861A6F3A0F589D15D471FC8D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_422F8F1861A6F3A0F589D15D471FC8D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_422F8F1861A6F3A0F589D15D471FC8D5" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_422F8F1861A6F3A0F589D15D471FC8D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8183D453E1E713869118D15D471F9B98_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8183D453E1E713869118D15D471F9B98" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares - Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8183D453E1E713869118D15D471F9B98_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8183D453E1E713869118D15D471F9B98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8183D453E1E713869118D15D471F9B98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8183D453E1E713869118D15D471F9B98" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8183D453E1E713869118D15D471F9B98" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_42D78C9783D60F7F384AD15D471F5EEF_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_42D78C9783D60F7F384AD15D471F5EEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective of diluted shares:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_42D78C9783D60F7F384AD15D471F5EEF_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_42D78C9783D60F7F384AD15D471F5EEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_42D78C9783D60F7F384AD15D471F5EEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_42D78C9783D60F7F384AD15D471F5EEF" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_42D78C9783D60F7F384AD15D471F5EEF" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_18711CFA10D40C1E61DAD15D471FCA58_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_18711CFA10D40C1E61DAD15D471FCA58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based awards (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_18711CFA10D40C1E61DAD15D471FCA58_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_18711CFA10D40C1E61DAD15D471FCA58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_18711CFA10D40C1E61DAD15D471FCA58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_18711CFA10D40C1E61DAD15D471FCA58" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_18711CFA10D40C1E61DAD15D471FCA58" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_A64E231182D5CD9E76EBD15D471F8736_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_A64E231182D5CD9E76EBD15D471F8736" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_A64E231182D5CD9E76EBD15D471F8736_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_A64E231182D5CD9E76EBD15D471F8736" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_A64E231182D5CD9E76EBD15D471F8736" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_A64E231182D5CD9E76EBD15D471F8736" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_A64E231182D5CD9E76EBD15D471F8736" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_136ED01EACA0672EAC99D15D471F5C42_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_136ED01EACA0672EAC99D15D471F5C42" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Diluted weighted average common shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_136ED01EACA0672EAC99D15D471F5C42_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_136ED01EACA0672EAC99D15D471F5C42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_136ED01EACA0672EAC99D15D471F5C42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_136ED01EACA0672EAC99D15D471F5C42" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_136ED01EACA0672EAC99D15D471F5C42" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasic_AC8951E9F767D1187C43D15D471F48F5_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_AC8951E9F767D1187C43D15D471F48F5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income per share attributable to common shareholders - Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_AC8951E9F767D1187C43D15D471F48F5_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_AC8951E9F767D1187C43D15D471F48F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_AC8951E9F767D1187C43D15D471F48F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_AC8951E9F767D1187C43D15D471F48F5" xlink:to="lab_us-gaap_EarningsPerShareBasic_AC8951E9F767D1187C43D15D471F48F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5818EC6B83D3AEAB5D1FD15D471F1A67_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_5818EC6B83D3AEAB5D1FD15D471F1A67" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income per share attributable to common shareholders - Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5818EC6B83D3AEAB5D1FD15D471F1A67_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_5818EC6B83D3AEAB5D1FD15D471F1A67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5818EC6B83D3AEAB5D1FD15D471F1A67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_5818EC6B83D3AEAB5D1FD15D471F1A67" xlink:to="lab_us-gaap_EarningsPerShareDiluted_5818EC6B83D3AEAB5D1FD15D471F1A67" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_746B6DB1E6956F65F0E4A88FFE772FB6_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_746B6DB1E6956F65F0E4A88FFE772FB6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_746B6DB1E6956F65F0E4A88FFE772FB6_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_746B6DB1E6956F65F0E4A88FFE772FB6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_746B6DB1E6956F65F0E4A88FFE772FB6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_746B6DB1E6956F65F0E4A88FFE772FB6" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_746B6DB1E6956F65F0E4A88FFE772FB6" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_EE522313D1214183D10AA88FFE77FC95_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_EE522313D1214183D10AA88FFE77FC95" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_EE522313D1214183D10AA88FFE77FC95_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_EE522313D1214183D10AA88FFE77FC95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_EE522313D1214183D10AA88FFE77FC95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_EE522313D1214183D10AA88FFE77FC95" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_EE522313D1214183D10AA88FFE77FC95" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_CE24CC1EDAEE1EED0413FC5D40E6DB8A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_CE24CC1EDAEE1EED0413FC5D40E6DB8A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_CE24CC1EDAEE1EED0413FC5D40E6DB8A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_CE24CC1EDAEE1EED0413FC5D40E6DB8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_CE24CC1EDAEE1EED0413FC5D40E6DB8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_CE24CC1EDAEE1EED0413FC5D40E6DB8A" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_CE24CC1EDAEE1EED0413FC5D40E6DB8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Business Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4_label_en-US" xlink:label="lab_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:to="lab_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:type="arc" />
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59_terseLabel_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nurse and allied staffing [Member]</link:label>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59_label_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nurse And Allied Staffing [Member]</link:label>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59_documentation_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nurse and allied staffing [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59" xlink:to="lab_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59" xlink:type="arc" />
    <link:label id="lab_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA_verboseLabel_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Physician staffing [Member]</link:label>
    <link:label id="lab_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA_label_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Physician Staffing [Member]</link:label>
    <link:label id="lab_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA_documentation_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Physician staffing [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA" xlink:to="lab_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA" xlink:type="arc" />
    <link:label id="lab_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF_terseLabel_en-US" xlink:label="lab_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other human capital management services [Member]</link:label>
    <link:label id="lab_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF_label_en-US" xlink:label="lab_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Human Capital Management Services [Member]</link:label>
    <link:label id="lab_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF_documentation_en-US" xlink:label="lab_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other human capital management services [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF" xlink:to="lab_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesRevenueServicesNet_941F7A81EB5D2ED3BE49CB46A7B68A1B_verboseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueServicesNet_941F7A81EB5D2ED3BE49CB46A7B68A1B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_SalesRevenueServicesNet_941F7A81EB5D2ED3BE49CB46A7B68A1B_label_en-US" xlink:label="lab_us-gaap_SalesRevenueServicesNet_941F7A81EB5D2ED3BE49CB46A7B68A1B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Revenue, Services, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet_941F7A81EB5D2ED3BE49CB46A7B68A1B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueServicesNet_941F7A81EB5D2ED3BE49CB46A7B68A1B" xlink:to="lab_us-gaap_SalesRevenueServicesNet_941F7A81EB5D2ED3BE49CB46A7B68A1B" xlink:type="arc" />
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD_terseLabel_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contribution income</link:label>
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD_label_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income Loss Before Depreciation Amortization Loss on Sale of Business Acquisition and Integration Cost Contingent Consideration Restructuring Charge Impairment Charge And Corporate Expenses</link:label>
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD_documentation_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Income Loss Before Depreciation Amortization Loss on Sale of Business Acquisition and Integration Cost Contingent Consideration Restructuring Charge Impairment Charge And Corporate Expenses</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD" xlink:to="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD" xlink:type="arc" />
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984_terseLabel_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unallocated corporate overhead</link:label>
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984_label_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Unallocated Corporate Expenses</link:label>
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984_documentation_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Segment Reporting Unallocated Corporate Expenses</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984" xlink:to="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_30110DDCB7D4AF352C24CB51A706364F_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_30110DDCB7D4AF352C24CB51A706364F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_30110DDCB7D4AF352C24CB51A706364F_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_30110DDCB7D4AF352C24CB51A706364F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_30110DDCB7D4AF352C24CB51A706364F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_30110DDCB7D4AF352C24CB51A706364F" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_30110DDCB7D4AF352C24CB51A706364F" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition-related contingent consideration</link:label>
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043_label_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Expense</link:label>
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Expense</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043" xlink:to="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2449E7F9B4839B7562B9CB46A7B8C581_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_2449E7F9B4839B7562B9CB46A7B8C581" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2449E7F9B4839B7562B9CB46A7B8C581_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_2449E7F9B4839B7562B9CB46A7B8C581" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_2449E7F9B4839B7562B9CB46A7B8C581" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_2449E7F9B4839B7562B9CB46A7B8C581" xlink:to="lab_us-gaap_OperatingIncomeLoss_2449E7F9B4839B7562B9CB46A7B8C581" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_BE8186209199CF45C8CC87DC273F34FC_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_BE8186209199CF45C8CC87DC273F34FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_BE8186209199CF45C8CC87DC273F34FC_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_BE8186209199CF45C8CC87DC273F34FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_BE8186209199CF45C8CC87DC273F34FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_BE8186209199CF45C8CC87DC273F34FC" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_BE8186209199CF45C8CC87DC273F34FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986_label_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:to="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:type="arc" />
    <link:label id="lab_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E_verboseLabel_en-US" xlink:label="lab_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Term Loan, Net [Member]</link:label>
    <link:label id="lab_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E_label_en-US" xlink:label="lab_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E_documentation_en-US" xlink:label="lab_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E" xlink:to="lab_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E" xlink:type="arc" />
    <link:label id="lab_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E_terseLabel_en-US" xlink:label="lab_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes, Net [Member]</link:label>
    <link:label id="lab_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E_label_en-US" xlink:label="lab_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes, Net [Member]</link:label>
    <link:label id="lab_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E_documentation_en-US" xlink:label="lab_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Notes, Net [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleNotesNetMember" xlink:label="loc_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E" xlink:to="lab_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_B964E3055599C8784FF5A07E9FE13291_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_B964E3055599C8784FF5A07E9FE13291" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_B964E3055599C8784FF5A07E9FE13291_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_B964E3055599C8784FF5A07E9FE13291" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_B964E3055599C8784FF5A07E9FE13291" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_B964E3055599C8784FF5A07E9FE13291" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_B964E3055599C8784FF5A07E9FE13291" xlink:type="arc" />
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_23300642F88B5A7745CEA07E9FE1474E_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_23300642F88B5A7745CEA07E9FE1474E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_23300642F88B5A7745CEA07E9FE1474E_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_23300642F88B5A7745CEA07E9FE1474E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_23300642F88B5A7745CEA07E9FE1474E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_23300642F88B5A7745CEA07E9FE1474E" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_23300642F88B5A7745CEA07E9FE1474E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0AAB3E2044796EA02F1DA07E9FE20E4D_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_0AAB3E2044796EA02F1DA07E9FE20E4D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0AAB3E2044796EA02F1DA07E9FE20E4D_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_0AAB3E2044796EA02F1DA07E9FE20E4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0AAB3E2044796EA02F1DA07E9FE20E4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_0AAB3E2044796EA02F1DA07E9FE20E4D" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_0AAB3E2044796EA02F1DA07E9FE20E4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049_label_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:to="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_129B05B7EDB808DB379AA07E9FE23F4E_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_129B05B7EDB808DB379AA07E9FE23F4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Liabilities, Carrying Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_129B05B7EDB808DB379AA07E9FE23F4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_129B05B7EDB808DB379AA07E9FE23F4E" xlink:to="lab_us-gaap_LongTermDebt_129B05B7EDB808DB379AA07E9FE23F4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_AD74BCEFA84DD21D3708A07E9FE22692_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_AD74BCEFA84DD21D3708A07E9FE22692" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial Liabilities, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_AD74BCEFA84DD21D3708A07E9FE22692_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_AD74BCEFA84DD21D3708A07E9FE22692" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_AD74BCEFA84DD21D3708A07E9FE22692" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue_AD74BCEFA84DD21D3708A07E9FE22692" xlink:to="lab_us-gaap_DebtInstrumentFairValue_AD74BCEFA84DD21D3708A07E9FE22692" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_EE40000DB3AFDFD5D47FCB46A7AFD77C_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_EE40000DB3AFDFD5D47FCB46A7AFD77C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_EE40000DB3AFDFD5D47FCB46A7AFD77C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_EE40000DB3AFDFD5D47FCB46A7AFD77C" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_EE40000DB3AFDFD5D47FCB46A7AFD77C" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1080F65D8571F87C2532CB46A7AFA799_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1080F65D8571F87C2532CB46A7AFA799" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective tax rate (percentage)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1080F65D8571F87C2532CB46A7AFA799_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1080F65D8571F87C2532CB46A7AFA799" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1080F65D8571F87C2532CB46A7AFA799" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1080F65D8571F87C2532CB46A7AFA799" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1080F65D8571F87C2532CB46A7AFA799" xlink:type="arc" />
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_477635A6F191FFC5AA82CB46A7AF2672_terseLabel_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_477635A6F191FFC5AA82CB46A7AF2672" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate continuing operations excluding discrete items (percentage)</link:label>
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_477635A6F191FFC5AA82CB46A7AF2672_label_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_477635A6F191FFC5AA82CB46A7AF2672" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate, Continuing Operations, Excluding Discrete Items</link:label>
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_477635A6F191FFC5AA82CB46A7AF2672_documentation_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_477635A6F191FFC5AA82CB46A7AF2672" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Continuing Operations Excluding Discrete Items</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:label="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_477635A6F191FFC5AA82CB46A7AF2672" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_477635A6F191FFC5AA82CB46A7AF2672" xlink:to="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_477635A6F191FFC5AA82CB46A7AF2672" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_81D98F60B3A43672DE4BCB46A7AF568F_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_81D98F60B3A43672DE4BCB46A7AF568F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_81D98F60B3A43672DE4BCB46A7AF568F_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_81D98F60B3A43672DE4BCB46A7AF568F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_81D98F60B3A43672DE4BCB46A7AF568F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_81D98F60B3A43672DE4BCB46A7AF568F" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_81D98F60B3A43672DE4BCB46A7AF568F" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203BDF555E703242AEAFCB46A7AFC81F_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203BDF555E703242AEAFCB46A7AFC81F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203BDF555E703242AEAFCB46A7AFC81F_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203BDF555E703242AEAFCB46A7AFC81F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203BDF555E703242AEAFCB46A7AFC81F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203BDF555E703242AEAFCB46A7AFC81F" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203BDF555E703242AEAFCB46A7AFC81F" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DEA710C1F6A04841C6BCB46A7AF0184_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DEA710C1F6A04841C6BCB46A7AF0184" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross increase to current year unrecognized tax benefits related to federal and state tax issues</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DEA710C1F6A04841C6BCB46A7AF0184_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DEA710C1F6A04841C6BCB46A7AF0184" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DEA710C1F6A04841C6BCB46A7AF0184" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DEA710C1F6A04841C6BCB46A7AF0184" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DEA710C1F6A04841C6BCB46A7AF0184" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_8A05A2E2E89CB7F08B03FC5D40B13C3C_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_8A05A2E2E89CB7F08B03FC5D40B13C3C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_8A05A2E2E89CB7F08B03FC5D40B13C3C_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_8A05A2E2E89CB7F08B03FC5D40B13C3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8A05A2E2E89CB7F08B03FC5D40B13C3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_8A05A2E2E89CB7F08B03FC5D40B13C3C" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_8A05A2E2E89CB7F08B03FC5D40B13C3C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsMember_2802F2A81D26B088E932CED513822C15_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_2802F2A81D26B088E932CED513822C15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_2802F2A81D26B088E932CED513822C15_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_2802F2A81D26B088E932CED513822C15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_2802F2A81D26B088E932CED513822C15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_2802F2A81D26B088E932CED513822C15" xlink:to="lab_us-gaap_RetainedEarningsMember_2802F2A81D26B088E932CED513822C15" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:to="lab_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:type="arc" />
    <link:label id="lab_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E_terseLabel_en-US" xlink:label="lab_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-09, Forfeiture Rate Component [Member]</link:label>
    <link:label id="lab_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E_label_en-US" xlink:label="lab_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-09, Forfeiture Rate Component [Member]</link:label>
    <link:label id="lab_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E_documentation_en-US" xlink:label="lab_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-09, Forfeiture Rate Component [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember" xlink:label="loc_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E" xlink:to="lab_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E" xlink:type="arc" />
    <link:label id="lab_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF_terseLabel_en-US" xlink:label="lab_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-09 [Member]</link:label>
    <link:label id="lab_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF_label_en-US" xlink:label="lab_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-09 [Member]</link:label>
    <link:label id="lab_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF_documentation_en-US" xlink:label="lab_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-09 [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_AccountingStandardsUpdate201609Member" xlink:label="loc_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF" xlink:to="lab_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_FA56EA7DB336D8F2843BCF32BCCC4C8A_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_FA56EA7DB336D8F2843BCF32BCCC4C8A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_FA56EA7DB336D8F2843BCF32BCCC4C8A_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_FA56EA7DB336D8F2843BCF32BCCC4C8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_FA56EA7DB336D8F2843BCF32BCCC4C8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_FA56EA7DB336D8F2843BCF32BCCC4C8A" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_FA56EA7DB336D8F2843BCF32BCCC4C8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_5A712F1EB012A605E101CF3338D76812_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_5A712F1EB012A605E101CF3338D76812" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_5A712F1EB012A605E101CF3338D76812_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_5A712F1EB012A605E101CF3338D76812" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5A712F1EB012A605E101CF3338D76812" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5A712F1EB012A605E101CF3338D76812" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_5A712F1EB012A605E101CF3338D76812" xlink:type="arc" />
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_19844520739F7FB00C1DCED51384C011_verboseLabel_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_19844520739F7FB00C1DCED51384C011" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cumulative effect adjustment</link:label>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_19844520739F7FB00C1DCED51384C011_label_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_19844520739F7FB00C1DCED51384C011" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Effect of New Accounting Principle in Period of Adoption</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_19844520739F7FB00C1DCED51384C011" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_19844520739F7FB00C1DCED51384C011" xlink:to="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_19844520739F7FB00C1DCED51384C011" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_57EAB1B13422FAFAC79ECED513846048_negatedLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_57EAB1B13422FAFAC79ECED513846048" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_57EAB1B13422FAFAC79ECED513846048_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_57EAB1B13422FAFAC79ECED513846048" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocated Share-based Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_57EAB1B13422FAFAC79ECED513846048" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_57EAB1B13422FAFAC79ECED513846048" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_57EAB1B13422FAFAC79ECED513846048" xlink:type="arc" />
    <link:label id="lab_ccrn_TermLoanMember_04FAA021C3D3F447AB48CED5130C1250_terseLabel_en-US" xlink:label="lab_ccrn_TermLoanMember_04FAA021C3D3F447AB48CED5130C1250" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_04FAA021C3D3F447AB48CED5130C1250" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_TermLoanMember_04FAA021C3D3F447AB48CED5130C1250" xlink:to="lab_ccrn_TermLoanMember_04FAA021C3D3F447AB48CED5130C1250" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_736494C0C1CF34972D54CED5130C6251_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount_736494C0C1CF34972D54CED5130C6251" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_736494C0C1CF34972D54CED5130C6251_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount_736494C0C1CF34972D54CED5130C6251" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_736494C0C1CF34972D54CED5130C6251" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_736494C0C1CF34972D54CED5130C6251" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount_736494C0C1CF34972D54CED5130C6251" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalLeaseObligations_61AE7D7E3E8274909D91CED5130CA854_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligations_61AE7D7E3E8274909D91CED5130CA854" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital lease obligations</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligations_61AE7D7E3E8274909D91CED5130CA854_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligations_61AE7D7E3E8274909D91CED5130CA854" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Lease Obligations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligations" xlink:label="loc_us-gaap_CapitalLeaseObligations_61AE7D7E3E8274909D91CED5130CA854" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligations_61AE7D7E3E8274909D91CED5130CA854" xlink:to="lab_us-gaap_CapitalLeaseObligations_61AE7D7E3E8274909D91CED5130CA854" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_D3D44507BCA6C32B2120CED5130D1DE7_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_D3D44507BCA6C32B2120CED5130D1DE7" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_D3D44507BCA6C32B2120CED5130D1DE7_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_D3D44507BCA6C32B2120CED5130D1DE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Including Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_D3D44507BCA6C32B2120CED5130D1DE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_D3D44507BCA6C32B2120CED5130D1DE7" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_D3D44507BCA6C32B2120CED5130D1DE7" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_D165D5657CA30BDC8E31CED5130D08E3_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_D165D5657CA30BDC8E31CED5130D08E3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_D165D5657CA30BDC8E31CED5130D08E3_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_D165D5657CA30BDC8E31CED5130D08E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_D165D5657CA30BDC8E31CED5130D08E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_D165D5657CA30BDC8E31CED5130D08E3" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_D165D5657CA30BDC8E31CED5130D08E3" xlink:type="arc" />
    <link:label id="lab_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5_terseLabel_en-US" xlink:label="lab_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt and Capital Lease Obligations</link:label>
    <link:label id="lab_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5_label_en-US" xlink:label="lab_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Gross</link:label>
    <link:label id="lab_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5_documentation_en-US" xlink:label="lab_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Gross</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LongtermDebtandCapitalLeaseObligationsGross" xlink:label="loc_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5" xlink:to="lab_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_92EBD208B7D779E93A4DCED5130EC2E4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_92EBD208B7D779E93A4DCED5130EC2E4" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unamortized Discount and Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_92EBD208B7D779E93A4DCED5130EC2E4_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_92EBD208B7D779E93A4DCED5130EC2E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_92EBD208B7D779E93A4DCED5130EC2E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_92EBD208B7D779E93A4DCED5130EC2E4" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_92EBD208B7D779E93A4DCED5130EC2E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_2FF7A1B4CEB06123E3C8CED5130E246D_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_2FF7A1B4CEB06123E3C8CED5130E246D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2FF7A1B4CEB06123E3C8CED5130E246D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2FF7A1B4CEB06123E3C8CED5130E246D" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_2FF7A1B4CEB06123E3C8CED5130E246D" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_CEA94C9AE9010C943BEACED513AD7D12_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts_CEA94C9AE9010C943BEACED513AD7D12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt discount and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_CEA94C9AE9010C943BEACED513AD7D12_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts_CEA94C9AE9010C943BEACED513AD7D12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_CEA94C9AE9010C943BEACED513AD7D12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts_CEA94C9AE9010C943BEACED513AD7D12" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts_CEA94C9AE9010C943BEACED513AD7D12" xlink:type="arc" />
    <link:label id="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_8A0BEC51AAC4C67160A4CED513AD5189_verboseLabel_en-US" xlink:label="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_8A0BEC51AAC4C67160A4CED513AD5189" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Provision for allowances</link:label>
    <link:label id="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_8A0BEC51AAC4C67160A4CED513AD5189_label_en-US" xlink:label="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_8A0BEC51AAC4C67160A4CED513AD5189" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for Doubtful Accounts and Other Allowances</link:label>
    <link:label id="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_8A0BEC51AAC4C67160A4CED513AD5189_documentation_en-US" xlink:label="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_8A0BEC51AAC4C67160A4CED513AD5189" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Provision for Doubtful Accounts and Other Allowances</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ProvisionforDoubtfulAccountsandOtherAllowances" xlink:label="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_8A0BEC51AAC4C67160A4CED513AD5189" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_8A0BEC51AAC4C67160A4CED513AD5189" xlink:to="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_8A0BEC51AAC4C67160A4CED513AD5189" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_FA322ED794637D98ADF5CED513AD0CB8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_FA322ED794637D98ADF5CED513AD0CB8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_FA322ED794637D98ADF5CED513AD0CB8_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_FA322ED794637D98ADF5CED513AD0CB8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_FA322ED794637D98ADF5CED513AD0CB8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_FA322ED794637D98ADF5CED513AD0CB8" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_FA322ED794637D98ADF5CED513AD0CB8" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_D6A0171E5075D90CD70BCED513AD3CE0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_D6A0171E5075D90CD70BCED513AD3CE0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition-related contingent consideration</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_D6A0171E5075D90CD70BCED513AD3CE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_D6A0171E5075D90CD70BCED513AD3CE0" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_D6A0171E5075D90CD70BCED513AD3CE0" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_C5C30263CC63455ECC5ECED513AE08D9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_C5C30263CC63455ECC5ECED513AE08D9" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_C5C30263CC63455ECC5ECED513AE08D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_C5C30263CC63455ECC5ECED513AE08D9" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_C5C30263CC63455ECC5ECED513AE08D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_87298CD2E01EC1FB680DCED513AE431E_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_87298CD2E01EC1FB680DCED513AE431E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_87298CD2E01EC1FB680DCED513AE431E_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_87298CD2E01EC1FB680DCED513AE431E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_87298CD2E01EC1FB680DCED513AE431E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_87298CD2E01EC1FB680DCED513AE431E" xlink:to="lab_us-gaap_ShareBasedCompensation_87298CD2E01EC1FB680DCED513AE431E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncashExpense_FDC333E8E2248A3A9675CED513AE0F29_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashExpense_FDC333E8E2248A3A9675CED513AE0F29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-cash costs</link:label>
    <link:label id="lab_us-gaap_OtherNoncashExpense_FDC333E8E2248A3A9675CED513AE0F29_label_en-US" xlink:label="lab_us-gaap_OtherNoncashExpense_FDC333E8E2248A3A9675CED513AE0F29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaap_OtherNoncashExpense_FDC333E8E2248A3A9675CED513AE0F29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashExpense_FDC333E8E2248A3A9675CED513AE0F29" xlink:to="lab_us-gaap_OtherNoncashExpense_FDC333E8E2248A3A9675CED513AE0F29" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_630685DB178FA5C8FB88CED513AEF070_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_630685DB178FA5C8FB88CED513AEF070" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_630685DB178FA5C8FB88CED513AEF070_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_630685DB178FA5C8FB88CED513AEF070" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_630685DB178FA5C8FB88CED513AEF070" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_630685DB178FA5C8FB88CED513AEF070" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_630685DB178FA5C8FB88CED513AEF070" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_330EE9CD18E61B0230E1CED513AEE475_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_330EE9CD18E61B0230E1CED513AEE475" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_330EE9CD18E61B0230E1CED513AEE475_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_330EE9CD18E61B0230E1CED513AEE475" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_330EE9CD18E61B0230E1CED513AEE475" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_330EE9CD18E61B0230E1CED513AEE475" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_330EE9CD18E61B0230E1CED513AEE475" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_B26953BF236A664526AECED513AFE305_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_B26953BF236A664526AECED513AFE305" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_B26953BF236A664526AECED513AFE305_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_B26953BF236A664526AECED513AFE305" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_B26953BF236A664526AECED513AFE305" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_B26953BF236A664526AECED513AFE305" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_B26953BF236A664526AECED513AFE305" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6BF6BC26B194E8F2FCC5CED513AF0393_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6BF6BC26B194E8F2FCC5CED513AF0393" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6BF6BC26B194E8F2FCC5CED513AF0393_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6BF6BC26B194E8F2FCC5CED513AF0393" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6BF6BC26B194E8F2FCC5CED513AF0393" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6BF6BC26B194E8F2FCC5CED513AF0393" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6BF6BC26B194E8F2FCC5CED513AF0393" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4293387023D33FD95496CED513B05DDF_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4293387023D33FD95496CED513B05DDF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4293387023D33FD95496CED513B05DDF_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4293387023D33FD95496CED513B05DDF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4293387023D33FD95496CED513B05DDF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4293387023D33FD95496CED513B05DDF" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4293387023D33FD95496CED513B05DDF" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308" xlink:type="arc" />
    <link:label id="lab_ccrn_WorkingCapitalAdjustmentInvestingActivities_949A3C3AE5EA6E0561C4CED513B0C506_terseLabel_en-US" xlink:label="lab_ccrn_WorkingCapitalAdjustmentInvestingActivities_949A3C3AE5EA6E0561C4CED513B0C506" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition-related settlements - Mediscan</link:label>
    <link:label id="lab_ccrn_WorkingCapitalAdjustmentInvestingActivities_949A3C3AE5EA6E0561C4CED513B0C506_label_en-US" xlink:label="lab_ccrn_WorkingCapitalAdjustmentInvestingActivities_949A3C3AE5EA6E0561C4CED513B0C506" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Working Capital Adjustment, Investing Activities</link:label>
    <link:label id="lab_ccrn_WorkingCapitalAdjustmentInvestingActivities_949A3C3AE5EA6E0561C4CED513B0C506_documentation_en-US" xlink:label="lab_ccrn_WorkingCapitalAdjustmentInvestingActivities_949A3C3AE5EA6E0561C4CED513B0C506" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Working Capital Adjustment, Investing Activities</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_WorkingCapitalAdjustmentInvestingActivities" xlink:label="loc_ccrn_WorkingCapitalAdjustmentInvestingActivities_949A3C3AE5EA6E0561C4CED513B0C506" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_WorkingCapitalAdjustmentInvestingActivities_949A3C3AE5EA6E0561C4CED513B0C506" xlink:to="lab_ccrn_WorkingCapitalAdjustmentInvestingActivities_949A3C3AE5EA6E0561C4CED513B0C506" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_087D7BF1093AA8B93455CED513B04FC6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_087D7BF1093AA8B93455CED513B04FC6" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_087D7BF1093AA8B93455CED513B04FC6_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_087D7BF1093AA8B93455CED513B04FC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_087D7BF1093AA8B93455CED513B04FC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_087D7BF1093AA8B93455CED513B04FC6" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_087D7BF1093AA8B93455CED513B04FC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B74751D10D1E2EF00768CED513B03759_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B74751D10D1E2EF00768CED513B03759" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B74751D10D1E2EF00768CED513B03759_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B74751D10D1E2EF00768CED513B03759" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B74751D10D1E2EF00768CED513B03759" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B74751D10D1E2EF00768CED513B03759" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B74751D10D1E2EF00768CED513B03759" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_C1CEB00F305EA421C4D8CED513B0A6CD_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_C1CEB00F305EA421C4D8CED513B0A6CD" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayments of debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_C1CEB00F305EA421C4D8CED513B0A6CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_C1CEB00F305EA421C4D8CED513B0A6CD" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_C1CEB00F305EA421C4D8CED513B0A6CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_727F1464EBC457B016C8CED513B0042F_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_727F1464EBC457B016C8CED513B0042F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings on debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_727F1464EBC457B016C8CED513B0042F_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_727F1464EBC457B016C8CED513B0042F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_727F1464EBC457B016C8CED513B0042F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_727F1464EBC457B016C8CED513B0042F" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_727F1464EBC457B016C8CED513B0042F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_B90B6D29D8740B6BEF45CED513B136D2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_B90B6D29D8740B6BEF45CED513B136D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_B90B6D29D8740B6BEF45CED513B136D2_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_B90B6D29D8740B6BEF45CED513B136D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_B90B6D29D8740B6BEF45CED513B136D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_B90B6D29D8740B6BEF45CED513B136D2" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_B90B6D29D8740B6BEF45CED513B136D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_09AADB59AFFC155CC574CED513B10081_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_09AADB59AFFC155CC574CED513B10081" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_09AADB59AFFC155CC574CED513B10081_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_09AADB59AFFC155CC574CED513B10081" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_09AADB59AFFC155CC574CED513B10081" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_09AADB59AFFC155CC574CED513B10081" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_09AADB59AFFC155CC574CED513B10081" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5E473578C0C091BE4935CED513B119AE_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5E473578C0C091BE4935CED513B119AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5E473578C0C091BE4935CED513B119AE_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5E473578C0C091BE4935CED513B119AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5E473578C0C091BE4935CED513B119AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5E473578C0C091BE4935CED513B119AE" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5E473578C0C091BE4935CED513B119AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_AFC15194147F5E78BCB6CED513B1EA76_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_AFC15194147F5E78BCB6CED513B1EA76" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_AFC15194147F5E78BCB6CED513B1EA76_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_AFC15194147F5E78BCB6CED513B1EA76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_AFC15194147F5E78BCB6CED513B1EA76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_AFC15194147F5E78BCB6CED513B1EA76" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_AFC15194147F5E78BCB6CED513B1EA76" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_881610BC2DE7695AA91BCED513B206E9_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_881610BC2DE7695AA91BCED513B206E9" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_881610BC2DE7695AA91BCED513B206E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_881610BC2DE7695AA91BCED513B206E9" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_881610BC2DE7695AA91BCED513B206E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0180C8A5719C67E24F52CED513B3B25F_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0180C8A5719C67E24F52CED513B3B25F" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0180C8A5719C67E24F52CED513B3B25F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0180C8A5719C67E24F52CED513B3B25F" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0180C8A5719C67E24F52CED513B3B25F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_02827B47DDFFC3F34D2C87DC272EE497_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_02827B47DDFFC3F34D2C87DC272EE497" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_02827B47DDFFC3F34D2C87DC272EE497_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_02827B47DDFFC3F34D2C87DC272EE497" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_02827B47DDFFC3F34D2C87DC272EE497" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_02827B47DDFFC3F34D2C87DC272EE497" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_02827B47DDFFC3F34D2C87DC272EE497" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_CEBB334914ADF15DC8A487DC272F83AD_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_CEBB334914ADF15DC8A487DC272F83AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Annual Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_CEBB334914ADF15DC8A487DC272F83AD_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_CEBB334914ADF15DC8A487DC272F83AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_CEBB334914ADF15DC8A487DC272F83AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_CEBB334914ADF15DC8A487DC272F83AD" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_CEBB334914ADF15DC8A487DC272F83AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_3C06549028C389ED4E8E87DC272F35C2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_3C06549028C389ED4E8E87DC272F35C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_3C06549028C389ED4E8E87DC272F35C2_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_3C06549028C389ED4E8E87DC272F35C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_3C06549028C389ED4E8E87DC272F35C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock_3C06549028C389ED4E8E87DC272F35C2" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock_3C06549028C389ED4E8E87DC272F35C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_931EE380534C783EE7D9D458E724EEA8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_931EE380534C783EE7D9D458E724EEA8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_931EE380534C783EE7D9D458E724EEA8_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_931EE380534C783EE7D9D458E724EEA8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_931EE380534C783EE7D9D458E724EEA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_931EE380534C783EE7D9D458E724EEA8" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_931EE380534C783EE7D9D458E724EEA8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_30907EA472B7AB4494BBD458E7293FFB_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_30907EA472B7AB4494BBD458E7293FFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_30907EA472B7AB4494BBD458E7293FFB_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_30907EA472B7AB4494BBD458E7293FFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_30907EA472B7AB4494BBD458E7293FFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_30907EA472B7AB4494BBD458E7293FFB" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_30907EA472B7AB4494BBD458E7293FFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2" xlink:type="arc" />
    <link:label id="lab_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377_terseLabel_en-US" xlink:label="lab_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation [Member]</link:label>
    <link:label id="lab_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377_label_en-US" xlink:label="lab_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:label id="lab_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377_documentation_en-US" xlink:label="lab_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DeferredCompensationMember" xlink:label="loc_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377" xlink:to="lab_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377" xlink:type="arc" />
    <link:label id="lab_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A_terseLabel_en-US" xlink:label="lab_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes, Derivative Liability [Member]</link:label>
    <link:label id="lab_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A_label_en-US" xlink:label="lab_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes, Derivative Liability [Member]</link:label>
    <link:label id="lab_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A_documentation_en-US" xlink:label="lab_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Notes, Derivative Liability [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleNotesDerivativeLiabilityMember" xlink:label="loc_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A" xlink:to="lab_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_FA1A7037B44A76F4BD76D458E72BF727_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_FA1A7037B44A76F4BD76D458E72BF727" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_FA1A7037B44A76F4BD76D458E72BF727_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_FA1A7037B44A76F4BD76D458E72BF727" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_FA1A7037B44A76F4BD76D458E72BF727" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_FA1A7037B44A76F4BD76D458E72BF727" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_FA1A7037B44A76F4BD76D458E72BF727" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_E69938A3217207C1D99CD458E72D8641_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_E69938A3217207C1D99CD458E72D8641" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes derivative liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_E69938A3217207C1D99CD458E72D8641" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue_E69938A3217207C1D99CD458E72D8641" xlink:to="lab_us-gaap_DebtInstrumentFairValue_E69938A3217207C1D99CD458E72D8641" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EFD601342928E10A597FA05061709662_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EFD601342928E10A597FA05061709662" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EFD601342928E10A597FA05061709662_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EFD601342928E10A597FA05061709662" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EFD601342928E10A597FA05061709662" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EFD601342928E10A597FA05061709662" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EFD601342928E10A597FA05061709662" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_085982139382B26F7EF387FF98170C8D_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_085982139382B26F7EF387FF98170C8D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_085982139382B26F7EF387FF98170C8D_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_085982139382B26F7EF387FF98170C8D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_085982139382B26F7EF387FF98170C8D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_085982139382B26F7EF387FF98170C8D" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_085982139382B26F7EF387FF98170C8D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DD8E2D60C49EF2B6607B87FF9817117D_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DD8E2D60C49EF2B6607B87FF9817117D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DD8E2D60C49EF2B6607B87FF9817117D_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DD8E2D60C49EF2B6607B87FF9817117D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DD8E2D60C49EF2B6607B87FF9817117D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DD8E2D60C49EF2B6607B87FF9817117D" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DD8E2D60C49EF2B6607B87FF9817117D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_18B98198330889E8FD6A87FF98176969_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_18B98198330889E8FD6A87FF98176969" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_18B98198330889E8FD6A87FF98176969_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_18B98198330889E8FD6A87FF98176969" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_18B98198330889E8FD6A87FF98176969" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_18B98198330889E8FD6A87FF98176969" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_18B98198330889E8FD6A87FF98176969" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_01006471F3273210BC8487FF98171C42_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_01006471F3273210BC8487FF98171C42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_01006471F3273210BC8487FF98171C42_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_01006471F3273210BC8487FF98171C42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_01006471F3273210BC8487FF98171C42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_01006471F3273210BC8487FF98171C42" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_01006471F3273210BC8487FF98171C42" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_D0FAA7D9BC02E6B13A4287FF9818A6AE_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_D0FAA7D9BC02E6B13A4287FF9818A6AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_D0FAA7D9BC02E6B13A4287FF9818A6AE_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_D0FAA7D9BC02E6B13A4287FF9818A6AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_D0FAA7D9BC02E6B13A4287FF9818A6AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_D0FAA7D9BC02E6B13A4287FF9818A6AE" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_D0FAA7D9BC02E6B13A4287FF9818A6AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_837615E8E257AA31B86E87FF9818356A_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_837615E8E257AA31B86E87FF9818356A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_837615E8E257AA31B86E87FF9818356A_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_837615E8E257AA31B86E87FF9818356A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_837615E8E257AA31B86E87FF9818356A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_837615E8E257AA31B86E87FF9818356A" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_837615E8E257AA31B86E87FF9818356A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59FB19D164D9B006EECFFC5D410BFEF4_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59FB19D164D9B006EECFFC5D410BFEF4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59FB19D164D9B006EECFFC5D410BFEF4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59FB19D164D9B006EECFFC5D410BFEF4" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59FB19D164D9B006EECFFC5D410BFEF4" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_B78434C2A7439D0502F0FC5D410BE0AA_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_B78434C2A7439D0502F0FC5D410BE0AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ORGANIZATION AND BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_B78434C2A7439D0502F0FC5D410BE0AA_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_B78434C2A7439D0502F0FC5D410BE0AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_B78434C2A7439D0502F0FC5D410BE0AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_B78434C2A7439D0502F0FC5D410BE0AA" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_B78434C2A7439D0502F0FC5D410BE0AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:to="lab_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908" xlink:to="lab_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908" xlink:type="arc" />
    <link:label id="lab_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7_terseLabel_en-US" xlink:label="lab_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Omnibus Plan [Member]</link:label>
    <link:label id="lab_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7_label_en-US" xlink:label="lab_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Omnibus Plan [Member]</link:label>
    <link:label id="lab_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7_documentation_en-US" xlink:label="lab_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Omnibus Plan [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OmnibusPlanMember" xlink:label="loc_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7" xlink:to="lab_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_12A1189BBE0E14B99D3CFC5D407CD223_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_12A1189BBE0E14B99D3CFC5D407CD223" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_12A1189BBE0E14B99D3CFC5D407CD223_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_12A1189BBE0E14B99D3CFC5D407CD223" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_12A1189BBE0E14B99D3CFC5D407CD223" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_12A1189BBE0E14B99D3CFC5D407CD223" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_12A1189BBE0E14B99D3CFC5D407CD223" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2C078F6249D5D469EFC0FC5D407C9E1F_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2C078F6249D5D469EFC0FC5D407C9E1F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares left remaining to repurchase under the plan (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2C078F6249D5D469EFC0FC5D407C9E1F_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2C078F6249D5D469EFC0FC5D407C9E1F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2C078F6249D5D469EFC0FC5D407C9E1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2C078F6249D5D469EFC0FC5D407C9E1F" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2C078F6249D5D469EFC0FC5D407C9E1F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4B8497F01B4E8256EAAFFC5D407C71DA_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4B8497F01B4E8256EAAFFC5D407C71DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, authorized amount (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4B8497F01B4E8256EAAFFC5D407C71DA_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4B8497F01B4E8256EAAFFC5D407C71DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4B8497F01B4E8256EAAFFC5D407C71DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4B8497F01B4E8256EAAFFC5D407C71DA" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4B8497F01B4E8256EAAFFC5D407C71DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_929F7B019F5A8737882DFC5D407C376C_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_929F7B019F5A8737882DFC5D407C376C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares of common stock outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_929F7B019F5A8737882DFC5D407C376C_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_929F7B019F5A8737882DFC5D407C376C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_929F7B019F5A8737882DFC5D407C376C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_929F7B019F5A8737882DFC5D407C376C" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_929F7B019F5A8737882DFC5D407C376C" xlink:type="arc" />
    <link:label id="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291_terseLabel_en-US" xlink:label="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level of performance attained and approved (percent)</link:label>
    <link:label id="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291_label_en-US" xlink:label="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Level of Performance Attained, Percentage</link:label>
    <link:label id="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291_documentation_en-US" xlink:label="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Level of Performance Attained, Percentage</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage" xlink:label="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291" xlink:to="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_E1BAF5BC11108E978572FC5D407C9F41_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_E1BAF5BC11108E978572FC5D407C9F41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_E1BAF5BC11108E978572FC5D407C9F41_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_E1BAF5BC11108E978572FC5D407C9F41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_E1BAF5BC11108E978572FC5D407C9F41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_E1BAF5BC11108E978572FC5D407C9F41" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_E1BAF5BC11108E978572FC5D407C9F41" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_9F1B4020589B21C734EFFC5D407C5A1C_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_9F1B4020589B21C734EFFC5D407C5A1C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9F1B4020589B21C734EFFC5D407C5A1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_9F1B4020589B21C734EFFC5D407C5A1C" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_9F1B4020589B21C734EFFC5D407C5A1C" xlink:type="arc" />
    <link:label id="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE_terseLabel_en-US" xlink:label="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested in period, net (in shares)</link:label>
    <link:label id="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE_label_en-US" xlink:label="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Net</link:label>
    <link:label id="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE_documentation_en-US" xlink:label="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Net</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet" xlink:label="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE" xlink:to="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="lab_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesRevenueServicesNet_1681A1449F7D86070B85A88FFE6B4E2F_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueServicesNet_1681A1449F7D86070B85A88FFE6B4E2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from services</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet_1681A1449F7D86070B85A88FFE6B4E2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueServicesNet_1681A1449F7D86070B85A88FFE6B4E2F" xlink:to="lab_us-gaap_SalesRevenueServicesNet_1681A1449F7D86070B85A88FFE6B4E2F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfServices_527C4ABEB5B9733ACB43A88FFE6BC11D_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfServices_527C4ABEB5B9733ACB43A88FFE6BC11D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfServices_527C4ABEB5B9733ACB43A88FFE6BC11D_label_en-US" xlink:label="lab_us-gaap_CostOfServices_527C4ABEB5B9733ACB43A88FFE6BC11D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Services</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfServices" xlink:label="loc_us-gaap_CostOfServices_527C4ABEB5B9733ACB43A88FFE6BC11D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfServices_527C4ABEB5B9733ACB43A88FFE6BC11D" xlink:to="lab_us-gaap_CostOfServices_527C4ABEB5B9733ACB43A88FFE6BC11D" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_23FF0C030CC0584E3F4AA88FFE6BFB83_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_23FF0C030CC0584E3F4AA88FFE6BFB83" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_23FF0C030CC0584E3F4AA88FFE6BFB83_label_en-US" xlink:label="lab_us-gaap_GrossProfit_23FF0C030CC0584E3F4AA88FFE6BFB83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_23FF0C030CC0584E3F4AA88FFE6BFB83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_23FF0C030CC0584E3F4AA88FFE6BFB83" xlink:to="lab_us-gaap_GrossProfit_23FF0C030CC0584E3F4AA88FFE6BFB83" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:to="lab_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4BB962A0F8AE56F0AF77A88FFE6B6DB0_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4BB962A0F8AE56F0AF77A88FFE6B6DB0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4BB962A0F8AE56F0AF77A88FFE6B6DB0_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4BB962A0F8AE56F0AF77A88FFE6B6DB0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4BB962A0F8AE56F0AF77A88FFE6B6DB0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4BB962A0F8AE56F0AF77A88FFE6B6DB0" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4BB962A0F8AE56F0AF77A88FFE6B6DB0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_9AEC092B755D6EAAD0B2A88FFE72123A_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_9AEC092B755D6EAAD0B2A88FFE72123A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_9AEC092B755D6EAAD0B2A88FFE72123A_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_9AEC092B755D6EAAD0B2A88FFE72123A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for Doubtful Accounts</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9AEC092B755D6EAAD0B2A88FFE72123A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts_9AEC092B755D6EAAD0B2A88FFE72123A" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts_9AEC092B755D6EAAD0B2A88FFE72123A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostsAndExpenses_14D1AE335BB175615663A88FFE73E72D_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses_14D1AE335BB175615663A88FFE73E72D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_14D1AE335BB175615663A88FFE73E72D_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses_14D1AE335BB175615663A88FFE73E72D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_14D1AE335BB175615663A88FFE73E72D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses_14D1AE335BB175615663A88FFE73E72D" xlink:to="lab_us-gaap_CostsAndExpenses_14D1AE335BB175615663A88FFE73E72D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_EC9C15ADAAA1E48054E0A88FFE73D391_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_EC9C15ADAAA1E48054E0A88FFE73D391" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income from operations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_EC9C15ADAAA1E48054E0A88FFE73D391" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_EC9C15ADAAA1E48054E0A88FFE73D391" xlink:to="lab_us-gaap_OperatingIncomeLoss_EC9C15ADAAA1E48054E0A88FFE73D391" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expenses (income):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpense_4549BB0B399DF8B39AD6A88FFE737A29_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense_4549BB0B399DF8B39AD6A88FFE737A29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_4549BB0B399DF8B39AD6A88FFE737A29_label_en-US" xlink:label="lab_us-gaap_InterestExpense_4549BB0B399DF8B39AD6A88FFE737A29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_4549BB0B399DF8B39AD6A88FFE737A29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_4549BB0B399DF8B39AD6A88FFE737A29" xlink:to="lab_us-gaap_InterestExpense_4549BB0B399DF8B39AD6A88FFE737A29" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_FA0DE887FEBEC6A40920A88FFE737079_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet_FA0DE887FEBEC6A40920A88FFE737079" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on derivative liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_FA0DE887FEBEC6A40920A88FFE737079" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet_FA0DE887FEBEC6A40920A88FFE737079" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet_FA0DE887FEBEC6A40920A88FFE737079" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_236BE039B60AC8055B85A88FFE73ECDA_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_236BE039B60AC8055B85A88FFE73ECDA" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_236BE039B60AC8055B85A88FFE73ECDA_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_236BE039B60AC8055B85A88FFE73ECDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_236BE039B60AC8055B85A88FFE73ECDA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_236BE039B60AC8055B85A88FFE73ECDA" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_236BE039B60AC8055B85A88FFE73ECDA" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_CA0D209BEC421BA1EBA4A88FFE73DC2A_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_CA0D209BEC421BA1EBA4A88FFE73DC2A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">(Loss) income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_CA0D209BEC421BA1EBA4A88FFE73DC2A_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_CA0D209BEC421BA1EBA4A88FFE73DC2A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_CA0D209BEC421BA1EBA4A88FFE73DC2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_CA0D209BEC421BA1EBA4A88FFE73DC2A" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_CA0D209BEC421BA1EBA4A88FFE73DC2A" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4F34143D7B9DFB8CEDD4A88FFE73A89F_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_4F34143D7B9DFB8CEDD4A88FFE73A89F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4F34143D7B9DFB8CEDD4A88FFE73A89F_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_4F34143D7B9DFB8CEDD4A88FFE73A89F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4F34143D7B9DFB8CEDD4A88FFE73A89F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4F34143D7B9DFB8CEDD4A88FFE73A89F" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_4F34143D7B9DFB8CEDD4A88FFE73A89F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_DD461AF092ABD2ED2696A88FFE73EB1A_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_DD461AF092ABD2ED2696A88FFE73EB1A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Consolidated net (loss) income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_DD461AF092ABD2ED2696A88FFE73EB1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_DD461AF092ABD2ED2696A88FFE73EB1A" xlink:to="lab_us-gaap_ProfitLoss_DD461AF092ABD2ED2696A88FFE73EB1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_EDF26B22990DD507F8CAA88FFE737BF6_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_EDF26B22990DD507F8CAA88FFE737BF6" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_EDF26B22990DD507F8CAA88FFE737BF6_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_EDF26B22990DD507F8CAA88FFE737BF6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_EDF26B22990DD507F8CAA88FFE737BF6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_EDF26B22990DD507F8CAA88FFE737BF6" xlink:to="lab_us-gaap_NetIncomeLoss_EDF26B22990DD507F8CAA88FFE737BF6" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_1FD6918C55D9B52FC611A88FFE736D3A_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract_1FD6918C55D9B52FC611A88FFE736D3A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income per share attributable to common shareholders - Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_1FD6918C55D9B52FC611A88FFE736D3A_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract_1FD6918C55D9B52FC611A88FFE736D3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_1FD6918C55D9B52FC611A88FFE736D3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_1FD6918C55D9B52FC611A88FFE736D3A" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract_1FD6918C55D9B52FC611A88FFE736D3A" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_005A8B33D3FD5691D455A88FFE747449_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract_005A8B33D3FD5691D455A88FFE747449" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income per share attributable to common shareholders - Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_005A8B33D3FD5691D455A88FFE747449_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract_005A8B33D3FD5691D455A88FFE747449" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_005A8B33D3FD5691D455A88FFE747449" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_005A8B33D3FD5691D455A88FFE747449" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract_005A8B33D3FD5691D455A88FFE747449" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B5308F1D5B108B3C404DA88FFE746124_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B5308F1D5B108B3C404DA88FFE746124" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B5308F1D5B108B3C404DA88FFE746124_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B5308F1D5B108B3C404DA88FFE746124" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B5308F1D5B108B3C404DA88FFE746124" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B5308F1D5B108B3C404DA88FFE746124" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B5308F1D5B108B3C404DA88FFE746124" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ADF19D39CD5898842E6A88FFE740AD1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ADF19D39CD5898842E6A88FFE740AD1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ADF19D39CD5898842E6A88FFE740AD1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ADF19D39CD5898842E6A88FFE740AD1" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ADF19D39CD5898842E6A88FFE740AD1" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9FAF9821DD7B24CF2E7EA88FFE74F8B0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9FAF9821DD7B24CF2E7EA88FFE74F8B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9FAF9821DD7B24CF2E7EA88FFE74F8B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9FAF9821DD7B24CF2E7EA88FFE74F8B0" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9FAF9821DD7B24CF2E7EA88FFE74F8B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:to="lab_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:type="arc" />
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_69E40631C5268ADA76CCC1EEF79C4D93_verboseLabel_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember_69E40631C5268ADA76CCC1EEF79C4D93" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Nurse And Allied Staffing [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_69E40631C5268ADA76CCC1EEF79C4D93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_NurseAndAlliedStaffingMember_69E40631C5268ADA76CCC1EEF79C4D93" xlink:to="lab_ccrn_NurseAndAlliedStaffingMember_69E40631C5268ADA76CCC1EEF79C4D93" xlink:type="arc" />
    <link:label id="lab_ccrn_PhysicianStaffingMember_005EB7299FBBE249873EC1EEF79C96B5_terseLabel_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember_005EB7299FBBE249873EC1EEF79C96B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Physician Staffing [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_005EB7299FBBE249873EC1EEF79C96B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PhysicianStaffingMember_005EB7299FBBE249873EC1EEF79C96B5" xlink:to="lab_ccrn_PhysicianStaffingMember_005EB7299FBBE249873EC1EEF79C96B5" xlink:type="arc" />
    <link:label id="lab_ccrn_OtherHumanCapitalManagementServicesMember_6BF9E612DB8DBFB30C65C1EEF79C1C92_verboseLabel_en-US" xlink:label="lab_ccrn_OtherHumanCapitalManagementServicesMember_6BF9E612DB8DBFB30C65C1EEF79C1C92" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other Human Capital Management Services [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_6BF9E612DB8DBFB30C65C1EEF79C1C92" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OtherHumanCapitalManagementServicesMember_6BF9E612DB8DBFB30C65C1EEF79C1C92" xlink:to="lab_ccrn_OtherHumanCapitalManagementServicesMember_6BF9E612DB8DBFB30C65C1EEF79C1C92" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438" xlink:to="lab_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_84446E63B2129C9C717AC1EEF79C7F07_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_84446E63B2129C9C717AC1EEF79C7F07" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_84446E63B2129C9C717AC1EEF79C7F07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_84446E63B2129C9C717AC1EEF79C7F07" xlink:to="lab_us-gaap_Goodwill_84446E63B2129C9C717AC1EEF79C7F07" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:type="arc" />
    <link:label id="lab_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088_terseLabel_en-US" xlink:label="lab_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liabilities [Member]</link:label>
    <link:label id="lab_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088_label_en-US" xlink:label="lab_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:label id="lab_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088_documentation_en-US" xlink:label="lab_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ContingentConsiderationLiabilityMember" xlink:label="loc_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088" xlink:to="lab_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8D3065A33AB94817C2CAD458FBCB5578_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8D3065A33AB94817C2CAD458FBCB5578" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes Derivative Liability [Member]</link:label>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8D3065A33AB94817C2CAD458FBCB5578_label_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8D3065A33AB94817C2CAD458FBCB5578" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Financial Instruments, Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8D3065A33AB94817C2CAD458FBCB5578" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8D3065A33AB94817C2CAD458FBCB5578" xlink:to="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8D3065A33AB94817C2CAD458FBCB5578" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Assets Measures on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Note Derivative Liability</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26B04FC74CA6A10EE730D458FBCC2570_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26B04FC74CA6A10EE730D458FBCC2570" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26B04FC74CA6A10EE730D458FBCC2570_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26B04FC74CA6A10EE730D458FBCC2570" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26B04FC74CA6A10EE730D458FBCC2570" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26B04FC74CA6A10EE730D458FBCC2570" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26B04FC74CA6A10EE730D458FBCC2570" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_CBF5B39B768F68076CB4D458FBCCDA88_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_CBF5B39B768F68076CB4D458FBCCDA88" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_CBF5B39B768F68076CB4D458FBCCDA88_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_CBF5B39B768F68076CB4D458FBCCDA88" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_CBF5B39B768F68076CB4D458FBCCDA88" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_CBF5B39B768F68076CB4D458FBCCDA88" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_CBF5B39B768F68076CB4D458FBCCDA88" xlink:type="arc" />
    <link:label id="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD_terseLabel_en-US" xlink:label="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accretion expense</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD_label_en-US" xlink:label="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Accretion Expense</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD_documentation_en-US" xlink:label="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Accretion Expense</link:label>
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense" xlink:label="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD" xlink:to="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AAAF0A2636629FFEE422D458FBCCB66B_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AAAF0A2636629FFEE422D458FBCCB66B" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Valuation gain for the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AAAF0A2636629FFEE422D458FBCCB66B_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AAAF0A2636629FFEE422D458FBCCB66B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AAAF0A2636629FFEE422D458FBCCB66B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AAAF0A2636629FFEE422D458FBCCB66B" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AAAF0A2636629FFEE422D458FBCCB66B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_D8D000B2BEB806E80E31D458FBCC2D4E_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_D8D000B2BEB806E80E31D458FBCC2D4E" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_D8D000B2BEB806E80E31D458FBCC2D4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_D8D000B2BEB806E80E31D458FBCC2D4E" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_D8D000B2BEB806E80E31D458FBCC2D4E" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>ccrn-20170331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:href="ccrn-20170331.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:href="ccrn-20170331.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:href="ccrn-20170331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLoss" xlink:href="ccrn-20170331.xsd#ComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLossDetails" xlink:href="ccrn-20170331.xsd#ComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:href="ccrn-20170331.xsd#CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConvertibleNotesDerivativeLiability" xlink:href="ccrn-20170331.xsd#ConvertibleNotesDerivativeLiability" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Debt" xlink:href="ccrn-20170331.xsd#Debt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:href="ccrn-20170331.xsd#DebtConsolidatedNetLeverageRatioDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:href="ccrn-20170331.xsd#DebtDebtMaturitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:href="ccrn-20170331.xsd#DebtLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtNarrativeDetails" xlink:href="ccrn-20170331.xsd#DebtNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:href="ccrn-20170331.xsd#DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:href="ccrn-20170331.xsd#DebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:href="ccrn-20170331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:href="ccrn-20170331.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:href="ccrn-20170331.xsd#EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:href="ccrn-20170331.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:href="ccrn-20170331.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:href="ccrn-20170331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:href="ccrn-20170331.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:href="ccrn-20170331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesDetails" xlink:href="ccrn-20170331.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:href="ccrn-20170331.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RecentAccountingPronouncements" xlink:href="ccrn-20170331.xsd#RecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:href="ccrn-20170331.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:href="ccrn-20170331.xsd#RelatedPartyTransactionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:href="ccrn-20170331.xsd#SegmentData" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails" xlink:href="ccrn-20170331.xsd#SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataNarrativeDetails" xlink:href="ccrn-20170331.xsd#SegmentDataNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:href="ccrn-20170331.xsd#SegmentDataTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:href="ccrn-20170331.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:href="ccrn-20170331.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails" xlink:href="ccrn-20170331.xsd#StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:href="ccrn-20170331.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ccrn-20170331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="ccrn-20170331.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ccrn-20170331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_D9A9D0E2ACEE90800BA6FC5D410C3C9F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_C95474DB398C1668C0E5FC5D410C63C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_D9A9D0E2ACEE90800BA6FC5D410C3C9F" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_C95474DB398C1668C0E5FC5D410C63C4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_A7E06A7548803C203CB3D458FCABF953" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_A7E06A7548803C203CB3D458FCABF953" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_B93C8ACB3397D3DF8CAAD458FCABC36C" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_D5FF7FC024416B6BF585D458FCAC29AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3E15FAA83AA67E62A72DD458FCACE679" xlink:to="loc_us-gaap_SubsequentEventMember_D5FF7FC024416B6BF585D458FCAC29AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_3CBB17B6849997C92505D458FCAC76E3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_D3EAC7F2FF8D70518968D458FCACB4AF" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E6CDDC5289F12B109DBFD458FCACB116" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PotentialEarnoutMember" xlink:label="loc_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:to="loc_ccrn_PotentialEarnoutMember_512EE8E93D12BF69C277D458FCACCAAE" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" xlink:label="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_183344B2B1B1290494EDD458FCACB51B" xlink:to="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_903C878DF19F358267AED458FCAC3E57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_34855FDB6060585BDA4ED458FCACCB44" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_MediscanMember" xlink:label="loc_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:to="loc_ccrn_MediscanMember_0B8007DD7E28A4D19A51D458FCAC7499" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_MedicalStaffingNetworkMember" xlink:label="loc_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70542C833C1EC21F4997D458FCAC6894" xlink:to="loc_ccrn_MedicalStaffingNetworkMember_E3D26F2F20DBA213DB1BD458FCAC9DE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_953B5C210BF3EC0F0D28D458FCABD132" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_89174C1D3A746DA04C44D458FCADA814" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_89174C1D3A746DA04C44D458FCADA814" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_16244E22803952AA8BD4D458FCAD1B97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2022F86894C1ED9C3B89D458FCADC96B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2022F86894C1ED9C3B89D458FCADC96B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8F11022F2439542999FCD458FCADB65E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8F11022F2439542999FCD458FCADB65E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationEscrowDepositRelease" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_ccrn_BusinessCombinationEscrowDepositRelease_46EAE8C564D57023D9F0D458FCADFF77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_DFC03624C3039FA5C8D4D458FCAD229C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_DFC03624C3039FA5C8D4D458FCAD229C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AEE1DDBF1ECC2AAC928CD458FCAD759C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AEE1DDBF1ECC2AAC928CD458FCAD759C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForPreviousAcquisition" xlink:label="loc_us-gaap_PaymentsForPreviousAcquisition_D397BADF03803F8285B3D458FCAD17FE" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_PaymentsForPreviousAcquisition_D397BADF03803F8285B3D458FCAD17FE" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationConsiderationDeferredPeriod" xlink:label="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_F7052B0AC68F69DD841CD458FCADC97D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5C8208098DAE517BA7A5D458FCADDB1D" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_D9CAE9CDCB4BA5E8EF44D458FCAC92FB" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5C8208098DAE517BA7A5D458FCADDB1D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98FB7C8841E2729EAA27FC5D4063F944" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_BBCFB9C3DF08B6052A2EFC5D4063CB02" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98FB7C8841E2729EAA27FC5D4063F944" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_BBCFB9C3DF08B6052A2EFC5D4063CB02" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1C465185A272EA1792CFFC5D4052D826" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_E89A9441424380027BBBFC5D40525B0F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1C465185A272EA1792CFFC5D4052D826" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_E89A9441424380027BBBFC5D40525B0F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_911FF320051077810CAECED5135A6EAC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1BD556B31A50276BB220CED5135B3DF8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_911FF320051077810CAECED5135A6EAC" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1BD556B31A50276BB220CED5135B3DF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_18915BFBC58BCAF703A3CED5135B1BAC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_911FF320051077810CAECED5135A6EAC" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_18915BFBC58BCAF703A3CED5135B1BAC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_457F0BE6C73EC58C1FDCB2A3202589C1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_457F0BE6C73EC58C1FDCB2A3202589C1" xlink:to="loc_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:to="loc_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_C485E126708C718918B1B2A32025661F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_C485E126708C718918B1B2A32025661F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7BA59E738EE8B8508874B2A320251C83" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7BA59E738EE8B8508874B2A320251C83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_7BA0DD91ABF15E359262B2A320250618" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_7BA0DD91ABF15E359262B2A320250618" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_9EDD9669B054693CA484B2A32025D012" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableCurrent_9EDD9669B054693CA484B2A32025D012" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_945AFBCEF7CAB1F9CCFEB2A320265922" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:to="loc_us-gaap_OtherAssetsCurrent_945AFBCEF7CAB1F9CCFEB2A320265922" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_F89D9135AB944D3229B0B2A320261570" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_533A96ECC40320A64292B2A320256854" xlink:to="loc_us-gaap_AssetsCurrent_F89D9135AB944D3229B0B2A320261570" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_66A154E4D4FF97F5E1B6B2A320268873" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_66A154E4D4FF97F5E1B6B2A320268873" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_F209DEF3D712850F97A8B2A320264001" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:to="loc_us-gaap_Goodwill_F209DEF3D712850F97A8B2A320264001" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_6599947765D5FB40C578B2A32026F790" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_6599947765D5FB40C578B2A32026F790" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_10D9B7E613E3477C38E5B2A32026DC0B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_10D9B7E613E3477C38E5B2A32026DC0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2E392B7D6DCECE9CC323B2A320269409" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2E392B7D6DCECE9CC323B2A320269409" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_F7F7DE0368E921AEFAC1B2A32026B788" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_E6AAA8C5B46F94B73A3AB2A3202590AF" xlink:to="loc_us-gaap_Assets_F7F7DE0368E921AEFAC1B2A32026B788" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_457F0BE6C73EC58C1FDCB2A3202589C1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8DED8C7ADC5232E45854B2A32026E844" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8DED8C7ADC5232E45854B2A32026E844" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1620FB224D7FFCF9B864B2A32026383F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1620FB224D7FFCF9B864B2A32026383F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_578700A71BCCE737C549B2A32026A66B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_578700A71BCCE737C549B2A32026A66B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_F6092A8FA4E1F79E842BB2A32026516F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9254FC23134F9EDC3B4DB2A320264CD2" xlink:to="loc_us-gaap_LiabilitiesCurrent_F6092A8FA4E1F79E842BB2A32026516F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_62A928E198B51A9C571AB2A320268B3B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_62A928E198B51A9C571AB2A320268B3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_162B0B70BD120B7E923CB2A320276931" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_162B0B70BD120B7E923CB2A320276931" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42FA6B61FA5CF2AEC32BB2A3202706A1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_42FA6B61FA5CF2AEC32BB2A3202706A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2F7FF65A35A3B7222DA2B2A320278282" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_2F7FF65A35A3B7222DA2B2A320278282" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_FE335318E718E15CF27EB2A320276175" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_FE335318E718E15CF27EB2A320276175" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_5BF2D27134461CDD2532B2A3202C72D8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:to="loc_us-gaap_Liabilities_5BF2D27134461CDD2532B2A3202C72D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7BAB41E3098FD7A9FD95B2A3202CE330" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7BAB41E3098FD7A9FD95B2A3202CE330" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_0C246B49CBCBB6FCF5D2B2A3202C4CC7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:to="loc_us-gaap_CommonStockValue_0C246B49CBCBB6FCF5D2B2A3202C4CC7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4A990CA5817EEF5DE2F7B2A3202C1CBE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4A990CA5817EEF5DE2F7B2A3202C1CBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_677CC919CE02AF306842B2A3202C7C63" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_677CC919CE02AF306842B2A3202C7C63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E95C9DE4C012476D5C34B2A3202C2BDC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_E95C9DE4C012476D5C34B2A3202C2BDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_9EF114D02E79BB68C5B7B2A3202CC677" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:to="loc_us-gaap_StockholdersEquity_9EF114D02E79BB68C5B7B2A3202CC677" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_D8FE26005DF75D097B8AB2A3202C33B9" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:to="loc_us-gaap_MinorityInterest_D8FE26005DF75D097B8AB2A3202C33B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B7C744E87A5D388E3132B2A3202CDF59" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2104A326BF27AEBD59FAB2A3202CEF85" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B7C744E87A5D388E3132B2A3202CDF59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8B2BC4E601AAE61AED24B2A3202DB7BD" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_E0E195A38113D68E178CB2A320266991" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8B2BC4E601AAE61AED24B2A3202DB7BD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_312519CA1AE2188FED69A88FFE779286" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_746B6DB1E6956F65F0E4A88FFE772FB6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_312519CA1AE2188FED69A88FFE779286" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_746B6DB1E6956F65F0E4A88FFE772FB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_EE522313D1214183D10AA88FFE77FC95" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_312519CA1AE2188FED69A88FFE779286" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_EE522313D1214183D10AA88FFE77FC95" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_DBCFF5045BB300759D19CED513AC95A6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629" xlink:to="loc_us-gaap_ProfitLoss_DBCFF5045BB300759D19CED513AC95A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8C72FE02C700B5B04183CED513ADEA00" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8C72FE02C700B5B04183CED513ADEA00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_CEA94C9AE9010C943BEACED513AD7D12" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_CEA94C9AE9010C943BEACED513AD7D12" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ProvisionforDoubtfulAccountsandOtherAllowances" xlink:label="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_8A0BEC51AAC4C67160A4CED513AD5189" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:to="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_8A0BEC51AAC4C67160A4CED513AD5189" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_FA322ED794637D98ADF5CED513AD0CB8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_FA322ED794637D98ADF5CED513AD0CB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_22708386D60136B4E2BDCED513ADAB75" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_22708386D60136B4E2BDCED513ADAB75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_D6A0171E5075D90CD70BCED513AD3CE0" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_D6A0171E5075D90CD70BCED513AD3CE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_C5C30263CC63455ECC5ECED513AE08D9" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_C5C30263CC63455ECC5ECED513AE08D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_87298CD2E01EC1FB680DCED513AE431E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:to="loc_us-gaap_ShareBasedCompensation_87298CD2E01EC1FB680DCED513AE431E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaap_OtherNoncashExpense_FDC333E8E2248A3A9675CED513AE0F29" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:to="loc_us-gaap_OtherNoncashExpense_FDC333E8E2248A3A9675CED513AE0F29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_A36224D288ED517097F7CED513AC5E34" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_630685DB178FA5C8FB88CED513AEF070" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_630685DB178FA5C8FB88CED513AEF070" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_330EE9CD18E61B0230E1CED513AEE475" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_330EE9CD18E61B0230E1CED513AEE475" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_B26953BF236A664526AECED513AFE305" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_B26953BF236A664526AECED513AFE305" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6BF6BC26B194E8F2FCC5CED513AF0393" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_A268C9D489CA05C62378CED513AEE941" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6BF6BC26B194E8F2FCC5CED513AF0393" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4293387023D33FD95496CED513B05DDF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3B45E90D503227715ADBCED513AB4629" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4293387023D33FD95496CED513B05DDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_WorkingCapitalAdjustmentInvestingActivities" xlink:label="loc_ccrn_WorkingCapitalAdjustmentInvestingActivities_949A3C3AE5EA6E0561C4CED513B0C506" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308" xlink:to="loc_ccrn_WorkingCapitalAdjustmentInvestingActivities_949A3C3AE5EA6E0561C4CED513B0C506" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_087D7BF1093AA8B93455CED513B04FC6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_087D7BF1093AA8B93455CED513B04FC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B74751D10D1E2EF00768CED513B03759" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_E83D1647E9E05A9057EFCED513B0D308" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B74751D10D1E2EF00768CED513B03759" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_C1CEB00F305EA421C4D8CED513B0A6CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_C1CEB00F305EA421C4D8CED513B0A6CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_727F1464EBC457B016C8CED513B0042F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_727F1464EBC457B016C8CED513B0042F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_DFE12016E5715BD56368CED513B1902B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_DFE12016E5715BD56368CED513B1902B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_B90B6D29D8740B6BEF45CED513B136D2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_B90B6D29D8740B6BEF45CED513B136D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_09AADB59AFFC155CC574CED513B10081" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410F8B1F11D7A094439CCED513B0B6F5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_09AADB59AFFC155CC574CED513B10081" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5E473578C0C091BE4935CED513B119AE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5E473578C0C091BE4935CED513B119AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_AFC15194147F5E78BCB6CED513B1EA76" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_AFC15194147F5E78BCB6CED513B1EA76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_881610BC2DE7695AA91BCED513B206E9" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_881610BC2DE7695AA91BCED513B206E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0180C8A5719C67E24F52CED513B3B25F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2D5FDC5F5BCDE6F5111ACED513ABD2C6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0180C8A5719C67E24F52CED513B3B25F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_FD6242A33EFD57DA6B92AAF20C4314F2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_2A992D74D03A67686CF5AAF20C437AB7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_FD6242A33EFD57DA6B92AAF20C4314F2" xlink:to="loc_us-gaap_ProfitLoss_2A992D74D03A67686CF5AAF20C437AB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_7A3E4057275781016BA6AAF20C4321E6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_FD6242A33EFD57DA6B92AAF20C4314F2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_7A3E4057275781016BA6AAF20C4321E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_0F1826D5D55E1EB0C73CAAF20C431802" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_7A3E4057275781016BA6AAF20C4321E6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_0F1826D5D55E1EB0C73CAAF20C431802" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_408AC517776D320394C7AAF20C4419FE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_7A3E4057275781016BA6AAF20C4321E6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_408AC517776D320394C7AAF20C4419FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_860410B6000C05C2375BAAF20C44B9D5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_FD6242A33EFD57DA6B92AAF20C4314F2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_860410B6000C05C2375BAAF20C44B9D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_850C397C16C74CB07064AAF20C44E68D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_FD6242A33EFD57DA6B92AAF20C4314F2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_850C397C16C74CB07064AAF20C44E68D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_207285694A609867303CAAF20C44FD6E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_FD6242A33EFD57DA6B92AAF20C4314F2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_207285694A609867303CAAF20C44FD6E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet_1681A1449F7D86070B85A88FFE6B4E2F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_SalesRevenueServicesNet_1681A1449F7D86070B85A88FFE6B4E2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfServices" xlink:label="loc_us-gaap_CostOfServices_527C4ABEB5B9733ACB43A88FFE6BC11D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_CostOfServices_527C4ABEB5B9733ACB43A88FFE6BC11D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_23FF0C030CC0584E3F4AA88FFE6BFB83" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_GrossProfit_23FF0C030CC0584E3F4AA88FFE6BFB83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4BB962A0F8AE56F0AF77A88FFE6B6DB0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4BB962A0F8AE56F0AF77A88FFE6B6DB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9AEC092B755D6EAAD0B2A88FFE72123A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_9AEC092B755D6EAAD0B2A88FFE72123A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_89EBD8F14DC35B8C8B64A89492615A11" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_89EBD8F14DC35B8C8B64A89492615A11" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_056A300EF457627EF61EA88FFE733701" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_056A300EF457627EF61EA88FFE733701" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_14D1AE335BB175615663A88FFE73E72D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_AF8461C01796B6D8B496A88FFE6B0236" xlink:to="loc_us-gaap_CostsAndExpenses_14D1AE335BB175615663A88FFE73E72D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_EC9C15ADAAA1E48054E0A88FFE73D391" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_OperatingIncomeLoss_EC9C15ADAAA1E48054E0A88FFE73D391" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_4549BB0B399DF8B39AD6A88FFE737A29" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903" xlink:to="loc_us-gaap_InterestExpense_4549BB0B399DF8B39AD6A88FFE737A29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_FA0DE887FEBEC6A40920A88FFE737079" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_FA0DE887FEBEC6A40920A88FFE737079" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9502530779F55447FD38A88FFE739ADD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9502530779F55447FD38A88FFE739ADD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_236BE039B60AC8055B85A88FFE73ECDA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1B01961744682A903CCCA88FFE732903" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_236BE039B60AC8055B85A88FFE73ECDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_CA0D209BEC421BA1EBA4A88FFE73DC2A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_CA0D209BEC421BA1EBA4A88FFE73DC2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4F34143D7B9DFB8CEDD4A88FFE73A89F" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4F34143D7B9DFB8CEDD4A88FFE73A89F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_DD461AF092ABD2ED2696A88FFE73EB1A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_ProfitLoss_DD461AF092ABD2ED2696A88FFE73EB1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6A43BC070BD6E8E439EAA88FFE73A054" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6A43BC070BD6E8E439EAA88FFE73A054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_EDF26B22990DD507F8CAA88FFE737BF6" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_NetIncomeLoss_EDF26B22990DD507F8CAA88FFE737BF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_1FD6918C55D9B52FC611A88FFE736D3A" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_1FD6918C55D9B52FC611A88FFE736D3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_311CF23E638BEF234654A88FFE748937" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_1FD6918C55D9B52FC611A88FFE736D3A" xlink:to="loc_us-gaap_EarningsPerShareBasic_311CF23E638BEF234654A88FFE748937" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_005A8B33D3FD5691D455A88FFE747449" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_005A8B33D3FD5691D455A88FFE747449" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3C29DE8E664831618A70A88FFE74701F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_005A8B33D3FD5691D455A88FFE747449" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3C29DE8E664831618A70A88FFE74701F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B5308F1D5B108B3C404DA88FFE746124" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1A37A147679D520DC6D3A88FFE64BD41" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B5308F1D5B108B3C404DA88FFE746124" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ADF19D39CD5898842E6A88FFE740AD1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B5308F1D5B108B3C404DA88FFE746124" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7ADF19D39CD5898842E6A88FFE740AD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9FAF9821DD7B24CF2E7EA88FFE74F8B0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_B5308F1D5B108B3C404DA88FFE746124" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9FAF9821DD7B24CF2E7EA88FFE74F8B0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConvertibleNotesDerivativeLiability" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40F8AB7FCB35E716E521FC5D413F71C2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_D70A0CC51BD72370818AFC5D413FA126" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40F8AB7FCB35E716E521FC5D413F71C2" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_D70A0CC51BD72370818AFC5D413FA126" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/Debt" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_DCE4DDFA23A3B9F4E1F2FC5D41C2D4B6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_75535A23560086BBCD0BFC5D41C2E672" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_DCE4DDFA23A3B9F4E1F2FC5D41C2D4B6" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_75535A23560086BBCD0BFC5D41C2E672" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_41ADFF22CDB335E378BEFC5D410457C0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_41ADFF22CDB335E378BEFC5D410457C0" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsAxis" xlink:label="loc_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:to="loc_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsAxis_AD3E26C889337D719E8FFC5D4104B911" xlink:to="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm1Member" xlink:label="loc_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:to="loc_ccrn_CovenantTerm1Member_022189E9FF8AC77BE206FC5D410485D6" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm2Member" xlink:label="loc_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:to="loc_ccrn_CovenantTerm2Member_735E79769BCC993E0BB0FC5D41041F18" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm3Member" xlink:label="loc_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:to="loc_ccrn_CovenantTerm3Member_C96598F3C6C45F293B5EFC5D410494F4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm4Member" xlink:label="loc_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:to="loc_ccrn_CovenantTerm4Member_BEAEAE9F771030D61ECEFC5D41044806" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CovenantTerm5Member" xlink:label="loc_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_DC16F23179FCF7BAFD2FFC5D41047813" xlink:to="loc_ccrn_CovenantTerm5Member_594826D63876B057ADBDFC5D4104EE5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_A59659638354BF22CB10FC5D41043DB5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:to="loc_us-gaap_RangeAxis_A59659638354BF22CB10FC5D41043DB5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_1D65F41E5A1AC409D3E6FC5D4104C383" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_A59659638354BF22CB10FC5D41043DB5" xlink:to="loc_us-gaap_RangeMember_1D65F41E5A1AC409D3E6FC5D4104C383" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_BCA126A52C8114B883FFFC5D4104E0CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_1D65F41E5A1AC409D3E6FC5D4104C383" xlink:to="loc_us-gaap_MinimumMember_BCA126A52C8114B883FFFC5D4104E0CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_4A81D5A84524F7EE216DFC5D410405D4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_1D65F41E5A1AC409D3E6FC5D4104C383" xlink:to="loc_us-gaap_MaximumMember_4A81D5A84524F7EE216DFC5D410405D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:to="loc_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_B449A2EBBD2B063D95A7FC5D41042C2A" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7948A3F3A21D9ADC27B3FC5D4105CF19" xlink:to="loc_ccrn_CreditAgreementMember_427B0CDAA9054A21E538FC5D4105525A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:to="loc_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_46A933FBD850801E32C0FC5D4105A326" xlink:to="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_2D20D6EFDEBE83A6F1E8FC5D410525A2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:to="loc_us-gaap_EurodollarMember_2D20D6EFDEBE83A6F1E8FC5D410525A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_D6EADD3A3C6886894CCCFC5D41058FFE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_D6EADD3A3C6886894CCCFC5D41058FFE" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LetterofCreditFeeMember" xlink:label="loc_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:to="loc_ccrn_LetterofCreditFeeMember_7444475F64C3439D53A0FC5D4105FECA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_41AFDEC2C542794783CAFC5D410556A2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_E0730EE9EF32CE87A52CFC5D4105229A" xlink:to="loc_us-gaap_BaseRateMember_41AFDEC2C542794783CAFC5D410556A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3107DFACF532ECC8F6C9FC5D4104EEEE" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConsolidatedNetLeverageRatio" xlink:label="loc_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:to="loc_ccrn_ConsolidatedNetLeverageRatio_584405216646672D240AFC5D41055AD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_968FFEA7C2557F227EDCFC5D410577A1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_968FFEA7C2557F227EDCFC5D410577A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7F6FE0A0B15A0C71FC05FC5D410538CD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_C693982E8D3F5314711CFC5D410594A0" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7F6FE0A0B15A0C71FC05FC5D410538CD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_85357725BEA69F56B764B2A3007E1793" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_85357725BEA69F56B764B2A3007E1793" xlink:to="loc_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0ABB80E0B5CBBC0699C5B2A30081088D" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_4CFAC201BA3B34CADCF3B2A30081A52A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_E5AFE5C68435071206CBB2A300816613" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_4CFAC201BA3B34CADCF3B2A30081A52A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8136D59CDA0F40B40926B2A30080BAFB" xlink:to="loc_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_FA840083F61381641E01B2A300815304" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_FA840083F61381641E01B2A300815304" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4EE6064D8FEE34AB354AB2A30082CB7D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4EE6064D8FEE34AB354AB2A30082CB7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3BAE169B338B5863EE0EB2A30082FA1A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3BAE169B338B5863EE0EB2A30082FA1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_D312214273A952B67FB3B2A300826851" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_D312214273A952B67FB3B2A300826851" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ED89FFDF7005060E527B2A30087D697" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_5ED89FFDF7005060E527B2A30087D697" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_79B460F199D6A570AF23B2A30089C73F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_E7BD4994DA0C4991FE42B2A300810D3E" xlink:to="loc_us-gaap_LongTermDebt_79B460F199D6A570AF23B2A30089C73F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsAbstract" xlink:label="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A3DE613A775399F4B7A8B2A30081F153" xlink:to="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_F271F9983E06867102F5B2A300899438" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear_F271F9983E06867102F5B2A300899438" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_046C9C58201DA06D4744B2A300892D1D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_046C9C58201DA06D4744B2A300892D1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_E9AA7D6FD98EF7623895B2A30089CD13" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_E9AA7D6FD98EF7623895B2A30089CD13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_CED8634B2979C95BDD96B2A300893878" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_CED8634B2979C95BDD96B2A300893878" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_F97C028B1B1E483E7563B2A3008AD84E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears_F97C028B1B1E483E7563B2A3008AD84E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_791ACB947DBE94796AD4B2A3008A8CDB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeaseObligationsAbstract_EA246064F73B7BD1A929B2A300893B90" xlink:to="loc_us-gaap_CapitalLeasesFutureMinimumPaymentsDue_791ACB947DBE94796AD4B2A3008A8CDB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3D08820D4DE9E21B2C96CED5130A418D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_3452E77A4DDFF4EAB0E4CED5130A344B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3D08820D4DE9E21B2C96CED5130A418D" xlink:to="loc_us-gaap_DebtInstrumentTable_3452E77A4DDFF4EAB0E4CED5130A344B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_70FAEF2712E889F462BFCED5130BBDBF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3452E77A4DDFF4EAB0E4CED5130A344B" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_70FAEF2712E889F462BFCED5130BBDBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9CF68C4B441786FB5B97CED5130BBE7E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_70FAEF2712E889F462BFCED5130BBDBF" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9CF68C4B441786FB5B97CED5130BBE7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_BD4D8841EAC6A2FE9F18CED5130BDF13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9CF68C4B441786FB5B97CED5130BBE7E" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_BD4D8841EAC6A2FE9F18CED5130BDF13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_97989C3F9C8E04928CDECED5130B4EF0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9CF68C4B441786FB5B97CED5130BBE7E" xlink:to="loc_us-gaap_ConvertibleDebtMember_97989C3F9C8E04928CDECED5130B4EF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_0E52E0AE2AA7E7E59EDECED5130B37CA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3452E77A4DDFF4EAB0E4CED5130A344B" xlink:to="loc_us-gaap_DebtInstrumentAxis_0E52E0AE2AA7E7E59EDECED5130B37CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0E52E0AE2AA7E7E59EDECED5130B37CA" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_04FAA021C3D3F447AB48CED5130C1250" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09" xlink:to="loc_ccrn_TermLoanMember_04FAA021C3D3F447AB48CED5130C1250" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_A8ConvertibleNotesMember" xlink:label="loc_ccrn_A8ConvertibleNotesMember_BE2AFF4BC1A9212A94C9CED5130C5340" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09" xlink:to="loc_ccrn_A8ConvertibleNotesMember_BE2AFF4BC1A9212A94C9CED5130C5340" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleNoteDerivativeLiabilityMember" xlink:label="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_6A7797B3DC452AE337B9CED5130CF93F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5DF399DF7A4BC021433DCED5130B9C09" xlink:to="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_6A7797B3DC452AE337B9CED5130CF93F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3452E77A4DDFF4EAB0E4CED5130A344B" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_736494C0C1CF34972D54CED5130C6251" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_736494C0C1CF34972D54CED5130C6251" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligations" xlink:label="loc_us-gaap_CapitalLeaseObligations_61AE7D7E3E8274909D91CED5130CA854" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_CapitalLeaseObligations_61AE7D7E3E8274909D91CED5130CA854" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_D3D44507BCA6C32B2120CED5130D1DE7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_D3D44507BCA6C32B2120CED5130D1DE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_D165D5657CA30BDC8E31CED5130D08E3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_D165D5657CA30BDC8E31CED5130D08E3" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LongtermDebtandCapitalLeaseObligationsGross" xlink:label="loc_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_ccrn_LongtermDebtandCapitalLeaseObligationsGross_A60D09FEAEE811E0CD65CED5130D91F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_92EBD208B7D779E93A4DCED5130EC2E4" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_92EBD208B7D779E93A4DCED5130EC2E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2FF7A1B4CEB06123E3C8CED5130E246D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8F76B18EAC0C4DF30118CED5130CA38F" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2FF7A1B4CEB06123E3C8CED5130E246D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4FE21C62110C8BA6ECFFD0DE6FD2E82C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4FE21C62110C8BA6ECFFD0DE6FD2E82C" xlink:to="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsAxis" xlink:label="loc_ccrn_DebtCovenantTermsAxis_ADCD20C7C21DC990B8B2D0DE6FD2CAB0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_ccrn_DebtCovenantTermsAxis_ADCD20C7C21DC990B8B2D0DE6FD2CAB0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsAxis_ADCD20C7C21DC990B8B2D0DE6FD2CAB0" xlink:to="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member" xlink:label="loc_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F" xlink:to="loc_ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member_B97448365A1C1B1A9291D0DE6FD2F84F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member" xlink:label="loc_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F" xlink:to="loc_ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member_4F6DD98A2D117DD1D3A8D0DE6FD2F9E0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_EachFiscalQuarterEndingThereafterMember" xlink:label="loc_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3243A2575CDA60A60D8AD0DE6FD2D79F" xlink:to="loc_ccrn_EachFiscalQuarterEndingThereafterMember_9019AF5926CE679138BCD0DE6FD36DE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2E446017DBDA262BA59AD0DE6FD33378" xlink:to="loc_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_13F4B17B89F25D1CBCEAD0DE6FD3BDDC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5EBDE18313D29A920E45D0DE6FD32627" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_13F4B17B89F25D1CBCEAD0DE6FD3BDDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_2CCF727CDDDB05EAAB5BD0DE6FD36B32" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_us-gaap_DebtInstrumentAxis_2CCF727CDDDB05EAAB5BD0DE6FD36B32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_375BE166EC5894B2BD89D0DE6FD398BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2CCF727CDDDB05EAAB5BD0DE6FD36B32" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_375BE166EC5894B2BD89D0DE6FD398BF" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_5C2D800AA476E69ACCBCD0DE6FD31278" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_375BE166EC5894B2BD89D0DE6FD398BF" xlink:to="loc_ccrn_CreditAgreementMember_5C2D800AA476E69ACCBCD0DE6FD31278" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_FBFED42160FCF873E844D0DE6FD39560" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_us-gaap_VariableRateAxis_FBFED42160FCF873E844D0DE6FD39560" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_67CBAEB6890980EE7720D0DE6FD375E8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_FBFED42160FCF873E844D0DE6FD39560" xlink:to="loc_us-gaap_VariableRateDomain_67CBAEB6890980EE7720D0DE6FD375E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2F0FBD916C107221F81ED0DE6FD3FCEE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_67CBAEB6890980EE7720D0DE6FD375E8" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2F0FBD916C107221F81ED0DE6FD3FCEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_DA331887DA79BAB2218BD0DE6FD3D174" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_us-gaap_RangeAxis_DA331887DA79BAB2218BD0DE6FD3D174" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_B8C030E968D47210D0B0D0DE6FD34BE3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_DA331887DA79BAB2218BD0DE6FD3D174" xlink:to="loc_us-gaap_RangeMember_B8C030E968D47210D0B0D0DE6FD34BE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_1499E7E5F6392DD5ADDCD0DE6FD4D0E9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_B8C030E968D47210D0B0D0DE6FD34BE3" xlink:to="loc_us-gaap_MaximumMember_1499E7E5F6392DD5ADDCD0DE6FD4D0E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_2E78C39206D149A95BC4D0DE6FD42AB9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_B8C030E968D47210D0B0D0DE6FD34BE3" xlink:to="loc_us-gaap_MinimumMember_2E78C39206D149A95BC4D0DE6FD42AB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_64C79BB2D61DB3CD411CD0DE6FD47EFD" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_64C79BB2D61DB3CD411CD0DE6FD47EFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_311410E46098F4CFDF2ED0DE6FD4DB0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_64C79BB2D61DB3CD411CD0DE6FD47EFD" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_311410E46098F4CFDF2ED0DE6FD4DB0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_5CD2CADAEB58A20048A1D0DE6FD41F48" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_311410E46098F4CFDF2ED0DE6FD4DB0B" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_5CD2CADAEB58A20048A1D0DE6FD41F48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D78AA5599804D6065F6DD0DE6FD2A483" xlink:to="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3067B1125843D3F00D3FD0DE6FD44BF1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3067B1125843D3F00D3FD0DE6FD44BF1" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit" xlink:label="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_86ECBE2D7EF18B077718D0DE6FD54344" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans" xlink:label="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_B91F5038F9902C5E5A69D0DE6FD5E13D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityAdditionalCapacity" xlink:label="loc_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineofCreditFacilityAdditionalCapacity_E692EEF189DEB7E4D0C3D0DE6FD57F10" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments" xlink:label="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments_06D2D70946D7222F8576D0DE6FD57DCF" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments" xlink:label="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments_376DDEBDEB96334A144FD0DE6FD5351D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments" xlink:label="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments_BD951B0B8C48C38E42E3D0DE6FD5C463" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_BB8024451EF657104B36D0DE6FD5C5A2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_BB8024451EF657104B36D0DE6FD5C5A2" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault" xlink:label="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_B8AD79DC11EF32119CADD0DE6FD5D1D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ECC44F619BFF57897CC1D0DE6FD5EB9D" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ECC44F619BFF57897CC1D0DE6FD5EB9D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_NumberofFinancialCovenants" xlink:label="loc_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_NumberofFinancialCovenants_ECA710BDDF226DB2DCEDD0DE6FD60140" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RatioOfIndebtednessToNetCapital1" xlink:label="loc_us-gaap_RatioOfIndebtednessToNetCapital1_12391D3675127EFFFB7ED0DE6FD6CF62" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_RatioOfIndebtednessToNetCapital1_12391D3675127EFFFB7ED0DE6FD6CF62" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio" xlink:label="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_952629717BE839A69D86D0DE6FD6C0ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_E21CEBF9C753746119B1D0DE6FD68CAB" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_E21CEBF9C753746119B1D0DE6FD68CAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_7B8B797D93B9B1AC5ECBD0DE6FD68F96" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_73C3062C180985B2F19FD0DE6FD41DAC" xlink:to="loc_us-gaap_LineOfCredit_7B8B797D93B9B1AC5ECBD0DE6FD68F96" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_10F2CC433864626D6C67D49E321CAD9F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_74DC275E530A9386A608D49E321F7689" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_10F2CC433864626D6C67D49E321CAD9F" xlink:to="loc_us-gaap_DebtInstrumentTable_74DC275E530A9386A608D49E321F7689" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_AFDB67CF616FDE4DA8A5D49E321F421B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_74DC275E530A9386A608D49E321F7689" xlink:to="loc_us-gaap_DebtInstrumentAxis_AFDB67CF616FDE4DA8A5D49E321F421B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_776F00A46EDC024E7EE5D49E3220150D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_AFDB67CF616FDE4DA8A5D49E321F421B" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_776F00A46EDC024E7EE5D49E3220150D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_A8ConvertibleNotesMember" xlink:label="loc_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_776F00A46EDC024E7EE5D49E3220150D" xlink:to="loc_ccrn_A8ConvertibleNotesMember_3F8E3B8FA7AA7AB336C4D49E32205B5F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleNoteDerivativeLiabilityMember" xlink:label="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_776F00A46EDC024E7EE5D49E3220150D" xlink:to="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_F8F5E3EB2AAAED63AF56D49E3220B0B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_74DC275E530A9386A608D49E321F7689" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_CE793E759A3616781954D49E3220FFFA" xlink:to="loc_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_E30510C22AA54B7AB151D49E32201746" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_37D1450ED19425CF674ED49E322052BE" xlink:to="loc_us-gaap_CommonStockMember_E30510C22AA54B7AB151D49E32201746" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_DF4E203583DEBE37F813D49E322044F1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_74DC275E530A9386A608D49E321F7689" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_DF4E203583DEBE37F813D49E322044F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_FB4E0186BAB7CA259CA6D49E3220AAC2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_DF4E203583DEBE37F813D49E322044F1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_FB4E0186BAB7CA259CA6D49E3220AAC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_294B1F86D3580B9C6144D49E32219427" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_FB4E0186BAB7CA259CA6D49E3220AAC2" xlink:to="loc_us-gaap_ConvertibleDebtMember_294B1F86D3580B9C6144D49E32219427" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_74DC275E530A9386A608D49E321F7689" xlink:to="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7C27BEA75FD9AE0E3FAAD49E3221A332" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7C27BEA75FD9AE0E3FAAD49E3221A332" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_40575C3BAB6A575F895ED49E3221C525" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_40575C3BAB6A575F895ED49E3221C525" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8DF72085A8D35E0C3187D49E3221A7EC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8DF72085A8D35E0C3187D49E3221A7EC" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" xlink:label="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_234C28B9861D7C81B5CAD49E322107D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_DBAF1BFEEFA0641E3B90D49E32219778" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_DBAF1BFEEFA0641E3B90D49E32219778" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_84A0E7BA79D4C698BD91D49E32216FDF" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_84A0E7BA79D4C698BD91D49E32216FDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_1FC65283B5781761AA18D49E3221B3C0" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_1FC65283B5781761AA18D49E3221B3C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_E71B9AD1B57BB905BFD2D49E3221909E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_E71B9AD1B57BB905BFD2D49E3221909E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_FED19F45380D55EEACDAD49E374B5A58" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_FED19F45380D55EEACDAD49E374B5A58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0D586396729043BD9542D49E32212D36" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0D586396729043BD9542D49E32212D36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_92FFC93AC63DED910809D49E3221ED8F" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_92FFC93AC63DED910809D49E3221ED8F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate" xlink:label="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_1D948F4324A7A03AB6C0D49E3221CA25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_B26824B9B2EA3127737CD49E3221825E" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_B26824B9B2EA3127737CD49E3221825E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_7890E281BFB2AA924068D49E32217098" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_7890E281BFB2AA924068D49E32217098" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_957E3684D1CCE2D9E5FBD49E32215B83" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_957E3684D1CCE2D9E5FBD49E32215B83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_BABADD899713CDB0F033D49E3222B031" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_BABADD899713CDB0F033D49E3222B031" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal" xlink:label="loc_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_E868A92FFFD9C50F6D43D49E3221732A" xlink:to="loc_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal_A789D90CB34C789A4AB2D49E3222E9B2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_BB6288269F1A2075592CFC5D41C06C46" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_F9142A26094D8BAA75E0FC5D41C0587B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_BB6288269F1A2075592CFC5D41C06C46" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_F9142A26094D8BAA75E0FC5D41C0587B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8EC23DBDDE9F7B778792FC5D41C0C005" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_BB6288269F1A2075592CFC5D41C06C46" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8EC23DBDDE9F7B778792FC5D41C0C005" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DocumentandEntityInformationAbstract" xlink:label="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_2FB0B1144D46D66B01D9FC5D40EA01C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="loc_dei_TradingSymbol_2FB0B1144D46D66B01D9FC5D40EA01C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_DB21F9603526157B23DCFC5D40EA9F6C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="loc_dei_EntityRegistrantName_DB21F9603526157B23DCFC5D40EA9F6C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_BE9D36F7E97D6E8FBDAEFC5D40EA67CD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="loc_dei_EntityCentralIndexKey_BE9D36F7E97D6E8FBDAEFC5D40EA67CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_FB30D25A5E3D7C1B4657FC5D40EA6D14" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="loc_dei_CurrentFiscalYearEndDate_FB30D25A5E3D7C1B4657FC5D40EA6D14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_AEE6B708C20E3B54DABAFC5D40EA83D0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="loc_dei_EntityFilerCategory_AEE6B708C20E3B54DABAFC5D40EA83D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_E21D336984303B94D130FC5D40EA8F6A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="loc_dei_DocumentType_E21D336984303B94D130FC5D40EA8F6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_01A2D95C5DDCC2A84509FC5D40EACF25" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="loc_dei_DocumentPeriodEndDate_01A2D95C5DDCC2A84509FC5D40EACF25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_C21DD7316DDF21943387FC5D40EAA72C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="loc_dei_DocumentFiscalYearFocus_C21DD7316DDF21943387FC5D40EAA72C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_406785DE8460B3EB7373FC5D40EBA4F1" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="loc_dei_DocumentFiscalPeriodFocus_406785DE8460B3EB7373FC5D40EBA4F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_F6B84A50BC6E0C4ACAE7FC5D40EB0620" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="loc_dei_AmendmentFlag_F6B84A50BC6E0C4ACAE7FC5D40EB0620" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2AECEFC7506F34A93536FC5D40EB1C29" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentandEntityInformationAbstract_C250CC75CAEBF01ABC29FC5D40E9FAC3" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2AECEFC7506F34A93536FC5D40EB1C29" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2EF8B0F97A0B59F1F4D6FC5D4148C816" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_840EDAE0D159A889235DFC5D4148B2EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2EF8B0F97A0B59F1F4D6FC5D4148C816" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_840EDAE0D159A889235DFC5D4148B2EC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_F42859AF499617DAD8E0D15D471F23FD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5BBE2DF84FFA5E8ABFDAD15D471F3186" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F42859AF499617DAD8E0D15D471F23FD" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5BBE2DF84FFA5E8ABFDAD15D471F3186" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_7926FA089577221CD871D15D471F2E85" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F42859AF499617DAD8E0D15D471F23FD" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_7926FA089577221CD871D15D471F2E85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_A861DC3CD566AA060197D15D471FB949" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F42859AF499617DAD8E0D15D471F23FD" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_A861DC3CD566AA060197D15D471FB949" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_422F8F1861A6F3A0F589D15D471FC8D5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F42859AF499617DAD8E0D15D471F23FD" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_422F8F1861A6F3A0F589D15D471FC8D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8183D453E1E713869118D15D471F9B98" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F42859AF499617DAD8E0D15D471F23FD" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8183D453E1E713869118D15D471F9B98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_42D78C9783D60F7F384AD15D471F5EEF" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F42859AF499617DAD8E0D15D471F23FD" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_42D78C9783D60F7F384AD15D471F5EEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_18711CFA10D40C1E61DAD15D471FCA58" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_42D78C9783D60F7F384AD15D471F5EEF" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_18711CFA10D40C1E61DAD15D471FCA58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_A64E231182D5CD9E76EBD15D471F8736" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_42D78C9783D60F7F384AD15D471F5EEF" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_A64E231182D5CD9E76EBD15D471F8736" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_136ED01EACA0672EAC99D15D471F5C42" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F42859AF499617DAD8E0D15D471F23FD" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_136ED01EACA0672EAC99D15D471F5C42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_AC8951E9F767D1187C43D15D471F48F5" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F42859AF499617DAD8E0D15D471F23FD" xlink:to="loc_us-gaap_EarningsPerShareBasic_AC8951E9F767D1187C43D15D471F48F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5818EC6B83D3AEAB5D1FD15D471F1A67" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F42859AF499617DAD8E0D15D471F23FD" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5818EC6B83D3AEAB5D1FD15D471F1A67" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_087BC90640F2282C41FBA0506170FFBE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EFD601342928E10A597FA05061709662" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_087BC90640F2282C41FBA0506170FFBE" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_EFD601342928E10A597FA05061709662" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_F6CB3846C0FC834060AFFC5D4086E484" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_BC72EBA9C4116FDC21EEFC5D408680EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_F6CB3846C0FC834060AFFC5D4086E484" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_BC72EBA9C4116FDC21EEFC5D408680EA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0B529FC0C42503FC58BBD458E7205CA2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0B529FC0C42503FC58BBD458E7205CA2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07945D5CD164127A2B5AD458E7234DF1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07945D5CD164127A2B5AD458E7234DF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E612F0BF714E9E095EE1D458E7245F12" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_07945D5CD164127A2B5AD458E7234DF1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E612F0BF714E9E095EE1D458E7245F12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_931EE380534C783EE7D9D458E724EEA8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E612F0BF714E9E095EE1D458E7245F12" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_931EE380534C783EE7D9D458E724EEA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_30907EA472B7AB4494BBD458E7293FFB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E612F0BF714E9E095EE1D458E7245F12" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_30907EA472B7AB4494BBD458E7293FFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_17469A7EDC73ED1822BFD458E72A5817" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_DeferredCompensationMember" xlink:label="loc_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F7E75D7C6544E0FA8FDBD458E72A8CE2" xlink:to="loc_ccrn_DeferredCompensationMember_1DD5BD9A24B93C32F862D458E72A0377" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_365719655A0FDAE47BDED458E72BA2F1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_365719655A0FDAE47BDED458E72BA2F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_289C760D8A7E9B9C48BAD458E72B4037" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_365719655A0FDAE47BDED458E72BA2F1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_289C760D8A7E9B9C48BAD458E72B4037" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleNotesDerivativeLiabilityMember" xlink:label="loc_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_289C760D8A7E9B9C48BAD458E72B4037" xlink:to="loc_ccrn_ConvertibleNotesDerivativeLiabilityMember_097389E6FC0D9D1954AAD458E72BB45A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_B2B1FA84301F5F1F2A59D458E72344ED" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_FA1A7037B44A76F4BD76D458E72BF727" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_FA1A7037B44A76F4BD76D458E72BF727" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_E69938A3217207C1D99CD458E72D8641" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:to="loc_us-gaap_DebtInstrumentFairValue_E69938A3217207C1D99CD458E72D8641" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8FD998C7496B095C7F43D458E72DD3CE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8D4067E3A8CFC88B6374D458E72B6A6E" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8FD998C7496B095C7F43D458E72DD3CE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_AD3D542C4D34AB9C2310A07E9FE14496" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_AD3D542C4D34AB9C2310A07E9FE14496" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_95985C6CD81D18D546A2A07E9FE164B9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_95985C6CD81D18D546A2A07E9FE164B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8ED881ED8F307EF6F79EA07E9FE12D81" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_95985C6CD81D18D546A2A07E9FE164B9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8ED881ED8F307EF6F79EA07E9FE12D81" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8ED881ED8F307EF6F79EA07E9FE12D81" xlink:to="loc_ccrn_TermLoanMember_DE2BC6A0314B3E09A813A07E9FE1284E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ConvertibleNotesNetMember" xlink:label="loc_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8ED881ED8F307EF6F79EA07E9FE12D81" xlink:to="loc_ccrn_ConvertibleNotesNetMember_911022B1565A30A2203FA07E9FE1E48E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_0A1237055E10E7D4A039A07E9FE1E8BC" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_DF8710400B7E350D7F66A07E9FE18D1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_B964E3055599C8784FF5A07E9FE13291" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_B964E3055599C8784FF5A07E9FE13291" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_23300642F88B5A7745CEA07E9FE1474E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3F86FE7C0A34DC64585DA07E9FE187BB" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_23300642F88B5A7745CEA07E9FE1474E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31EBBA4788A58BFD882BA07E9FE11A5C" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0AAB3E2044796EA02F1DA07E9FE20E4D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E891EA3555F6D4A9304CA07E9FE1FB94" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0AAB3E2044796EA02F1DA07E9FE20E4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_15624F4EA8995B891D23A07E9FE13986" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_129B05B7EDB808DB379AA07E9FE23F4E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:to="loc_us-gaap_LongTermDebt_129B05B7EDB808DB379AA07E9FE23F4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_AD74BCEFA84DD21D3708A07E9FE22692" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_EE1AD8A3423602AF8BCEA07E9FE29049" xlink:to="loc_us-gaap_DebtInstrumentFairValue_AD74BCEFA84DD21D3708A07E9FE22692" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0E3ACCF3976A8F436C06AAF20B906931" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FairValueMeasurementTable" xlink:label="loc_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0E3ACCF3976A8F436C06AAF20B906931" xlink:to="loc_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:to="loc_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_F10D2D0F04CC76DCC168AAF20B90E605" xlink:to="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_E795992FC99F63BCB9FDAAF20B9022B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:to="loc_us-gaap_MinimumMember_E795992FC99F63BCB9FDAAF20B9022B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_5391AC4EF8DD5A838FCFAAF20B905AEB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_1A4E3DAF4FF81142AC24AAF20B90C381" xlink:to="loc_us-gaap_MaximumMember_5391AC4EF8DD5A838FCFAAF20B905AEB" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FairValueMeasurementLineItems" xlink:label="loc_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FairValueMeasurementTable_E588AAF322B74A3C789BAAF20B90F612" xlink:to="loc_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_ED1A966D1CC8F8644ED1AAF89FC21067" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:to="loc_us-gaap_AssetImpairmentCharges_ED1A966D1CC8F8644ED1AAF89FC21067" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided" xlink:label="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FairValueMeasurementLineItems_1F166BF693C376D1FFC8AAF20B907B4E" xlink:to="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_9575D547A9444F417ED6AAF20B905542" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_B5C61BF5F6CBCD5E88A3D458FBCBC317" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_B5C61BF5F6CBCD5E88A3D458FBCBC317" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_B9C1150A77C2228F9C38D458FBCBBBEE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_B9C1150A77C2228F9C38D458FBCBBBEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7D94C625F64FFE095C2DD458FBCB660F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_B9C1150A77C2228F9C38D458FBCBBBEE" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7D94C625F64FFE095C2DD458FBCB660F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ContingentConsiderationLiabilityMember" xlink:label="loc_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7D94C625F64FFE095C2DD458FBCB660F" xlink:to="loc_ccrn_ContingentConsiderationLiabilityMember_804E4629E7214FD891DAD458FBCBA088" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8D3065A33AB94817C2CAD458FBCB5578" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_7D94C625F64FFE095C2DD458FBCB660F" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_8D3065A33AB94817C2CAD458FBCB5578" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_D92D37E9D4DD18BC8FA6D458FBCBDB94" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4DA65FF565900DFCAA4FD458FBCC50CB" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26B04FC74CA6A10EE730D458FBCC2570" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26B04FC74CA6A10EE730D458FBCC2570" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_CBF5B39B768F68076CB4D458FBCCDA88" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_CBF5B39B768F68076CB4D458FBCCDA88" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense" xlink:label="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:to="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_95AB68E4A03D3CDFA6E2D458FBCC58AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AAAF0A2636629FFEE422D458FBCCB66B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_AAAF0A2636629FFEE422D458FBCCB66B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_D8D000B2BEB806E80E31D458FBCC2D4E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_84E0DEC97C16BF74486CD458FBCC0E8E" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_D8D000B2BEB806E80E31D458FBCC2D4E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_413F60A07DB9AAE8EB2BFC5D40543630" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_E2534A613FED3E168B7CFC5D40541BB6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_413F60A07DB9AAE8EB2BFC5D40543630" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_E2534A613FED3E168B7CFC5D40541BB6" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:label="loc_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock_1B05AD5AC33A6684232EFC5D40544EE5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_413F60A07DB9AAE8EB2BFC5D40543630" xlink:to="loc_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock_1B05AD5AC33A6684232EFC5D40544EE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_CF7AA01AB31F7F9E9130FC5D4054DDC0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_413F60A07DB9AAE8EB2BFC5D40543630" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_CF7AA01AB31F7F9E9130FC5D4054DDC0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_97CC50F1D8C6555EF86187DC273E6316" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_BE8186209199CF45C8CC87DC273F34FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_97CC50F1D8C6555EF86187DC273E6316" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_BE8186209199CF45C8CC87DC273F34FC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_AE2A25E1CAF2DDA5C0A887FF4C752FCE" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_AE2A25E1CAF2DDA5C0A887FF4C752FCE" xlink:to="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_97A6DA0F4FC8B9E2DF6387FF4C82013C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DatabasesMember" xlink:label="loc_us-gaap_DatabasesMember_C3B36FD23163B2891FE087FF4C837FB2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:to="loc_us-gaap_DatabasesMember_C3B36FD23163B2891FE087FF4C837FB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3751A1B391BCC126F6B787FF4C849855" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3751A1B391BCC126F6B787FF4C849855" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_6D929DCC185EA3CE96E387FF4C849C8C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_6D929DCC185EA3CE96E387FF4C849C8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_FA47028D3DFC8773B4E287FF4C84EBC1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8C27BEF0ED61C82B314C87FF4C825ED9" xlink:to="loc_us-gaap_TradeNamesMember_FA47028D3DFC8773B4E287FF4C84EBC1" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_9662A382684EB1C655FB87FF4C7FE2AD" xlink:to="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_85554974152F27DD5D6487FF4C859757" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_85554974152F27DD5D6487FF4C859757" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_B2AF09F7B41CAF6FF95587FF4C8D6DED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_B2AF09F7B41CAF6FF95587FF4C8D6DED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_D4B50C48E93D7915934587FF4C8D8611" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_D4B50C48E93D7915934587FF4C8D8611" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_9C20C0053FDD1517C5D887FF4C8D5484" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_9C20C0053FDD1517C5D887FF4C8D5484" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6F1C050937296EF45D5F880119391647" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_55654CEA8BE6E81A7C7187FF4C856883" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6F1C050937296EF45D5F880119391647" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5E5545FDD1A0A741F50D87FF98112656" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_085982139382B26F7EF387FF98170C8D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5E5545FDD1A0A741F50D87FF98112656" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_085982139382B26F7EF387FF98170C8D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DD8E2D60C49EF2B6607B87FF9817117D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5E5545FDD1A0A741F50D87FF98112656" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DD8E2D60C49EF2B6607B87FF9817117D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_18B98198330889E8FD6A87FF98176969" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5E5545FDD1A0A741F50D87FF98112656" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_18B98198330889E8FD6A87FF98176969" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_01006471F3273210BC8487FF98171C42" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5E5545FDD1A0A741F50D87FF98112656" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_01006471F3273210BC8487FF98171C42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_D0FAA7D9BC02E6B13A4287FF9818A6AE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5E5545FDD1A0A741F50D87FF98112656" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_D0FAA7D9BC02E6B13A4287FF9818A6AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_837615E8E257AA31B86E87FF9818356A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5E5545FDD1A0A741F50D87FF98112656" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_837615E8E257AA31B86E87FF9818356A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7FB828962C0AC738EEC787FF9819ED8C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5E5545FDD1A0A741F50D87FF98112656" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7FB828962C0AC738EEC787FF9819ED8C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9910DA0E51DD55C3E99AC1EEF79B317D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9910DA0E51DD55C3E99AC1EEF79B317D" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_C2C8AB4D486DF528CF24C1EEF79C1CF7" xlink:to="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_69E40631C5268ADA76CCC1EEF79C4D93" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_69E40631C5268ADA76CCC1EEF79C4D93" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_005EB7299FBBE249873EC1EEF79C96B5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:to="loc_ccrn_PhysicianStaffingMember_005EB7299FBBE249873EC1EEF79C96B5" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_6BF9E612DB8DBFB30C65C1EEF79C1C92" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_014728B379B048D59400C1EEF79C3DD9" xlink:to="loc_ccrn_OtherHumanCapitalManagementServicesMember_6BF9E612DB8DBFB30C65C1EEF79C1C92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_66E00091C5EA1D2ADE7DC1EEF79BB7C6" xlink:to="loc_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_84446E63B2129C9C717AC1EEF79C7F07" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_6795B270F5E547FFB6ADC1EEF79CA438" xlink:to="loc_us-gaap_Goodwill_84446E63B2129C9C717AC1EEF79C7F07" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C1211ED51B8A58E10AA987DC272E8339" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_02827B47DDFFC3F34D2C87DC272EE497" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C1211ED51B8A58E10AA987DC272E8339" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_02827B47DDFFC3F34D2C87DC272EE497" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_CEBB334914ADF15DC8A487DC272F83AD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C1211ED51B8A58E10AA987DC272E8339" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_CEBB334914ADF15DC8A487DC272F83AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_3C06549028C389ED4E8E87DC272F35C2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C1211ED51B8A58E10AA987DC272E8339" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_3C06549028C389ED4E8E87DC272F35C2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0AA3617049D5A04315C5FC5D40B068A8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8A05A2E2E89CB7F08B03FC5D40B13C3C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0AA3617049D5A04315C5FC5D40B068A8" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8A05A2E2E89CB7F08B03FC5D40B13C3C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_EE40000DB3AFDFD5D47FCB46A7AFD77C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1080F65D8571F87C2532CB46A7AFA799" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_EE40000DB3AFDFD5D47FCB46A7AFD77C" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1080F65D8571F87C2532CB46A7AFA799" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:label="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_477635A6F191FFC5AA82CB46A7AF2672" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_EE40000DB3AFDFD5D47FCB46A7AFD77C" xlink:to="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_477635A6F191FFC5AA82CB46A7AF2672" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_81D98F60B3A43672DE4BCB46A7AF568F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_EE40000DB3AFDFD5D47FCB46A7AFD77C" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_81D98F60B3A43672DE4BCB46A7AF568F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203BDF555E703242AEAFCB46A7AFC81F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_EE40000DB3AFDFD5D47FCB46A7AFD77C" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_203BDF555E703242AEAFCB46A7AFC81F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DEA710C1F6A04841C6BCB46A7AF0184" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_EE40000DB3AFDFD5D47FCB46A7AFD77C" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7DEA710C1F6A04841C6BCB46A7AF0184" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59FB19D164D9B006EECFFC5D410BFEF4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_B78434C2A7439D0502F0FC5D410BE0AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_59FB19D164D9B006EECFFC5D410BFEF4" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_B78434C2A7439D0502F0FC5D410BE0AA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RecentAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_80389B56CA6737A8009AFC5D40801BDC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_83B6FC7EB1E0BE46286FFC5D4080E904" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_80389B56CA6737A8009AFC5D40801BDC" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_83B6FC7EB1E0BE46286FFC5D4080E904" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_79E56AFAE4C067FDEA4AFC5D414173CE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_B2D7D048EAF8CC62CD08FC5D414108C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_79E56AFAE4C067FDEA4AFC5D414173CE" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_B2D7D048EAF8CC62CD08FC5D414108C9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_830AFD44AF8CFD13DCCBA0745C1E4777" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_830AFD44AF8CFD13DCCBA0745C1E4777" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9DEDC23992528860654EA0745C1E2C24" xlink:to="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="loc_us-gaap_CorporateJointVentureMember_DA1953671DCAC6DEAFA3A0745C1EF636" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:to="loc_us-gaap_CorporateJointVentureMember_DA1953671DCAC6DEAFA3A0745C1EF636" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AffiliatedEntityMember" xlink:label="loc_us-gaap_AffiliatedEntityMember_24B5DB0967572403CF26A0745C1FBCDA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3763BD2AF4F9ECBC847CA0745C1EE33A" xlink:to="loc_us-gaap_AffiliatedEntityMember_24B5DB0967572403CF26A0745C1FBCDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_15606FD1DF8CCDC94093A0745C1E4904" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaap_RevenueFromRelatedParties_42544AB5639198B5F7E1A0745C1F5EAA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_us-gaap_RevenueFromRelatedParties_42544AB5639198B5F7E1A0745C1F5EAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableRelatedParties" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_B03E314E7AC55D54718DA07D9911F5C4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_B03E314E7AC55D54718DA07D9911F5C4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_JointVenturePercentOwnership" xlink:label="loc_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_ccrn_JointVenturePercentOwnership_8DE1BD186DAA12B6D223A0745C1FC9EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueFromJointVenturesCurrent" xlink:label="loc_us-gaap_DueFromJointVenturesCurrent_FFDA41736A8E3D4354EBA0745C1F0EB4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_us-gaap_DueFromJointVenturesCurrent_FFDA41736A8E3D4354EBA0745C1F0EB4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_5AC5555DBC7735A17C30A0745C1FC85D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_5AC5555DBC7735A17C30A0745C1FC85D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaap_PaymentsForRent_E9D6EECFBF0057C7B1A8A0745C1F84BC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_9EC776ED9F4F473DE904A0745C1FD27E" xlink:to="loc_us-gaap_PaymentsForRent_E9D6EECFBF0057C7B1A8A0745C1F84BC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_C8DFA528EFD9723CF06FFC5D407EE744" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_F7682E2C10D9803DAAEBFC5D407EBD3F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_C8DFA528EFD9723CF06FFC5D407EE744" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_F7682E2C10D9803DAAEBFC5D407EBD3F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_E1C9CFC907018BBF47BACB46A7B68D23" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_E1C9CFC907018BBF47BACB46A7B68D23" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_488DBDD336DB8374624ECB46A7B640A4" xlink:to="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_7CE4FA21ADF52D3E7702CB46A7B6BF59" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:to="loc_ccrn_PhysicianStaffingMember_E9A1BFA3320751EFFE40CB46A7B63DBA" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_F1380E22D142ADF8BF8DCB46A7B6B5F4" xlink:to="loc_ccrn_OtherHumanCapitalManagementServicesMember_E7F71CACCDA673C1EF90CB46A7B6DAEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_45ACCC8BF4F46EC6EC8DCB46A7B68028" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet_941F7A81EB5D2ED3BE49CB46A7B68A1B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_us-gaap_SalesRevenueServicesNet_941F7A81EB5D2ED3BE49CB46A7B68A1B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses_690E01B6DF4B6C84A4D8CB46A7B62ECD" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_6E6FEF1D81AA37197610CB46A7B68984" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_30110DDCB7D4AF352C24CB51A706364F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_30110DDCB7D4AF352C24CB51A706364F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_375FD23E0FF507F8A2D1CB46A7B89043" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_2449E7F9B4839B7562B9CB46A7B8C581" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_9C2E437A2250F45AAD0CCB46A7B668CD" xlink:to="loc_us-gaap_OperatingIncomeLoss_2449E7F9B4839B7562B9CB46A7B8C581" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_43829AB67F5C7FEB7303FC5D40AF3CCB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_7D329102F623038BF18EFC5D40AF4D11" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_43829AB67F5C7FEB7303FC5D40AF3CCB" xlink:to="loc_us-gaap_NumberOfOperatingSegments_7D329102F623038BF18EFC5D40AF4D11" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_351D40AD8509FA2498CCFC5D405F3575" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_0057119D139DB7858934FC5D405F8AB1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_351D40AD8509FA2498CCFC5D405F3575" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_0057119D139DB7858934FC5D405F8AB1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_E3D8195EF9B681B67CA3FC5D40EC1F42" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_ADB10997ACB0732106DBFC5D40EC48D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_E3D8195EF9B681B67CA3FC5D40EC1F42" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_ADB10997ACB0732106DBFC5D40EC48D5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_04404E4EF8852E0BBA12FC5D407A5784" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_A2CDAA40AA41C2973CE6FC5D407A9779" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_04404E4EF8852E0BBA12FC5D407A5784" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_A2CDAA40AA41C2973CE6FC5D407A9779" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_04570A9B4C75EFECDE50FC5D407BDE60" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_A2CDAA40AA41C2973CE6FC5D407A9779" xlink:to="loc_us-gaap_AwardTypeAxis_04570A9B4C75EFECDE50FC5D407BDE60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22A783E405E158ADFD44FC5D407B9BF9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_04570A9B4C75EFECDE50FC5D407BDE60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22A783E405E158ADFD44FC5D407B9BF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_4FF718CB868CB5AC796EFC5D407BFFF2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22A783E405E158ADFD44FC5D407B9BF9" xlink:to="loc_us-gaap_RestrictedStockMember_4FF718CB868CB5AC796EFC5D407BFFF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_99CA8CB3921D96A4D1C3FC5D407B8FBB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22A783E405E158ADFD44FC5D407B9BF9" xlink:to="loc_us-gaap_PerformanceSharesMember_99CA8CB3921D96A4D1C3FC5D407B8FBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_A2CDAA40AA41C2973CE6FC5D407A9779" xlink:to="loc_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5ACF9E42D2EEABEC85D4FC5D407B7450" xlink:to="loc_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_OmnibusPlanMember" xlink:label="loc_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3497FB3E7B7D6036271AFC5D407B4908" xlink:to="loc_ccrn_OmnibusPlanMember_8D06ABDEF13CA26BDF88FC5D407BBAD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_A2CDAA40AA41C2973CE6FC5D407A9779" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16ECCC21F94674C3F9F8FC5D407B7783" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_12A1189BBE0E14B99D3CFC5D407CD223" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_675A1E3A8143524A35E8FC5D407BC68C" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_12A1189BBE0E14B99D3CFC5D407CD223" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_A2CDAA40AA41C2973CE6FC5D407A9779" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2C078F6249D5D469EFC0FC5D407C9E1F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2C078F6249D5D469EFC0FC5D407C9E1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4B8497F01B4E8256EAAFFC5D407C71DA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4B8497F01B4E8256EAAFFC5D407C71DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_929F7B019F5A8737882DFC5D407C376C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_929F7B019F5A8737882DFC5D407C376C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1F383B5104C83C2BB9B5FC5D407CC9A4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1F383B5104C83C2BB9B5FC5D407CC9A4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage" xlink:label="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_9F825DE7EA6A1142235EFC5D407C9291" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_E1BAF5BC11108E978572FC5D407C9F41" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_E1BAF5BC11108E978572FC5D407C9F41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9F1B4020589B21C734EFFC5D407C5A1C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9F1B4020589B21C734EFFC5D407C5A1C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet" xlink:label="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_B04E3D6B1AE4CE69671DFC5D407C633A" xlink:to="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet_8FD29250DE4AF59ECA90FC5D407C7DCE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_4A8E01F3A0F20D2E910EFC5D40F5EA97" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4A8E01F3A0F20D2E910EFC5D40F5EA97" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:to="loc_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_BEE141EE3F2CA97F2F2CFC5D40F5902B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_411BF831DFEB9CFA42BDFC5D40F666DE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:to="loc_us-gaap_RestrictedStockMember_411BF831DFEB9CFA42BDFC5D40F666DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_BC9F0AE6C74DDA7C98CEFC5D40F6E416" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2341666C373D801C6AB2FC5D40F6D688" xlink:to="loc_us-gaap_PerformanceSharesMember_BC9F0AE6C74DDA7C98CEFC5D40F6E416" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_716E51070BBE0E1D539DFC5D40F5F0CA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9998D71FD7EA74DDCEDFC5D40F6DEC2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9998D71FD7EA74DDCEDFC5D40F6DEC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3F49FE3146A311DDAE27FC5D40F69FD0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3F49FE3146A311DDAE27FC5D40F69FD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ABEAAC98E6ED3ACDBDC0FC5D40F6D4C5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ABEAAC98E6ED3ACDBDC0FC5D40F6D4C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5E889574A7D8BB27D619FC5D40F675C1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5E889574A7D8BB27D619FC5D40F675C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_955AF67A4608BDA50213FC5D40F69F9B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0226B2716751F676AEE3FC5D40F6F90B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_955AF67A4608BDA50213FC5D40F69F9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C595DFD2CBE6735CE96FC5D40F6C5ED" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A05334E9EBF954366FEAFC5D40F60F84" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A05334E9EBF954366FEAFC5D40F60F84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_F6544BC491C8E413234EFC5D40F77B0C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_F6544BC491C8E413234EFC5D40F77B0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_93A91F387BAC0F604EA4FC5D40F7A21A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_93A91F387BAC0F604EA4FC5D40F7A21A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_BAD9F7FCE30CFE5D924AFC5D40F76E33" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_BAD9F7FCE30CFE5D924AFC5D40F76E33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_34EF5C53DD404ECBD5ABFC5D40F732B5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_4506E90D930FACCDB676FC5D40F68152" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_34EF5C53DD404ECBD5ABFC5D40F732B5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_05C06CA35579A2984EF6FC5D40E6A5BD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_CE24CC1EDAEE1EED0413FC5D40E6DB8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_05C06CA35579A2984EF6FC5D40E6A5BD" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_CE24CC1EDAEE1EED0413FC5D40E6DB8A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_F7518BE6DFBEBC0FEB77FC5D40EDB433" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_DDD2A8CCF3A0DDA22FCFFC5D40EDE47C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_F7518BE6DFBEBC0FEB77FC5D40EDB433" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_DDD2A8CCF3A0DDA22FCFFC5D40EDE47C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_56D040DC7CD73E733469CED513821199" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56D040DC7CD73E733469CED513821199" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7A429DD4C9E46B88946CCED513829B17" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7A429DD4C9E46B88946CCED513829B17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_4EF9B5A772301A694414CED5138214CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7A429DD4C9E46B88946CCED513829B17" xlink:to="loc_us-gaap_EquityComponentDomain_4EF9B5A772301A694414CED5138214CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_2802F2A81D26B088E932CED513822C15" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4EF9B5A772301A694414CED5138214CB" xlink:to="loc_us-gaap_RetainedEarningsMember_2802F2A81D26B088E932CED513822C15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_BEC7446BB6F9766C67F9CED513838CC2" xlink:to="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember" xlink:label="loc_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:to="loc_ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember_2D25A95F72B72DDF8AC9CED51383420E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20170331.xsd#ccrn_AccountingStandardsUpdate201609Member" xlink:label="loc_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_5D14E5244F42A525AFD7CED513830419" xlink:to="loc_ccrn_AccountingStandardsUpdate201609Member_7254CA08E282F5F784A2CED51384E9DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_80C432D6A8A03BC8D303CED513827905" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_FA56EA7DB336D8F2843BCF32BCCC4C8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_FA56EA7DB336D8F2843BCF32BCCC4C8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5A712F1EB012A605E101CF3338D76812" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5A712F1EB012A605E101CF3338D76812" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_19844520739F7FB00C1DCED51384C011" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_19844520739F7FB00C1DCED51384C011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_57EAB1B13422FAFAC79ECED513846048" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_706AD44FFB038EDE43DFCED51384C01E" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_57EAB1B13422FAFAC79ECED513846048" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_E5F0E2D6CF78FB5DF8DAA0506191C147" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ADE49B36780FC226C42CA0506191A56A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_E5F0E2D6CF78FB5DF8DAA0506191C147" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ADE49B36780FC226C42CA0506191A56A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_AE4E9614F60259F25C09A0506191D124" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_E5F0E2D6CF78FB5DF8DAA0506191C147" xlink:to="loc_us-gaap_UseOfEstimates_AE4E9614F60259F25C09A0506191D124" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_AD584DB1FDC7D71808D5A05061915343" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_E5F0E2D6CF78FB5DF8DAA0506191C147" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_AD584DB1FDC7D71808D5A05061915343" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>12
<FILENAME>ccrn2017033110q.pdf
<DESCRIPTION>10-Q
<TEXT>
<PDF>
begin 644 ccrn2017033110q.pdf
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M<.N_+K5Y;6X4[>@OB0Z@5OW !!UG.^W K0=NM7GGZA>"X3*N 7V5FG0FF<E
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MU@&IPOZ0V.Z0&O-I3C?SR3F?A.QO$2F(I"'U(?&Z5R-]#>E-2''N@WF#Z)\
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MO?4(/4;?!/V)H. "] G:VWJ8GJ1O@SXEZ$_INZ _H^^U'J)]@CY-WP?].?T
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M;(=6[  %+UX&9J_,D0<ZP+R;_^],N&P5FUMUF]ETG-BD6\7FL384B@ZR.)2
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M@J-@1\3V/[<XX5,& 6>0=%#%OE3FTV=G+CE"?HH]Z(X'--4>USABH%/UL8/
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M[.?H+R4@H' X<3@A!'@J<PA'PAV5 MB)AP.!5$(+V[T9?UA1(N")F6M;8B+
M,0ZFQ"\LB*HS$0B$78E@/)#P,Z?,)W/)L1"'ZY;PY6,)OZL0YYB O )A=A!8
M*(EXVI-()YV):#02CKM9I%&(/ 05)9/8NS?H# 1\GJ ?,*!!@=".+Q)#(1"+
MI$(Q#2B7RR5CO(]H*![)!Z#>6"Z.*:!E/9&(ELN)7"C6$8.+"0B(PUWS!Z)P
MJ ) 'SZ]J50PYO,FV=H!8BYG,H$.>">4BX$ U>I9PB,*=VH^BW=L(.)27/+!
MJ\4EXSS[RZE$4H]%=%WQZK&2KD?T9"2>2G7HJ1C<WZ"FP/O"A,$@K,R5AI<7
M5+VR%DSAG@[:@I!$,J;KJ;:%^WUS3^V@".+^\B)3_5HF4Y7=X;*N"T#5]!Q<
MWDP"CET$\!<+!FNIE%[2M5K KRAA3&^#"P!K<"F!6BJ6BL78'< M"+F[V"]U
M\^]J:@P&%?/;="T5C(2$S6;2&4T/*A%OTI_$1:ND JF GM!C/D07DJH'.2;5
M)* I)L?]*0T>D3_FC^KI4- 7]D:UD+M:"W(,5O5(-!*+Z8<3TIELK,8A%H]U
MULN93"@9U;2,'H[9??D@[I&8)Q5@Y@1+OC8['"%L$;TX]%H,)*6U.<69D9E+
MCAW0MYS"X=4UN2/%,16$+Q_+("B*#'#+^?1\VI5B.](AL!(VCUW$4WHZK<#_
M"+DTS8_#Z]*"."9!O!;\\00*6B*6P;%5%&^QF$Y"SI%$-!DK:;J>3,(H]$@R
MKF=U/5&KI8J11&<RH.$^]Z6\>/UH\7 P#(\JB#.G\7[AJ,#Y!(S!$'0=9H!W
M0JVB:=3H*9 LJ[A3RWD;G)@8_'5W>"&XX;O& M6,KF>3T6S6X\LD*MEL+*O'
MDMEL+9M-P-W0PFHP% P'E7#(A3LN%XK 0_"AE,6%$'*$HIF,CM[9X,' ]A@2
M=Y=8Q<<N73"2SW<I:K2:S0+\P_%PMN26U;P>]JNQ:#B:#(4:F4RVD@TW D%^
M?6E96QA>;S0L>P*-3#*33+(OFA7!A7N&?Y*$7YJ$B26"CFPXJ\7";+/N?#X?
MSH8];45CX4PP$\RFLLE@,IAP)>$09<%Y-J)[=/1)NI,!C TS9L:SN4@H$/7'
MPU&UW@AQ#'5E8PE@1>9P NPQT>A"2"03W3VU?#ZB)R+A?":6< 3*(6PCY<VT
MCX2(O#PBF/(L_ *4 22[LJ%,.!MA3L&G,M<M#*UH[@P.2C;LKF4Y9N%MAA/8
M=MX#H60RQ4"VE),S>BJ9R'I8I"FH- X5Y7*>;"00D6%!@4A(#H>B6C 2]H>#
M25T&ENO)?%R/>3R^2B6G9[*9N!Y/)ZOA;%9/PRBR,3V9*:+0:&0J<;T;L@T%
MPL&,'U=X&$Y8- RS2^%J*!0B:2V0@VT AV$(V2QNF*CF;=3#8>I=7":WVQ.,
M1JLEO*6C";?7K407@J(P+C?RV6Q!3Q0*GD A52\4$H5L7"\4N@L%'=Y%..H%
M<D=#W@BZ1Y02C_,&E&BD $XBCD@\G\^B=R%T,#"2'5PD&HQ$>8Y2J=?C3?#\
M0/UDM-"A*)Y2-JIY4$S #>K-YPOU0K07@.K%;5.P1[W>>#P&<._-ZWE=9WLL
MB*#@:L ;".]IKZ[$ WK(48@6HGPOP7DME4K10L03#["*L7 ^E \5,@4]I(=2
M"C#'QWT+T:PWBYL: *)QB5N3A4(LK,6#R6C<LZ@WRC':4TBD "_YPPDX5GIO
M#X*>UOL6=Y5*L5PJ%BWE$[HS6(WH?G_:E^<C$=)%+$1$!!-\Q#@&E$(DFE(*
MT?P<I\QGF^M"%%J)*OE0/8NLN\"Q #E%4]AV">]$;SY7"18J126?!<H4(+ Z
M-E_ !5@H%(N>0DR+036A8"P"#>*9PJ^%4#K+ZLKJI60V[O$$.CN+V7PAG\PF
M<WH]6BAD<U!:(9'5\QV%0J:W-]^9S/9#MI$@O,E /!Z)IN/1>!2399"5R[%L
M6"N&0Y&@%H A@#^@<\C7NR@:I8&A*D'M6CQ>K^(M'=45GZ+&%X*B HC#/:5\
MH9Q)EDL^K91>5"ZGRH54IESN*Y<S/L47C?LB<42\1S!4Z8AAG _>6:P<BT5B
MCEBR5"J@=_D0CY[M,2868"\[@=7C_DBB4AGP>%/=Y1)N7)R]4EU5O=5"/.S1
M4_%4-A8;*)7*B\KQ 7[PI.*QL@,N*7JZ?=&!4J:4R; G(/RRLH('$)QD#_SD
MC)+2,A%'.5Z.Z7%ALY6."@J^E,9J!JNE2"E2SI<SD4PDK61":7\9G)?C!5\!
M?3)J)LQET0K/*!I*:GH\X>T?B'.,+R[#J#*9TN$$V&-F8#$"L')PJ*=221;2
MB7BEE,HX0_58!JZ\OR1L,".B8"=60FS_\Y\/[F(I'D\KJ(QC7_$VG^UNY1BT
M$E-+D>Y".:[VE3EBL[YXIH+@\WE\I6)GJ-S9H9;R.?#M8Y'F(/(T5-31X2LG
M0@DUGHB$$C$U'DM&(" M'LGFV2;RF4HZG_+YM.[NC@+V@5N_F%D4AWH+BTJ8
MHI IU<JE_,! J5O/-PNXSD.)2%%+)F/Q7#*>C$?"L7PL&:]6$P4XSG!S0F%X
M7"KX SI'_ -]\3B-+5]$'H\_FD[W=\.ET_.>H,>77@A>'\YS?$EGM5HO93OK
M_DAGH5FOY^K57+%>7U*O%^%=)-/!1#J1C@?UM,^7]BY*PP\)1GQIO9/MR)7*
M=G962_5Z?<Z;9RMDRTFW?2D.$61:(MWH'H4N!C%_+I<NZ/4^KS?074W'_/E<
M.@<C'>OLK#?KZ;%X(AC,Z:FZ$ZXJ>GJ"\;'.4F>IQ.^CN@@^]F$#\%Z#P9(W
M%RG&Y7JZGLH!QM"ET6BD.W5_+E)-5!-@M3/1F:AWU$OQ4KS@!71JZ)NNZ]5@
M-9B+E'S%.)>+\6*\4._*I&+9:"&="8R,Z1SUT7J^F"\6.P\GU&KUTM@H0K%<
M'%\^U&ADJ\5TNM&9*\JQ_E1)TTJAS@0SQRR5XITZ1V:"3QG'B*\SG2YXZ]A&
M76=.L46?X!IQ26<]Y>M,#%;K:=^23H[U5#"8+O*?4PE"*)VUWEB]K^'MK':4
MBG5_9U<3FZ_G"E!H5\-?S\0R7CT-5S'E3:>R"6!_5$^4*U[HJE)J%"HYOS\R
M,-"H=M8[\]5"K=1,U^O5*HRBGJL6.WOJ]<KX>.= OC(!V:: B[4(KG"]G-6S
M.'-X<F33BQ9EJLEX(QE/1>,1&$)7'1:3383&AM-IFEHU0#Z\'//Y)0/P&S)E
MO",#!Z\6/&K+97VBI]'HK95[>L/QWNI8;V]';Z-<[>U;UM=;B_@CF7Q(Y_LR
ME$/W7& QCPO' _E<3PY<R-E23T^CUMO;>XA'SP^;0RZP> XCTKG%BU>$PL61
MWAZ<O7Q'KF=)P*<--/+I$ Y=J9;)3/7T]([UYJ?XP5/*97OE//)2WA?6IWIJ
M/;4:NZ*](@3:WJ^FA<.U0#E>T^6^?&^V(U<NPT+[%_?G>W+A<KRA-V"AX1Z]
M1^^M]];TFEX-U!+52&^>8R/<0)]:H)KB$K=V]/85,JEBHB-?#ATQE>68/:*W
M7"U7JSV'$V"/M:D5"-5:]<A5$_W]Q>YJ/M_?4ZJZDTNSU6BD,]*C,W,U$7MR
M')D)\0L+8CS0F\M7 [WY=C7SR:5V7-;3FPWTZ".-WGQ@60_'WFPXG*_V(X3#
MH7#/HJ%D[U"_OZ=1K]5Z(; Q;+ZWHP*%]O6'>PNI@C^7UY.%K#^?+:;U?"Z1
MTSN[4)?KJO5W-,KA<'QDI+_1T]O3T>CHKHWE>WL;W3"*WHY&M6>PK[=KY<J>
MD8[&D9!M)IG7%R6*Q6RN$X<6'E6V*U<$?A8:Z51_!D^25!R&T->;S^:+Z<C4
M9#Y/:XX;H4 @"K">&';'8L7.0#2@E1>"IN$\YU<.]O<UNVO-9DQO-E8TFYW-
MOMJB9G-5L]F(!6.%<C0'R,_!_]-")6UI">-B*:U4&B@5<T6E6!T<[.MN-INY
M@X%?U26Q -]?91TIEBLO77HT+NW)YB">GN5Z:7!<TZ+#?9BXLU:NP0U:,SC8
M7-$LK\GFHM%:J=AT ^BKU7(@EETSV#W8W<UW?U,$#3< "B&\?+NU6JJ14YKE
M9A$@V@DK7;)T2;E9BM52?;D^6&AL,#>8:_8VNW/=N8;6G6[$FR7$<E^L#WVZ
MM449+C=RC5R].=11R%3U>KDSLGI-D6/QJ&9GH[/1&#R<,##0;*PY&J'1W3CF
MN)5+EE3[NLKE)8.UAC<S46S$8XW$8(Z9ZQ91L",B?#L1]5"S5&YH34@8^RHS
MGXNT^4ZK!II%;3 WV=<L:ZL&.#:+L5BIL02!':C!@;%T<WQ)<+"_I[O1A,!6
M-'N@TCH4.K0DUNS(= 1+Y5RZHQ@L%ZMY7.5Z*;>H#W6EONXE];X:'N63DTOZ
M!IN#]?[ZXNX5Y6:SKQ]&T>SL6S0XVFSVKET[.%GO.P:R+:3+N<5ZI5(L]53*
ME7(N6^PM5<K#PQW]^>R2?*Z8SJ8T+=1LEHKE2BZ^9E6Y3!LV3Y*F)?*UVI'+
ME62RMDB+:Y':0HA$%BU:5%H[.C0TVM\].AK/C?4?/3K:/3K4O7AT[+BQT;YD
M.-E12Y1JB,EJ+1*M1I;QN&0V4JN.UJK%BJ?2&!T=ZL?M=(@'Q3[DP44ZLR"I
M4FW9LC<G]*[5F+^[N]93'5T9#L67#]6*B47=M>[%E<H&3'+T:&U#J91,=E>K
MHTHMF6PT.K5D:<-H_VA_/WL"HR)$DLE4,HEW1S+9'^G.]A6]H[71:G=MT:)8
M+#HQ,8%"O#L[5!HJ@=71$N+@:'\),=*?ZT^A+^)0<BC9G>V/+"YPJ:_85^P9
M':MW%!JYGMJB^/H-M0VU-]=JQX\NZEO4WS]R. 'VV+?AS0A K!,VKYV8:"SM
MZZQ-C'3W^_-'5OKU%%@H,7."I=)H540P$8^T8RXZ5JWU1T9K(W.<=F<71]I<
MC]:.&QVM1D9+JX=&:Y'C1CF.5J'8/FQ[(IE,)$>'5^1'I\;#HT- F='XV-C1
MV/QH=R\4.CX>'ZT7ZN%:9RE?KX1KU:XR!)2ME0:&PE#14/]$SU!W/)Y;O7I\
M:&1TM&>H9VG_T36H=PF,8K1[:/'($6.CS;>\961US]#&H5)G1[ZS-)SMZJK6
M!KIJ78"0:A/9\N7U)>7"1+E4R1>RD4AT;*Q6K7654AO6U6JT[90W43BLP[M8
M<Z1'UQO]83T<:RR$6 PRJVV8'!V;'.J;G$P6)P?73T[V3X[U#TU.;IR<;*8C
MZ<Y&JM) U+O0O1%[$X_3"YADLKNS6O?6>R<GQ]![LG(P,)(=7*2;?9M,M;%R
MY994IN?8R>5]?7V-@:[E1T=CR2/'&E6]OZ_1-U2K;<,DZR<;VRH57>_KZIST
M-'0=ET58KVZ;')H<&H(%)B=%B,$Q18PG=7THUE]H5KV3C<G._J[^?CBP4U-3
MC<FN9']AK#)6 :N3%<21R:'*4&4P-E0:3*,O(KN'_86AV% 'EYK59G5@\HA%
MG>7>XD!C<6KSMBZ.75LF^P?[F\WEAQ.6+9ML;MN*T!QJGGC*AJFIWK'![L;4
M\KZFO[RFWLQFEV0G*\S<D(B372*"B62L'8NQ24 RR+*N-J?,9YOKR0:TTAF;
MK!P[-MF(;9SD.-D)Q3:Q;7@Z*7URXJC2Y-$KHI.CPT/-R>3D$>LGAZ'2 :AH
MQ8KDY*+RHFBCNU):5(\VZKW5:J-1;%26CD:AHM&AJ8'1_F2R>-QQ*\:63TXN
M'AT8'SJ^ ?6.PR@F^\>&EJ^:G!R9GEY^W.+1D\8JW9VE[LI$L;>WJ[&TM]';
MJ%0Z1[I[&T<>N6BLUC%5J]1+'048PA&3C:Y&;S6S;6.CT?[;>.T4:_\%<O,,
M2I(HF\Q7(;^'SB<+#=#[I/.DCTHMP[V&^PP_-[[/N--XJ?%ZXT,FEVF5:8-I
MH^G*Q(6)/Z8"J40JG<JGZJGNU$"JF5J2&D^=E_IBZJ;4;;I9Y]_\X)/ *SI!
M_[A^<]J0MJ25M#<=@%TGTZ5T1WHRO3D]G3'@7:OG*&?(N7)JSI\+Y6*Y;*Z2
M6Y1KYD[/G9^[('=1[M+<QW+7YV[+S>;NR7T]][W< [F'<S_-O91OYH?SH_E-
M^:WY$_.G_</0:HF_9GX=>'_-\ /P_A1XOP"\?\3X!9-D<IN.,IU@NB)Q?N+5
M%-ZI>-HS[XW4X@7>O_"?>'^S?L4"[Q[P'L9SKLW[IO0VP7OJO^!]]0+O5^2N
MR]VRP/O]X/TI\#ZPP/MT_M1_\-]U?)ZHY6OM(SK@)OKG=<A/9BT=*!\H'2@>
M*/SKK\]O^,4K[3]RN/^"_5<]=_S^#^[_VW,W[3]G_UVHN7R_LO_B_><^=]:S
MIS[[SOUW[[_LV9N>_?@S5S]S_3.7$#US X]Z-OC,]F=.0*G^S-)G&L]DGIYX
M>OSIP:?[G^YYNO%TY]/%I_6G(T_[GJ9]O]OWZWV_W/?"ON=XU+[O[_OFOF_L
MPQK[OK?OB_N^O&]\W\B^X7V9??J^U+ZX^1O"@O:(OQ[_]KGT;J0+#+>\X:_<
MOVKX"_]Q^#?4_HW^%\'P#"?#_KG2T_2_'0QW&NY:^)[]+[L9Z?-T 5UHN)2N
MIA?I0_01NH0^0S?3%TBEG=2B#]+'Z _T"EU&GZ"+L-%]]'OZ+'V)7J7_H#_2
M]70KW4O?I]MH"VVE*V@;W4?3] /Z(3U(]],#Q'\_[41ZA!ZBA^EV.HE^1U?2
M8\1_S>UD^A7]FBZF4^D4.HW.H-/IK70MG4EOH^WT=MI!9]-9= Z]@WY)[Z1W
MT[OH/?1>.I?NHNOH/'H?3NG[Z67Z#>V1/BY=+4F203)*)GJ-_B%]0OJD=(WT
M*?HG_4LR2Q;)2@>D3TN?D3XK?4ZZ5KI.LDEVR2$YI>NES].?Z2_2%Z0O2C=(
M-THW23=+7Y)ND6Z5;I-NE[XLW2'-2+ND6?HK_42Z6-HI[9;NE+XBW25]57))
MLK1'NEMR2XJD2AYZEO9+7LDGW2-]3?)+ >D2Z>O2-Z1O2M^2]DK?EH*21E^F
M.Z20%):^(WU7BDA1*2;%I>])WZ>_T=_I.?J%E)"24DK2I1](]TH_E.Z3[I<>
MD'XD/2BEI8R4E7+20]+#TB/2H]*/I<?H;BDO%:2B5*+GZ07I)_0X/4-/T4_I
M9_1S>H*>EGXO_4%Z1=HG_8?TJO1'Z<_27Z2_2G^3_BZ5I=>D?TC_E/XE=4@'
M@&QDD P&@]%@,I@-%H/58#/8I8K!87 :7 ;9X#8H!M7@,7@-/JEJ\!L"4DWJ
M- 0-FB%D"!LBAJ@A9H@;$H:DX1)#RJ!+=:G+D)8:AHPA:\@9\H:"H6@H&<HT
M0[L,%TO=="=]A;XCO4"SM)N^2Q^@O?1A^I/T$EU#OZ5O\]]1D9;0Y=*P=+9T
MA70ET.L<^JKT'B+)0@O_J0BPV_Y/,QP:T,A_P,!JLSN<+MFMJ/PS8R"HA<*1
M:"R>2*;X'^1R^4*Q5,:KL=99[VIT+^KI[>M?/# (EWWI\ @\I8EERR>/6#&U
M\L@WK5I]U-%KUAYS[''KUA__Y@UO.6'CILVT9>NVZ1-/.OF44T\[_8RWGKG]
M;6_?<=;9Y[SCG>]Z]WO.?>_[SCO__1_XX 47?NC#%UV\\Y)++_O(Y5=<^=&/
M7?7QJS_QR6L^19_^S&<_=^UUUW_^"U^\X<:;;O[2+<9;;[O]RW?,[)K=?>=7
M[OKJGKOO^=K7O_'-;^VE[WSW>]__P;T_O._^!W[TX$,/TR./_OBQGSS^!#WU
MTY_M>_KG./_#H\>L'5ZZ9*@Y.+"XOZ^W9U%WHZO>6:M6.LJE8B&?RV;2_.\K
M\5@TPO^_"+_/ZU$5-_]_L.TVJ\5L,AHDJDQDEFU*S>0WS9CRF<G)*I<SFU&Q
M^9"*33,I5"U[?9^9U";1+?7ZGL/H>>(;>@ZW>PXO])345).:U4IJ(I.:>7 \
MD]HC'7_4.GQ?-IY9GYKYG?@^4GQ?(;YE?.LZ!J0F0B>/IV:D3:F)F67GG+QS
M8M,XIMOE=(QEQJ8=U0KM<CCQZ<37C);9ODO2EDCBPZ!-#.PRD$T&4S.1S/C$
M3#@SSAS,&',3F[?-K#YJW<1X5-?75RLSTMC6S)89RHS.*!VB"XV)968L8S-6
ML4SJ%-X-79+:5=F[\](]*FW9U.':EMFV><.Z&>/F];R&IP/KCL]H[WXA=+"(
MR;UCZSY\:&O4N',B=$J*BSMW?C@U<]U1ZPYMU9FN7X\Y9@RY99MV+L/"ET*$
M4VO@3,\8+ER_;D:Z$ NF>!^\I_;NIC,37+/IU-2,/3.:.7GGJ9N@F,C.&3KZ
M7?IL)#)\=VL_1292.]>NR^@S2Z.9]9O'8[O\M//H=^T.#Z?"KV^I5G:IGK98
M=[F5N0^7?.C']$*;^!+=^6OJZ 6Y2LQ1Y@B8PTQJ:PJ<K,M@3_U,IOMIY];^
MJ/AA;;V$43/;H(]39NQCFW:J ZA7>?R,.0>W8N>?"?K/_.ZWKZ_9/%=CR:E_
M)OYD*UDP-+3/?\]T=,R4RVP@UC%H%#PN$>6>:N6</8:9S'8UA0SBH]60[>;U
M YT0OJZS>B_9,TQ;4)@Y_ZAU[7**MD1G:;BS8_V,81.W[)UO"1S#+>?/MRP,
MWY2!'=\IX"LP8\LO_$]1@[Z)DP=FI.#_HGFZW3ZU)C-UU/'K4A,[-\W)=FKM
MZTKM]OZ%MKDOJ=T @<^8<I#4$1F8WM''K^,*_,^<6Y:9.&73)(X:>)SQC:TS
M1@WKVU^&J%%,!?O=L# S%]:Y>"Y3SB+L?]L>JPT&+&JDU+(9==-DFZYW\*_"
M_UN#]K1>X5$B.SAL;D\S QVO+P^^KOPZ]EP[C6#8E#=,K3U^YT['Z]J6 :QV
M[ER622W;N6GGYCVM\[=D4FIFY]W&=<9U.[=/;)I7_Y[6/9=$9Y9=NAZ;.%D:
M@&D;:'171KKHJ%W#TD5KCE]WMPK7^J*UZV9Q<8YM&EV_*XNV=7>G@,^BUL"U
M7,F%%!=H2L*IF,75ROVC=P\3G2]:3:)"E+?ND4C4V>;K)-JZQ]"N4^?K#*@S
MM>N&11T'1HJQM>L.M0%QL-9785-WTUKC;W<;R\FE(P'C"[3)^#)=:WR1GD4R
MD8H:%5]+D;;CNX5D;NTU/K=[8J(QO =Y1TWDL\52XVYNF(W$&M\P/F>XC0J4
M1,6SL\&H:'EF=G1T[J.WO_VQNUQM/#OB,#Y#?T R&)\Q/DO%]JC=Q5KCE1$9
M%9+Q?:1($B7I.N//:0;)0,/&G^W.YAO7?LOX([3?;[P/[B0/NV]6]C0PX;W&
MKY*7DL:[C%^9:_G*;K>G02,[C/S?C]H+^@C2?J17D$QTIO$F.@_I<J0[D$RD
M@":1.I%6<8WQ5N.MX/,&C%= .Y'.1+H<R001WH+ZTY@:;S:>RG_[$&^IJRB
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M)MJ,UO?03R6?U&4<;A5:HZUK4'L3O6KH,/S : 4?'70$;:3+Z'I(XPEZ :Z
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MKI:[R$+"JY0"8Z$ _S]82!@+%3(+^5X6"A=92)&%Q1)  RR4WRG@0>"I$9J
MLN/5L 'XA0!&2.*I:?CK!?XEV.>RCB%=J$1:R1HD$L_F=5.DF8U&MB'9?J%&
MGI4R3Y&C_Q\9"LQ[0"7[ST\^]P:WX?QT/D/ORI5-@'MA[:6Y(L;1J3V?<WV$
M>21$RLCIO6J5,44I"VYJ4I699*HAU92:EKI>?8=ZDVZ3ZW&W.J;2Z0V<:..$
MH)\'H\&B89^L$I64K;XH66$!2Q;V[=4,=B)CL]P8R1V6"K68M9)8B7+G)UXP
M>L';&1.OLGU1DLK"5?MC4J D54)+#E$]2:([KMX=?&1*?O7'%_)0:GO[Q?4?
M9^LQ:F_I'?^VUQ)3?AZ[=Z@3C;C+[E'IW%&M0^\E:I?2"SJ[Q@LJ#Q8D;[/1
M7J/%:X=P5>^,<MY[7K0G>=.-0;Q"^6M3^'*ALGQ4?:1SQL29]67!HD$O;/[S
M]*&-E][3:.VUC2#];M/OVY?U6[%V3"HZWQ,I'SN\_9FED^8->VC.$RO/-";E
ML4EY;<WTW&!EB7 WZ4_&P=^DN9O)YL9O&CD,LSRBT^II=H[W++$I022)T^2K
MQI,3S@[B)S5OMFZV'9_ !YH#EP3&3'/P01( S/N;^#GD"CK;VTGX9605.=?(
M[50ULF\$DZ8QY?T;*>&UO*NHJ3%-^0%NDN7Z2VJQ'_2;0P;  #S:W]\X.$;Z
M*SV'4+B=Q,T-V3ORQBK?8'N6NT2J4@XNRU1IQLSF:\K+QT_0#BYJ<#T=<*?<
MDIMSNR;4UAB'=0RCP[98Z@*A5$@*-8?XD'/\A"Q\@ R\S)&%ZEM[9PO1EH\6
MY<4(,B.[/R<-9[J1L\C?SQL:NL3_M'2W?"X[8_.%*0WQU4[14"^SM,_ $=5]
MA=20H8.'#AK**?K4U==114E,';7& E%3-!)+8 HQL.^PQ61$]3 O421Y+U&5
M:A>#S8^2>,UNXO"Z<+\?/&ZG2XRR<Y*7&.)XQ="Z 8MA>,U(+Q%22B_1%"L7
MDX*@7;[+Z<GOS6$C[O>"KM"X&'X]QRVO:/C-OZ*B?-#&_M74D)9VX"Z$9.;*
M#(V$0SRU%ICY=(!8TI0$0Q%:*9I)NH(W6^715A8[],YYRJ.P-GNUD@7JO8U4
ML3GPF-!Q3:.G.##LS7LWY?ZZ[Q^YQ?]X'=K> 25L75PW)1?+O?UM;LYG/\+1
M<V_!J&<>/[]RY"CS?;L&#EGPW"-77SI@LAA\8<2H]N8^0TKJ.NX,U SCCN3:
M3RZ-!$KNA:&[MD'HX?_D,C]^D;O]><#(*_=M;ONG\(<?006O FS+[3^P/_?@
M$T,;:R[=/7?%W'M@3OO808,66)H6O[1F4D/3I/U3-\SL/QHE7&1?:D6+XB%^
MZMA)9;MK!K^/^KP$LS[B]0/F?@5'N,^('4&)H.$^D^PJZO%Q1I7'YB7^-K2C
MZ A51JHBR086MKUY_,UDDLD'6KMOOX'>/\ @WM#YXHLB0CF33)7!:-2+&I_:
MWQQ46-F?!#2YW&Z/PZL(LD^^1"O9;G=J4D;>%Y?)^UV%^=.!6/ZTRY<_;9=/
M[[+*.^D!T9+1&[78>*UQN'&P.,S7%)QLG"B.+YCDFVN<+<[Q+1$[^$[#*F.G
MV&E>Z;O=_[#Q8?%!T\.^ \8#XG.N [[7C:^)KWA?\WUD/"%^;3PMGO;]9/Q1
M_,G[DZ]$;1SAIG[,[I!(Q.OS>=0&C5MM\]C=-A55NE564X';NM1G% .BS^,)
MF<0"4YL)V&<##5GZJF2BO@)*?7[O)G0;,N&RL%?2J40C9[795"JURI.%GR6U
M$>^AFPR2*4M3NYM\X,O2;R1#0#(T&[XS<(8G _-6R;[&Z4*==;C8D$G7+RO
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MM'V, JF[KA)Y-4<1MM2!G[0((K)"FL/V6H]N!^D7) @=-#4+EIIU2\V'EQ!
M>\!2D_&G[,E *^-6QJV$6^ELI$KK;P@_9[)5(PT$8-/5QGM\<RLP^+P>DEL$
MV48>TW$'XC#)@Z>7_'VB^[PMMT:R/WEWPYIZ,D674LG2@<E;+I@74F6?0[%Z
M^D>OZ.A#7\ZO7KB^=^4='W?Z/WW-@HZ%-Z]/[+FBK2W?5^RL%-9/9*/GY^YL
M_/CV>6[!UM_[I87WHN%^?WZDMG0+QOPS'YPYR1S%_,E+)= O3,Q_(L(!!BN
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M< QWWC4<A"F3ZQ40UL(&9,QJ5;PD\9+!2YJJ0#!7E=BQJMU4VAG.LV#%*I5
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MUN<DG]:Y;F6Y1>_+\$'A\Y5):"Q\XW*.')7KZ%G<.FIQZZC%I%X<'+5X8,D
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M_648EON]TR >5*GY< VO&@D>"+X5Q >",*A.]M"(N,%,9O)Z3TQ<[Y=P#S0
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MD>URRB!2KUEXKW*]>]^X1.II$3S@..)XWX$=Q@"IA9#MBM86O/T%CII=[@O
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MW\Z]G_NT5B-U2)W()I;HHK%:O5[,&=T>@T$4 =%8Q.-V&'423FI5<!(F&O$
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MK8R>%Q^J.JI54Z43[4A5^2LGT73J4MAI< J+6^?,.'5."[KJ7P9^!&\O+3R
M&HN/_63@QZ6;X%/W%;^/D\A0_,^EI7N'BN-(1[,G 73I]P!P%TCOU0ZFP1Y^
MN#Z93'1V>#R='1U>D5.A:!#7B%SVFEJG*Y*(UD0X)T(-; T7]H9JPA[2)283
M";>W0^_U=M2HK-Y$N"OI:@QX0MZ$59^$';EVM\<]K?-M!-T*I;*VW=V8!\WJ
M9M0\AG["AYMR1YL:D<7Z^YJ:VDA8_X3M:+A6;#G:35C-VA1N/JK*V_,HW\M9
MCUK.0Q?@@ A%> E0N3I<KJ[N\!CZKY,12U?WBVB8#'_H>"4'K" AY8M$AOJ8
M]B_%"Q7$4=J?C)=I_CD-,E>7"'7'J^<*X>?:QLN[#L&CHZ*="OIHQ8^G[-91
M!BJL^'C<2=-KYD5YZNY'U1_J<)&B\7E^G]M9[D$$%PS26I5TOLX)7[16U #+
MJBEI/G<YQ3SI6!D,X=:E8H]''DR8ADJ7E)'&,]=N;^B-^S9\SJ7F^LVEZW9U
MM2PO+8@4IC?"1_IJ7"/,0I5+X:U)V=87_Z?T,%S%HN+O%VPJ!5=.,\A*A<5N
MLR?=N:GTK+?><0.L^\/MP=JXR.N%GJ7K,-Z?=&@MG+?T[G#6KY46Y]',#+V7
M?LS>P.X 1N ""8CYC8,FF(C'W&X34K:*L<+M42H14)M<*JC6>EPF!6 =F(N2
MDEJ!@<@2@"J56XGTY"RERJ&%Y+M7!:3( +$E8,"!@%2BE$3S=M*]6/DD3#KR
M:BU4:9=ID=923^5D(<,%-8%N_G@+;3\!?D/3>)FU4UDU=Y9-!M2FT"A2Y@4[
MI[*,8T%%XE@P8K7K]"))G=UFK[77V!E.[ M'0A'$6?6.* A*HE%HUUFB,"(*
M1"NP%J$P3<QX"T?:M!PQ/@0;3%0;4Y>SU(G\#3Z-&CB3IG*X.%?.RRQ()F3P
M("W*W'A;TQUKEEY\Z;?#_S[OEN;;WX![H?[?EUWWDZ'LC.;^Z;WHW>+<;.O@
MM6OW;)NG53+O/AIY:O/OOU9ZYJ>/S>@\''_\+=@&??"^ST\;Z]H7E0[_[CCF
M/C\QQY<KW/[1J1O7]M$VJ@?KV9WX!0H" %+@/'\=1SHJB5:B-RDL^CN9O?Z'
M4L\@Z6[E;M7NY%[Q60.[TW%];'L27X^N-V^OPU\Q/&5XRH1O-QQ2'M3@U<E]
MFK,FO+INO6,XA@<=PVC8C#-H&EJDPGZ+ C"<SN\C6U9M; JIFQ()5RCDJFV2
MC,'MO,;5A$7V+LZ:B7;I+.G*R$!;[^.^\M2 1O ]I -TQ?I3,>T(?V1<FFH'
MG&HKU$UF *0.39-6P88LVM?YZ-W?^,W/[U@Q/W<U?W##@>^-W;C@]F=GW+_X
MQB>>VS!M.&1^L_[F)>OVWS.XK#>.'G[DAM^?.SO>FWABU[4_>NR)'PR6GGED
M_?$''WBEJR\Z;^.:!V^ZX_#\'!EW3. >9A;S*I'IW^ ]<1"'<2;..J0.F4/I
M4(D=(H>89E@Z(CHBYI1D6$'P//:3DP&>?0*+16-X-B_A9%@JD7 <*PP_#"/'
MRV5'9$AV7AAB=,LI3CAWGEVN/$*^C?-BFG:1[*]!+$-&XB,(H?,0 KXI _AL
MAB9X^&<U3:B\5!#9:?K0"T,5V2@O:(Q"QMQ\=:10"^E@+E9".<O.4PV9<C;C
M5#D!M,$$_UQ2PC\/P(LE.?R?>V;#1^? /Y54<TI+9Q-YP'QIB)G)_(STN5*(
M3^V UR-4EKG.0D8J8>0R\I;^LU+,2Y1I#$ \'HZ/"TU:<XKE6(83QE&:NI@F
M+F8YFMCX#$9ZC!$<P^UGT4%"3HE(TJ8DA!.C'P- $QC3I%WH%X EBP-PL)/W
M 8DXS=!\TQP\PGU$D=5'N%$.+R>K QP&G(/C.<R]B.8"%OZ)MR"8EDI5(K4H
M(<*;1+M%^XG:MT16'GYI_J>+>:+M" "UA"P7\R ^;K44BU8R*G],*6FE4WS5
M%,E"_O=*KF2PV0LST"!!A'3,],_>8NH_GX[/?/8C)OW9#S^&WY\+7U]=NKYT
M76GI$+B"=IY3U\,=7TP[0&E'/N#_#[1#+^)V ''[2=8AD;:I*.W(F/AC<A%.
MH!Z8H!ZA)I_ 4E$:<X2TRS!483LN8'P8/X_1)KP;[\=X$UD=QEB%X[@?+\,,
MKM(QA C9:<[O(_ 5^#[$(W 4'H 80!XNA]@!$W  8KA$7B&L0%#J4O:Y4-Q<
MME9<1EW"B?\7XNJ@@9 74AG&PM1_]A8^\_ET2&G+_*R4FUMJ6@WWP;L_ZQVB
M<<'D([M$I!4>[N#S+KO3[0HY,VE[UI5QIT.IS'!FCWU/2+[ OB"T((.[[%VA
MK@S.1-+MF6QS0WO6;7<1@23D;?<8QN!3I]H5/W$QI,!KV^4_<=?9[:Y06!\*
MA9LC82)<O,%G\LUZ"@#>; ^U&2+->=S.V$.19L;-6Q4U+?E\.%Q79_/5MA8*
M-36J6GMMO+90R]12W;S;! &P6,P^$S8:D<FDR&8R'C>2*\0MK:V$K@BBL]A6
M6VLV/V^"IK-6"QE37#QA?^:@PQY>%D;[PS!!1J 7X7G05DZD;A'B9*TT9L%J
M+@JIGJIND^5M.>63H#U-$2*K1R=Z!F'@G+"^-PKNRA/1#E2((5+4/W!6+BM0
M1$5REDWGJ2GXE1G2MV3\9(5]%?3D20]FOXONH0,D;6(1F@^_65H@DUB\B6"Q
MZ.ARF25,:1%\6E4:AC>\X^W.P1=[ZK7OOF,P*),2+;PJ7Q,.OPMO*PV)X#.]
M&T;L1K4Q&+3J?+I5&WH/>'KA1PMST.=C/09UN/@W^$G28M K&/(8)O?5I9I>
M->&:/:4NIHM&!H'?G --% (Z0V,F>+TJ,]+T0A-2-T&;Q(.E%BGDU#0&Q6+H
M-T(CM2.K+:*(PV&1154>#\K9) 8:-6:\7RZ1TL PETPFYU44QS@K ./(85Q>
MD"^38[6\7_Z\_"TY(Q^# 5[O:%K>--(TVL0T)09"H1P9,7*0UE?1'(4., H.
M !9\J?%$.36JH!4++44&RZ%*HGH!JW1<74%)*D\C;LY7P4F%X))P6)>J FII
M)DJ5</S*D$HWM/6JNE@9\-K_VN-:15=P^_8GQ"*7SJJURD*2#;-GA>K$"[_2
ME_'7NJ%+D?-YDS8]DD/\Y>)_WI<))/>@YXM;5MK--49[]PV;FL*#JQ<9U F[
MJO](2SC1VI2*73]@'I[)=@FY02[]%E,O5R>(@Z_P41<OEJ0Y):N;H\2KW>L"
MVQP[ WO][+ #3HM-BR-O33-&7HO7BB+']*XQTI=)P"[O09M$?!\[1CHHLQR(
M#TIVF5S#8!HZZ% GU+P:JZ?5!\?@-WB9PY0P\29LLB3FG8/_5DF4UB?H A]_
M($3@%2_FX^,7Q^/C50$$#H$PK$H8@F<H%?(P<@HB2-EQ@SIUT..H(GK@K\F_
M];5U=S?$^D[<?-6S:[]ZK/371\X.W;MP\[8Y=X1K9/Z'AZYZ;G3C_!M''T-O
M;NX]]=V!_J_OO^:7+Y:^7OJP]-U3#V_[[2.Q?"%:>V#3EEVE-Q[><N.M3Q).
M#9>ZV+O9NX$!W,XWY^77RG?@/4HFC,.*Q7BQXFY$H2A<U.5=H<2,0JF0*]T(
MZQ'"^ F'@NB;,OD3' M5RC'XES.@ "%4,B^B^X$"W7\:S36^/T29BSIJT&RE
M!;((G@;6\<G@0G&E%ZAX7#M)ORPH)50C@4Z*I]5@8F=^^A[Z6G$%4ZH)J&_<
M6*Q%R>*7<+)K;N,,2Z#4Y<5WX.N]I>?OVEZ4?7Z\1GOU&AK_&RMU<6O(FWG!
M*"^U^C^T;<PJ+[3KQN",4V[+A78]+;B\%]H=0D%QH5TL%-"%=I%PCO5"NYT4
M>)?;[G"(1 4Q%"N)8J[70>!U6:R?^B%R*14?^A91&4D0?3XN0WZ2%RUW@54K
M4!@*2 !38#K=-,1"F$"9LI_Y^><?3%_D*3[K7C1C^J";:W(OFCY]D9O^GLZV
M_NV-N3T^7_<\]KMS>[S>GKF?-I=_ WBI>,F#HJ)N$ -+>+G%%(1 9P(V=4X^
MABTG.5_.3;:\Q,8%@Z2#!))OH7\E J>#KN&?S@"0B"\BW;WP\5]07YB(Z:.S
MIN.5:2<-!=\@G6O#5(FY/ 6J->@QFO1%FIST_*Y6'*I9&DO.R/C=09-&8Y)X
MU>(YV8%T>\H?:-)KC!*-1(YWHVE?7=71UA&(-WKT-G=P36G5YUW%3TJ_6-/1
MF8EF^5IG:-;^5_\&T*5/L0HEV37D+7/@HI#0]X2L4<CTND;6R $]\,7: )^8
M ]YS_RKZJ_I?-+R7DZD\JH9^]_3Z_MQ^]_Z<*!YKC>U0[%4<5#RM&%-\7R&V
M* **46Y4Q.3<\8SM8.U;CG2FR1<_V QF@,5$RBD +.'5C1)>U;C?!WUC\#NG
M[9(XC;]'K_,*?%!%QM11?=-S.CI-^?!I=RY'1-,7810DX<.\,DBAPVZ1MP8M
MC4U?=HZ5AU7!0C:^63U>SI](V.9#PC@4KV'S^&8*IK$];J9 *!>%N4#:SPHN
M,50_K,PZ3]+::*B,BTD:E3#%X4'(A%:Q8&<;X+Q,)A%S6DS.S3<L65&#B,K
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M+UP^N*U#43<04HN7ET9V/V!?7*"[.A7V@9!*O(SV5S8 F#<)IR/2$]S!SY(
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M8VQC<K!V67)MS;KD9N:&FNO"NY+;FV]C]L6?=)QQO.Y08;%$A>X3JVL3S0S
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M I6)@$(?G8R^.#X%I*LR/5*>^:=M,%7)\'[Q;MBU:*94HE!$M,&6Z0T=&^Y
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M*(2:'5#PXA<R!-($;]2!*54)[DI.Q)>Z-5.]&6DL6":5KOB Z<O&O++-CC/
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MR9Z>9*J;D/A\:2?\B(SG!G" #[.FKRJ'L[T&.&A8:T W&/894,C09$!2@]5
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MJXVUQ@['3L5^CHG(D>&35..(=L_I8,4K_UG:=@^A;9A/M =>!4^8X58LRLH
M>4N7::!(6J5YV&BKC<D^WT1.7G="&Y5-"3:&;5!M<]G0*MM6&[*Q5'DS922S
M6!2B.V5=&:[$8.(^5CI7,[T4O83)O!B.PS+C9[R2P5@C%?)<<2P-82,6B5V(
M1PC-E4A_D^B*DHCJ9*XK(@$/B<>_+2ZBR:Z$A%<C1N")L:)O+SU*KK@/7JPE
M7T<ER5SP&C_#Z5^J7VIBY':Y&XG-<*U]G1OY)")G-G![Y,YLC=MKM>5X A*O
M/RRME2*I)U>KU2!;KL4"),2A1.JQ.?'7B+Q ("_HK#9:FX,PF&/%[Q)Y-R]X
MO7O*M%16+N%@0 @4IOZV$="0JLF,\QUJ<G! 3I>2AP)6NUMGUOO<.N=H:#?C
MB\O@&0T=)MOHI*\/B7;> EL:H\FX7MZ2*,%30L]<K-:@!NX YE% HP88<TGP
M'6]TM,]P[)@M,"2*<F$5+'PM<4]BV2>K1G\'(XEW?QZ_&-Z16.8K=RV&^P;"
M^:M<^;X-B>/O)[Y*-$^WP7[0!"VPCSTA'TAFLD_G&68OGDDGR(?[^;^40BB%
M<H055U2!'E$^F"4>" >AV6 Y8/-A+JJ&%8A%2":3R750C[)E5GD1+$(\Y-%X
MQT3G=>;K/$\X?X&:-7"-8K7R"<A>;[G><6/^:L!>I[Q6NUR_W, .0 .5 QR#
MG&P5KJLR?P!D\W#%B(4Y, 9[0;9<PDAE,DQAY'*2-L#H4$C%#! %O0Z70BIB
M (?;Q%HDDNEQ/S#UDGGEJJ <049F%0,9=/F 56UML#)6O,AU\F!;YX4]Q.0P
M2).*$O(:;"#T0C3*J8(J:Z&QK?,RGTU0WTLILY>:)GH;U$9HM!1TN7Z%J+WU
MHM"0I'5A8X>0(S=I =<]CE@RI*Z6&/70G GX4OV:P"WV.,JEVA@(C1-V(7/=
M>6J+V>_S:_QNB]<%_'I\R=4&7=!C<KE@CB'@ GGJ '4,2WM $[NVQF0H2A+8
MG#J%!<J,)N(IIA5VZ5 RSX+1Y!=[4L9O)3$$/_BGX^^]>I=E7[?J@N>;5XXN
M/K%J]^5U2Y\H#C@C#5,GWSQLW: )-S[*WG-;V9K>93FAZJ8[RV[>GEA\X,Z_
MWPSE?W[_H9N4LISM3SU^]/9O%CZZ\RNH3MEA4&V_.KG'T)K>8PAPO]UC$"Q
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MU8RY:XL&?7YP3(6>*=IB/W+]P+X]1E1535VXI*[7H&MWF4GHQ7QT!Y)CZ(3
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MR)\F7$[?33H4K",7)*TC,8UH$>BARD+%0^X!LA[-5\J@M!6Z_RFT\@DL@DN
M'_/&L.&P 349X"H#-,A2Q,V<01 I111:K4C;9'Y"^1UYO\F"F]YJ0?C;HFJ#
M^?1]6S?B3RPS</MSL<9C!"-YBY9807DUSFREVR-Q9BO<)/RP&B)(HC9:@$CL
M!4:D4 (4X3''AF:QQ*/5/&JB=MF::+BQ@T9@2$9/%"1-NG7MSLAS'/,'2M@9
M7( =.&]&8DW?E?&#-_;K=R,W.'%L\A+GI5]NK6-]/K;N5F82*9$=A,&8*Z[
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MLZYTW^UN+6;G^.8$9A?,#K,#? ,#]<6SK&RYKR)0'NYG957%N9:@->AGL[*
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M.XX8$TVCR4O2A)>6PA\'5U4-$55=.#Y[TM";#DX;<Y29O[1I\HSY;VZ\OZC
MMX7T]<'$"&8V5X7[NI:W2[1K]0M*Q4J3,J L4_97CE:*)FN;M8AE9#(EZ6&6
M6KQ# G9(8@OI+B'I(B-7M*&9>["B)):TX='(Y(\H%;A TF^3Y-%GU8QZK48(
M/]%834=P7NAZ<B!JDN$G&1NE!5,Y$H'$:#)@%/%J\( >O&>SKS!\_\8WY\^8
MW+24>73MT='3#MXT9-*LBS7<T<'55=W@O8#7=O5^C%+$L$K:JUTRF;R-J=ZE
M4"A)'X%:)(Q' 7:H8^(="R6K)$AR".[';(R%G^^7RQ5I@&.6A(GRN12\A02B
M*8B3CHJ(:7@9M0T*B'3I[ETX+JK"W6/FX_X7%-'^3YFTM!O$5_-6F7:M:D$I
MP0V4RU:PB& +4F:QK)@BA&R'%*01@O1/";(PL$4<DLK(0$3B1PC+E?,:> )
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M,J"GOCH$$VF;Z52JLA;Z+T02Q_T+<&):_3L@37R.WHE'_R5@?_W#5&)Q.1<
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M70%I.2<EZ]!5@ F_0($%:4H.AB7E*8E<CIF:5";#I(AC2Y4(MW\0/H9[C(F
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MXT CF )F@#G@&M "K@77@Y7@)K 6W '6@WO _>!!\ ?P&-@.G@$[P$ZP%QP
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M?';BG%P%WIU+PC?H6XS?30[F'N$R] &/8%J<@+P N?V[D-9G^NP(Y.3DT#$
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M1D(\"1D%CT<N5ZA,1IG=P3F09PZL<D<P@#P+(,\"J*G3!X8#-!%H#0P&^*'
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MJ)+?4ERLHVVD:'(FUC::G+&N-3:G"#![R+O]7E;Q 7%F8;/,7G]$"$L%6?%
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MRNY@<J,*&I'# 7*C*"OJ8-#-VXD]J[%6V^WF\=&6B3SJ_,6LMR"Q>]7'U.=
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M5\ODH52J7!.K"*G5&A57+G/9<0!'3=IFUR'7:1>O<WE<"5>K2\)V=B_;UZW
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M%P$VY=L ^_-K !<@O0CQ,8@9Y700)\H9$(,0)P'IG #,0)P$Y(IA X8WY=.
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M6920?T#6 @&A!0)""P2$%@@(+1 PA2'0 @&A!5(E:X& $O86:X& .A:'M4!
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MSW\?< ##5V#\#4 W0OK#@"S]1DR_$=)G-$NS$=)< #@#PUEJC9#:G8#SD1[
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M!;R)WMD\1!^B=Z'\8;H>Y8\(^%': W@SO1OP%GI/\V?T,;H!\./T7L!/T/L
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M)D G/<0. N@13^?]J6Q:CL?"T6A*3<6+\6@J%8I$$_%4FMV/H.R'N@[Z9?
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M3Z,TG.UD.!GVQ1*JEE!KB2A_$- 2L;9H+!AP!>(L(Z5*J;6BD$+V]%A;1:/
M-H'W42SF2R3+Y0%-3PY4VN#IQ%*QMIKBT7B:EDK&DG"9L5]EH!0;8+2 <,DA
MT(N[M=@@-B@4V/Y7*A5LI_+GR%8HJ,E /NAB=F:2*;R(/>WM[;%*#+X7\S(9
MT[BK5"X5PH@J!"%02I02E:CH#12T0ISK^6 ^F*MT)..A9"03R_@6#<0XQA:U
MI3*I3*;M^$(I,[ ( 9IR\5!/>WLBGX['VFO)DIJL^3.ZGM'G!$W$2DS$1"4A
MODPAQK1*(EE0@27P9$P93\:2XT!;*::"2J5*3!MHXU@"G6(9'+L=]"A5>^*5
M>M4+?A;RE4"EU%\J5"K9//@)'Z24#*7XFV@P%?<FHZEP.)K E2VT>6$$V@K5
M7"$9",0&!JJE<J64+^2*A44)$+S<#[)G2Q#U4J6\9$G[HGQA%'Q+X!U?"K!_
M4DQ%4\EP-%:$8U.KI2OQ4#LD-,P?\[1*%;XHW@P# \D8T?AT-WD\@5PZ/=:O
M^?WIO,?OT=(+ 0_ ?#X]7*O4:I6V[NYPNKNRI-;=UEW+H66LH];NU_R%M!_W
M)A</I'.:/Z/UYN"(Q,/^7*HSE8Z'W>%,#9-KW;76BL*?9T')B2H_,Q,1% +9
M7+T^[@_FQK%X+I<NI&I]'I^_"],">2S9EDZ/UVK=X[7T.*,%#Z;FY#R7\OC3
M$]B@4F%)[^[NQG8:?_YIA8J6"[?'W;5T+=V6R^?AO-;K]71W&N_.6KP6SZ7]
MW%7KK%7BB&!T)5++U7+=:=$;KO@K&:ZWQ]OCY>[^7":63932Q<#$>)IC>JR6
M+^:+Q8[C"YW%\3&$8K$XL6RH7L^V%]/I>E^N4\OUAXK!8#%8$]L+E.+=:1%S
MW;FPUHII?W<F5]& 98Z[6G@REAS'.FMI#52J=:?]8YT<:Z!3NLB_2@7TJ/4.
M9;H'>O5:I51I[PYWUY;4*MW=;>V56D=7;[B6B^7U3"81S6?T7"H?CZ>ST4RB
MHU//I#.=E=YR)1<.I\?'>SL[NVOME7*U,IKI[NZL+P'9VVJ5SH&.[L[ER[O&
MVBO3X%LVGH[7(C!7^6HA7<!;)UU-%?*+%A6ZL[&N;#R+)Y6F^;M[<NC-A,?'
M<VFBZ74#!)>@E,\O'];Q?"]K(4T_:ECP "R7\TM[NWI[Z]6!@5A^<7VJ=Z"Z
MN+=4[^U9T=/;&=)#[?E0KBW5EH('I(>*^F!;KJTM%0NUY?H+^53<$R_T8G+O
M0*_XQ)$3_CQ;UC9196V18=\FU%;J[Y\.A=NF!WK1EB_G>H:]_M! ;SX?+)?R
M;1WY_'1O[\!T;WZ:T8)L]<K(2Z6<-Y2?P0;U.JO?@8$!;*>'PO,><!VZIC/E
MZ<WWYG&KR^!(/SR<@3R48F^J-U7*AWISB'V]]12B7L_4X[UMO6T#.=$;@Y-8
MX'HG;E=M8+A42+9EJOE*>,5TGF-^>4^Y4JY4>HXO]%6F5R! J\R<,-G?7^RL
MY//]PVU]>MMPM!*)5"*]8GN!4FH@+V(;3(/>BOG0XF*IKO>R]LLQIHPG8\EQ
M17]O7N_-3?<.Y$,K^CGV@D[Y"H[=#WKT#DX4!D8' [U='?7.@=CBWJG>+BB\
M3O!S8!"6,%D.%(J91!EF(E=.IW+%9"'3W1<HY I]]<%:%]1>?GIZL+=OH+?>
M5>NNKRB"X/U3('NUM]XWTC/0MV;-HA7UKG6]N7Q;.I_JC4. 2EWE7+DME<UW
M%\JEX>'V@6(2=J683L9T/30P6"KGRX78]'1;GFCMZT8)+D&U5%H[&8C"L]"C
M>J"T$/  [.@HS0SV#P[V=8V,)DNC?:L'1[M&!JM]@X-K!P=[\-:LE:*E:JZ:
M PQ$*X'Q:@D/L&2T6AIJ*T%[I<J#F#PX.MA:44@A6]:JJ/(SLYA"(5:I#@^O
MC4:K:T<'T5:JM2V>@#<]@FF1#BP)%P7[C:X=+*UEM*IMI4&W0*_LBY;688.^
M/OZB,3HZBNT"T870%Z@F>W*>P=)@J:O:T0&.# \/ET9*R6IR,#>8JY:BW#4X
M--B70PST%?I2@]7!ZFA)]";[HGUEKO?D$$<GJ^5,)=]5JL?6K"UQ+)TXT%'O
MJ-<7'U\8JJ]=@P"-]9K7K@2#>CM+I>&)ZE"@.IG M:K# >'M!4JYD1+'T>IH
MM?7C%C@:T=%*M2\P6!T!GHPIX\E8<EP[-%@*@$J#HZ7HVB&.@Z!3J8YC#X,>
M@V/3Y=&IL?!@?W=?SVAR='#U8/_H:%<O^#DZEARL9CK"Y?9"NJ,<KK9UY'*E
M]DPYOV@P7"Z5!_O&>OJKR61I[=JQP:'1P;[^GD5])[:#X,.K0?:NP;ZA98.C
M0Z><,K*FK_]UX%LE7\HMAGVN=2RJE6K57+FTJ*W6L6Q9;;0]NZ22J^2SL/[1
MT;$J>LO)M6LK):*-VZ<H$$AT5:NGS(03B6IW(!$(5Q<"'N[=W=63QH;'QH86
M+9O*5J>&7CLVM6AJK&MH;&SCV/@@W(">:J+:U=;5EJQVA1-=X9FN:E=76Q9+
M3E2JQ:PO6X-E&AJ;&FNM*/PGMJQ=HMJ%T)[CG>I=DY,;$^FNC5B\JZO:4QE;
M&8S&EV%:HAM++JI6-XZ-36T<JVYDM+HJU7%%H-<12%1/PP9#0WA89Z>FIK!=
M&(^,N3 4[LH.%GUCU?%J?U=W-S@R.3E975;-=F7'VL;:NJJ)L2KB^-A0&V)X
MJ#R4'>L:ZYJJBM[L4&*HQO7!XF!Q\=3*KEJA7EI4[4]NW%CE6#UYM+NONQ\<
M/:XPWK_Q% 1HK%,WKYN<[!SLZZA.KNP:#W?-9/I3J?[4F-A>H-2VK,IQJFNJ
M*QMNQ6IBJJMK*#S6M0QX,J:,)V/)<>/$>#4,*HU-51,;)SB.@T[5/AQ[$O08
M6[&N-K5Z16QL>&!H<"H[-?;:L>&IJ46#0^-CRU9DQ[L*W;%:K9SOKL6Z*MUM
M;=7.0JT\,AJK56NC0RL6#W=EL]6-&U>,3TR-#0XO7C*TH7-J:GSRM2#[HK&A
MB55C4Q-GG+'TY,'A[>!;O=31-IJ#.>A>TE/MZ6JK5(<J/=TS,[U3G<6E];;.
M4C$;#B>FEG>AMY;=N+%>)=IRX2H*A5+]]?K6M7 VZXM"J5"TOA!2*;C=]==-
MC6/7P9E5A?K,^*E3JP973?6C90MX#T=U $:EO[V_/5WOCZ;ZHVOZZ_W][04L
MN;Q>;R_HA6X@.SZU:JJU(KO5[:RX^D65K4B=?9MT;__T])94MF_+JJF^OK[Z
M0.>R-:%X:@;3THOZZGW#]3KV6[5EJKZ%T>KKK$]Y.._K"J;JF[#!^#@\E<*J
M5:NP7325GO_4-Q[M+XRUZU/UJ?I0_Z)%<%ZGIZ?K,_5"?V&J?:J]OY[BKJGE
M4^/MB-'QCO'B5/]4_ZJZZ"V,I\:[N3[6/M8^LFI=?W>YMSI<'\QLV5+G6#]]
MZ:+!18.#RXXO+!_<<@8"-/FVLS9.3_>,+>ZJ3Z_I6Q[M6YL?S&0&,U-B>X%2
M^TR=XZK^5?W\S8=C/373WS\>G>J? 9Z,*>/)6'+<LGRJ'@65IE;54UN6<YP"
MG>J#./8TZ#&U^I3N52>M3DR-+QD?6U68F3IU:F+5JL%1\/.$U86I_O*B1'=/
M1]NB[D1_YZ)*I=Y;ZJXN79'HKG>O&%\],M%?*-2W;%F]?/DJ$'QD<GQ+SZI5
MRZ=/!=D'I\:7GS2U:OGYY\^</CYQ(?C66^EJ7P9[/M _,5 ?Z&^OUR>0K5DS
ML*JGO+*WO;=2+D2CJ56K^P>Z!KH+6[;TU<4O 3?.I6CK-X^;9U&31-UD?B_R
M>VD766B +I,NE]XC-0T/&KYE^)GQ,N-NXW7&CQF_9W*93C!M-)UF>G?\JOB?
MDGHRGDPG\\E:LBLYD!Q,#B<GDI<G;TW>EOQ,RIS2Q*?G?*J:.C7UOM3M:4/:
MDE;2WK2>#J<3Z;9T.3V5WIS>FC%DU$PJ1SE#SI53<[Y<,!?-97/M<. '<^?F
M=N6NS%V3NRYW0^YCN<_D&KE[<_?GOI;[3N[AW$]SO\H/YD?R8_E-^3/RV_+G
MO&AH-L5O,;\%N+]@^ 9P?PRX7PG<WV7\A$DRN4TGFDXU[8GOBC^?U& ,DP+W
M>G+1 NZ?^"^XGY+:LX"[![B'TO$YW#>EMPC<D_\-[JL7<-^3NR5WQP+NWP;N
MCP'W@07<M^;/?E%J-IM/$C6UYD&BE]U$_[P%^9G,I9?;7BZ^7'@Y_])?G]SX
MB^=:O\W]R)5'WOOSDX^\_<C??W[;D4N/W(V6ZX\H1]YQY"T_WWGX[,-O.'+/
MD7<>ONWP^PZ]_]#'#EU+=.B3/.NP_]".0Z>B5CNTY%#]4.:)R2<FGEC\1/\3
M/4_4G^AXHOA$ZHGP$]H3=/ /!W]W\-<'GSKX<YYU\.L'OWCP@8/8X^#7#MYZ
M\',')PZ.'APYF#F8.I@\&#,_("1HO_BM\1?-I3<A\>^W?N5OMW_>\%>CB?XE
M&/Y._T,P'.)D.#)7>X+^U\'P></="^7&?SO,2!^G*^DJP[7T?OHE_0>]BZZE
M#]/M] E2:3<UZ>UT SU+S]$[Z0-T#0YZD)ZAC]"GZ7GZ(_V)/D9WTH/T=?H,
MG4YGT![:0M^BK?0-^B8]1-^F[]!WZ5>TC1ZA[]'#]%DZD_Y [R;^31$_H.WT
M&_H=O8/.IK/H'#J/SJ7SZ6:Z@"ZD'701[:1+Z&*ZE%Y/OZ8WT)OHC?1F>BN]
MA>ZF6^ARN@RW] KZ+?V>]DOOD]XO29)!,DHF>H%>E#X@?5"Z4;J)_DDO26;)
M(EGI9>E#TH>ECT@?E6Z6;I%LDEUR2$[I8]+'Z2_T5^D3TJW2)Z5/2;=)MTN?
MENZ0[I0^(WU6^IQTES0K[94:]#?ZD?0.:;>T3_J\])_2W=(7))<D2_NE>R2W
MI$BJY*'#=$3R2IITKW2?Y)-TZ5KI?ND!Z8O2EZ0#TI<EOQ2@S]%=4E *25^1
MOBJ%I8@4E6+2UZ2OT]_I'_1S^H44EQ)24DI)WY >E+XI?4OZMO0=Z;O20U):
MRDA9*2=]3WI8>D3ZOO0#Z8=TCY27"E)1:J,GZ2GI1_0H':+'Z*?T./V,?DQ/
M2'^0GI&>E0Y*STE_E)Z7_BS]1?JK]#?I[U))^H?T@O2B]$^I++TDO0S=1@;)
M8# 8#2:#V6 Q6 TVJ=U@-S@,3H/+(!O<!L6@&CP&KU0Q: :?5)4Z#+K!;P@8
M@H:0(6R(&**&F"%NV&U(&))23>HTI*2Z(6W(&+*&G"%O*!B*AC::I;V&:Z0N
M^CS])WU%>HH:M(^^2F^C W0U_5GZ%=U(3].7Z59ZCS1,UTLCTB72'NG=T%Z7
MTA>D-Q-)%EKX$Q% MO4G&8X-Z#2:S!:KS<[_2YQ;43U>S:?[ \%0.!*-Q1/)
M5#J3S>4+Q;92N;U2[:AUUKNZ>WK[^A<-+!X<&EXR,CHV/C&Y=-G4\A73*V=6
MG;#ZQ#5KU[WFI->NWW#R*1M?=^IIFS;3Z6=LV;KMS.UGG7W.N>>=?\&."R_:
M>?$EE[[^#6]\TYO?\M;++M]UQ=O>?N55_W'U->_8?>UU[WS7]7O>_9X;WON^
M]W_@@S?>1!_Z\$<^>O,M'_OX)V[]Y*=NN_W3=QCO_,QG/W?7[-[&OL__Y]U?
MV'_/O??=_\ 7OW2 OO+5KWW]&P]^\UO?_LYW'_K>P_3(]W_PPQ\]^F-Z[*>/
M'WSB9[C_(V.O63>R9'AH</' HOZ^GNZN>F>MHUII+Y?:BH5\+IM)IY*)>"P:
M"8>" ;_NT[P>57'+_'\%V*P6L\EHD*A],K-T4W(VOVG6E,],356XGMF,ALW'
M-&R:3:)IZ2O'S"8WB6')5XX<P<AM_S)RI#5R9&&DI"8':;#2GIS,)&<?FL@D
M]TLGG[@>Y7=.9#8D9_\@RC.BO$>49913*4Q(3@:W3R1GI4W)R=FEEV[?/;EI
M LOM=3K&,^-;'95VVNMPHNA$:3:0V;%7"@Q+HF (3 [L-9!-!E*SX<S$Y&PH
M,\$8S!ISDYNWS*X^<?WD1"25VE!IGY7&S\B</DN9L5FE+(;0N-AFUC(^:Q7;
M),_BT]"UR;WM!W9?MU^ETS>575LR6S9O7#]KW+R!]_"4L>_$;.!-3P6/5K&X
M=WS]U<?V1HR[)X-G);FZ>_?5R=E;3EQ_;&^*X88-6 -S#;FEFW8OQ=;7@8C3
M:Y/8S7#5AO6STE78,LDGX5.USK<U,\DMF\Y.SMHS8YGMN\_>!-:$=\_2FC>F
M&N'PR#W-(Q2>3.Y>MSZ3FET2R6S8/!'=ZZ/=:]ZX+S22#+VRI]*^5_6T"+O7
MK<P57/*QA:T+?:(DAG-I>LT"927&*+,< C&;/",)3-9G<*9^!EO[:?<9_1'A
M/V^0,&MV"SARUJQ]?--N=8#;>?ZL.0?'8O=?"!*0^</3KVS9/-=BR:E_(2ZR
MG"R(&OKGR[/E\BR>TA 1ZSAX"AR'1;VGTG[I?L/-F1UJ$AG(1ZM!V\T;!CI
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M^_RT42S51QW&VXQO$4-V&B^D;N3G&L]IU!/)^XRWLCP:G]YG=S)^3S=4O?Z
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M:MA=(-V;6[S Q#<Q#QXP[C*^35#B"D&!V2^B"ODWOEU,;NYS>>J7@_OK4+T
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M3$0\K\ V)J-EN/(R0J;=2<AT_&XF]GT6XG,U[L^S$#(?KUV N"_$ZQ=A?V_
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M0"@:BT6KJVHJ*VQ6BT(AY]A:'@JR8W!UB2)6E9PX9/"DBFI/L'G2I.;F25?
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M/F(7,%EC]=ID;RE."NU87;(KT]&-UH:DN\^D,Y+&L8 _%.V+^*61B@N2W6N
MY7+%Q9IXIH@Z9P5F#JJ)>,SQYHJZ8<<.''E[Y@/3TJ;F*ZYH1H!#\^;^_KHQ
M*V[QVAQ"L+VF?,"(_HMV'[Q]TF-3!UQU'D]AX^=7("4FY@8J6I 2S60,;! ;
M>! ,@D7P"L&Q[F=*7RA5^@3!;+*;7,&F.]SR(>Z9[B5N[EEE<UD9*4N0YDM!
M(W,X8V7-+>WD$&<DP)E$BZB?C*2;+"H\C0):F5L5D^-HB;VBH?W>FAH?VD?U
M@".77I^ 0[ #(XXK1;=LHY" 1&+LN,+GU,_%^CM=XRK[C_AYR(K4;E,6:O?Y
MG&/G7>G(0LD*IC3MZ.3.L$%C9AB,4M;$QHZ_).D,QAU?"MU=&6D( 8-H)L.]
M#H_YPM0J0=\H6?94Z[#:-%\ZN&U0V\ V3MY0WUC?K[ZI7B8OBJHB0B00C41:
MTT-N(<-JAP2(O$06(,IBS4M@\2(^2_<0FQNQ67H 7$Z[PQ!DQT0OT87QC+;Z
MEEM@:%U[@/"EB@!1%RI>(N8"JW25W95?&_UZ7.\#;53_$EP8W$*OP63[HJ&N
MXN+;F =A;KF68PX7_:VI6L 44$:MN/*3VDK*5D;!% Y4R"2_(LE'K52+[ZO&
M2F$Y*\DJ\HW4,D&+164/=1WP)8.MGZ[+/9+[XFQN[K=P$$:#$U[.]+L^5YT[
MD;LUI_T9#H/P9QBZ?4_NQ\U7SG1<FD@W%58.FM)__GT3DS5U;;KKHI&*U(R(
MS1RN7#C$9>8>47??.;/*GWP48D^"!:[\*C?X?&Y[;A D_I7[)/<Z_ -N!CF\
M\E_/YP[O/IY[^HFI[35CUU8/"E@[KIG_T4L/EKL&CAU=G%KQ_3TE99[8H2\F
MMX;=S*,([%VK&!$$2!C*Q/N"@L:4GB$L$A:'5@DK0T_K#@B*!W5[=!3"(4J"
MH5! K==XU?: PVO78+A$E5Z5S6CUVM!+DZ#MVI!!\(=(0 C00(@&2MF/ZAJ%
M$ T%:*'>P'[]F2[2@UZ]Q @!HV"0V4(!HQY]MCUD"(8+468!3@NB8.#L[&>
M54J##6R'8!D:C(08\JN=9='Y:"&V1$]$3T7E$68OQ.A(/+(^NBNJ6'<-&K4.
M(=,E&;$,<?1-9G"Q>E,WYKT70LZ,*961PC>E-.2%Y@TW,D?CK,R22CF(T G"
MX?PR<_&.0FAL5#0V]L9T<0CD;8K=&D W68M)O2V_PTIV4A@2PV#SLEP@Y4FX
M9^?ZM5W1"E^:X9N!I<&F[OGN$7Z;G'IFOW4"EBT?$$^Y!64DHKGR(5G]N1V_
M*_+QD8A-*#"950/^">_G2M'[Q)%7>LPRW!B;E\-H\9Z-=C!-=R^BB\J>=#Q3
M<JC@4,DQQ<G2?R75A5 '@Z'-/9J.=T^G*^GRLAWP>LD')6<*O@Z>+?@YB+9T
ML#(:\83#,;W?JPH&#7ZO)1@JBQ1P89+PEY47DTA!V(.IGL63B$14EG#"BDI0
MG% J54KB%_S4_YGS$9/,51DN-\1\,1HK->B=%959D.T)]!LG#4\WL@B069/F
M<?M)0DC01/LW&??SB?;.\5UL#*E1Z&3 #$VGLW>"@JFORH4\PD84:%8:\X:E
M(EX:"-D<O,(>"4;M$7FT)!*R^9,09(NX(I&$@"/,%B$\%BKEBY,8,C*MASZM
MO^VV?-C(TB?3DK)O2FFT)%Z6"HXO65GR)W2B+%COF_^@D <"U1>JD-4!J:HF
MYRNDZ0Y1A=&HD(R&M,>M^_WP^3=NR)WJ'G%%L]O=DJ%KOSDR_^[NS^]>-7C0
M\GNAMF;DJL'C-M/CI>+E]VR:=D,D5#>7FS\W%8Q<NBTS=9-)7#AAPK6-T/UP
MKKVBIG;0JDLG;6AD-;A1/9]C:#0']=)[D-AZENY1J:L\V?Q:WKO6X5H<CQM:
ME\I=8VYWK;3=X5KG7N-1SC'.,=U@O,&TQOBD?(=NF_UU^]MNM1P];;.MOV>I
M;85]I7NYYX#LA0)U,CK3MUB^2+?(O=)\R*"HU1M-82^90+T8U( %[>^$P%-&
MDYZ?[>7TLZTJF)0T@M$U/PI14V3N0:B0RG#-XT250>U34W6[T]G%&+TGO]4Y
M?KB0.9MAV2O+^5*I;[M0D="Q$%; ''KI#<]7*)&]89M'KM,B8Y4JA8K*W5&=
M31TA<@\N- Y]A*A<? 3RS"QFK(1,!\ET2+P%-B<%$RBFBB9II-G*DH*PE/.S
M<AX[Q(^-E?RP\=8/RM,3CSZ\],-%"W[:]I^YG0?>AO%'UCTZT>E/*O@YN>+L
MT7L7;3BX/_?AIOEKKEL\YSD8F#T"$P\WA9.5S%:BP>0[)/V+@T:<Z%J*A ^Q
MA< 6<;:XRCS3<55D<U&VD+_*. MW-A@WVK::Y5?J%7XO"0:5?J\^&/(D#'H:
MK':[B=)4ZC%X?5[J;5*6*6 DYOTWE_3;EP_0.Y@*-;8SX@I2B!1M)Q;!4F;A
M+#5(4B3R_FA[&495;*]S?*]*=<;C><)>P0@[)!077":ST4SEA;&B6'&,D_^Z
M1^4V*_L14J=5)@]'XD(T L5L$7+A(F;VL$4<C\4CUF#D(G7*CV!(VL1V*UG%
MOK9769BVV%DJIJ?H*3FCI7=NB%$:U7"7-J0-*EMSJI1.^N?]^UZ8>.\K:_O=
M/D$PNRN?''?])?UG#(Y$_-99W$TSJV*1 :-RV>/K_O'())=6UG/NL\NB:L."
MS= "_,-+2GQ2G$QDOR _RF&XV&F3.5747UE6.;]R?>4.^T>6C^QG[#_953>H
M%UIO2JSA[K7P:]0;N8WJ^ZP[N!UJN=_2:A4K1U;>P/%J3JVFE:Q =[_L8=56
MV7.J[19>"T0Q2JM]6^E5^/U>1S 8'U5>_GF)-RX?!? V[Y4'_-ZB8 CD1*O0
M$:M@I59;W&*U<7:%W;;'E'"4%Q9!0JMU%%&'4JXP*$8H:!H7ZQ0[%<<5?U'(
M#6R415%1N3/^2IPFX^GXB/BD^+SXK?%U\4?CROCM@FV^;;V-L[G$2@QS\]-#
MF@)^9T6O>$C"T:M<F0XV,M"Q(,F*O/F,6^CL;.RK2V3RH5H<%>];(G3WKOIV
M.8'O=6GQ#FG21P<8&4,KC:$$#>5'9=@NE_=K$J.E#!M9G9\/%J()]VT+A6A4
MVSYCBKFJ?M3+7U9$^IV[NK0A[-)K>+4[.J!4-B_JG36Y;K,LU_WQX[_KKE]X
M?V5NV?P*_ZZ]N5$1JS[HF,'=--$:0J'+S;MO:0%[8V("^;L=^5L" ;%=(5.I
M2[B@9HB&E_-R-2H#AZF".JJ):D=P ]4C-#/4B]0KU?HE1>L3^V3[U*_)7E.?
MD9U1G^7/JM5ZR;UY_5YK,!@=55*2I87B[)@W:E""DC%9Y5425+U1E+XM]RH*
M_-YP,*14**)4.T)'1T#TE0A$7+LPE":@,^A]>JIO\AJ(#VU"4T&!UUEJL984
MAFDA%&IUNK!%[TVQ Q%2& E3J[(T\2)@.$GZ@8)-W&)E/,:?QBYI6EYCI[0#
M$D>%S@R+51KS?,7],\(9Z:1>7OV8^;<UTW5F"_,LDWC&=/"BH;3:BS6SCUV5
ML0D+1FA#(?-3<V)V5,;NACRKF&+*KB_27WM-X^/(J/=KEE[3/?;W-^:F,'7L
MXQ+;SMVX9KG;@#RZM.>4/,Q?32KA:M&F%O@P%]$77>];[5L>7AZYJVAUL3K4
MZZNT_^:[BIGO:L:-F8J9FL6:Q>&#W,NRK/Q ^$#T0+&Z)32P2"Q>5;2RF-\4
MW5#\I/P)Q0[-'R)O%RF&Z!VL[#G? 05O>!T3@W8I]<8CM]K!^(;7'@Q57N2^
M@F1"V5/Q A\(/IW=X0CRU7%.5QU486QOI,8F*'!5L^M56J&JVE3HK*I^$2Y%
M7LV%4_E)=BQZ,:A\*JJ2HA>5Y-#B9QO;>Z?!Y"=5IH#-IQ3Z?!L;T,P/:A)F
MB%N9(:[P%\L-&B1_)!9&(ZR(:$.J"-$'A '@]QD$>3'NJ6.Z"#'X=0.(LDCR
M=VAN>W.7?'4;.B2#R]@=BH;1Z=$^G]?'82N;+V(ULI$#QFJ6U?2.:-7R*R+-
MN:Y'-[YUV<1W[BJ_JL;66AZB]PUM$%3+<E]M^'W/J[4# 5W>]%$E?S!YRBSH
M$(-'CSV3>_>Q5W.?K+5:P#4RB>D;[PN;A^3.U#?,>F;.VF>@ K8+RJ%%*1:Q
M8'PJMZ"^-D-:-#4',0_ 2-&K# 8=;-S#P>BLK_6DB4-P;'%PS*IFZ7\>"%;X
MO<7!8+U4S\'SZD4\QU#OJ]]9SPWP>^OQG/U!!6M!<:$%A:#8HN# [U6P%D)&
M/V-[45\+15(+1;ZBG45<"*TTGB->$:KT>U/!4#!0V$R8ZJ99.:>XJ,CAL-/Z
M5$JI5"A#9( P@ YHJC!4 OY/0KM[,VF=W$K%UI&M6UIWM<I:_?GQ[B8C$0#_
M1PH@W-S2;U&OOU[0Z[ S'6?[=LC%,ZI-*;30W8V2;,1[EQ=M2H988+88_C<%
MMH;RZ:8Q\-^._/L5M.S?-9O^@6T;-/ 76TNJA!XM:0SA'MON;LQOTSMS$_]=
MU?/;N:6P]->]\\M_W8:M).^+Z7?LG1YDK5@:8 Q0^[TT&'3YO:9@T.WW8E2N
M\7N-P9#)2"DH7:P>2=U-&FF:EF-@*'U*#65J43U??5@MFX0+JG;Z ^Q+M]M;
M=2H \P.' [0L( 8F!98&=N&.7*([$CHNT3[>1^^TE.NS>FOD_R @(Q?][G\B
M#Y(M\C]00.HS]M36\SG7A3TM)F-%=;Z34>Q>EGX@.D)6JX$"#50;5%$2$2(T
MTJ1^5 .:+$S=4^)%>8<9>TPCXNL.2N9%.-N92@IHY[OSTS/9[&P)\8O1E%]<
MKNJ=;?OK! D(T?=*&L-.@V;XZW<^\_Z8IGZ7*F2UKFB_>)T=^\'W(=\]\]7G
M%^^]9N#8X2F/53W*Z#)[2C(?T ]9E_*>5CX2^]0 4PZ2?CV']P0+J_HQVC\L
M&*N4H-9IDIJ&-FC3S=4M(JO(9MBLV](O"R]IL[H##;OZG2>F+>C=$O9$ S3I
M+DU>UC ;KDHHB;ZAP6 P-"02R5(#NE>=4O*MMF"PU.^-3@S6-M1Y:^6 L12:
M">O$D,_OC01#AAJH259[:UY/0C+QAP9(%!H:+-@*>QTWFV10JM=9]'H=:="Q
MX1T4G :&:!W;2&)<K0.B["=<V+35UD0CU&95R)5RE]@/^I6RQRNHT.3;4@ %
MSL9^+]++)-_LS-O[CKZP2IH^S>9--_85#>)QY:KV1#S#ILG*V&,0TE:FMUJ
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MR[?,3.E5P[9NR=LTQ4RD0 V,$!<4L,J8I@!4!3<6T+*ZUIJ1=4^2-P@?\=3
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MSKSABO<9I&"@4&501Z,1?403429)K% 7$C!:":ABVB0Q!''!2"QYJ%ZCU+$
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MF,);&J'-U-9&?)C7*1S[H,'E=R% G$B)!5E3BR^B$Q@5CP%=**:/-\=- 7,
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M[*SP9F !/M$L6 0?YXR*%@(FP\:H:"8G$5=4]+T$?X^A/D>LC$L-I7T<Y&0
M#3[.8M9I21_X\%5%%I>9E,&@>#FF74X9-T\C(+:4:4#$8$0)Y&EUTE*6<H72
M?B?<[H1*/)";Y$!? (F!98$G OL#*BE0"6S')\<#)P.<?]9QS'CPP'TQ4+-X
M(L.&A?':"E0Y77/!^9L0/1?V,^[3^*3%2V1Y\>*W\Y.KZHZ +=_)7DDOR/*2
M:NNH=WFC*AI%8>=R%,:GN-_.O5GM@:-XM=>#(OA7(D">D0,.5PG4PU6%5<5K
M"]<6[[+=6KBUN+^POWB\_F2]GF8(-IC,)5 4BB@;%8M$Q#5%7)^&=UGXHH$C
MG4CT8;CG2&?:1QA&MA'+)9([0/;VT?P!F[U:[PBC'HYG,K2?G7^OGS_-9JC]
MMTDH8>)Z)7,R@Z5M(8,R+Z/W0!WZ#[J8"[37QGM,.%4=(B&#,@.DXT[7>FU@
M"'R]Y]1?<URI^:TH41',C;0[5\C]BRN5Q?UOF]T[;KSINO94/ N1(+B=(4X'
M&9CI9M?T5TCO5OJK;5\UW3GIDG4KIF0GY7(&P:Z)F,W)F*U]K?,TZBQ5)'4,
M\\(NS MOI[83_R5/1D%[\U'T ],'Z!/T5R/KUWKT<5\X'(XT^A885QBO,:XW
M;S;>X_VV<2>_4WC6<\!XD/] ^%BP(9X1M!Z/)6EA:XKS$ RD4[9408(!/Z^*
M:7)B'N@Q\^-LSG!,C#JB.L($1E]__?7*Z.OCD<V:FZ71-J]\#8B"O! 5\H4(
MR_."W^\+!$P0(GP4=2:]J'/XG*(C%16CF.\BW*I=L(EV,2I&(I%T5,Q'(@S[
M*L)8[3BNU1,PV7!%@><O\?MLN"W>&/#[!-Z$H*8@@CS0:3G3.AXC\@/^)0&,
MT&57-!IQV'4?%CXKH$T%6,#0T-ZE@[_4CL#!X12-T;SO@&F=< P2#6] =OCZ
M%(?T]8& J"@MT^DT5: (F$5*J>.I$ZF3*57*+15>A@P(@5GP5,UN-:,8@I H
MX:=&3YT].S#ZD:!L^@T-T.U ]TSA[%G7Z"DR[:AX3-P%ON9/ \PD],-$7YH)
MY]2?AFX0M]'8:F0I'\",L;&VO4MWZ-366A@.2FZ,VO[U:?SJ+R:'LC+\A[;%
MMZWZ]58LK%3]07_Z:%NRH^JO<<>OMKP[J<7KC6IB,:9^\XKJ__N1*XSGMLOD
M[(!\ZS.49TY@D(KW(XI2G3IF:Q;"'Y=9X'X+Y%G  4%D!4X0.#V&\91+8CS/
M4BZ)X;U 9K@C@FMRK Z, 7,]X8%ZA0>28CA7*NEKO)"4<@0SP_UZN%T/%:N!
MFT3+$Y;]%D:R5"S;+<<M)RVLA=Q?+)5(>3B7+YDI*R1+V06\<,QI3EEMAJBI
M\(4]-GR>X<WX\OIQ-L?\^!N$S>&WGP$ =QU&RCUHEBQ.0=!B$65=H%'#6T$;
MZ!&M>(GLX6!#HSLJVD;0^P?#N:B8Q">R+3PI*K9%PGQ4M$8B<@*&HV)B!'UP
M)"*WPL:HV(K/Y72D,RKV1"+J<*XAI(:J0%O=*E5@E8[$XNKAVEJ3"9M5URMC
M]$EA[X) N 1ZG^C=WWN\5]6+*=[$\R*/^+3'C0&*FZ"1W>Y7W.^X&=F]W8W<
MGX3"Z7P.?Y6C7^5>R;V38^3<]AS*?0+X1K$1-:8[)U&H[@^7EDTZ.0D],6G_
MI..3& D?3DQB)KFG](Z@><,A A\RL\Z[(U*XVS8Z5@ZT*;.AMCM.]L<KQ.M;
M&.<9U!54\0FMH0@JP$:EHM>O-[)<(>Z+%]E\ ')JO]X3@ :CQ-4%H-<04,38
M,1,J&NUDZOP-LD4,:K1!32#!BMI0 @1#&C6DIEE 415&E_6>[$6<(6HH&>3>
M]_3L;':V9I9VMOYX+]N$9G.S#7_E5$0"&UJGJ#YZ2>A3/^WH8<%>X4C>%0QI
M:(F!#I8<SXR79J-R'9?T,Z]7/O.U[X5:/5R2SR_JFR?D)(&*+L6NZ$[^;^A#
M),.:#EO]-P3\ULS;9BV^,=3W0-^EU^02>)XW>RVVC#^S*&=V3JKZ$CG>)GF3
M(:F,OPM0'L#LO6G^Y/D+%_?U;]M9_>:5)8R(V(3W4GC_QJY0I5+5K?3$R"R(
M%.?"^S?)4;LXO:I;7N$H6[@2"90M*.B\$<^+#%(1=/[Q(7VSEH,YJH^>7N[+
M018C\QC'_ *]Q[SK8>Q<&6-VYCWXH1=9>!/FKAG1)(2$S#[^%5X#O3Y;5.05
MI!['Z#P2UF'D3I%ZD"!U>P3C]TPD$@H&>=ZD<Z]B&97:.P*7#I^@,>H.R0M=
M9;@!@ RGH]C=;K<1\&[#M,_;8-#VC@W9")"W81!O(R#>)I<;\ %C;QN9&S8"
MYVT$R=L(DK<1)"_8H(W =U[,[<\A*3>(IPW&[KD:=J<E;B17P_"Y&F;/U;!\
MKH;E:9_P&,/G?+5E)Y&(CX/X.)3BQ^,GXDR\!N+C-1 ?5\![M!1W9\^#=XK=
MA0G@/4-V9<[3%IV.M3#DN,(0!N]M$VP6+T#P007!!\<0/$\0?' ,P?-4[T(0
M/$\0//]U!(\%SG5$HS2PCNRWC%'SWR'DOZ79'_9NF;'D!IN 23)1=@J6C&?A
MM$2YFJB1YX994U9.;WZJ^N"5%,#'W,OA$]>TA6ZJZB]O4E] AK4(_D<P'1I!
M",Z776]Z8,( +1=I3'$C!&IG7*W5Z/VR:DRWJY+CF1*O@BI/1-'MTF**4E1H
M,=S<7B*E'$UF2L<C)R((1.3(L@@Y9>7([@B** Y)\@GB :WH]FB)FR;E88.I
MI'<3/\?-!Q/EIB'".97!4[3 -4F+Q/:G20K:Z"!1=M@%0\2Y6@P$ XBS6>U6
MQ'%QK\_C<_L8XK>4(!:; >C06@+ I?8GB-]2 @884P!:=<X \+'.Q(28_)DT
MV3C!S+"8A,UP*IPJ;#"P@]PFPR9AT+V9VV[8+FQV_QB](>HVJ0>-@_PFUW;U
M9N-F?KM+0W:0A_J)BU+-')XJ^"W.L.*I74N+1(U68?7&GU^U\L;W__G4)^_4
M3W6:]+WY7"!AM,5C'N:'MWQ\UYNW/P63/WP+9J;,_/>?K!F8,LT=;E\*0\]M
M\MO)"":JTU3X1BR^2_!:V6V1-$1I",Q$;2B8.:L4P9)5E"CR?R_K:_K"FBPF
M>R.Y+4ZUV8+E+BX6%_6<VB2D8$KV>BQ%97R+-=U]D6H-\2SL*YXHHD)1+O85
M!XNJHJ4&2XP6V0 +!MG09SAN.&%@#>["!3MD!D4Q;J@IQ@U?VR&K*??IK47E
MUF+MUN+$';*:V]-I13XC$_("C7\PGG4%W+%,W!]/Q+*N5 +& _B0]N02,.F+
MC6OZ,[7]L-:H7)E2BI##)M>FP*;XIJSJ6MLF]Z#_YLA@8E-FJ^WNR$[;+M?#
M@8?#CT;WV)X-/Q<];'LY:NFR0ZKU)WX0L3$?B/$9&K(K4:;'M$CQA&,L\AN>
MSW"?L] S^CN*FN"=Q?JI"R][=M&2[U\Q<W)=X\)O-$1*S7%YY:2EU:=[2ZY8
M#(6<RYA?$:GQIMZ@=.M_;+GW=S>%/4_?V#S_O_[8WWH_H8!9F *F80KP8_GF
M<MEFL?1H>"=PB4[!I0H OZ6V'1J/^-\07:^'HW&#.KM%I7<Y3?PZ03"K>=XL
MBL O8'"?-EO&MW$LLRT(XU2+IZ"00J%&"H7Q;9S"B0(B%N"H(":Q2$&M0W2D
MJ@:>T$#-V/:8QBW5=G(R?[.50]$04>4!NN_9II@:7;#U&<RP)-IW/!0,!Q&7
MCG.QF#Z9 !&C&( F/L/B\X0VFH!!4S0 4^KLW]_Z3 ^R@_K!V&!F?^%X@<.3
M6+<I/IB^*;\M_Q!\F'TL_PR[+S_"OI)_*V\"X]LY!844"S52+$S<SHE1?>#Y
M39S&^C' 00U<S&.; F9%P$5'V\L],_:OFG/3^S?T;<P]'A8\LT=/=339(Y(K
M-B/=V9SHB"[YANR)/K[QA6^?NZ.A\:HONR]VQF LYLM/@3^ WWQR==PZ^;+J
MQ^]?U%I'D/5T )BK\:BG8$+6Z>/Z9KW-("B,%"_#>N)-ZQ5);CN*]'&Y^8!8
MIA_] >4R+]!23M@<)2$#=^KORR ]R8S$^T$ I$2_$!!2'+0[G$X0?DH,4 '%
M^8;HIP)*)"JF"%GY([HZ7@ZTX77.UUCA+R/0 J2X@%_'#P#=,;@4J.#2(_>I
M218[!G.A8[(>I'BGZ$3.="2LD%:88H 2]? 8]@853P^;Q5$Z'H:#8ZD ?IF>
MM6!,[Z (*%B2/'U:.*5H:]I(A#/"$M24)= -@LQY7S8R\^T-$S=8:X[F=J>R
M*:?X$]=VN=\:N'M2T^1)^?(LM<[H]Z3L0:@V2$U5=7M&HXL7F+W_\NVEW97)
MT[I4G"-<N?2Z]YN:!:^;P5"P^4;$]CE\'C9&8_6=0O^"QZ@./2=?K"_8A8I*
M,*9L@C^EXFP.VQNQ-^*_$#X5_B*H4T(LW20TI._0[XCLB#ZK_X?(B/Y@1,\:
M6*,F93=,T4\W<+)>-B!+G0@>12*$!&U HH??33U;NF4K>-0BX0LEZ4\9E^A^
MU"MZ/&0YQ;?<YX&>$;A&#K@?=?S)8F'C&;4E$+?H:]Q;MMA+< GQ:C]Y4&OC
M%I 36:>UH06*XSK=P-/S)>53F&@CY18\ST62<)0O0:DTN[2TM+:TJ;2OQ)4L
MFB!IA!S1 L7+2<:5E;.P)Y4<V_^K.4,2%I%TUY.%GK (S"%.G1[ !5D-#FF"
M&#Q13N+$532R+531M-DC^."(X8_XW6IXB@"#+]81[C)6-114-*HG92UN(W0)
MKD_>A-C&TA*W0DO<$"D/C+>5Z3^5H7Z/;B@G7;B3?69\$+SX0/S29:.CEM@!
M5$Z3'PH$ GPE,'+NM\,&FU+B.TA)W-CIC?2^HX#%0-N"[V4#^$8V@.]B;6.W
MD"!1 YDQORZ:(H:79)VY(LE:'A^4;!(D1&9&N8O\<BR''PU/]1/#2HE?%0/.
M6 Y#3_SIGV4M/HGE,!J-C9S[PS#F7+@\=82LOS[,UL[+5/U@2$DS,4!V0"8X
MAJG&ES \6R+,N$^8DIFH82R,(GJ0#[??-BG58@O"^,"L>Q=.'@SH0XZ0$,X]
MWE-H;UO]<*YSQSTSIGC-%H>+>;7ZZKVK&Z->=^K-;RV<M;,OK:^#?5NVM*8+
M/5.N:)J[_,I],9Z/$!X7/_<GM%,U"MS@(=FT7;_=@.A!;P#N$7@8CX_*9F/L
MMR'(!?4%O:QG].NT*TUZDB+$)/M9_6&#QPM5*L"S(HO8M-5AWV"S667<^U9%
M<14N2=;CUA-6QNKV$.ZB;"!C$>%LFZ*Q:J.IL/!'4!D]-4 \O^@><AND!AQ*
M@#5[9-P.BC(6LA%)PKZ._.8W?%R8U!*8<[C_)K/NQEM>[%2-5I];/OK*',F_
MW'%\>7MX)_Q+I/]'&\B[5LZ=4A69O2 ,[R<VW,?E/5@.C)Z((JW!:T@;IAI4
MS89'?,_Z1GRJS]2_UZ PL3H-4=-3%EA%5K"J/E3#<VI(5$B1B*(W"9!MFPC+
ML3KW2JU>IP?A,.X #G#I&FX+<$2LX["<QV'1CB.B'4>D.HX(=!P1Z#@BWW%$
MJN/H_@P'>0X&N7<X-!:.^R59%R728A1+=]&:=!>M2771FE1'R@-IY6O<<K0F
MW$5I,CX,*X]'H1C='T52=#"*HC;1#NUIGC":8=RPJ2;;F6JRG4EIC/(A*Q;Q
MSIB@9#IN.F%B3.[(K'&C$;I*T)V:B;LS7]NKP<O(Z?/1N+ L06$#<9"D&:CI
MI%@WKOGBE"U !>751IT&64N4F;>3[=7;)M\^;_9-Z40'W&A->:/^9!.1R$:C
M1"^XL6_JI;<^!:\AHM?H-U>T!*R>V?!L31]@Q7+8[_'H^^ 6V6-! $$+L$!5
M(=#O['?U!8X83@;.!-3$U?V L1P@+Q[WB:6*8[9C(<>H31I1K7)"IQ>#/F54
M("MR#L$N.D;.;9.OX($OZ/7Y>GC!QO,"!. 2WH3/3#X3!"I."&(.(1!N28QO
MD.!U\EZ!-T'6AQ=&M9KC?$#O_6]A0X&7^3Z>X0=,GT*25X0N04'X!$2$F-Z!
M#.PC3S;<-KM$G] ;290"LI$O"73_Y61 )03@?OP>R(^Q!#,<>G6!BVZ?D5$A
MWI.C[K,#9UVGQRWVQ_3E^"LE<PFUVV=K!OR9OQ>/>:R@@Z?D1+$'R,,&R,,B
M@5BKDP.FG9,';,VTL)/BSP?T?&7,";Z?);X>"27:TIA1_Y@:&<+?55]O#CIS
M\ ^2V95]Y*9RKAG699N:JC_VH7=OBWBTL9C9$8BMJCX)I5L;Q 2*Q;B&+:-A
M,LO-YTZQ!_ X9]%%!RW #+,DB,1>DE*8 2J]0^\4@, (*K5DDQR2LV*K."K.
MV;;9CMG.1>PBR\+ 5>PJW0K]:LL:QQKGBL J\7KA1LM&Q\W.:P(;@C<DMN<?
MRGS ?0P^,GV:_3/X7/>Y_@O3E]DXI^/TG$DEL&950,[WY9?EM1 BB\5LM0*=
MH!=U6&@27:H$3&228D+9#U)I1*W3&L1/9G6(SG@P)L;ED7/7#YL9%!PY=XU\
MN0BRP4PVVR,&;:(8M (MX$0$+A$#^&- Q6@9R%RBQ/G&? :@'K,%GUL$%8-4
MVFS :H& ,^N#\'?!+X,HF$F(F:"(KYH%%=1E$W&74Z?EL@P"^CRA^:RRY=O8
MI&SM!D/*UJ[+[2GE96) A-\)[<O#O-/I25P7%$=@[K"\S#QH1N:78 X$@7;,
MPDR[27M.RQ2TLK9/RVC=N?P(6D@I<=Q+<HAZN@U,='4;4!C&USS>*&D.D42Y
MBL_;N*O;D.EOSRC%7NA0F?F[I#OF7DGV,A3O$\R$*'P(G#M)+#A($)U:^6<,
M$)H=&ENS$__!,=)E(LP8]2K$FYC@ 7<A*3.GSH$O2W]I2KCKX0>%:'#;%ET@
M)\$/FP+^+3=XXHW0GF_(5/_J0R^,SD5['I6")BR/6,P+J@_ JUS34V07Q.UT
M3,<?^WH]B:@*4WKYYE$WH70)RR<?8DIO03^2IR?\#XO(XQ-:D&5O +88;R@<
M;6$L)IL8%]>CG:9'BF_!#]LT@EK0"$1J=3DU:J(_$]5]ZC-8:E!S[E(Y'A.B
M),D/@;1\)=H0H:DL-EO=E4<:CC6@? Y*_H!HE/PFT=C"@QQLX=5&S!C=?H_H
MCN9B8K2AI5%L.,9!RAU=6 9Q1<2P&"E+);&<#Y@P*Z3'B'NW]+R$+I;NEEZ6
M&,F_BW^^Y>46YN*6NUO^FV<NXN_@=[<P_AZ^!;/0EEQ-@X7+'\NW8R#][SDX
M+[<Y]WSNGW.J'+08DW@*L= .8W =W +9;<8?BO\M,O/%V\0'Q&=$U3\8?VW\
MPLA\"SX,7X+,+S"6O\0HVHQ&L46V1"H\Y(V\Q+>H1"@:14EL4;5(.='/&Z&&
M&S]S-Y2C$<[M4G.Z)]J.MZ$VL@W,FTMM>#*0/CJ,(2=>MCFRE0=AX(!TG_\'
M, !R:#UH!6VH9SCT1\*(SY[^8A2C'\4[>.#",'?.YJ&AC.*81_X-*9H:B D1
MCQ(D!.G,*:4MJ91\@)8'##6=9S_9P\.,G#KUX2;HQ__-L^_O.?-]W;%OS ]4
MMOE=.E.))P<3.03( =04K73_9*,TX&IK^PW1-=PL#61<^!2CW2'%*=!3SG1G
MT!7@<OUE@2OR>^'SXO/!H^)/C9\8=9"H\4BDB['-0VKYG%"/9;"F\GYC(Z-,
M,74M\+^S<<(L0U<_-;_HE4;_N]T?G-,M<1IK*%N]OVOHRIE/SIY50)RWI&$9
M]]1X7R0'I[=?T8G:JV\_F7$B+$TZK+ZVAU9V&ZV86/EH=/KN=3!]?R>>9M"B
M%GA!+=W9<'76[F=C,31E%5U?JCW,:3SK)+C\$-W--Q"IX 6KO8.804\#TXR]
MGG[/8N^B_!6>*[RK\]N\(]X?>TU):]+6!)H\/:#'>!EWF?HRPT/2,^ 9S_MN
M(V[5*!D-DHDSJ$7.[G:(=H&%+%2)6'BQBK:T/9&,9DR2U.-QVSP>M\%H=&')
MQG@)"7%F)!07DCQND]$ U/:$!*+D%+*L)_IIYKX '_TT8+=A$8/E/$"_K'BR
M>*;(4%VCT98L%3$!\W:))+R'C.QD4ZE@HI3H2C")MT(9P)[ F-Y=*)Z'$K-H
M\J*!4QBZ*U2\;AQ*S!2(&;:2U5P)VV@AB6PRM>3F-08-:G9A_TNF!XV@\&7"
ME@=8^#]R5G1!1F8E%DXC_&/UYUV3\O /Q63=$U>U%CM@<[ZEJ_KYRF+WZGF7
M32G5M4.HT? N;[(AC@X]WHNY+0J[XH/5^Z%W5VLLBY$$V_[BZ/3J5VWSETYN
MF2%/CNOU_O1.,O)VS&^OQ"-O06DL%@/&P7S"?,FHC"/G/I:UD5B)"7K\)"[9
MQ\.!("G/R-/=WE(+FH96,YN8ZPQWH;N9G<8OB=7O=*;'T&5<PBPTO,3\A%$C
M 5>_SO!'A"2-I V:@Y:%AO<-_VGX;X-&CU0&+[(95+5YF#0@FU6'/&@CN@L=
M0BPR0M9@-UQGV&HX9F -C([IT7'&'JBKI7JC(<@'Z$KJ/0HL>-R;S;J*1FNV
MF/$K&(R6%<9KC5N,#QJ?-AXTOF$\A5FEUGB)DKL80<8(M :;'ID@TZ/7CC!Q
MV:C7 8M@P=@&ZC@+N9(T]@!T&$"=C6P# QO)1&TJV3!EZ36'M5K=$LA<IT]9
M,M0$6; U QGSZPHX!]!:8I^,8@>,U\%QQ2;)[&JUC<#IXQ0WE)DY2H6-L\3!
MKDTXK5BQ9H8(6L"2X^G?D\#K T+;[ZD_X_ET<!C.KJ-<U(BY)9DPA&MB;HG+
M8V1YIY\%NU+R]/K) R;K>)[(C3\B;1'G1T!WDPA7ANN&%),EVC"#*VIYNH,J
M:S'F12Y\P,W\_D42-!,+^IG^4*@,B<^A.F(.V:$2SGWR5S]':.>E\TN^"&.M
M(OGX<QF?@YD?F;D<"MZO#EY]/Z&V[U8O12?8-: (WI6;HIJH%D7X5FT]/UW;
MS?=KY_.7:U?P&[3K^?7V]=Z[O#ORW\T+AEA;- J<;2[8AL$NA"[G"%R.97$5
ME6%IFE+J4)C-^M7TDN*(@"\9DTDSO6(6,: C5PPA&[U@$VW(1B[X0[+970K5
M^Z<87HB!J! -1D]&ST39J+ON@VUCT4A.GSV5(;9*^*^-'!3+I;-$I,?T*-&<
M=,TUNV(ZIQ6K3S6>ON2,VHM$N'C-KAA/=<4+AFB &QO0B15+"W-FE*^]N6G:
MM.*2RR*KC@R(SA7+EJUPB+.N[VE@U^2LEW5.?G-:USUU$3$1K[^KH^W'TZ9<
M9I/@LEU3NF_H[YF]5F@7KIW7M6!]QZ3;YUMYTL^[JSTP1+T\([(%D>2P[!K$
M5/!7:U3$AU'X@D2 ^@A(F,\5"U9SO7GWK=4>=>S/OR*UEU2_@6YGK\*C]#NY
MDN*S HIJ2]HVODL[@U^H[>=7:2_GUS/7:S?PZZ5M^1W>I[U'O&]Z+89HVVZB
M>28CA<>+P0*CR_D27 YL6'ZI.8#2P!:XYX=#H:1MW"W4)BCC,>S/9M7C5VE<
MDV/HCR!Y[O@A/$S)>M7X=RJA-NZ.+!ZZ*/'+DV*?Q<[%V)BG?BWUTOR"#AT>
MJK.9\4&KC=_$H1L:&SLE8SNUT6UH)#[[^(P.5V.#HV9SA@>2&_-HPR.\9/FR
M0M],,G33IQ477Q99.8*';OFEERYW!&;BH:M^(X^'KO/-:=WWU(6#M:&;VKO*
MGH=X['J[R-@-\F-CU[FU-G8)>*MJ-7H#>,!%A_2"U5GRX)EX$)>8KS#F \(^
MS+("!U0&(_XD:UW[5(87C. %RFP,6DL)>GQ&M_=$S:'TBPQA)D ZC7G,5Z-G
M2=Q@/-'K.>Y\R*8&JH^K)8152<W<PU>7U__T_DE=2\PMF@<N+]>O/+"L/A"9
M<BEZ???3X07M\Y8]O=ODGY$V:2XY=T[)^,3]&L5!%#^\&MP+[X9;0-TAAK#:
MS#'T,$AA"0ES#875'P*E/"_(&:^L>X+8YN:%2"^6N/O+Y?&VCHVW]4OX"/0#
MCVS" ET^B:OA)AN9U(C28(;6F5.]A>2UP77BM,ZOX%L @,AAJ 3,QKURT& N
MQ>PCYTX?[LU &-.D2-W,0!G@VC3GA]J+:R=I[7O@ O@DR YCAEU_E#S[Q <O
M 8 ?_*!0AN7T2-7VHO+@N!4:Y97V09&V\A[<"F\%#EF'Q9F8UR1#F!QK+$/N
MIW%#Z?UUM3[[*>ZSJ&QGT-(DE)*5Y-HDDP2]O1G\PK'QJ@-#](UI1"=:NVE"
MC_MD Y:7N^K2H@P1*D_H>*6?J+\O>R.NU:6\*7@.]U/P" K*9V0DBR/G3AW$
MOP<[CJ%'<,TBK3GT]VI.IC43LA%U$#^0#MGN*'6,UY<GUL]D:"\K+3PPWL*[
MX!G<@F<8WXWK_=?!U8FO_>YXG?[Q.O>"Y_'<*"ET-7G"S<KPC)S[[&!/CU9+
M*8OO$7M0CQ@X3UE*:Q>/M_8>(#[04=F*UK;#8'M?^[EVIEW\C+S Q+9)EX_7
M?GR\]B]I#R0/X <A*D6KJX3?7M9.GBR*\M>>+J/T_JSJ+<1/$;?0HU IV$:H
M5.;AAW6?U:'==?OJ7JECZC!_^R]*I5&%2@<4*J4>6'0$>G%M#MQS'0#. RAJ
M'>OT\%'RBW2L__9^,F*/XU\+O(C"RI:,L12VZDB]Z'@]2I=*O0?&?^?=:R;\
MSNK_Z7?ZQW_G7K =CQ&EX]GII6G$I\4T2ENCE(X3XW5K=$QLP/OH4_Z+\E8_
M!< N:Z'-L(5T@>6"WSKW!VHQ?O[NR3\ESP8M:.3<X$%RO^W"^_\5W[^4OHMR
M_[L_!B!#9J3M,QN:36R,,&?0&DHVS#B7X9>;^(/D"4D;O\5M?(.^G]+&O6]#
M$#F H(?6U9<\&/WM.81_'"'GA)ZD?4,MM2C%S:E1W"\QQ4DO0NK98C8*I4H6
M@JR0#68_S*JR8 3>1U^C;D(W*;U,;6WHF\^=,',CL@W%")@)QN!VO.H"0 8T
M\G_6G@R>Q;5%V8RD"%0BC)I\I&ILXOB<K_G >,UWP5Y 1DB'[P4:,F?/_]KY
M^_O'[[\7? ]3@ULV8.Y=S.A59&HDSP_2A-^X>+S.>^!IW$MUL@N="\/-X7?"
M*!CN"R,Y#&D9QMT4IA1_OJ$A$FB%T!/=":%ONJC63R>5-X4QV>$JD4ZR 3JY
MSK^ITD=?KSD98.H!T1=AC*)[7)F/;<:+28!6CT^L/E[[@?':[X+?X-IT#1E_
MRK$U)!GE 651<=DGEN(>L)J \O.M](^W<B_X+=G=.83!&T*IK[=3E[4%<#M'
M01V1>4WFDEA7J4-R':P+C)R;2U:FH76XW3+!$\NK:YG'V!E !@\?"FJP%!<@
MMI*X;"*:0*?54YK:OJ@=M=6%.3. 85\;QP%HPN#B8-F9U)9'T/"!EM>2+Z-A
M8&/,0&+$PR)H26J=G2/PZ@-UMX?Q#8>2KSG-MSO)F>_ I'_91N*&G#I%8A-\
M1!/!5LZ>.CMZBDC4IZ2V9JFMEK66)G"&1/: $9)$/8$!,3?1TM]9@V&UU.MJ
MDN"ZL>&\OS/14#J<^+H9V8L1>UVQJ,DYPS<EZWJZI>1WIJBE@#"MKC1#:#-J
M6:E1SNH=[G)/=]'CYF^?R@^TV;W5M8OAQL]VW)VY?!ZKT?=T%8N=\W7]*SJ;
M I79,SK#S>MSP0:5->96<5UUA4X-.XU[:/:+WWF[>B^FTE9T$'W&K@9&X ;?
MDH,Z?5K_&?.97O6(L,.RP_&(2[4'[N&>TSQC5+5K;-/5(_"6PZ;I #JG8]S:
M=,0\7>?V?/\>)53'Z5'B!#&J6*/EH=L01S'>: X!-W2&H%6#S^P</A/TIA!T
M,?A@T=I"P,'BP[C=F1(G>V!(,1T;B[C@/.]G%H<[+MHS\-/MVW\ZL.>BQ1MO
MZ>^_Y19V=?_>Q=M_^M/MB_?VWTJOX#]B';2Y>@=S']L%0B -.^77%OIW^=&O
MK+^RG4DQ^L3*]'=3C( I<FM@5WHOVAOZ*?@ ? *T0^G;TSO23(__C\D_IIBX
M$$Z&4XPE84E:4DRC9H9O1GA/^+_][*-I^(CO4?\C82S/Z7WZ,./16*TVGY]E
M51QG$<)IC4:K5IM).)R@UQ=Q6SBN1VVVX4M]9NCS B:=<B0M9N#^733.&TWJ
M8"]2,7I.#9(0XR<^*291<G+:D8&>;/I3H._3([T[<PP^"K>#L? M9'\6H^.!
M=4-4!E*, 4]7%,IT-@\H^>Y!+;LR%-XBFG536QM+W 5^A$^(-L>%1TN()0S&
M>"QF3 9 PA E9M-022E(H\H-@77X"-?%R"9O@HE8XXKWK]-:SXP-4X(A&X+,
M6+@,9C!X^U\NFO-P]],7+?KL6*)Q9^]W^N=U-=1-MNW.73;YZI>#22E2"OW)
M^>=,]0:XK_?$C?\(4RJXK;H\O+;2U%UHKEXR9P;Z86-I^O;5V\A(1C"/?8\=
MQ-BE#WPHNZ<Y^AW7Y9AP,D823S-ID@XB^40")D;0CV1]'#%,+!:/YRV]QY@P
M$!G[ 1V/F8'O<% ')>K?$3Y@T<\:83RRUJTO?5A9EF>+^*+,-\IF6ZEQ32=&
M=093"8Z@'\IFIK.322?B61_/##+O, PS@CZ3;>GTW#FFUY[@(;]B[O2UOA5S
M2 )IX0N:=IGZ9Y*\'>1$()FDO\B0R4%R!8\.#)TE?D,TAYD2UUB);TPU<U2*
MJ[='B*Q6VV&M5_J74U_ 4A*1<GW\@K )$SU^;1:F9L= [:\<O_I'5"Q?U71%
M<]*6>O&VCBOG95)-<M^JP>6..A^KG_*+H_S X(%;]TUM:9^*H-T1CQ1*KR;K
M_%*I+AKO8?B'ZCWW/V@PA)SE%W\D=;>X0RLZ>]=HM!W9?WMH;=M3&W<]>G''
MC!D=NI25+SJ=+1U3JV=')_NM4DC,URM9GYFGL1S?!>;![\EWZ;N\78GXKGE'
M?2/^D?:7.D:F:;=-NVWZMGG,*OFRJ;=-91;-N\QW>87I#G>U=4]GKI>OGWK=
M-*9Y;O.\U3XF)3?)S=U,7).(I]*,OJ*?II_KQ;799[N>F[IW#O/0Y&>]STQF
M;IUSV]PM\Y@[Y#NGW]K'K/==/V]K!W,]O,YSC9?I!F#.]-#4T-2I),RU5FZW
MR7*[U^<CGUKF -N<.:!=;NF<&IWB\P9<<V8QH>G=0,4EIX>F1+O!+$9)W,H;
M1,-2 V-H7);D[<LXEA]!U8-:[8+Y+2/HG*R+;H[>%T71!?-=]".SG=G-(&;!
M_"*^3>8S<J8O@S9G[LN@S(+YL^@M-!9%(+!@_A3RT:"X&W<NF+\6+T1*YNGQ
MX\"0I,0'.W\D*;XQ=4D#TL"X<R\8<Z 8\_3%!8F+?8':5VUJN\-$TIB# >4?
M'!C[!R<L6PKIT9SABI9?1=1#XT%2QN\[[P!<,Y-II!H'MA97, [KYO;\[*E=
M1R?5%3L,E?;IJU+)'7#ULO6+*@N?6_N=Y_ "-<G=5EET:2CW[4-7+%CV_-*6
M;F@I9YVQJ1$F,773E!M?>KB_H:LC8VVU)ALO:93+#9=\>+)_Q]P%-TV=MZWO
M_J7U4^2$<XK3FU_8,CG;NFCM+:N67O1D_=PEQ95-;Q?GI:64W.PC>&(FO!W=
MR;P&]" N6[D'@=KH='J8![5N@_%T:.T]1+WYU<Q1HDG_/:B0:%837?G@FO5[
M]EZ_?N\>YK6]ZZ]_YAE\2MJ$U1[5 HQ1W&#! 8A<Q]!DP,#;,(=Y@1=>XTV
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ME VO^:=4(MI*HV_BJ0:(ZSPS'GWSX":(1V($=AUD;D!NU0@\]^+R&A 9!=(
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M@"2YR!0G4C5HGCYGT?[%GG[.)/R,_'G4U(351"*VU4ZH5C3-61-IOVBVJKA
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MJ@W,7I 'K\C2_@+,YE.AB"BB5#8=#JGB(NM0NS60,_4ZV%4^GT,?Y_D(C&Q
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MV?/DU?^:W-*ALRM32RM;7O7U7/?M;7 L-*V]L_+\TY4WNTC6]>G#1[D;F&=
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MN9@HXLUY6>TW[[->>,\:?-6G\&ZIX3^Z2FKXXH_2,+Q[+9:/T]%KS&-8;[*
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M?S/<!H]@HV0VWW?M2-Q3[PEO0)%BZ8I. -$!@  Q_;O_]C<)? 6^7,E5\,^
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MR4L-]NP+\,WVX^W,M?S&]HT=5XUEQXX1BAWM/(<'+53.EE0#<B@J8;U26Y2
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M/'W6Z>6WSR%SH,>Z$DXLS2HA^](\:L":P;G#'[!>B1=K!DU4,W@/O(?EIUO
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M0=$@:,3$G( [@ )"RB)8T#3+$0NRG,C+&4G,*5<#U49GYM+0?6E-9(]PG+4
M[4L:"86\EM0H)47\')(TDS>;+7F+A-0TJF:QT\7 4$A"L-RT-0@=TBCPK6^\
M_^Q999EZSI1/W;][?/_RWVZX[+<K9BX_W#[;F^'JA:!!.2Z1&*LV^#K8"V]H
MN;IWNM_5W'1EZ^K;*WM>^$5E^/(-'URWZ_+[G*?-?[MQW8[*WV>VMN3;9T!P
M^+)4;>V:VB^%JHUU -LO04$!02-L%!2Z;&-P<'B0&HY)T82)BO:5R'$@KK"O
M'5EAOQ%\A"6%3S#1_-E-C8<:7VOD0&,C9\)Z?^,)>47B,(E]?@\>J?6@!=PH
M-&YA'V8?D#(+6Q]J?+B) 0U)A;+.XS3Z?/4>9Y .2X//[_0X SY_LD%#D;1#
M^XTM#: :"FD+!@S& #)*L^_Q]K9Z I*,E/7.NDM;!^'IN^92SJ;JD"0S+Q$J
MQTHD@9>0U\<9+4?X1:L@ T3W%_.<_&(8F)ASGJ^90;7I5F2RUU4S5_%AY.IY
M?/&&N_K?_%>WL2[8'"_/;"P&;'+.9 _BF?>Q>L&//]RPS!'H;DNL9%TV[^"&
M%7M/[[@HK;4$@PY]4#^/N?"BG,;L]]OT0>.YUY=W9;(3UIU[O8/$IH-PI8NU
MXQ'B TGP%R%V5^"1P!,!Y@[KG2Z4E!J2?@ U/!:R.C>OE6AU/%DJ>\Y?74#;
MZU,%W#HRV\K]]6=;K+@+2I('X4)@0.\)#7J]#OB_ &N"@VX/UI$4$EZMQ4TM
M..R-^IJ=J3RB@BI;:LI 3<!I:]59JL&/$#\S69 4/U KDE%KQ8HERV.AA-5E
M"\9#SE XF+!&PS#DPIN8O3X,(W7!<#584UP> Z524%>E>APQ/[VZIGQMH5)<
M]QC)J,*M 7=84EWEOU/K%%[3F)DP>]G#<\]X[-S>SG1^]EE-_FQ+2%@Z9F'E
M_HDY:RB$O);%W+;%36RP_.L>3_+R#S?>]/=U/OO]:UMF??JO>6V4;RV"EK _
M0I_@N:MQ/RA2XY7FA6*C IMV)Q*-6-'^.AH?T'X4'SAAYD5H?,XG&\EO_10<
M9[YEB65U1 ACC8C!)AV'9!(IH^#E"EZ&4()G$IR4 0FI(B'C%4@F(RR2==;Z
MK*PH98Q2_!7'>?!'KL@K< 4H9-P@8]K-(_ $8\)E5*"./5)>IAA$'7L1/X9C
M\(Z@\F#C<;,4 :E'BDA0_QZ=*2L=1*_N49)9UD9"+P>L!4*Z6[ =*^ M2!9L
M9;)CT^(-@:([@=M-]Z!4^X'V [JI @I":(%0 F$8PB^PTC%K?N4Q.*M4>;2R
M?3Z<7GF4G5MY%,Z<CS\_6H*S*COP07@:J9.): LR<LN!'0SLT3V>Q6JA<Z\/
M/IZ5_@HZ\51NPUL].KS;FK4-HE\*:KL=ZJQ2F]TLP_:PE+C[[8 #>/@OWJO?
M@/7")^%]V)3IHX:JN')+_.VXFXJ)M@0O#1M)WT(*KPEUH\!L:D.;=*-P$-XK
MX;QQ5V6L-VM4<3*I65>7T<-&;GGYF;$&I=[CD4L4IK%P68-9;72OP<]AQ<^1
MP\_A $\(GI<0UF(>9WYM9)XU_M[X%\-?C/\$W"[#+N.S!L8(B$6O%Q1R.93:
M!<<T!W*0QC,!Q#@/0.,.TR'"NXG.WPM)_1 E22V=I.9 QGY8XX".#'<0+L8J
M<%Q0RP\K4G 'GMSR=3/$%/O"L:'RT+$!"BN,'YH8&D/4M, *Q]$J*/6DG74S
M)^U,3#]][A/ ./Q;8!C^;7/S/)&3%7JK!BVN@QIFA(3.1/D,DE1T?YDQ+GM:
M8\QSU?SE&Y8]O65"0,\Q#6B+_N^W"YGQ,U1+EZX:W_[@?7J?G*7X8>A:%,-U
M$@%_$$QA_8.:P<B+D3]%AB*\1&_1(SV@%:&1RTD A]PBA8<!4+D(.:',?[E%
M.@E0-*3+L%V*FQ@J/!SLQS;A(/QRGU;KT2+M('I=<!CEAQ<JMBIV*-Y7?*;@
MDGC63SD\(=@?@B%\IN!+&05COW&KD4T:BT9DM,?Z'%#C>,V!W+@R;=$CI.(^
M6C5 (I 'R$0_H#TV0&:%@7)I@& RXYHLD9AT$IQ.3(7D45U&-!0,N:;\2&6)
MN-ZCPB?H#"*Z+7;,L31T9":W1D_?LZ#OS*OV_ZP_[4OX3&;%CY+A_ KF<X?)
M&,I&6J>J]RYLFYDM7G#.S[P6CRTD8Z>VQ#O/)['>/<//<:_24>("K;!3< 'W
M\^EG,\RBS,[,T^FG,V^D/TS_TWTL?2PCTTBA[>!)HV:OO3JPA'HZLK;Z78ZZ
MNAU.E]'I=%EE-K/=K@<.5RI6YX0ZAXNK<ZIJHVL/L',QTD@R0@&[0U,/Z_'1
M ^Y6H65:"VK!LF=_9D?V4!9EGT#G8[W-RS@%I=N3R7C<'F\J>CAV$,9! #>H
M#J1@*M-RN#6C<4/WEP4 ":TA,>7NV]/6=Z,X-Q=P$QPCW1?W8=IE <D.(*@:
M)6*[E7%S'"V23DTFFQ']2P36Q:9S->R-@%G1(5XZI;.G<6?/5#O[P+\9^U[H
MA_]N(,"[OU<V,(]\VWXM\RQDJL,D'3UYF/R ["!!>5^?8_C[3X3LN!GJ)4L'
MQK<_=)_>3T802]O]K6J[1T$"M@A6W+[!0#3D]?EC(6\\$8[Y(R30_ ?;7/AN
MF\<2B9D>M]'C<2=B'MP![.98!+=7 G<#5]21\([T Z_& SUD!-:%_3Y?/.Z.
M]4>CD4 P>"@"(]WA<*C63P05%L/NZ/V11#P>B83)$-:$_($Q0:\O&/H2:VAZ
M*$JM^_;4]XE4)41!.$XBEHZ-("53('W<O,G1@&4CT"K)48U>,]RK;4]WJAFT
M)/=N="^@=-7_5M:3I4J4T65,?A-6ZO*9W \U\#,DCO)0I0Q_?,;$B7LK;\]\
MX]^TZ3<7P.<KK0-WW37P%6E)5;4E(R !\G@,WRT8'M1\&D$A_;L1M$\'PU*M
MB41&?BDLTNBSK-Y(Y&,JFVQLSF23>2Q&6O/IEN;&7&LB&HOMB">,\7BBM;FY
MJ[[!6%_?T-K<T-Q2G\A'DZUQ1\P8:DBVQN**:(*33Y4OE/?)U\M9+%_KFY.:
M!MA [>Y<8RK5TM+<G\\WI3.90TVPJ3N;@_NK GB?__*:\%5+EZJX^OS]N=:6
M%CPD2-,ZLHWI,=ED*I7);L8C&7+R_729X37BK(;Q_2<$M2#39D8)8XW&"(D8
MGFI<;]QDY(P$@%!V",OAN]M^?1.=P,I8]I:P$"@-D#W*4G.\4$6Y&]5+\.0F
M2N1DX61H.Y'/AAK4-2%1ZQ\CO87(";:&FX6["NDA0!3J1/T<*/WGDAV>VG4>
M^[>BGJW[3@_ZOY+^\+I3.Y/(./U[;#>1^-W"HPWPQH:;HW<W_#S*KO6='UW;
ML"'*<C*-W"!SRUD62X%+_/H7LO)+?&YWTEUT3W4O=/>YU[NWNJ7N)]"?01 $
MT5%!X<FZ+0>SSDNPN8.;>+<!(OQV@*D_G$C$#E-"C;#.F!6P=M[M.>QV'W)!
MU[WI$!-.I0#0,&X&,1UZO2&!C0H2X>YO3-37"WI#MIX$!M?+4G$0T\90;%IL
M$=Z&PNP.6?()!G=P$&%T0C"U/5P,3PVC, B9L>(P$S$& S+--(I]A3$Z97)Y
M<)#1'0C-=#D1T;2)H#A*G*>EY-"(DT@DI"%Q6T-5N&7JVTL6(&'K/39"=J2E
M07W85BG%*60VH40JU'#72S4(Y1+E0C*>+#1RHSPE)(,,VQ^Z)A%>.11&]E=?
MM78VUY?;ZL<$' K)(>HE89Z*RMO/GMBX_,+K=7Z_]L<_AM[)<S*A8-!F\)H[
MY9.93N(?J:PKK1FO5<#R[]GK?E*><]\-:F)=SQS^@ ]( +:N8]2Z?AM^!'\"
M'((:-@N.8+8Y+B5V^8F5;]$+V(MM\G<IH^M$\2KP%+7)=<QT$JNR=3J<GM3V
MQ!DX7>39K*57GEBA?G=D_?B/( >O %9!"4&4+$=##1G+^'[%4DY<TSZW<AGK
MI7=KJC)S?DK8^W;!5LK]I\6]IG53*_*T0OR_U50CZ&RM$G0.#,1%%MKUZ ^4
MWU/T>;Z;@2"Q'WHRJ0S*T !R:S9#LT[UV8R^]B.9*A>MR+,Z??B_N3G4EQ&J
M^C)>AS\#6*D6"<V<6+KNK?(/GN1OG3)\E%E(?1A=51_&%L).*FBA-NP)HTUA
MF,3]$X45M17T44R/I5%W]H[<^3WX/C9!@H(91@1[7;:/T*KUD2( XK:-C]Q_
MH.JW%4MPZT@)W@.[< EPR;>%=XHW_HHR;,9&.U  (ORA['@L"8(@"^<+F7[=
M>M/Z6'_JVLQ=F8>TCV4>USZ1D?=K^\W]T?[&GVJWQ/F\M#\  X+"D T\Y_*[
M ]0?S]XG(X[Y,X06A:L^E&45V9!=R7*1M"O@?].)Z@:AQNEV(J?3$@"1D$62
MWJC1*!1H33 H+E'%'&2Y>??\''V;1-\$8VO.H]BD0-,4_8H-"D9<ASZ(7@--
M!&]$J<[V-VUKVMG$-#D'H72?&VN6@H$&^..OCAB@Q@ -MESSCT7^G1+!T?Q0
M6XH?+]'82FK9'!4=J$.4YYUHCQ_I6T8\<S5#KTQA3,MQ$5\I$FW4FN.)6 +Q
MIE"R(=6 >%TP:JX/@T8MWB2,D3!LT*='_! 4 $=T")G\54H%+G=RPB"!0*78
MZCDOK#+U5%VFS.OGG\_C6;=R07=?UY[ELY;O6]ZYO*VR"TZ!O*IQ#-Q:^63B
MBJ UF,S66R)SI[!WS?KV=S\R>CVLM_>VV1W;+O_5'9^MS8[Y:E9!XZF+E:^Z
MR>B^^V>[?ADR7 ?@\!"WGS7P+=@V\#R.N\S_[J^N-!^$MU1Q(\75YG)CBGIQ
MV= W[_ M5^#9XW>H"/_(= $%,#\.&*3<#V10!J[D07(()@=.7=4]+=\[I2G?
MV\MT]9*W?%/O2&8WE4N!JERZ7I1+*"KHS=FHAI+C1D^12R(+\(H1%N"WP9XJ
MB_$8]^#PQWM)!,B84UB,M94N;B>W'#71.UG GYA9^!K%?@1B,8M9J,:P$):W
M][#T:**_C,^"?ZN>-7=N,%@[RX%+/4!':;@Z2OOQ*+4)2B0D85+31:*?TJ-E
M Z[=F<-'N1=HWED3& \30K(_V!_O;^T?^W#P\>"^<5\AZ4!H?6Q]V\"8.X-<
M7IK,C_=Z0).V":7N<S<]YW>3\66[S^5VD_%E];2$$I+.C9Z HI:\9FT"U6C.
M3D#".36ZK(8DKV@$BR/;IX&:S5:-S6U#MI@GE4SF\^/'>[U3/5#K*7HV>%[S
M_-/#I3R"I]^SS;/3PWD&4:.@TG2X.U"'$+%U-9]66QP^1H([M*. "BLD,/%8
MH4P3(TCV(6&P$D?,*3Z[2.O88)R$&"(^%B*!A(@/!5OC'6$P-H@W[=&6,"R&
M.T\>,R35%OY '"G\@8&DR])19#AY$+%]J\_A)1)>Y8RWS5[<<]JZQRI/?G=0
MR92IL5>/'DQBYIY..BKF%G5_\\IWAQ>TKS [3QE>/[R*](#E8?M@2B*N)#'_
M_RK2_]=6D8@&4^EBO^8F8UD0$64!>AO+ O7C6&C^86\Z;;$(HMXR%<N,$I49
M/5698:W*C'Q(J11.1/BQ7U.9$:G*C *6&5U"%.:$.F<V)WC\64T.OI9[/X=>
MRPWGT/K<H1Q*YOIR".2T.91K%.,J1VMIE-ATU?<QAI.9G^@>%BP3"6GXEY39
M/7P22S36,#@5U7*256WE E'+B9+5FJA]</A^JJ2$3Y&^<=RMV^EU4\7KA@>K
ML8T&):CRA=]5BPNDV"OX/E3RM8/=@NDLV[JVN]L>*GR%.)_':??YTAYG;!#]
M0:CS^3W.J,]?:&ME,FV%%BMHU[;WMV]HW];.M9/P"$MS<TO$'HLBF]0N/3EI
M=Q^$ &0T@\BX+]W^NO4>&XV;2&LR;JSU=?A]M@ZA".E0((2F9"@<([%;1VG8
MM)@U7107A<7X"8*F)0((_Z#T,3 G>P!&K>.,Q$PTY9FM1.I(JT'\/:>M??29
MS#>3Z]L"=K7"3#KM[]OPOD9A]=L6#:S<?$[R>S*%*V]5 D&3VF<]F[F$=%YQ
M_]MMRUO4LLGW;R-UC+5ZYA>TCB-@HV#\"F%-"[A Q.W4NK01WA]PN^C*C2W@
M=M* B4# '2%+.'K_R 02 2YG+7O!C>LSHUE7FS("Z_V;_$B$]%H7);CD)!Z"
M*$_'CXDU6!"E_XEPOQ^6V2>' :)>6D'<*+%\<"0P\'LJ PO?"T=B!9D7S\JS
MP5I?QF.UVI<A@ N'_P"R@@J2&=G^->F6"3B(BH*Y)[P9; ZB16!1$$T#TX)(
M $(04>+06CPJ[N%,',OL:@_'OS9C^"_ (B@@M,-^$NUKX?!O[>H)U\:2$^OM
M=] QT5BU&*Z@\<DZN#ZX*?A^D '!8)U*&!TS2^\D<M.O'>&FOQ$<H1:6 B:)
MA>7&A<>&3C\=A_6GL)V+]_2.W/,]>#>6*&+,L'BSR$DQP^*];AVYUWO@K_A>
ML?WX5G4N@A:#C2R],0N2_4F4!%<349,>=<L3B#D2^TCD[7_!E^$V@#5N!B6]
M?5Z4\G[F15JOQXN\8'#8N@]K;PP:%>U;BZ@65^C7CK#-_Q=X!)#8%!F#/@L,
M!U  7^T4K_:/,E5R-;GU1UK7N6I=7XGKNF$/0C!Y<FS*X/"K>U,I@X%&E4QM
M7-B(&@UC>FJQ*9-P*Y]'RW :M11O/ ]02ZN>A /7"RI==A@;$R8JTN(G5<2)
M4GA'2O$>UI=O G%2BNRII7AC;T,V$,.E." TPD9#6@R/ 2-EN+5:!M(F5^-Z
M(+$]A''04Y^J9^L!#=%)C;;81J*"'"/6\HW@35P+8<$*VTG/:<=MB3<F<[:]
MT4.>H.V$%*\^P70:';1VQ%*^,2!&!RULZFM"30*VCYOB++DT.W+KZEK]Q,IE
MG)+.C'DZX[T+!3KC09 .666U&2]4N0S=SI;Q67/P66;PKDL\A_!BU,Z9B&M1
M26LQ7ZW%TW MVLFX#4 0"-BDPN@)B*[V!X?_E]536=<(M@H:+.O\@1$AUC@(
M]PL&6UTBX:@?M-MX_RKOTI"B*M6,1*IMTNS0'-)\IAG6<)J[[78')6UP!O;[
MWW':ZNJLHH4:BS?4KTDDDOB>MG2-AZ'06_7]4,?/D)@W6Y5_Q(E4KCH8*0 '
M 9;Y=V*0VH&C,+=#1.W!$P9Z8O2$T3U[[:.5Z>^]IPEIQ[2ZIN^?MTXG7WO9
MKN\3C/#+RB\7EP]-3SH7FY]>W.Z['7[EG_?LFA.QY6-'8LO?@??#7P"KH$ 0
M-*>C;@'!''7%Y(@KAHR-XO!1MI&[!U\Q5[P"_ 6W,+%P($B$3"Z2)Q$=Z1:Y
M41'L]I&[_!>\#,L&GV! <&&R+XDV86&F)/'U"*5.2K$8N=_:D?O]%[T?L>C\
M+BR8]M&K J-N.!*CYAB)4;L1KL C($=BR\RGQJA9S%@3PU) .=6ZT(HT5K<5
M6158L%($ANI8%&/5UH[$JMT(+L=E*)+?,YX:JV8RLBSY/6.?:=B$/B.;3:9M
M)D0X@-G!X?\1?[<T,.]$-!WUA8DE_2-<":\ SGT0CU8K&*RL)3XHLB8[X@\K
MC2K1W)$2_1'<A4O4*'B@F8QQCQD>,0^34+GU9M1GWFI&9N8\,F!M)V3% -8/
M<Q3U%$O_-RCCYF+!<0<'91ZC1V/R (:11FQ.@%1:IT;*.&FFOENIR2+D4/MD
M-HV/(MO*.H"1< )-,T+CI7:2CK9JB'3]H[I,DI#"DS3F<CI)<ETIO8:!.C7]
MWV5?B+*/!JV35FZK?-HYSU]N#\T5<@OP5%O9?$V_YYL_KRH&@YWG,0_-[\46
M<R^>:X9H-+L5ZS='!$&JE%C1'[7OZ/]H^+WI3?/OK5^8O[!*?RK]J?)%]!+W
M@O(=#3\7S67G2.<H;X>W<[R4@R%MT"9(55F;+>RG$)4R_*&NCE ^#Z)!H2D9
M/A1&R3 ,AWEU#C#&'"_S!9W)0!%/00$+MF@$CSUE1W:[SM(K8^8F=+TR^7E8
M^2%4:1OL\[ *.6G&W)V"W4$_X<HHV<L%\D;B!41"WH%2N91.QLG1.(D*:B8+
M R4P #U IP7>$<I6I-/J,VF]3@O]NHP8J)[1^;-^'\\S7M@.-U765AY_O_+X
M8\_ "2_\\ND#NQ[^5?G34*C[[*43@L&[YH_Q<RLJRRI_Q/]*A^"$7[\.BSLG
M5YZM/%7Y?640-L$\NNK;*^&_>EI;>RKJC:8B\4E, 8 G7-_8S,1ZXW\+?5*)
M5"$Q2^Q6B55A,5OL;P7?"G\<_#BLO,.\Q?Z0Y$'%@^:'["])GE<\;W[)+E^N
M6&Y>:EON/MN[/+Q%<H=".D<R5S'7/-L^USW'.S>\1"HU2AV>K(IL(JZ<TF0Z
MHH1*I5[C)&#Q.0?EO+(835F>![CG277 Y] B'Q^;&^JP#C))028H?7R'S.1W
MX$\'/!W8Q)"=%R5HR5C45IL []G+0Q^)OG?2$4E=$YA7O%,J)&F0)Z"#$9:"
M8B)\ .2R($@=;28?+V'Q: :<V0Q9G9;S8GFM#;*[RX6+NV!E7^53J(>]J+<?
M/=LWB8.M,%+YI+(?3JCT5SZ&-MAU_>;*A\%@$'8LT,+,8X_"A'YZ:S#8=)J\
M\M:![957U N*;%1:.;.R5H^>?1?>(2&Z^APLZR8QSP ["(._/@YLPQ\(4[#>
MI=#R-JO68F,C=5 :QNV5=\Q!IYGG.,XV7VC>J-]HOB8D=^!KPL #X&JP$?^2
M)Q++@@4B]*B&E>!O>5?((I$-,G'!*3E;I5 %0CJ%W1%FO!R"B-4P(-8/-Y"L
M#X*G)E=D(92Y-7(X3(+@2."S4IV5RZ,:KQLK<,(1/-B)\"4(]<T1$MTS5"*]
MN#0P1+9#EDP)FTFXGV?(]#=4S&1TF0Q9%(L/E$APCT0MAL$-K )8M2;4D'2^
MHPDD8?Q"5<1OD8).)T+!HV&H7^CSR%I<T[D@FI";'^K[^/&__/>V&:N:'2VG
MM>2$:%MD4CWS8*5KVVFYKMMV7?+22Q"]^B9L/6?=);]8<7UEYZ\?F_^':@SH
M[VF$6P(\(*S(6;NM<ZRGU;$]:#PWFY^;.)M?GK@(7,A?6'=%W16>)_S*L/47
M-N0'+6B.9IGF(LU+D;?L']ND?JSG65Q%U3854NE"*@F,A@27@E!68',H))?'
M!1D1W ,-QA#+AH0C7L)!2JO,VUQ/JRR3Q%)BH"8P,DEL799 T8ZK:XB0=;>(
M?$0#H#0 PZ'1:-Y5AA6SA5"\ [\O@#MF%3%?EX6?W=[5>-6MMS]?B';-F#8G
M,^O,]0?N7EWY^Z'=E3)\?<Z<21,?8I9<U#P_,^.B^=,3C8L6Y//9V4U35OSE
MQB.53[]Y&<Y,!F]_]G]O@K..X;EA#*ZK7MPC.\"'@JZ)Z6;NR#^8_[OI: 0/
M#HBGLP_(HDGKX/ 106:T9J'6$\B2HX+=YL"?#"8\FIQ.K]<6"@:Y%D_FG^)*
MBQ#1&;*93 O)+>7X:*A% ;!U@B6O6VKN2\%4JJE/#=5JJ;2)+,O8?5GR+IAE
MUFQ3DX!0P6RN0OT=*<!"M5(+S452J42B$E@_W WCF206MT3D4N!TO$,%;X9^
M28_A_32N=9'GG, IE&#@9-!TLD;K]U4QU3-IDU&L?)/Q!-+S25!C6RNO/?'.
M [?FF[)YGE]R4UN7(Z=7Y/$$9]#<=$M\/.+;$TUM3VYYY=,M\*/,X)*;EG2%
M6S,VF=VN:'QJ92<'(T$6_O[U:)U<Y=''4L7Z:0,_.7\F]19.P+(!=VZ@QO/T
M6J%^G':C%LV2S5,NE9VC7"V[6'D7\X!,:@I)%!J$U#S2%+%R JTQ04/;"=<>
M;J@4*[#3V'X6_SGT,=D1<6R3VI,WVTGMU?HBJ;3X@!W73RF=!D5<D<4AFC<W
M $U>ECXNEI1- :^$'TF=8NLK#T'^'T_]N?+M3Z &VF_^\6W73!D_B7GPT\O?
MO?L]..:EFU]<]"FZZN%;?_?8[;N(WH%PW[H"/Y$#K-EGL80MR()[S@&=*6LT
MV@#!%3T@4V6U6@*+3,@5%)JL1*+@.#S$&*U*XI9*&4:E,E'EB+()FK,.A]-(
ML &3 QG2Q@.XB4D?P(^CRY"G( >+&7'&I1EK)<CPI"U%R4-@XTEZ2[@#9;PF
MU*UF)D]2!M&/SW_<&+AF_D*/+[IFY9WP'?1$Y?BXT,MW7/O 9PMNJ,0+FAON
M='^*6VA:92+[&)7>?O"D,*.);;)VL5W6>?PY_#DVB;3.6A=S7RBY4'Z]\7JW
MY&SF;,DYNG.L:W07F2YR?2'YTBAKU4W2S69F2^;IYEIYX($>C\$@<TLE#G7(
MCA10+:-K7E9GUH,G.QDVY6%P(.F$3L$\R*0$A29)6MR?)!%]3&J?4CA" B3$
MYN6: U3B8 LEG5Q5* ^5/AJ@;4S2@XB&1C43FODS@/4/OXZRKN9--%!<1YWG
M@.*!Y$B\.!$^Z,B#1S\__O+\F2_$UO1NANSY'USWXH*TWU29".\VP/@3AZ"7
M#=4=>:MRGA_-.O^JZ97R[S;\ZS:F&(+KWWWTS)\3?N>A2A=K&+Z=YFST""I)
MT<.F6 18+4E)8ZQ"'5-T SQF\0D\Q_T?UKX$/*HB:[2J[KV][_N2WI<LG:23
M].WLZ=P$2,(>]D4#R*H@0E#9$<0%%11<$'%4<$9!1\>@"$0=!T1!_6>!<0'4
M<<097,:1@?\?!A7HFU=5M[O3*//>O.\]2-^UMGOJU*ESJLZ"I><*I9QE&;!#
M09Q+&O[5F!>:,$Z<0W=A')4': A!:3>*_.:N'7H;X9A[^KY@(]3[#XLY93E@
M$>9[2:PU%$._9+OQ7+!-:-W+'>;0:OU"/UJM6^A#V\MWE2.=8+#R.F(1;7F%
MUYT+1E_A ^>"BE=X[;E0P2N\_URH\!6^]%PHX/?K=-I>>&@WXWX!DC!2/F<I
M>,'Y#"-7/&"U_"X*('2["QXH-$1A]/NR#V9DU4<S*B>8+XRG\=V_3F<43;)^
M"TBW+,(3);1F S+9LX9#U<E,7)7+ULY(F$3H&SLI,=RK4)>)[YDM*I7*94Z6
M6B+B^V5J!7[(7M,^@1\]]WBC2J<(A30R9^7Y5I]IH/A)O5L>"BETJD98VZ#6
M*L(8^-&^+^5/8EYP&!@'%L"[A#DO7??6W+?F,<]X?WY=KY>Y>]Y6XT/7,=<9
MEQGO-C+UAL'&JXT,!FTK*ILZ;5II^ZM\Z[9@QZO#>+ MW/ JW[(R9'1J9;#.
MF#!?,ZUBVIIIFZ8QT[166]RV$0LJC"VB52H44+M@/ ELZ56K5!'MB!?JZUN&
MCWN!+.5:S#+G"UI9U]#*F=.(PH;@J%2WMJBZ[797T'S04F$[:$V .88Y:([D
M64S/SPEN(G$QT0HA.#]VL+3BFH/3OI^@+_ 5H +BTK@@.'_\>,5!I5*E&C]^
M0B\,OYS$K."H5V$;D!$O8,-'C*BOUS?X&E!#+WSYY8YVY\+N7C1M=V Y]=,N
MK1E33?\TT27*]"?QS1'K)G[LB7HAOCR'KVB04VIE)'DC/9VQ-\HH?I*M%7J2
M]EF,-,KFJ9S]F)SLF&451[JP(%5%?/P0S9  10Q"QF@H/L(;>)D<IR /%<HR
M@0R-,EEAQ@5Q/K9P1IL4CEMR%D5*RECQ)GD2W*DFBA0[C[64VT8D I"K+O<6
M7F<+VT.ZH.OACGA3Q3\G-^]8,FIV@2;H#'#A0%EMTZRJ41\_6U9<Y!B2?J&U
MP&SWU\-MZQ\8/&TL.JV4ZY4ZMT<9;+U#J!DX^.3H!,\-ZQQ>/6/H2G&O51&I
M%/]KWMIJ7T'JD=$K!B_;6::IG5)E=@KS%\&O6P= \<89@]080U45OFN9.Q?X
MBA71]*_0@UOFKT^(5>F=-1Z;1E'^\X>O;XD73KQ[\+4#Q@XF8WPD>%R^B[F>
M["D3(V5"(VQVHDZ#.QI^.ZRA8;BLX8=#UTX9<>NK,R8<9*Y?/'7:K.O?W;2Y
MHBSR",F_51S#7,LUD/QFHHI#MA:CA<80!J=\Z_U;(N7QS9O>O7[6M*F+F2?N
M.#A^QJNW#I\RYT**.SBLL>'']9.\,A*EH(9LZD<+9>9<CA\.R1IP#N9Z7&19
M!2WRFBF++Z_?GL0%X/FLNH:6$HUN73)%:FR\/++%,*RA<1AW\$)JSI3A^%O&
M'Y1J?P+7?@/9FX;9JG.?CV<^>8#:;,MW3=F[MG/0J@M?K1K4N7;O%.F.<]([
M5% 6>^"AY]>O?_ZA!V)EI?=O)I>;[Z?^CL8Q<[A]M/0L8'*-*TSBQI)9HQK^
M#>=ZZ+D-&YY[Z/Y24A:]?(#;-V4?KN:6"U_>,G#DVGU3\-W(@;=PKEMPI?OP
MG/I(^J%,Z;[_0_FX3_]-'>*?T._3B?]M3=\_3GPWP;E8ZIW']@&.U$5B0,.Y
M,]G'+_2Q?1=GS<3?NA< 3L5M!@&RNO@N=UB+WG' -H7)B.E2+ZP4O*ZARA F
M1 :SJ<=H-&Q& ="#!3!G,+0Y0)SL4VHAV1?BOPPUB \_G8YG=\)K\<#5>KP%
M7D0<G3(R1LZP,@T6UQ#ALRQVB\/"RMP*WRW J3+? KV,ZQ9HT>*#Y(&<;IJ2
MC?% R,C7I)A$E1?9;5:,J7QA.1,*DMU2*ZRY5:9IV?C>DNXC6UM5[!J9JFK>
MTQ,G_NJ&4AF+QOPP8.G/'NZ:].ASM_)G\-":?")UPYKNP<-7;9Y9?8BL#$2@
MFYW'QNBLK0:3!(-:@6=EH%+*.%8+03/3RT1>8IOE^+17T:R^W)I%VV_-HOFQ
M-0OU22N9MMGK),N6[/\(B>F<^\76'L+_"4^\%0"69V_%,[H2@(010F,D@(];
MX>_A'R[M13^(MXFWH^5(GOXA?><H)(?/B>-P_2&XG[V.1OGI> G2*#][27".
M9H[RR2J=B6=Q'\IHE#;,5N+&VNU.N=3<O"#5-&9)HQ3I!UHC&,;L=9?JUS!W
MKD'B/O@V\:(:3*>9H[)W =$XQ%V0)[]EW1ZBW??O[A[0GHAXW::XW:A3L?)T
M6F[^Y,\MI46\7C58HS 'YA+]UW0:[<Z4E#!:\B+/9'T)H:!44MA78"J72I*]
M^_UIJ22#JD.ML/KG$L^LR,:]@0[1(-V8 G%O7"CB3B!;#\'_ ^D'T0)Y!WV'
M:0P\T)-^4+GG_%#R+;>D'^0.XGQD;%AI8*.#Z7D]Z%#/Q55<%2DW_2!3FGD?
M()J+:%7Z>F9 #R[ZPA](?ESO05PV)Y6-^>M;>M!F_+#JXJH>J5U,:>8]R9]@
M2B^]CAXB^=G;LO7C]_)L_H"1EI">1]J(R[BX*MN*;"I:C)&T Y>3?I"]#9>$
M/X:FHC"02W59,ZWE3I OLO60HK*0RI0E%46A1=JTF;8J6R--I>Y/E2V/II2*
M)(E)L:CO;W B]P9S&QT_4HY<+]">^* G_6$/0*0OF+_3OLA^,;%';B1OI4ZA
M'9.!"RY/2;]8&B\8,LS ]#P).-S9GM_W7&K(]"_MPVQ:W(LAW,LL$HM[?H_?
M5>$FLC==W "D^FD[.?IE(4H-C>2$%O2P\-(+<&4/NH.6+MY^J8&]J2<+_4Q;
M C1N=PX2%!?@1-R4"X9,RF\R+3'39*0E^Z%8S$+2%-Q7%_Y (8RDM+F6T%Z5
M,(QIN/0""],?BB7H#@P4K@67S6"$W$#Q%<.9X(LRAR_6#,X1P."79R\UX-80
MJ&0PD[::B(JTIP]>%/%K>%S"4-H4 A72>Q1+U5D8DIG'F$ +F-$7^U ,'DNO
MZ)%W7-C?0RM@;Z*8!"=2K,R'2P:_*990N#"',J/@F_Z44FN8;R[VP6,X20:1
M\'B@>$132BU)$+#0[TPR#3T7^YC1XNT]Z16X(88>N)(Y='%#3]X84N?#)#>.
MLF.)P@4CC(0#TICKSY'%0WA<+,[@(D5MB4XPN3P,_@:]E,M,<V:@=8!"-;T<
MW8GS4T3F6MB;<)T7]F,DHGB:&\69,54H04+"I,V0@BP+,UQI!D-R[33G "=A
M% 5=;OAGVIG+D]=.";>,&=S">)U> 8]ED$L:<1B,S"$,4HQB2!KY="1GVIFE
M)=)HOO3K+$6A0YI\6C_ER;;3FH?YW EI&.*&YL8ADU>+U,Y,/<90@,)3JNNB
M2)L)5Q*H2O5=W""!,T-Q<M#)T*@LU:$T*D-XF$.7&@CQR:-]ZGP\E.@?!2<9
M%QE<Q .#R=7!48_UF3PP5Q.Z@8"RAQF37HZSYJHC;92J[*>CYOPQDD/1'!7)
MT%1*5S,HD,77R\O(PX++H)QI?@[4V8_HR7P+FRN%?(L1V$E[R B71I<$>XD2
M,G^GHSV-X9U%%%2*J2*#2\7?14<=[0G2Q@R%1/-IV73V-69GW_GL)SG<F'_Y
M.]S&C_.^#+]C,$CMY$5F9B;OT(=Y[]"W_;/VL=QH)-3*B([E7GK!;%&1*5-.
M>\V,OY7PV2%0"&(@#A*@!C2 9C  M(.A6(H8 R: J\!4, /, ?/  G C6(+E
MH80U%,G\N+QK^7_PW/[_D'[VJE7P?_#OGZM6I2WDO'(EN?]AU2I1BW^Z5:O8
M/Y/SRI7D_H?^U#]<\>F_*>.'_J?RCE7DW\J\XZJ5Y-^J_^ Y:.S[YO\#M%>
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MRG,T9@!\$D/ NP=_S-D*W-M_W5=1(9-)\1M_2F66YZC, (HK4<$.IU9"C&6
M1G]DLM$?JRZK&>/*%O1'1#Q"6D'%OO,6:"7.('OAP)=E4)F@CA]5IJ$;F?T,
M8I;;B"(*T?))GZ,D ?[$Y1(1X>$_GGM^V82AT\8VEGDTG&W^0O3'RB_NOO&N
MV:FFJ49Y8-S/RP'L.\$.0._3".W&O6 7@Q 'Z)X4V8XBKJJ+T,4T1P*S$U=1
M>#0<XQ:"9C 8*O=.5L/S)"!2WUFAW&CFMZJ_TJ#!_"1^L8:)FZ'YLX)I6BX@
M[PGJL9 J.#V\3%8(>Z)X)!/O?+NQY$3.>XT6S* 4M/8RP=T"\9#$6'<;2%0>
MIF"OOQ3&L93:"X,O555U]#(NP5FM9@PXIX)C0*HD$O(K5<&1A5,+4>%KZ$U0
M! PP*!AM B[3-L_KU1<M+#I"%O_0&<&J5_E42*6J*S\8GSE4!DL'+:B;.83X
MO"!.,(F#N]-==?'S,1H?CBROX&%)O&1VG^HZ1R/OQ&+=F+LAWIBH$YK379+4
M2U;@R'IV(3E(GL!^[(^)&(/8R$$FIWXO+!G'85GE17G&0U:B"A;W?:#4O?X<
M_.2I%7L'U[<,0G#4F+)OCLG@D3^PL6N6'? 5]ZY<>L>H%1.F7GM]21VK;*XM
M3];X)B)V?;!M@]^X%\JV3$L-ZZQ7%9OU4Y<..KTA5;+^UM6.^:_\^J:;YC4T
MWV0<^VE%>3!4@OMR<M^?V95L!\9V)_A8*"YFZ]C!["#5&-58W62#?*D";F&W
MZ+88=K([=3L-QUDYD!ED7\L866_?7L&$NT"F!)R!&\5=P[& .N]Y7FAWN7F.
M<;8159X#1+5%:6O3,VU*)==6)QLFNUHV7_::['>R3V6G98K=LD.R#V5D4];!
MRZ:9H8 Q1F8^8^HS(1-UJ*?4\":3VSF2. H2-)LT2$-V;#5X/DR02#9D8B2[
MIMW4D1ON++K%VG7:F(AU=^%#5W91PIC3WP942Q:8"XUT/P*VK/FE>&_'K"/;
M3HM_@M&_'X,5ZJ_6/-^S#)G%>Y>=C]UW)Q3^]1U,B:?$KX; XF7+Q1. V.'W
M'>(^Y:X%%N  95@F$N"-0K<L9 M%0\R*X!)A76Q+;$=H;^APZ'"S@BVWE;MK
M&#XT,#2^<*(PNW!>V9+"%66OU9PK5TTNF.P?5S@N-K=@KG]6X:S8DL(-P<>"
M:H?59NNQ.RQVNZ/<CX'@)(<0.90[0S5L0Q6O+X;%)!25M8'W:JT.SF;7<@H>
MOJ)Y!>"1]AJ\!;=-BP[N-O&"F42)-%NX4* F5><L+:](6AVE<:)00H-117=L
MK-M& ]<U[@;$YQM\8Z][3<4FLM;.-.X52G?X4S#U&OP>=ZB;L)8J ^^>V6JQ
MVQAH;M% #]#@*CV$4R)'. -HX,]!"QY0).K0MW@8&<['+M\@3W>=[CJ7>Y07
MOLQ4!YIQBF])"BQ-4%?<ITF4.^K"/!/,CG;J(BE>W>4N.;.1ZLQY.^)Y6L%D
M)!(5O,SJ A^%CWD:2$BS 7Z3)R]>W1LO;]J^8MF&1X<)#RZ]9>7AT.1 I:7D
MF@@_EX0V&Q[U^T.=<$["EPUJ]MW5-W3=.&?$[,%58QN&S9LM3+.5=*R(12:^
M537IGJIXX[487WP87_Z$\26,R5,3: .=\&MALBQA2T03S(JJ)9WK&K8T[-3N
M2.Q-'$X<'JF,&CX)?QMFV)0MY6YG^,3 Q/B:B9VS:^8U+:E9T?1:^[F4:G+I
MY(IQ->,:YI;.K9A5,ZMA2<V&JL>JU"$2,DU%0J:5DY!I!HL!10N+BGHB44LD
M$DT1#"HFAP0YI(H3[>S05EY/U& P+GF'\N7:2!$7+=2.5$Q5+%"L5K *A55F
M(#'0U"X2 \VWEKB%)8EMLEF"FDM4MH\87-R8$@9%BAKC@^ @":>J=VP<O&TP
M&DQQJA)6$IR*K1$V"4B@.-6XPS\"CL!I7S;L(NI49*T*HU5LYNAHH<D.(:/8
M2S;,T1','O7"V,N"GX&8:_I^KT&7\)/E&5R+P: WP;BIV332M-JTT<29>N&!
M/?LQ#_[8*"EH6C_.Y2]3=;LR4=2("D:^"[G_ #5=N1AK";KG>67\S 1-HSC:
MU6U.7C%J6D9#NC]FVG^,M/L?2U5UUA1/WCWIIFONW/W46W&?PY^LCI=6S6:^
MO92Z@_DUQM[ER]=O'=KRT!*"O9/"<6O)M$AR+O,OMV<V#:IV=6H,W[1D]E,3
MW6%]M# 522V'=_][5"X/]J,RQN58!I<9+!$E00ITP)\)*V0Q6RP:V^=B5Y0L
MZ5B7V"K?DGA6OB/VBGQO['#L<+N:K;95NYL9/C8P-CX^L6-V?%YR27Q%\K7F
M<]6JR>')1>/BXQ)SPW.+9L5G)9;$-Y0\5O*N2@,1P_0 :,&,5#7!UP YQ,BA
M.A!K9@?4\WJ*6[<(Z@%\5 L8#B(M6;78;3#QWE>91J# UR75/ GPNU=GXA4*
MN27SFD1TV^-8"W101V)Z'I%#>2^Z4;"Q;*RXN:TEP%?7-@&&CS?!U4VP">/;
MOO(=&UNVM: 6BM.4^KZQ-[2F=E,MJL6/!"6_P]\&%[;!-IQXMT#V?S%6>S%6
MAV8.@4AM5,A9&>OG.+7;K5=#M=KH]QOCU,5?%SUB0IE!R6XIW)^$B_CZ1UAX
MNHM@88QN!9V._9]H),8LS( %Y'E65<0&0,(E$A[Z/T0[+GRIZ0[F]4N%<&.K
M>-BYZ_/?;)ZP,.Z-CVDL*J\_](2MB MLVK;B2GC'74MP2W=_';=I_MR?\5%W
M*!%N+!I[ TIW7WW#U3?][]"- Z4Y;-."((B!)+Q/&"%SV!Q1![/"OB2YSK_%
MO\.QUW'8<9A7L'@&=I<RO&.@8WS!Q.3L@GG!)04K@J^5G@NI)ALG6\<5C///
M-<ZUSBJ8Y5]2L,'^F%W-L6POTR24:C46K38?X^ALJR,'!YU\=8Y2MJ*0UWNA
MEV"<J8(W9S!.I>*T@(7LJWC2Y0AV67B.XI*&==A*$^6Z0"A2 IA O 2N)LLT
M&)?<.S:6;R-:ZP27;-!&<,FP)K(I@B(4EP([_ FX, $3%)<,D#B7%.(8EPPS
M:R!2<1J6?4L+M5K5",U=FD<T#(GKOE&S37-$PVG4&K62QQ*A"G.SF#ERQ@D"
M81QSQ D._2?X%4M3WNK*F$5BB5)=]SP$@V:B0A2J"<#_%)O8/D*J]E^:_O$C
M8\<YRU+P7^(91L2$:\E]6X<*6[M7KWP[-"E09<U,NP2!T@'4Z*O\(AT7CQ$J
M-7ODK"$8;3KG7&'"Q;S(_>)J^$7?NY@W$5X#3-\_<<_\4_ H&@D'BV0R#4(:
MH- (&A.O46C8[08"KZ[3=&,+Q/&)>&(E4E4MJ+73/8E B!#RT.=%X5[QR_KG
MKFKDMNR.L]=U8)GO%.M#=V"9ST;U?IF^VUD?$^664^M(-YBU1XH%280W&V(-
M=]AL*A5RWF$V(_D=FZ@W7K+]HM;R6BW HIZ@UN/);BD20D54.-J7K.&1T)Q$
M1!'@7%>ZBO@KQMUS&E!?H>E& Q%#<#>8N7]COHA&B2^/NPFNJAXYHJ9FQ(CT
M-NEB)+=<?!I>U3FLKF;D2'Q/SB-J:T9D5X*H%!NF*_?WG@0@\'(H A'927Q)
MZ>9[^]+[(I%02$ 1")KI1D$7\9%Y,P R!?WV"KA=L,L5:JU-X=9V:"=JKU,L
MU2JT"H.9T./OA5)\H;$K',7V!*BS7U=^&W@0_,[^)_L_@7JU?47Y\_;G':R]
MPA?B/RHGGJV.[E;;>(B!N%N)"R=PJB- &I!$ E_#3T7P,RQ3"DHGAE48 TXS
MRJ <Q149# 4A?W'07^!W5CC1&N=1YTDGXR2CZ5&-GG<Z;44>3X&B=%1%49&G
M&!47!(-*C4<8J88+U' ;IM)$W%"3]7.U$(CR:K6+-::4^F!G$(T,PGAP9/!(
M\$R0#0J8V0H*H4(^N,W=XT9N=]!5ZNF)[8_A3FN.C8Q-C2V(K8YMC&V+*6*W
M.3T;74=<J,<%]2[H$EJ3KCU59%U9T.CX*L%DX3'O0$9IUZ+3Y[!88Z1ZH92?
MR.W1DF5V^L25S@9_/87%4>K0FNS&X@&?QB=(LBV*Q2ZE07.6IR&^@[N(V@"6
M92G2&*DM! G6&<JH ))[YD=;M'0C ]K$/>-O8L:X;[W)&(UJ;UCO-M36C3I^
MO##2=/'Z,D$P&P8(9>R"B'?NED<EY%J9/O'DMG3]+:^+:V?7!__PL#A*VJ*=
M7!^/B LVKXYG<$;NISC3#*_:S8!<=Y.SX"DHXBO\(;_?;_8[*_TI/^<W^36!
M(H%EG<0^J4VP8(R(%;D=GF(GJJY3:3VU&@7%D"BS5,C@1*20)\B"D>0(@MM0
M'T+(1>(O;E<S:K(IK@QP*9/2J0F:Z/Y7)4\%T)*:>K["))BVF0Z8CIK.FF1Q
M?(G\F.$\:CI#]M\KB_6UOMJ>6J:6%)(,IE*5RI+J8"6N2E^Y@*STZ"N;*T=6
MKJ[LJ^2F5FZK1)5"98*O7-720K;U6P2C#7<W84.[%\7R-U;.41+<M:B;1*2[
M7.,3OXIW+R):Q*Y+)%Q1O^9GKI,)=^HZ3;7S,OJ?>( N(MT-K[P#3W1 959C
MX$?WEZ?-=G^_KB>Y0F^1*_@9V:U'AP@6Y/;MS1(2I$UY>IXKLU?B&K@F>WWI
M]GZ=T Q&,"+%"!]X,Q\C:'\[<'^[_%J_V6KRF)';K_'+6+E')O7Y!-KG Y)3
MT7YT!#&4,)#>[B<-V\@J0U"3<BNM;- M-";=> SJW=O<1]R,WKW:O='-3'5#
M]ZK :BP-DUX*Y 8EW<7.ZZ9SC9F1*75%;D\0'_/'FP3Y?P-S F,)LJPU3]N!
M0A+#5P+AA>=^!#T*,3S7W$4C2Q!(F8 'O"D47FN?XY[CV2Q[6/V(=JON$>-W
M[N\\JDFR2:H)N@G&:ZV<P@C?,4(*1PV&HSG),LXDOB*P:Y?&BPX#RF##A]8!
M^-#8S ,T%2U #"H8KA044#&1!DU&MN%*/4FL)XGU-WA]Y,9';BA&YV3^KA]I
MDL1)F$4)8,2C;#^@Z%I-ES2394S:_<#XHX@2Q10'P\=@R]X7Q/U_%O>*2]Z$
M@P\_^\:^EUYZ60*6_C5Q_UN_$?<>A(_"^'LP]6)_\(A6&$-W9N>I#RC<2N&O
M!5U"UB9KDX^7C9?_#Y!1LF,TV7BCS^C'8R)F+'TD(CVM4AMYI:$YZ?3CGV-
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M/?%H3_3(3D-:!N%JB5A+335C5*3 )#I@3'A1(E!(/+N#@!]@>B"7!ZIH9/&
M.84D1^+4502TDVY%3P72C^&A%QT)!\B_^1K.A!/A'#C^JV_DL'5H<2&*IA\+
MM V,=3R^Y.8M(R=(G7SQDG@/7-D4<X\J@MZ73\"1XLX_[!;_4CS*45DOW@X7
M!T:_OO57KRWM[OW-I^_V]?7-Z#O%<(0O1@ZJ0_./SP"([&80+),LV(P\*',;
MD$#D2%O_KG52VE.2N.IKL9R N6K)(H;3<</P/48C@(B6(OL>E74QL1'FU<!:
M5,NVPP[4P2Z!R] R=AU4W<WU<@AWCTQR.U^&H 4AR,DX5E;$  N#>Q#@2\0H
M(&!D' -8!#TD+-IL\!1Q),\@P>KB2]!D-!=MQ80%*02RM$;T0?!S&6-CHLQX
M9C;S,"-C2$@%ZG2?R(]I*A_6T?"(A $EXB!5+N7PH.Q29$1"V 43,!"!$-WD
M1@,N3F7JQ,?$K5B >Z2#F7#IV5ST4/K512 748K>-V6A0FQX\'T,Y'3:Z7TI
MO2_'[SOI?3GUAZ_$^9_#4'."=X0B)0?GR)]%W[.,4A;ABF1CN8FRI:;_,KQM
M52S00)]F@6:UAM%HJ$K[#,S6.QP6DUEO]IF1N4PFM\C,%IG<;#&;+$4L9V%9
MSLQ:3'(,74:E=4 /%AG'RV=SLV5W<'?(-G.;9:_*#G&'9"J'?)Y\-_LF^S[+
ML18S)S/)Y40 5[DA6=CIMM=U=^7X-$DQ5Y$E9UTYO=P8'BC=DJ9<@OBYQH"4
MU'&I:3B$1':V*H?,' O?#\ _IE)3TXN[.IK$/XO_:G\QHKGI559Y\?>;EB@C
M$6_8MQ'](KWSB<1U$0E^\FLIO"I +KXCO:\DTBJX4>H/H,:\5AEX2S MMRQW
M+_$^:WC%P#DU9.!K>IG:ESPV';44U?$Z?"LX!5.G"9E,"SUK/"CNF>K9[V$\
M'N3GP*M,+5#"X%XE0K% ,-I++OT*F]/CZ&5J,$LX,N9A1_K+("B#965QC=ZC
M(\]58&30 T<*?NB/+SJ5/G=>BCW5+5WFQ!?,<37GVZ9(RE==BW#2<S&J(4VT
ML,Q4\PJ3AT!0AJ^)9_A 3LC!SZ!$6B1:LBO"3HQR X:E74,&O1Z-,HFY<-*P
M%EDDPJ9&B;^</%!,1YB"P9/0B9$I"Q-AWH&WBRM;:FO2+\(S->VU;:)Q0*HZ
M?0$>GM/HB*0FBO4@JP'(S<,PKLKBL,Q$8([:Z3V/8?XT[8,$Q6$-OO\!]X$1
MX[!>!FP U2GJC(,5@XVLAMH+. .\TN@T(H5<H01DK9*I%T+ : ' J% JY,HB
M@]%B,!@54XW0:%0RC+Q( $BK56+H"UZE0:&4 _QNC1$9C5H2H$I0X_E%C_1:
MCXY&'5#I\61B!L @K4C&R$H(/E+@)NBP[R?GS23,BI/J ]/!_U,J$,-(;,[T
M (0!29Z$%G9M2>#N7XB;X#!Q!)JW9E4P&KU8A^3<,/&FK<^*)>E/QZP1P^B>
M;"Q%"I\:D-N-I_>-]%Z'[U^A]PT4?CXZ U\-VF"=H$X9,!W6D$."J.K;',2"
MY:Q@P1=W)V![_?AZ]%4*)AQ8M'<0<\ *?-'J5_A1F3?9HE1&4*VYQNRQ6)(V
MIC#LB2 :T$M?XZM!-9]UG,34N!<V"-Z:>"6L3*UN/-*(#(U"X[3&78WLFL9M
M^/YL(TMB_ B5[<G&1I_"%X$1%)0FZ51I*PFF 8.K6X^T(J*-,*UU5RN[IG5;
MZ]E6II6LK=0GZ:F9G@1;>[)5,@RRM/JQ4)+Z3'=2AW2OP ;03H*'=646!X@,
M<JYQD:$QW45/="5@$7[]97>\B^H.D=VT1/PTF7XE=45#1BSL7@0H0Q[),4[!
M<B3YJTA62_[821SRRV26%*I)H425W5I(EO5T2$Y9+W9MNM$S8+!MS!<;XPAY
M>(4ZF9BXOMW,<M-':(1)+O26JZM1,W2$G64K'UV82)IXOWO1;Q\W#NJ(8/ZJ
M<2:<.G##DSMO:X=1W9#NFQ[=?#V$[X]M3$0BU557B66*MJ6WW/9@MRX*AR^]
M?>O6J]7BDU,:2JB>-^Y]#S</4Z]_"L6,7F,TZPN,K,+FL+VJVV-Z5W?8=*+T
MZ](?-.<MJ@#EO73/F)",='W,[>&+D@;&#SR"3458*I5*85=X &-@\!3>3.PY
MO$CAM]D97XZE\OE\G;XU/M;G"P]7FM\KP"P5613&KTLQ@^3UQH%211F[J7 C
M9"%AI"",#5=JWV/QP,-))%8N_E/FZ?^&=2)[3!*W])]R2KB/T'V818J@:.$(
MS"+][6LX T["_V?\Z5]R.("P2)'TXY1%>F+QPX>NAHOS>:/CL%/<=?QY\<^E
M/^*-CHEG_O9&SB;NXYP5V'V@%JX%12^1@)P8-J;I,WDAN9"$ *=V> CU:UEU
M2U$PZ2BG)31F]'?NQ25@Z1O!S@'0, "" 95V&<DJ7!9TDU $&HF.<&:P+*.C
M]9>L#G5)L=TNH!]Y8*!QPFCZN+3".5>R##&TPN;6!:VHM^_TOM961&R,6R[3
MYR+M%(>P3LH%VC)UG94\YH#@QB#.>79?,&@RX9S!R_4^2_M.H9O[N4=P[U\E
M752_S68P"#349UX+5;B%)VGJ -7R_@=XE7H\T&%VT])0;&(IEYD?2)180,\6
MAS!?X[% N*,3@NN8#BIEG$IN=,BL*KMQJ>XNG4)K4.N)]=))(8;EBEX9C'JU
MC#\<]OL5)JBS6YQX.N"=3I,Z%E7@Z4-KQ&*"/4K2\^%:7AOU,D5QLH'E*X)%
M104E@EZ(QGB]'NJ[*[95[*K  %=":+&7*#NQQ(A8RC5H>38>ZS=GNLR(F2X0
MQ%P8VXE6AQ'+$ 3+R>( ,2E(-!MI5"P:8R%K[A;(4WN4LS2\0*'58LRXT:';
MJY@Z23M<,BM<*7X33KWVV.'?O0]5[[PP;U9=Y[A1@V/E8T95%7OK1PU,BD-N
M.\.<Z7GVVN=O_=6,V\13+Z1';CD,]X]Z_J/S@QWU=;;1&Q^:.W,GIC2,V,:\
MR+P)_*!',.[DGC$@%UO";F4>8;<H.%-O7UHH=B;E!9 S^!D5D-G(:+=U6J9A
M^FVSN.0JG4'+R?VY17_!@*<>K58N]_MM!EPH(A$<=FL,/#U;[?C,- AF24B$
M09M/;X>22ZHX71C&7'DLMHA,Q9A_S,2((SLXDBN!6#.&&>RFX9@PR*RR_+V^
M&HG"A^@6C=EFMZ-5D&]O$<\XQ]?P'=?4I.J'M]QBB<R:,GE6DE64,#O5MZU+
M__[5.7?<.*7UJ@]7???7>P]\W/.\^#^6X#X,EU8,EX'<6E +_B $KRM<!I<6
MW@WO*MP*GX%R1@612ATRJ=RADM 2U;LAN8J0W@D8"4%15#A:=;(*557Q3JO3
MJM<KE5XO)RB#ZG)?61D/R\I!A=+,5X&B<K:ZPF2*5%<71/58T)U?KR=A]Z9A
M=$!DC1[%D#X"C^*I-A- +%)+-_>[JS!EI<33(';3B(5Q:C<7I^'5^A>?2%P]
M C62@,0]I=25: XA8S:4WA7V3W.AD$UTMZN&[&])NT4R>.__W#/&6-H6>OK6
MMU8V3DB4!:O* W7#5A2,'>/=]=RB#0,GO*P>-?4WCW:<85O$WXCBEMD,]]KV
M7?O:RH,)@Z&M:;E<]H^CS\#V/<HQ#7>&PV7#IJJ_:A]W.X8UI3X8!WU@[QY/
MA=--XQ?N5FK(^2RQ'7:]RL2 @RD1=%Z3J0V<)_X8*2Z1/<1H*>8]O8;9"".C
M146VO4J4!@S0$KE2J9=/DV^3,V0O7(YICMGE<_<RI4) DH]*CE@^LR!B$R]8
M=EE8PI7X+9LL?1;.$I=BZ!*,I$Q[(F[ @YJXRVINIGMJ,=P#\?0I*6XAS)K\
MV /1K%UX0#I3=(0?W_G$I*7AJ/A5))(<,T3\.A08J(VL6OXD$_CYY&7WI7_V
MES\^<P[=N7K4BG0SFK:I;N/*7Q$Y9@RFEQ_1&+LV/)3NPY-Y!1Y)"G*0D=5C
M?$9D":^=/.7D2@=G5[)WN=9YD%UF5Z##Z!WNL(;1M4GNP>QR=Q2HS5$Y-/@$
M/093=W!;$#KT-I\-V82C4HQ"@FAL;4 *X]A(R%A>K%RZH$EV2 ESQ07QY&P@
MFF=&"Y+!0-) 9V2KU4#=7!J3R+;HV K(''@#HA4?BF=A_<2V]G%7#8P-C10\
M!FO^"J^#UXH/BUN_$'_W.#K="L>\]5_B[GL&BO<^/V8_U!+G2=+LPNP$9K!V
MSS+M75JD(E^KQPBB%91&WA V^X!,3G"#8TI>5JOE/@7I78\>^1!")2#DUY_5
M(^*-[JR>V:[?I3^J9_09YT#D_%(J24\=TJDSJ8]G3,^_Q4RG%#?\]"E R$V,
M</^6G)YCE'9S82F\SU,X4!=9M73HM=&JP<S.]/WSAV]>O:MU_@KXWK1FLLH?
MQG+0<HS;03A)*&DSCS<C)5*8E4XG<IB=SA@J=M6B.G,'&FS6_!:]:W[;>0)]
MC3A(Z,F8*IY'9I/Y;C<S%LZ$R&RVNMPNI]MH=CD-3NB<8C5;K%8S=!N-O0RT
M, SL=$]S+W2O<6]U/^M^V2UGW0/=8]V,&[JL+K.141@\5/2JP4-'8Q!\ =Z@
M,>!QX0O*[#ZGTZ-JL ZUKF#6,^PDUW6N=QG&ZB399&Z[4MEIAW9*R8T\-;5Q
MF^V\W1X.ACP"=)<HSWI@A4?P'/ <];">C"F>)V.*Y\F8XGE&A#*F>'DVP-_2
MU54L[!(:1M<4:$PVR1R3/%O435V?L:LR AEQ@K9.87A+(>W7QS(FOY1Y[_<B
MD['[A9EAF(1[7FJO'#<N\4!#Q%%:&8D/;/ERX? :\0'QBT;QZT0;LU,L_GIJ
MZXB"FRJ2=F?K1'''LV.X"-P]2GP"_6ZQ$,']6-#W3U:&QZ(7ZH1[3=XR;P42
MT*/>7WIE<JV#;==>"UCBEM<*;9I"6*A)>@=Y)Q;,UEQ7L-F[$^W4/>T]KCFF
M/>[]4O.E]BNOU0N\GFQL8)U6V\9X</=Y=!XMB[PRF?%C%Z%$6$)RN0!4 1)K
M4O:Q&BH\%8AGJCT"&LBT><8R,YD=C,I#)$&?P<PC+Z/5>606!1"@Q;?+"JU6
MO\*G5.ZBX9_.[BXIY6&<@)H0M46G#71-.D9\8"2(WA>-U&H@FA$$X+JL!$P$
M8"FNNJ#25BNQ4$T.(!:;E F,&PC S,1KPK.(6?+(F\@Z"61@L_@I?$EG;1]Z
MES5BVG5O[3O>H:FF,2B"IDP;-2(\EMF7'+EB"QQV\M*72T8-:_/KEV^;N0D.
MQA"?)[:Q<_'HCX#W!)//CZ<!E5!<RJL41OVF3$2K*5CFAS#<P7IFLPJUWR$#
M/@&2G6L(9;X2I3X8#W8&5V,RQ^GIZ4BP+\A-PQ=G@TQ0P))24&A(!H.%*I5=
MIS.;726JD?9.^S3[0CN[((/PF%38,YXKZ#D0YNV$2N2VKD\3P&7#W9(=[;RU
M'"*T$E,R+*AB>!-VIMF8B-&PI[DXRX4V>U9_KB;CHP93&7).5+&#(O#.:[95
M+]^6BFM]SM;F-58O=$02(T9!1T/+_Z+NS>/C*,[\X:[J[KF/GON>[IGIGON0
M-#.21AI)+1^29=F2?,N'D(V-S65L&;"YC&W & /!))MP)1N;D(1 #AQ.&[*Q
M.<*1[ ;O+G?(0G8-(00';]8Q)+%:OZKJT6%C$O:S[S\O'M?TS+3&Z'FJGOOY
M/D!SQZUWWYV8=_XBL6/A]N0YNW],1T9WC/1> P^-=FVDP-A'2'^L0[(G2'W_
M($6/?8J+TRF\72[RA4H,37<Y'4XG33D=-$4S*E!AVH/T/17TN&C&X6&<+F.
M#P8IRJ1=X%S@VNWZDN<^QS[G/M<CCN<=^IL==SL@NIMV,0ZM-6@P((NY#LE8
M:+6&J2 7K L>"3)!=?SOR)03CBL]2-009T%TIV=!\! UM\?15)OL.XYO"&)
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MK5Q>VT;M%X&?*.LNJ];V"=*9%*4I$IU)'T1'_%/Y :0C:9/+!)/HMS!;!*_
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M61]L=^LI1Y1R _08< /WUOAG])1_ZBB+]XL%$FL]1OH*L45R#-LHX^6=9)S
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MB3>(&C$533/YI,=CMR>3[: ^FJ>*T2:--<_G8;Z=:@+H,= $FK:V$=:/DGW
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M*:4J,P=I?*_'T\4R3I9E/ SKC8A>52N:2U[1+5I$6U2DQ4-8WNLM):0Z1'W
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M,BVG<J4]-,#MC1N074+'_/E<KBO@=P8"_IP_D&\2\^,<S8M94103S:)//!0
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MY06JIZJ9J? 'B-FDU>]T/'C<!X\!\/PD'XLGF8\<&Y\/6R'M/1VU+K4A-2"
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MZ3@-.RX?,/+L3X &Q(3 4L#$@ TP);"%GD(MIU#+]S0MT!\P'5%"S$ \31R
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M9=I1NPH/*A9Q_'.BM?S8)(LC4FK(0;<%;34#:H=_(QYJO'@44_" VRB.=/Q
M9B3ER&/K.(SYP2M^F%H E':$UPYC#7A(<Z%EVD%4Z; O>!QK01OX9=4KCJE>
M<;SRPURS.&Y:X<D>$C5^./-@?(+'=J^P+1@1[=+6B''2CK26<ZY^7M2MB$.Q
M0UQ^S[W(_/Y5<(B(D(HRS"$7".W ^?O71!GQPO4+C; 6(Z>PU-G1Y\$#:R.N
MEY:M"AR2?>)0&SS4J^+HKL6H.>0Z:>XXQ/-8-..'!<T=5V(K7GHZK^+:"C5=
M<+&_O$NUYD\QYHJ6R:X.B[5,5#LN?MX+8JQEF44<QOG*^#&FP4NGMT/G9)3E
MQEWKQXM'\#H[&;R34;XJ+O#J.?FK[5[M:FW'&5[,,[O(,QNNG"ST:K;YT#NO
MN *&[AANK8R7E="K:&/'"BCB.F-'^=J:VK$"JB!+Q>N)=M'7/@)QXZ@%-:@8
M>R[-!7\M*,TL/NQPP!PMUM. SX(:6CLNBYT5I 'G-IUSX7?@)5PFBSJNLJ'5
MP8.7+Q?FA#;B.N=#$PMFE/^<50Q*YCO/*ZZ_FC0+QL^-:])Z#J=%?*#@0PYM
M7=/QXS<?\!>0D?"W!?^F8ZQ#KXYF<95/%_5FY'\\+UAASJU\VI6<RW2 Y?_W
MT<[_?;03^M%.-OP;VO%QRK#_CS[B^<\L^[^/>B[Q40\QD&C\5XZY?V%\@F\4
M[43D#3FEI*+E=CR[:%'B$IMQK[;\INT7VTN=>K7SAR)6^=QWQ>7XDWI!+3$+
M7NVM=_D[K#,R)>=)*(<G;?<Y0O@+D/=RI7/>_ZRNGSOKTF\!!<^;,IRWI9"Z
M'[RIJ/^M>XW&706MEA\N[/%?<OZ%,R9@-+R7G!GD&P]W(SN\ZT^#C"^@[])W
MGG/Y@W*\XL[DNFS-G3.F(G6I>1I7&>[N9KRI77K.N=R3881'VX^G**VZ74K"
MQ>:$KIKKO[7&+GU__1C]*'V)/D>?I[]2/UI?J<^_E(3?F'.Y=^!.SDH>#6H"
M^E)S.CDKQ=FNZ3(\#>&E\>0CW4 8N<2<#KXJ/*VJE[$BG9SX70O\$QA ]I*+
M_&%K**,ZJB?\VPYA))Q$D$@2!24BAL1"J8@C74A7$D^ZD>XD@?0@/4DOTIOT
M(7U)/Y)(DD@RZ0\*!Y 4,I ,(E>0P7"A&PJOR.%D!!3$--CV(XE$P^"RG4FR
MX$6:0W))'ER_"\@H4DA&DS%D++D22E<Q%*M2>'6-A^0O@S)7 :&J@FO,1+@&
M3297@7M3P.TZ2/%I9#J\\.O)3#*+S"9SR%PR#X^#9BQ#5KS0J60^A-@. 7'B
M*VF!^$C #XG> J_'5CBD+R97DR7D&K*4+"/+21NYEJP@*\DJLII<1ZXG-Y ;
MR1IR$[F9W$)N)6O);>1V\@=R!UE'P\E=Y&YR#[F7_(G<1R/(>K*!/$ >)!O)
M0^1A\F<:23:31\BCY*_D,?(XV4*>(%O)DX3__M,.\C?R%'F:["3/D%TTBCQ'
M=I/GR0MD#ZS,B^0E\G?R,GF%["/[R:OD'^0 >8V\3OY)WB 'R5OD;?(.>9>\
M1PZ1]\EA\B]RA'Q CI(/R3'R$?F8?$(^)9^1S\EQ2.$OR5?D:_)O<H)\0[XE
MWY&3Y!3YGOP Y:B=_$C.D)_(S^07\BLY2P*4T&@:0V.I@<;1+K0KC:?=:'>:
M0'O0GK07[4W[T+ZT'TVD2329]J=&.H"FT(%T$+V"#J9#Z% ZC ZG(V@J3:/I
M="25J(EFT$R:1;-I#LVE>32?%M!1M)".IF/H6'HE+:+%M(26TG%T/)U RV@Y
MK:"5M(I6TXET$IU,KZ(U= JMI75T*IU&I],9M)[.I+/H;#J'SJ7SJ$P;J)E:
MJ$*MM)':J$KGTR9JIP[JI"[JI@NHAWJIC_II,VVA"VDK7407TZOI$GH-74J7
MT>6TC5Y+5]"5=!5=3:^CU],;Z(UT#;V)WDQOH;?2M?0V>CO] [V#KJ-WTKOH
MW?0>^D=Z+_T3O8_>3]?3#?0!^B#=2!^B#],_TTUT,WV$/DK_0O]*'Z./TRWT
M";J5/DFWT>UT!_T;?8H^37?29^@N^BQ]CNZFS],7Z!ZZE[Y(7Z)_Y__3)[J/
M[J>OTG_0 _0U^CK])WV#ODD/TK?HV_0=^BY]CQZB[]/#]%_T"/V 'J4?TF/T
M(_HQ_81^2C^CG]/C] OZ)?V*?DW_34_0;^BW]#MZDIZBW],?Z&G:3G^D9^A/
M]&?Z"_V5GJ4!1AAEC.F8GH6Q<!;!(ED4BV8Q+);_5@SKPKJR>-:-=6<)_/=7
MR/VL%^O-^K"^K!]+Y+\1POHS(QO 4MA -HA=0>YD@]D0-I0-8\/9");*TE@Z
M&\DD9F(9+)-EL6R6PW)9'LMG!?QW#]AH_FU^=B4K8L6LA)6R<6P\F\"_2<XJ
M^'>8636;R":QR>PJ5L.F\&_>LJEL&IO.9K!Z_AU2-IM_TY/-8S)K8&9F80JS
MLD9F8RK_[B&S,P=S,A=SLP7,P[S,Q_RLF;6PA:R5+6*+V=5L";N&+67+V'+6
MQJYE*]A*MHJM9M>QZ]D-[$:VAMW$;F:WL%O96G8;NYW\D3P;X7>J$OP1;6E7
MI\O)?^*F.AL]BL_O<48UVEO=-I,I/U=C*<[F;88I(R<21[*E7/TXO\>%HR:3
M2>,J&B^X<\.+&CQ*LQ(N8Q-1Y&IT.96F"%EKPTO-LL?E#+=@(V1($>,$ER*X
MQFE<BM94R6:_3PFW:TV5UFG'1E]E<?GT=H#PB=JP4VLF:ES.$#W9DFA-X34:
MDT=K:C1>C]9,T3J]V&@S<C)$FQE>JS'YL FK\T#<POP<-8Y<H2/7%%ZOR5D4
M(B>W6+0E81-DAT,.J[4I/EDWV::&R7:W30ZS*':?'*&XO:H=I'O51H>L\\E^
MG=NF&O G-UZSRZ-8&NQ1RD*S779PRNGU\Y_3N3SA;L4+XJ)DC\?58E>LO@BD
M_.YH;#W\Q\O:H,75XM2H!I?/%B78+,[8#JK!JT2[/#X;7P_9'JLZ^8]0M)]4
MQB@+_&JS;%><9B7,YO)[%0.LM-W5R'\JXG3YHCESHT>V^]P=9(,/DRA;RSMH
M,T1;HK4FT6_*$FV>:,5XANC/$,^9XCE3/&>+^=DFT0KYV9FB%?S9V:+-$6VN
M:(6^['S1%HFV6+1!/:6B'2?:\5J;(_3G"/TY0G^.T)\C].<(_3E"?X[0GR/T
MYPC].4)_CM"? _K=#7:7N2D"UH:W8=J3W:JU'I]X]GEMLD4)0XRP-&$;957M
M=L@:U\)HC>(_<X[P>52YT>_66H]XMCBUUFX--ZL>LUV)4IW-#7Z8Y..4Z/,Z
M5#O^:!X2H[GC0>?U.\.MB@-20\\AS.L&Y7JSW=\09E-D4&%198?+:8EQ^+TB
M692X$!JRF957,'5^C%-VN[P^C\MM4\(=JA/W(_]9KT6K19*H2281WB(1]B(1
MMB(1MI+QT2ZWXM3LCRARR&9>#&2MC2GAWO@=5KNR,,;<26M;5"H2;7'$.#%/
MT=KP<5J!4[0"IY6P'-'FQDP(D=IXOM0,41XR3*(5A24C,Z8L9)ZMD]:7-<@>
MO0T@O-RGVBU*N(I-1+FP2A56E6M6J9I5Y:*@JEH;4Q$B??[Y5F4*ZS-S8YOX
M3Q>==MEI4<VB4]0L;:M)IJQLT>;HQCD;=0I4ODG"%)<P99)FBBLD0-E"179N
MS)004[PACM9R1WW<T3K-4;_F:)V0[A?2ZS3I?DUZG7#4+QR=%B*])82>$4*W
M=M)A4&<;O=%%O()CH89:&20CBL9IK:Q@&S/):Y=A0R'MZJ2C9)Z\=D65PZ=!
ML0/;6K1FFO8&:-&XIEE4Q:-X56]42Y *GZ$QMF)C6. '.=PK*+5:IDN9X_1V
MU2-'\1\,.V38(E'@I<(KN2W69X.UTFAO#/^QMZ!CO2#"*1ZZ^K4?Q<+;1C:;
M%:<OS.=RNKR&H GX%%W$WSY(QH[37C[X$#G.I_5&E;L$%3O)H?)ET![J0IBC
M)SF41HTI7@7V<S2$H09],;R?PDKQ)2?TZ.OY&Q#TZ+F*L$K9[9;AA>]HL,BL
MVL\F^MET-4+H9)-578W-%38%WXNULC]"Z->5V%3=9*\:6QZBMXL8##Y'RYU.
M*J%.*D$GU:"3"?YSIV*GOH$;W\C?V_I%W&C^Z.,O<#V?&-:$IMLUTYU^ME"%
M#8%VZSPV5SB^S&';"XO-8#&082X>M-C0>'4Y3WFL*S3B_M"(NSHBCKLK2S*)
M-D.TF:+-$FVV:'-$FRO:/-'FB[9(M,6B+1'M.-%JI[TL[;4-K=!K$GI-0J])
MZ#4)O:),9IF$7I/0:Q)Z34*O2>@U";VF4M$*_2:A7Y33+%%.LT0YS<H0^C.$
M_@RA/T/HSQ#Z,X3^#*$_0^C/$/HSA/X,H3]#Z,\0^C.%_DRA/U/HSQ3Z,X7^
M3*%?%-JL3*$_4^C/%/HSA7Y1<[-$S<W*%/HSA?Y,H3]+Z,\2^K.$_BRA/TOH
M%S4[*TOHSQ+ZLX3^+*$_2^C/$OJSA/XLH3]+Z,\2^K.%WFRA-UOHS19ZLX5>
M4?VSLH7>;*$W6^C-%GJSA=YLH3=;Z,L6^O*%O_G:^UXR!<\!.43\U@W_310#
MX?]=;AW_+9AJ]MEX1G1_)J0X+*P*GL6W!8LM1OP3@#]D;.!L;?7$8DG2D55$
M_%8/Q=^A@7\]6J!-T+I[N*2V'DWA4<-7E:UJ-] (MKZMQRSHFLXH-<5)L>&1
MV@@+"R/2O/#H$>%43]MR&=6OKY$F2ZDA/8D/)"]+)(7X=Q)^1<*%'_SS'U:,
MX7\EX[GR]%WOK:_]YZM/M.YY^.RL[?]PQ+RYOBT^06K3+9+:6,-Z';\%=\V[
MXMV??I0?O^_[6S\?O/V=^K<E0X>QE-LTQ10C187KZO3AW5G=%%,OJ0=_B.X>
M-Q4N$%!5G:G&<J<YW31"&L8'=-U3@@,8-_[]18>;?^5OBN)I5LT0R)(B*;F7
M0<J5<N!ZA7_J>QG@F)-C@DV8G9^=7R_-NDRE4+4TI2,NI70*?HW.F&:<D"$M
MOS_421I&=,MO(M+RZ]GRY>3%[2=K>NRZ;M6\83TK9HZL7-NT>NVI[-KIV5^^
MD3.GH;KFJJP%>Q9;DZY_Y<CP%^='G\X]=)=O[>G;'MNRO7G==YLKS.,FI#?%
MW#:Q<L2:$],K;GPKXI.^J3^V/3+]T('B4VG/^S^XZ=&7;TZZQUX5>4?R!X>_
M:3SFV5.^Y[YYA<<^>J[G@^:%:L+BOZ8Q':31@\M?E):_(&6%1\+BAX5%4*H?
M*@V6!@6?);JJM_CBE,OL=:<W\^]&@H/\FU.0 KJZI.Z4!O1,(E(F?^JO3Y6&
M2T/7#UX_:%6*F&CVV,^9-]+G]::9Y73HEWKR25=P$;%2=%"I+E**X_U=>+]>
MQ\*?EY+Y<[P>EF=C=RG>U 7"BJL17CNER)26<5XJZ=HH)9-?JGQET+*CGQ@&
M[?F@[Q,;V(:'V])BK^VQ/#>Z+2YU2WTO>?M[86>O._S=VK5/3NU[Y<-?W?9<
M7OX6?XZOX*Y)G^3NO/OZ_7<4)VUY^N7U-TW[\*>W+?KB[(GTC<P'>KU2_<B0
MET\>6U7%\JJO7?CW7Z9\^-6'X:N/;%QWWYS8NSYZZ+G=;2OWSCMV]*]#WWOY
MH4K+^R_WF_GL7_(CW\Y+V9!YX\@;[OEJ5\2 L:5%41';E<1!N\H.EB[[:L/K
M^]BVA-=K7^[YX+)99UK'S/8LN:[7?:DE#^R?\MJ2T:>'%SPUZ0_D(4?TM;//
MS)GR?>\GIW5Q[_WYA[_>L3ZNUP<O]EPV;U^7$<Y5^N^^^G[AD#?"7CJ1-7/.
MT^49)S-A][T(_]+$[INPN\\=1V^J&5_2?MA19C!M/'_W+;\Q9"?4%YEZ2-WY
M0V3WV&EPO%,\3F.)[%9,"5(WWAW1/:;4[VF0G<W\RA9<CVA8#YO<XE-,25(_
MWA'3/4'K,);P+ZGRKR;R2[JIOY2DK5]/,8R%+[B5Q+;-A)V:U;EM^6-F<-O^
MC]2*-IIR_G9MHUT(]$<SGE&;]V_=^(\#QL>CEUS_E]7^;[=-_.[H"UUV-\K/
M/FA)?/^9,_LS'UTA73_]FC6'FX[DW-=E]QM?+SS9\O UKL+=MS]NV&G[WOZ'
M_<_6I#U:-OJ''6_/GMN/W?_3R*;DC>T/WO-PWU?8L:55-1_'S?OZRL1KGC9\
M,/;E;4=7/SMWT7Q3NN[NY=TW33"^9O(:IJ4=6)B5>4>WN[L]_8%MY".??;SG
MAC7#]]XX8+7UV6NG3W/Y=Q<^,GCU[/U=>Q3>O^++VA>BG2^>?:GBR-,1\7>F
M7'UXS) WDA=^?;]IWW>?I?0Y_.*3$TKNZ3MW??*MG\SYX<35WRUYM('>\D-U
MS ?_3)FZZ8X#CUW7_-B)G893GU0?6O^S;?UC":.>7/W",Z)B'):6O_<?5HQN
M'14C4@J'AE$B%6EUHT#*DW+69ZW/6"7]5MW0<B4T54J*L(ITQRKR>R6$AH.%
M6$(@,S?VD7H%\UO7/19*""1:7IHI+3OS_$("=;JBZ<R7T_>4)IJN;[U[Q+K=
M;7^A[R16'=ARPW3GT<AA#\YY9?_MW3_7UQB^F3!D),G;\LF^VR?>\U9*0X_V
ML;D#)KE-R[Z[,6_UD\>/WTG.OEZW;N*@-S</F;CHL;_)1:>&O_;YOD-SCCPS
M8N68[7_:?NC8M,!SVUZZYH?78^_[]LZS(PZ.JNG7+V](^]@*J4V_&_X-%?NX
M:.V&^OR%1U\O5ZQY257^/>?OX[F7N3-RI6QMAZ:7P%W1:\PT3O8WV%6S<;('
M[G*>UG-WK+'([[.Y/*JO%;<FG,U-.9U;DS]F![?F\FV7:8$H C'=>W;N38_?
MZS-.5'S\%P%,HZ1\C2&C-OAM</XU:]EGY!GB%=_S/2=%/&[9.-0\# [AZ7"B
MP?6]HD-ZT-$2ET7!US0O !F2E'4YF_^Y72=V7?/-M5]]F#OI9UW7O.<BWURS
MY$\_W;:T3^R>IA/%-6L^.)A8UOV*+U\P+SISE7+BX".C?OCV#_>.^/FD]:U!
M[[?_<+^S3W[.KG\^V!R9G#)DD#UO[9"/5I0_UN^&#;]>T9;:53J^X-&AQULJ
MKOKNZP,_?EO[ENOYCQW1MQQZSW*3>6O:Q"&G5\:==7P\[.Z/5DZX.FW5TN/3
M;OEKXY[,C+7=C;]L'IAPCV//BLIFF_[M!:FS!_QTG6'PK_W3UH[XG-95GW1D
M#VT[>JAIUHYW#CVR_->Y!Z[=:?[3/U-^V3RJ6-UZ<\'V7=ONZS+GQ2]3VVX<
M^NN4R'5'ME/C&V<>ZOWY\R>N<N<>VQ%65E/FROMR[W'[XM(58O.WT?40D7LO
MNI%+>9]1/UKBZQ8S;U497?7C.!K12\=/!,&-R6C/Q-];/<FDE0.8(L$A8GW*
M*N-OE0.W6<[$[9^D;?^>4D+']F<=E.Z"0A ?'J495PRU"[H(Q9<$U(84R;@Q
M64HT]95Z:[D3CRF361(L$'"G0F5Q^I[ZA,@?KCK^\]G1HRTY5]M>G[EPT]&G
M7\J5EB_CXP/UK5++!O-&^7]\.[9U=>_\)*GKH6%9._+V+];]8^?NBY2PQPIZ
M/56QN.XG2]W75V[\=WG1K7??>_VNQ].3]B\<>":Q3Y>E7]EV91RZ+N^#?XT]
M>/VVL4^TK?MN8_W.?Z<//OC!U=1)HLG&\-OBRZ*N/)/8N[5QX* /GWG[V.3'
M^OT0=^3#].4'ECUHKYFTUE]WP\Z4DV]^6>2_;J2Y;DER;?T=,_8?REK^_-PY
MIQ=ME]K@O="F^T:4L'FK"PK6[?9=(ZTUS%BS<W+A!4>1_YT5A!?&'),I]*HA
M2::,O(["N/]<M^*E+MH)*[+<;E>=+M4;3+R([O'C[$W&"1Y7LV*<"B<LN;'C
M2!6=D'"QWWPPC9$*-5>S2]5&U2?;C>6E'?:F&:OYIS3\]RZ,4X*_FS)5MJL6
M+9V:,_"&R.<GA(UW.7W>H#K=Q=7][LWF[?9-&=G#R,VSM\S>L5VZY="5IVYY
MIW5GW/YO\S]:.#WAR3D31L[5Q^W8=O\;S[SX?HKWCOS[[EX^;$Z:>I7ABKCL
M#<OIZ+>[W/'I[CF/I)S6-Y3K8O]U]4MW*'^(KU[Y66M@U#7W]M4UM3KNO;ME
MT&UUO^P]$&:K./S)S.*\APY$G_C\XY<GS-G4[<:[@Z5J*92JQ1CQI.YX13FG
M$D0LDZ[4:DT^W!"SUV>N-ZT*_I94R922S#2^KFD75)V.(2P]_V]JWD7.+SK)
M'W+"4J7&RSQAC>W@8JLR+_!&5N7?\ :'S(I'ZJ_5K]Y2SV47KW#GET]]5[C%
M=7YVT$][(Q"(\L5N9>-W/?"WOEV?>Z!I4?N2E_->.;4A8U)E][^=REY=..OL
MH&<*G'NOD1+(J7=;>N_H^O1/?]LR^L]Y0Z8<JC9++QW/*GIVPK_OJK[JMIN?
MMIK";RJX9J\2HPO<M'.5]9N/U[SUPYC9!E?6\JL_ZG/?D=%'CY,#SC6[,K_8
M].&ZF*)C-9NNVO%=_R61-RU^8:W]RQ=N#;.NJ5DS\N\Y?_QBG:OQUU^RFCVE
M=&F/J/9W6_]UZD#JN_&!G:</S?DB?=<7CW^[I-6\?9HOO/+'/ONR1O[%,S5U
M:DR7^G>&_]MTRR$/V;9BL7GLP12C\MJ#,\;-?C[%D7+#EBX]5CZ\;^!&9?3I
M^W9DUDT8-O"]RD?S C4_3S$;KUCYQ.I-IC;=RU *]S)*I>7[_I>6NHN4\',^
M#EJ__#5X%T>)G!A*31&Z,/P/U4A].C(B2F>*#?T02DH,>8K!<M3YW /2LF.B
MWM1-WW7XYZO#]JY=\Y,KYV!VSR=R%DBS0MAC31.EJO7#EPV]W/]:Q8;D98F_
M]PN2Y]4Z_?)EZ1,^FW5JK.GVR6]>^>, Z<6?5YZ^^>&'UATTW/FOKD\I)1,_
MG/AJN'_9([::J[MFU:ZM?N_XT%&?S.U_]-LG3VT;T\^[\,>__WG5]HVZ/ZH)
M:9D'XY>,6_GK\?:\PJIYO4R65(OW^('5!:___/.4Y.E737[?-N#TS46O9VZ.
MK_!^^N:H5_]<6OGD5S]T+]L@REMG6,)-;=0.73:>6HW_(S?DBWR&%Q4>-B).
MQ_K"HL^&EU?(ZL9T?A1)87$[1L),7>!%F2_E9&2;LK-S,G+KI8&ABPLGJXCM
M=;].J'_%&;=AV+PC!9.[&*N+RBY<@J<>:2D>O&/?SNT/?C&Z:-O+AL.YAV*?
MF-*M<M%'P]]_9\**7FT#UCQW9/WJ??,2%SQW:T_;\<57[S!';XM(_/2GG[V]
MGO[FC?:[,V-63NU=?O+X@,FK]4==],9[3J;JEJPI?W[5T*<F##YK;*U\]._O
M%X[ZX]:QNE7TR%/KMHZ^]X/2?[QSO# VYZ6NWVPF_P7KMY8<"F5N9'-T<F5A
M;0IE;F1O8FH*.#<@,"!O8FH*/#PO5'EP92 O1F]N= HO0F%S949O;G0@+U1I
M;65S3F5W4F]M86XM0F]L9 HO4W5B='EP92 O5')U951Y<&4*+T9I<G-T0VAA
M<B S,@HO3&%S=$-H87(@,C4U"B]7:61T:',@.#@@,"!2"B]&;VYT1&5S8W)I
M<'1O<B X.2 P(%(*+T5N8V]D:6YG("]7:6Y!;G-I16YC;V1I;F<*/CX*96YD
M;V)J"C@X(# @;V)J"EL@,C4P(#,S,R U-34@-3 P(#4P," Q,# P(#@S,R R
M-S@@,S,S(#,S,R U,# @-3<P(#(U," S,S,@,C4P(#(W." U,# @-3 P(#4P
M," U,# @-3 P(#4P," U,# @-3 P(#4P," U,# @,S,S(#,S,R U-S @-3<P
M(#4W," U,# @.3,P(#<R,B V-C<@-S(R(#<R,B V-C<@-C$Q(#<W." W-S@@
M,S@Y(#4P," W-S@@-C8W(#DT-" W,C(@-S<X(#8Q,2 W-S@@-S(R(#4U-B V
M-C<@-S(R(#<R,B Q,# P(#<R,B W,C(@-C8W(#,S,R R-S@@,S,S(#4X,2 U
M,# @,S,S(#4P," U-38@-#0T(#4U-B T-#0@,S,S(#4P," U-38@,C<X(#,S
M,R U-38@,C<X(#@S,R U-38@-3 P(#4U-B U-38@-#0T(#,X.2 S,S,@-34V
M(#4P," W,C(@-3 P(#4P," T-#0@,SDT(#(R," S.30@-3(P(#<W." U,# @
M-S<X(#,S,R U,# @-3 P(#$P,# @-3 P(#4P," S,S,@,3 P," U-38@,S,S
M(#$P,# @-S<X(#8V-R W-S@@-S<X(#,S,R S,S,@-3 P(#4P," S-3 @-3 P
M(#$P,# @,S,S(#$P,# @,S@Y(#,S,R W,C(@-S<X(#0T-" W,C(@,C4P(#,S
M,R U,# @-3 P(#4P," U,# @,C(P(#4P," S,S,@-S0W(#,P," U,# @-3<P
M(#,S,R W-#<@,S,S(#0P," U-#D@,S P(#,P," S,S,@-38W(#4T," R-3 @
M,S,S(#,P," S,S @-3 P(#<U," W-3 @-S4P(#4P," W,C(@-S(R(#<R,B W
M,C(@-S(R(#<R,B Q,# P(#<R,B V-C<@-C8W(#8V-R V-C<@,S@Y(#,X.2 S
M.#D@,S@Y(#<R,B W,C(@-S<X(#<W." W-S@@-S<X(#<W." U-S @-S<X(#<R
M,B W,C(@-S(R(#<R,B W,C(@-C$Q(#4U-B U,# @-3 P(#4P," U,# @-3 P
M(#4P," W,C(@-#0T(#0T-" T-#0@-#0T(#0T-" R-S@@,C<X(#(W." R-S@@
M-3 P(#4U-B U,# @-3 P(#4P," U,# @-3 P(#4T.2 U,# @-34V(#4U-B U
M-38@-34V(#4P," U-38@-3 P(%T*96YD;V)J"C@Y(# @;V)J"CP\+U1Y<&4@
M+T9O;G1$97-C<FEP=&]R"B]&;VYT3F%M92 O5&EM97-.97=2;VUA;BU";VQD
M"B]&;VYT5V5I9VAT("]";VQD"B]$97-C96YT("TR,38*+T%S8V5N=" X.3$*
M+T%V9U=I9'1H(#<W. HO1FQA9W,@,S(*+T9O;G1"0F]X(%LM,3@T("TS,#<@
M,3 X.2 Q,#(V70HO271A;&EC06YG;&4@, HO4W1E;58@-S *+TUI<W-I;F=7
M:61T:" W-S@*+T-A<$AE:6=H=" V-C(*+T9O;G1&:6QE,B X-B P(%(*/CX*
M96YD;V)J"CDP(# @;V)J"CP\+TQE;F=T:" Q,C0X-3$*+T9I;'1E<B O1FQA
M=&5$96-O9&4*+TQE;F=T:#$@,3DR-3@X/CX*<W1R96%M"GC:[+T)>%S%\2]:
M?<[LZYE]GS/[:$;22)J1I;$MR;)DV09C%MN #0[8&(/9@HF! &$-D(!9PQ8@
M$""!0# )LLPBL\4)A"TA!!+"8@)FWP(A)"&$Q?-^U2/9AO^[_WO]WON^][UW
MT^VN/J>[NKNZJKJJ^LB621"1'\! @[,6[C+GZ^435Y#RPGU$@8MW6[1P[CWF
MO5\G<BPE4KZWQ\*.ZJ<GK;Z<2#R*4<OV'-YMT;JCGOLE\,_">\\^L^8OWCV^
MZCM$K@^)/)>M.&KYZD.N4(M$!SB(3'>M./[8E-%ZR[Y$QP'??,4AJP\]2NQW
M[R5$!S]$9'SBT.5K5E.,K)CO6,RG'7KDB8?<=,:2IXF^NX@4^]6K#C[JA!4W
MM1J(4AC??\ZJE<L/?J[M]8=!SVZ\_BHTN/YI?@3O3$]NU5''GG#8XBO/!.TM
M1+;N(U9^X^O?FG/:$Z1< OI\>QYY](KEROA-=Q"=$D=__:CE)ZPV_T[=C/&W
M8'SJZ\N/6OFC<TX;(>4G@T09W^JCUQS[YJ-_WT+*HXN(O/KJ;ZQ<_;4C3PT2
M'7X9QK]/S$LCT9*GECYWH+OOGY:(A3C]6!^_G^N'#WUE]ZVG?'&^Y6-+)RG8
MIY CB*$YO76$]K4<L?64K=^P?$QA,M,.2;F <0 _HCXZ &LHI%$'[0VQ?5]9
M3"K>5<-)XF+T6(Q7&VO4)O*RWDV]G@Y1O,*H*$;5:#!:5</UI-P^2"=\-CEW
MU\R%PY@]]9EBO'#K;%$SI\6]RXBN>_E9(O48(W,V!>E-%7%)R62YE:Y6EXH"
MA'$IRCZF6^EBTU0Z2-PEG.@[7[FUD3:0R!@/H0<4:KR'MAZ,&U&F-NX%_DDH
MI[ @46:A#*+L@G(&RMLHNZ-,QYB34'*8XPJ41[E&^\/FI;3<\%KC&I2GC/O0
M6N,CC0?Q_#3*[XR/T(5X?QSK;U(O:-QCW*?QF&%-XP'3K8W[\?P(^D\"WI.H
M>8ZG,)_+L(8NPOL+AM<$81__1OLWT3:.<9^K"7(J4^D%-=&HJ<NH;J#&7Y5;
MQ2J,ZT3I42_@-BJB'E2F;OT!^A_#>PEC%N/]>K3[\;P'YL\R'DH?<)*HVS%W
M&?.^C_Y%W [<-NPG"[K'49:B[Q&U1A<H-7I?K34.-2PB_\2^?\C[YCU/[DG2
MWZ3IOQ3,RW,/[EB:]&TOVVG[GY8_@Z8_HOX&2A?V\KGR!/W,T$%'&FCKW28_
MG<?%_"SD?JNX"L5A.)@BYD3C,M XUW@'3<$[EP-0]L/XCPS7-)Y6_T&#Z&LU
M74&7*%W0KRDTIGR+7C?E:7_LM1UK&5E'P+.+I1X<+'FFH$X:WF@\A&=^SYL3
MPC;!HVN8+^8+J!WC>[#.!Z#A?<,:L1;E.- UAO(]I@5K=X#?RR#SN\4^6]=A
M'@_T[EB4"O9T2K,T7H/^/HVVF<!+XF2?-K'.TSO43[/>[5@F9#-97I@LDN^W
MTE:4AU$^!BT%E%^BG()QFU%WH!UTB 70PX>!7V-=A4Y\V-3+QB.L%]#UWZ.]
MEVF7>X!NLWXUSXPX23F$?HQR-,I9)J(;)LJW@2//"NLKTSDQ]_NL5ZPOD_6$
M7OQ:62<^D/MDG9JHY;E[B8J2!NR=]6I;C3/'>B_K=W">N;Z<=F%]Y3FWU8](
M6]#'9Y'/P[9Z@AX^F[ 9]\OZ'=IG0L_[)NM)7FRK+VC<A;Y33"&ZUE"#WH]#
M_XL45#^"_?DS>'@4[<IGV' Y7:V<37[S>]0!6>Z!N:[Z2GTE%_,SXG#,MPG\
M?-CP!%V%^DK#,TK&\(PP&M<UWC&\+S89URFG\O-_K;]:)G&YYK)CW\ZV_U\I
MRI^,Z^@0/+]K?*;1,#Q#E["',K\G.E%2DS7:QU!.1RE;6L65EB/$N'EOTJ W
M_T YVC!(TXR#T+E--,,0D+8[C_:]301]$#3/\$-:(S8)I[JW*)C6T9'JWCBC
M6$OY$YW)A>='O7J;'C5U;=ID_5]T::*>U->OU(^RO6>;.UG+LP>;.E$O_O)[
MXV'V"VR;V3>P?>;2U-?&C[;IY27P'YNWZ^=7]#2T@WY>JDRCKJ_JY5=K]BML
MV]FO8/T#L/ZUF.LFWK^TC;!Q;!_9SN',SY_$_VJ];?RMXG[8A[NE#7Z"]IL\
MURA\SM]&WVX3=@0VF.Z0]O!H^III'UJB]M)\:8_FT@'&)RDE_<^$/S6,-6Z6
MM@SG:=*/2A_Z3..B;3XTT?BH:<\:OY;VYI>-C7P^I<^$[S1>+WS&QR@F[<H:
MND^>0SZ#G] TK+6W>AML[N>-;Z*M2^V'[46[^@'M)_N>)5W])L89&I>Q/U2/
MHKSTC<\VCE9GT PY]NS&H.$3^.R?T-S)^20.:N/ET$G$ :9E]$MI"_9C'2'7
MI#UFV9N/:-QK/J#Q*]/!]+!Q3^SG('H%>WE"\F"\\;#D X\--=J9%^9%C8O5
MCQM;@?-;67C,$8V-DA_@T8Z\D'Z9XPG,:3J:+I?\X#%GTEN6Q8W7N1A7T?&F
M3[$.UC+VPY<,-1XP#C6^)VVK"3[N1.Q3AV]S4#_KO?F81D/5&[^;],'J Y17
M3VG<9(PU;@3O2A/M1;;['(]PK,'Q@_'G[/<;XW+,4XC1;#3(Q5"$7AY!AZ@W
MHGR7W,8;$8>,-\Z2<<(SU*(:&K>JIR"V:<8F'!_L+<_+T8V?&,>D;2Y)&K &
MGWW(XT'8TGU@2V::SVO<8E"HBO;].&(U"R&^>&.%[>&'/O[X#9O%8K78MB>K
MU6*QV&H1C\5CFV[S1*TYB\WBF>[QV"RVZ1?8-EB^L#5LMN_;]%RA6+/9XBW!
MF&;SVVP16]0&-*O-)F>SV"S;9T3:806;<Z+=9EMYT'Z??FXSVE;*=T6(AL4F
M+/X'/[*(%?L+&WKD5$;0:+4]:+4(3":$#11_O&WJ;:M@5\+:V IHLPF!Y2U6
MVS\"%EL#]-I$1431DT,&T2*.]TJ\&"^*&%J[>&C%'X_$(T(F=,HZ66D/.(2B
MV8!2;7:)R!4!$8C\:U#L5(I$1!4I@EJTRA8LZG/AY2^M:(J (B:.28H7*V(R
M1YOY!N'*!073FDA4_$PI)HA-(ETP?8,(Q>46\,QY R_@:*[\J9!=\UI%/![&
MOJ.Y1%!$*Y7I0FQ 3W1#0 2%'QS# D(3'CQ[_"(3$7Z__\*X2 (E*M""]<"W
MI(B;E0JX$ZS(*6+A>(5;V^1:_J)+%-V\<*=#PY!<17@](I338HZHM\51C-@Z
M04V+(R.QW2@KFA<>E5399%15 36@L/$O]DWTB:5!%C(WMN)>9@&TD0W03O;&
M%^0@!Z!30A<Y =V G^,.Y@;T2.@E#= '^!GYR0,8("]@D/R (<!/<:L+ $8H
M!!B5,$;AQK\I3E' !,4 DQ0'U"D!F +\A-*4!,Q0"C!+:< <X+\H3QG  F4!
MBQ*V4+[Q,96H %B6L)6*@&W4TO@GM5,)L$)EP X).ZFU\0_JDK!*[8 UJ@!V
M4T?C[S2%.@%[).RE+L Z51L?$2)1P&G4#3B=IC3X3MH#V _X-QJ@7L 95 =$
MG  X$_!#&J+I@,/4!SB+^@%' /]*LVD&X!P:!)PKX2XTL_$![4I#@/-H&' W
MF@4XGT8:[]/N-!MP#YH#N*>$>]'<QE]H >T*N%#"130/<&_:K?$>[4/S ?>5
M<#'M ;B$]@3<C_9JO$O[2[B4%@!^C18"'D"+&N_0@;0WX#+:!W Y[0MX$.#;
MM((6 ^+> KB2]@<\!/ M.I26 JZBKP$>)N'A=&#C33J"E@$>2<L!CY+PZW10
MXPTZFE8 KJ:# 8^AE8#?H$,:K],:.A3P6 F/HU6 Q]-A@-^D(QJOT0D2GDA'
M IY$1P%^B[[>>)5.EO 46@UX*AT#>!K@*W0Z?0/P#%H#^&TZ%O!,.JZQA<ZB
MXP'/IF\"?H=. /PNX,MT#IT(>"Y]"W"MA.?1R8V7Z'PZ!? ".A7P0@DOHM,;
M?Z:+Z0S []&W 2^1\%(Z$_ R.JOQ(EU.9P->0=\!_#Y]%Z.NI'/0>Y6$5].Y
M@#^@\P"OH?.!<ZV$/Z0+ *^C"P&O!]Q,-]#%@#^B[P'^F"X!O!'P!;J)+@7\
M"5T&>#-= 7@+X//T4_H^X*UT)> ZN@KMMTGX,_H!6GY.UP#>+N$H70NXGG[8
M>([&Z#K #70]X!UT ^"=]"/ N^C'@'=+.$XW FZDGP#>(^&]='/C6;J/;@&\
MGW[:^!,] /@L_8+6X7D3W8;G7]+/\/PK"1^DGP,^1+<#_II&&\_0P[2^\4=Z
MA,8 'Z4-@(])^#C=T?@#_8;N OPMW0WXA(2_H_'&T_0D;03\O81/T;V 3]-]
MC:?H#W0_X!\E?(8>0/N?Z!=X?I8V 3Y'OP1\GGX%^ (]V/@];9;P17H(\,_T
M:\"7Z)'&D_2RA%OH4<!7Z#' 5^GQQN_H-0E?I]\"OD%/ +XIX5OTN\83]#8]
M"?@._1[P77JJ\5MZCYYN_(;^0G\ ?)_^"/B!A'^E9P _I&<!_R;A1_0<\/].
MS^/Y'_0"X#\E_)A>!/P7_;GQ.'U"+P'^&_ Q^I1>QO-GM 7/G],K@%_0JX!;
MZ37 !KW>>/0_-OU_<YO^GK3I[TF;_JZTZ>]*F_ZNM.GO2IO^CK3I[TB;_HZT
MZ>](F_Z.M.GO2)O^CK3I[TB;_K:TZ6]+F_ZVM.EO2YO^EK3I;TF;_I:TZ6])
MF_ZFM.EO2IO^IK3I;TJ;_J:TZ6](F_Z&M.EO2)O^AK3IKTN;_KJTZ:]+F_ZZ
MM.FO29O^FK3IKTF;_IJTZ:]*F_ZJM.FO2IO^JK3IKTB;_HJTZ:](F_Z*M.E;
MI$W?(FWZ%FG3MTB;_K*TZ2]+F_ZRM.DO2YO^LK3I+TF;_I*TZ2_]OVC3KYRP
MZ<__QZ;_QZ;__]:FM_['IO_'IO]O8].O^K]ETY_]CTW__[!-)UA<4BZV.ZRD
MJ@:#R62S*JC,JD%53=N2P6 VFTTV  O^6 Q&L\F*1XO99+*8&*JJT6C":*/)
MJ,HWU=H<IYJ,9J,1->;D9+$T9S1R4M4=%^'Q7*P6!RBP36 :+59@\1I8U&1"
M 1D6&ZCAZ3&/2>$:BQI,#KF$ <DBDVJ82.A3,;5!M? T1K.9I\0"%F[$NQ%S
MF3$W;XG?)+)L,)D-9CQS"Z-SNXDI,V!AK&FWFSB;[);FYLR6G4IF.R>,M#MX
MOV;F)R97C XCMF%F$HR3F9=O9FQ'9J,*UII4\T1SD\YM:&:(@F4&?$M35D;F
M$R_++#&;K<PEU2RWR:^2?E#  N:-JBPW3&)D:6&PT6BVX,5H,5LQQ& P6FT\
MAL>;S?SQ%G-8Y!2\G,5F,]M,9KNY.=HF9[$PTXQ6KHU6J\F"%JB,P6B0\F@N
M8[>9C.1P2GT$MMW*:FGYJCZR], X"RBP6@V@R89'*Y:VFJ$;9L-7]-'4U$<C
MOUFDZAFE,ENLUO^Q/AJ;^FAA?33;K5:SY)75!L*LK$BLE/@#,JQV20W0=M1'
M\W9]E!_'K=OT$8CR8#!54&N6B(I^DQ7K@3F627WD+;'P5=9"EJI5*H1)ME@G
MWLR2&)[';' X3)Q-#JN4.<;O5#([.(%FA]/.\L'N4)G5[?K(Q#7UD9=OYNWZ
M:&'*FG0R;?PVB62S2'VT6X O?VQ@D?HH"90,L=B,5IQUR3*HIIE_8M%DN<4J
M):E*34)E-#7_L#Z"T4!E)3<8[78>(P^BV6[BGW#P3PZ8#S;PR.% 97%8FH/M
M4A.EB8$^6HURHQ/ZV-0$BU6N87#@>)/399/ZB)-JAVJ9K;QA\[8D!6QV,,5<
M#! <^&>QRB-A S1"KF ?RQ0[-+#T>!Q.&(3,^X))Y9_06.66>==--3?LL C;
M+2YVJQ/-#JNMB6BU0ZUP$K$/>?(D&0XK*Q_0H*&*6<["^FB9//U-<1MVT$=I
M!IDJEAYZ5!L.L)6;I2S-THCPEIHVT<@[X#RA$(S')D3J(TX@2P>#G$XS9[-3
M<J.YP9U(%B<GT.QT.9@<[,X&,:D0'\M*FB+KA,%KDL-Y<D\X]'PF)IN;=$Z^
M28Y9P$;@VZR<V::9Y8^SI >Q2GV4G@3Z:+78K5*Z;'.L!MXH*R4.G4$: =ZQ
MB145 K%(QAE,T$>K_#D;1.LP\7[L_([58:RL3B>LAM5IE2;7Y#1*XV^2$F6&
MFWB_)E8./D?2/C27<3K,)G)K#I+*87$ZH(\6&VRH8;M?,?)/U"PNJ]6&%>UV
M(PZ3$X_8 K8!VV"1=HU--OP=^W,+SJ1%^C4^36:V>_RS.(RW3WBJ+WM6F=B7
M8+3=YC(:+,XF)A3?H1J,[,Z,/"76@NSM+A# 9/&*JJQY44T*F2VO](-V@[&9
M4%NDN3/8F?F0B9%/M]UBQWIP:3C'%A:.A;?$DC6P%K)-8?,B%0(MC"X5 P.E
MD[-8C6ZWA;/%;6>)8[1]IY+5S0DTNS479K4Q/[&D:G*;L W8$0L3UU0P7KZ9
M0;S,4#1LGZV?[&S2.8D$CN$(L9@LX!YGO"/XX669)U:;PV2WV>7)M=B--JO3
M!N%(>P,$BSR4K"!<63B2,;%;,K IA,1MX+G9Q8?(+G^8:G7!D-EL3MX3Z $?
M;)IF<UIM;@B-1[M,+'.I%-B1'=-(^VFV-YT@K*V-[1IH=+LL9M(\4A_YI$I]
MM']5'UEZ;IN5%W5 'V'#\,A'RF%SLNMFJK^DCXZF/K)^6:0^6D$[=NSX[_61
MO;5=,QFL+H=#'C:+'=;2Z( J&%G]L2,7)G+;^72 JSOJHU63/V*>T$<XPFWZ
M"-MJ8*?&5($I+!$3^N%-C.SX[6;+A/I!;*P [)N-3;DV]9%;&%WZ0@?O"&W0
M1TVS<+9H#NS-!F;LE#HZ(#0DT*QYW-@O^S]0!?/D0NR%"!D4@3B;S+R\@Q5M
M!WVTLVF;U$!)I[&)YL!YABA@0\!PH]/.6>JCC0,$&=#9G29H*6PGM,ENM$.7
M;" (1P+5A#Y:.)ADQR'_0)V:^FACRR?UT<E[D#_<=X-PNUV^0QF=4!+-8W=9
M;1Y[4Q_=.^BCP\RF!ANU2WVT-/613SFKCX;C31ZO$_H(GVIU.:&/. B(,K?[
M%01M?)AMDF+L!X8$&[4Q+0Z;"Y#]+(XSSC$,C95=C4/&1WQ$F2+IY5@?I9;)
M*$.JN=&X8S0E0SJKTZ'!L;J;F#:+PP4L&5ZQ^F,MD.'00 V3Q<>9@T*K#"*V
MZZ.,RQS&[1<EJW2W3)5E0A_A*''0T<PBQUQLX*09P?$R2GVT2DO0-%!H<5C9
M^<$3(MB&@+"FS>CQ6#E;/5(?V0SM5+)Y.(%FCU=C_V:3;LYF,&L3^FB5^BC#
M/UZ^F2=.F9%-MH7I=,C.)IV32"YP"U;/C9NJR67GS&&OU<8! @=JV(79 <V3
M?TG$ 7UT\1'FOS#" N:-3MQ0.&B0?Z")D#P"0TC<SC+6V*@[> )80]9'AXOW
M9&?WY7!XO7:WS>Z5]P"K10.+,8&E&?>AMC#[H946>8^3(F-AFHT>S6HAG]]-
MD)$9BNY&C&!S<I2Y_:_*F%AZT'4'XAR'"[;7:=?P"'MM=SDT0.B;A?^:#/AF
M9(VP&%W\%VO,?$2=?+QP,G%\,-[5G-$RJ8\[_+T<CFV8 J</[/(T,:'X&@AS
MPTF;G<WSX+';75ZF!H$O#U)9=%C49-?LX(F#-= EDW'[10D>"9(%53:V'<XF
M"A@+;^T$A=@B*Q1OB8V0$6I@<L+RNZP.'&<,10NCLWK874Z;=* VN\GGLW&V
M^9QL@3#:N3/)9?=QPEGW^7F_4&H;*KL!(8"T'3!%(*YI\'CY9N;@E3,,'[R/
M$71:75:FE.F<1-+@MK GC]-E-6E.SG@W05Y(S!&'TVUQ.5U&9IG=96*!0K*P
M<5!4EPSN(!J.)3EHD!<'<,Z)-IO3X88!1'SF];IY#Y+I'BNLI5/#Y+B:.=T.
ME]/O=T)A_+!9[)*\9C:]#I:TQ<4,!S[H1O!EX1L0FQPGVV:+R>>U62D0U(BO
M,7:[1X-:VEU\J]SN6,RPS6 >* 4%;K<9WM2+1S=$X'9Z -E:@'UL4DQ23TQN
M'L>7<G"* TP+B,;^W>Z)R*EI=DT[+ *?8^<Y-"U@,CM\;EA([-3F]H @G$3L
M ^8''L'G<+C]3 UN--BMW<"BXZ 6FX?&.SD2D'&9VS1Y4X*/,+&G8ZH0*$$B
M9C,<)=R^F1V_"_MF8V'G+2$$=[!O-K-- >?!/ Q%BQMO4C7<FET:++O#' C8
M.=L#;NP-K'&Z=RHY YR@F8&@#^2P.J"">?):^9($FI@XI\R\?#/++RQ\L3#A
MT#M,KHGF)IV32!X81(SWN8#O<7'&N]GNY "!0S:GRV-QN]PF9IG#;78YO2X0
M[P3+6< L##[L,-ELI*U6&1\[W5!HV N/P\4?.7P^'")(B9GN@R%SN;R\)QQJ
MC]/M"@9=7H<KZ.);N-WJM_#MQVF3?A:9XTN843@[OOSPO=O%,3AH#/CM-@I'
M?(1@ 6;6XX6==FA\%=KN5Q @:9HCZ'(CSG%[/!8<)C\>$?0X/6X_=)3M&BP)
MR]3">@(>2'_$+&$=0#],HX;QGN:,DQ_>S#MZ+U[)Z?!YPY!% "&$$T?6X?%#
M>;P:S#F?8&P_X')Y0IHCP!=3)]C'02%&PFC[7>"PFRVO](.>R:^!J"%;ONMY
MH-!N!TO$[/5Z'1[V=!K;5=@?7@M;8LGBONQ$3*@!P8V0'$/1XL$;*X8+E+$G
M!S66<-C!V1&&[]+<+HS?F>1UASE!B)%(T.N%>6$WAP %)A?AB!O'GHF;4##'
M9&Y^3H3W,VOP.69MHKE)YR02I *3[@C@9F#QNSDC@D3P@VU[F2-NS6?S:!XS
ML\SIL6ANOP;BW7RH(&!VIG#/[+MQYF&WV0_;W1K:[)K;Y]+ <WN0#Q&K))@>
M='@\FN;'IMRPQ3[,$8EH 9<6T5@+'/:@%3*WN:7H/<@..S8*\N'E'/([IAF$
MLJFUA$,..\42 8(9@34/^F'J7%Z^9;JV):L5NW!%P$&_1_/[K1!<T.O'\BYL
M(P =A1;R49;^#N@($?P\#L<,0F;M,]M!HA?C_<T9)]3<LL,B+O8E5J8@BO@W
M[/=#3B[-Z0N"L !.KPWNP8WMAST>?\3K"O/%U.URN(T@#R/-5G=,2IDMKU\F
MR_; %,Z)+0LTUN&!3"P2Q>7'>G:O RK@LK()X2VQ9'%U<UN]+B\0F'D8BA9&
MEZKA#R"0=]H@!FLLYN+LBOJ\FE?S^#R^G4E^+<8)9ST>CX <+_P=*LUDC]@1
M"VL(6IBX"05S36:^Y?''&8<%K'5;O"Z?TR\I93HGD2 5]+O"7N '/)S=\)8N
MC?G"]T2/-V#W>_TXN3 L?JO'$_1Z_'Y-@[WQ^<%7F%MV1CCT;!3@VM@I^Z#0
M#I\GZ/:"YPYYB/P\'MH'_^SU!C&YYG5[@QZ_+Y'PAC5OW,M!@,L1@7"=#D0/
M>/4[?-*?8W,.'XPK]!T^W>MS\4K66,3EHH0>@CY:X4\C00[A_/P-9+M?L=FP
MD#OF]?H"7D\@8'-ZM; />_2ZH8UA0+:*,,,P^4X,LR F"_ XOI0[.;:"'=(P
M&N,#$YYJXL/;#HNX';P2CEH@ 7L<#00@)^A?((PH)NAS.VU^V"!XA*C7&XCY
MW%&^F&I8T>CFJ-=MMFD)/OQ>#CNE'PQ,_MUQ7(,TN%M0B=7AF%@BUF PZ Y@
M/;L/%&)AL-$=\ :\3M@I"\R2U>?V <&+D!Q#T1+ &YLK3R (6X,(S>VQ)A)N
MSNZXW^^!/#!^IY(WP0DT)_48R/'A9*/RF!Q1![;A!4U,G%=F7KZ9F_<;#LSA
M0C2+#]%+0%+*=$XBA<$QB]<=]0$_[.,,#B+XP;:#''5[_2%'P!= $(B[5,#F
M]89]$ ZTT^WU!\!/.Z(\W%E=+@L+U>'FT!CJBV>_-^3Q@>?.6"SD\T,AD+TQ
M5R#@\X>Q)X]/\X>\ 7]2]T<\OB3B+K@D9\P.X^)$],!!"C+[<[??Z?1S!,J6
MV^P/2/6Q)F)N-Z4R$;)8;"Z/%@OA6J\%^0JD;4MVV.:@EO#[ R&_+Q2RN_S>
M6"#D"^$PA'P1/QP85%FSL=-R89@5,5F(Q[&3Q5EUL9_#Z0M@?*@YXX39M>ZP
MB,:Q#>+72"AEM7GCH1#D!*,3BD*=(@'XLB!><8(A^U RH,5Q@;/#HGB,&D==
MFL7N34FKR)% 2*;)KX'8D=>JP=* *AA!-TO$!D>IA:!?\/_P*YH=ME'C+8%>
MKQ5FR1;0 D#PXSAC*%I">&-SY0V%/6ZGAK6]ME1*XZSI\%U!'T:'=BKY4IQ@
M*=.91#CL"<#_@2JOV1EWXI;C TU,7-/@\?+-S%$Z9Y<5K/5: UK0'9*4,IV3
M2) *^K5X /@1/V=$D';-QP$"Q_G^8,09"H3@)GQ0,+O?%PN >)\/5A("]GB<
MFA6>%R*!E=$XU((*^4-H<X?\46\ /'<E$]% ,,3C_?Z$%@H%@C'>4\ ;C/I#
MP70Z&/<%TK JB#I<201)F$"*/H2L(52!G76%X&78*EHMP9#&*]E224VC=#;:
MU$=/G/71(_5Q>Z C]=&3]/N#83]V9(<AB05QYJ")85\4T &/Z;%Y./[",*O%
M;0WS.(0A'C?;).@CB YB?+@YX^2'X!T6\3A1$(9$PZR/D _T$8<M',.E+!+T
M:$U]]'AP+,)ZT)-HZB.L"<CS<%#K36_31QF7A;^DCQ[8&*8*$8;4QT@DX@G#
M&SN#;I@DCQT&SA/VASG2DOIH#WJ"0/#C"&,H6L)X8T/E"T=8'QT@SI9.>SA[
M4B'L#:S9.7T,^].<0',FFXQ$X.XX[/+XS*ZDR^_ 0?![F+AF^,?+-_.D/KJM
M8*W7&D0T'9:4,IV32%$X:*O?DP@"/QK@C-#8CD@'J:F/46<X&&[J8]@>\,>"
M@7 8S]#'\)?T$4<>D;$&'P+UA8"AC[X@>.[6D]$@*X3?!VN(@Q0,QL!T7] ;
MC/G#H4PFF/ %,T&/QX5+AN[DX!31+*JP.^2&V8E@<WAR:W#>K(]AOINX;6G=
MXZ%\,4&X1&D^7S(&U^N+\/>L[8&. [%"Q)<)A2*Q4# 6<VB1@!Z)X3CX K%0
M,A0(P'MI/KL/IEK#,)M5L\5X'.[T4"@<"?A%B"J"\;'FC),?@G=8!/[1!_?D
M2\0*=KL_'8M!3CALT:3-9H]',%D$6\<)3H="L6S$EPX$(#+X&A/(PTBK(Y"3
M4N;(5,9E,=OVBU+ YH.E 56P>5Z6B"T>C_MB/@>F1="-+<(V^F*A&-N6@ TN
MQ1'Q18# AQE#T1+#&YNK0"P.Q^IU@CA'/N_C[,M%(\$(Y!&*[DR*!?.<<-8+
MQ4P\[@_#Q(*J@,6MNX-.9] )YP/BF@:/EV_FYH];'(@O(QIHC?BBWIBDE.F<
M1$J& YHMY$M'@)\,<P[ 7?F"V':<[YVA2,(="\=LH5 P%(@Y(D$]$HXA: @$
M0M$8/+G;:\-]RXWPQZM!6CXO5"@4M2%$CH82@0AXKF4R.$0Q'@_M\\9BD8@.
MI@<C@4@R%(L4BY%4,%Q &*"Y?%K&A=NX%O:RZ&-:%/-AHQ&/%O5H7K:*-FLD
M"@2?YLAG?5XJMZ4)%ABQ84JW.IV!.&)CQ_8XQ^7"+@+%:#2>C$:229<O'LK&
MDY%D-!!*1C+14,B#>V$  WP!GX/U!#S@<?#8 5\4),#N051QC$\V9YQ0<\<.
MBR >1709#*231:<]E$_JT*U .)#,VAW.5#P0U.+P+P@K\]%HLB4>R(="+E<H
MX N901Y&VEVAO)0R1P))F1S;+TH(EB!34!7R10/QN-/A@*,,)*%=6MP'%0BX
MV(0DH\DHZ TY0NZ0*QZ( R$*YF$H6I)X8\4()U,P9 $WB'.6RP'.@5*"_]4@
M1B=W)NF1,B><]=:V8BH5C$? _U0@;/5FO!%<NMT@%<1%9>;EFYEOC9Q]CCA"
M!$<\D/ G):5,YR02I.)S1 /Y./ S4<XAF(= A ,$7"U<T43:DTSHCF@T$@TE
M7?%(-AY+0K]"(>S!%0IZ @[<$" 2G/F #_&@QP?3@#9?,IH.Q\%S7Y$/$10B
M&HY%"X%D,A[/8E.1>"B>B283;6WQ?"3>&D>4K 5\12T0X""/19]$#OAYOS!_
ML#&LA0Y'(AE@\^,LMP0"5.G,$2Y1,+.%M,VMA72'V^'<[EC<;EW70^5X7$_'
M8^FTVZ]'"WHZEHZ'HNE8$8)@NP9+@OC)CV$<IJ9YG-?K#/D3?/-R>B,8C?'I
MYHS2L_*=9@?WY471V-"WN9R14CH#.<%>I0L(>;,Z@C8=]A5A92D>3[?JH5(T
M"I&%_!$+R&.SZ(YV\.&/<R0@_6#:N?VB%'6&O%$OJ(KXXR%=AY)FL]E0&GKG
MU?TZ;+<;; REX^FX/^Z/.J.>J%L/Z4"(XXJ(H6A)XRV*2:+I;#C@1806BKHJ
ME1#G4+N.O<5CJ7AZ9U(F7N$$FCLZR]EL.(GX"U3%;+Z2+XY &2>0B8O+S,LW
M,W\EY>QWZG[0JH=2P;2DE.F<1"HF(GYG/%32@5],<([XP:<XMIW%U<(=UW/>
M=#+MC,=C\6C:K<<+>B(-IQ2-Q%-I=R3L#3D#(2\N"\X@A(IX$"J42*$MD(KG
MHSIX[F\MYW56B'@T$2^'TFE=+V!3,3VJY^/I5&>GWA)+=B0A:V_(WPKA!OT)
M*?HT<BB(_>K0RH ?EW'^M =">257I344HNJ4(B%8"$0CY9Q=\T0RB$5<D6W)
MX\ED,A$P/9W3D[F<)YB.E].Y9$Z/Q'/)DAZ+(^ .P+6PTW)'<&$/NG(\CIUL
MD&-]],<P&N-SS1GYFA=DV[5]D0C'-MYHI)#O=+MC;;D<C'\D$<F5<%4JI-&5
MB45B>B32INNYCG2D+1[W>&*18,P2X:@KXO3$JSHG#D5S,KDF E,.BUT16!I0
M%0OJX4P&44NA4(CD(AXX_F ZB"WJ$3W"6P*]<1>T4$M'TD#0?3K\-K?D\,;F
M*IXK1'$,O/%(0NNJ1CA'NN"[,DD]JV=W)N62U2XD&)7:E$JA$$O#V("JA#W0
M%DCBTNW5(TR<+C,OW\S-S]L>,#D=!*WI2#:<DY0RG9-(D$K0I4?:TL OZ9QC
M".4B26R[P'&^GFGQY](YEZXG]'C.DTZ6TZE<#D8NIF=SGEC4'W'A[$(DKC"$
M&H@@- [J6;2%LGI+/ V>!RN5EG0&"J''4WHEDLNE,V4P/9F.9UKT7*:[.].6
M3'=#<$%_)-B!F4+!E!1]#CD2+A2B&6AE"/>0("RW*Y,#0B2H53LB$>J96B;^
MS!R+M97@>F,YE]?ECFU+7B\6BE73Z5PQG2H6O>%<LCU73!73L60QU9Z&J45X
M&$,($8Z%,<R-D+7(X^!_8^%,.!Q 6([3A_T7B\T9)S\$[[ (XE%$E_%8N=CK
M<R<[BT7(*:;'BFTNMZ<$Y?3GDK$D3G!G.EVLY6*=2199+)RP@CR,='F34Z35
MX6\^19G<WF;R =$=@Q,#58EP.I;+:1ZM5"K%BJ YD OG$#EY8>YCQ70Q'4Z'
MD^ZD/^G)Q7) 2..*B*%H*>*-/:%>+,&Q(D*+Z9XI/3'.L2GY7"J73A72A9U)
MQ73/%"30W#NUJU1*9%/Q&*C2'<'V8!J!L@^D@KBTS+Q\,_.7*<YA=RX,6G.Q
M0K0H*64Z)Y':<6-WIV.=.>"W9S@G<$&,I;#M$G,DG6\-%G-%>)(4 B1O+MV>
MRQ81-"03Z4+1FX@'8NY(##?FF#L:BH5#L2A4*%- 6Z0 [Y0#S\/5:FN.%2*M
M9])=L6(QEV\'TU,XU*WI8KY>SW>DLO5L+(;X-%P-P+B$,U+T1425L6BI!'\>
M+D3"47^8/P+F"T"(A3T]M5B,IO6W$VXWH62BO>ST^A)%M\^M);8E'V*%8F)*
M-ELL9S/ELB]:3'46RYER-I$J9SJR>@IQ53CA3R2BB2B&:8BYRCP._C<1152'
M.@334<3X<G-&&>GQG6;[(HD0BI\IF.[WI+K+K8AT$NE$J5/3O.W%1")03"52
MV42B.YLM]Q83W?RA)!6+ZC:0AY%N7VJ*M#H<F<JXK*Q-?G<&HI8(@<IR0H]F
M$\6BQ^MI:VM+E!.^1*@8+4:QQ6PBFRAGR]EH-IK24H&4CWU<.9$-94,8BI8R
MWE*8)%UN@V--!$"<=^JT!.?$U!;L+9LMY4H[D\K9:5.10//T_BEM;7HAPV%7
M(NT,=X:S@4 V %)!7%9F7KZ9?5HS1S5$]"FMF&B)ER6E3.<D4D=>CVK91'<1
M^!UYSCH"^406VVYCCF2+E5"Y6-:RV4PV5?85LYW%?+F<R:3T;*GLTY.AA!:#
M_!((&B*):"01APKE2FB+E;*5=!$\C_9,J119(;+I?'9*HEPN%CO!] SL5$>V
MW-+?7ZQE"GV%1"(22D1[(-Q8)"]%7XZ6X.';VI(@OQ2+QH,1_@A8+"5B4!_O
MM-Y$G(;G=!."UT0FTUMU!X.9=D_0X\ML2\%@>WM[9J!4:N\LE3H[@\GV?!V/
MG:5,OK-4+^7R,5\TG@E)IX5A"%-]G3PN&O5EDNW)9!1V"*)JQ_C.YHPRGF==
MV;Y()H82RF:Z.X=#@7Q?9Q>NGIEBNK,75Z5:>R8=:<^G\Z5,I@\DS&C/]/'%
M-)]*YNP@#R,]P?R0E#)' ITR^8(3*13,^S(X&-[.#.*+='N[/^"O5JN9SDPP
M$VT'A=AB*5/*\):2I22NS.%\D&U*9Z8$YF$H6CKQEL<DA<Y:5D=,G\\4 D/#
M&<Z9H4I[2WM+2T>I8V=25\OP$%)+2\NL.?W5:JZM)9,!545W?%J\)1QN"9<R
M3%Q)9EZ^F?E3)^>D#ZS-^]HS':E.22G3.8E4;\\E?:5,7SOPZ^V<<TGPJ85_
MG0HSI%29$NML[_*52L52OC/8WE)O;^WL++7D<Z6.SF N&TW[]'04EP5?*H%C
MDDG%]$2YPZ=G]([2E$([>)X<&.AIAQ:TE JMI?YT9V=[>QU,+[7GVWM*G979
ML]NGM;2-M&4RB6@F.1#-9/1$:YI%WXF<2=5J69#?H2=3T'<H0J4SHR<SB<#P
MC$R:YNTQC7R^<*I0F%[WA".%&F*1P';'$HG4:K7"2*52[:E4>GHBZ6IY (\]
ME4*YIS)0*9?CN!<6H@7XJS2&!>#C>G@<C%HA#3</AYXL833&]S1GE)Z5;UL[
MN"^.;:+%PM2>N=%@:;BG%[I5:,U/&? %0M.JA5R\5LJ7$&8-@X0YU<(P7TQ+
MN739"?(PTA<ISY;7 XY1>F0*3 2F"-++@0*,!J@JIRNY6@TZ6J_7"SV%2"%1
M!8788J50*?"6TI4TKLRQ<KA:J *ADJ@D,!0M/7ACR]/:,[683>9C("Z\Z[P"
MY\(NW;7V6GO[E,J4G4F][?-V1<)9G[_'2+W>TM5>*("J5DV?H;?'8NVQ2H&)
MJ\C,RS=S)-#,Z0!86PY4"]VY'DDITSF)-% MIP.5PG 5^ -5SF6$<H5V;+L>
MB40CE=KT9$^U)U"IM%7*/9%J^T"ULZ>GTEXN5Z;T1,K%9#Z0R4/=\X$<PI!4
M(9?,I#NF!#*%S)1*7VL5/$_/'NFK0@O:*JV=E9%\3T^U-@"F5ZKE:E^EIWOW
MW6LSV[KF=T'6B4)Z=J)0R*8[\RSZGO24="$W=2KL9WI*-IV+IQ-0A-H4(!32
MX7ES"CE:N.],"@3BN=;R2#^"L7(]$ ^$RMM2/(Y=E'>KU7K[:K6^OGB^MS*"
MQ[Y:N=)7FU6K5-*A7+:<+)?SY3R&A4+Y4!^/2Z5"Y7QO/I_"C:\=HS&^KSFC
M_/#&MZWMBY33*(G6<G__7O%P9=>^/NA6N;,T?58@%!WLQ63U2JE2*Y=W!0F[
M]Y9WY8MII25?<8$\C S$*WO5./$=NT^F4+R9$D ,E5.5%*BJY&LEEDAD8&"@
MW%>.EU.]H!!;K)5K9=Y2OI;'E3E9B?66>X%02]52&(J6/KQ5,$E'WXRV8KJ4
M!''1!0O+G,M[3:M7Z]7J]-KTG4G]U84+D&"Q]MYWMX&!MIZN<AE4=7JSNV2K
MB40U42LS<369>?EFYB\!G/,AL+82ZBU/:^F3E#*=DTBS>BOY4*V\:R_P9_5R
MKN3!IRJV/< \J=6'TGV]?:%:K:M6Z8OW5D=ZI_3UU;HJE=JTOGBE+5T*%4KI
M3*D4:LF5\[ER2Z:0[YX>*I0+TVM#'77P/#]_MZ'>.H;4.J;4=BOU]?761\#T
M6F^E/ESKF[KOOO6Y73W[0'"Y5#D_/P5_GIM28M'WY:?GRRTS9K36"_GIQ3PN
M/RDH0GUZ&1%#/KIP]W*)EBZ?2Z%0LMA1V67$GTQ6!D)Z*%K9EG0=NZ@LJM?[
MA^KUH2&]U%^;C\>A>J4V5)]7[Z[EH\4B9 6%*6$8PH+H$(_+Y:*54G\)#CV2
MKV(TQ@\U9Y2>E6/([8M4\B@I'+59^^GQVH*A6="MRI3VH=W"D<2<_DI[;J!6
MJ=4KE04@8=_^RH):3==K[:5N-\C#R)!>VYL/?YWOV$,R1?5F2@$Q"K.8BPQ5
MNDOU"DLD-C(R4AFJZ)5</RC$%NN5>H6WA/BC%JVE:\G^2C\0ZKEZ#D/1,H2W
M&B;I'IK=V9IK3X.XQ/Y+*YPK^PT.] [4>V=.G;DS:;B^='\DT'S \D4C(UU]
MO1T54#7%7YA?J*?3]72]PL359>;EFUF/-G,I"M;6HOV5P;8A22G3.8DTK[^[
M%*U7%O0#?UX_Y^X2^-2+;8\P3^H#N^2'^H>C]7I/O3:D]]?G]T\?&JKWUKKK
M,X?U[LY<)5JNY/*5]FA;2Z54K+1!A:;.1%MY9GV7[@'PO+3WWKOV#PQA?/?T
M^J+*T%#_P'PPO=Y?&]BU/C1CV;*!/7OZ#H15:<EUE/;)52JM+=.EZ(=*,TN5
MMI&1SH%R:69KJ2W;DH,B# Q56DN5EL32?2OM=/!ANU,DDFFM51?N&DREJL.1
M="1>W9;2Z>'AX>K2_O[AN?W]<^>FVX;K"_$XM[]:G]N_5__4>C'>5JYFJ]6V
M:AN&Q>-M\;D\KEB,5]N&V]J*+;&6'HS&^+G-&3FL;N-SNGV1*L<VV>[J+KL=
ME$GT+IF[2V]O;W5:UYP%L;@^?[A::QGNK=819BT!"0<,5Y?4(;+>KK:I'I#'
MOV,N75_1SXDC@;DR37X-S$*V\6JQ7HS-K4YMZ^\:'D[JR7GSYE7GPAT6AT$A
MMMA?[:_REMKZV^IQ:&%JN#H,A/YB?Q%#T3(7;W5,,G7N;MV58E>NMSHUM>+@
M*N?J0;.'^X;[^N<,S-F9M$O?P2N08%0..6SIO'E3AJ;7JJ!J6K"\N-R7S?9E
M^ZM,7+_,O'PS\U=2SFUQL+8>'Z[.[IPK*64Z)Y'V&I[:%N^O+AD&_E[#G*>V
M@4]]V/:\=#J3[I^U1\O<H5WB_?W3^^MST\-]"X<'Y\[MGUZ?VC][;GIJ=[$:
MKU2++=6N>&=KM:VUV@D5&IB#MLJ<_CVG#H/G;5];NN<0M&!Z_]3!_J75N7.'
M9BT$T_N'Z\-[]L\=6;5JUK[39QXZA%MXL=;VM6*UVM$V*$4_MVU.6[5SWKSN
M696V.96VSD);$8HP:PX0JFVI@P^H=C5_-UZSQ)N_F=PXBC<AWPW&RU#?0Z>3
MB:;1J>(T<8EH*(\HCRE_5D]5UZKGJS>HOS,X#'L8EAH.-'PO>7;R[[B?)E.9
M5"'5"7<W+=67&DC-2IV6NC%U<^JVM#'-W_PR"!8JZ0/2EZ=OR2@94\:=\68"
MF6A&Q[VB-3,WLSRS,JMD-5S>**_D'7DM[\<M(Y[/Y=ORW;#Y1^9/SY^5/R=_
M?O[2_ WYV_)C^7OR]^4?RO\F_V3^^?R;N-D-%H8*RPHK"H<4COA,:33D;S._
M'K1_JCP,VI\#[6>!]@O5'QN$P678RW" X>+DZ<F/4C[<HE.2]FIJZC;:?_Q?
M:-\_??$VVCV@/8+K7)/V99F#)>VI_P'M>VZC_>+\]?E;M]'^.&A_#K1/VT;[
MRL+AGXE&H_$:4</7V$RTU47T^?6H5[&4MI:WEK:V;"U^\:_7EK[Z8?.7'&XY
M:\MEK^RWY<PMG[QR\Y;CM]R%EHNVN+><N^7D5XY]^?"73]BR<<L%+]_\\N4O
M7?'2#2^=1_3233SJY>!+JU\Z &^=+\UXJ?I2]L61%V>]./W%^HM37JR^V/%B
MRXOI%Z,O^EZDS>]O?G?S6YM?W_P*C]K\Z\T/;+Y_,];8_-#F&S?_?/.LS3,W
M#V[.;DYO3FU.&.^7&C0N?WO\-R;*22AG*;?2EY+RD?*Q:J"O).43^F^2\A(7
M9<O$VXOTOYR4.Y2[MCV/_0_15/H1G45G*^?3%?0&?8<NI//H&KJ%?DP:K:4&
MG4F7TE_I0[J OD_GT"]I,WU U])/Z2/Z&_V=;J!U] C]FFZC@V@%74P'TV.T
MDAZF1^D)>IQ^0[^E-^D0^CW]CIZDG]&A]#Y]C_Y 3]'3M(K>IG?I7#J<#J,C
MZ"@ZDKY.U]'1= RMIF_0&CJ.CJ7CZ9OT%IU )]&)]"TZA4ZFN^AZ.HU.Q2D]
M@]ZA]VA<7"ZN$$(H0A4&^I0^$]\75XJKQ-7T.7TAC,(DS+15_$!<(ZX5/Q37
MB>N%15B%3=C%#>)']$_Z6/Q8W"AN$C\1-XM;Q$_%K6*=N$W\3/Q<W"Y&Q7HQ
M1O^B/XISQ5JQ0=PA[A1WB;N%0SC%N-@H7,+-O^.37J8MPBM\XAYQK_"+@#A/
MW"?N%P^(7XA-XI<B*$+T<[I=A$5$_$H\**(B)N(B(1X2OZ9/Z-_T"KTJDD(7
M*9$6#XM'Q*/B,?&X^(WXK7A"9$16Y$1>_$X\*7XOGA)/BS_01E$01=$B2O0:
MO2[^2,_02_0</4\OT)_I3_2B^$#\57PH-HN_B8_$W\4_Q<?B7^(3\6]1%I^*
MS\3GX@O1*K;"LI$B%$51%8-B5$R*6;$H5M&FV!2[XE"<BDMQ*YKB4;R*3[0K
M?B4@*J)#"2HA):Q$E*@24^)*0DDJNG*>DE+2HE-T*1E15;)*3LDK!:6HM"@E
MI4RCM%XY5]3H#KJ3?B5>IS':0 _2MVD3?9?^(=ZDJ^@OT*D;Z1(Q0!>)07&<
MN%A\#];K>+I;?(M(F&CBOY! K2C-_YIAQX1.U6#D?[UNXW_7X]8\7I\_$ R%
M(]%8/)'44^E,-I<O%%M*Y=:V]DI'9U>UUCVEI[<^==KTOOZ!&8,SAX9GC<R>
M,W>77>?M-G_W/?;<:\'"17OOL^_B)?OMO_1K!QRX;#D=M.+@E8<<NNJPPX\X
M\JBO'[WZF&^L.?:XX[]YPHDG?>OD4TX][?0SOGWF66=_Y[OGG+OVO/,ON/"B
MB[]WR:6777[%]Z^\ZFKZP377_O"ZZV_XT8]OO.DG-]_RTUO5=;?][.>WCZX?
MVW#'G7?=/;[QGGOON_^!7VSZY:\>?.C7#S_RZ&./_^:W3_SN2?K]4T__X8_/
M_(F>>_Z%S2_^&>=_<.:BP1D#_7W3ITVM]T[IKE6[.CLJ[6VMY5)+L9#/93/I
ME)Y,Q&/12#@4#/A]7H_F=CD==OY'*R:C054$M8UD9R]+C1:6C1H*V;ESV_D]
MNQP-RW=H6#::0M/L+^.,II9)M-27,0>!><A7, >;F(/;,(66ZJ.^]K;42#8U
M^L2L;&I<[+?78CQ?,"N[)#7ZOGR>+Y\OEL]./*?3&) :":^:E1H5RU(CH[./
M7[5V9-DL3+?>;AO.#J^TM;?1>IL=CW8\C8:RJ]>+T("0#TIH9-IZA2Q.$#4:
MS<X:&8UD9S$%HVI^9/G!HWONM7AD5BR=7M+>-BJ&5V0/&J7LT*B[5:+0L%QF
MU#0\:I;+I [CW=!YJ?5MF]:>/Z[10<M:'0=G#UZ^=/&HNGP)K^%IQ;JS1D,G
MO1[>_HK)O<.+O[MC;TQ=.Q(^+,6O:]=^-S5Z_5Z+=^Q-,URR!'-@K)*?O6SM
M;"Q]/C,QW %"F'S>2G-3*[,CW++L\-2H-3N47;7V\&601W3M*"TX,3T6C0YN
M;&RAZ$AJ[:+%V?3HC%AVR?)9\?5^6KO@Q V1P53DRSWM;>LU3Y.;ZUWNB0>'
M<\>'E=OZY)-$YZ=Y"[:Q4S!%V5V@!:.I%2E0LCB+C=09K*S3VA7UF R;EPB,
M&CT88CALU#J\;*TVC=MY_*@QCV!B[3\)8L^^_Y<OMRR?:#'EM7\2/[)R;-,O
M]$\^C[:VCI;+K!?F80@2- [(]RGM;<>/*Q]D5VLI5& ?[;D8PY9,ZP#/TVF6
MZGGC@W007D9/WVMQ\SU%!\7&:+"C=<FHLHQ[-DWV!/;FGM,G>[8-7Y:%^MXA
MC59@U%+8]L>M!7TCJZ:-BN!_T[VRV3]O87;>7OLM3HVL73;!VWF+OO36[*]O
MZYMX&O4-+U9CRL23$E-E+S1QZ39D?EGL&#7D\<<D-?G@<;,%JBA;1&KVJ+9L
M;A,NL:73_XN#QAL?\BA9;1\V0>;HM-8OOT__TON7R'.L54&PH:#,6[3?VK6V
M+_7-AME9NW9V-C5[[;*UR\<;IQ^436G9M1O5475T[>J199,2'6_<<UYL=/;Y
M2[")56(:M%6AH?59<<Y>ZP?%.0OW6[Q10XQ\SJ+%8_" P\N&EJS/H6_QQA0,
MK6Q5MK7R6XK?:)Z IH_!27)7;.,@T>FRUR ;Y/N*<4&RS3+9)FC%N-)LTV0;
M4CLDOWX1S72H]U$GRB#*]2BC*,;&)O7>#2,CU<%QU*T568^UE*H;94>T4#U]
MID^]EZY#N1WE212$DX ZBJ+>J]Q.1=*!O'$L&).CQL>&AB8>>NK-APWE]NK+
M,VWJ./T515''U8W4TARUH:52_7"F&PWL5^\F@:):"-,_H/Z"6B72+\9RY>I&
M]2[UC+%INGMF2-U FCI&*90]45:C;$$Q@;H-]#+*7U$:* ;RJK>,O7JN_H!Z
MG3@"$9JN7DF76L2@0S_-<)I1.4TY354.O%<9)='8)$)CD4.JXXU-&U9&#P'=
MIXLUW'"_>I8(,4&-3<KM8UVUP7%4%5EM )]D72@VZW2^6<=3LA[+-K$CM>OO
M Y]&4;8HM]^I#JKI$A;Z:,.T0G_U/O7;G&F:A>[4!_-+:\EQ['/IP4#X8$.^
M4O/CE05SV /J&>#16@E=W-91U;AOK_VK#JYWWZN:X7K._*J+IYA=LZ$:M!;F
M5+WYX<42::Q:XS%CY9J747O[J]Y[,6$_U1K_& SD^VOA_)3]JUJ^T%TUY<LU
M!]8?;VP=S.7;:XYI';7J5;A3W9-_+&\PYGO06ZU7(]-*T^K3U' ^A GO:,G7
M\X;[U#,X4]Y"@YKNUIEX_01=L>N=->SJ;QMTN>W3.9,.I(#>>Z#Y=K-RH.EV
MDY*Y#?C6VSJP\(N#MMOT3#63;5W 6SIMK%2358:9<MI8,H79WKH[V5JK)L$,
MUK33[MIMCVJUT%:;:6M\H)XF?U_C)ZA;4;^+(=-J*8S<,&-V-<EUQ[2JEV>J
MU.0KM%3.7Z@9^'677;NY!B-EE:Z%40TZ$K5,H;-:S11J=:S_R:"M@,6MA5BZ
MNO8!+"74TSA3 1NKZ+VZJ<,TPZ1>I]RN_$)Y4C%<I]ZN_D)]4C4<#:R+5%57
M.]09ZA[J@:K1/7.*PO_AV8& UZ&\C*)2!^ ,E*/EV^W0(4%[ &)&A*8=@#/D
MTPS68MESX%=Z^'P(=4P=4]Y''D7&+(/17D&="'_YU_5;!<(7"H5@*+P>R^!,
MN_(M)4O=Y!3]$O9*&!N,=CLOZG:>U>U<U>U<TNU<U.V<V^ULZW:V=#MG:LH4
M2I%3B3$4GTOXH(1[2M@V&$TY/TPY'T@Y+TLY3TPY#T\YEZ><!Z:<LU+.F4XQ
M(.KDI'X).R5,,!1?W.&>[R;K+\07-)^<ZGJP-D"Z$A@K=.OCBG^L, .592QY
MKSXSHI@H:1'H-:*L0S%,U"KI!FX7U,560'Q&6;$/ZI^/%<KZN/A9LUK'<\X,
MB%NHP*/$3904>=0WTCKY_B/JDO4-$_6U8]DC,>P:KF9:Q0\HRXM@@9I<Y/BQ
M0@7=1XYU?4.?Z1%'8$UN7D4YB38"%>%ZQL2P[%CRA_I](DU)A5_ICL*)^A<8
MGQ_3/ZV-6\28_N_<N+)N3'^[,"[P]@;ZKA[37^_"VZ!=?ZWK=?W5KG/UIPOC
MBKA+_WWA"?V)_+@!B'=W2<2?%^0DMR71"/P?=AV@?[_P0_W2YMQK<Q+I3#!S
MW:!/_S:V=%SV=7TUICDX^PW]@.947\M*"O9^4[XM!#VH]JC)QMT+/+%/G]-U
MJ#Z[L$X?[GI"'\@>H$_3T7Z7/C7WNMZ;E6M5LG)X.8G-@9)2=IU>[%JG[]U[
MGWB8S&(M2NM@Q7R:^1CS8>9#S//,@^:ZN<?<;LZ8TV:_Q6O1+"Z+@_]UO?R%
M0(J%+/[QQI;!5KZ<^4T:5R8#0X-\UA2&2O/NI@B+0KO2J$^=I\Q;.#3:VSIO
MW-Q8,%IOG3=JW7/_Q>N%N'")F#>Z:07-.R@U^O'"[+BP(68P9H?$J'<>S5LT
M% ;RJ'(.G.^BQ>.BP2/.CG'T#2<F!L^^(,;UDK,O6+*$@L?/",_P#GBFSI[U
M?P*63<#6[2G<^N443HQ>,6_AXM%;$TM&J_S02"R9-SIG86KIXHW**<JW1F9M
M5$[F:LGBC6*V<LK( FX7LV<MV88&A3H9:%#JDYMHIU&2T:#=ITFT YIH.D8#
M+<\5H]U"ND33Q2V,!C5CO/7K])%9ZW5=XAA6TSJ)L\ZPNHF3ESAO[H!CU.A-
MB?.F49/+A21*+@>4KARCK,_D@+ ^EY'=>VWOSC:[3VEVGR*[O[Z]N];LOK79
M?2NZ6_\?2BN'_F<8(X<M'!+S]ER\WD)#2Q"KRCJHK1Z0>N"YL__TV#TBKCY/
M=H3K-MSW[-DAFC$CW*KUB8ZOF1RC)K2941A]>CI\:NP> _\?F8SN0+-SHJM]
M9OM,[H(Z<Y>+;XX37>%3IZ>QR"T371J:/5@$>EQ9"+T\8F2TO Q5=M82"H\<
M-@M_)JHU2,<==]R:-<<>QPD#"@OGC?8C4%Y?*.#*MVS6DE9<'&<=^]_LG^:-
MEC%H!@\RFT=P!9NU9,V:5CFNM?6XY@/FYL>OIF.;;1*56M=L:Q<\[QJ>I56
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MST.;+< _K?]&:/_5"+5!/0?_AM AH.?AVQ Z L\= 1H=A3: C.@$X/8$G+P
MN/W-#0B]"'AZ$>CV(O3K1<#/2T#OWQT%@/I>!AK]'ESOW\-X7H'QO0*?OPI]
M^ /@[P_0AS] &W_X%J$_ MW^"+SV.O#RGP'>!!S]SRF$WHH  ,_]!?K^#CS[
M#HSK7>#A=X'>[T(][T(?WGT+H?>@C?>: (#&[T%?WP.<O@\X?1_XXWWXWOOP
MS%]_C]#?@/9_@_'_'3[[^U: =Q'Z &CQ ?#XAT#+#\\@]!'4^PG4_^EV@),
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M&F'KS0!0A\T!BG8ZPJ[% /]$V'TM /3' _<$>$XXC+#W3@!HWP?U^D, 4%?
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M?!KPUZ70M\L!AU>^B/ ,Z,,L^&P6T&3V  #HYU5 CSF W[G0[WF N_G7(+P
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M0%W/0UTMT&8;A7 [Z)Y#<.\(X.@(X.@(X.@(X.@(X.C(=@#HXQ'@J6/ 1R<
M#R>@3[\!?O\MX.HEH.7O 5>O #_^ >[]$>Z]#CKG#>C+FU"^"3+_%O3A+U#O
MV]#O=V!<[T![[T'Y/LCL^]"WOP-/?@"\\A'HJ(_A^4^G 8#N^G05 .B)3V%L
MGP+>/CV.\&F0E],@?U] _[[\/<)?%1#^)^B_;T"G_0O.OX-^=$+;W\/S_X'[
M_P$\_ BT^ GJ.0MC. NX/@O\? [&?0YT=Q?0H!MXIQOHV/TT^);3$45?ARB6
M093"!3 "4:JG$*4>BRC-#O@<[ 7K84G4IT2-^RG\@T+93LV4S(AE?J"16LG\
M@)%3I6!_H.AV/*25>_1OCCA_)M>5&\%WYH9WY5 CG//GX%"9)N_&"<,!>QAT
MSD^_<$YB(:[U,R] )+.C^T-J,WBT%H@JFUK5-)")WB=QUA%N3K3;7;K#N#]X
M]6(+VH7;\;R#CA%>9Z!IBB,.S0SOZ.SH[!K1?T:_SU#C\*XSN<;*- [6UM:9
MZFKK:JNK;%:+4D&3WXH@IXJ@&*G)U.+F2&7,6:6Q)*QA3]1<MJR7PGQ3/)>+
ME^=R>$C;B1VXH69RREX1+FO<7'CI+F-]X4'YL_)X#K 2@:C^(>@M#U[Y,BFZ
MW( UO,;GYMT^!L)BX[W\;I[)*K+>88I^^F8#RVN0SV5$[7A=BTIEA$+2V>D
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M)-=XP?$7'VU@D_&5_,D-20<I?ODB7.#WO-T<K*DV!VH"YFJ:0+4U"!"@@^8
M3?9:+\SO/=*_&[RH*6.FX$LN'W/IGD,#N@O?YB^94GCFTFOQF$&%O1[\\F@\
M811^N9 E,*JP>W3QC'+B": !QG<OH[]D=Z *5(,:\:W2V-;,H49*I5>Y[T2/
MHT/\H5J%P[T8+V]8AQBNMA$C,1!0:VWVFH3/'U"K?]+X+1J-7Z/6<K9:>V,-
M3B"?Z _P48/H0S78WFA3U"8BAZF=*$P]UB(&_'TU^"<40R*^%\0,[ 5*X-G
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MEBX@OS)01\THZ_JI#'>O7P_?Z]_])?2U%?#C/02VXO86A08"ONO;.*>VIX/
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M<I>SP\)X\,ZNO;LG+=TV9UAN5&W4[XWHK6+%Y%5SGZ&H!9Y(6@%X?@4\L[<
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MH>6M5</=5KO.1'X#N1UX93SP2AJO)'-Y'T@OF;,Z;*"TM%:I51FT!IU!KS-
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M&L-KJ!;801ISR32JX6019<&W-M):L+^*V2-,>D$$T]IH-L([[P?#&28"WXO
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MK?AEDE7/<DI#BXH?OCR+1X]\/:C)LYRF&OW+^V].D6;]M/&<@@BN#F@6_HC
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M@XREXM;2*A>/UCIB,2Z.8YSC+<UTKD4\Q&NZ&R@=\7=Z&[^WZ.&4VFY)13<
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M^E\A6@T0FZDYQ&]$7Z*(Z$M4]NL?YH$T!WM*$)LQ0#CX*521OZ?:D6WV &>
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MN8R+19MB#"EK8FQZ:Y,M0)).5H^T-[TNKV$)%N23)"1#^9I4BK$Y^\GGN.J
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M8.HF5TXJ'H,/(J(@O(4"^:[D)#(X&CB%3JTB94:5CE70_?!33@YD5C,Q#;&
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M%O*2FE$T\!BH)3N #NJ>(Q4HJ),A62GE<JT2*CL,F@L2(1-+H<U*)#*X&F"
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M=2L4=F1N C4&"L44*A7#Z8Q9ADF:<B8BAVS((=.7IJ],M,ED!3CITBK09K(
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MH[Y3<Z>V$QQ0=VHZM9WA(^"(^HCFD/90\%#89S"J31HU"(?HH%:G-WA]?DF
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MNA];]V/K?C;&1P#'^3;2 3!VYP%C.-*S9 +@N0L? Y[GR ABLF\-'0@SXD'
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M%T:*2\V$F@G([Q%65V.\S&B7!ZYUI) 8(!MYW)3X-F)/WN;&F'I /^\C=XY
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M"3YD*(2K@4&PX[R1-+ V0 K)&LGBDF4>C6S-E<T3C#A.7##(OZ)A/(30[M*
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MW$77?YZ\Z>/!GQXGAQRK]AK^]=!G&\)*CXY]Z+I=/_6:%[QZ[@MK;=^\<$M
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M/UB]0 /Y>YDL3+*KB&?9.9NLOH_JX^[_/05<$FP,/!>TC3T24#J=+%NK-#S
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MIQDRQRD-X$9LCT9BWHC7Z7.&W"&$??:0-^2-1"-<:^JC]'+>D#.$,6B1/B\
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M2R00EL;"'-.& ^YPU(F8-1L-<P3HC 6T<,#GP05%X^FZWL0H[[_L6:.RRHQ
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M#KU+>Z'[L]IS^HSXV+3V[(!\;%LF'T\MNX]II1^+X>GKM2?O87%.:X_79["
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M>?N;F%&,XBS#E<C7BQL,>0E1E+-H/_%=98,:50>4A#H@WA"7*&<H-O$&ZC=
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M<V_R O4"P3-N@O(2=5O?"'0%$)1]/?#R9BL0U/]F>.[-NX& U[? N5N@#K?
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M7K=#>3J UQVO(CRV"@CX.A9D/Q9X,!:>/0YX-0[*- XP.P[P,"Z/\'C@U7C
MR/B'@.!<)WRO$]XY <K8!=^="/R9#'R? F6<6@$$SYX&/)X&O)@!^YF@"[.!
MGYD/$)X#]>QM1'CN[Q">!V6:!W6<!QB9=P0(GCWO3T @YWF N?D@N_D_(+P
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M6UGX".5'40A^2X:.[8.+)5G8P_42N+Z7L8-2UN[YDE3K3&<.Q^,#IZ3<%8Z
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M[02\RGBW%FL%;0EX*HHO>JJ5?"[3!Q%+_'QC<$IJ[?GBXA9A?+[;HC@4Y=_
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MML?O]1Q7G=*<=)_RF64Q6=P:L\:I@-\?0N(=JE1JC]<KAY#P^KQR'Y"KA(X
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M2-.^HI#Z['&%THYLD AY8/2G\.%%N?K<DJ9 EX0K'OSE_6\3]W?IC!:IN0G
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MI=/6T-N56WT-E?Z@3"Y,6F@]G&L2RBEX$UI,3?=^KZ )]0J5QF2[*]6RKO)
MI4PL'WT(:C[[5IL_0+D7]+:NVIM83CB0%O,=Q%_EB+X,I$^#PMA'S-42>:G>
MU>WMR]T/'O$\6GC*\V3N><_SN9]X7BV(-2 +"",R#8O>8K9#W>WJ\?3D%WKF
M>N?F%N;G%F[WW)Y[H/!@\8SFQX57ZGZA5?/4&C51\!1RGJ":Q$YV-4FJ"QX*
M.HJ%I$>F)B%?!.1G$&>50HH1\_F0.0^0.<DSFU^ .J"'AX$#Q" %4B1@I(&
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MR&YD;(!0H7LAATL2@.11%#JBFR! ,I?+PWE(XTN*Q=8>WX<8WY_F3*XENUU
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M1HAHH]4@,5FL!K%9RLHD)A$K$YLA2]FAQJ"U:]0RE5UM-IE6&R1B\186_<K
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MS?T0<8K#M)F!)P^3P&9"ZE7X=/X&U-^?D=T=?VYW1P[W"+NQ;MM87+9WB"9
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M)4M+=$K/%.,U*]IKZF=0]E'133L+>O6B@E[]^_"O\$H0X*1(-*I+UU%UELS
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M[61)SSR$:FKP%[7\  ///PTW'*"N)Z7SV\XW,%<>R(]^KBVH5S4%.*!N)[
MIZ*FG%7G4GZ6:XF.),,M.0[Y<@;BIJ"Y.OL6&6%*2%MH"9E5 <+HAO-/,S#[
M+A^BKD>#PK:@LFD$D#L)O*)QQO B+<"+(0=S>&#0RR_/-Z#6X%')029I-9;%
MR4R_>HY'K^%O!0@E3<&C@F>/0*D\/X9XA=(DJ.7T^',#5!B>RJX_(!YQ]O@!
M4@%S)8$D.)5 9?&XY.";0 D9%_I$#@L^&TPIM(;^[-P /(62Y  )X0.!(Y)2
M:$D"#POI9PW=<.#< #V>WW8@NQXU1'T ;J!/G-MYH B'Y,5C4L"C/"Z1<4$
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M,)CZATL^_3=E_##X5#QB(_ZWH>ASXP;\;^-_\!PT#GSV_V"TUX/-8"O8#G:
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M NQ/9M_ ZZ+UQ+=F %2#8>"%@[GH#7(A>@.@JU3L,;H?,)03^.FCG%3:;7C
M<,! &S)P=7]9GXJF(#[BEE?6] 6;^BJE';WAEU#:5G@UJ$??573KH7;P#SI#
MK>(L\!\49XE7=U/+J0/4_R'N/<#CJ*Z^\;DSLW6VS/:^LVVVS6I7VJIF[4@N
MLBW)LBUW6Y8,+H !%YJ-<0$#-AACJB&$%D(H"6""*:8%DA!""($D)I2/\"8D
M#LG[@L%?7DH2O*/OWCNS*K;)Q_L]_^?Y/R!YRXSN[CWWGO,[YY[?.10YRT O
M5LVR^F=9GX-7NLEC1)3DGC#<-A4U<$"<3,2E.LI^-BB@\V=TWH(:E_\>=6VH
MUHX._OYH#;Z/&<^C/=' **F'.$4S)IE/B7O5$8I]=XVG6<(UJDY]%=U,OU<S
MNWJF#ZU9LP4D'UZPL"L9S:7\C-ESUH-S*ANI::=MD3[XR6F;]G[8D_$U7RH$
M>/?T\Q*JM?]:KKJG]E_V):G*Q2M? >7>EL+TAE":LUN,.J-T]+:>)<G-PT]+
M3UXX=-GQJU*^%NG>JV)9WRPPZ])$!NGVV,@1:B>4111:K4.BCHC&6!"AG<(A
MZIG'U(3G&2@%-]"*?K\NQN9L($)R.9OM,XZT<QSI><@MVAQ%]R$0/&C379-\
MEJJ@F,[(BZ+9ZBD2N>@0QS4F28[-/4]^#-]!)5%L4("SN6&.Y Y1]XNZ1L[%
M->KGY"<0KN1\:<"BJKBH;KQP="SG5*E]2+A1URU4\PP=TMLJM@Y2*?>A-I/U
M4_6QY! -&"VCI-;$[EK=MG+?HM7G6MTK.BZ>/;>-]\V?7^RY?_7\C8G(N>"7
M]R^H-@0;PHV3P:_/ 0.O/+MH5:^0K6XMK&R5OOQ1?SSY8\L#-VT:G'W)63/
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M_9 Z/R*12-L/V]"SB^$SV[VFQG3NHW13/FUB&"'@M0<"WGPL5N;3<&&DO:8
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MQV^?'QL@X</IE^-4J#AZ F9<3JWL2<O94GV7*JN!/H!7@Y<X</!*(SAQ+2Q
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MN'@+062?@K 8X>'4B2.F4EXO'K'08J+E$4N(J3</?NHJ7/5NB)1>$\_W(Q(
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MI:4J<_5/B &,]DQTRPQMY/!B]V=P$(I22?B"NJUP I&A0B)KHS&1]3)M( S
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MG1==?MUY.Z];_?9[KG/N/E^U)ZY;T&N;<^;DJ6LUZV8G(],7-U4[FM_;.+1
M2T?.7G;%SZ<7PEEG:-Z"AMO/?@SXSDRFS]@07-$R5^&%_01+8BZ./0]+,ZE?
M0=UL)3CBQH,,BYKFR3UO.1MK"1)4T&)1T+5-%:3\K,-"F8"_3:MQM)D@I ZJ
M+%0(06I/ZQ!S%_,"0V&6@1'^ 88)8U0=&D/5PN#)F!JGP8['TM86Q+S$?CNQ
M 4'G>@DK8A0T*XZB6K-*^JK:<_&434]O??8YZ5=_7]N9;[RX4>R_<EMG:UMW
MNS3SBN/@]C]_</ZSU[TOG9-]^+O@SL(^</VFR8,K7X.K<)KT,/4X_.Y98A'T
MK>$F51.:2,0=#"8)-W"[+7"-/95D?#YH/7BTC'3K'3L<I,/1:$1H;WT&9,8Z
M-D+=-7'9Y# E'(QK2TEB-'?2DI!U'$9RY#4WWYB-II9L/'/O;Z<,G[=QP\#K
MYXG]V09/MB>>+HDK[KW[+%"B[EI3YO/-TZ61G9,&?33%G;OHQI>;TUS>:,_&
M4IG"P[L^!&?#;P=],NIV^.UXXF9Q<IOC>9Z,I'7VHIS3&/,Y#MOO-05\/L'$
M0+C&, &3CPXY+!;[_2X7T08T(8@_?*; 4A-@XDD3P\8.@0=$MI$>HM?1%$TG
M&,;%Q,=(M2>D0N \9[BS)OA(,MK*#<HZ"52<8X7?3@!9&KFA*RK">KKVICND
M#XYN^6YLD9ESIDNA:VYIFY??NK3ZPW.I2Z+F']_X,^F<+5NF[P%LSA9)SW)\
M,*N[<Y_TK8$SG@0]%Z"*]7.DQ90$Y\%/?$OTDT:H2?PLJO!O,O6:";O93!A)
MUD\#LQ.9-!LT<&X- =0X[4H%#5Q,;S:9300@369VF]]/;C,:'0!H#FM%/5/4
M:H..PTXGBLX<-!B+9G3T(F<IR6U>ZPUN91N'?]6K">S:^M(N^J67=D$8@#.8
MG/6<[W@"/HO+9@_5#W61'P-K[0/+W/Y^CO?<<=8LK?2\]"'9ZYHUO9<3,C=6
MY[D8:N?Q?_W'PPN/??:)U$)-^N/6@2,#5_P6RGFS-%-U)U[A7XK9FY+W)DG2
M9K>#K-/A(!@(UZ.12( UF<H:E5VC40FI5!D=W 9\ (4=[Q>G. @[O#(::>,U
MC*%-IR&=V38; PBUW6$R:5A5*B!X ;Q&E4MJ5(2#_8,*F%7#JO6J-U2TRN=
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M4DJ&P,+[EFW<-%GZQ<K$ IX?N(GZG/D"L>2AQ#9#I%P&:47"#X'ORK%8+FC
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MR)ADV\PDVTK]GFS1G,R0;+,DDU6!R<3N#C<06&>CX3L&IL]WH4%(ZI94/N*
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MPX"-\5<!FSG2=WD(/8'T1TB?1(QS9"D\G&D #<00OX84$@&Q#K$A/@K8&.\
M;,:0?@S9@+@)\1' $DCU*F!Z[)^ >L1"2%4%X0\#UL'=*LB-TXV(S8B;$!^!
MG#T8TX,Y># '#^0P2FHAU:N C8C-B)L ZT@ZY%]'=(AZ1!O$KR-VQ$+(LX[4
M8,P.O-N)N!BQ%WC5D95(KT%Z+=+KD=Z R&5KP'(UH%0-P.L:0#W2G%<#\FI
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M+D:$UH 58OZ%F%LAYER,(<7(L1C#BS&\!,-+,*0$0\JA=EP(J(^/ -J(A]5
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M(,_5X%'W 2Z+9P.N@?Q7(]\UD)9C*^AY#4J[!F(^""C>W00>M0;\C>-0_ /
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M=Q:2,?CG("LA;!NDCY!I_!6$:Q!B[P(<AIBKX?XXACK(4KCNQEAA" M 3FU
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M>P),-XZAC9HSQ=5\AI=+MTYS_F!T+%#M1J_'X8?8T8M@MV (NU;3V 4)?.Y
MY;-31TB4:B#>?\.='7CG7/+.6>7[Z2E'I,[#CB1.GY?;F=)THLR\P]#S;^1T
MQE3"9<+WA.>$IP"_31S"$>&[PC>%AX2C\.MS\OO,E(FNS532X&]N )(81(U
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MR@=9DL.]#NR"2=^"<@63<\E7:V>(T0XP'O]#8LCQB2$*"$-O@C !P)+'#6.
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MA(].D\X4U(K$7Y-+0":\#4+A/4$8#& T_4=1MP#"/UD.*F \A>9BL1E-:,%
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M'AX>'AX>'AX>'A[_P  1" !4 $H# 2(  A$! Q$!_\0 'P   04! 0$! 0$
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MWZ^(/^"E?_(T^#?^O&Y_]#2@#LO^";/_ "3OQ1_V%D_]$K7U;7RE_P $V?\
MDG?BC_L+)_Z)6OJV@#"^(?\ R('B+_L%77_HIJ_*OX2?\E5\(_\ 8<LO_1Z5
M^JGQ#_Y$#Q%_V"KK_P!%-7Y5_"3_ )*KX1_[#EE_Z/2@#]<:*** "BBB@ KX
M@_X*5_\ (T^#?^O&Y_\ 0TK[?KX@_P""E?\ R-/@W_KQN?\ T-* .R_X)L_\
MD[\4?]A9/_1*U]6U\I?\$V?^2=^*/^PLG_HE:^K: ,+XA_\ (@>(O^P5=?\
MHIJ_*OX2?\E5\(_]ARR_]'I7ZJ?$/_D0/$7_ &"KK_T4U?D=I&H7>DZK::II
M\WDWEG.EQ;R;0VR1&#*<$$'! .""* /V.HK\S?\ AJ/X[?\ 0]?^4FR_^,T?
M\-1_';_H>O\ RDV7_P 9H _3*BOS-_X:C^.W_0]?^4FR_P#C-'_#4?QV_P"A
MZ_\ *39?_&: /TRKX@_X*5_\C3X-_P"O&Y_]#2O+/^&H_CM_T/7_ )2;+_XS
M7#_$OXE>-?B1=6=UXTUK^U)K)&CMV^RPP[%8@D8C10>0.N: /KW_ ()L_P#)
M._%'_863_P!$K7U;7RE_P39_Y)WXH_["R?\ HE:^K: (-1L[?4-/N;"\C\VV
MN8FAF3<1N1@0PR.1P3TKR#_AESX$_P#0C?\ E6O?_CU>S44 >,_\,N? G_H1
MO_*M>_\ QZC_ (9<^!/_ $(W_E6O?_CU>S44 >,_\,N? G_H1O\ RK7O_P >
MH_X9<^!/_0C?^5:]_P#CU>S44 >,_P##+GP)_P"A&_\ *M>__'J/^&7/@3_T
M(W_E6O?_ (]7LU% '*?#;X=>#?AQIUUI_@S1_P"R[:[F$TZ?:9IM[@;<YD=B
M.!VKJZ** "BBB@ HHHH **** "BBB@ HHHH _]D*96YD<W1R96%M"F5N9&]B
M:@HY.2 P(&]B:@H\/"]4>7!E("]83V)J96-T"B]3=6)T>7!E("]);6%G90HO
M5VED=&@@-S0*+TAE:6=H=" X- HO0V]L;W)3<&%C92 O1&5V:6-E4D=""B]"
M:71S4&5R0V]M<&]N96YT(#@*+T9I;'1E<B O1$-41&5C;V1E"B],96YG=&@@
M,3@R,3X^"G-T<F5A;0K_V/_@ !!*1DE&  $!   !  $  /_; $, !0,$! 0#
M!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3%!H5$1$8(1@:'1T?
M'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'O_  !$( %0
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M'AX>'AX>'O_  !$( %0 E@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M>X+B4$)?:I=7$7&,J"L7X_-&U 'T%1110 4444 %%%% !1110 4444 %%%%
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M<45OT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M'AX>'A[_P  1" !4 $H# 2(  A$! Q$!_\0 'P   04! 0$! 0$
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M#Q%_V"KK_P!%-7Y5_"3_ )*KX1_[#EE_Z/2@#]<:*** "BBB@ KX@_X*5_\
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MN1@0PR.1P3TKR#_AESX$_P#0C?\ E6O?_CU>S44 >,_\,N? G_H1O_*M>_\
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M'AX>'AX>'O_  !$( %0 E@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M>X+B4$)?:I=7$7&,J"L7X_-&U 'T%1110 4444 %%%% !1110 4444 %%%%
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M<45OT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'__9"F5N9'-T<F5A;0IE;F1O8FH*,3 W(# @;V)J"CP\+U1Y<&4@+UA/8FIE
M8W0*+U-U8G1Y<&4@+TEM86=E"B]7:61T:" W- HO2&5I9VAT(#@Y"B]#;VQO
M<E-P86-E("]$979I8V521T(*+T)I='-097)#;VUP;VYE;G0@. HO1FEL=&5R
M("]$0U1$96-O9&4*+TQE;F=T:" Q.#<Y/CX*<W1R96%M"O_8_^  $$I&248
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MGB/X1ZS8:5XDO=)NY[ZW-Q$VGRR.H4,5P=Z(<Y'8&OU7KX4_X*3?\E$\+?\
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M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'A[_P  1" !4 $H# 2(
M A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1
M @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152
MT? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D
M969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0
M'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%
M! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D
M-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T
M=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$
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M "('B+_L%77_ **:OA'_ ()Y?\EZN/\ L!W'_HR&ON[XA_\ (@>(O^P5=?\
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M_P!"-_Y5KW_X]1_PRY\"?^A&_P#*M>__ !ZO9J* /&?^&7/@3_T(W_E6O?\
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M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>_\  $0@
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MOBEMHW'5D!..<>4*^KJ ,+XA_P#(@>(O^P5=?^BFKX1_X)Y?\EZN/^P'<?\
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M9&4*+TQE;F=T:" R-#8S/CX*<W1R96%M"O_8_^  $$I&248  0$   $  0
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M $/!_P#!3>__ !FO'_\ AAJU_P"BES?^"4?_ !ZE_P"&&K/_ **5/_X)A_\
M'J /7_\ AJ3X%?\ 0\'_ ,%-[_\ &:/^&I/@5_T/!_\ !3>__&:\+\8?L?\
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M+7SU_P % _\ DWYO^PO;?R>@#!_X)O?\DG\0_P#8=;_T1%7U'7RY_P $WO\
MDD_B'_L.M_Z(BKZCH XOX\?\D/\ 'G_8MZA_Z325\8?\$Y_^2YZI_P!B[/\
M^E%O7V?\>/\ DA_CS_L6]0_])I*_.;]G3XJ?\*@\<W7B?^PO[;\_3I++[/\
M:_L^W=)&^[=L?./+QC'?KQ0!^IM?&O[9GP/\1^+?C%H>K>"M(-U-KUN8;Y@
ML4,D.T>;*W\(*,HS_L8&20*;_P -SG_HEP_\'W_W/1_PW.?^B7#_ ,'W_P!S
MT >R?LX?L_>'_A)$VJR7+:KXFN(/*GO6&V.)202D2]AD#YCR<=AQ7M%?&?\
MPW.?^B7#_P 'W_W/1_PW.?\ HEP_\'W_ -ST ?9E?/7_  4#_P"3?F_["]M_
M)Z\X_P"&YS_T2X?^#[_[GKSS]H']IL_%CX?GPG_PA/\ 8V;N*Y^T_P!J^?\
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M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'A[_P  1" !8 /H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[+H)JMJ-R
M;33[FY"AS#$TFTG&< G'Z5XCJWQ+\3WI(@FAL8ST$,8)_-LU$YJ.Y48N6Q[M
MS1S7S3<^(==N&S-K-^Y_Z^&_QJ;1KGQ/J-ZMOI=YJ<TY[1S/Q[DYP![FLO;K
ML5[+S/I'%%<KX&T?Q!I]L9-=UN:[D9>+?(94^K$9)^G'UKJC6R=T9M6"BH+>
MX@N%9[>>.958JQ1@P!'4<=ZGJ@"BBB@!.M,ED2)"\CJJCJ6. *\Y^/OQ0LOA
M=X,.IR1)=:I=L8=/M2<"1P,EF[[%!!/U [YK!^%7@"^\1:1:^+_BI<RZ]K-^
M@N(K"X)^R6$;<JBP_=W8QDD'T]S:A[O/+1&3G[W*MSU^WO;2Y)6WNH)B.HCD
M#']*L<5Q6O\ PM\":O9M _ANQL9,?N[G3XA:SQ'LRO'@@BO.OA7>^//!7Q+\
M1>"O%6K:EXBT*RTP:AID[6[3W4D9E5  5RS$98$<\KD8%"BI)M/8'-II-'O7
MX4O->8:#\:_"FN>(+S0-(T_Q#>:I8HSW5JNFNDD05@K;E?!!!(&/>MO1/B7X
M3U7Q$/#;75SIFN,NY-/U*UDM9I!ZH' #]#]TGI2<)+=%*<7U.THJ"[G@M+:2
MYN9HX((U+R22,%5%')))X KC;+XFZ'JH>3P[I^N>(+=&*&ZT^P9K<D=0LK[5
M?_@)-))O8;DEN=S17(Z%\0O#6JZW_8#W-QIFM%=RZ?J-N]M.X]4#@"0>Z$UK
M^)]?TGPSHTVL:U>I9V<. SL"26)P%4#)9B>  "32<6G:P<RM<U\48KBU^(FC
MPM"VKZ?K6A6T[!8KO4[)H8"QZ!GY$9/8/MR>.O%:5SXO\/6_@N+Q?<ZG'!HD
MUM'<QW+@C<D@!3"XR2<C"XR2<8I\LNP<R.B%'X5Q47Q$TB,P2:KINN:+:3NJ
M17FHV#0P$MPH9N?+SD >9MY..M=+X>U:PU[1;36=,G\^RO(A+!)@C<AZ'!H<
M6MT"DGL:%%%%(H**** "BBB@ HHHH H>(?\ D :C_P!>LO\ Z :^<-*TO4=5
MG$&G6<US)W"+D#ZGH/QKZ9F2.6%XYE5HW4JX;H01SFL2;7?"NAV_D?VAI]HB
M=(HF&1_P%>:QJ04GJRHRL<+X9^%,C;9]?NMJ]?L\!R?H6[?A^=>EZ1I6GZ3:
MBVTVSBMH^X0<GW)ZD_6N+U;XK:+;Y73K6YO7[,P\M/UY_2N(U[XC>(]2#1PS
MK80G^&W&&_[Z//Y8J5*$-BN64MSU[Q%XFT;0(2=0O%$N,K"GS2-^';ZG KRC
MQ1X^UKQ%-_9VE1R6MO(=JQ19,LN>Q(_D/UK!\.^'M9\3WI%G$\@+?O;B4G8O
MU;N?;K7M/@KP;IOAN(2(!<7K##W#CD>RCL*2<JGD@M&'J97PO\'76@1M?ZA<
MR+<SI@VR/\B#_:[,W\J[T5%/-%!"\T\B1QH,L['  ]2:\W\0_$*YN]2BTGPC
M!]IF:0 S%<A\'HH]/4G_ .O6MXP5B-9,]-HJ&V:9K>-IT5)2@+JIR%;'(![\
MU-6@CXP_:YGDUO\ :2\*^';IO]!BCLX0A/'[Z<[V_$;1_P !%?9B *@51@ <
M"OE']N+P?J5KKFB?$[2(G=+-4MKPH,^2R.7BD/L2Q4GMA?6OHSX<>+-,\;>#
M=-\1Z7*LD-W"&90<F*3'SHWH0<BNFMK2@UL<U+2I),Z6H?(A^T"X\I/.V;/,
MVC=MSG&>N,]JF-<?-XXL#\4+;P%9JMS??8)+Z]<2?\>J J$4CNS%LXXP!GN*
MYK-[&[:6YXM\& !^V;\2/^O*7_T;;U5_:VA?Q1\2O N@>$"+KQ1;SO([6QRU
MLA:,HSL/N %6;GIU[U0\$^&M%\5_M:?$O2M=LDN[5[*0J"2&1M\ W*1R& )P
M:E^&VK7?P%^+-Q\/?%+(_AK69/,TO59$ 9=QPN]^XS\K _=.#T-=^T^9;I+3
MY''O'E>S>_S-/]J77+_Q%\3O!OP?M[N:#3]3F@FU4Q':9D>7:%..P".V.F2I
M["OH[3+&TT[3[?3["WCMK6WC6*&&-=JHBC  'I7S)^TG9OX8_:0\ ?$&Y&-'
MEEM[:>?'RQ,DC;B3V^23(_W3Z5]2J05!'.17/6LJ<+;?J;4_CE<\A_:Q\-0:
MW\(M0U>(-#JV@[=0L+I#MDA*,-^&'(!7/XA3VKROQ?XO\3^+_P!GCP1\1(+8
MZC=^'-92?5H0N1*825$C =C\I/IOSVKV7]J#6+;1?@9XGEGD56NK7['"I/+O
M*0F!^!)^@-<?^S;+'X$^&W@CPQKMNT=UXLFN[F(2$ )\H=%8'J63;QZFM*3M
M24K7L_TU)FKS:[K]=#I/ OQ:^&WQ8T.70Y+N&WN;^!H+G2;]@DC!AAE4GA_;
M;SWP*YC]HOPYK'AGX*^$U\/QR:I#X/O+*:>-D_UT4";0[*.V0"?3)/:M'XK?
MLX^"?%L-Q?:#;KX=ULY>.:U&('?J-\8X&3W7![\UE_LW_$F_;P1H.@^+GDN;
MR?6;K1(KN5\[C%$)%#$_>ZE ?8=:4>5>_3Z;I@[OW9]>IU'P\^,GPX^*6D-H
MT]U!:7EY"8;C2=0(4R!AAE4GY9 <GIS["O0? ^@0>%O"&E>';:=[B'3K9+=)
M'&&8*, D5Y?\5?V=/ _B^*>^TFV7P]K+ LMQ:#;$[]M\?3&>ZX/UIW[(NO:_
MJWPWO=.\23R7-YH>JS:9Y\C[V=453@MWP6(SZ 5G.,'!RIO3L5%R4K37S/:J
M***Q.@**** "BBB@ HHHH S_ !!QH&H_]>LO_H!KYE&*^H=0M_M=C<6Q;;YT
M31YQG&01G]:Y70OASX<TS;)/"U_,/XK@Y7_OD<?GFL*D')JQ<)**/&]"T#6-
M;E"Z98RS+G!DQA%^K'BO3/#'PLL[<I/KMQ]KD'/D1$K&/J>I_2NUO]9T+1X0
MEU?V=HJ# C#@$?11S^E<EK7Q5T>V#)IEK/?..C-^[3]>?TI*$(;L;E*6QWEI
M;6]I;I;VL$<$2#"I&H51^ KG/%7CC1- 5HWE%W>#I;PD$@_[1Z+_ #]J\G\0
M>/O$.L!HVNOL<#?\LK?Y<CW/4_G4G@SP+JGB"1;F8-:V!.3.XY?_ '1W^O2A
MU6](H/9VUD27NJ^)_B!JBV,"D0YR((R1%&/[SGO]3^ KU7P1X1L?#-I^[Q/>
M2#][.PY/L/05I>']%T[0K!;/3H!&@^\QY9SZL>YJ36=5T_1[%KS4+A((E[D\
ML?0#N:N$+:RW)<KZ(OXHKR676]?\>ZM]@T7S-/TN)PTLW? /!8COZ*/QKUA,
MA &.X@<GUJHRYMA-6.*^,GC3PWX&\$7>J^)XUNK653;QV14,;MV!_=@'@@C.
M2> ,UXK\'OA-XNU'1+SQ5I'B2Z^'5KKKK<6NBZ>'FC2'JK2;W#!F']TJ0#VZ
M#EOVJKZ3Q=^TGX6\$3R'^SK:2TMVCSQON)%,C?784'X5]BQ1I%$L:*%1%"J!
MT '05V-.C35MY:G*K59N^R/(I?AG\2$0OI_Q=N;*41, J6$LJNY'!;[1<2X'
M^Z :XG]F>WUK3/$_C/PEJ>D6>G^-K,)+=:_<>9=M>*[\%E9P2",$;64'C(R*
M^E_QKA_B3J.B^ M$U[XCR6*-J,&G+ S;B#/M8^5&>WWWZ]<&HC5E).#6Y<J:
M34NQYW9?"V?P'X_U'XD7OQ4L+*_U/S$NGU'3HX[=U=E8J 9EQ@HN,'/ KH?B
M+IOPX^+_ (9A\+W_ (KT:?5$P]K<6EQ&)HY<8+)&6)*GNN3QWR :POV9M"F\
M6:(?BKXU8:MK^JS2?8FN%W)96Z.5"Q(>$RP;D=L>^?6O%_A/0/%>C3:5KFG0
M75M*I )0!XSV9&ZJP[$4YS<9ZO5=281O'1:,\YA\#6.@^#$\'_$GQ]IVN^'9
MHC%;PZO#';3*5QM,<QDSE>W!(R.0*M>#UN]+2#0O"7Q:\.ZU:(/+L[?5(DO+
MF-0.$$D,\9< #NI.!UKSKX5^)]0>^\=?!GQM*NLR:+:79TZZNU#R20*,;&)Z
MG:R,#UQGT%7_ -@W3K(?"[4M0^S0&Z?5W7SC&"X CCP-W7')_,U=2#C&3D_\
MM>I,9)R22_I'<^)_ NE7FJV'B'XL^+K/4;:SF_T&QD5+#34E()R4=V,CX!QN
M<\ \8S3OB#!\,_&=[HMYJ?CG28/[):66T-MJ\,;+*P4+(K!N"A4$=1GJ".*]
M)U?3;#5K"6PU*SM[RUF4K)#/&'1@1CD&O%;#P?X<7]E..U32+14ET9;F1O*&
M]I#ARQ;KG/?-9P=[-OR^\TE&VB1V45IXS\0:&T&D?$C0YK&0&+^T[+2A)=8Z
M'#K.8A)_M!,#^Z*P=>^'?POTC1O#?AC4O$%OH\.B/)>6R3:DD%Q+*ZLOGEB0
M=P?+ @8RN,8&*\OT*ZO?V;OBZVA:E+-+\/\ Q#+OMIVR1:-G&X^ZY ;U7#=1
MBO=?C=I&CZ]\*M<:^LK6]5;!Y89&56*D#*LK=O7(JI)PDK/1]42FI)W6J,2_
MUR]>Q.G1?&CP7!$Z;1>M;Q&]"_W@?M BW_[7EX_V:TOA[>_#'P1X8MO#^C>+
MM"\B(L\DLNJPM+/(QRTCMNY8G_ <"IM ^&/A_2O'M]XD72M.\HZ?;6.GPK;K
MBV2/>7(&, L2O(YX]Z\@_:FL[2'XS_"J.*U@C234 '58P W[^+J!UI04:CY$
M_,)-P7,T?0">-?!SIO3Q9H++ZC48B/\ T*JK_$7P CA&\;^&]Y.-HU2$G/T#
M53^)_P /]%\:>!]5T"33[".>YMV%K.80#!-CY'R!D8;&<=1D5X;\3],LM/\
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M/;2KNY-M<6S]/DD(*D8XYZ@#TR=YU8U(N"?:WR,HTY1:D_/\3W<\<5Y/8_\
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MXG_Q-8U%)_"5!Q6YY?J7BOQ'J.1=:S=LIZJC[%_)<"L9R68LQ+,>I/>O:/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'A[_P  1" !9 $H# 2(  A$! Q$!_\0
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MFD#^4TA/EQE\+O? ). /7 R*]5O=0\=_M3?&JWL03;68),4():#3+0$;G/\
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M/8:?;275U+L9O+BC4L[84$G !. "?2O)O^&I/@5_T/!_\%-[_P#&:[+X\?\
M)#_'G_8MZA_Z325^<W[.7PK'Q?\ '5SX8.N_V*(-.DO?M'V3[1NVR1ILV[TQ
MGS,YSVZ<T ?<_P#PU)\"O^AX/_@IO?\ XS1_PU)\"O\ H>#_ ."F]_\ C->.
M#]AF+O\ $Y__  1#_P"/T[_AAJW_ .BFR_\ @D'_ ,?H ]A_X:D^!7_0\'_P
M4WO_ ,9H_P"&I/@5_P!#P?\ P4WO_P 9KQ__ (8:M?\ HI<W_@E'_P >I?\
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M!V&!7H?['OP73X9^#O[:UNV \5:O$K76[DVD758!Z'NV.IP.=HJE_P % _\
MDWYO^PO;?R>@#!_X)O?\DG\0_P#8=;_T1%7U'7RY_P $WO\ DD_B'_L.M_Z(
MBKZCH XOX\?\D/\ 'G_8MZA_Z325\8?\$Y_^2Y:I_P!B[/\ ^E%O7V?\>/\
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&)25%3T8*

end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>cchlogoq314a06.jpg
<TEXT>
begin 644 cchlogoq314a06.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  24DJ  @    $ !H!!0 !
M    /@   !L!!0 !    1@   "@! P !     @   #$! @ 0    3@
M  !@     0   &     !    4&%I;G0N3D54('8U+C P /_; $, !0,$! 0#
M!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3%!H5$1$8(1@:'1T?
M'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'O_  !$( %@
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M8G?MOCZ8SW7!^M._9!U[Q!JWPVO=-\23R7-YH6JS:8)Y'WLZHJG!;O@L1GT
MK.<8.#E3>G8J+DI6FOF>ST445SFX4444 %%%% !1110!1\0?\@#4?^O67_T
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M8C+*.$DP.Y P?<'UK7?PCX=\>_%=_%-[H]G<V/AT/8VTCQ*1=W>097;^\L6
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=44 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811273824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Apr. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DocumentandEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CCRN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CROSS COUNTRY HEALTHCARE INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001141103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,433,655<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DocumentandEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DocumentandEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811891056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 13,401<span></span>
</td>
<td class="nump">$ 20,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $3,473 in 2017 and $3,245 in 2016</a></td>
<td class="nump">161,765<span></span>
</td>
<td class="nump">173,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">5,727<span></span>
</td>
<td class="nump">6,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivableCurrent', window );">Insurance recovery receivable</a></td>
<td class="nump">3,386<span></span>
</td>
<td class="nump">3,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">1,857<span></span>
</td>
<td class="nump">2,198<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">186,136<span></span>
</td>
<td class="nump">205,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation of $44,178 in 2017 and $43,141 in 2016</a></td>
<td class="nump">12,779<span></span>
</td>
<td class="nump">12,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">79,648<span></span>
</td>
<td class="nump">79,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Trade names, indefinite-lived</a></td>
<td class="nump">35,402<span></span>
</td>
<td class="nump">35,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">35,762<span></span>
</td>
<td class="nump">36,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">18,668<span></span>
</td>
<td class="nump">18,064<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">368,395<span></span>
</td>
<td class="nump">388,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">46,606<span></span>
</td>
<td class="nump">58,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">28,745<span></span>
</td>
<td class="nump">33,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">4,546<span></span>
</td>
<td class="nump">5,012<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">79,897<span></span>
</td>
<td class="nump">97,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt and capital lease obligations, less current portion</a></td>
<td class="nump">36,169<span></span>
</td>
<td class="nump">84,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Non-current deferred tax liabilities</a></td>
<td class="nump">13,751<span></span>
</td>
<td class="nump">13,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Long-term accrued claims</a></td>
<td class="nump">29,512<span></span>
</td>
<td class="nump">28,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration</a></td>
<td class="nump">5,571<span></span>
</td>
<td class="nump">5,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">7,601<span></span>
</td>
<td class="nump">7,399<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">172,501<span></span>
</td>
<td class="nump">236,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">303,115<span></span>
</td>
<td class="nump">256,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,207)<span></span>
</td>
<td class="num">(1,241)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(106,634)<span></span>
</td>
<td class="num">(104,089)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Cross Country Healthcare, Inc. stockholders' equity</a></td>
<td class="nump">195,278<span></span>
</td>
<td class="nump">151,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">559<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">195,894<span></span>
</td>
<td class="nump">151,802<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 368,395<span></span>
</td>
<td class="nump">$ 388,378<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31958-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.   For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65670824&amp;loc=d3e14764-158437<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=65670824&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and capital lease obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4590271-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4568740-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798171568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for doubtful accounts</a></td>
<td class="nump">$ 3,473<span></span>
</td>
<td class="nump">$ 3,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">$ 44,178<span></span>
</td>
<td class="nump">$ 43,141<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811809504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueServicesNet', window );">Revenue from services</a></td>
<td class="nump">$ 207,573<span></span>
</td>
<td class="nump">$ 196,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfServices', window );">Cost of services</a></td>
<td class="nump">154,298<span></span>
</td>
<td class="nump">145,537<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">53,275<span></span>
</td>
<td class="nump">51,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">47,236<span></span>
</td>
<td class="nump">42,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,191<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">270<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">50,020<span></span>
</td>
<td class="nump">45,881<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">3,255<span></span>
</td>
<td class="nump">5,165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expenses (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1,219<span></span>
</td>
<td class="nump">1,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain on derivative liability</a></td>
<td class="num">(1,581)<span></span>
</td>
<td class="num">(16,436)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">4,969<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">(Loss) income before income taxes</a></td>
<td class="num">(1,352)<span></span>
</td>
<td class="nump">19,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">366<span></span>
</td>
<td class="nump">797<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Consolidated net (loss) income</a></td>
<td class="num">(1,718)<span></span>
</td>
<td class="nump">19,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interest in subsidiary</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income attributable to common shareholders</a></td>
<td class="num">$ (2,010)<span></span>
</td>
<td class="nump">$ 19,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Net (loss) income per share attributable to common shareholders - Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net (loss) income per share attributable to common shareholders - Basic (in dollars per share)</a></td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="nump">$ 0.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Net (loss) income per share attributable to common shareholders - Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net (loss) income per share attributable to common shareholders - Diluted (in dollars per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (shares)</a></td>
<td class="nump">32,872<span></span>
</td>
<td class="nump">31,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (shares)</a></td>
<td class="nump">36,480<span></span>
</td>
<td class="nump">36,180<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationContingentConsiderationArrangementsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to services rendered by an entity during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5618551-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a),(c),(d),(e)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueServicesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueServicesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6805432096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Consolidated net (loss) income</a></td>
<td class="num">$ (1,718)<span></span>
</td>
<td class="nump">$ 19,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss), before income tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Unrealized foreign currency translation gain (loss)</a></td>
<td class="nump">34<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">34<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive (loss) income</a></td>
<td class="num">(1,684)<span></span>
</td>
<td class="nump">19,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interest in subsidiary</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income attributable to common shareholders</a></td>
<td class="num">$ (1,976)<span></span>
</td>
<td class="nump">$ 19,015<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831223<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004921&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812474112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Consolidated net (loss) income</a></td>
<td class="num">$ (1,718)<span></span>
</td>
<td class="nump">$ 19,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,191<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances', window );">Provision for allowances</a></td>
<td class="nump">1,038<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax expense</a></td>
<td class="nump">597<span></span>
</td>
<td class="nump">471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain on derivative liability</a></td>
<td class="num">(1,581)<span></span>
</td>
<td class="num">(16,436)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">270<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">4,969<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity compensation</a></td>
<td class="nump">737<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Other non-cash costs</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">10,817<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(264)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(16,087)<span></span>
</td>
<td class="num">(6,068)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">76<span></span>
</td>
<td class="num">(1,599)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,410<span></span>
</td>
<td class="nump">2,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_WorkingCapitalAdjustmentInvestingActivities', window );">Acquisition-related settlements - Mediscan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,090)<span></span>
</td>
<td class="num">(982)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,090)<span></span>
</td>
<td class="num">(705)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of debt</a></td>
<td class="num">(6,005)<span></span>
</td>
<td class="num">(59,227)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Borrowings on debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">57,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Extinguishment fees</a></td>
<td class="num">(578)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(403)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(7,583)<span></span>
</td>
<td class="num">(2,430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="nump">34<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Change in cash and cash equivalents</a></td>
<td class="num">(7,229)<span></span>
</td>
<td class="num">(577)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">20,630<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 13,401<span></span>
</td>
<td class="nump">$ 1,876<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for Doubtful Accounts and Other Allowances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ProvisionforDoubtfulAccountsandOtherAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_WorkingCapitalAdjustmentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working Capital Adjustment, Investing Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_WorkingCapitalAdjustmentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5618551-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a),(c),(d),(e)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for incremental, external costs directly pertaining to an early extinguishment of debt, including legal costs and prepayment penalties, and excluding interest and repayment of debt principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3095-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6802176240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND BASIS OF PRESENTATION</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ORGANIZATION AND BASIS OF PRESENTATION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). The condensed consolidated financial statements include all assets, liabilities, revenue, and expenses of InteliStaf of Oklahoma, LLC, which is controlled by the Company but not wholly-owned. The Company records the ownership interest of the noncontrolling shareholder as noncontrolling interest in subsidiary. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (U.S. GAAP) for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2016 included in the Company&#8217;s Annual Report on Form&#160;10-K as filed with the Securities and Exchange Commission. The </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> condensed consolidated balance sheet included herein was derived from the </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> audited consolidated balance sheet included in the Company&#8217;s Annual Report on Form&#160;10-K.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35735333&amp;loc=d3e288-107754<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798013568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions are used for, but not limited to: (1) the valuation of accounts receivable; (2) goodwill, trade names, and other intangible assets; (3) other long-lived assets; (4) share-based compensation; (5) accruals for health, workers&#8217; compensation and professional liability claims; (6) valuation of deferred tax assets; (7) purchase price allocation; (8) derivative liability; (9) legal contingencies; (10) contingent considerations; (11) income taxes; and (12) sales and other non-income tax liabilities. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. Actual results could differ from those estimates.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments</font><font style="font-family:inherit;font-size:10pt;">, which amends the guidance in ASC 230 on the classification of certain cash receipts and payments in the statement of cash flows. This update intended to reduce the diversity that has resulted from the lack of consistent principles on this topic by adding or clarifying guidance on eight cash flow issues, including: debt prepayment or debt extinguishment costs, contingent consideration payments made after a business combination, and separately identifiable cash flows and application of the predominance principle. ASU 2016-15 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. Early adoption was permitted. The Company elected to early adopt this standard in its first quarter of 2017, applying the guidance retrospectively with no material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation-Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. </font><font style="font-family:inherit;font-size:10pt;">The Company adopted this guidance in the first quarter of 2017. ASU 2016-09 eliminates the requirement to delay the recognition of excess tax benefits until they reduce current taxes payable. Required method of adoption is modified retrospective transition method. Upon adoption, previously unrecognized excess tax benefits of </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> had no impact on the Company's accumulated deficit balance as the related deferred tax assets were fully offset by a valuation allowance. ASU 2016-09 also requires excess tax benefits and deficiencies to be recognized prospectively in the provision for income taxes rather than additional paid-in capital. As a result of the adoption, the Company's provision for income taxes was not impacted due to its full valuation allowance. Additionally, as permitted by the ASU, the Company elected to account for forfeitures as they occur rather than estimate expected forfeitures using a modified retrospective transition method. As a result, the Company recorded a cumulative-effect adjustment of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> to accumulated deficit and lower share-based compensation expense of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> compared to the amount of expense that would have been recorded for its first quarter of 2017. Under ASU 2016-09, the threshold for awards to qualify for equity treatment permits withholding up to the maximum statutory tax rates in the applicable jurisdictions. Prior to the adoption of ASU 2016-09, the Company did not allow an award to be partially settled in cash in excess of the minimum statutory withholding requirements. Subsequent to the adoption of the standard, the Company will allow awards to be partially settled at the maximum applicable statutory rates. Finally, ASU 2016-09 requires excess tax benefits to be presented as a component of operating cash flows rather than financing cash flows. The Company elected to adopt this requirement prospectively and accordingly, prior periods have not been adjusted. Excess tax benefits were not material for all periods presented.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-06, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments</font><font style="font-family:inherit;font-size:10pt;">, to clarify the steps required to assess whether a call or put option meets the criteria for bifurcation as an embedded derivative. ASU 2016-06 is effective for interim and annual periods beginning after December 15, 2016, and requires a modified retrospective approach to adoption. The Company adopted this guidance in the first quarter of 2017. The adoption of this guidance had no impact on the Company's results of operations.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6802823344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ACQUISITIONS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">US Resources Healthcare</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 1, 2016, the Company completed the acquisition of a recruitment process outsourcing business, US Resources Healthcare, LLC (USR). This acquisition expands the Company's workforce solutions offerings to deliver financial and operating efficiencies through labor optimization services while enhancing the quality of care.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition was deemed immaterial and has been accounted for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">using the acquisition method of accounting. USR's results of operations are included in the consolidated statements of operations from December 1, 2016 and have been included in the Company's Nurse and Allied Staffing business segment. See Note 6 - Goodwill, Trade Names, and Other Intangible Assets and Note 9 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Mediscan</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 30, 2015, the Company completed the acquisition of all of the membership interests of New Mediscan II, LLC, Mediscan Diagnostic Services, LLC, and Mediscan Nursing Staffing, LLC (collectively Mediscan) for a purchase price of  </font><font style="font-family:inherit;font-size:10pt;">$29.9 million</font><font style="font-family:inherit;font-size:10pt;"> in cash (</font><font style="font-family:inherit;font-size:10pt;">$28.0 million</font><font style="font-family:inherit;font-size:10pt;"> plus working capital estimate) and </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;"> in shares (or </font><font style="font-family:inherit;font-size:10pt;">349,871</font><font style="font-family:inherit;font-size:10pt;"> shares) of the Company's Common Stock, subject to a net working capital adjustment. The shares of Common Stock issued in connection with the acquisition were subject to a lockup period, which ended April 30, 2016. In the first quarter of 2016, the net working capital adjustment was settled consistent with the receivable balance as of December 31, 2015. An amount of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> of the purchase price was held in escrow to cover any post-closing liabilities, which was released to the seller on May 3, 2017. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The agreement also specified that the sellers were eligible to receive additional purchase price consideration of </font><font style="font-family:inherit;font-size:10pt;">$7.0 million</font><font style="font-family:inherit;font-size:10pt;">, with </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> per year based on attainment of specific performance criteria in 2016 and 2017. As of December 31, 2016, the Company determined that the first year earnout was not achieved for 2016 and as a result, only </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> remains as a potential earnout for 2017. As of March 31, 2017, the fair value of the remaining obligation was estimated at </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Mediscan acquisition, the Company also assumed additional contingent purchase price liabilities for a previously acquired business that are payable annually based on specific performance criteria for the 2016 through 2019 years. Payments related to the 2016 through 2018 years are limited to </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> per year and 2019 is uncapped. During the three months ended March 31, 2017, the Company paid </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">. As of March 31, 2017, the fair value of the remaining obligations on an undiscounted basis was estimated at </font><font style="font-family:inherit;font-size:10pt;">$3.6 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of March 31, 2017, a total of </font><font style="font-family:inherit;font-size:10pt;">$4.4 million</font><font style="font-family:inherit;font-size:10pt;"> was estimated as the fair value of these contingent consideration payments and is included in other current liabilities and contingent consideration on the condensed consolidated balance sheets. See Note 9 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Medical Staffing Network</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 30, 2014, the Company acquired substantially all of the assets and certain liabilities of Medical Staffing Network Healthcare, LLC (MSN). Of the purchase price, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> was deferred and due to the seller </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">21 months</font><font style="font-family:inherit;font-size:10pt;"> from the acquisition date, less any COBRA expenses incurred by the Company on behalf of former MSN employees over that period.  The Company incurred </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> in COBRA expenses since the MSN acquisition and, on April 1, 2016, released to the seller the remaining liability of </font><font style="font-family:inherit;font-size:10pt;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1497-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1490-128463<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1486-128463<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1524-128463<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7000-128479<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4922-128472<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4934-128472<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4926-128472<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=SL65897772-128472<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1383-128463<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6996-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798013280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (LOSS)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">COMPREHENSIVE INCOME (LOSS)</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total comprehensive income (loss) includes net income or loss and foreign currency translation adjustments, net of any related deferred taxes. Certain of the Company&#8217;s foreign subsidiaries use their respective local currency as their functional currency. In accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Matters </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying condensed consolidated balance sheets and was approximately </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> at both </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There was no income tax impact related to foreign currency translation adjustments for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> month periods ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e640-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e716-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e709-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Reclassification Adjustments<br> -URI http://asc.fasb.org/extlink&amp;oid=6522872<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6802146976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EARNINGS PER SHARE</font></div><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,010</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,022</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Interest on Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,436</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net (loss) income attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,897</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,424</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,872</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,956</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Effective of diluted shares:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based awards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">703</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Convertible Notes </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,934</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,521</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.09</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the periods presented, no tax benefits have been assumed in the weighted average share calculation due to a full valuation allowance on the Company's deferred tax assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes were repaid in full on March 17, 2017. Applying the if-converted method, </font><font style="font-family:inherit;font-size:10pt;">2,934,271</font><font style="font-family:inherit;font-size:10pt;"> shares (the weighted average shares outstanding through March 17, 2017) were included in diluted weighted average shares for the three months ended March 31, 2017 because their effect was dilutive.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797998928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had the following acquired intangible assets:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets subject to amortization:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Databases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,609</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,655</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,954</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,609</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,147</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,724</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,793</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,931</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,724</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,316</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,408</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,537</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,527</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names, definite-lived</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,216</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">421</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,216</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">343</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,873</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,168</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,406</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,762</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,168</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,835</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets not subject to amortization:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,164</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72,237</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, estimated annual amortization expense is as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,175</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,799</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,522</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,762</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The March 31, 2017 and December 31, 2016 carrying amount of goodwill by segment is as follows:&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended March 31, 2017 and 2016, the Company noted no indicators at any of its reporting units that warranted impairment testing.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6802150464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DEBT</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, long-term debt consists of the following:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unamortized Discount and Debt Issuance Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unamortized Discount and Debt Issuance Costs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan, interest 2.78%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes, fixed rate interest of 8.00%</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,669</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Convertible Notes derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,518</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,032</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,010</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,263</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,508</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(339</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,792</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,032</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the aggregate scheduled maturities of debt are as follows: </font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Term Loan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capital Leases </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Through Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company and certain of its domestic subsidiaries entered into a Convertible Note Purchase Agreement (the Note Purchase Agreement), with certain note holders (collectively, the Noteholders) on June 30, 2014. Pursuant to the Note Purchase Agreement, the Company sold to the Noteholders an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> of convertible senior notes (the Convertible Notes). On March 17, 2017, the Company repaid in full the Convertible Notes. In connection with the repayment, the Company issued to the Noteholders an aggregate of </font><font style="font-family:inherit;font-size:10pt;">3,175,584</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock, par value </font><font style="font-family:inherit;font-size:10pt;">$0.0001</font><font style="font-family:inherit;font-size:10pt;">, and cash in the aggregate amount of </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;"> (of which </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> is included in repayment of debt and </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> is presented as extinguishment fees, both within financing activities on the condensed consolidated statements of cash flows).&#160;Upon derecognition of the net carrying amounts of the Convertible Notes (the remaining </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;"> after the </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> cash payment) and derivative liability (</font><font style="font-family:inherit;font-size:10pt;">$26.0 million</font><font style="font-family:inherit;font-size:10pt;">), the Company recognized a non-cash charge of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> as loss on early extinguishment and a non-cash addition to additional paid-in capital of </font><font style="font-family:inherit;font-size:10pt;">$46.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the fair value of the shares, which is not presented on the condensed consolidated statements of cash flows. The loss on early extinguishment of debt includes the write-off of unamortized loan fees and remaining interest due through the Forced Conversion date (defined below) of June 30, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes were convertible at the option of the holders thereof at any time into shares of the Company&#8217;s common stock, par value </font><font style="font-family:inherit;font-size:10pt;">$0.0001</font><font style="font-family:inherit;font-size:10pt;"> per share (Common Stock), at a conversion price of </font><font style="font-family:inherit;font-size:10pt;">$7.10</font><font style="font-family:inherit;font-size:10pt;"> per share, or </font><font style="font-family:inherit;font-size:10pt;">3,521,126</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock.  After </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;"> from the issuance date, the Company had the right to force a conversion of the Convertible Notes if the volume-weighted average price (VWAP) per share of its Common Stock exceeded </font><font style="font-family:inherit;font-size:10pt;">125%</font><font style="font-family:inherit;font-size:10pt;"> of the then conversion price for </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> days of a </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> day trading period (Forced Conversion date).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes bore interest at a rate of </font><font style="font-family:inherit;font-size:10pt;">8.00%</font><font style="font-family:inherit;font-size:10pt;"> per annum, payable in quarterly cash installments. The Convertible Notes would have matured on June 30, 2020, unless earlier repurchased, redeemed or converted. Subject to certain exceptions, the Company was not permitted to redeem the Convertible Notes until June 30, 2017. If the Company redeemed the Convertible Notes on or after June 30, 2017, the Company was required to pay a premium of </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> of the amount of principal of the Convertible Notes redeemed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2016 Senior Credit Facilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a senior credit agreement (Credit Agreement), entered into on June 22, 2016, which provides a term loan of </font><font style="font-family:inherit;font-size:10pt;">$40.0 million</font><font style="font-family:inherit;font-size:10pt;"> (Term Loan) and a revolving credit facility of up to </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;"> (Revolving Credit Facility) (together with the Term Loan, the Senior Credit Facilities) both of which mature on June 22, 2021. The Revolving Credit Facility includes a subfacility for swingline loans up to an amount not to exceed </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;">, and a </font><font style="font-family:inherit;font-size:10pt;">$35.0 million</font><font style="font-family:inherit;font-size:10pt;"> sublimit for the issuance of standby letters of credit.&#160; The Credit Agreement also includes a provision permitting the Company, subject to certain conditions, to increase the aggregate amount of the commitments under the Revolving Credit Facility or establish one or more additional term loans in an aggregate amount of up to </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;"> with optional additional commitments from existing lenders or new commitments from additional lenders. The Term Loan is payable in quarterly installments, with the first payment made September 30, 2016, and each such installment being in the aggregate principal amount (subject to adjustment as a result of prepayments) equal to </font><font style="font-family:inherit;font-size:10pt;">1.25%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount for the first four installments, </font><font style="font-family:inherit;font-size:10pt;">1.875%</font><font style="font-family:inherit;font-size:10pt;"> for the next eight installments and </font><font style="font-family:inherit;font-size:10pt;">2.50%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount for the remaining installments. The Revolving Credit Facility can be used to provide ongoing working capital, fund permitted acquisitions and for other general corporate purposes of the Company and its subsidiaries.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to the Credit Agreement, the Company pays interest on (i) each Base Rate Loan at the Base Rate (as defined therein) plus the Applicable Margin in effect from time to time, (ii) each LIBOR Index Rate Loan at the One Month LIBOR Index Rate (as defined therein) plus the Applicable Margin in effect from time to time and (iii) each Eurodollar Loan at the Adjusted LIBOR for the applicable Interest Period (as defined therein) in effect for such Loan plus the Applicable Margin in effect from time to time.  The Applicable Margin, as of any date, is a percentage per annum determined by reference to the applicable Consolidated Net Leverage Ratio (as defined by the agreement) in effect on such date as set forth in the table below.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Level</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Consolidated Net Leverage Ratio</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Eurodollar Loans, LIBOR Index Rate Loans and Letter of Credit Fee</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Base Rate Loans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Commitment Fee</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">I</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Less than 1.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.25%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">II</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 1.50:1.00 <br clear="none"/>but less than 2.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">III</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 2.00:1.00<br clear="none"/> but less than 2.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">IV</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 2.50:1.00<br clear="none"/> but less than 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.35%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">V</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.40%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Term Loan and Revolving Credit Facility bore interest at a rate equal to </font><font style="font-family:inherit;font-size:10pt;">One Month LIBOR</font><font style="font-family:inherit;font-size:10pt;"> plus </font><font style="font-family:inherit;font-size:10pt;">200</font><font style="font-family:inherit;font-size:10pt;"> basis points. The interest rate is subject to an increase of </font><font style="font-family:inherit;font-size:10pt;">200</font><font style="font-family:inherit;font-size:10pt;"> basis points if an event of default exists under the Credit Agreement.  The Company is required to pay a commitment fee on the average daily unused portion of the Revolving Credit Facility, based on the Applicable Margin which was </font><font style="font-family:inherit;font-size:10pt;">0.30%</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has the right at any time and from time to time to prepay any borrowing, in whole or in part, without premium or penalty, by giving irrevocable written notice (or telephonic notice promptly confirmed in writing) except that such notice shall be revocable if a prepayment is being made in anticipation of concluding a financing arrangement, and the Company is ultimately unable to secure such financing arrangement.  The Company is required to prepay the Senior Credit Facilities under certain circumstances including from net cash proceeds from asset sales or dispositions in excess of certain thresholds, as well as from net cash proceeds from the issuance of certain debt by the Company.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement contains customary representations, warranties, and affirmative covenants. The Credit Agreement also contains customary negative covenants, subject to some exceptions, on (i)&#160;indebtedness and preferred equity, (ii)&#160;liens, (iii)&#160;fundamental changes, (iv)&#160;investments, (v)&#160;restricted payments, and (vi) sale of assets and certain other restrictive agreements. The Credit Agreement also contains customary events of default, such as payment defaults, cross-defaults to other material indebtedness, bankruptcy and insolvency, the occurrence of a defined change in control and the failure to observe the negative covenants and other covenants related to the operation of the Company&#8217;s business.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement also includes </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> financial covenants: (i) limiting a maximum Consolidated Total Leverage ratio (as defined therein) to be no greater than </font><font style="font-family:inherit;font-size:10pt;">3.50</font><font style="font-family:inherit;font-size:10pt;">:1.00 for the fiscal quarters ending September 30, 2016 through June 30, 2017, </font><font style="font-family:inherit;font-size:10pt;">3.25</font><font style="font-family:inherit;font-size:10pt;">:1.00 for the fiscal quarters ending September 30, 2017 through June 30, 2018, and </font><font style="font-family:inherit;font-size:10pt;">3.00</font><font style="font-family:inherit;font-size:10pt;">:1.00 for each fiscal quarter ending thereafter and as adjusted pursuant to a Qualified Permitted Acquisition (as defined therein); and (ii) requiring a minimum Consolidated Fixed Charge Coverage ratio (as defined therein) as of the end of each fiscal quarter of </font><font style="font-family:inherit;font-size:10pt;">1.50</font><font style="font-family:inherit;font-size:10pt;">:1.00. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company was in compliance with the financial covenants and other covenants contained in the Credit Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The obligations under the Credit Agreement are guaranteed by all of the Company&#8217;s domestic wholly-owned subsidiaries. The obligations under the Credit Agreement are secured by a first-priority security interest in the Collateral (as defined therein).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$22.1 million</font><font style="font-family:inherit;font-size:10pt;"> letters of credit outstanding and </font><font style="font-family:inherit;font-size:10pt;">$77.9 million</font><font style="font-family:inherit;font-size:10pt;"> available under the Revolving Credit Facility. The letters of credit relate to the Company&#8217;s workers&#8217; compensation and professional liability insurance policies.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6802181200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE NOTES DERIVATIVE LIABILITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">CONVERTIBLE NOTES DERIVATIVE LIABILITY</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONVERTIBLE NOTES DERIVATIVE LIABILITY</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, wrote off the derivative liability. See Note 7 - Debt. The Company does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company issued Convertible Notes with features that were either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting for Derivative Financial Instruments and Hedging Activities </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC, in certain instances, these instruments were required to be carried as derivative liabilities, at fair value, in the financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes were subject to anti-dilution adjustments that allowed for the reduction in the Conversion Price, as defined in the agreement, in the event the Company subsequently issued equity securities including Common Stock or any security convertible or exchangeable for shares of Common Stock for a price less than the then current conversion price. In addition, the Convertible Notes allowed the issuer to exercise optional redemption features and the holder to exercise an offer to purchase feature, under certain conditions. The Company accounted for the conversion option in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting for Derivative Financial Instruments and Hedging Activities </font><font style="font-family:inherit;font-size:10pt;">Topic. Since this conversion feature is not considered to be solely indexed to the Company&#8217;s own stock the derivative was recorded as a liability in the line item long-term debt on the Company's condensed consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s Convertible Notes derivative liability was measured at fair value using a trinomial lattice model. The optional redemption features, along with the offer to purchase features were incorporated into the valuation model. Inputs into the model required estimates, including such items as estimated volatility of the Company's stock, estimated credit risk of the Company, estimated probabilities of change of control and issuance of additional financing, risk-free interest rate, and the estimated life of the financial instruments being fair valued. In addition, since the conversion price contained an anti-dilution adjustment, the probability that the Conversion Price of the Notes would decrease as the share price decreased was incorporated into the valuation calculation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the derivative liability was primarily determined by fluctuations in our stock price. In addition, changes in our credit risk profile impacted the fair value determination. These fluctuations resulted in a current period gain or loss that was presented on the condensed consolidated statements of operations as (gain) loss on derivative liability.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797886896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FAIR VALUE MEASUREMENTS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures</font><font style="font-family:inherit;font-size:10pt;"> Topic also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 1</font><font style="font-family:inherit;font-size:10pt;">&#8212;Quoted prices in active markets for identical assets or liabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 2</font><font style="font-family:inherit;font-size:10pt;">&#8212;Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 3</font><font style="font-family:inherit;font-size:10pt;">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Items Measured at Fair Value on a Recurring Basis:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s financial assets/liabilities required to be measured on a recurring basis were its: deferred compensation liability included in other long-term liabilities, Convertible Notes derivative liability included in long-term debt and capital lease obligations, and contingent consideration liabilities included in other current liabilities and contingent consideration on the condensed consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred compensation</font><font style="font-family:inherit;font-size:10pt;">&#8212;The Company utilizes Level 1 inputs to value its deferred compensation liability. The Company&#8217;s deferred compensation liability is measured using publicly available indices that define the liability amounts, as per the plan documents.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes derivative liability</font><font style="font-family:inherit;font-size:10pt;">&#8212;The Company utilized Level 3 inputs to value its Convertible Notes derivative liability.  See Note 7 - Debt and Note 8 - Convertible Notes derivative liability.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent consideration liabilities</font><font style="font-family:inherit;font-size:10pt;">&#8212;Potential earnout payments related to the acquisition of Mediscan and USR are contingent upon meeting certain performance requirements through 2019. See Note 3 - Acquisitions. The long-term portion of these liabilities is included in contingent consideration, and the short-term portion is included in other current liabilities on the condensed consolidated balance sheets. The Company utilized Level 3 inputs to value these contingent consideration liabilities as significant unobservable inputs were used in the calculation of their fair value. The Mediscan contingent consideration is recorded as a liability and measured at fair value using a discounted cash flow model in a Monte Carlo simulation setting, utilizing significant unobservable inputs, including the expected volatility of the acquisitions' gross profits and an estimated discount rate commensurate with the risks of the expected gross profit stream. The USR contingent consideration is recorded as a liability and measured at fair value using a discounted cash flow model utilizing significant unobservable inputs, including the probability of achieving each of the potential milestones and an estimated discount rate commensurate with the risks of the expected cash flows attributable to the milestones.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of contingent consideration and the associated liabilities will be adjusted to fair value at each reporting date until actual settlement occurs, with the changes in fair value and related accretion reflected as acquisition-related contingent consideration on the condensed consolidated statements of operations. Significant increases (decreases) in the volatility or in any of the probabilities of success, or decreases (increases) in the discount rate would result in a significantly higher (lower) fair value, respectively, and commensurate changes to these liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table which follows summarizes the estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Financial Liabilities:</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Deferred compensation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,213</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Convertible Notes derivative liability</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,773</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,603</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table which follows reconciles the opening balances to the closing balances for fair value measurements categorized within Level 3 of the fair value hierarchy:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingent Consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Convertible Notes</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities (a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative Liability</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,951</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation gain for the period</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,773</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Related to the Mediscan acquisition on October 30, 2015 and the USR acquisition on December 1, 2016. See Note 3 - Acquisitions. Valuation gain and accretion expense is included as acquisition-related contingent consideration on the condensed consolidated statements of operations.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Items Measured at Fair Value on a Non-Recurring Basis:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's non-financial assets, such as goodwill, trade names, other intangible assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. During the three months ended March 31, 2017 and December 31, 2016, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> impairment charges were deemed necessary.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Fair Value Disclosures:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments not measured or recorded at fair value in the accompanying condensed consolidated balance sheets consist of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and short and long-term debt. The estimated fair value of accounts receivable, accounts payable and&#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. The estimated fair value of the Company's debt was calculated using a discounted cash flow analysis and appropriate valuation methodologies using Level 2 inputs from available market information.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March&#160;31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair<br clear="none"/>Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair<br clear="none"/>Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Financial Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">(amounts in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 2)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Term Loan, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,161</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,137</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,331</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,250</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Risk:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has invested its excess cash in highly-rated overnight funds and other highly-rated liquid accounts. The Company has been exposed to credit risk associated with these investments. The Company minimizes its credit risk relating to these positions by monitoring the financial condition of the financial institutions involved and by primarily conducting business with large, well established financial institutions and diversifying its counterparties.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts represents the Company&#8217;s estimate of uncollectible receivables based on a review of specific accounts and the Company&#8217;s historical collection experience. The Company writes off specific&#160;accounts based on an ongoing review of collectability as well as past experience with the customer. The Company&#8217;s contract terms typically require payment between </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;"> days from the date services are provided and are considered past due based on the particular negotiated contract terms. Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13504-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797982592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">STOCKHOLDERS&#8217; EQUITY</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Repurchase Program</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the Company did not repurchase any shares of its Common Stock under its February 2008 Board authorization. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company may purchase up to an additional </font><font style="font-family:inherit;font-size:10pt;">942,443</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock under the February 2008 Board authorization, subject to certain conditions in the Company's Credit Agreement.  The Company may repurchase up to an aggregate amount not to exceed </font><font style="font-family:inherit;font-size:10pt;">$2.5</font><font style="font-family:inherit;font-size:10pt;"> million in any fiscal year, or an unlimited amount if the Company meets certain conditions as described in its Credit Agreement. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">35,596,380</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock outstanding.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Share-Based Payments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended </font><font style="font-family:inherit;font-size:10pt;text-transform:default;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">244,205</font><font style="font-family:inherit;font-size:10pt;"> of restricted stock awards and </font><font style="font-family:inherit;font-size:10pt;">181,067</font><font style="font-family:inherit;font-size:10pt;"> of performance stock awards were granted under the 2014 Omnibus Incentive Plan (2014 Plan) to the Company's management team. Pursuant to the 2014 Plan, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets.&#160;If the minimum level of performance is attained for the 2017 awards, restricted stock will be issued with a vesting date of March 31, 2020, subject to the employee&#8217;s continuing employment.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2017, the Company's Compensation Committee of the Board of Directors approved a </font><font style="font-family:inherit;font-size:10pt;">48%</font><font style="font-family:inherit;font-size:10pt;"> level of attainment for the 2016 performance-based share awards, resulting in the issuance of </font><font style="font-family:inherit;font-size:10pt;">86,784</font><font style="font-family:inherit;font-size:10pt;"> performance shares that will vest on December 31, 2018.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2014 Plan for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Performance Stock Awards</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Grant Date<br clear="none"/>Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Target <br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Grant Date<br clear="none"/>Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, January&#160;1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">532,294</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332,092</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.73</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244,205</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181,067</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.36</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(122,061</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,838</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.39</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(112,434</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.65</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628,600</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">400,725</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> was included in selling, general and administrative expenses related to share-based payments, and a net of </font><font style="font-family:inherit;font-size:10pt;">74,878</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock were issued upon the vesting of restricted stock.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> was included in selling, general and administrative expenses related to share-based payments, and a net of </font><font style="font-family:inherit;font-size:10pt;">51,091</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock were issued upon the vesting of restricted stock.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6802207936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT DATA<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT DATA</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SEGMENT DATA</font></div><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC, the Company reports </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> business segments &#8211; Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Company manages and segments its business based on the services it offers to its customers as described below:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Nurse and Allied Staffing </font><font style="font-family:inherit;font-size:10pt;">&#8211; Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added workforce solutions including: temporary and permanent placement of travel and local branch-based nurse and allied professionals, MSP services, education healthcare services, and outsourcing services. Its clients include: public and private acute-care and non-acute care hospitals, government facilities, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and many other healthcare providers throughout the U.S. The results of the Mediscan and USR acquisitions have been aggregated with the Company's Nurse and Allied Staffing business segment. See Note 3 - Acquisitions.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Physician Staffing</font><font style="font-family:inherit;font-size:10pt;"> &#8211; Physician Staffing provides physicians in many specialties, certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) as independent contractors on temporary assignments throughout the U.S. at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Human Capital Management Services</font><font style="font-family:inherit;font-size:10pt;"> &#8211; Other Human Capital Management Services includes retained and contingent search services for physicians, healthcare executives and other healthcare professionals within the U.S.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s management evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income or loss from operations before depreciation, amortization, loss on sale of business, acquisition and integration costs, acquisition-related contingent consideration, restructuring costs, impairment charges, and corporate expenses not specifically identified to a reporting segment. Contribution income is a financial measure used by management when assessing segment performance and is provided in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC. The Company&#8217;s management does not evaluate, manage or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&#8217; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information on operating segments and a</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">reconciliation to income (loss) from operations for the periods indicated are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183,108</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168,765</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,464</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,001</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,365</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207,573</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,583</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,622</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,790</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(440</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(111</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,002</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate overhead</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,286</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,191</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,412</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,255</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8981-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9038-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 33<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8971-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8595-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8380-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 35<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8984-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9031-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8538-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8864-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797982592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">COMMITMENTS AND CONTINGENCIES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingencies:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Legal Proceedings</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to legal proceedings and claims that arise in the ordinary course of its business. The Company does not believe the outcome of these matters will have a material adverse effect on the Company's business, financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sales and Other State Non-Income Tax Liabilities </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company's business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions.&#160;The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised. The expense is included in selling, general and administrative expenses on its condensed consolidated statements of operations and the liability is reflected in other current liabilities as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, on its condensed consolidated balance sheets.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800064800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the periods ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the Company has calculated its effective tax rate based on year-to-date results as opposed to estimating its annual effective tax rate.&#160;The Company&#8217;s effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">(27.1)%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">4.0%</font><font style="font-family:inherit;font-size:10pt;">, respectively, including the impact of discrete items. Excluding discrete items, the Company&#8217;s effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">(53.8)%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">3.9%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The effective tax rates are different than the statutory rates primarily due to the impact from amortization of indefinite-lived intangible assets for tax purposes, the partial non-deductibility of certain per diem expenses, and international and state taxes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company records valuation allowances to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The assessment of whether or not a valuation allowance is required often requires significant judgment, including the long-range forecast of future taxable income and the evaluation of tax planning initiatives. Adjustments to the deferred tax valuation allowances are made to earnings in the period when such assessments are made. The Company believes it is necessary to see further positive evidence, such as sustained achievement of cumulative profits, before these valuation allowances can be released. If such positive evidence develops, the Company may release all or a portion of the remaining valuation allowances, but at this point in time cannot determine in which period they would reverse. The Company will continue to assess the realizability of its deferred tax assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had approximately </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> of unrecognized tax benefits included in other current liabilities and other long-term liabilities (</font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;">, net of deferred taxes, which would affect the effective tax rate if recognized). During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had gross increases of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> to its current year unrecognized tax benefits related to federal and state tax issues.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax years of </font><font style="font-family:inherit;font-size:10pt;">2004, 2005, 2008, and 2010 through 2016</font><font style="font-family:inherit;font-size:10pt;"> remain open to examination by certain taxing jurisdictions to which the Company is subject to tax, other than certain states in which the statute of limitations has been extended.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797980768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RELATED PARTY TRANSACTIONS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company provides services to hospitals which are affiliated with certain members of the Company&#8217;s Board of Directors. Management believes services with related parties were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. Accounts receivable due from these hospitals at </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> were approximately </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the acquisition of MSN, the Company acquired a </font><font style="font-family:inherit;font-size:10pt;">68%</font><font style="font-family:inherit;font-size:10pt;"> ownership interest in InteliStaf of Oklahoma, LLC, a joint venture between the Company and a hospital system.&#160;The Company generated revenue providing staffing services to the hospital system of </font><font style="font-family:inherit;font-size:10pt;">$4.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had a receivable balance of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and a payable balance of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subsequent to the Company's acquisition of Mediscan on October 30, 2015, Mediscan continued to operate at premises owned, in part, by the founding members of Mediscan. The Company paid </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> in rent expense for these premises for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800064800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING PRONOUNCEMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, </font><font style="font-family:inherit;font-size:10pt;">to simplify how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under this guidance, an entity would perform its annual, or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity would consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019 and is to be applied prospectively. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company expects to early adopt this standard in 2017 in the first quarter in which an impairment test is performed, and does not expect this guidance to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations (Topic 805): Clarifying the Definition of a Business</font><font style="font-family:inherit;font-size:10pt;">, which clarifies the definition of a business, with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This update provides a framework to assist entities in evaluating whether both an input and a substantive process are present, and narrows the definition of the term output so that the term is consistent with how outputs are described in the new revenue recognition standard. ASU 2017-01 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. Early adoption is permitted depending upon the date of the transaction. Entities should apply the guidance prospectively on or after the effective date. No disclosures are required at transition. The Company expects to adopt this standard in its first quarter of 2018, and does not expect this guidance to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;">, which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Full retrospective application is prohibited. The Company expects the valuation of right of use assets and lease liabilities, previously described as operating leases, to be the present value of our forecasted future lease commitments. The Company is continuing to assess the overall impacts of the new standard, including the discount rate to be applied in these valuations. See Note 12 - Commitments and Contingencies to the audited consolidated financial statements included in the Company's Annual Report on Form 10-K.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB and the International Accounting Standards Board jointly issued ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Topic 606)</font><font style="font-family:inherit;font-size:10pt;">, that introduces a new five-step revenue recognition model in which an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires disclosures sufficient to enable users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers, including qualitative and quantitative disclosures about contracts with customers, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. In March 2016, the FASB issued ASU 2016-08 which further clarifies the guidance on the principal versus agent considerations within ASU 2014-09. In April 2016, the FASB issued ASU 2016-10 to expand the guidance on identifying performance obligations and licensing within ASU 2014-09. In May 2016, the FASB issued ASU 2016-12 to improve revenue recognition in the areas of collectability, presentation of sales tax and other similar taxes collected from customers, non-cash consideration, contract modifications and completed contracts at transition. This update also amends the disclosure requirements within ASU 2014-09 for entities that retrospectively apply the guidance. The latest amendments are intended to address implementation issues that were raised by stakeholders and discussed by the Revenue Recognition Transition Resource Group, and provide additional practical expedients. These updates are effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period. The Company established a cross-functional implementation team consisting of representatives from across all of its business segments. Management is in the process of reviewing its contract portfolio and its existing accounting policies and practices to identify potential differences that would result from applying the requirements of the new standard to its contracts. Management expects this assessment will continue throughout the first half of 2017. Once this phase has been completed, if applicable,</font><font style="font-family:inherit;font-size:10pt;color:#1f497d;"> </font><font style="font-family:inherit;font-size:10pt;">management intends to implement appropriate changes to its business processes, systems and controls to support the recognition and disclosure under the new standard. The Company is continuing to assess which transition method it will use to adopt this accounting standard and expects a full assessment by the fourth quarter of 2017.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Change in Accounting Principle<br> -URI http://asc.fasb.org/extlink&amp;oid=6507316<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Direct Effects of a Change in Accounting Principle<br> -URI http://asc.fasb.org/extlink&amp;oid=66092750<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64853466&amp;loc=d3e22583-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Indirect Effects of a Change in Accounting Principle<br> -URI http://asc.fasb.org/extlink&amp;oid=6515603<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64853466&amp;loc=d3e22580-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.10-01.(b)(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=27015980&amp;loc=d3e46468-122699<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Accounting Change<br> -URI http://asc.fasb.org/extlink&amp;oid=6503790<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64853466&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Retrospective Application<br> -URI http://asc.fasb.org/extlink&amp;oid=6523989<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=68064558&amp;loc=d3e765-108305<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=68064558&amp;loc=d3e725-108305<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6797914960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (U.S. GAAP) for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2016 included in the Company&#8217;s Annual Report on Form&#160;10-K as filed with the Securities and Exchange Commission. The </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> condensed consolidated balance sheet included herein was derived from the </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> audited consolidated balance sheet included in the Company&#8217;s Annual Report on Form&#160;10-K.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions are used for, but not limited to: (1) the valuation of accounts receivable; (2) goodwill, trade names, and other intangible assets; (3) other long-lived assets; (4) share-based compensation; (5) accruals for health, workers&#8217; compensation and professional liability claims; (6) valuation of deferred tax assets; (7) purchase price allocation; (8) derivative liability; (9) legal contingencies; (10) contingent considerations; (11) income taxes; and (12) sales and other non-income tax liabilities. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. Actual results could differ from those estimates.  </font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncement</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments</font><font style="font-family:inherit;font-size:10pt;">, which amends the guidance in ASC 230 on the classification of certain cash receipts and payments in the statement of cash flows. This update intended to reduce the diversity that has resulted from the lack of consistent principles on this topic by adding or clarifying guidance on eight cash flow issues, including: debt prepayment or debt extinguishment costs, contingent consideration payments made after a business combination, and separately identifiable cash flows and application of the predominance principle. ASU 2016-15 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. Early adoption was permitted. The Company elected to early adopt this standard in its first quarter of 2017, applying the guidance retrospectively with no material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation-Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. </font><font style="font-family:inherit;font-size:10pt;">The Company adopted this guidance in the first quarter of 2017. ASU 2016-09 eliminates the requirement to delay the recognition of excess tax benefits until they reduce current taxes payable. Required method of adoption is modified retrospective transition method. Upon adoption, previously unrecognized excess tax benefits of </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> had no impact on the Company's accumulated deficit balance as the related deferred tax assets were fully offset by a valuation allowance. ASU 2016-09 also requires excess tax benefits and deficiencies to be recognized prospectively in the provision for income taxes rather than additional paid-in capital. As a result of the adoption, the Company's provision for income taxes was not impacted due to its full valuation allowance. Additionally, as permitted by the ASU, the Company elected to account for forfeitures as they occur rather than estimate expected forfeitures using a modified retrospective transition method. As a result, the Company recorded a cumulative-effect adjustment of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> to accumulated deficit and lower share-based compensation expense of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> compared to the amount of expense that would have been recorded for its first quarter of 2017. Under ASU 2016-09, the threshold for awards to qualify for equity treatment permits withholding up to the maximum statutory tax rates in the applicable jurisdictions. Prior to the adoption of ASU 2016-09, the Company did not allow an award to be partially settled in cash in excess of the minimum statutory withholding requirements. Subsequent to the adoption of the standard, the Company will allow awards to be partially settled at the maximum applicable statutory rates. Finally, ASU 2016-09 requires excess tax benefits to be presented as a component of operating cash flows rather than financing cash flows. The Company elected to adopt this requirement prospectively and accordingly, prior periods have not been adjusted. Excess tax benefits were not material for all periods presented.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-06, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments</font><font style="font-family:inherit;font-size:10pt;">, to clarify the steps required to assess whether a call or put option meets the criteria for bifurcation as an embedded derivative. ASU 2016-06 is effective for interim and annual periods beginning after December 15, 2016, and requires a modified retrospective approach to adoption. The Company adopted this guidance in the first quarter of 2017. The adoption of this guidance had no impact on the Company's results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, </font><font style="font-family:inherit;font-size:10pt;">to simplify how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under this guidance, an entity would perform its annual, or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity would consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019 and is to be applied prospectively. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company expects to early adopt this standard in 2017 in the first quarter in which an impairment test is performed, and does not expect this guidance to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations (Topic 805): Clarifying the Definition of a Business</font><font style="font-family:inherit;font-size:10pt;">, which clarifies the definition of a business, with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This update provides a framework to assist entities in evaluating whether both an input and a substantive process are present, and narrows the definition of the term output so that the term is consistent with how outputs are described in the new revenue recognition standard. ASU 2017-01 is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods. Early adoption is permitted depending upon the date of the transaction. Entities should apply the guidance prospectively on or after the effective date. No disclosures are required at transition. The Company expects to adopt this standard in its first quarter of 2018, and does not expect this guidance to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;">, which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Full retrospective application is prohibited. The Company expects the valuation of right of use assets and lease liabilities, previously described as operating leases, to be the present value of our forecasted future lease commitments. The Company is continuing to assess the overall impacts of the new standard, including the discount rate to be applied in these valuations. See Note 12 - Commitments and Contingencies to the audited consolidated financial statements included in the Company's Annual Report on Form 10-K.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB and the International Accounting Standards Board jointly issued ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">(Topic 606)</font><font style="font-family:inherit;font-size:10pt;">, that introduces a new five-step revenue recognition model in which an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires disclosures sufficient to enable users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers, including qualitative and quantitative disclosures about contracts with customers, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. In March 2016, the FASB issued ASU 2016-08 which further clarifies the guidance on the principal versus agent considerations within ASU 2014-09. In April 2016, the FASB issued ASU 2016-10 to expand the guidance on identifying performance obligations and licensing within ASU 2014-09. In May 2016, the FASB issued ASU 2016-12 to improve revenue recognition in the areas of collectability, presentation of sales tax and other similar taxes collected from customers, non-cash consideration, contract modifications and completed contracts at transition. This update also amends the disclosure requirements within ASU 2014-09 for entities that retrospectively apply the guidance. The latest amendments are intended to address implementation issues that were raised by stakeholders and discussed by the Revenue Recognition Transition Resource Group, and provide additional practical expedients. These updates are effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period. The Company established a cross-functional implementation team consisting of representatives from across all of its business segments. Management is in the process of reviewing its contract portfolio and its existing accounting policies and practices to identify potential differences that would result from applying the requirements of the new standard to its contracts. Management expects this assessment will continue throughout the first half of 2017. Once this phase has been completed, if applicable,</font><font style="font-family:inherit;font-size:10pt;color:#1f497d;"> </font><font style="font-family:inherit;font-size:10pt;">management intends to implement appropriate changes to its business processes, systems and controls to support the recognition and disclosure under the new standard. The Company is continuing to assess which transition method it will use to adopt this accounting standard and expects a full assessment by the fourth quarter of 2017.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6802273280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,010</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,022</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Interest on Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,436</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net (loss) income attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,897</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,424</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,872</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,956</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Effective of diluted shares:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based awards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">703</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Convertible Notes </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,934</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,521</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,480</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.09</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6793021504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Acquired Intangible Assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company had the following acquired intangible assets:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets subject to amortization:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Databases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,609</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,655</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,954</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,609</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,147</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,724</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,793</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,931</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,724</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,316</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,408</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,537</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,619</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,527</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names, definite-lived</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,216</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">421</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,795</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,216</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">343</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,873</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,168</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,406</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,762</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,168</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,835</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets not subject to amortization:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,164</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72,237</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated Annual Amortization Expense</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, estimated annual amortization expense is as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,175</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,799</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,522</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,762</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The March 31, 2017 and December 31, 2016 carrying amount of goodwill by segment is as follows:&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,648</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812499104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Long-term Debt</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, long-term debt consists of the following:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unamortized Discount and Debt Issuance Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unamortized Discount and Debt Issuance Costs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan, interest 2.78%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes, fixed rate interest of 8.00%</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,669</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Convertible Notes derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,518</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,032</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,010</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,263</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,508</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(339</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,792</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,032</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Applicable Margin, as of any date, is a percentage per annum determined by reference to the applicable Consolidated Net Leverage Ratio (as defined by the agreement) in effect on such date as set forth in the table below.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Level</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Consolidated Net Leverage Ratio</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Eurodollar Loans, LIBOR Index Rate Loans and Letter of Credit Fee</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Base Rate Loans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;font-weight:bold;">Commitment Fee</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">I</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Less than 1.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.25%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">II</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 1.50:1.00 <br clear="none"/>but less than 2.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">III</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 2.00:1.00<br clear="none"/> but less than 2.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">IV</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 2.50:1.00<br clear="none"/> but less than 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.35%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">V</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">Greater than or equal to 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">2.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#404040;">0.40%</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Aggregate scheduled maturities of debt</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the aggregate scheduled maturities of debt are as follows: </font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Term Loan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capital Leases </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Through Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6793021504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table which follows summarizes the estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Financial Liabilities:</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Deferred compensation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,213</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Convertible Notes derivative liability</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,773</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,603</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock', window );">Schedule of reconciliation of opening and closing balances for fair value measurements categorized within Level 3</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table which follows reconciles the opening balances to the closing balances for fair value measurements categorized within Level 3 of the fair value hierarchy:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingent Consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Convertible Notes</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities (a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative Liability</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(100</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,951</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation gain for the period</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,773</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Related to the Mediscan acquisition on October 30, 2015 and the USR acquisition on December 1, 2016. See Note 3 - Acquisitions. Valuation gain and accretion expense is included as acquisition-related contingent consideration on the condensed consolidated statements of operations.</font></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March&#160;31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair<br clear="none"/>Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair<br clear="none"/>Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Financial Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;background-color:#cceeff;">(amounts in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Level 2)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Term Loan, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,161</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,300</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,137</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,331</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,250</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets and Liabilities Measured on recurring Basis, Unobservable Input Reconciliation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FairValueAssetsandLiabilitiesMeasuredonrecurringBasisUnobservableInputReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13476-108611<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13467-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6447952&amp;loc=d3e13220-108610<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6802182544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Activity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2014 Plan for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Performance Stock Awards</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Grant Date<br clear="none"/>Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Target <br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Grant Date<br clear="none"/>Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, January&#160;1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">532,294</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332,092</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.73</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244,205</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181,067</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.36</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(122,061</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,838</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.39</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(112,434</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.65</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">628,600</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">400,725</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798013280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Information on Operating Segments and Reconciliation to Loss From Operations</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information on operating segments and a</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">reconciliation to income (loss) from operations for the periods indicated are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183,108</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168,765</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,464</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,001</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,365</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207,573</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196,583</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,622</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,790</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(440</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(111</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,002</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate overhead</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,286</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,191</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,412</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,255</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811781216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jan. 01, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=ccrn_AccountingStandardsUpdate201609Member', window );">Accounting Standards Update 2016-09 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit [Member] | Accounting Standards Update 2016-09, Forfeiture Rate Component [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Cumulative effect adjustment</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=ccrn_AccountingStandardsUpdate201609Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=ccrn_AccountingStandardsUpdate201609Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=ccrn_AccountingStandardsUpdate201609ForfeitureRateComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813398720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">21 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 03, 2017</div></th>
<th class="th"><div>Oct. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Apr. 01, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Release of remaining contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (270)<span></span>
</td>
<td class="num">$ (287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_MediscanMember', window );">Mediscan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash purchase price paid at closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated', window );">Cash consideration plus working capital estimate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Fair value of shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_MedicalStaffingNetworkMember', window );">Medical Staffing Network [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationDeferredPeriod', window );">Period of deferred consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">21 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Release of remaining contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member', window );">Potential Earnout, Attainment of Specific Performance Criteria in 2016 [Member] | Mediscan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member', window );">Potential Earnout, Attainment of Specific Performance Criteria in 2017 [Member] | Mediscan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutMember', window );">Potential Earnout [Member] | Mediscan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember', window );">Assumed Additional Contingent Purchase Price Liabilities [Member] | Mediscan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForPreviousAcquisition', window );">Contingent liability paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Mediscan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationEscrowDepositRelease', window );">Release of escrow to seller</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationDeferredPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Deferred, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationDeferredPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Cash Consideration Negotiated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationEscrowDepositRelease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Escrow Deposit Release</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationEscrowDepositRelease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPreviousAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow representing an adjustment to the purchase price of a previous acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPreviousAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_MediscanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_MediscanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_MedicalStaffingNetworkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_MedicalStaffingNetworkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800175616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (LOSS) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Loss on currency fluctuations</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Income tax impact related to foreign currency translation adjustments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32022-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800130624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (loss) income attributable to common shareholders - Basic</a></td>
<td class="num">$ (2,010)<span></span>
</td>
<td class="nump">$ 19,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Interest on Convertible Notes</a></td>
<td class="nump">694<span></span>
</td>
<td class="nump">838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain on derivative liability</a></td>
<td class="num">(1,581)<span></span>
</td>
<td class="num">(16,436)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net (loss) income attributable to common shareholders - Diluted</a></td>
<td class="num">$ (2,897)<span></span>
</td>
<td class="nump">$ 3,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares - Basic</a></td>
<td class="nump">32,872,000<span></span>
</td>
<td class="nump">31,956,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effective of diluted shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Share-based awards (shares)</a></td>
<td class="nump">674,000<span></span>
</td>
<td class="nump">703,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Convertible Notes (shares)</a></td>
<td class="nump">2,934,271<span></span>
</td>
<td class="nump">3,521,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares outstanding (shares)</a></td>
<td class="nump">36,480,000<span></span>
</td>
<td class="nump">36,180,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net (loss) income per share attributable to common shareholders - Basic (in dollars per share)</a></td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="nump">$ 0.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net (loss) income per share attributable to common shareholders - Diluted (in dollars per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5618551-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a),(c),(d),(e)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1500-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The after-tax amount of interest recognized in the period associated with any convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income or Loss Available to Common Stockholders plus adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812383312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 80,168<span></span>
</td>
<td class="nump">$ 80,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">44,406<span></span>
</td>
<td class="nump">43,333<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets subject to amortization, net carrying amount</a></td>
<td class="nump">35,762<span></span>
</td>
<td class="nump">36,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Trade names</a></td>
<td class="nump">35,402<span></span>
</td>
<td class="nump">35,402<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">71,164<span></span>
</td>
<td class="nump">72,237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Database [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">31,609<span></span>
</td>
<td class="nump">31,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">16,655<span></span>
</td>
<td class="nump">16,147<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets subject to amortization, net carrying amount</a></td>
<td class="nump">14,954<span></span>
</td>
<td class="nump">15,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">41,724<span></span>
</td>
<td class="nump">41,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">23,793<span></span>
</td>
<td class="nump">23,316<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets subject to amortization, net carrying amount</a></td>
<td class="nump">17,931<span></span>
</td>
<td class="nump">18,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">3,619<span></span>
</td>
<td class="nump">3,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,537<span></span>
</td>
<td class="nump">3,527<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets subject to amortization, net carrying amount</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">3,216<span></span>
</td>
<td class="nump">3,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets subject to amortization, net carrying amount</a></td>
<td class="nump">$ 2,795<span></span>
</td>
<td class="nump">$ 2,873<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800764512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Annual Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2017</a></td>
<td class="nump">$ 3,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2018</a></td>
<td class="nump">4,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2019</a></td>
<td class="nump">4,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2020</a></td>
<td class="nump">4,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2021</a></td>
<td class="nump">3,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">16,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets subject to amortization, net carrying amount</a></td>
<td class="nump">$ 35,762<span></span>
</td>
<td class="nump">$ 36,835<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811800384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 79,648<span></span>
</td>
<td class="nump">$ 79,648<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">44,545<span></span>
</td>
<td class="nump">44,545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">25,685<span></span>
</td>
<td class="nump">25,685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember', window );">Other Human Capital Management Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 9,418<span></span>
</td>
<td class="nump">$ 9,418<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813396112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Long- Term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligations', window );">Capital lease obligations</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Total debt</a></td>
<td class="nump">38,518<span></span>
</td>
<td class="nump">92,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less current portion</a></td>
<td class="num">(2,010)<span></span>
</td>
<td class="num">(2,263)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LongtermDebtandCapitalLeaseObligationsGross', window );">Long-term Debt and Capital Lease Obligations</a></td>
<td class="nump">36,508<span></span>
</td>
<td class="nump">89,792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized Discount and Debt Issuance Costs</a></td>
<td class="num">(339)<span></span>
</td>
<td class="num">(5,032)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember', window );">Senior Debt [Member] | Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt</a></td>
<td class="nump">38,500<span></span>
</td>
<td class="nump">39,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized Discount and Debt Issuance Costs</a></td>
<td class="num">$ (339)<span></span>
</td>
<td class="num">(363)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">2.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member] | 8% Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized Discount and Debt Issuance Costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(4,669)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member] | Convertible Note Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">27,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized Discount and Debt Issuance Costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LongtermDebtandCapitalLeaseObligationsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt and Capital Lease Obligations, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LongtermDebtandCapitalLeaseObligationsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and capital leases due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and capital lease obligations including current maturities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A8ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A8ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_ConvertibleNoteDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_ConvertibleNoteDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800124992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Debt Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsAbstract', window );"><strong>Capital Lease Obligations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">2017</a></td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears', window );">2018</a></td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears', window );">2019</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears', window );">2020</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember', window );">Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2017</a></td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2018</a></td>
<td class="nump">3,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2019</a></td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2020</a></td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2021</a></td>
<td class="nump">26,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 38,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804829568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Private Placement of Convertible Notes Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 17, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($) </div>
<div>instrument </div>
<div>d </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,005,000<span></span>
</td>
<td class="nump">$ 59,227,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Extinguishment fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(578,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,969,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt', window );">Payment of debt and extinguishment fees</a></td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of debt</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Extinguishment fees</a></td>
<td class="num">(600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Non-cash write off related to settlement of convertible notes</a></td>
<td class="nump">$ 46,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt conversion price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Debt instrument, convertible, number of equity instruments | instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,521,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate', window );">Debt Instrument, convertible, threshold period following issuance date (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Debt instrument, convertible, threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Debt instrument, convertible, threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays', window );">Debt instrument, convertible, threshold consecutive trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal', window );">Convertible debt redeemed after permissible date, redemption premium, percent of principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">3,175,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_A8ConvertibleNotesMember', window );">8% Convertible Notes [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Original debt amount in debt conversion</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_ConvertibleNoteDerivativeLiabilityMember', window );">Convertible Note Derivative Liability [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Original debt amount in debt conversion</a></td>
<td class="nump">$ 26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Debt Redeemed after Permissible Date, Redemption Premium, Percent of Principal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ConvertibleDebtRedeemedAfterPermissibleDateRedemptionPremiumPercentofPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible,Threshold Period Following Issuance Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Debt Extinguishment Costs And Repayment Of Long Term Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instruments must exceed threshold percentage for a specified number of trading days to trigger conversion feature, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for incremental, external costs directly pertaining to an early extinguishment of debt, including legal costs and prepayment penalties, and excluding interest and repayment of debt principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A8ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A8ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_ConvertibleNoteDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_ConvertibleNoteDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812757248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Narrative (Details) - Credit Agreement [Member]<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 22, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($) </div>
<div>financial_covenant</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault', window );">Interest rate increase (decrease) (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Quarterly commitment fee on the average daily unused portion (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_NumberofFinancialCovenants', window );">Number of financial covenants | financial_covenant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember', window );">Senior Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility maximum borrowing capacity</a></td>
<td class="nump">$ 40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments', window );">Percentage of principal payment for first four installments</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments', window );">Percentage of principal payment for next eight installments</a></td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments', window );">Percentage of principal payment for remaining installments</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio', window );">Consolidated Fixed Charge Coverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember', window );">LIBOR [Member] | Senior Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility maximum borrowing capacity</a></td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit', window );">Line of credit, subfacility for standby letters of credit</a></td>
<td class="nump">35,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans', window );">Sub facility for swingline loans</a></td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineofCreditFacilityAdditionalCapacity', window );">Additional capacity</a></td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | LIBOR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member', window );">Fiscal Quarters Ending September 30, 2016 through June 30, 2017 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RatioOfIndebtednessToNetCapital1', window );">Consolidated Net Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member', window );">Fiscal Quarters Ending September 30, 2017 through June 30, 2018 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RatioOfIndebtednessToNetCapital1', window );">Consolidated Net Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_EachFiscalQuarterEndingThereafterMember', window );">Each Fiscal Quarter Ending Thereafter [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RatioOfIndebtednessToNetCapital1', window );">Consolidated Net Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Covenant, Consolidated Fixed Charge Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Increase (Decrease) in Event of Default</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Sub Facility For Swingline Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of credit, subfacility for standby letters of credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineofCreditFacilityAdditionalCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Additional Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineofCreditFacilityAdditionalCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Periodic Payment, Percentage of Principal, First Four Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalFirstFourInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Periodic Payment, Percentage of Principal, Next Eight Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalNextEightInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Periodic Payment, Percentage of Principal, Remaining Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineofCreditFacilityPeriodicPaymentPercentageofPrincipalRemainingInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_NumberofFinancialCovenants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Financial Covenants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_NumberofFinancialCovenants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RatioOfIndebtednessToNetCapital1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indebtedness divided by net capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RatioOfIndebtednessToNetCapital1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_FiscalQuartersEndingSeptember302016throughJune302017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_FiscalQuartersEndingSeptember302017throughJune302018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_EachFiscalQuarterEndingThereafterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_EachFiscalQuarterEndingThereafterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813050224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Consolidated Net Leverage Ratio (Details) - Credit Agreement [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1 [Member] | Eurodollar Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1 [Member] | LIBOR Index Rate Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1 [Member] | Letter of Credit Fee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1 [Member] | Base Rate Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 [Member] | Eurodollar Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 [Member] | LIBOR Index Rate Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 [Member] | Letter of Credit Fee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 [Member] | Base Rate Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 [Member] | Eurodollar Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 [Member] | LIBOR Index Rate Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 [Member] | Letter of Credit Fee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 [Member] | Base Rate Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 [Member] | Eurodollar Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 [Member] | LIBOR Index Rate Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 [Member] | Letter of Credit Fee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 [Member] | Base Rate Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5 [Member] | Eurodollar Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5 [Member] | LIBOR Index Rate Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5 [Member] | Letter of Credit Fee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5 [Member] | Base Rate Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ConsolidatedNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consolidated Net Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ConsolidatedNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=ccrn_LetterofCreditFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=ccrn_LetterofCreditFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800994880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Estimated Fair values Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Deferred compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Deferred compensation</a></td>
<td class="nump">$ 1,213<span></span>
</td>
<td class="nump">$ 1,472<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">5,773<span></span>
</td>
<td class="nump">5,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Convertible Notes, Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Convertible Notes derivative liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 27,532<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13476-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ccrn_DeferredCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ccrn_DeferredCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ccrn_ConvertibleNotesDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ccrn_ConvertibleNotesDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801304624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Schedule of reconciliation of opening and closing balances for fair value measurements categorized within Level 3 (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=ccrn_ContingentConsiderationLiabilityMember', window );">Contingent Consideration Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Convertible Note Derivative Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 5,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense', window );">Accretion expense</a></td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Valuation gain for the period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">5,773<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Convertible Notes Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Convertible Note Derivative Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">27,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(25,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense', window );">Accretion expense</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Valuation gain for the period</a></td>
<td class="num">(1,581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Accretion Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ccrn_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ccrn_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801233584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueMeasurementLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueMeasurementLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided', window );">Threshold period, past due for payment of services provided</a></td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueMeasurementLineItems', window );"><strong>Fair Value Measurement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided', window );">Threshold period, past due for payment of services provided</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FairValueMeasurementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Measurement [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FairValueMeasurementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold Period, Past Due for Payment of Services Provided</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68055307&amp;loc=d3e2420-110228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812087296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Financial Instrument that were not Measured at Fair Value (Details) - Fair Value, Inputs, Level 2 [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, Net [Member] | Reported Value Measurement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Financial Liabilities, Carrying Amount</a></td>
<td class="nump">$ 38,161<span></span>
</td>
<td class="nump">$ 39,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, Net [Member] | Estimate of Fair Value Measurement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Financial Liabilities, Fair Value</a></td>
<td class="nump">39,300<span></span>
</td>
<td class="nump">41,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_ConvertibleNotesNetMember', window );">Convertible Notes, Net [Member] | Reported Value Measurement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Financial Liabilities, Carrying Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_ConvertibleNotesNetMember', window );">Convertible Notes, Net [Member] | Estimate of Fair Value Measurement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Financial Liabilities, Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 27,250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13476-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionQuantitativeDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ccrn_ConvertibleNotesNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ccrn_ConvertibleNotesNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812662448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Common shares left remaining to repurchase under the plan (up to)</a></td>
<td class="nump">942,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount (up to)</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of shares of common stock outstanding</a></td>
<td class="nump">35,596,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">244,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet', window );">Vested in period, net (in shares)</a></td>
<td class="nump">74,878<span></span>
</td>
<td class="nump">51,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Omnibus Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">244,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">181,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock [Member] | Omnibus Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">181,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage', window );">Level of performance attained and approved (percent)</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued in period</a></td>
<td class="nump">86,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVestedinPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Level of Performance Attained, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share instruments newly issued under a share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800863504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Summary of Restricted Stock and Performance Shares (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, Beginning balance (in shares) | shares</a></td>
<td class="nump">532,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">244,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(122,061)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(25,838)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, Ending balance (in shares) | shares</a></td>
<td class="nump">628,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted Average Grant Date Fair Value (in usd per share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 9.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">14.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">10.83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">9.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, Beginning balance (in shares) | shares</a></td>
<td class="nump">332,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">181,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(112,434)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, Ending balance (in shares) | shares</a></td>
<td class="nump">400,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted Average Grant Date Fair Value (in usd per share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">14.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">11.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 12.94<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6642583632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT DATA - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2017 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813464176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT DATA - Information on Operating Segments and Reconciliation to Loss From Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueServicesNet', window );">Revenues</a></td>
<td class="nump">$ 207,573<span></span>
</td>
<td class="nump">$ 196,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses', window );">Contribution income</a></td>
<td class="nump">16,002<span></span>
</td>
<td class="nump">18,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SegmentReportingUnallocatedCorporateExpenses', window );">Unallocated corporate overhead</a></td>
<td class="nump">10,286<span></span>
</td>
<td class="nump">10,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,191<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">270<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">3,255<span></span>
</td>
<td class="nump">5,165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse and allied staffing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueServicesNet', window );">Revenues</a></td>
<td class="nump">183,108<span></span>
</td>
<td class="nump">168,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses', window );">Contribution income</a></td>
<td class="nump">15,622<span></span>
</td>
<td class="nump">16,790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician staffing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueServicesNet', window );">Revenues</a></td>
<td class="nump">21,464<span></span>
</td>
<td class="nump">24,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses', window );">Contribution income</a></td>
<td class="nump">820<span></span>
</td>
<td class="nump">1,553<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember', window );">Other human capital management services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueServicesNet', window );">Revenues</a></td>
<td class="nump">3,001<span></span>
</td>
<td class="nump">3,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses', window );">Contribution income</a></td>
<td class="num">$ (440)<span></span>
</td>
<td class="num">$ (111)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationContingentConsiderationArrangementsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income Loss Before Depreciation Amortization Loss on Sale of Business Acquisition and Integration Cost Contingent Consideration Restructuring Charge Impairment Charge And Corporate Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_OperatingIncomeLossBeforeDepreciationAmortizationLossonSaleofBusinessAcquisitionandIntegrationCostContingentConsiderationRestructuringChargeImpairmentChargeAndCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_SegmentReportingUnallocatedCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Unallocated Corporate Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_SegmentReportingUnallocatedCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueServicesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueServicesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804679056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate (percentage)</a></td>
<td class="nump">27.10%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems', window );">Effective income tax rate continuing operations excluding discrete items (percentage)</a></td>
<td class="nump">53.80%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Gross increase to current year unrecognized tax benefits related to federal and state tax issues</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Continuing Operations Excluding Discrete Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Unrecognized Tax Benefit<br> -URI http://asc.fasb.org/extlink&amp;oid=6527854<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801411328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedParties', window );">Accounts receivable</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">InteliStaf [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_JointVenturePercentOwnership', window );">Joint venture, percent ownership</a></td>
<td class="nump">68.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromJointVenturesCurrent', window );">Receivable balance with joint venture</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Payable balance with joint venture</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_AffiliatedEntityMember', window );">Affiliated Entity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Rent expense</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_JointVenturePercentOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Percent Ownership</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_JointVenturePercentOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amount of receivables arising from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromJointVenturesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from an entity in which the reporting entity shares joint control with another party or group, due within 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39599-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromJointVenturesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Related Parties<br> -URI http://asc.fasb.org/extlink&amp;oid=16382449<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488393&amp;loc=d3e606610-122999<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>64
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M#_*5<T5U0,F3#J72/7I:,'I59KK2<S$TJF&A>#<V83#]$RC_ %!+ P04
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MT]2>=_,&?[X8VNOR\2)X?$'9_0=02P,$%     @ N(RD2GY-@<)7 @  5@<
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MGV&NYQTE<_%?X0H*PX,2S%$:Y>)*RL%YHV<6E*+%R[3++N[C=,,/,VP;P&<
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MHF0I_B-<0?KPH,3GJ%':N))ZM [5PN*E*/XR[T+'?9IOLAML'Y N@'0%W$<
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MYG#<A?@8\$/ X!9G$BHY&_,<C*]53I,@""24/C!PW"YP!U(&(I3Q:^*D<\H
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MKP,(/18XQ9? *V\[%P*DS'O6PC=PW_NC\1Y95&HN05FN%3+0%/@AW1^R@(^
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M*NNV][C7X\",AE7]]!:P^4'*_P)02P,$%     @ N(RD2JQ%]BVW 0  T@,
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M7#C>^K.9QVPV' [+#V+K-R[_ %!+ P04    " "XC*1*6VP$P[@!  #2 P
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MY</Q@&<[CMEH>---/XC-WSC_ U!+ P04    " "XC*1*<-K'S1("   =!@
M&0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6R-5=N.VR 0_17$!P1?<I=C
M:9.J:J56BK9J^TR<26PM&!=(O/W[ G:\WNQLM2\&QG/.F8-AG+5*/YD2P))G
M*6JSH:6US9HQ4Y0@N9FH!FKWYJ2TY-8M]9F91@,_!I 4+(FB.9.\JFF>A=A>
MYYFZ6%'5L-?$7*3D^N\6A&HW-*:WP&-U+JT/L#QK^!E^@/W9[+5;L8'E6$FH
M3:5JHN&TH0_Q>A=''A R?E70FM&<>"L'I9[\XNMQ0R-?$0@HK*?@;KC"#H3P
M3*Z./STI'30]<#R_L7\.YIV9 S>P4^)W=;3EABXI.<*)7X1]5.T7Z W-*.G=
M?X,K")?N*W$:A1(F/$EQ,5;)GL65(OES-U9U&-N>_P;# 4D/2 : T_X?(.T!
MZ0M@&LQWE06KG[CE>:952W3WM1KN#T6\3MUF%CX8]BZ\<VZ-BU[S)%IF[.J)
M^IQMEY.,<N(A@SGV02+!)+;)&WCR6F"'9$0K7")%7:2!8#HFB".<8(H23 -!
M^HK@'9,SE&"&5'!OL\M9A9RZV\=)BHO,49$Y(I+>B<P_+K) 11:(R/3N1"S>
MB$23=[9KB8HL$9$93K!""58?_V"NRZ G/T)JF-\?_0AQ>E\H&UTV"?H<^I(A
MA;K4H2F.HD/O>TC"97U)[QKG=Z[/56W(05EWY</%/"EEP=7B="DI7:\>%@).
MUD\7;JZ[AM4MK&KZ9LR&/T+^#U!+ P04    " "XC*1*_4@ 1$\#  #*#P
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M.?5#+T9G+31@,HOQ)Y@K BGU,86_E"+S[^C^;8+\'K%>WT)V"R+1LHE@L<[
M\(-I#<'798%P42 T N'-0<WJR"QF8S"-3:(NH/K-BOD_[L90M&@H6C 4S Q%
M=XEF5O)'"&L"35J) C^9:RJ<@G6-U%]D$AU?@F=?M^(LGGG;W%[HJXQ]7GYB
M?JH;X1R85(UNVO'(F 1E</6D'%;J11L7!(Y23S=JSNV]M@O)VN')0N.[F?X#
M4$L#!!0    ( +B,I$K"((;^R@(  +D)   9    >&PO=V]R:W-H965T<R]S
M:&5E=#,R+GAM;'V6;6_:,!#'OTJ4]R6VXR1.!4B%:=JD3:HZ;7OM@H&H2<P<
M ]VWG^V$--C'WA#;_._N=WZ\^46JM^X@A([>F[KM%O%!Z^-CDG2;@VAX-Y-'
MT9I_=E(U7)NNVB?=40F^=49-G1"$\J3A51LOYV[L62WG\J3KJA7/*NI.3</5
MWY6HY641X_@Z\%+M#]H.),OYD>_%#Z%_'I^5Z26CEVW5B+:K9!LIL5O$3_AQ
MC:DU<(I?E;ATDW9D4WF5\LUVOFX7,;)$HA8;;5UP\SF+M:AKZ\EP_!F<QF-,
M:SAM7[U_=LF;9%YY)]:R_EUM]6$1LSC:BAT_U?I%7KZ((:$LCH;LOXFSJ(W<
MDI@8&UEW[C?:G#HMF\&+06GX>_^M6O>]#/ZO9K !&0S(:&!B_\\@'0S2#P,W
MFTE/YE+]Q#5?SI6\1*I?K2.WFP(_IF8R-W;0S9W[SV3;F='SDE Z3\[6T:!9
M]1HRT>!1D1CO8P@"A5B1P)S<!EB'BCR'(Z1@$JFS3Z> E, .*.B .@?T9A8R
M;Q9Z3>$TK=,\$(21ETJHPB4B=V R$"8#8'(/IM=DDS!YZ2W;.M2PE,$@.0B2
M!R#,2W>5!S$><,:P1P*I<IK>6>,"A"F 62D\F@)8(E9ZJG6H2BFA, L#61C
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M.A2X3M?[[_(L,R.OG9@V-BJKFO_.YE1IE7=9C)4\>6N?:=$\+UW^]S Z +L
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MU 8XQ>^:]>JF']BE[(5XLX-OQTT8V8P89P=M+:AIKNR%<6Z=3!Y_1]-P8MK
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M@^$:06V18%8;:E R"19?N7H05P!J2P CIBYJT'2O& =*P7&H4%PL:(S$LLY
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M#(-@X6X%AD& U#!SBT2D6Z)Z C!H GV!81 1!93 , B0&N9N@4@3M8' Q @
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M[0+^K)ZD-& EHR<;;6G;][@0<#)NFMFYZGM8OS"R'?HS&7\2Q5]02P,$%
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M8 ;# C-08/9X'"DHD (.)C]]U6&2JT)I- EM?8N*<3)"79F9@V;F@!D*"RQ
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MW%G',8N&5</\@\CRC:O_4$L#!!0    ( +B,I$J*YX&7# ,  !(,   9
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MK(!H;.640<3Z (\%Z&^CQR8@-$U!&FNW$"ZW\>-6).2[TW\'E*&%PSKE$KZ
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MO!KBU7A.TFT.1[]=R8+_0>%3Y<5B^%F[V0V6(*;@D$\1*A(*0Y1 _,>\$-M
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M"PEHSC!D-T G74?!X>JNT+RG<)WAL'D"J*#MC]G6%Q*M8 7P_@(8/'W*T5<
MUCAB8/#A,W_"=_$TMFNS\&7T-5ENET37MYLT>Z$+E!')D]L@;!89\-] E<]G
M"1N4FB! )FA/2#WTQEV45FY.<):018*Q-< [A)N0:PD0W21D'F(9>F;= LG*
M7&^Y2QC)XR];;T_1:=3RM@\Y?"!$N[A4$=V(K_IK11W-+-2"NG*9T<:#I0*8
M6U_&\C@*U'0M-2';2<-D4K:7DM:'Z ]K3%>"Z\[PI00D?4&=_\:72ZOOOY,W
M-+_S":71J*V!<$VH8&0APG@\9\)ZOIDHZ)Q7[(^H/SYK!1'QO]K1[-Z/%#G@
M@?=6MV1F\',\>T0XB*@Q:O<;;P,5]WJSW8@2 ?-?BP$ L.\]2KT79$TU>@6Z
MYEFP%AR*U\KDB8 $[@:;_?(4LR\5@(\64X 23"((N*2H1U(]LH2V3[M_2.:@
M,PMAQY4'*('.9D2\S(XT,QR4I5HCG])1'2?A#D)1<@4M:XDW8'J61G <!F^L
M.>_W2&#WI2NJW]TCBQC=V-T+)%4EN]K9+Y\O[B[0,U:RN;TS>LF9TTMV6=WT
M6,'G.Q#@\A1.#^#F'&+!]4I!.53H:P!E3-PS<;)9IS8)@,@YLFVR,5>1:>%V
M0S/A01IE*JQ; 3FN@I//=[<-44GU',"U(J,?.UBBA0A0"4VBZ6++<$C1V$!>
M9Y: 47-5^@'95ES(XES+7D]9NGU\ CWV = 3CW=I8C9,&"@JZPOTVSP)O<+U
M$'?;O+!:G<7&2^,6SS9?(%/ ,):6BN!*4)%F$L1"C>&\9;<,3E1]\$PIA%,0
ML4&C02AR3?&PE-"N=!* >AUJDGFQ:&OVE*_<"^-1;Y)EH(A5LN^B2ZQ@Q8;5
M7&VSG!,I)B#3L(L)CDOA$AS+(\X++!3TKJL4)+Q!<!I\M/9+SBNY<O9+C@RY
M</;+B8M2H??'\/X']/_]"H)K''R*HWQK&;6)T\#+<CW=I&2QYP2^_C&7Q?FE
ME@0:SZU*0+R*O[C9+B[$J6L_>9]$CZL4I-HI[)PQ4Q[!C=C'$()BYB+ R173
M[FO[<$.<GP5;*,J5G7%S; 5+(_&<P.>C9LM^OEYL^3XR%^<<$B-X-R0YJ#G4
MXTB8X0G,V^V-P]&P+1\U#'@<,OAI:/GVX6]D?P>J3F%9Q8F=K,VWT40TSKV!
M#%=F+\$J+OJQ]!5&(<";=@$#@)C*+,M8\=AV-@'8+0QF#*PKNHJ;")'=O0<B
M($:64]8UNU)GP==J+<Q0="SU@2>OE#+PIJ^.T)BH? S N9_B!4$ISJ<92)L4
M](=D%5%]#7AX.EVDA&E>Y *#Y O9"BF;R&HC>;S =,T4A:67H!MJOOJ8Q2S0
MD?:,G)P9.^DK[F61RX"^\T7F\+V8F+Y2>_V]^%8_W/]0[3]D@+[I*LT,@V?)
M%\FZ%XH[&[2W&C5.UC?%!\G%3'9X(RI)&AQAOQAO*H^EP&IG,:8M)2N]:T8>
M=HM&V0I8JU6^0;Y)XF=A'7:^2"NIZ0JNNK<Q(&JPC9P?6Z>(3V3PE[%E*+MB
M%FJ-/YF72W$2ST0GK:<:!R6KKLT;HV4Z[P-L!Q35D5T'W8ZJVV>IF+J&/I@(
M0<@1AN.Z0U=FWL+YZ[P@(7?.Z$3SL%M#V N[^K)89?6AF K/6FS8??[&FTV'
M8L0+^&-,!XD*JC$\&_.37)#B"R-^@1;C''L(R6X9507;QBAR;U= 3M:HF;S?
M9D8>0#4=> \GKC/)JCI? V<*OO2L"[\?*\@? (>[79DP6/)O V6KP)=N<[!W
MZ@C@0>DHF)C:[-GG"Z/EU6O,XP.< V14SSV)17+JRHF6?JY@<<ATIXO8<_/G
M2KC9*YQ,.2:/I:2K>(,L!865?]VN8L./>H5+9+ >H[% +!++@9)15""O<3;I
MC>)9U$U=DNX_W5V!=']=Q6A"$"@4?6*966RQ9"9ERZ)B'YVVP6'K@M(L&X$I
M.:NXT;/K=[<3%T#GG)A^5!R\^! _10L*JL,;#1/!JD&_9?,^;/B9S18;X?V^
M/FG'A0O3T]).87X@,>);P]'UNF&S2+!%BK ,HH:'^A?,><%)<--7MA1E>OWI
MYO;\Y_.KNXM?J8C#]:?SX.3R^NZNE'4@8>+U&N:.L0+)1:Y/63 7*B<I2+Y*
M,\I-I9/?F2SAI*3<9:V3*;9LST?[EO'+^A*F#9HQ<WD!GULRE\9P\8"?&M,"
MQ@@LW)J8LL C<XF'4E\2CZM2Z#[(;&=FE$\@7:!L4ZG3A34Q]8Z&%;0V R=G
M ?1"G\EP),9IH4A^A!'>H*9)CG'N8XI%K)G 9!(5)C*,4-\89R&WMI*Y@^=\
ML<58 MY,@3OZJ]384"#/T0'IS]:*?$!8I4^9.901!2BT,GTE%H-B5KO9L=<.
M([YAY@*[HC?+05\$ERP6P4[G;PB %!P.O106](KI6SM;%>]G%5)_-"@3C_/)
M[=7%U<>[X.;\-KC[>7)[7GH"!$FRPMS #LDENH-^E(<C#)FG:-PFJ86-U3'O
M1VZ/M3%;J_L*1$% N#03Q]J*7.T;=A39=[8;SR7_0*EL](*DK<5F[39U[BVL
M!\&GB_T4X4:0.O&BP&QF,]K-UQN5S@?X%#5 09?U<KKFT7E6-G'Q37#2"5OM
M5H!94NUQV.IT ILH"R^=I2NXF!O2E*XHX'(P[@6C[BC8E2X;G+3#_J@-@YX
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M &QL%4O8]#HSH5-<<D'DHT42XULLF: \B96G*$2;"R'C5\\X'-:-%FGY!#Y
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MNK7'B107MKN0XX1KL&*(2X-IH3*FIK7]G!H.N1-?:AA/ 1\>TXPD ,D7-H*
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M%S(.7Z!<X9F5AE2P$2T669N7V\4NV2UZXU:@K&P2*Y"Z%8)X\DR(6<@+H_N
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M;SR0_M=NI=]MCF0KW>:XN!6YB:6)Q7=*H2)<4$GJ%>&5VI)YCA]3=3)<<*8
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M\SN?4!K5W-H"UX0*1A8BC.=<8*RE)8T-*8F\M#_7A\4((H3<"R>0V;T?*7+
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M?NH/\C<]>ND61R]'OC&!NXX4%E.SN(-+O6 NQ>D]V\Z/>;[Y\_\%4$L#!!0
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M<CJHI <MIH,6]*#+Z:!+>M#5=- 5/>AZ.NB:'B1S(..<GX2PYFLM@&OA>RT
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "XC*1*[:)=K/     K @  $0
M            @ &9 0  9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "X
MC*1*F5R<(Q &  "<)P  $P              @ &X @  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( +B,I$JF8=1%8P(  !4(   8
M  "  ?D(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "X
MC*1*D(#X;5D$   4%0  &               @ &2"P  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ N(RD2O>L@M3' 0  6P0  !@
M         ( !(1   'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0
M   ( +B,I$HA<270Y@,  $T1   8              "  1X2  !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "XC*1*?DV!PE<"  !6!P
M&               @ $Z%@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M A0#%     @ N(RD2KS**QHW!   U!,  !@              ( !QQ@  'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( +B,I$I2>5CEL $
M -(#   8              "  30=  !X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"% ,4    " "XC*1*^:7)#[,!  #2 P  &               @ $:
M'P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ N(RD2@1L
M%MJT 0  T@,  !@              ( ! R$  'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+ 0(4 Q0    ( +B,I$I(4L2_M0$  -(#   9
M  "  >TB  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @
MN(RD2K'!BA6R 0  T@,  !D              ( !V20  'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"% ,4    " "XC*1*EZ#]DK0!  #2 P  &0
M            @ '")@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4
M Q0    ( +B,I$HL2-2)M $  -(#   9              "  :TH  !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ N(RD2EO+5B.T 0
MT@,  !D              ( !F"H  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"% ,4    " "XC*1*X /].[0!  #2 P  &0              @ &#
M+   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( +B,I$IX
M2M3BM $  -(#   9              "  6XN  !X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L! A0#%     @ N(RD2O3#C&*U 0  T@,  !D
M     ( !63   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M" "XC*1*/&R@/+0!  #2 P  &0              @ %%,@  >&PO=V]R:W-H
M965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( +B,I$I_LF3<M $  -(#   9
M              "  3 T  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L!
M A0#%     @ N(RD2J#%6:RU 0  T@,  !D              ( !&S8  'AL
M+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "XC*1*/R#1-;,!
M  #2 P  &0              @ $'.   >&PO=V]R:W-H965T<R]S:&5E=#(Q
M+GAM;%!+ 0(4 Q0    ( +B,I$H14%D"T@$  )P$   9              "
M ?$Y  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ N(RD
M2CCV'LRQ 0  T@,  !D              ( !^CL  'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"% ,4    " "XC*1*L35U+-$!  "<!   &0
M        @ 'B/0  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0
M   ( +B,I$I39ED7Q0$  #<$   9              "  >H_  !X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ N(RD2K#?\PS1 0  G 0
M !D              ( !YD$  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"% ,4    " "XC*1*K$7V+;<!  #2 P  &0              @ 'N0P
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( +B,I$I;; 3#
MN $  -(#   9              "  =Q%  !X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L! A0#%     @ N(RD2G#:Q\T2 @  '08  !D
M ( !RT<  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " "X
MC*1*_4@ 1$\#  #*#P  &0              @ $42@  >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( +B,I$I@CXM9_0$  $,%   9
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M970S-2YX;6Q02P$"% ,4    " "XC*1*NC$4F_ "  ">#   &0
M    @ 'F6@  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (
M +B,I$J!G41,20(  $\(   9              "  0U>  !X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L! A0#%     @ N(RD2FU$!&-W P  N \  !D
M             ( !C6   'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M% ,4    " "XC*1*=>612C0#  !$#P  &0              @ $[9   >&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( +B,I$KQESJ#' 4
M ,TA   9              "  :9G  !X;"]W;W)K<VAE971S+W-H965T-# N
M>&UL4$L! A0#%     @ N(RD2E'TAW@. @  , 8  !D              ( !
M^6P  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " "XC*1*
M%:*+$F8"   \"   &0              @ $^;P  >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+ 0(4 Q0    ( +B,I$KH)L+)%@(  # &   9
M      "  =MQ  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%
M  @ N(RD2BWN0BXP @  1P<  !D              ( !*'0  'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " "XC*1*"H!@&=H"  !-"P
M&0              @ &/=@  >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M 0(4 Q0    ( +B,I$JK\]6%+P,   D-   9              "  :!Y  !X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ N(RD2J^TJ@B\
M 0  T@,  !D              ( !!GT  'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"% ,4    " "XC*1*BN>!EPP#   2#   &0
M@ 'Y?@  >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( +B,
MI$KG<M H'@(  !D&   9              "  3R"  !X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L! A0#%     @ N(RD2KS3Q9R/ @  W0@  !D
M         ( !D80  'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4
M    " "XC*1*R)*TN.1>  !\? $ %               @ %7AP  >&PO<VAA
M<F5D4W1R:6YG<RYX;6Q02P$"% ,4    " "XC*1*>[4Q>UL"   !#0  #0
M            @ %MY@  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +B,I$I>
MBX8V300  ,$@   /              "  ?/H  !X;"]W;W)K8F]O:RYX;6Q0
M2P$"% ,4    " "XC*1*%O],-MH!  ";'@  &@              @ %M[0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "XC*1*2I4E
MW<<!  "('@  $P              @ %_[P  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     .P [  \0  !W\0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.7.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>142</ContextCount>
  <ElementCount>234</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>56</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002000 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003000 - Statement - Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation</Role>
      <ShortName>ORGANIZATION AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2102100 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/Acquisitions</Role>
      <ShortName>ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2106100 - Disclosure - COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLoss</Role>
      <ShortName>COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EarningsPerShare</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2109100 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/Debt</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - CONVERTIBLE NOTES DERIVATIVE LIABILITY</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ConvertibleNotesDerivativeLiability</Role>
      <ShortName>CONVERTIBLE NOTES DERIVATIVE LIABILITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2111100 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquity</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2113100 - Disclosure - SEGMENT DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SegmentData</Role>
      <ShortName>SEGMENT DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2114100 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2115100 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2116100 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2117100 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RecentAccountingPronouncements</Role>
      <ShortName>RECENT ACCOUNTING PRONOUNCEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EarningsPerShareTables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/EarningsPerShare</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2308301 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2309301 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/Debt</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2311301 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/FairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2312301 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquityTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/StockholdersEquity</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2313301 - Disclosure - SEGMENT DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SegmentDataTables</Role>
      <ShortName>SEGMENT DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/SegmentData</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2402402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - ACQUISITIONS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>ACQUISITIONS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - COMPREHENSIVE INCOME (LOSS) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLossDetails</Role>
      <ShortName>COMPREHENSIVE INCOME (LOSS) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/ComprehensiveIncomeLoss</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails</Role>
      <ShortName>EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Annual Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAnnualAmortizationExpenseDetails</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Annual Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsGoodwillRollforwardDetails</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2409402 - Disclosure - DEBT - Long- Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails</Role>
      <ShortName>DEBT - Long- Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - DEBT - Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails</Role>
      <ShortName>DEBT - Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - DEBT - Private Placement of Convertible Notes Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails</Role>
      <ShortName>DEBT - Private Placement of Convertible Notes Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - DEBT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtNarrativeDetails</Role>
      <ShortName>DEBT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - DEBT - Consolidated Net Leverage Ratio (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails</Role>
      <ShortName>DEBT - Consolidated Net Leverage Ratio (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2411402 - Disclosure - FAIR VALUE MEASUREMENTS - Estimated Fair values Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Estimated Fair values Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2411403 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of reconciliation of opening and closing balances for fair value measurements categorized within Level 3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Schedule of reconciliation of opening and closing balances for fair value measurements categorized within Level 3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - FAIR VALUE MEASUREMENTS - Financial Instrument that were not Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentThatWereNotMeasuredAtFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Financial Instrument that were not Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2412402 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2412403 - Disclosure - STOCKHOLDERS' EQUITY - Summary of Restricted Stock and Performance Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAndPerformanceSharesDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Summary of Restricted Stock and Performance Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2413402 - Disclosure - SEGMENT DATA - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SegmentDataNarrativeDetails</Role>
      <ShortName>SEGMENT DATA - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2413403 - Disclosure - SEGMENT DATA - Information on Operating Segments and Reconciliation to Loss From Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SegmentDataInformationOnOperatingSegmentsAndReconciliationToLossFromOperationsDetails</Role>
      <ShortName>SEGMENT DATA - Information on Operating Segments and Reconciliation to Loss From Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2415401 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/IncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/IncomeTaxes</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="ccrn-20170331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2416401 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions</ParentRole>
      <Position>50</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ccrn-20170331.xml</File>
    <File>ccrn-20170331.xsd</File>
    <File>ccrn-20170331_cal.xml</File>
    <File>ccrn-20170331_def.xml</File>
    <File>ccrn-20170331_lab.xml</File>
    <File>ccrn-20170331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>70
<FILENAME>0001628280-17-004975-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-17-004975-xbrl.zip
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MH42'Q0\55Q8]-,JSSTOII'^"Z]6MZ4*G)N13>DXNSMTZ6G@KG]PZFKVUNTI
M^\-1J]^>BMS7AHC^28N[L=;ZI^+J]-9A9]&-\%K\T__[[=</[8?LL?5\<W?]
MS:^GT/SR/__'7]*W?AX6%]YG]S\4W_[YH9"[I+E>5RKI1P#D57DY\>&OKX;=
MQZ<>H/13>LU$[;4'_5'V=?1#%V"./CWZ._[/CSY]J+H%E')W]"W]HOI-MY-^
M=]_-\A\*.+(Y%"JY=&_^[ZM?$"""&<:(_N6G^L/%-WZJ?Z3\QA,LJD%G]JM
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MA-I3_VSEX+WWB@Z-<S(;QOF@,^CU6OEEB&LAD@M)-PU?&K0[D*0NCY@6D?Y
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MD'](9K8'MZ69N_/Z;U*VF#:#,D*>$9U[6>TD])=![PN\;_Z>?2*$Y3;6XQA
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MW$@ZJ?T@'S^.BZNSV7CXN5><UDE;R3.9>8@CGB!\_Y;"V1%<2^']T^/62R&
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M,G<VWD-((YF6B'ENN&!6T8IN 3S 9E-!3LF9T"T9NE\'C?XCNR[LY8<)P4O
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M>$.J[NDTI/[]#5D2C(H:#FM@VA.!=9U7$8H",\5E&C-@!/@150=0XB ^:W8
M574>; /_.(OYX/$?@VY_]$]8*.,\&[H5^F>FNKY7Y,!:^>A;,;<>8$]>DOTV
M>Z7FLN9/@QRNS7YMC5+6A%(&H3XH!&&MQR&:0C4PH*,5S<$+S7W.Y0CN3(=9
MM_-$=$ @U];%&,"'QPH693JR,:&#4M@W-A%PHZ9Z8SI\',Q WCTO<8A<.A,4
M3Q4Q@0CPUKPJR:#3&)O%30[GJ+ $O5V)\!UDP3 1& N!,A6"L0X6AS%(6D6\
M#B8V;$W#3]F("%7#UZJB,>U+MC=1QV3.++JHHZ1*(PY 1B5=U6K91*U6C"T0
M,P O!&4'6)N:=Q96G(:,@8*1TDK.# O$^1)6'"E;.EC@-?H1B3V ]=W>&#BQ
M+6F%<89&!?$*>'K@/5DS60H KD/,\.6D17HYM"4P.\&[FKP&6TR8 %GU3H))
MXPZ;"EX!.*PBK]H.X+)S</C:?D@SJ=..S5U_\5"4K?T+1;3EX.5Y33!FJ8\O
M*R7:*"KJ@S@ _'GG8AO8#H?3&I<#P@5*?= 1!#^ MT>=1E60G(H &@J%'1"G
M:7=X\-TG[:I3!#<&'M\]E:,<-^+2W&:!8HZ&2 3$_IQK9R&0FY@)%&%A+SF@
MSAHX;0+;H3!J\FBN&@,0D#0([3R'V$%3/ZG&2!AQ[Q;O[!*)]\;H\:DW^)9E
MI;F8":Y6N07+S^] 9.=4\F0 =A52#;VMYO,829N21@F;WV18"]">T*\<26E)
M\"Q0IR+V5BI#R^UUB%.5ULWP2$G&=X=^6N\Q-_6Z*!3JW/7?9RFV!<85!4/K
M1I@>LGBFWOUSYI735+;KM88SF9DJ/D_-PC/PBQ*@:VO .(>(36K+:&JO JO8
M595YJ;=U<TJ#G(^H=R3?43APX/*E$W& N  .)G'*!PE6CB5'J.2 #*:9*"28
M'HT#,Q5R_]$=/?S1'WP:9OF7='YV0AAXW:"?CG@7+YE_^90H540\F4"2TKJ5
M/[&VKG\#&KLUDXC7;7%#1(LUAT W.&HQ<\E1*NBM(<0SJ\Z@G8Q,E\B;YQVB
M*@D2N_T6P-/JS9PIFI/1U7N8C&!)C&4J%6 CF_Y?\BGU[5N0DZAE:*Z!6Q^R
MT:B7;7;H[/A+ATKXEV-K Z4\1 B%"#+(<.J8I=0T0N+ZV/CC$><B6'#H%>+2
MZ$H:./>:.F&U4DZ7[ B&VD9%!>&:'W6)')@APR6?V>Y\Q)'6 @0%PG+)P1I'
MB*RIEUQ4ZHF9V-SR3'VC#T'[E50Y:[(?6OZQHPA<)Z*L40HK9C'U%0L$"\T6
M&(U3)=?"@R6.[[%$WQHB/26&"!PH(VF.2$EWS1QOA)=<RNL4_<W)?FC1AR"!
M8D&I\MA+")89K4ZF:2-M/8MZ$"=V<^)WX=,0C'Q)/M*HU?^<JJ<F6_6FW9Y,
M'LM6[*"NRVY(YQR*$C.FN8O4J> FV8V@79#-/7A&X9]Y^=L:PB/@]RPYR]]G
MO_W6^N]!WI0C-QZ.!H]97F0X$G,>ND]K'6KAN2/40IP)_@$)A$M=TDTEWZ&A
M+BF(V)71S;=&K4^MX?KU1:R&]<4I)Q;#(F.^W%$)H.)\,U>+!6;RRFA53 A]
M?,I&V;2CV#JR\>"CP=YZ#"LQ1F1]69U7#$5J6@8@[[51+1WXS]ZV'M>*F/+>
M"V8P^(HD(*FDTM5RU!!>-6IT*3LW);8JB:N8D-('S(GG6G+L1'GB%R3!RJ8D
M,,;0N2F;.?-^(B5M,$?&.\8D%@(9$W$,E50@U#R 0:C49R@7)U'20C"?VMP[
M$21R,1)7%LR"C&'GFJ6$(M7"7Q>M=E#2*# $MI]A[PDU8.*K)EQ!&X5<PW>D
M];',ET^UC96T-%$Y1:P,R =$#:.\$C%8C[RQ%\4(/A&I9AXIBZ7-_2C+_S-K
MY1$>V$Y;&XE=Q&D6?> 4Q$-$4MHBPPQONH88M#G9&-$UH.Z.\?OLL=7M=U+S
MJM@=MEN]],KM,&?"(A$4YDQ*0WCJ@\,KS*GCS5:'6&ZN0C:$>'<"[,9M#LN=
M8BP-IL8&$QQAM,+9D>91>3 Q>@^<]^=S\8;!>$O6@@OJ2)I.:"' H1;8YER%
M)N---!E"F^NYY4#NAV9J'+4E.ZGS*@0GE=&T..[EM:_PE*)9RLHPWEQ)K8!R
M3T3_'&R'9E 2/*/HG.>*$NLT]:)"4PG:Z)3!,%/[HOGG8$,DFX=0UJ8QD'?1
M>*8UQ $(<2L"=Y7W H+:*,=7\+J-$6J<%=D)]I-[O]PJ0!$[RKB0B@BLB)QZ
MOZYYT)YA2=@%T613SS:2(" HQ%$*KJ3%%BE5N6B<ZN99V73PYH+HL(/7"AX^
M+&AP^(E&UFB@"C/5<I&X>7J%"GQ)%-G8(P6)#\0B#BX+4H9I80RMZ* 6]+E)
M\P5/2(=5&EPP96B(B.K(!6>A&$912G4*,KZWQOLN\;XRTNK(/$V':+1T$56)
M1JL):ZST4VN\4\7R <R@(\H[0;RV009,IQJ/1-L,2D^L\;Y#G&Z#]5(I0;05
M4E)-8"57QE!$T=AA/K'&.UD,[H565B577L("(:EO1)CN6QC3-(9'TGA;MPT2
M#E$I D*">T2L2G4SDT+6B!E99+(4W3BXK)TPVP'ND^LZYBVX--@XC8*+P4<J
M*A-N,,?-+(-B:&/]_YWIL:F> ^.''<BG3ZU=73#P7V6^E=6Z80,Q9V+C3,MW
MIL$..HY1$3F&",@@SSU64:DJOV:T)PUO1E\*+3;6;MH9#08/8CZN1(R&VFG(
M U=$,^&OZL441Z/!2E\.V>"0511QYD3$W*#I8?* \8*=/GDR.?X>?EP06 2:
M"O!B5"A2J96?)M49:D2N6&JZ<1;F.]-C4]U&G0Q6@(\/_II66&G-T=2_-[A)
M Z;YQK[L=Z;!#KK-,VL(TQA$ GOE$*R-J6X3E#16MKJ4];&Q;C-1Z*3(+4[U
M8MBS**>Z38 CURS0T[OZ/ZDZ>YC*L[/A73]\3>5MX^[P(?'I[CYU\MGZ""(-
MQ'A$TRP6ES:!C+-E.QZF-/!V18G56F#VA'S-04-,+?6$&8NMMXPYGW:1)\T9
MHD"BL:?QFNE:"\73('"H%ERSI[8IUU9:3ZF1J<$M\<ZF+H:::Z8A0&HLNM>-
ML6C;X3X8=/[L]GK;!08>"ZL" B7 G4322JDGD9WST4*\4 <2+M=RV=5W-X;E
MN>E6:JI:=, >#[O];#C\D'VN-?AY.\Z'66HGTNMULPX\<'\/1%AG #'RX-(2
M9!B#\$80SL#R@>VCVEBUH'M5&B)].ISN1@]9_O?Q8ZOO6D_=4:OW6ZO?^EP\
M]"'+OW3;ZZL- OBGV EF*%*6>:49*Q%DA*"&QZ,9/B'/WCU\&W;;W59_0W9A
M'C!SS$L:@S RC?TP)3;("+9@_(=0^[!KY<Z.]#)X;AP#T3$4Y :KJJF2\,T]
MV'V7PZS].]9R8-QR4+V!<4DYLZG?I9_05WDJ%^QD[+D<ML1I_^60.DV 1A56
MH]0S)B+,;8D@L! WJG#W7 Y;XK?M<K!,<2M9:HV5ME )P2"/!396IG/M.RZ'
ME%UZEP]VZ088G$4<I_RX)6#)0-_(J$#R;0#%2F+#D'&,V'S::^;K&P.UQK-@
MDFO-I #I5J#\X#\5)D !?" 1#: HJ95++ %J<EH^6=W4/F?1<7F;W0_RYU/U
M()_=_B O!I9-.H;#"IU_RV2>V6_9Z&$ 5[YD99N[K3F!69 6*^K!_],QM>N*
M54L-Y7ELMHK26LV'Z"?$[FR(ND:2(%X&#RTR9!#$P6!T]+2!6$2HJ3[ J>7D
M?(BZ?[?/=!B/(NM23QFD!81#@952I0UJ'MZ3M9:9&[3*/%1W3T8H+'Q)+%%:
M>&*]4E6O-"<-:RA'L H[@)IGK2%X^),_W_3++I/#=ZUOZ41*LK^@V<=SW1RV
M[Q\8*>@NE09@> 31I@JT:BO#Q7S'DJJM3&T'<C= CX'J&J8A$<"1<]QPCQ#8
M,QV$J[K)6FH;6NLU%D@U1.QHN+[/VEFW.&NT?9]<% @3@!N+45O@)XD5$X7S
MS69UKTF]6]TF8.V/QAH&1>9A/3G%"(NIL#0*5VI 2REX5$T&(84W9="F>!1^
M8*DQ^Y\GF96M&0*>2DQ-7+W6('.@OGG9L 48XH5KJ#*,^!HT%H%U"$36*;H@
MB/($@T?CF-0^S:&M$(F1-N)R(MB1$=E'V3%8_4%'KG#J[ZK FT5EZS(34F>M
MIH#Q6IWG%M =#*DU+)+I,!9*/<" (PS1H''9/LYB&YJ=[67#%.V,47(%6CTW
M>'P<](NF:$,S&N7=3^-16F<?!VXZ8WB2)_J0SDONQKJT\TD)Z ."L4'>&$S*
MU#$%/6YF[=2P@&0R[[>)ZNXP'Q7])I/GAPH9'T%B39!2H>@P6&GIE/21D4C)
M_.#%"G^B*9OKQ'59^,_;;H183,<S@@[@'T8CRJ9, 0P%Q-I+T/^N[*^Z,*9F
ME]^*V0!YGMK4[19S03B 9;!6"LNL, RB3ETM .DP64 !B1I!UYY0'YL&:Z2
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MLBNX*T>%<Q;2=BPWFAIK#->T.L4'6H<U-*L4M1.S6X";+K6&#[OV%'"""J3
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M?4NB_?_LO6ESXSB2/_QZYU,@:J=W7!&R6O=1-=T1LF3W>+?:56.[9W>>-_^
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M5$$['90J)>?G-A!D_8%JE#Z3"V$Y4X>4)P\SY)=*O,#+568EK(WB:'B$;9,
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MR<P'74J2'#3(]-_<9:B_CT%R+5UPH+#Y=HI>-3;UE5!,N1/K4BWI2NG6M"(
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M%<GNW^1VA&(D;+4(&WJQZ[X(_#L''6G.J$$>N<S%A20*C]0=)95!/^IX2R#
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MAB"!\0BTP00"QJ\Q8F;?I;) \/>"!Z&J6.-'85K6,& +X7&7)..!W3HD-$Z
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MY!\R?GKRXNR#09 #P>>*YBA4^R?WSI2$&=S$0X Y<FOFB#O\4<"?\:P7"=P
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M!<G6/.*<VIE7;P-RP#+IN69'KQ0H[L"2+97;@\438=R-P53&-$;]&6/W<I8
MB@6Y=[1]DW<Y%/VSF]TPEBLA )W@VF:+'>.HXF$2J<8TM%L!ZR62S  .K\,)
M/HGJN>VU3%CV+Q)\1=*XE^3GH?R?H5_8;!S_S^ZJH&!8_Y43HG<RB![#R'DN
MXR>-P6*5)5H6R4Y\U*R_XX:]^[!&%72.&\/25,&EMJX(N7 - ^(?PH]Q)$%1
M B@6$[$O:09:B_4:O:*T&&$:K$;@8X80FM@H1U, &GB]6*RU2 $RA9OS9^,
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MO@I&3U8((J@Y2]U.[0W)<]SRJ)_H55CE'9O 8;@2EP%0KDI19+;"DP!0D:'
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MD=S6OWD5%N2NDKGKI7SB(^"^V=G)1\9TVJ48;W[21@E,MTS+S<\^/#R/'OK
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MTD2\3@)_[&=ZZ8*\L=YF $Z#=$8]FF&GT& N\^^%0_V>O+'?DF$4>:+6JD%
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M;BTR,#$W,#,S,2YX<V3M/6N3VCBVW^=7Z/:7FZU:TJ]D\JA)MIS&W6$O#3U
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M^0[8P#=IGRQ6KX^CE]FFO(0&+K2APDMI>%BB^?[<MCY]]^[=L7V;-M5^44,
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MQ,:QS:%CEEE!O.1*@VA#A44+&@3QJ?O5;-D%Z',G357IZ4"*X?+QQ.R32:N
M_JA,ZC$TWAAN[9%)JX ^.Y.D&)OX6V.0$8.%X(!>&^MZW6' QU'UX KW[:8L
MV*K+H1F:E7'"-0"#R*UOZ C"^7&'F7NION6#A35M#B^>180A'A7+9.2>/G^H
MTPD1%3E*+P)/5AA2M2MM45W+()1E8Z;VSOE.J#2#]- ) FX_&6PU)B^'-6T.
M3YVZ4\&'H;X)%C6JZ,7S*U5ZSC\JC^)I_D]L)/&C-C/%O*B^D;V@$5M(T:<!
MF.YDDYZ]"%1'$11F^Z N*MZZJ,V*;6#V4%[HX6<QQ3A:PFQ-9Y0KNZ!D_\;K
ML*6:2>C XA)*JNH_(-X_3NW'WN[W.9Q2$7NN:RIHM-6TS]0=]Q;W=&_3X?EU
M/@Y"\')U=-#N \H9%&$2K67J^.J-6=2L.\I^;#2A>$<8/XXNW$P>-8?Y)(KM
M\^K7AV>:;Z2!]^ 6\0M.,C2.,3#,U"[,]F=@-$80H,Z/!5\H0$UQ:((EN@6R
M]P+J/XM%;_;'HD.N?R[254[U\Q,R1US).XZ[9(#E31D.S2@,XG-(N-)G;;B#
MVS7LQQM2@K;M=6@G$%8*<OXYCH7U";#<EZM7*W+K9SO".* EMO@N&W!9&#.)
M\:V %%SB5SI6!V%;]CDTS9C3CO<_#"$YS^UMR1RP&3[.F\2>W\%KIZ,[#N9[
M@+2=#F9"1==NYM=?(%H$=RRB^@<DPRGKONN0.ZRJV:LQ=M>NJN3:;\+(4<91
M1'[$GI6+:T@[\W3#00YMRQ;&D[@XD?= 2T^?W_,L; J\H=HT0\S68B% 0!!G
M"=;;^/-C@Y5Z'L#FPJ]2?</\,,J&'/__0FVB38)W,#WQ4T^X)\ENJTE(W:[+
ML]O2Z"B\!O\WI1]_^7]02P,$%     @ N(RD2I0?!YSS'0  ZSP! !4   !C
M8W)N+3(P,3<P,S,Q7V-A;"YX;6SM?5MS&SN2YOO\"J_G&6W<+QU]>D*^=3C"
MQW+8[CFS3Q6X2K6'8GFK2%_ZUV^B2,F2+)$E%@NDO/U@F:(*J,2'#XE,()'X
MVW]]NY@]^1+;KF[FOSTE?\%/G\2Y;T(]/_OMZ3\_HI./+]Z\>?I??_^/O_TO
MA/[G^8>W3UXV?GD1YXLG+]IH%S$\^5HOSI_\$6+WYY/4-A=/_FC:/^LO%J%5
MH2?]AUD]__.O^8>S77SRK:O_VOGS>&'?-MXN^G>?+Q:?__KLV=>O7__RS;6S
MOS3MV3.*,7MV5>K>)_)OZ/(QE+]"A")&_O*M"T^?0 OG7?_N 2^Y?/S;3\]_
M9?W3Q!CSK/_KU:-=?=>#4"UY]C^_O_W8MQ/5\VYAYSX^_?M_/'FR@J-M9O%#
M3$_R___\\.9&);YMNLXWR_FB_7X>[6QQ[FT;_^*;BV?Y\6<G_O\NZZ[.T'4@
M2%_?>1O3;T^];^>  5&8K1#XS[N>77S_''][VM47GV?0YF?[%^J=;5OHV2_Q
M95S8>O8@(>\K.XG0+YJ+BWJ1&=V=S,.+9KX [L,8J.-6F0<4G4KDSVT\C_,.
M,'H#P_4BOH42 \3=5*RDJ -),:ST1(+/ [PWYF[MFED=LJY[;F=Y#'\\CW'1
M_7-NEZ&&;[>WXL%5';I)[Z'@?'$>%[6WLSVV[\YZRS7VXP)^]N/U-+VPW?GK
M6?-U9#\.J_) 3;P^?/+ 60VA/39XX L.T_S3S['MC8L]=O&&.J=J)%AGB]K-
MXKMF$4'UM6!;Y;GQ;6U=/:L7WP>T:6@5DS3A972+;3)>?V8R(:[WZ;NX>!L!
M%GL6/^3^'#@A/;":R9J2__UN%\L6#*8X=#;=6G R<=\V\[-/L;U823!8V W%
M)A/UH7;KIC*3"?F^'\'Q_<SZ7C%E37QSD._2C-UKG:RAGRR\>I#P-Y^<1J"U
MYPNV_BLP]1??W\Q3TU[TT\%6$0>4G43H5[:=@U?2O8_MQW/XRS9![WN^B'#9
MGFCFJYGV'> %9&M:@.QEG#<7]3S_]KII\U/+10_=:7INN]KG1^K9$A3R[1H'
MTK^X($7@'#9Z-I>:1-#7MF[_V\Z6\?=HNV6[,JZVR;FQ4#DQ7W6+^B+/_5=_
M[4ZZ+O9+ )<&%4RMZR+A=/XA^F7; L*9(4/GZ@*O+@?9:Q@Q<U_;V9MYMVA[
M/?CIW"[^B&V>5B[%/5E<%1X#TMB7E8/EH7/T@RHIUXR\P!F6LWB:@&X-0#^K
MURH1G*6L6?+:V*SI>AKVBP(=Z,X[JWH!Y#YKVOI?,?Q1+\[K>3:N9VP,/L6E
M*P?\,/4^H.@D(O^C:<+7>C;[U-H0W]F+F+74Z>(\MF_F"SL_RT;E2GMM:\'#
M:SIP@_JU;% RM[\?R..]O^C0<,SG2SL[N6C D_A7/_A>??N<5UGVC\? -QT8
MD,LG/S2S&7@!7VT;]@[%]G<<&(1AVFO7^B9IW&IU\Y/]MEWN.QZ=6J2!%+J_
MQ"0"GK9G=KX>C-!UO2%ZFMZWL8-Y:)#K/+R&21H 9D/VVWW_"%@)[]MF#A_]
M,*=E6.F)!)_9U9;+XCL,GWEG_:#MXFWEB@H[D-0#BT\B^L=XECOSI5W8;6+>
M\>C4(EU;9SJ=KW<OYF?K![(RO6D6?VKR-L[KMKGXL=,QL \F?>G4,#W4%QM0
M=&J1ATV@]Q:81KQ%X_\\;V8AMMTKL$VW[T[=7Z*0@ _N^<$U%&K Q^7%A6V_
M9P>W6[2U[W<LX2$89N]CVP_$?B,>JAD\E/?YDD(P#!P.6\I-(^PE>!_KLWF=
M:F]OF 3-K!X2;?2P6@[8D*$DVZ6R S9KO_TTN+^\G?GEK)\4W\+OZ\>SW*,#
M!E?OC-\6<1YR',.T;]VL)J>48G"<WL1";(^^.X  !^B-'</AKH3*(ET*-6O\
MC?&X%J2/[DVV<WTL[K)#9]9^?@;C5#Z+LT5W^4T>N1)AL@X6_L_UU]6UW11@
MS/TVRLRZ./OM*0A1#2U:81Z)2HXAXY1"Q!N-$I<8J21"P!X3C/7-AL]RD'33
MKCMCVI;_+#!09;8,O>IJ>Q]\ 0: 6R[RO/FI>0=V/ PHZ%D0Y>S-?!'! EAL
MP&<_+ZBXMI%$3I!V3J% F $4,4>2.,X=4X"Q&8+B-5*?M/Y)TX)<OSTE3Y]\
MC?79^:+_N*K%MOXGKM\,(E\_\:S+,T"N$0&)+R[+Y^#X*:G2' G.@,*!F/H@
MUE54<AXL84@Y:Q&V-"')(D;88&FE(<YB<NP,.D0G;^79#LB6XDRV!)IY+W*_
M)[:!,;<?K8)@3.NH$/?:(QYE0#(:&(Q61FQA*#K%'Q]?'M99S=XQ*M7S)R'T
M9JB=O;=U>#-_83_7"SN[UH(-7-A>N'+$2NVP0-%3B9PV$OFH(S),>6^- 9CC
M[NR@CY$=DZ!6C"_>+R^6_:IRO]UTC_7\+BY.TR?[;1-Y'E939:,CF&*+!-86
M6>T)2HQ[Y&Q*B4@ RKO=F<0>)9,FA[ 4K3YD;VO^(SSP6LM>QE3[>I/IO+UP
ME90P43$808DG9#B)B!"F$3?.<YZD(V20<W$W>?AC),\DJ)7BR^_UO&E[LVZK
M8W7[T0H[&H+%"7'- N)$1-"PW(!5%YW!A&&!P^.;DHH;N'O M11;KCF4PU8H
M*AE8],8(T)22HI@,12$HBIQ0V)-H4_ C]$49CDSJ1H\#ZP =_V+9YC.6P_I_
M_7!EM3 .2(PT:#H$%KQ'@C")-$O!$1YU8O38?9N=>^K^'M\=GH)F:EYI[=[;
M[UD!7@9'P=?M,H8'T>*A556":>X"AL&$$PPK8DB&AH/Q+A0QFAKJ1LPOQ4FS
M4V?_;*A.C6$I9KVZ^#QKOL>X#JUY$)6VEJTBQ9$S</>(S1.R 9!!-QL4B574
M1DEQL(]HWMD'=Z8 K119>I8_B"+WE*AP2E2D  -"AHBB2A9YZ1G2(AB>8!H7
MZNB]WST38W]0%3-'KAW<S3NNJX6?M]%V\=3-ZC-[8QOZ+A-E4 65-EP*@CUB
MTAGD>#3(V@"SOM4&,VEY2(])BXPS6Z:"K!1IP!F/0.SPR7Z[ADEVZ+8JDVU%
M*^:8#AK&!F,"1A[S&@E  25AE)3):1+$(](JHX@R 5BEW9SO^?#MS-87?3S'
MZD/X/\NNC_%8'_D8X  -J:92PE&NDD36)XWR@C0*#* V1MH8'(#)\+&OJ.W;
M-9H(N%(T>K[LZGGLNA?-A<N'N0' JZ"@/KU''=9AR%<-'J2&1M5;>>P=*.8\
MB4N%#-4*1:P"2DPKHZC"BHZP?,2C(EII) ]E)P^BU?V%*B>%UBHR1+04@#&+
MR&L;P<I4&D!(R<01NX[R47%FKS"5#$C8$IIX3VS"/:4J;H(45L++..?($:.1
M"12F<(_!]W#$A<0>D:FS_Q7=_8)7;*'OQ@'GNY;O^@<JK%V,&AL4J8J(9S,N
M6!J0"((:KJ/C:I"Y,F4K!JQ%7G^N"@[:!(,4I< 9DD001(P(" M&%=764R*/
M?:%QE^ZYO;@X$I1B.LUVY[T'VIWGX?K%SOJQMGAAV_8[C+6MD5=#RE?1"\X3
MC$WCE4.$*8\BS[_:R)6G3(GD'P<I=NK1VTIM(LQ*[V/D\[(@?4XX%A?#]RSN
M*E:!XM:*)XNX #R%XA)Y0RPXLR8H"R,M*77LJT/[8\B>H2I%C/=M_&SKL'8J
MMS/BSN<K[D,D$=J'E=4HQ-"O9E!$??3.,OC"IF,WBO9'A7UA5(H#;^;=LNV/
MA\3%8K8Z.O^#QMLY,:A\%9*6,F"!L 0G06IBP MA!"F%B0H,8#4CK(PR"SW[
MX\A4F!7UM(>:FS\_7*4 GD5D&#DK-<(Y=L@Z#RW#6FA'2(CBZ%=C]L>&O0!4
M;LIH/L=V\?W]S*X2;H)!]#D3&":\C3/'_<4JJ:/R#)IGG Y(\Q01L\*C((TG
M(J2H[(@ F9*VQ"@79,\8E9M 0DSU'.!Y6W^)X4<RH8V3QCUE*E!J049H'<]\
MYYHIL)A$0HES3H(U*=@1GD=)8V(4%_8)4"DB7*:3VM#OEX]405&&-8LH*0OZ
M,FB#\H$$Q*A-UF*"@QZQN5S2'AC5S2/P*-6KKW^P\'96L,TJ?W/!*F\4<!<)
M\DE3% 6&R=)[A9*5Q/"DM!NVEG9X&V 4 _:.T@%LP.$;+;>?KZ($Q4; $0+R
M&^1" .<(X(27,JTLCIJ..2=:9H]E#RS8%S@_.O]OSV[C\A9^/V2^@0W7TQ3/
MB/"0BV4*9D:X>Z'Q?6SK!K2#;W.\T<NX^O_!:[QW5U,1S&U2A".F*3B801G$
M\N8/%@;\3\_ !1TT$T^#2%Y&@V: :?REACYX_OV?75:45VG/3ORB_K+M3,;P
M2BJCA&7).J02!S2(S$LT3H!8SA&NC&%DQ%I6F87OZ;J_*8AK08<VU8OKV6+N
M=E_7#U486ZY$P,C$P)'PEB,=0>L3S1)A%EO+CWZ_;*J.^]FAW1VU<I&1G]OH
M5[D2X?,LKE.A7D]TO#$Z<GOQRF%PV32&F=LJ\-D<"QE)A63DA'MI"64CUKO*
M+' 4XLQ$>!;;:KLFYFE:7Y<P/WO1=)OC"S84JXRE/''A$8D&0)2 J4J"(BUB
M8)XKZLB(Y;$R2R*%V+-G'+>SYN<,=?F;JF]GOO8W->W+9ND6:3F[W".TE^>6
M9F!T]G<BW$&,'6JI@A;2)AZ1)T$@DG!"08+C@+T4(GDO0QS!DS)K*A/SI RL
MQ1;<;#WO\O0:N]/YJV\9GV7=G:^N%[M^Z]]=*W';RE;.$R&\UZ!5(T$B6H6"
MIAP9;TCP6%#)1A@ZUQ9HT./ETY1HECX:<I6[?KUU_3S.8]J8,F-+R<K G,PE
MO-1H$Y#!42/"< XXI2FO<S)L1IQ_+[.X4\SLV3>4Y>AS>>-I'@1Y#)S.?WRW
M>8EX:]DJ2!Z\UA;<4\F0CU$BP@E&V#K,#8T^B!%*2/U22F@*-(_OU,A)VUKX
M=G5IU'G^^&8.9M]R?:7FQF,,9 ,7"TE06<FP#UX@2U5"6/" .-8&^20B#&;/
M?1AQL%__2DKQ>+NDU+#H<[X_M_WJ]46>$+8M1]Q=H.*,<JV#1E1[BT0.(9#*
M@/]L7"04&Z'<B".:YE<BW=X0++H1EW>-\GKOUN.9=SQ=Q4"\"I'E@QD!*>8E
MDA1F"9U43@ &YJD;<:J%X%^)'OO!KUQLSLWE?M"*/T4J;PS3V5Z\2BD2DP_S
M2)(T<E%:^$0(XC1)+C3F$H])W4I^*1MM(D0/QZ=^//Q :=M!JF$55$%[;"GA
M"#L<$$G9;];2H1A$]):#$R3&;,/17YQ3>\+T\%KJ1ZJGG[,\[:2W-E58:8V3
MR9Y1")H@13E&G!.-O$G$69Z"8",._))?:J6]&,3'HMIV9=Z]M53*@B0Q.A2X
MHJ#<X0=--B"CHN+&RN3\F+R O\2"?1E<2W'L'K#>S+_$;FPTRQV55*#1I6("
MHWSR'XG "8K,400#+2I+3"1CSEF4V7<^=#3+?G#=>2?QCZ;],^]@KC)._4@$
M,XPS#ZVB>JTYT\_Y:\$H%?BU/N$OJ5"2*OGR1+/CO[-CJDYLBN!9+.;)?E_=
M5-^L+SF_]^C)IIBHP954QI"@300]+'(B3BP)2@)<&RVM]X8DHN1^]- !K/E]
M4:L(K >>Z*X",L9,='=44F$M"4_8(\\L3/G>4*0\"<B"<Q,BT0#[B,,$90SW
M0T]T^\&U%,,^Q,_K@7*:KF=GW,"G^XI4!OO0'[E)C BDM$XH*!B]6%CPD*6*
M;,P^]6$7L$;WZD\7/NP-Q((1OC[&T-^!_:;KECFL9S!IMA>NH'41!\90M"XA
MZKA$%BH".'$D@5+CU-&G^2_$GDG0+&TUK2)Z;D;Y; OPW%H6VNTC]X!H(,:C
MX&V^CX5Z)+7V)&$96=Q/;N9?0 E-@>8AM-%E.UXW;;^<\3#[Z($U5:"".0D
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MG,I3-ZO/5D$J5_FV5LF KG7)P&&P2]45ITRK2 U23(#]@VV.-B$:64*AH[6
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M-DF!5P<N7>32L'#TT9XE>7D0R(^*K"N'MNNGP&RY?(Q^^R+JR)HK801C%-P
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MPO.Q/IO7J?;VQFS0S&I?'Y\\Y3MJD%@#X%K;IOF'LUW\^W_\/U!+ P04
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M[*41#I#M,]2NXHTX/\&KM(X%WP4LXR1)7UX=-%[\.Z <4HH'2*AT]UQAWJ*
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M&2N@A<)2PA2JX&!$#_E*9;/SNRY%7N>$[C+ 7MK)C'!6B&T9"1QX\LQS6<U
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MUH8).!H#V0%'QT"+5VKZ.2[H2HY/7VQM",A06^B6OK/V\X-6"53$8:L\\5Y
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M3#IOJC-F(QUL'I8YWM%GCW??8V ^KL;><Z'N8N@.O%@EOQLA(5I$CP5 39Q
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M),Q4 $D-ARPH?%$:ST!J\5V!J^ZP',H>?T+JV82&9]LGQ'FIJ>(<80 5DX1
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M[RZY7Z<+ZD<1_W#7<>+00RX.(QCWQEA@.XO-;@0YV:4&FI#I3)L3XYE8CSJ
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M:&U;$GGB'8]]]:58=YNA;I-J0[;I0U'>)B^UZ>+A<UI^S99I=5L67[-5NEI
M/_2)[X4(>I['/#ND9+=UP/<]\=5\ [8-*](.,7AN(%^ 9PX:K/@(SF'SOS2X
M0?$ J@XY>.Z@2V1()F(BD'Y.' XYL=M'XK:+1(T7D"X2M_M(]*#![3PB(9'
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M;).E!X6L_:UH5KV0%C(<NSX-[8#ZCMTB<EEH"S^4:A*"N3ZX1WVTJ[^>#W3
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MR&+8<0+L.;@WCOQ Z@X=328-YP@-RGJ'[1ZG7$*@BUDQJ9J 5#G9>H//BU;
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MJ-/WOGB,PIR<?BB1ID%#3E%Q0D8&,S>]D@QWH=#8DF3S#Y:MTQ)S"X]%^;)
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MGO7C9OA75<9Y:O8\Q2^[#,O%<6R'<1!Y$,(00\>W=G;#@$H]5SK<FNF=1CN
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MYFVJNZ*;RO<8TNHO95%5BPC:H8=MXJ+0"PBR/+PS2U!D2Y4-!QLSK%<XJ;Z
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M8N[S/Q:$$ =%&#,7680@QV&8,>P3SZ*$>J'4)2":3!I.*3__\O$C^O1W<,/
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M? = \IS5'2E-JO1@5^5^-P!RO+J<R4(W#F-B(^C WJH;0ZE;AH?:,IP^=?!
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M/@X@77U\&H=O+2/413-$[<:K>I3:0097D\=@^"@U3BP&C%-:8S)HF#I)E>1
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M"/7.HPO0^ 1JI\#E#Q'?@:/G/.*L>9 U&&_U,5F9:9FAVWPX9SK"C^#X>XG
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M97EM=_?NUD,&I:1L3J=(#<FTR_WK%^ M4Y>D ! @Z=J)F2E9ESS?^0[P 3@
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M[]Y=@<\?$2;@/?J=?+H"Z#T&UY__1CZ"M^\_H_>_O8W?$8 ^?2*?/\F)D^Y
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M=T7VA7^*F$AK,BHD!%$G!.?XA/6@A??K#<<';L\ 2IX?UD2QF/ NR:W:;MH
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MQ\7!&9Y.7G_\#;U_^W_1Y[?7[P%ZCT&,/KW]!*XI^/"1?"+O/[<_D9MJ+A_
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M"*GOP @S1'Y$:&(-X")B4RG!70:2825.ROM[-O>I6Y3@D-TUH!I< $W)_C%
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M>^5"C=V,XK93W5V ,+4C[$8)]L(H#*%#AC0@M!"6>J9*KV7#6MNMZ-Z\]I+
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M<EZ$J6\:;*NX-KX=Y9]'X]'\>PV9ZC;1B@BV^#P_U,>G95KKQ%.=OBOF;XL
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M>C$;38K9S)0/G^,1<>R,^ARLI>"+5IT:1UC^_G/H0%:G6F:EDA8XI(QS$@@
MM&+>4$L@,-A(_US8<0RF+Z=KB#N7UHYFU^,RGC%\"K#K\-T_CY-[2P.9D91P
M8C66PD#&A &.5@@P;$@=!)[23$VO?RJGP?S[^\_PYY_"W]P6T^EZA=MS/V!)
ML_F3N>)+F/"FP7S\^\^HZD(^O7[%W.>MK$O\^F49!OO+]?UHO D?C'<GVF!&
MV0'L0:YJ7/^Z=6"W.^3W.V!G/@4H[@!3G!(A #8H_*NQ)51XH[27%/<W!3P>
MK58"/%6*_O[D3TLG:P\"QS:5!<$U-0@"[;$SP .+1(6*A1CU-2WT,!/4)DC9
M*>:/<T+++%Q\GA7_N0@HNJ\QUB-\7'T;S?:1;7N-3$MLA KH8<DMMEX8I2KY
M#&;FLCC5GOI?\JP1N'NDDRT?\M'D.$*MZF380>J5$E@IQAU#BB.[EM$XQN6%
M42I5TX>9<Q*N/7'G]^+A<S&MSYM5^<Q2[[DW !$"F6;:4T$KV9!4^N(Y<ZR.
M][/F)%2[8LSFSNCR5LGH9GWZI;_76,8.ULV"): AUTP0*24W$E&PD9DS5\MT
MW,$D-$ F=;6@-0U\SV2KM<0=K)M!@3$A&FFH(9* 2.(VPU53>&'35H,<J,>N
MDY$^S*[71QCQ)]G[,OC-\U$^CA<$RL5<S8-S/8F'R>7MQR_%=3S:>'+V9Z:C
M /LH%(GTV[GV-=5T9K$+0'KDO; <4"@D$QL4B*JU-7;V?#N%%66OBNB%CKP]
M.JZ;SAPSUAJ*A/0PZ !(J_T&!0C99:VU Z3C:8IHC([',6S=5PJ1<\));$-7
M/9,&<5[U-?A(+H$T^(<ES4G8GLP#-9LM'HH;=7.SM"SS\:.4[Q?3Z_M\5KR?
MCJZ+9_>S]E'EY 8S"8*;S87U4'I,!6)<N4IB["A/8!/Y8=C4%?Q=&?U;?*$#
M?N6.&ADF@E)O-0,,!.=96T4V\H6%/N4D;H"356?>9#-P]TFGU26DPS[DP;I9
M,!\),F'8&N@"E#ZX3ILYFPG9VV%ONZ<Z)VN^!I-2\#UY3?R]N!G-KO/)_H7N
M>:D,: $ MY8[)!2Q4"H*-_YRZ.CEZ_Y$795-89JD[^M\_'&>W]Z&I?)=,?^K
MG/YY6/N[ZF0.6\2"1XF U0I!;,,27O5;6B<NRYEJD0L-(=SCZO(V_.#-O'@X
MTF+95,NL-,I)8\/,J14-'H$G9",I\BG[D@.TBOLT6T[%O"MVO<^_KRZ_E^OA
M5<E0S'Z;/DF$N85AAZIF0D).#+18<<*L L1L)+9*P,NW7$Y0?MDJQB>O9EN"
M;9Y[F/%^X4H=,>'CL[][5]R5\U'^)"O@RW6OF=8SR! A#B$!L*1(*1%F[PH+
MJ&6*KW\>*^3I?.M/#5TOHS6$6]V!>C,).BQF\]F;V6Q1W*C)3?S-@9B]!K^2
M(8"0%]&4"19.4"C60E8X&LE2%ND![BVT,GWVIXX>K<.MDEQ-*T'>+:*Q>W6[
MNI>X^MOC[,@3/I )#V$$$)$P*1 DI?2F0D\SFK*K/T"+LU4R=ZJ))BT&-PL8
M_F6++V7H_8=B7*S>%JAK$FRKGA'FE!.&,F(I!PA;&:SUM33>\Y0UGUXXKUK$
MN=]%?=L1B)J&J?YNE6'D0_S=U>W58AZSOLR6B<#^=71W?_2Z?NJ',NL-P,%,
M,CC82%Y1(QY-)(1D2E0UNW#6#D(CP^/WJ[3E223>M)8IYZ"UVD-G3+#E@TK$
M9K7@-(FI_+^8VA#L76\6^7+Z?EI\'96+ITC5V"K:7C&S6'(=UA& @\_H!1)T
M<UO'0NY3C$/Q@Y"L481;VR:R:TVLKL:?NAWTO)7,<T"1!G'7WS-IK2#0/#IF
MW":P1UXX>]J'>W@KY5-SP-S'W[Z9J(=XJ7:9VW_OO P;-Q&/[D$63!,$!)#"
M*D=A&-5<53'48<6 *72'H#;?]V16&33CAZVM'NZ,UWZOK<,KXWOZ]'@OO\8=
M\J/:R:3PFAL1YC.'.)).*<27U_L!PU[6B^7J$8\Z^26.:RC3VG@M#0YV@] L
M3/L*N0H1HT%O%\H[R#/1$G5>W6MI41_]3":'7U/L<")9[8_6F"F>%\R@(8Q"
M08,:D5.02V3\"FB*K$"U+BZT-A6\1#B^0E1S\.^MFCDA52 K)(@$-P$@KK6N
MI*8:]'9[J(/A?JK^7X_G)B$>S@CN.XG,J0-90N@]#H2@$' N( C6HG&60DP5
M<ZK6]E4[$JGKZ\7#8IFA>9FZ?0?PP9\O1G<3LP@C9W*]RN,\7HVNF_]8S)9K
MQ[LBF**?\F][8&GA:QG4EE*F,50T$)EIC1!88ZMC0H-.IHNM?DCW$T9MGI5#
MTTM7#GJJ>/OYW4#K&1024NVUH4(;Y3G "E>X05UOKCB?\*&&"-P]\+TLBB<^
M5MWA"KEYD/?J=O/:U_MR'3E]>-VL4STCE'N@'3,<NZ L [TU&JE &T2%-+#'
MU73UU,UA.9\7S!Q32@E#-6'!3],\,$]5$DG0WX7Y#E:P9C7^<EU+@;FK)6G5
MR=7T-*_-G1?E,XJQDLP90T"01S&")*ID8X)><C+.4[6\E2QIN':6+R:?W<>M
MFO!+7$&_YN/EYLW<Y-/I]]'D;AE1L,\)KU,_,T10!Q'C0!@>ET<1%L)*=@8O
M>5I*),-+A[P%N#N;GE;Y\6?QN:30\QC/5\S7P.QW]796R[A65#J.A7-""PJ$
MX*22%!K16_:KLR-6@RAW%KTQ+;[DHYOUZW^'B;2U?)0-6"NATAY2AZE$; ,8
M8##%ZT^*2C\[!C4!;U?4>3.9+:9+;Z>8S\?K4+H-\P]3J5;]3+H@.6-2 TJ8
MQ$81L1DV%L"4XZ:D&/&SHU8;<'>Z3_0,CD/;/L\*9Y)0Y;5QGANEH9?&>+>6
MBH71E$*BI(#PLR-1,K:]N'%UW;?,"QFF64R5EH18C% 8!Y4LD'+0:0CVD[=+
MSHXG*;!V9_J47XKI_/O[<7QW:K*\[/5EO6F^UP+:72UC3$%*'+'$>\E]<" T
MJR0-!M_EF]+)?G^#\'9%I.KIY3VDJ8ID'@%IG<>60Q2<@""%$I4$!(!:NZ5-
M6<I?B^GG\@PI<B*8W=G%-\7M:#*:%V]'7XN;QP>Y]]K".^ID80V5DG#.J*5>
M$V HW\CHN4Q9DHZV?Y\39M <:0K0KDCC'_OZ\KWV_<O1_HH9!%9J[AC$#@>A
M#1:.5M): U+NBP_P*F1#Y&D4TQY\I'?EY/H8-^FQ?(8<#A8>MT$09UPPYC'"
ME6R2@)3D8DF7$,]G=6H"UVZ]I(/N4>:YY]8!S(23""KGE:GVPIGF(F5_[_@+
M?WWX10T=9QT)9%<T>)*B-5C<KU]^KG$,6K>)S $')5580(AM@ %R41T>,R9E
MB@$\= ^IU</UEA30 P7KG[WOKI1)1(DW"$-,O'368$WLQC4P]I)O*33/A-U4
M2X.]ZT/3]_GWN-<=4%DMTM?7TT70X2MQ:ARDUFTJ$]998;B*F?8Q<H0*6FVH
M,R>2DD&?$1%/YLF.$]:6X.^*D.[AR[C\7A0?BF64[U$,/%@WYEH#7B-$+/?>
M>*D%V\B,!4X)%!GZ$ML"Y9K&NU-_\"AF[:B142XX (I#;8SCF!M*9"6?8OWE
MG#M//C6#<G]VV5'V6.89D$@)KXB#GLLPY2*].1V$+&4N.O[XOEO/L07N) /<
M&6W*R=VG8OI@B\_S9:C=EU'$/F8-N_H\'MVM7F;>1Z5:#60,*8F"Y2J%IE!)
M0SFLW'$F-$Z9FLYHJ6O)S&]#!5T1L,I/\BG_]@2H6ANCAZK&]5X#S8&V$(5?
MG42X I0SB3L]PVM_3[UUGC6,=]<KXW=?3LTX'STL;^NO?K.YR;0.Y*NQ9M9I
M)B/(*Z89C+GH/%+.X,UDSP%3*<P;>C!<9[L:+2AB>/F.-L+6FA&3VLV0#VX1
M"QH)_]<<(615%4/$!1*]!=^=*4^[5$9?OFK] \SM*X9W&%,,A>/A7QB'*'>;
M%0-R>L&GF*WSKS'8>W!AZ_FN&=4>6<2#=T88--8BBJM!8CBREWS<V>7AP9$X
M=W:;[W#RL^.R:,7[&YI AX$4WG(EO955P(@)0R8EABLIE>DE\*DYW+OBUTGG
MZWN00Q"0(!,+@XDKIRV57FVD]")EL4M*=7H)[&H,]BXGKW*R[/;!6\<OBF;
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MFL+'I*W4L^%C+WH8RL63A LGF=!(&^(8@$HY!I6SJ#();)CE.WH2Y?)W\9M
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M'10/&U%/ITDF8GAD?/?S8%Z>+:4S;PW&V D7P!(JOHS$Z690^:1SSZ2;MC\
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M- YZ#T<I+I_&MW]G+[.&='XB_[(C-<[D=U7)D/-" R^Y II*#SVQ*]0A$4;
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MG*40"P2AK'5@:C>2?BI_/!GWO)J%OUZLN^4^S\U-S(\_S)Y>,9U=3._#9'.
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M_$/\$:O=__F/_P-02P$"% ,4    " "XC*1*"VMJV:GV   T^@T $0
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64$L%!@     &  8 B@$  'EQ @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
